data_1hk6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hk6 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.576 0.226 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.98 144.79 99.43 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.521 2.147 . . . . 0.0 111.888 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.506 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 54.2 Cg_exo -51.41 118.47 4.39 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.317 2.011 . . . . 0.0 112.4 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.5 tp -99.41 131.27 45.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 85.1 t -116.6 135.91 55.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.672 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -168.82 52.47 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.098 0.475 . . . . 0.0 111.34 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.93 143.53 8.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.579 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.539 HG12 ' HD2' ' A' ' 15' ' ' PRO . 12.7 tt -161.36 131.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.564 0.221 . . . . 0.0 110.782 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.678 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 43.8 t -62.3 -60.23 10.65 Favored Pre-proline 0 CA--C 1.531 0.218 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.132 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 84.8 Cg_endo -79.71 -160.14 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.875 1.717 . . . . 0.0 111.742 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -173.22 21.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.761 0.315 . . . . 0.0 110.967 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 177.78 127.45 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.3 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.09 153.03 7.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.886 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.405 ' N ' ' HG1' ' A' ' 22' ' ' THR . 34.7 pt -53.92 159.65 2.65 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.435 0.16 . . . . 0.0 110.922 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.673 ' O ' HG21 ' A' ' 64' ' ' VAL . 75.8 Cg_exo -51.41 -40.75 61.94 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.64 2.227 . . . . 0.0 113.392 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.486 ' HE3' HH11 ' A' ' 63' ' ' ARG . 78.6 m95 -69.56 -5.35 23.79 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.405 ' HG1' ' N ' ' A' ' 19' ' ' ILE . 94.0 m -66.96 132.23 47.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 111.314 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -70.31 138.74 51.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.69 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.539 ' O ' HG21 ' A' ' 24' ' ' VAL . 35.2 m -145.9 128.55 9.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.96 0.409 . . . . 0.0 111.06 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.583 HG23 ' HE ' ' A' ' 27' ' ' ARG . 84.3 m -87.13 120.99 28.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.474 HG21 ' N ' ' A' ' 27' ' ' ARG . 62.8 mt -79.79 139.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.115 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.583 ' HE ' HG23 ' A' ' 25' ' ' THR . 19.2 mmt85 -137.33 134.74 36.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.33 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.05 -136.25 2.24 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.871 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -152.16 134.42 15.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.972 0.415 . . . . 0.0 111.497 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 60.63 42.0 14.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.603 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 9.1 mp -83.85 50.47 1.82 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 110.399 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.48 126.56 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.31 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.9 p -94.97 43.51 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 0.0 111.252 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.41 142.74 4.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.707 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.2 -42.26 58.6 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.595 2.196 . . . . 0.0 112.044 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.3 p -62.96 -38.68 92.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.955 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -56.56 -37.33 70.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.976 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.491 HD22 HD21 ' A' ' 41' ' ' LEU . 1.4 tt -75.46 62.8 1.4 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.466 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 40' ' ' GLY . 35.9 pt -69.25 -41.24 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.495 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.443 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -110.41 137.87 14.54 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.957 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.503 ' O ' HG21 ' A' ' 42' ' ' THR . 2.3 tm? -149.05 128.96 13.4 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.503 HG21 ' O ' ' A' ' 41' ' ' LEU . 12.2 p -152.08 138.41 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.148 0.499 . . . . 0.0 111.864 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.445 HD12 ' SG ' ' A' ' 62' ' ' CYS . 71.4 mt -127.53 127.36 68.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.364 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 71.2 m 58.14 36.03 25.55 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.24 -26.71 1.81 Allowed Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.768 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -76.3 135.06 39.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.786 0.327 . . . . 0.0 111.337 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.551 HD21 ' H ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -73.23 136.22 44.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.659 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.551 ' H ' HD21 ' A' ' 47' ' ' ASN . 72.7 m -152.47 41.87 0.63 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.728 0.299 . . . . 0.0 111.292 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.3 tp -71.38 -43.16 67.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.124 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.31 -41.92 51.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.605 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.4 p -80.3 -36.51 34.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.379 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.89 133.66 55.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.712 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -126.9 130.94 51.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.615 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -70.59 146.5 50.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.056 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.8 mmt -136.36 -52.4 0.72 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.643 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.0 m -160.52 -172.61 3.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.462 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.48 41.67 0.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.205 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 t -175.27 -47.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.753 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.546 ' HZ1' ' HE ' ' A' ' 27' ' ' ARG . 25.0 ttmm -87.8 136.23 33.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.866 0.365 . . . . 0.0 111.638 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -150.51 117.17 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.529 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.5 t -85.04 124.17 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.968 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.8 p -170.93 143.82 2.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 0.0 111.238 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.486 HH11 ' HE3' ' A' ' 21' ' ' TRP . 99.2 mtt180 -84.23 132.51 34.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.331 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 20' ' ' PRO . 16.1 m . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.198 0.523 . . . . 0.0 111.635 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.31 0 CA-C-O 120.457 -0.079 . . . . 0.0 113.159 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -75.5 129.57 37.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.752 0.311 . . . . 0.0 110.94 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 74' ' ' ILE . 65.1 mt -86.6 92.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.996 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.457 HG21 ' N ' ' A' ' 76' ' ' VAL . 47.3 mm -86.52 139.78 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.205 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.457 ' N ' HG21 ' A' ' 75' ' ' ILE . 60.9 t -139.6 113.44 6.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.2 m -81.87 144.28 31.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.496 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.0 p -141.32 134.95 30.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.718 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -59.24 -44.98 92.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.102 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.9 m -61.61 -42.88 99.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.979 0.418 . . . . 0.0 110.068 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.77 -118.15 3.25 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.081 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 -142.42 3.39 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.398 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -70.65 130.98 43.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.873 0.368 . . . . 0.0 110.963 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.48 136.81 15.98 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.67 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.7 p -98.92 140.17 33.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.662 0.268 . . . . 0.0 110.507 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 39.7 t -129.32 128.78 43.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.977 0.418 . . . . 0.0 111.727 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.2 p -75.4 -35.92 60.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.991 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.8 m -85.27 159.41 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.22 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.9 m -146.35 137.13 24.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -86.15 129.01 34.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.427 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HE3' HD23 ' A' ' 93' ' ' LEU . 38.8 ttpt -83.36 117.92 23.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.265 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.453 ' CD2' HG22 ' A' ' 64' ' ' VAL . 86.5 mt -83.02 128.46 34.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 111.286 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.426 HD23 ' HE3' ' A' ' 91' ' ' LYS . 80.3 mt -99.62 144.16 29.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.892 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -57.93 139.09 83.06 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo . . . . . 0 C--N 1.348 0.517 0 C-N-CA 122.666 2.244 . . . . 0.0 112.939 -179.633 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 . . . . . 0 CA--C 1.529 0.151 0 CA-C-O 120.567 0.223 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.24 145.56 96.1 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.509 2.139 . . . . 0.0 111.82 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.72 118.71 3.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.401 2.068 . . . . 0.0 112.317 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -98.52 117.79 33.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.646 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 58.8 t -96.1 139.52 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.908 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 t -171.05 48.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 111.205 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.74 139.32 5.59 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.027 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.453 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 15.6 tt -165.03 132.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.75 0.31 . . . . 0.0 110.629 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.796 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.9 t -68.41 -59.35 6.06 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.135 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.796 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 68.1 Cg_endo -92.94 121.98 0.48 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.247 1.965 . . . . 0.0 112.961 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -96.71 29.62 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.528 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 179.73 132.24 0.09 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.395 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.483 ' O ' HD13 ' A' ' 92' ' ' LEU . . . 171.92 143.38 4.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.095 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.537 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 35.2 pt -59.14 165.06 3.91 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 120.38 0.134 . . . . 0.0 111.083 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 19' ' ' ILE . 95.7 Cg_exo -46.27 -41.89 22.16 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.927 2.418 . . . . 0.0 113.61 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -77.22 -17.42 58.49 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.402 ' OG1' HG12 ' A' ' 19' ' ' ILE . 80.9 m -56.89 131.48 49.71 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.68 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -73.63 139.84 45.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.566 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.731 HG23 HG11 ' A' ' 64' ' ' VAL . 35.0 m -139.55 128.25 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 111.075 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.6 m -89.2 118.3 28.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.55 HG23 HD22 ' A' ' 31' ' ' LEU . 62.1 mt -85.74 138.98 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.425 ' N ' HG21 ' A' ' 26' ' ' ILE . 97.7 mtt180 -143.16 137.34 28.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.82 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -172.98 -129.32 1.14 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.722 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -146.75 136.37 23.03 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 110.939 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 61.65 40.02 13.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.87 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.55 HD22 HG23 ' A' ' 26' ' ' ILE . 10.7 mp -82.95 50.55 1.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 110.707 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.79 132.5 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.501 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.3 p -60.14 -34.34 73.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.697 0.284 . . . . 0.0 111.037 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 54' ' ' TRP . . . -158.93 -161.43 11.11 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.825 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.86 -43.61 1.67 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.634 2.223 . . . . 0.0 112.7 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.5 p -57.23 -40.92 78.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.287 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.34 -36.77 84.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.0 tp -75.82 62.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.15 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.4 pt -69.16 -36.13 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.114 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -126.71 139.85 11.56 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.781 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.487 ' O ' HG21 ' A' ' 42' ' ' THR . 58.4 tp -150.0 151.78 33.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.683 0.278 . . . . 0.0 110.685 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.487 HG21 ' O ' ' A' ' 41' ' ' LEU . 3.1 p -149.72 141.46 23.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.29 0.567 . . . . 0.0 111.975 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.6 mt -137.83 130.69 41.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.246 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 83.3 m 52.83 30.49 9.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.404 . . . . 0.0 110.101 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.1 -38.66 3.19 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.987 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -86.5 140.5 29.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 117.457 0.628 . . . . 0.0 111.781 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -60.86 145.22 50.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.534 ' O ' ' HB1' ' A' ' 52' ' ' ALA . 81.4 m -149.72 38.03 0.75 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.9 tp -71.57 -47.09 57.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.618 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.599 HD13 HG22 ' A' ' 51' ' ' THR . 3.3 pp -58.49 -34.96 71.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.514 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.599 HG22 HD13 ' A' ' 50' ' ' LEU . 22.0 p -80.45 -38.28 30.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.941 0.4 . . . . 0.0 110.891 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 48' ' ' CYS . . . -68.62 135.5 51.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.168 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -126.77 128.73 47.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.017 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.54 ' CE2' ' HA3' ' A' ' 34' ' ' GLY . 78.6 t90 -61.73 150.08 37.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.914 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.4 mmm -143.12 -44.11 0.29 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.575 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 67.4 m -161.09 160.72 30.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.028 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.76 -30.36 32.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.559 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.9 m -126.21 36.94 4.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.241 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 60.0 tttm -165.02 132.62 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.4 mt -150.43 122.89 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.7 t -82.98 129.45 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.242 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.9 p -170.47 136.67 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 111.569 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 59.3 mtt85 -85.18 138.15 32.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.584 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.731 HG11 HG23 ' A' ' 24' ' ' VAL . 31.7 m . . . . . 0 CA--C 1.533 0.319 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.673 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.296 -0.322 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.85 130.14 42.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.131 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.4 mt -97.42 128.39 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.319 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.82 138.0 49.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.418 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.3 t -124.81 129.1 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.633 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 40' ' ' GLY . 88.0 m -97.71 138.31 35.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.403 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.1 p -135.41 140.32 44.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.155 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.539 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 7.2 mtpm? -56.56 -46.72 80.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.779 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.401 ' HG ' ' N ' ' A' ' 81' ' ' GLY . 79.7 p -65.56 -53.59 39.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.092 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.401 ' N ' ' HG ' ' A' ' 80' ' ' SER . . . -88.52 -124.41 2.24 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.099 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.7 -142.71 3.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.088 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.57 ' HB3' ' NZ ' ' A' ' 83' ' ' LYS . 5.9 ttpm? -71.53 123.29 22.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.715 0.293 . . . . 0.0 110.514 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.91 -160.55 36.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.746 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.0 p -154.97 -169.84 3.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.68 0.276 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.62 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 41.0 t -170.99 127.81 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.916 0.389 . . . . 0.0 111.318 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 82.5 p -72.53 -34.05 67.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.14 0.495 . . . . 0.0 110.084 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.458 HG21 ' OG ' ' A' ' 86' ' ' SER . 35.3 m -84.9 173.62 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.377 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.8 p -157.41 135.6 11.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.712 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.508 ' CD2' HG12 ' A' ' 64' ' ' VAL . 53.4 t80 -85.4 127.03 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.184 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.64 ' HZ2' ' HB3' ' A' ' 91' ' ' LYS . 5.7 ttpm? -83.88 119.86 25.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.952 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 20' ' ' PRO . 26.6 tp -85.19 131.14 34.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.244 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.63 136.28 35.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.777 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -63.49 137.92 97.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 C--N 1.346 0.439 0 C-N-CA 122.493 2.129 . . . . 0.0 112.421 -179.955 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.53 0.205 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.23 144.03 82.98 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.656 2.237 . . . . 0.0 112.473 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.573 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 14.4 Cg_endo -57.34 141.32 94.74 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.744 2.296 . . . . 0.0 112.196 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.562 HD21 HG21 ' A' ' 11' ' ' THR . 4.4 tt -141.0 121.9 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 0.0 110.435 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.496 ' HA ' ' HA2' ' A' ' 28' ' ' GLY . 98.5 t -84.61 134.61 26.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.712 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.562 HG21 HD21 ' A' ' 9' ' ' LEU . 34.3 p -153.7 47.26 0.64 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.862 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.95 143.22 6.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.854 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.502 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 14.5 tt -160.53 130.35 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.713 0.292 . . . . 0.0 110.448 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.798 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 52.0 m -63.95 -59.55 11.07 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.155 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.798 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 91.4 Cg_endo -89.56 128.06 1.7 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.232 1.955 . . . . 0.0 112.69 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.3 25.05 11.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 0.0 110.242 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 177.57 131.3 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.547 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.25 149.56 5.82 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.445 -0.884 . . . . 0.0 112.8 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 93' ' ' LEU . 35.3 pt -57.16 157.48 11.75 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.437 0.161 . . . . 0.0 110.868 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.561 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 85.8 Cg_exo -48.69 -39.88 38.26 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.874 2.382 . . . . 0.0 113.576 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.91 -20.49 61.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.9 m -56.75 131.41 49.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 111.144 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -65.98 135.94 55.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.426 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.573 HG13 ' HG2' ' A' ' 15' ' ' PRO . 33.4 m -134.36 129.42 53.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.39 . . . . 0.0 111.216 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.4 m -85.58 122.78 30.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.011 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 63.8 mt -83.3 137.42 20.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.028 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.455 ' O ' HG11 ' A' ' 10' ' ' VAL . 44.5 mmm-85 -143.89 133.37 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.668 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -169.13 -134.45 1.73 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.527 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 67.8 mm-40 -142.96 128.64 19.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.391 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.573 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 63.7 m-80 52.63 41.47 31.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.139 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.489 HD22 HG23 ' A' ' 26' ' ' ILE . 10.0 mp -60.11 -39.47 86.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.745 0.307 . . . . 0.0 111.047 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.02 132.15 1.97 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.647 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.8 p -64.68 -36.42 84.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 0.0 111.212 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.34 174.52 37.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.424 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.49 -43.46 55.19 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.427 2.085 . . . . 0.0 112.087 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -61.04 -40.88 95.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.014 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 64.7 t0 -59.06 -48.66 80.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.663 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.694 HD13 HD12 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -71.18 128.31 35.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.962 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.534 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 38.4 pt -143.57 -39.94 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.945 0.402 . . . . 0.0 110.673 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.443 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -105.49 133.33 11.53 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.482 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.0 tp -150.25 149.39 30.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.689 0.28 . . . . 0.0 110.337 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.2 m -159.41 140.34 12.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 111.508 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.08 126.53 37.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.337 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.425 ' HA ' ' HA3' ' A' ' 72' ' ' GLY . 77.4 m 54.82 38.98 31.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.992 0.425 . . . . 0.0 110.545 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.35 27.99 71.61 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.427 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -131.0 132.91 45.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.685 0.279 . . . . 0.0 110.824 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.481 HD21 ' H ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -67.03 133.5 50.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.705 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.481 ' H ' HD21 ' A' ' 47' ' ' ASN . 74.4 m -152.18 40.03 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.96 0.409 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 3.3 tm? -81.52 -43.29 18.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.874 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -53.59 -38.75 64.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.818 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.9 p -79.88 -37.43 34.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.699 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.529 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.34 135.74 57.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.974 0.416 . . . . 0.0 112.025 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -126.45 132.35 51.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.359 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -66.29 151.78 46.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.412 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.486 ' HE2' HG13 ' A' ' 61' ' ' VAL . 55.0 mtt -149.83 -42.77 0.13 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.76 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 58' ' ' SER . 86.9 p -169.13 169.65 9.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.533 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.83 34.39 0.1 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.529 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 56' ' ' SER . 78.4 p -177.99 30.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.911 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.6 ttmt -165.04 130.12 2.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.791 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.694 HD12 HD13 ' A' ' 38' ' ' LEU . 72.3 mt -150.67 122.56 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.0 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.486 HG13 ' HE2' ' A' ' 55' ' ' MET . 9.0 p -88.33 132.93 32.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.522 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.529 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 26.7 p -170.89 156.32 4.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.035 0.445 . . . . 0.0 111.4 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.01 134.93 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.2 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.561 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.5 t . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.122 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -61.99 132.14 51.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.37 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.8 mt -85.45 92.5 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.165 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.453 HG21 ' N ' ' A' ' 76' ' ' VAL . 49.9 mm -91.08 145.63 7.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.153 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.453 ' N ' HG21 ' A' ' 75' ' ' ILE . 7.3 p -140.42 128.51 24.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.101 0.477 . . . . 0.0 111.058 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 m -100.63 143.78 30.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.239 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.4 p -130.59 140.76 50.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.583 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 8.0 mtpm? -56.94 -47.99 79.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.248 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 61.4 m -64.75 -54.81 25.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.946 0.403 . . . . 0.0 110.561 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.32 -125.03 1.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.127 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.43 -140.78 3.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.995 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.3 117.76 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.753 0.311 . . . . 0.0 110.375 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.439 ' O ' HG21 ' A' ' 85' ' ' THR . . . -75.65 -149.16 2.32 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.935 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 40.6 p -155.84 150.73 26.33 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.49 0.316 . . . . 0.0 110.392 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -157.26 127.61 6.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.968 0.413 . . . . 0.0 111.175 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.3 p -107.58 40.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.806 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.69 149.1 15.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.352 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 t -140.11 137.36 34.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.691 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -85.25 129.95 34.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.131 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -77.51 125.18 28.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.395 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.558 HD23 HG13 ' A' ' 64' ' ' VAL . 92.3 mt -92.49 124.55 36.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.163 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 19' ' ' ILE . 79.3 mt -89.47 135.25 33.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.641 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 53.3 mtmt -64.21 133.07 95.51 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.056 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 31.8 Cg_exo . . . . . 0 C--N 1.347 0.467 0 C-N-CA 122.538 2.159 . . . . 0.0 112.171 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.474 0.178 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.62 146.29 44.32 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.612 2.208 . . . . 0.0 112.436 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 8.9 Cg_endo -50.62 144.68 24.84 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.982 2.455 . . . . 0.0 112.383 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -141.68 119.95 12.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.208 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.533 ' HA ' ' HA2' ' A' ' 28' ' ' GLY . 92.7 t -77.37 134.66 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.618 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.501 HG21 ' O ' ' A' ' 10' ' ' VAL . 61.3 p -148.0 44.51 1.07 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.206 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.34 145.12 5.65 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.063 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.7 tt -164.57 128.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.64 0.257 . . . . 0.0 110.44 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.815 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 48.0 t -67.14 -60.06 6.56 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.66 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.815 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 68.1 Cg_endo -91.99 114.38 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.149 1.899 . . . . 0.0 112.18 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -92.93 30.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 0.0 110.499 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 178.08 131.21 0.07 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.446 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.8 144.6 4.27 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.067 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 93' ' ' LEU . 41.3 pt -59.42 161.54 10.2 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 121.969 0.107 . . . . 0.0 110.967 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.593 ' HA ' HG12 ' A' ' 64' ' ' VAL . 79.3 Cg_exo -47.92 -37.2 28.79 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.572 2.181 . . . . 0.0 113.036 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.09 -27.87 62.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.8 m -56.5 128.58 36.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 0.0 111.581 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.08 136.86 50.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.544 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 24' ' ' VAL . 29.4 m -135.85 121.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.947 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.543 HG22 ' HZ1' ' A' ' 59' ' ' LYS . 66.6 m -80.85 116.87 21.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.767 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 55.5 mt -77.42 141.22 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.555 HH11 ' HB2' ' A' ' 59' ' ' LYS . 25.8 mmm180 -146.9 131.01 17.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.411 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -170.28 -130.78 1.25 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.638 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -146.52 135.87 22.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 111.244 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.5 m-20 61.87 38.05 14.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.356 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 10.2 mp -84.14 51.01 1.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.951 0.405 . . . . 0.0 110.392 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 57' ' ' ALA . . . 70.87 118.78 0.04 OUTLIER Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.192 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.5 p -90.03 41.52 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 111.365 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.31 151.67 7.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.686 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.78 -43.07 62.72 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.473 2.115 . . . . 0.0 111.724 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.511 ' O ' ' HE2' ' A' ' 79' ' ' LYS . 2.5 t -61.79 -35.51 78.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.597 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.458 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 1.4 m-20 -51.93 -48.85 64.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.454 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.95 127.42 32.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.134 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.424 HG22 ' HD2' ' A' ' 79' ' ' LYS . 36.6 pt -147.26 20.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.094 0.474 . . . . 0.0 110.786 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 176.94 139.34 3.22 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.907 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 75' ' ' ILE . 18.1 tp -149.63 146.38 27.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.885 0.374 . . . . 0.0 111.023 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.44 HG21 ' O ' ' A' ' 41' ' ' LEU . 20.5 p -151.15 134.47 16.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.181 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.503 HD11 ' HA ' ' A' ' 64' ' ' VAL . 64.7 mt -134.51 125.19 46.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.857 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 66.2 m 56.71 36.43 27.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.09 0.471 . . . . 0.0 109.991 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.99 33.69 87.93 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.891 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -130.78 131.27 44.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.713 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.512 HD21 ' N ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -67.7 131.78 46.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.638 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.512 ' N ' HD21 ' A' ' 47' ' ' ASN . 71.8 m -153.09 39.01 0.51 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.88 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 69.3 tp -73.96 -47.07 40.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.286 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -52.3 -40.36 61.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.631 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.6 p -80.35 -33.37 37.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.292 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -52.74 134.4 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.767 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -126.67 130.24 50.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.669 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -71.95 147.43 46.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 96.1 mmm -138.89 -48.37 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 58' ' ' SER . 69.5 m -160.55 -175.03 4.76 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.645 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -78.52 36.23 0.25 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.983 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 31' ' ' LEU . 79.8 p -177.29 -43.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.754 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.555 ' HB2' HH11 ' A' ' 27' ' ' ARG . 24.6 ttmm -84.87 131.25 34.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.047 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.0 mt -149.97 113.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.682 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.2 t -82.81 130.82 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.431 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.4 p -170.41 160.28 7.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.0 111.199 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -83.65 126.17 32.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.805 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 20' ' ' PRO . 2.3 p . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.161 0.505 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.235 0 N-CA-C 112.189 -0.364 . . . . 0.0 112.189 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -74.76 140.19 43.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.838 0.352 . . . . 0.0 111.3 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.459 ' O ' HD12 ' A' ' 75' ' ' ILE . 76.9 mt -85.11 136.89 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.525 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.536 ' O ' HD13 ' A' ' 41' ' ' LEU . 49.8 mm -133.43 139.07 49.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.927 0.394 . . . . 0.0 111.624 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.444 ' N ' HG21 ' A' ' 75' ' ' ILE . 7.4 p -135.35 126.87 45.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.69 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.7 m -96.73 138.8 33.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.712 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 82' ' ' GLY . 56.7 p -151.95 142.4 22.59 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.465 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.651 ' HD3' ' H ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -54.68 -30.49 55.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.665 0.269 . . . . 0.0 111.353 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -61.73 -57.19 12.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.608 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.45 -45.42 0.92 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.719 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 78' ' ' THR . . . 75.35 120.98 0.12 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.866 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.8 tttm 47.82 65.08 1.38 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.821 0.343 . . . . 0.0 111.047 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.419 ' HA2' ' HG2' ' A' ' 8' ' ' PRO . . . -64.88 -138.88 0.02 OUTLIER Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.88 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.6 p -151.06 -168.35 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.887 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.4 p -169.09 129.64 1.12 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 61.8 p -93.62 29.21 2.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.101 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 m -154.57 140.72 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.0 p -120.2 140.52 51.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -89.35 129.95 35.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.621 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -88.33 123.68 33.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.242 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.429 HD22 HG23 ' A' ' 64' ' ' VAL . 93.2 mt -88.02 130.64 34.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.079 0.466 . . . . 0.0 111.974 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 19' ' ' ILE . 84.0 mt -88.69 140.7 29.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.723 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.46 128.03 92.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.651 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 C--N 1.347 0.454 0 C-N-CA 122.511 2.14 . . . . 0.0 112.604 -179.84 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.517 0.198 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -56.99 149.42 62.12 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.632 2.222 . . . . 0.0 112.242 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.469 ' HD3' ' H ' ' A' ' 82' ' ' GLY . 65.6 Cg_exo -51.9 137.09 52.48 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.54 2.16 . . . . 0.0 112.168 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 85' ' ' THR . 3.3 tt -133.78 117.87 17.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.354 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.533 ' HA ' ' HA2' ' A' ' 28' ' ' GLY . 95.2 t -82.17 135.82 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.184 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.455 HG21 ' O ' ' A' ' 10' ' ' VAL . 80.7 p -147.01 41.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.798 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.29 148.49 7.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.713 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.51 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.1 tt -160.36 132.76 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.763 0.315 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.795 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 45.4 t -66.43 -59.9 7.56 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.661 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.795 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 86.4 Cg_endo -89.87 119.01 0.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.041 1.827 . . . . 0.0 112.389 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -77.54 -20.56 53.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.411 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.502 ' OE1' HD12 ' A' ' 93' ' ' LEU . 15.4 pt-20 -157.07 139.88 15.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.03 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.53 147.57 8.58 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.654 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 37.4 pt -55.16 161.91 2.34 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-O 120.547 0.213 . . . . 0.0 111.362 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.618 ' O ' HG21 ' A' ' 64' ' ' VAL . 85.2 Cg_exo -47.52 -46.17 21.21 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.089 2.526 . . . . 0.0 114.097 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -73.11 -8.29 55.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 m -70.04 128.09 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.992 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 28.5 mtpp -75.65 124.02 26.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.549 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.553 HG23 HG12 ' A' ' 64' ' ' VAL . 30.7 m -113.03 121.25 64.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.966 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.5 m -78.4 118.77 20.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.038 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 62.3 mt -80.63 137.07 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.738 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 58' ' ' SER . 28.3 tpt180 -139.28 126.28 21.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.268 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -167.89 -132.91 1.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.613 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -146.96 137.88 23.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.852 0.358 . . . . 0.0 111.325 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.442 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 72.8 m-80 63.84 41.77 6.54 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.369 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.444 HD11 ' N ' ' A' ' 31' ' ' LEU . 8.8 mp -90.08 46.38 1.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.991 0.424 . . . . 0.0 110.265 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.21 120.34 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.185 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.1 p -91.88 42.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.678 0.275 . . . . 0.0 111.195 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.72 147.76 6.13 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.705 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.13 -45.17 42.65 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.519 2.146 . . . . 0.0 111.716 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 t -62.45 -36.59 82.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.158 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -55.55 -46.09 77.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.975 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.83 134.22 52.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.017 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.434 HG13 ' N ' ' A' ' 40' ' ' GLY . 30.2 pt -140.74 -42.5 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.317 . . . . 0.0 111.219 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.434 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -111.17 136.87 13.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.405 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -147.59 127.41 13.49 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.6 p -152.95 142.02 21.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.514 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 43' ' ' ILE . 70.1 mt -137.37 124.76 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.867 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 78.0 m 58.24 38.69 26.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 110.156 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.44 33.35 86.08 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.877 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -131.12 133.46 45.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.771 0.32 . . . . 0.0 110.8 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.501 HD21 ' N ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -66.48 131.29 45.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.468 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.501 ' N ' HD21 ' A' ' 47' ' ' ASN . 74.1 m -151.7 36.58 0.57 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.861 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.9 tp -75.72 -44.74 40.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.731 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.36 -39.33 69.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.9 p -79.93 -38.1 33.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.151 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -61.2 132.72 54.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.39 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -126.5 133.97 51.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.777 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -64.97 147.17 53.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.252 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 93.8 mmm -145.26 -42.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.407 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.752 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 54.7 m -161.59 157.47 24.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.911 0.386 . . . . 0.0 111.099 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 31' ' ' LEU . . . -50.39 -27.57 6.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.419 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.524 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 54.0 m -133.3 42.11 3.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.371 . . . . 0.0 110.719 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.752 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 60.5 tttm -164.5 128.14 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.868 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -149.97 118.07 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.489 ' CG1' ' HE3' ' A' ' 23' ' ' LYS . 50.1 t -84.46 130.46 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.553 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.527 ' O ' HG21 ' A' ' 24' ' ' VAL . 27.4 p -170.07 131.67 1.03 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.791 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 22.3 ptt-85 -84.96 138.32 32.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.873 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.618 HG21 ' O ' ' A' ' 20' ' ' PRO . 21.3 m . . . . . 0 CA--C 1.537 0.463 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.724 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.21 134.87 48.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.686 0.279 . . . . 0.0 111.179 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.2 mt -85.42 134.15 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.474 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.8 mm -132.97 133.98 58.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.145 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.71 ' H ' ' HA2' ' A' ' 84' ' ' GLY . 53.4 t -141.51 114.37 4.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.825 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.405 ' O ' HG21 ' A' ' 78' ' ' THR . 36.0 m -81.0 142.17 33.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.522 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.405 HG21 ' O ' ' A' ' 77' ' ' THR . 72.5 p -141.93 140.19 32.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.86 0.362 . . . . 0.0 111.426 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.3 mmmm -57.02 -50.69 71.96 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.074 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.0 m -65.07 -53.33 47.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.974 0.416 . . . . 0.0 110.346 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.37 -123.33 0.5 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.148 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.469 ' H ' ' HD3' ' A' ' 8' ' ' PRO . . . -169.44 -141.15 3.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.195 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -62.11 130.08 43.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 110.748 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.71 ' HA2' ' H ' ' A' ' 76' ' ' VAL . . . -69.69 150.05 48.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.083 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 47.3 p -149.09 145.99 27.5 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.53 ' HG ' ' HB ' ' A' ' 10' ' ' VAL . 48.1 t -158.29 134.13 9.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.11 0.481 . . . . 0.0 111.965 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -77.18 -33.41 56.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.517 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -83.74 139.08 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.371 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -120.38 140.27 51.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -86.22 132.75 33.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.721 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.506 ' HD3' HD22 ' A' ' 93' ' ' LEU . 31.7 ttmt -83.27 123.96 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.359 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 20' ' ' PRO . 56.4 tp -99.06 121.11 40.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.871 0.367 . . . . 0.0 110.734 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 60.4 mt -96.39 139.6 32.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.651 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 61.1 pttt -59.84 134.57 89.72 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.417 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.523 ' HG3' ' HD2' ' A' ' 20' ' ' PRO . 48.1 Cg_exo . . . . . 0 C--N 1.347 0.479 0 C-N-CA 122.869 2.379 . . . . 0.0 112.806 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.631 0.253 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.27 145.7 73.07 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.449 2.1 . . . . 0.0 111.796 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HG2' ' HA3' ' A' ' 84' ' ' GLY . 11.6 Cg_endo -55.93 120.88 8.99 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.367 2.045 . . . . 0.0 112.036 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.441 ' O ' HD21 ' A' ' 9' ' ' LEU . 5.7 tt -102.65 100.81 10.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.477 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.665 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 59.5 t -84.0 136.76 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.596 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -169.14 51.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.522 . . . . 0.0 111.188 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.03 141.48 7.01 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.417 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.526 HG12 ' HD2' ' A' ' 15' ' ' PRO . 13.9 tt -164.78 130.71 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.448 0.166 . . . . 0.0 110.662 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.754 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.3 t -59.97 -61.44 7.9 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.919 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 85.9 Cg_endo -83.91 -159.96 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.8 1.667 . . . . 0.0 111.104 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -175.25 24.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.111 0.482 . . . . 0.0 110.41 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -179.33 127.33 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.155 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 165.47 151.35 6.62 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.847 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.426 HG21 ' O ' ' A' ' 93' ' ' LEU . 33.7 pt -52.45 161.42 1.08 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.49 0.186 . . . . 0.0 110.986 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.627 ' O ' HG21 ' A' ' 64' ' ' VAL . 73.7 Cg_exo -50.47 -40.72 53.81 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.694 2.263 . . . . 0.0 113.562 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.505 ' HE3' HH11 ' A' ' 63' ' ' ARG . 84.5 m95 -73.86 -5.8 43.25 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -64.96 129.47 39.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.362 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.07 137.27 51.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.586 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.417 ' O ' HG21 ' A' ' 24' ' ' VAL . 34.6 m -144.84 130.59 14.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.973 0.416 . . . . 0.0 110.975 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.521 HG22 ' HZ3' ' A' ' 59' ' ' LYS . 91.6 m -87.67 117.46 26.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.949 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.444 HG21 ' N ' ' A' ' 27' ' ' ARG . 64.1 mt -80.38 137.91 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.754 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.604 ' NH1' ' HB2' ' A' ' 59' ' ' LYS . 25.9 mmm180 -139.72 137.59 35.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.949 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.14 -135.54 2.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.368 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 55.9 mm-40 -151.24 138.06 18.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.825 0.345 . . . . 0.0 111.286 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 76.1 m-20 62.59 38.79 12.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.288 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 mp -81.67 51.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.872 0.368 . . . . 0.0 111.063 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.419 ' HA3' ' OD2' ' A' ' 37' ' ' ASP . . . 76.5 134.56 0.56 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.893 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.5 p -59.75 -35.38 74.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.617 0.246 . . . . 0.0 111.314 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.572 ' HA3' ' CE2' ' A' ' 54' ' ' TRP . . . -168.24 -159.22 13.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.123 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.21 -46.36 15.63 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.954 2.436 . . . . 0.0 112.792 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 p -60.65 -41.22 94.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.511 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.419 ' OD2' ' HA3' ' A' ' 32' ' ' GLY . 64.9 t0 -66.33 -48.09 71.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.819 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.63 130.75 44.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.989 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.436 HG13 ' N ' ' A' ' 40' ' ' GLY . 25.0 pt -149.36 -43.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.436 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -93.94 52.54 2.25 Favored Glycine 0 CA--C 1.51 -0.24 0 C-N-CA 120.494 -0.86 . . . . 0.0 114.149 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.595 ' O ' HG21 ' A' ' 42' ' ' THR . 2.7 tm? -70.23 127.25 32.14 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.595 HG21 ' O ' ' A' ' 41' ' ' LEU . 6.9 p -155.58 144.96 20.98 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.153 0.502 . . . . 0.0 111.987 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 64' ' ' VAL . 80.7 mt -137.66 123.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.527 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.401 ' SG ' HD22 ' A' ' 92' ' ' LEU . 60.3 m 57.64 36.37 26.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.099 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.46 -36.36 2.95 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.637 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -72.87 131.94 42.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.02 0.41 . . . . 0.0 111.398 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -72.56 141.78 48.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 76.4 m -149.2 42.56 0.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.519 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 41' ' ' LEU . 33.0 tp -69.18 -44.47 72.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.19 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 pp -63.94 -34.48 78.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.173 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.3 p -79.92 -38.17 33.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.821 0.343 . . . . 0.0 111.281 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -66.21 137.88 57.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.934 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -126.32 128.48 47.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.247 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.572 ' CE2' ' HA3' ' A' ' 34' ' ' GLY . 82.0 t90 -65.4 149.77 49.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.225 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 93.4 mmm -142.6 -43.81 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.444 ' C ' ' H ' ' A' ' 58' ' ' SER . 48.7 m -155.83 178.02 10.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.674 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.2 37.21 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 56' ' ' SER . 80.7 p -178.81 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.176 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.604 ' HB2' ' NH1' ' A' ' 27' ' ' ARG . 63.0 tttp -83.96 132.52 34.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.5 mt -148.62 115.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.668 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.2 t -84.55 122.75 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.681 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 41.9 t -171.02 146.11 2.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.036 0.446 . . . . 0.0 111.179 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.505 HH11 ' HE3' ' A' ' 21' ' ' TRP . 98.9 mtt180 -85.19 134.09 34.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.207 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.627 HG21 ' O ' ' A' ' 20' ' ' PRO . 19.4 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.599 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.858 ' HA2' ' HB2' ' A' ' 89' ' ' SER . . . . . . . . 0 CA--C 1.517 0.217 0 N-CA-C 113.957 0.343 . . . . 0.0 113.957 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -45.16 127.49 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.373 . . . . 0.0 111.586 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.0 mt -115.47 117.93 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.134 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.472 HG21 ' N ' ' A' ' 76' ' ' VAL . 3.1 mp -120.98 137.5 54.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.37 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.665 ' H ' ' HA2' ' A' ' 84' ' ' GLY . 3.8 p -141.76 103.58 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.829 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -77.31 131.94 38.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.657 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 82.4 p -123.15 142.32 51.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.091 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -50.78 -48.04 59.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.5 m -69.44 -48.48 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.981 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.83 -128.52 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.615 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.4 -40.99 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.344 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -169.72 127.45 0.91 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.76 0.314 . . . . 0.0 110.631 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.665 ' HA2' ' H ' ' A' ' 76' ' ' VAL . . . -74.02 145.5 35.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.967 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 84' ' ' GLY . 69.1 p -143.58 138.63 29.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.597 0.237 . . . . 0.0 110.52 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.665 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 45.2 t -133.13 129.81 38.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.019 0.438 . . . . 0.0 111.493 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.6 p -74.02 -32.43 63.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.573 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.412 HG21 ' OG ' ' A' ' 86' ' ' SER . 33.8 m -83.88 176.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.372 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.858 ' HB2' ' HA2' ' A' ' 72' ' ' GLY . 72.5 p -157.44 133.2 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -85.62 127.32 34.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.815 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -85.04 122.31 29.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 110.607 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.401 HD22 ' SG ' ' A' ' 44' ' ' CYS . 2.9 mm? -82.21 129.73 34.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.929 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.47 ' HG ' ' N ' ' A' ' 18' ' ' GLY . 80.2 mt -100.59 138.94 36.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.6 139.48 96.0 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.039 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.518 2.145 . . . . 0.0 112.045 179.64 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.643 ' NE2' ' H ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.599 0.238 . . . . 0.0 111.023 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.22 144.28 95.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.614 2.21 . . . . 0.0 112.153 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 51.8 Cg_exo -51.86 133.49 45.63 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.524 2.149 . . . . 0.0 112.185 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' A' ' 85' ' ' THR . 3.3 tt -123.56 118.0 26.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.236 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.484 ' O ' HG21 ' A' ' 11' ' ' THR . 62.8 t -81.34 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.285 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 10' ' ' VAL . 71.4 p -147.0 45.2 1.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.033 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.0 147.51 6.92 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.206 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 15' ' ' PRO . 16.3 tt -160.98 130.42 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.728 0.299 . . . . 0.0 110.499 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.813 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.9 t -68.76 -58.2 7.05 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.685 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.813 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 68.8 Cg_endo -93.03 115.14 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.278 1.985 . . . . 0.0 112.592 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.509 ' N ' HD21 ' A' ' 16' ' ' ASN . 0.0 OUTLIER -96.96 27.79 3.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 0.0 110.61 179.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -179.67 130.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.17 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.532 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 171.88 146.03 5.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.828 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.451 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 29.1 pt -54.17 162.81 1.4 Allowed Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 120.486 0.184 . . . . 0.0 111.28 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.599 ' O ' HG11 ' A' ' 64' ' ' VAL . 85.2 Cg_exo -48.16 -37.87 31.79 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.822 2.348 . . . . 0.0 113.653 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -77.71 -15.71 58.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -60.64 124.71 21.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.678 0.275 . . . . 0.0 111.195 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 25.5 pttm -77.18 127.08 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 0.0 110.431 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.6 m -109.45 125.64 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.556 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 84.9 m -72.42 120.88 18.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.82 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.512 HD13 ' SG ' ' A' ' 62' ' ' CYS . 65.5 mt -80.96 139.01 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.002 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 58' ' ' SER . 27.8 tpt180 -147.42 127.3 13.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.894 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -169.17 -134.58 1.75 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.959 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -149.5 137.55 20.5 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.921 0.391 . . . . 0.0 111.579 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 73.6 m-20 60.61 40.6 16.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.578 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.474 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.2 mp -84.49 53.5 2.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.863 0.363 . . . . 0.0 110.597 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.51 129.32 0.43 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.539 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.4 p -97.91 42.56 1.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 0.0 111.369 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.97 142.21 3.98 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.699 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.53 ' HG3' ' CE3' ' A' ' 54' ' ' TRP . 36.0 Cg_exo -56.56 -47.25 24.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.519 2.146 . . . . 0.0 112.116 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.4 p -65.28 -33.97 77.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.421 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.607 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -51.29 -42.88 61.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.997 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.47 HD21 ' N ' ' A' ' 39' ' ' ILE . 1.2 tt -65.92 127.12 30.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.48 HG13 ' N ' ' A' ' 40' ' ' GLY . 32.9 pt -134.43 -44.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 111.32 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.48 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -100.86 136.46 12.71 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.463 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.482 ' O ' HG21 ' A' ' 42' ' ' THR . 2.2 tm? -148.8 126.67 11.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.518 HG23 ' HA ' ' A' ' 47' ' ' ASN . 7.1 p -155.34 141.75 18.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.161 0.505 . . . . 0.0 111.873 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 76.5 mt -129.97 124.0 57.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.401 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.51 ' SG ' ' HA3' ' A' ' 72' ' ' GLY . 63.0 m 55.4 39.45 31.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.11 -32.92 2.23 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.894 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -72.53 129.75 39.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 0.0 111.127 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.518 ' HA ' HG23 ' A' ' 42' ' ' THR . 5.4 m120 -70.44 140.41 51.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.844 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.1 m -150.39 40.36 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 41' ' ' LEU . 57.4 tp -72.38 -43.88 63.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.321 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -56.39 -38.63 71.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.4 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.0 p -79.84 -36.43 36.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.352 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.537 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -59.63 132.98 55.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.561 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -126.92 126.46 43.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.537 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.53 ' CE3' ' HG3' ' A' ' 35' ' ' PRO . 79.6 t90 -69.44 152.85 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.326 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 49.1 mtt -147.56 -44.38 0.17 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.025 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 58' ' ' SER . 79.2 p -169.58 173.57 6.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.637 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.93 37.31 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.524 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.471 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 79.0 p -176.68 24.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.087 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 59.4 tttp -165.31 128.83 2.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.138 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.4 mt -152.2 119.55 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.655 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.37 134.15 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.616 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.8 p -169.57 146.2 3.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.845 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.655 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 68.3 mtt-85 -84.03 131.64 34.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.599 HG11 ' O ' ' A' ' 20' ' ' PRO . 8.4 p . . . . . 0 CA--C 1.54 0.582 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.085 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.51 ' HA3' ' SG ' ' A' ' 44' ' ' CYS . . . . . . . . 0 CA--C 1.518 0.244 0 N-CA-C 112.843 -0.103 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -73.24 130.93 41.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 111.328 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.452 ' O ' HD11 ' A' ' 75' ' ' ILE . 70.4 mt -85.59 135.2 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.226 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.452 HD11 ' O ' ' A' ' 74' ' ' ILE . 40.0 mm -131.55 137.02 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.798 0.332 . . . . 0.0 111.703 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.4 t -141.53 117.84 6.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.937 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -86.05 147.33 26.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.347 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.9 p -139.44 143.7 37.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.4 mmmm -53.97 -55.06 30.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.365 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.1 t -67.65 -55.43 13.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.002 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.28 -128.65 0.38 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.644 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 -137.3 2.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.999 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -65.12 121.4 14.64 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.5 126.78 8.74 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.893 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 73.1 p -99.43 144.05 28.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.404 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 80.9 p -131.98 126.79 34.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.581 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.9 p -91.65 35.75 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.604 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.49 156.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.67 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.5 p -138.53 134.63 34.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.946 0.403 . . . . 0.0 111.192 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -86.06 131.42 34.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.347 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -83.93 124.79 31.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.062 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.463 HD22 HG23 ' A' ' 64' ' ' VAL . 89.2 mt -90.0 127.71 36.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 111.647 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 18' ' ' GLY . 78.3 mt -92.56 139.98 30.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.372 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -56.52 126.89 71.31 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.949 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo . . . . . 0 C--N 1.347 0.496 0 C-N-CA 122.869 2.379 . . . . 0.0 112.922 -179.854 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.434 ' H ' ' CD ' ' A' ' 6' ' ' GLN . 3.2 pm0 . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 120.663 0.268 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.71 148.59 36.94 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.755 2.303 . . . . 0.0 112.375 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.48 142.85 99.58 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.635 2.223 . . . . 0.0 112.054 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.53 HD11 ' C ' ' A' ' 9' ' ' LEU . 3.3 tm? -140.38 119.83 13.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.499 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.585 HG23 HG23 ' A' ' 74' ' ' ILE . 47.1 t -83.58 142.55 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.986 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.446 ' N ' HG11 ' A' ' 10' ' ' VAL . 6.3 t -167.99 49.02 0.05 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.037 0.446 . . . . 0.0 111.363 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.13 138.5 3.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.698 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.506 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.7 tt -165.24 130.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 0.0 110.604 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.805 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.6 t -65.46 -59.38 9.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.692 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 83.7 Cg_endo -90.58 111.72 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.164 1.909 . . . . 0.0 112.155 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -89.33 26.81 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.595 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 176.22 132.25 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.261 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.73 144.22 4.64 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.905 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.421 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 33.1 pt -56.7 160.77 5.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.496 0.189 . . . . 0.0 111.02 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.59 ' HA ' HG12 ' A' ' 64' ' ' VAL . 84.8 Cg_exo -47.07 -45.15 22.02 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.812 2.342 . . . . 0.0 113.544 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -67.2 -22.43 65.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.2 m -62.61 128.21 34.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.136 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 24.7 ttmm -73.83 138.18 44.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.622 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.484 ' O ' HG21 ' A' ' 24' ' ' VAL . 35.0 m -132.23 125.28 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.002 0.43 . . . . 0.0 111.032 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -85.57 118.8 25.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.097 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.4 mt -83.92 137.16 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.431 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -147.66 135.76 21.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.827 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.93 -126.6 0.85 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.21 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -145.18 134.85 23.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.329 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 60.97 42.21 13.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.079 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.571 HD11 ' N ' ' A' ' 31' ' ' LEU . 10.7 mp -83.91 54.93 3.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.964 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.21 134.19 1.9 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.76 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.6 p -67.4 -40.81 85.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.63 0.252 . . . . 0.0 111.62 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.545 ' HA3' ' CZ2' ' A' ' 54' ' ' TRP . . . -156.52 -177.92 30.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.755 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.85 -40.27 79.94 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.638 2.225 . . . . 0.0 112.042 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.8 p -59.95 -41.35 91.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.983 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.512 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 37.7 t70 -66.82 -46.88 73.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.898 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.468 ' O ' HG21 ' A' ' 39' ' ' ILE . 3.4 tm? -69.85 129.0 38.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.923 0.392 . . . . 0.0 110.347 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.478 ' O ' HD23 ' A' ' 49' ' ' LEU . 49.8 pt -147.96 -23.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.422 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.91 128.72 6.98 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.848 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' ' 52' ' ' ALA . 31.4 tp -150.41 147.15 27.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.64 0.257 . . . . 0.0 110.558 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.407 HG22 ' C ' ' A' ' 46' ' ' HIS . 98.2 m -161.69 129.28 4.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.396 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.8 mt -105.34 130.52 56.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.449 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 79.7 m 69.26 -66.42 0.26 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.53 0.519 . . . . 0.0 110.971 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.65 26.13 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.493 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' C ' HG22 ' A' ' 42' ' ' THR . 83.1 t60 -132.18 135.76 46.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.585 0.231 . . . . 0.0 110.707 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -59.29 136.83 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.772 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.404 ' O ' ' HB1' ' A' ' 52' ' ' ALA . 77.7 m -151.45 36.28 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.102 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 39' ' ' ILE . 49.5 tp -70.3 -44.69 67.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.964 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -54.12 -40.77 67.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.049 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.3 p -80.38 -32.67 37.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.04 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.15 133.27 55.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.087 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' O ' HG21 ' A' ' 60' ' ' ILE . 43.8 tt0 -127.14 127.1 44.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.129 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.545 ' CZ2' ' HA3' ' A' ' 34' ' ' GLY . 43.4 t90 -67.4 149.09 50.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 110.702 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 94.5 mmm -143.26 -43.13 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.096 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 58' ' ' SER . 32.2 t -166.86 172.84 9.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.846 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.58 25.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.641 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 56' ' ' SER . 66.8 m -167.78 21.35 0.03 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.696 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.641 ' HB2' ' HZ3' ' A' ' 59' ' ' LYS . 5.0 ttmp? -165.1 134.87 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.411 HG21 ' O ' ' A' ' 53' ' ' GLU . 79.3 mt -146.86 121.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -80.89 125.7 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.513 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.1 p -170.42 140.56 1.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.021 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 84.4 mtm180 -84.33 136.79 33.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.634 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 20' ' ' PRO . 4.8 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.395 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.311 -0.315 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -62.76 130.91 47.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.585 HG23 HG23 ' A' ' 10' ' ' VAL . 71.8 mt -85.3 131.58 33.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.468 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.0 mm -128.88 139.55 51.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.229 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.78 121.65 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.8 m -98.09 133.9 41.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.509 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 81.6 p -118.52 142.21 47.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.178 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 37' ' ' ASP . 29.4 mtpp -54.02 -44.88 71.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.633 0.254 . . . . 0.0 110.982 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.9 m -66.81 -47.13 72.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.984 0.421 . . . . 0.0 109.957 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.42 -132.53 1.69 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.47 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . 172.81 67.41 0.05 OUTLIER Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.247 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 82' ' ' GLY . 59.2 tttm 67.98 109.28 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.881 0.372 . . . . 0.0 110.439 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.06 -134.32 6.44 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.856 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.4 p -145.99 -168.26 2.94 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.578 0.227 . . . . 0.0 110.626 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.406 ' HA ' HD23 ' A' ' 9' ' ' LEU . 78.4 p -169.47 125.35 0.86 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 111.151 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.9 p -90.53 28.37 1.5 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.708 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 m -153.58 149.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.999 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.8 m -134.56 134.86 41.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -85.5 127.67 34.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -81.08 117.15 21.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.553 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 93' ' ' LEU . 1.5 tm? -81.16 128.47 33.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.523 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 92' ' ' LEU . 80.8 mt -99.65 133.51 43.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.845 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -68.05 134.1 91.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.661 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--N 1.347 0.484 0 C-N-CA 122.368 2.046 . . . . 0.0 112.349 -179.995 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.651 0.263 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.82 146.59 66.24 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.658 2.239 . . . . 0.0 112.206 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.478 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 18.0 Cg_endo -58.31 129.61 33.62 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.596 2.198 . . . . 0.0 112.3 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 85' ' ' THR . 63.2 tp -113.33 119.84 39.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.071 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 27' ' ' ARG . 69.7 t -85.29 132.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.069 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.9 p -151.57 47.91 0.81 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.51 144.57 6.43 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.869 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.555 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 13.0 tt -158.95 131.01 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.859 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 53.2 m -60.88 -60.69 9.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.565 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.859 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 3.7 Cg_exo -75.83 -150.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.954 1.769 . . . . 0.0 111.796 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.508 ' OD1' ' HG2' ' A' ' 17' ' ' GLU . 5.3 p30 -173.94 -22.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.024 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.508 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 16.2 pt-20 -159.51 129.38 5.52 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.685 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.69 159.81 16.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.56 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.6 pt -51.64 156.75 2.14 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.613 0.244 . . . . 0.0 111.03 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.578 ' O ' HG21 ' A' ' 64' ' ' VAL . 75.8 Cg_exo -51.88 -41.07 65.16 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.742 2.295 . . . . 0.0 113.496 -179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -70.67 -5.79 32.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -64.02 131.0 46.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.998 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.425 ' O ' HG11 ' A' ' 24' ' ' VAL . 17.3 tppt? -65.99 136.97 56.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.283 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.498 ' O ' HG21 ' A' ' 24' ' ' VAL . 26.3 m -141.45 131.34 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.007 0.432 . . . . 0.0 111.309 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.418 ' HB ' ' OG ' ' A' ' 14' ' ' SER . 99.7 m -90.3 122.53 33.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.479 HG21 ' N ' ' A' ' 27' ' ' ARG . 64.1 mt -79.41 141.5 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.782 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.495 ' O ' HG11 ' A' ' 10' ' ' VAL . 12.2 tpt180 -147.56 131.39 17.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.318 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -170.87 -135.62 1.95 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.663 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 67.0 mm-40 -145.93 135.86 23.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.842 0.353 . . . . 0.0 111.44 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.478 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 72.8 m-80 61.59 40.59 13.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.351 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 mp -83.57 49.05 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.704 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.72 124.24 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.476 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.8 p -88.29 39.25 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.763 0.316 . . . . 0.0 111.362 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.36 147.47 5.07 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.594 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.92 -41.6 62.54 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.334 2.023 . . . . 0.0 111.77 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.9 p -61.17 -34.67 75.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.771 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.94 46.09 0.56 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.815 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.51 HD21 ' N ' ' A' ' 39' ' ' ILE . 1.9 tt -157.4 121.9 4.35 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.51 ' N ' HD21 ' A' ' 38' ' ' LEU . 29.0 pt -144.21 33.16 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.989 0.423 . . . . 0.0 111.424 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.04 128.5 1.48 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.39 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.566 HD12 ' N ' ' A' ' 42' ' ' THR . 1.2 tm? -150.56 134.0 16.4 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.566 ' N ' HD12 ' A' ' 41' ' ' LEU . 94.0 m -158.33 128.08 5.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.079 0.466 . . . . 0.0 111.746 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.72 126.09 73.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.387 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.451 ' HA ' ' HA3' ' A' ' 72' ' ' GLY . 69.7 m 57.68 45.79 18.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.789 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.94 11.65 32.2 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.975 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -116.07 133.12 56.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.328 . . . . 0.0 111.026 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.13 133.29 54.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.987 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.1 m -153.35 39.01 0.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.669 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.1 tp -72.27 -41.97 66.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.459 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.419 HD13 HG22 ' A' ' 51' ' ' THR . 3.9 pp -58.07 -33.51 69.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.501 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.419 HG22 HD13 ' A' ' 50' ' ' LEU . 20.3 p -80.03 -37.7 33.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.766 0.317 . . . . 0.0 110.99 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -59.82 131.13 49.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.735 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -127.21 127.58 44.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.262 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -65.62 141.53 58.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.739 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 95.3 mmm -132.23 -42.65 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.139 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 m -160.93 -166.34 1.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.998 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.04 -7.53 54.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.478 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.4 m -156.23 47.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.078 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 87.3 tttt -164.44 129.11 2.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.9 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.427 HD12 HD13 ' A' ' 38' ' ' LEU . 76.2 mt -150.21 126.91 2.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.968 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 89.1 t -84.58 127.89 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.535 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.554 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.5 p -170.67 145.09 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.815 0.34 . . . . 0.0 111.198 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -84.63 131.63 34.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.341 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 20' ' ' PRO . 15.3 m . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.421 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.405 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -57.87 132.16 52.55 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.01 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.4 mt -86.77 121.18 37.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.748 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.9 mm -111.62 138.97 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.307 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.0 t -141.39 110.64 2.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.901 0.382 . . . . 0.0 111.095 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.7 m -79.73 143.39 34.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.823 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.5 p -136.86 139.74 41.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.893 0.377 . . . . 0.0 111.369 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -56.78 -47.43 80.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.055 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.7 m -67.25 -52.83 36.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.607 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 -125.14 2.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.068 -0.586 . . . . 0.0 112.411 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 -134.97 1.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.18 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -60.58 125.46 23.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 0.0 110.524 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.404 ' HA3' ' HG2' ' A' ' 8' ' ' PRO . . . -72.92 130.7 14.48 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.217 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 74.3 p -100.47 147.47 25.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.586 0.232 . . . . 0.0 110.773 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -159.88 125.74 4.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.32 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.48 ' O ' HG11 ' A' ' 88' ' ' VAL . 81.7 p -99.0 40.73 1.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.522 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.48 HG11 ' O ' ' A' ' 87' ' ' THR . 28.4 m -147.97 157.34 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.798 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.2 p -150.74 139.24 20.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -84.83 127.24 34.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.163 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -72.4 120.26 17.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.338 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.405 ' HA ' HD21 ' A' ' 92' ' ' LEU . 92.9 mt -90.19 128.95 36.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.285 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.1 mt -105.55 140.11 39.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.631 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -58.51 140.22 84.76 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--N 1.347 0.496 0 C-N-CA 122.534 2.156 . . . . 0.0 112.598 -179.584 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.64 ' NE2' ' H ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.096 0 CA-C-O 120.524 0.202 . . . . 0.0 110.975 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.72 141.78 38.32 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.51 2.14 . . . . 0.0 112.407 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 16.6 Cg_endo -57.57 143.46 94.65 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.735 2.29 . . . . 0.0 112.288 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -132.12 122.47 25.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.248 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.501 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 63.7 t -83.04 137.65 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.624 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.448 HG21 ' O ' ' A' ' 10' ' ' VAL . 68.9 p -148.94 45.6 1.0 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.94 146.34 6.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.126 -1.035 . . . . 0.0 113.449 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 13' ' ' ILE . 14.1 tt -163.59 128.32 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.677 0.275 . . . . 0.0 110.308 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.847 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 59.1 m -68.48 -60.05 5.21 Favored Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.717 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.847 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 70.1 Cg_endo -95.24 106.74 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.399 2.066 . . . . 0.0 112.157 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -91.07 32.31 1.03 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.562 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 179.31 128.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.36 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.03 149.45 6.23 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.593 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.3 pt -54.01 160.07 2.49 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.538 0.209 . . . . 0.0 111.04 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.523 ' O ' HG21 ' A' ' 64' ' ' VAL . 86.1 Cg_exo -49.26 -38.65 42.26 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.889 2.393 . . . . 0.0 113.651 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -75.8 -14.5 60.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 m -63.58 127.92 33.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 111.536 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 54.1 mtmt -74.97 134.65 41.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.324 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.718 HG23 HG12 ' A' ' 64' ' ' VAL . 28.4 m -123.41 128.57 74.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.941 0.4 . . . . 0.0 111.339 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.6 m -73.67 117.05 14.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.764 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 60' ' ' ILE . 67.9 mt -86.99 136.08 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.063 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.45 ' HE ' ' HG3' ' A' ' 59' ' ' LYS . 21.0 mmt85 -146.5 134.96 21.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.601 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -170.03 -130.99 1.27 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.466 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -146.49 132.48 19.21 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.855 0.36 . . . . 0.0 111.343 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.517 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.1 m-80 61.27 41.76 12.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.136 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mp -81.86 53.33 2.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.978 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.99 134.32 1.22 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.639 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 p -66.47 -37.47 85.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.665 0.269 . . . . 0.0 111.537 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 54' ' ' TRP . . . -154.79 -174.4 24.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.008 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.77 -43.93 15.0 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.737 2.291 . . . . 0.0 112.567 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.0 p -56.36 -40.63 74.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.828 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -66.28 -36.86 84.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.736 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.2 tp -74.61 63.06 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.5 pt -73.0 -37.14 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.158 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -113.51 142.27 17.36 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.037 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.418 ' O ' HG21 ' A' ' 42' ' ' THR . 3.0 tm? -149.62 134.71 18.06 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.545 HG21 ' HA ' ' A' ' 47' ' ' ASN . 18.5 p -150.31 151.16 32.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.079 0.466 . . . . 0.0 111.832 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.521 HD11 ' HA ' ' A' ' 64' ' ' VAL . 77.2 mt -136.15 117.49 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.328 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 85.3 m 73.78 -38.3 0.4 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.468 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 168.33 -40.1 0.22 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.962 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -80.24 140.68 36.14 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.92 0.39 . . . . 0.0 111.763 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.545 ' HA ' HG21 ' A' ' 42' ' ' THR . 39.3 t30 -59.8 144.59 48.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.965 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.5 m -149.96 38.28 0.74 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.08 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.8 tp -73.84 -47.67 36.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.237 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.418 ' HG ' ' N ' ' A' ' 51' ' ' THR . 2.3 pt? -48.41 -44.44 35.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.727 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.746 HG23 ' HE ' ' A' ' 63' ' ' ARG . 52.9 p -80.12 -37.87 32.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.722 0.296 . . . . 0.0 111.349 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -60.23 137.16 58.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.491 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -126.76 130.72 50.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.506 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.422 ' CE2' ' HA3' ' A' ' 34' ' ' GLY . 55.7 t90 -66.53 150.83 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.223 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.599 ' HG3' ' HZ1' ' A' ' 59' ' ' LYS . 23.8 mmt -141.2 -47.49 0.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.902 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 58' ' ' SER . 35.2 t -166.41 -175.1 3.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.401 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.73 38.23 0.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.756 0.312 . . . . 0.0 111.169 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 56' ' ' SER . 80.4 p -175.87 -43.54 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.599 ' HZ1' ' HG3' ' A' ' 55' ' ' MET . 61.9 tttm -82.87 131.94 35.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.227 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 77.2 mt -151.78 105.92 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.598 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.484 HG11 ' O ' ' A' ' 61' ' ' VAL . 8.8 p -80.25 130.67 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.825 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 31.7 t -170.82 141.33 1.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 111.407 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.746 ' HE ' HG23 ' A' ' 51' ' ' THR . 40.1 ptt180 -85.35 131.88 34.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.392 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.718 HG12 HG23 ' A' ' 24' ' ' VAL . 27.0 m . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.732 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.191 0 N-CA-C 112.717 -0.153 . . . . 0.0 112.717 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -63.81 128.63 36.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.928 0.394 . . . . 0.0 111.219 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.76 130.74 35.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.326 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 85' ' ' THR . 34.5 mm -134.19 145.77 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 111.449 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.2 p -139.55 128.36 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.833 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.5 m -93.61 143.79 25.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.403 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.8 p -137.0 137.42 39.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.605 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 7.5 mtpm? -55.65 -48.26 75.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.4 m -65.87 -55.46 16.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.928 0.394 . . . . 0.0 110.382 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.0 -123.64 0.72 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.161 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.82 -143.04 3.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.005 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.404 ' HE2' ' CG2' ' A' ' 75' ' ' ILE . 19.7 tptm -69.18 109.72 4.21 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.94 -161.25 7.28 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.181 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.437 ' HA ' HD11 ' A' ' 75' ' ' ILE . 44.0 p -154.29 -169.03 3.11 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.427 0.291 . . . . 0.0 110.451 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.533 ' OG ' HG21 ' A' ' 88' ' ' VAL . 45.4 t -171.16 131.86 0.8 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.755 0.312 . . . . 0.0 111.243 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.7 p -90.49 31.68 1.01 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.78 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.533 HG21 ' OG ' ' A' ' 86' ' ' SER . 27.4 m -152.03 142.48 15.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.922 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.3 p -125.07 133.72 52.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.72 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -85.77 128.08 34.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -82.48 123.13 28.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.572 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.8 mt -81.84 128.8 34.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.152 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.1 mt -98.89 133.38 43.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.724 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 31.0 mmmt -74.37 134.74 76.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 51.9 Cg_exo . . . . . 0 C--N 1.346 0.429 0 C-N-CA 122.53 2.153 . . . . 0.0 112.352 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.622 0.249 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.68 141.08 76.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.626 2.217 . . . . 0.0 112.289 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.52 137.98 82.66 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.515 2.143 . . . . 0.0 112.148 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 85' ' ' THR . 3.5 tt -130.39 113.25 14.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.107 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.542 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 90.3 t -81.01 135.69 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.421 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 10' ' ' VAL . 80.7 p -146.67 42.5 1.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.14 144.74 5.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.75 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.521 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.0 tt -163.07 130.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.62 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.813 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 50.4 m -65.64 -58.94 10.3 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.068 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.813 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 90.9 Cg_endo -95.0 119.99 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.575 2.183 . . . . 0.0 112.478 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -92.92 21.17 5.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.887 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 178.64 135.58 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.655 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.35 145.44 4.5 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.94 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.498 HG21 ' O ' ' A' ' 93' ' ' LEU . 33.4 pt -54.97 159.79 3.51 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 110.723 -0.103 . . . . 0.0 110.723 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.638 ' O ' HG21 ' A' ' 64' ' ' VAL . 73.7 Cg_exo -48.67 -39.93 38.11 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.574 2.183 . . . . 0.0 113.099 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.404 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 60.4 m95 -69.92 -21.19 63.31 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.6 m -60.94 129.83 43.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 111.452 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -70.34 140.59 52.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.422 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.613 HG23 HG11 ' A' ' 64' ' ' VAL . 19.6 m -136.66 133.15 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.2 m -88.13 110.59 20.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.782 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 26' ' ' ILE . 59.6 mt -75.95 138.8 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.466 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.533 ' O ' HG11 ' A' ' 10' ' ' VAL . 22.2 tpp180 -147.11 128.99 15.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.385 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -170.77 -136.22 2.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.62 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -148.57 138.41 22.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.941 0.4 . . . . 0.0 111.197 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 62.92 41.18 8.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.289 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.8 mp -85.47 52.07 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.495 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.85 125.14 0.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.305 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -91.92 39.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.753 0.311 . . . . 0.0 111.493 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.54 144.74 4.37 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.599 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.88 -43.5 58.74 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.491 2.128 . . . . 0.0 111.997 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.8 p -61.75 -37.48 84.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.193 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -57.1 -44.1 82.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.484 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.421 ' C ' HD21 ' A' ' 38' ' ' LEU . 1.2 tt -73.9 67.74 1.26 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.74 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.49 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 26.6 pt -75.92 -39.53 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.675 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -114.31 139.17 15.42 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.219 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 42' ' ' THR . 3.0 tm? -150.13 130.11 13.44 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.536 ' N ' HD12 ' A' ' 41' ' ' LEU . 36.2 p -151.61 137.08 17.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 111.748 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.522 HD11 ' HA ' ' A' ' 64' ' ' VAL . 69.1 mt -125.28 126.13 70.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.648 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.595 ' SG ' HD22 ' A' ' 92' ' ' LEU . 69.5 m 58.19 38.37 26.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.018 0.437 . . . . 0.0 110.335 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.07 34.28 89.49 Favored Glycine 0 C--N 1.331 0.285 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.171 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -131.34 133.38 45.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 0.0 110.556 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -68.56 132.94 47.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.051 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.0 m -154.64 36.67 0.41 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.628 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 3.3 tm? -77.51 -46.09 23.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.774 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -52.72 -39.73 62.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.053 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.497 HG23 ' NE ' ' A' ' 63' ' ' ARG . 67.8 p -80.48 -35.67 34.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -55.13 138.37 44.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.514 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -126.07 130.69 51.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.806 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -80.36 150.6 29.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.4 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.9 mtt -147.71 -44.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.482 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 t -165.52 176.42 8.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.447 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.18 43.37 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.219 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.7 p -172.31 -42.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.135 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -93.71 130.64 39.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 111.166 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -150.33 111.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.666 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 66.2 t -84.39 125.94 40.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.887 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 31.6 p -170.87 151.22 3.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.051 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.497 ' NE ' HG23 ' A' ' 51' ' ' THR . 39.0 ptt180 -83.94 132.37 34.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.501 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.638 HG21 ' O ' ' A' ' 20' ' ' PRO . 6.5 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.856 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.413 ' HA3' ' SG ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.384 0 N-CA-C 112.655 -0.178 . . . . 0.0 112.655 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.08 136.8 41.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.686 0.279 . . . . 0.0 110.449 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.6 mt -84.95 92.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.007 0.432 . . . . 0.0 110.935 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.8 mm -81.88 137.77 20.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.635 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.2 t -141.54 106.77 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.119 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.0 m -82.16 143.55 31.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.505 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.2 p -141.04 134.8 30.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.519 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.546 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 7.6 mtpm? -55.53 -43.57 75.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.794 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.8 m -64.43 -48.97 73.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.241 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.46 -121.33 4.85 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.164 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.42 -141.28 3.09 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.182 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.19 127.97 34.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 110.854 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.3 132.38 12.04 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.0 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 78.7 p -99.1 146.18 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.545 0.212 . . . . 0.0 110.64 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.546 ' HG ' HG21 ' A' ' 88' ' ' VAL . 47.5 t -149.37 132.06 15.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.982 0.42 . . . . 0.0 111.583 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.6 p -72.05 -33.49 68.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.746 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.546 HG21 ' HG ' ' A' ' 86' ' ' SER . 35.4 m -83.54 139.43 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.401 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.1 p -123.62 138.68 54.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.744 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -88.26 130.06 35.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -90.43 125.07 35.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.532 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.595 HD22 ' SG ' ' A' ' 44' ' ' CYS . 3.2 mm? -85.25 124.42 31.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 111.046 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.498 ' O ' HG21 ' A' ' 19' ' ' ILE . 80.7 mt -87.24 136.1 33.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.785 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -64.91 131.62 95.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.369 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 C--N 1.345 0.373 0 C-N-CA 122.419 2.08 . . . . 0.0 112.319 -179.745 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.662 0.268 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.34 142.79 99.57 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.755 2.303 . . . . 0.0 112.216 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.19 129.73 36.87 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.515 2.144 . . . . 0.0 112.275 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.7 tp -115.01 108.19 16.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 57.4 t -84.82 137.02 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.454 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 t -166.73 51.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.204 0.526 . . . . 0.0 111.414 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.33 136.77 4.13 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.392 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.531 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.4 tt -165.29 131.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.703 0.287 . . . . 0.0 110.622 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.793 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.6 t -69.35 -58.46 5.97 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.627 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 88.3 Cg_endo -93.24 113.18 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.364 2.043 . . . . 0.0 112.614 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.47 ' N ' HD21 ' A' ' 16' ' ' ASN . 0.0 OUTLIER -95.81 31.65 2.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.897 0.38 . . . . 0.0 110.863 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -179.45 129.34 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.358 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.512 ' N ' HD13 ' A' ' 93' ' ' LEU . . . 166.07 146.9 5.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.988 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 39.6 pt -53.43 160.39 1.86 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.342 0.115 . . . . 0.0 110.949 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.573 ' O ' HG21 ' A' ' 64' ' ' VAL . 89.3 Cg_exo -48.08 -38.8 32.89 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.622 2.215 . . . . 0.0 113.11 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.59 ' O ' ' HD2' ' A' ' 63' ' ' ARG . 97.4 m95 -72.76 -21.03 61.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.6 m -56.22 127.98 33.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.076 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.406 ' HE2' HG12 ' A' ' 61' ' ' VAL . 60.6 tttm -70.28 142.34 52.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.79 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.832 HG23 HG11 ' A' ' 64' ' ' VAL . 34.6 m -139.82 126.46 23.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 111.091 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 62.1 m -83.55 87.85 7.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.76 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.8 mm -54.69 133.8 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.758 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.47 ' O ' HG11 ' A' ' 10' ' ' VAL . 45.2 mmm-85 -140.44 137.29 33.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -168.12 -134.11 1.66 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.196 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -150.57 135.58 17.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 111.237 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 61.65 41.72 11.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.227 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 mp -82.79 51.24 1.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.865 0.364 . . . . 0.0 110.411 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.41 123.45 0.19 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.212 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.7 p -92.29 42.47 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.741 0.305 . . . . 0.0 111.352 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.63 143.75 4.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.653 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HG3' ' CE3' ' A' ' 54' ' ' TRP . 32.2 Cg_exo -57.3 -46.09 30.47 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.456 2.104 . . . . 0.0 111.749 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 t -62.48 -36.36 82.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.157 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.443 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 28.3 m-20 -53.7 -45.46 70.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.672 HD21 ' N ' ' A' ' 39' ' ' ILE . 1.4 tt -68.76 131.11 44.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.076 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.672 ' N ' HD21 ' A' ' 38' ' ' LEU . 30.0 pt -138.4 -44.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.593 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.467 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -104.55 135.82 12.71 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.216 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.535 ' O ' HG21 ' A' ' 42' ' ' THR . 0.2 OUTLIER -146.32 121.0 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.535 HG21 ' O ' ' A' ' 41' ' ' LEU . 33.3 p -153.13 134.82 14.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.179 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.511 HD11 ' HA ' ' A' ' 64' ' ' VAL . 76.0 mt -105.38 111.22 33.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.044 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.493 ' SG ' ' HA3' ' A' ' 72' ' ' GLY . 34.5 t 73.91 -37.8 0.38 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.748 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 171.9 -32.39 0.13 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.528 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -73.58 135.73 43.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.921 0.391 . . . . 0.0 111.459 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.525 ' HA ' HG21 ' A' ' 42' ' ' THR . 43.2 t30 -71.35 138.39 49.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.844 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.2 m -151.89 40.4 0.64 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.965 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.2 tp -74.28 -44.39 52.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.57 -42.71 55.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.497 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.1 p -80.31 -35.26 35.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 111.204 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.577 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.77 131.2 50.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.983 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -127.11 129.99 48.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.335 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.428 ' CE3' ' HG3' ' A' ' 35' ' ' PRO . 67.2 t90 -73.35 148.35 43.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.076 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.3 mtt -148.76 -44.01 0.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.317 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 58' ' ' SER . 64.7 m -160.62 169.97 21.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.727 0.298 . . . . 0.0 110.884 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.78 32.8 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.344 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 56' ' ' SER . 79.8 p -177.85 34.42 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.544 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -164.58 131.23 3.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.8 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.484 HD12 HD13 ' A' ' 38' ' ' LEU . 71.4 mt -150.1 118.81 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 70.5 t -83.7 125.37 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.5 p -170.43 148.24 3.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.826 0.346 . . . . 0.0 111.015 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.59 ' HD2' ' O ' ' A' ' 21' ' ' TRP . 37.6 mmt-85 -84.01 131.18 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.126 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.832 HG11 HG23 ' A' ' 24' ' ' VAL . 10.4 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.189 0.519 . . . . 0.0 112.131 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.493 ' HA3' ' SG ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.452 -0.246 0 N-CA-C 112.554 -0.219 . . . . 0.0 112.554 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -66.36 139.38 58.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.727 0.298 . . . . 0.0 110.958 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.2 mt -84.32 135.27 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.584 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.458 HD11 ' O ' ' A' ' 84' ' ' GLY . 46.1 mm -128.66 137.51 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.899 0.38 . . . . 0.0 111.72 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t -141.4 117.5 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.896 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.9 m -87.56 140.69 29.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.975 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.6 p -134.59 137.0 43.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.996 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 37' ' ' ASP . 28.9 mtpp -60.1 -46.27 90.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.3 m -65.11 -52.43 55.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.056 0.455 . . . . 0.0 110.159 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.72 -121.8 2.46 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.063 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.36 -142.19 3.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.355 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.461 ' C ' ' HD2' ' A' ' 83' ' ' LYS . 3.5 tmmm? -66.73 125.25 25.25 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.458 ' O ' HD11 ' A' ' 75' ' ' ILE . . . -79.45 131.31 10.5 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.061 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.7 p -99.27 148.24 24.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.642 0.258 . . . . 0.0 110.431 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.55 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 78.9 p -149.23 130.31 14.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 111.817 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 74.0 p -81.51 -31.74 32.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.376 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 m -84.22 148.31 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.205 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.0 p -138.97 135.25 34.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.797 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -85.64 133.34 34.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.538 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -88.45 123.71 33.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.403 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.438 ' HA ' HD11 ' A' ' 92' ' ' LEU . 3.2 mm? -80.13 128.27 33.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.056 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.512 HD13 ' N ' ' A' ' 18' ' ' GLY . 75.8 mt -101.45 135.97 42.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.002 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -67.69 140.97 94.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 C--N 1.346 0.437 0 C-N-CA 122.447 2.098 . . . . 0.0 112.284 -179.886 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.609 0.242 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.17 147.46 94.05 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.614 2.209 . . . . 0.0 112.241 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.09 143.36 18.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.571 2.181 . . . . 0.0 112.331 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 85' ' ' THR . 46.7 tp -135.93 111.57 9.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 58.8 t -78.36 130.0 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.791 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.483 HG21 ' O ' ' A' ' 10' ' ' VAL . 76.5 p -150.92 47.8 0.85 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.093 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.4 145.22 6.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.292 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.477 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.4 tt -164.35 128.18 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.31 . . . . 0.0 110.397 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.779 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.0 t -64.98 -58.26 13.31 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.861 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 79.8 Cg_endo -91.27 110.84 0.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.28 1.987 . . . . 0.0 112.397 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -90.31 24.41 2.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.943 0.402 . . . . 0.0 110.166 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -179.31 132.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.169 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.407 ' N ' HD13 ' A' ' 93' ' ' LEU . . . 172.17 145.84 5.1 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.852 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.482 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.9 pt -55.67 164.18 1.7 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 120.407 0.146 . . . . 0.0 110.707 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 19' ' ' ILE . 81.4 Cg_exo -47.7 -53.73 6.14 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.605 2.204 . . . . 0.0 113.966 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.412 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 80.2 m95 -68.31 -8.87 43.53 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.439 ' OG1' HG12 ' A' ' 19' ' ' ILE . 73.1 m -62.29 127.29 30.63 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.079 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.423 ' HD3' HG12 ' A' ' 61' ' ' VAL . 40.8 ttmt -69.43 131.63 45.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.36 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.456 HG13 ' HG2' ' A' ' 15' ' ' PRO . 34.0 m -125.94 127.78 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.978 0.418 . . . . 0.0 110.999 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.8 m -81.33 118.5 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 63.7 mt -79.74 138.49 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.775 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -147.21 136.94 22.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.346 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -170.17 -132.08 1.41 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.673 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -146.94 131.38 17.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.318 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 60.63 41.85 14.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.166 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.416 HD11 ' N ' ' A' ' 31' ' ' LEU . 10.5 mp -81.97 52.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.959 0.409 . . . . 0.0 110.841 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.81 121.44 0.04 OUTLIER Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.404 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.0 p -93.4 41.18 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.0 144.13 5.38 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.464 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HA ' ' CG ' ' A' ' 54' ' ' TRP . 51.3 Cg_exo -54.26 -43.04 62.23 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.538 2.159 . . . . 0.0 112.089 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.8 p -64.01 -35.69 81.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 28.6 m-20 -52.18 -49.06 64.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.005 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.12 132.46 47.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.33 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.546 ' O ' HD12 ' A' ' 49' ' ' LEU . 35.5 pt -147.97 -24.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.998 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.94 137.21 12.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.58 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.555 ' O ' HG21 ' A' ' 42' ' ' THR . 0.2 OUTLIER -149.64 131.67 15.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.555 HG21 ' O ' ' A' ' 41' ' ' LEU . 5.7 p -153.7 141.73 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.134 0.493 . . . . 0.0 111.657 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -135.97 123.23 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.168 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 78.9 m 58.41 40.1 24.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.941 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.02 -32.74 1.73 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.183 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -70.71 133.06 46.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 111.356 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -74.62 143.94 44.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.73 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.5 p -154.12 46.31 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 110.793 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 39' ' ' ILE . 60.2 tp -72.95 -48.9 32.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.58 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.439 HD13 HG22 ' A' ' 51' ' ' THR . 4.1 pp -62.24 -30.37 71.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.599 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.793 HG23 ' HE ' ' A' ' 63' ' ' ARG . 41.3 p -79.92 -38.39 32.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.903 0.383 . . . . 0.0 110.91 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.488 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -64.22 138.08 58.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.67 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.37 127.39 45.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.08 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.423 ' CG ' ' HA ' ' A' ' 35' ' ' PRO . 31.1 t90 -63.78 143.57 57.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.111 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 94.0 mmm -132.95 -51.17 0.9 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.718 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.2 m -161.2 -172.15 3.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.62 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.31 39.17 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.276 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.2 t -178.4 -43.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.7 tttm -86.81 134.05 33.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.483 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 75.3 mt -151.24 120.29 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.571 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.423 HG12 ' HD3' ' A' ' 23' ' ' LYS . 61.7 t -88.22 132.39 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 25.9 t -170.57 141.4 1.89 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.197 0.522 . . . . 0.0 111.545 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.793 ' HE ' HG23 ' A' ' 51' ' ' THR . 39.7 ptt180 -85.37 140.44 30.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.711 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t . . . . . 0 CA--C 1.515 -0.371 0 CA-C-O 121.647 0.737 . . . . 0.0 110.758 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.723 -0.151 . . . . 0.0 112.723 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -71.41 131.87 43.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 110.886 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.6 mt -85.6 100.33 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.085 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.48 HD11 ' O ' ' A' ' 84' ' ' GLY . 42.3 mm -98.6 138.97 21.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.99 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.52 120.17 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.0 111.288 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.1 m -90.87 145.87 24.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.271 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.4 p -140.49 142.93 35.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.953 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 32.2 mmmt -51.77 -49.12 63.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.231 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.4 t -67.0 -47.41 71.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.88 -127.81 0.19 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.819 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.12 -39.77 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.851 -0.499 . . . . 0.0 111.851 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -168.06 121.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.48 ' O ' HD11 ' A' ' 75' ' ' ILE . . . -79.98 127.05 7.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.368 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.445 ' O ' HD13 ' A' ' 9' ' ' LEU . 81.7 p -99.69 144.63 28.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.539 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 66.5 p -143.36 124.19 14.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.101 0.477 . . . . 0.0 111.794 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.7 p -81.02 -28.69 35.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.245 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.62 141.89 14.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.287 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.1 p -129.77 139.26 51.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.958 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -85.74 129.44 34.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.39 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.41 114.55 20.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.093 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 47.0 tp -78.86 131.07 36.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 111.406 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 18' ' ' GLY . 78.4 mt -98.82 141.27 31.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.764 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -61.92 123.32 77.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.015 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo . . . . . 0 C--N 1.348 0.545 0 C-N-CA 122.421 2.081 . . . . 0.0 111.987 179.612 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.437 0.161 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.18 139.15 85.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.57 2.18 . . . . 0.0 112.267 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -52.8 147.1 33.15 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.82 2.347 . . . . 0.0 112.625 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.553 HD11 ' OG1' ' A' ' 85' ' ' THR . 59.8 tp -149.97 112.24 4.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.741 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.538 ' O ' HG21 ' A' ' 11' ' ' THR . 57.3 t -79.02 131.5 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.538 HG21 ' O ' ' A' ' 10' ' ' VAL . 76.2 p -147.76 44.22 1.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.43 146.41 6.49 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.778 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.5 tt -161.45 129.66 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.762 0.315 . . . . 0.0 110.629 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.812 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 49.5 m -68.89 -59.88 4.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.805 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.812 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 72.2 Cg_endo -92.49 121.95 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.364 2.042 . . . . 0.0 112.077 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -105.78 28.51 7.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.881 0.372 . . . . 0.0 110.832 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -179.99 129.53 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.436 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.462 ' HA3' HD13 ' A' ' 93' ' ' LEU . . . 164.25 148.15 5.34 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.583 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.0 pt -51.62 158.56 1.5 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.481 0.181 . . . . 0.0 110.767 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.627 ' O ' HG21 ' A' ' 64' ' ' VAL . 73.4 Cg_exo -50.08 -41.67 48.3 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.656 2.237 . . . . 0.0 113.322 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -70.12 -8.97 53.94 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.9 m -67.93 126.9 30.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.765 0.317 . . . . 0.0 110.927 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.684 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 4.9 ttmp? -71.02 134.03 46.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.071 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.587 HG11 ' HG2' ' A' ' 15' ' ' PRO . 34.7 m -124.37 127.24 73.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 0.0 111.542 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.408 ' HB ' ' HG ' ' A' ' 14' ' ' SER . 85.1 m -78.54 102.33 7.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.563 HD13 ' SG ' ' A' ' 62' ' ' CYS . 70.7 mt -69.83 139.73 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.09 0.471 . . . . 0.0 111.403 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -144.11 130.95 20.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.205 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -169.31 -133.17 1.54 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.623 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -150.16 136.8 19.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.914 0.388 . . . . 0.0 111.325 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 61.94 39.05 13.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.508 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 mp -84.98 53.1 2.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.0 110.63 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.08 129.65 1.46 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.509 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.9 p -69.31 -36.63 77.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.76 0.314 . . . . 0.0 111.455 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.441 ' HA3' ' CZ2' ' A' ' 54' ' ' TRP . . . -150.86 174.84 30.07 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.517 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.28 -43.86 54.58 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.795 2.33 . . . . 0.0 112.486 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.3 t -58.56 -40.12 82.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.19 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.02 -46.79 85.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.156 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.62 HD21 ' N ' ' A' ' 39' ' ' ILE . 1.3 tt -59.71 129.73 43.33 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.62 ' N ' HD21 ' A' ' 38' ' ' LEU . 39.6 pt -141.95 -44.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.439 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.509 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -102.55 133.81 11.54 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.628 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.538 ' O ' HG21 ' A' ' 42' ' ' THR . 2.4 tm? -149.48 127.3 11.79 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.538 HG21 ' O ' ' A' ' 41' ' ' LEU . 11.8 p -155.87 140.82 17.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.525 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.557 HD12 ' SG ' ' A' ' 62' ' ' CYS . 73.3 mt -126.03 123.77 64.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.596 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.422 ' SG ' HD22 ' A' ' 92' ' ' LEU . 58.9 m 57.37 36.35 27.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.058 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.89 -31.66 3.05 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.055 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -73.7 133.18 43.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.854 0.359 . . . . 0.0 111.408 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.431 ' HA ' HG21 ' A' ' 42' ' ' THR . 42.0 t30 -69.2 138.3 53.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.7 m -151.04 39.27 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 110.7 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.3 tp -75.06 -43.19 54.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.107 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -52.21 -41.61 62.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.281 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.0 p -80.29 -34.62 36.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.175 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 61' ' ' VAL . . . -58.06 131.02 49.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.566 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -126.61 132.31 51.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.573 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.441 ' CZ2' ' HA3' ' A' ' 34' ' ' GLY . 77.0 t90 -68.31 144.84 54.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.196 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.7 mmt -132.65 -47.78 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.663 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.6 p -168.54 -157.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.635 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.37 32.32 1.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.355 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.7 p -179.98 37.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.278 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -164.88 129.62 2.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.102 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.4 mt -151.23 111.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.698 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -84.51 130.25 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.349 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.563 ' SG ' HD13 ' A' ' 26' ' ' ILE . 26.4 p -170.97 150.98 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.042 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -84.01 129.79 34.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.627 HG21 ' O ' ' A' ' 20' ' ' PRO . 14.3 m . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.102 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.414 ' HA3' ' SG ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.328 -0.309 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -64.14 131.58 47.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.861 0.362 . . . . 0.0 111.083 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.479 HG23 HG22 ' A' ' 10' ' ' VAL . 74.4 mt -85.36 135.43 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.522 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.4 ' N ' HG21 ' A' ' 74' ' ' ILE . 47.9 mm -134.55 133.82 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 0.0 111.713 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.0 t -141.55 118.66 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.22 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.4 m -98.68 131.88 44.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.555 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.1 p -99.48 146.29 26.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.844 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.61 ' HA ' HD12 ' A' ' 39' ' ' ILE . 56.5 tptt -58.57 -49.19 78.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.773 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 81.9 p -70.33 -54.43 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.76 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.53 -127.05 0.35 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.42 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.4 -137.25 2.18 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.17 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -65.17 126.12 27.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.7 0.286 . . . . 0.0 110.569 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.527 ' O ' HG21 ' A' ' 85' ' ' THR . . . -80.28 -150.19 6.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.154 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.553 ' OG1' HD11 ' A' ' 9' ' ' LEU . 21.5 p -158.09 151.59 23.44 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.706 0.402 . . . . 0.0 110.624 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.3 p -158.66 121.34 3.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.917 0.389 . . . . 0.0 111.431 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.427 ' O ' HG11 ' A' ' 88' ' ' VAL . 82.6 p -96.07 37.56 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.436 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.427 HG11 ' O ' ' A' ' 87' ' ' THR . 27.6 m -150.56 157.44 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.744 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.5 p -146.0 136.23 23.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -85.45 130.44 34.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.863 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -82.19 120.83 25.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.659 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.422 HD22 ' SG ' ' A' ' 44' ' ' CYS . 3.3 mm? -83.91 126.96 33.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.018 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.462 HD13 ' HA3' ' A' ' 18' ' ' GLY . 76.9 mt -94.6 134.94 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.823 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -67.01 129.21 94.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.956 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 C--N 1.347 0.481 0 C-N-CA 122.65 2.234 . . . . 0.0 112.471 179.915 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.597 0.237 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.15 138.01 78.89 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.543 2.162 . . . . 0.0 112.054 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HG2' ' HA3' ' A' ' 84' ' ' GLY . 14.1 Cg_endo -55.94 134.11 62.11 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.703 2.269 . . . . 0.0 112.331 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.422 HD11 ' O ' ' A' ' 85' ' ' THR . 64.8 tp -120.03 117.65 28.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.018 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.54 ' HB ' ' HG ' ' A' ' 86' ' ' SER . 94.8 t -83.29 132.92 30.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.841 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.529 HG21 ' O ' ' A' ' 10' ' ' VAL . 63.0 p -151.34 48.86 0.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.042 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.3 144.83 6.9 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.01 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.637 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.1 tt -163.01 131.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.579 0.228 . . . . 0.0 110.645 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.837 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 48.4 t -63.22 -59.18 12.87 Favored Pre-proline 0 C--N 1.331 -0.239 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.349 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.837 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 10.3 Cg_exo -70.7 -148.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.945 1.763 . . . . 0.0 112.035 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -175.4 -23.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.351 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.7 133.94 4.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.832 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.404 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 169.69 160.07 17.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.409 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.484 HG21 ' O ' ' A' ' 93' ' ' LEU . 30.6 pt -50.87 154.68 2.33 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.561 0.22 . . . . 0.0 111.009 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.597 ' O ' HG11 ' A' ' 64' ' ' VAL . 71.1 Cg_exo -50.18 -41.88 48.44 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.902 2.402 . . . . 0.0 113.807 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -70.51 -5.89 32.18 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -66.08 132.09 47.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.808 0.337 . . . . 0.0 111.227 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HE3' ' CG1' ' A' ' 61' ' ' VAL . 87.2 tttt -67.26 137.35 56.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.479 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.487 ' O ' HG21 ' A' ' 24' ' ' VAL . 35.9 m -140.98 127.23 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.977 0.417 . . . . 0.0 111.015 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.1 m -80.85 121.21 25.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.097 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 26' ' ' ILE . 68.0 mt -84.3 135.83 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.726 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -146.2 134.51 21.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.726 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -169.07 -132.58 1.46 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.58 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -146.09 132.88 20.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.873 0.368 . . . . 0.0 111.352 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 59.11 43.57 17.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.189 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 mp -83.31 47.88 1.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.829 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.47 125.24 0.06 OUTLIER Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.531 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.9 p -92.35 42.87 1.11 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.616 0.246 . . . . 0.0 111.211 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.05 144.81 4.78 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.752 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 10.5 Cg_endo -53.82 -42.87 62.9 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.686 2.258 . . . . 0.0 112.162 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.6 t -60.98 -37.03 81.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.954 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.57 -38.51 69.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.135 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.4 tp -76.31 60.41 1.53 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 0.0 110.914 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.479 ' O ' HD23 ' A' ' 49' ' ' LEU . 22.6 pt -69.12 -40.06 80.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.318 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.07 138.21 12.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.885 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.551 ' O ' HG21 ' A' ' 42' ' ' THR . 3.1 tm? -149.77 127.8 11.93 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.551 HG21 ' O ' ' A' ' 41' ' ' LEU . 39.3 p -151.53 136.73 17.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.976 0.417 . . . . 0.0 111.64 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.6 mm -107.65 105.62 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.911 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.419 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 38.0 t 58.28 45.22 17.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.731 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.14 -38.66 3.14 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.569 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -68.38 129.02 38.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.908 0.354 . . . . 0.0 111.141 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.479 ' HA ' HG21 ' A' ' 42' ' ' THR . 13.6 p-10 -73.62 140.76 46.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.603 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.508 ' O ' ' HB1' ' A' ' 52' ' ' ALA . 75.2 m -150.25 40.12 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.764 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 39' ' ' ILE . 61.6 tp -72.88 -49.36 30.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.224 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -54.08 -39.46 66.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.499 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.664 HG23 HH21 ' A' ' 63' ' ' ARG . 68.1 p -80.11 -38.11 32.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.576 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.547 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -62.5 130.44 45.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.847 0.356 . . . . 0.0 111.686 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -126.85 130.87 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.605 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.425 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 86.9 t90 -65.93 149.76 49.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.979 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.42 ' HE1' ' HB3' ' A' ' 55' ' ' MET . 94.9 mmm -142.37 -42.9 0.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.766 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 58' ' ' SER . 33.2 t -170.63 173.97 5.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.857 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.83 33.43 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.283 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 56' ' ' SER . 80.6 p -178.61 23.68 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.588 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -165.67 131.27 2.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.743 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.6 mt -149.43 120.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.008 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.4 ' CG1' ' HE3' ' A' ' 23' ' ' LYS . 57.4 t -81.82 126.33 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.471 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 52.7 t -171.08 149.71 2.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 0.0 111.138 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.664 HH21 HG23 ' A' ' 51' ' ' THR . 83.5 mtm180 -84.66 131.43 34.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.308 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.597 HG11 ' O ' ' A' ' 20' ' ' PRO . 5.5 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.065 0.459 . . . . 0.0 111.576 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 44' ' ' CYS . . . . . . . . 0 CA--C 1.518 0.231 0 CA-C-O 120.368 -0.129 . . . . 0.0 113.2 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -64.22 132.67 51.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.77 0.319 . . . . 0.0 111.042 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.5 92.48 3.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.817 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.416 HG22 ' HD3' ' A' ' 83' ' ' LYS . 44.5 mm -81.03 138.58 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.195 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.53 113.51 3.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.936 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.5 m -84.47 142.23 30.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.722 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.3 p -137.73 135.52 36.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.047 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -59.29 -46.72 87.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.004 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.9 p -64.42 -52.83 56.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.03 0.443 . . . . 0.0 110.331 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 -120.97 2.13 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.193 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.76 -140.77 2.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.117 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.449 ' C ' ' HD2' ' A' ' 83' ' ' LYS . 4.3 tmmm? -67.38 127.12 31.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.36 . . . . 0.0 110.169 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.445 ' HA3' ' HG2' ' A' ' 8' ' ' PRO . . . -78.15 130.64 10.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.346 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.422 ' O ' HD11 ' A' ' 9' ' ' LEU . 79.3 p -108.15 144.66 35.25 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.54 ' HG ' ' HB ' ' A' ' 10' ' ' VAL . 41.3 t -151.31 131.12 13.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.093 0.473 . . . . 0.0 111.875 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.8 p -78.17 -28.39 48.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.781 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.9 m -83.15 153.76 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.362 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.0 p -148.97 138.65 21.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.724 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -85.2 131.56 34.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.439 ' HD2' HD22 ' A' ' 93' ' ' LEU . 5.8 tmtt? -79.39 119.1 21.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.013 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.534 HD12 HG23 ' A' ' 64' ' ' VAL . 3.2 mm? -84.61 109.67 18.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 110.54 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.484 ' O ' HG21 ' A' ' 19' ' ' ILE . 54.9 mt -85.86 136.68 33.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.955 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -65.51 137.11 96.4 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.168 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--N 1.346 0.439 0 C-N-CA 122.441 2.094 . . . . 0.0 112.469 179.843 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.514 0.197 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -57.11 150.7 55.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.79 2.327 . . . . 0.0 112.308 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 82.1 Cg_exo -48.57 143.07 16.78 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.705 2.27 . . . . 0.0 112.746 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 85' ' ' THR . 4.9 tt -145.03 111.34 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.747 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' A' ' 28' ' ' GLY . 66.3 t -81.92 137.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.005 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.455 HG22 HD21 ' A' ' 9' ' ' LEU . 30.1 p -154.26 44.52 0.55 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.624 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.46 143.8 6.09 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.845 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.509 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.8 tt -164.47 129.47 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.0 110.51 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.825 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -65.22 -59.39 9.93 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.942 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.825 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 72.8 Cg_endo -94.86 118.89 0.26 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.447 2.098 . . . . 0.0 112.169 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -100.22 30.61 3.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.73 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 179.0 129.39 0.07 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.571 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.421 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . 165.09 152.29 6.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.738 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.424 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 31.9 pt -56.12 162.54 2.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.48 0.181 . . . . 0.0 111.11 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.543 ' HA ' HG22 ' A' ' 64' ' ' VAL . 87.2 Cg_exo -49.23 -46.31 26.42 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.881 2.388 . . . . 0.0 113.768 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -71.4 -4.97 29.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.1 m -63.33 126.99 29.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.845 0.355 . . . . 0.0 110.986 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.465 ' HD2' ' CG1' ' A' ' 61' ' ' VAL . 17.2 tppt? -67.13 136.31 54.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.148 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.505 HG11 ' HG2' ' A' ' 15' ' ' PRO . 31.6 m -140.59 131.67 29.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.036 0.445 . . . . 0.0 111.51 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.431 HG22 ' NZ ' ' A' ' 59' ' ' LYS . 94.9 m -89.75 116.28 27.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.549 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.577 HD13 ' HG ' ' A' ' 62' ' ' CYS . 57.3 mt -74.61 141.13 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.187 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 27' ' ' ARG . 11.9 tpt180 -147.48 130.75 16.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.997 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -170.56 -122.61 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.733 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -162.19 134.23 5.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.963 0.411 . . . . 0.0 111.598 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 60.86 40.21 16.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.86 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.6 mp -70.31 -41.96 72.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.609 0.242 . . . . 0.0 111.233 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.93 135.47 2.36 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.803 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.9 p -62.7 -39.75 94.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.798 0.332 . . . . 0.0 110.902 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.512 ' HA3' ' CE2' ' A' ' 54' ' ' TRP . . . -165.32 -164.11 20.04 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.66 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.28 -47.11 6.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.779 2.319 . . . . 0.0 112.514 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.516 ' O ' HG21 ' A' ' 39' ' ' ILE . 67.2 p -60.12 -40.91 91.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.379 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.703 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 36.5 t70 -62.65 -41.53 99.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.346 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 tt -78.33 62.15 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.947 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.516 HG21 ' O ' ' A' ' 36' ' ' THR . 27.2 pt -68.96 -41.79 82.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.19 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.414 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -112.21 140.61 16.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.098 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -146.89 134.85 21.4 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.629 HG21 ' HA ' ' A' ' 47' ' ' ASN . 14.1 p -150.36 149.82 30.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.101 0.477 . . . . 0.0 111.546 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.607 HD12 ' SG ' ' A' ' 62' ' ' CYS . 71.1 mt -135.75 116.56 18.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.484 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 65.4 m 72.82 -35.2 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.813 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 166.11 -41.08 0.27 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.026 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.401 ' H ' ' ND1' ' A' ' 46' ' ' HIS . 27.5 p-80 -80.67 138.48 36.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.959 0.409 . . . . 0.0 111.705 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.629 ' HA ' HG21 ' A' ' 42' ' ' THR . 42.2 t30 -60.68 141.51 56.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.679 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.3 m -143.76 38.15 1.34 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.846 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.55 -42.25 68.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -57.52 -42.41 82.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.58 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.8 p -80.19 -38.19 31.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.691 0.282 . . . . 0.0 111.351 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -63.09 132.9 53.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.333 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -126.38 127.39 45.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.552 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.512 ' CE2' ' HA3' ' A' ' 34' ' ' GLY . 75.2 t90 -67.46 149.97 49.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 90.4 mtp -146.04 -41.3 0.21 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.731 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.466 ' C ' ' H ' ' A' ' 58' ' ' SER . 33.8 t -165.38 173.86 10.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.685 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.34 21.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.489 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.3 m -167.72 35.31 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.884 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' NZ ' HG22 ' A' ' 25' ' ' THR . 55.0 tttp -165.09 127.95 2.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.867 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.441 HD13 HD21 ' A' ' 31' ' ' LEU . 73.9 mt -150.82 125.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.158 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 60.8 t -93.4 128.12 45.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.564 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.607 ' SG ' HD12 ' A' ' 43' ' ' ILE . 23.0 p -171.11 157.82 5.31 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.073 0.463 . . . . 0.0 111.772 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -84.59 134.76 34.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.857 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.543 HG22 ' HA ' ' A' ' 20' ' ' PRO . 18.0 m . . . . . 0 CA--C 1.516 -0.352 0 CA-C-O 121.404 0.621 . . . . 0.0 111.338 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.618 ' HA2' ' HB3' ' A' ' 89' ' ' SER . . . . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -61.43 120.31 10.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.806 0.336 . . . . 0.0 111.026 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.403 ' O ' HD11 ' A' ' 75' ' ' ILE . 69.8 mt -85.99 128.67 39.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.35 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.403 HD11 ' O ' ' A' ' 74' ' ' ILE . 37.0 mm -127.32 142.02 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.926 0.393 . . . . 0.0 111.484 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.778 ' H ' ' HA2' ' A' ' 84' ' ' GLY . 58.4 t -140.65 122.71 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.57 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.3 m -86.48 141.75 28.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.115 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.4 p -136.08 136.01 39.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.804 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.703 ' HE2' ' HA ' ' A' ' 37' ' ' ASP . 48.3 mtmt -57.16 -46.91 82.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.0 m -68.4 -53.12 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.083 0.468 . . . . 0.0 110.258 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.74 -123.37 0.67 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.189 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.63 -140.78 2.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.325 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -63.31 132.42 51.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.949 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.778 ' HA2' ' H ' ' A' ' 76' ' ' VAL . . . -68.11 159.48 51.34 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.946 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 74.2 p -143.37 145.67 32.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.9 p -157.14 131.51 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 0.0 111.698 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 65.3 p -79.2 -33.06 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.538 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.1 m -84.24 158.6 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.396 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.618 ' HB3' ' HA2' ' A' ' 72' ' ' GLY . 31.4 m -148.88 139.99 23.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.075 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.511 ' CE2' HG23 ' A' ' 64' ' ' VAL . 68.2 t80 -85.51 133.58 34.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.045 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 92' ' ' LEU . 5.5 tmtt? -80.76 121.41 25.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.299 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.52 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 94.0 mt -84.82 109.12 17.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 110.202 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.434 HD22 ' HD2' ' A' ' 91' ' ' LYS . 50.0 mt -83.64 138.0 33.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.342 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -62.61 141.59 96.86 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.287 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo . . . . . 0 C--N 1.348 0.503 0 C-N-CA 122.729 2.286 . . . . 0.0 112.503 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.664 0.269 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.21 144.34 98.83 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.754 2.302 . . . . 0.0 112.13 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.526 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 10.3 Cg_endo -54.18 115.86 2.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.533 2.155 . . . . 0.0 112.109 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.5 tp -90.62 98.37 11.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.196 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.477 ' HB ' ' CB ' ' A' ' 86' ' ' SER . 60.3 t -79.92 135.42 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.273 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 t -167.76 52.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.183 0.516 . . . . 0.0 111.271 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.06 137.67 4.79 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.483 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.521 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.8 tt -165.15 128.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.709 0.29 . . . . 0.0 110.624 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.797 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.3 t -66.54 -57.92 11.23 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.626 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.797 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 98.2 Cg_endo -91.47 110.54 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.336 2.024 . . . . 0.0 112.15 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.473 ' N ' HD21 ' A' ' 16' ' ' ASN . 1.8 m120 -88.49 26.79 1.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.728 0.299 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 179.82 130.16 0.09 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.521 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.494 ' O ' HD11 ' A' ' 92' ' ' LEU . . . 169.05 143.08 3.72 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.472 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.427 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.6 pt -53.14 161.31 1.34 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.434 0.159 . . . . 0.0 111.214 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.605 ' N ' HD13 ' A' ' 92' ' ' LEU . 88.8 Cg_exo -47.79 -43.48 28.95 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.79 2.327 . . . . 0.0 113.75 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -68.56 -20.66 64.55 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.7 m -59.48 129.1 40.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 111.003 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.554 ' HB3' ' NZ ' ' A' ' 23' ' ' LYS . 6.1 ttpm? -71.56 143.34 49.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.016 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.561 HG23 HG12 ' A' ' 64' ' ' VAL . 34.8 m -140.27 131.03 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.99 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.1 m -90.33 87.39 6.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.431 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.566 HD13 ' SG ' ' A' ' 62' ' ' CYS . 69.8 mt -60.77 137.3 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.572 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' A' ' 58' ' ' SER . 75.9 ttt180 -148.07 140.44 24.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.963 0.411 . . . . 0.0 111.054 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -167.07 -127.61 0.92 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.298 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -150.4 137.21 19.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.921 0.391 . . . . 0.0 111.214 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 72.4 m-80 64.82 32.49 10.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.496 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.526 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 9.2 mp -83.27 48.93 1.46 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.951 0.405 . . . . 0.0 110.607 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.58 121.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.597 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -89.54 41.02 1.02 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.729 0.299 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.4 146.42 5.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.733 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.21 -43.18 61.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.52 2.146 . . . . 0.0 112.07 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.5 p -59.01 -40.7 85.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.775 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 78' ' ' THR . 55.6 m-20 -58.07 -32.31 67.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.671 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.489 ' C ' HD21 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -76.91 58.09 1.42 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.34 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.9 pt -66.52 -22.49 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.915 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.13 141.94 10.66 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.426 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 42' ' ' THR . 2.9 tm? -149.78 130.4 14.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.48 ' N ' HD12 ' A' ' 41' ' ' LEU . 81.4 m -161.4 127.62 3.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 111.782 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.472 HD11 HG11 ' A' ' 64' ' ' VAL . 76.9 mt -100.56 129.75 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.588 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 48.8 t 65.47 -72.74 0.07 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.249 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.7 30.77 0.12 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.427 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -131.08 128.42 40.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 110.805 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -63.1 134.5 56.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 71.4 m -152.67 39.69 0.56 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.682 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.91 -46.23 45.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.385 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -55.5 -37.88 68.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.221 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.6 p -79.94 -36.91 35.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.93 134.97 56.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.243 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -126.18 129.08 48.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.804 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 87.3 t90 -70.52 145.21 51.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.093 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.6 mmt -132.63 -48.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.771 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.9 m -161.74 -161.78 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.702 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.97 32.86 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.253 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.61 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 83.4 p -178.77 35.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.247 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.563 ' NZ ' ' HB2' ' A' ' 59' ' ' LYS . 5.1 ttmp? -165.41 135.4 3.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.338 . . . . 0.0 111.078 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.6 mt -150.61 120.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.77 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 51.5 t -90.35 127.59 42.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.629 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.566 ' SG ' HD13 ' A' ' 26' ' ' ILE . 27.6 p -170.55 154.63 4.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.15 133.65 34.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.66 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.598 HG21 ' O ' ' A' ' 20' ' ' PRO . 11.5 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.934 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 N-CA-C 113.523 0.169 . . . . 0.0 113.523 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -65.62 121.94 16.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.524 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.5 mt -97.68 131.23 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.376 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.414 ' HA ' HD11 ' A' ' 75' ' ' ILE . 48.3 mm -134.22 140.19 46.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.458 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 p -140.85 125.68 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.78 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.627 ' HA ' ' H ' ' A' ' 83' ' ' LYS . 15.9 m -90.77 139.96 30.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.718 ' H ' ' HA3' ' A' ' 82' ' ' GLY . 73.8 p -147.41 143.86 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.118 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -54.02 -33.88 58.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.055 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.8 m -63.44 -49.41 73.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.703 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.77 -48.46 0.23 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.759 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.718 ' HA3' ' H ' ' A' ' 78' ' ' THR . . . 75.8 127.19 0.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.873 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.627 ' H ' ' HA ' ' A' ' 77' ' ' THR . 61.7 tttm 51.67 56.93 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 110.995 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.49 -138.4 0.05 OUTLIER Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.848 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.0 p -149.98 -168.2 3.04 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.723 0.297 . . . . 0.0 110.817 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.553 ' HG ' HG21 ' A' ' 88' ' ' VAL . 45.4 t -167.76 129.3 1.49 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.257 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 77.0 p -92.91 37.84 1.02 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.231 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.553 HG21 ' HG ' ' A' ' 86' ' ' SER . 29.6 m -150.73 139.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.88 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.0 m -118.97 127.99 53.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.164 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.459 ' CD2' HG13 ' A' ' 64' ' ' VAL . 44.3 t80 -89.31 124.06 34.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.979 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -85.06 91.7 8.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.12 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.605 HD13 ' N ' ' A' ' 20' ' ' PRO . 31.6 tp -65.14 128.39 35.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.249 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 18' ' ' GLY . 80.5 mt -80.41 137.0 36.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.072 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.616 ' HZ3' ' HB2' ' A' ' 94' ' ' LYS . 4.8 ttmp? -64.15 134.7 96.04 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.347 0.459 0 C-N-CA 122.487 2.125 . . . . 0.0 112.57 -179.875 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.605 0.241 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.91 139.66 80.79 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.552 2.168 . . . . 0.0 112.234 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.518 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 17.3 Cg_endo -58.16 123.2 13.11 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.58 2.187 . . . . 0.0 112.168 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -94.17 122.0 36.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.553 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 62.1 t -99.6 140.53 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.432 ' N ' HG11 ' A' ' 10' ' ' VAL . 6.4 t -166.99 50.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 111.348 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.71 140.53 5.74 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.695 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.502 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.3 tt -164.42 131.18 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.722 0.296 . . . . 0.0 110.507 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.833 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.8 t -66.39 -59.13 8.88 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.931 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.833 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 88.7 Cg_endo -96.08 119.87 0.21 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.652 2.235 . . . . 0.0 112.137 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -94.69 29.51 2.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 110.713 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 179.06 133.78 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.602 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.46 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 167.07 146.95 5.07 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.947 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.487 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 37.2 pt -55.78 159.24 5.46 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 110.736 -0.098 . . . . 0.0 110.736 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.605 ' HA ' HG22 ' A' ' 64' ' ' VAL . 3.7 Cg_endo -48.25 -41.9 34.22 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.708 2.272 . . . . 0.0 113.22 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -67.87 -23.06 65.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.444 ' HG1' ' N ' ' A' ' 19' ' ' ILE . 94.7 m -54.43 127.98 29.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.042 0.449 . . . . 0.0 111.659 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.443 ' HE3' HG12 ' A' ' 61' ' ' VAL . 86.8 tttt -73.04 140.2 47.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.445 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.591 HG23 HG12 ' A' ' 64' ' ' VAL . 30.3 m -141.69 132.91 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.908 0.385 . . . . 0.0 111.362 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.0 m -87.61 118.55 27.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.528 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.454 HG21 ' N ' ' A' ' 27' ' ' ARG . 63.5 mt -80.34 140.41 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.032 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.454 ' N ' HG21 ' A' ' 26' ' ' ILE . 25.1 mmm180 -141.38 135.63 30.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.682 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.24 -134.7 2.0 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.662 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -149.14 136.66 20.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 111.282 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.518 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.0 m-20 63.28 36.4 11.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.33 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.524 HD11 ' N ' ' A' ' 31' ' ' LEU . 9.1 mp -82.6 61.04 5.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.944 0.402 . . . . 0.0 110.503 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.96 121.27 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.124 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.3 p -92.18 33.67 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.817 0.341 . . . . 0.0 111.244 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.8 149.95 5.93 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.498 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.15 -45.04 41.71 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.525 2.15 . . . . 0.0 111.876 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 t -64.19 -38.14 89.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.231 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 56.7 m-20 -54.61 -54.24 44.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.756 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.99 127.15 30.17 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.443 ' O ' HD23 ' A' ' 49' ' ' LEU . 41.9 pt -138.31 -25.81 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.694 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.85 142.26 13.35 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.133 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' A' ' 52' ' ' ALA . 1.8 tm? -149.57 131.61 15.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.435 HG21 ' O ' ' A' ' 41' ' ' LEU . 3.4 p -151.66 146.43 25.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.161 0.505 . . . . 0.0 111.623 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 64' ' ' VAL . 80.5 mt -137.53 123.41 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.683 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.402 ' SG ' ' HA3' ' A' ' 72' ' ' GLY . 80.0 m 57.41 39.54 28.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.259 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.18 -31.29 1.82 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.549 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -73.5 131.09 41.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.829 0.347 . . . . 0.0 111.278 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -72.35 140.36 48.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.5 m -150.71 39.86 0.72 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.772 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 39' ' ' ILE . 60.8 tp -70.97 -42.57 69.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.364 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -51.13 -43.16 61.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.446 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.0 p -80.31 -32.1 38.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.327 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.525 ' HB2' ' HG ' ' A' ' 41' ' ' LEU . . . -56.4 131.27 47.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.774 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -127.12 131.96 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.198 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.428 ' CH2' ' HA ' ' A' ' 56' ' ' SER . 65.2 t90 -72.1 146.77 47.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.355 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.509 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 22.1 mmt -133.82 -50.24 0.83 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.066 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.428 ' HA ' ' CH2' ' A' ' 54' ' ' TRP . 78.0 p -169.18 -156.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.703 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -96.01 30.98 2.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.147 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.7 p -178.76 31.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.057 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 55' ' ' MET . 63.0 tttm -165.05 128.39 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.8 mt -151.66 114.6 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.882 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.443 HG12 ' HE3' ' A' ' 23' ' ' LYS . 90.7 t -80.3 131.87 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.084 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.4 p -169.08 155.02 6.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.992 0.425 . . . . 0.0 111.405 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -83.99 126.22 32.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.288 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.605 HG22 ' HA ' ' A' ' 20' ' ' PRO . 5.2 m . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.077 0.465 . . . . 0.0 111.103 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.402 ' HA3' ' SG ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.453 -0.212 0 N-CA-C 112.406 -0.277 . . . . 0.0 112.406 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.28 137.27 38.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.702 0.287 . . . . 0.0 111.055 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.07 127.78 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.227 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.484 HD11 ' O ' ' A' ' 84' ' ' GLY . 40.5 mm -128.1 138.41 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.899 0.381 . . . . 0.0 111.304 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -139.8 119.06 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.678 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 58.2 m -89.07 130.01 35.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.532 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 64.4 p -107.83 143.48 36.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.615 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 53.1 tptt -56.32 -43.79 79.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 110.369 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 87.2 p -73.06 -56.83 4.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.65 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.2 -125.42 2.02 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.587 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 77' ' ' THR . . . -160.54 -139.63 2.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.398 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.611 ' HZ2' ' HB3' ' A' ' 83' ' ' LYS . 9.0 mtpm? -64.34 126.06 26.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.897 0.379 . . . . 0.0 111.343 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' HD11 ' A' ' 75' ' ' ILE . . . -79.9 143.42 25.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.403 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.2 p -98.63 139.2 34.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.678 0.275 . . . . 0.0 110.995 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.52 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 63.5 p -136.26 132.27 35.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.418 . . . . 0.0 111.299 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -81.04 -32.16 34.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.922 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.6 m -84.18 176.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.322 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.5 m -156.88 138.11 13.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.644 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.458 ' CD2' HG13 ' A' ' 64' ' ' VAL . 52.3 t80 -88.85 132.48 34.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.431 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -91.99 122.3 34.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.276 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.41 HD11 ' HA ' ' A' ' 92' ' ' LEU . 3.7 mm? -84.49 127.02 33.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.948 0.404 . . . . 0.0 111.168 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.46 ' HG ' ' N ' ' A' ' 18' ' ' GLY . 77.9 mt -91.38 138.27 31.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.709 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.599 ' NZ ' ' HB3' ' A' ' 94' ' ' LYS . 3.3 mmmp? -59.21 129.84 86.65 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.546 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.405 ' HA ' HG23 ' A' ' 19' ' ' ILE . 53.2 Cg_exo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.52 2.147 . . . . 0.0 112.56 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.475 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 4.8 tp60 . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.475 ' HD2' ' OE1' ' A' ' 6' ' ' GLN . 61.9 Cg_exo -52.01 146.32 30.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.427 2.084 . . . . 0.0 112.222 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 51.2 Cg_exo -54.91 129.46 35.38 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.52 2.147 . . . . 0.0 112.244 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 85' ' ' THR . 59.6 tp -114.92 109.29 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.63 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.588 ' HB ' ' HG ' ' A' ' 86' ' ' SER . 61.2 t -74.76 129.72 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.743 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.526 HG21 ' O ' ' A' ' 10' ' ' VAL . 68.6 p -148.32 46.3 1.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.096 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.18 141.56 4.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.201 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.439 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 14.7 tt -164.66 129.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.714 0.292 . . . . 0.0 110.304 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.789 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.8 t -66.12 -58.64 10.33 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.167 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 90.2 Cg_endo -88.88 124.23 1.51 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.121 1.881 . . . . 0.0 112.881 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.81 26.28 6.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.072 0.463 . . . . 0.0 110.125 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 177.66 131.8 0.06 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.585 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.546 ' O ' HD13 ' A' ' 92' ' ' LEU . . . 169.06 141.58 3.26 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.006 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.461 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 37.6 pt -57.44 162.85 4.05 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 122.066 0.146 . . . . 0.0 111.012 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.585 ' HA ' HG22 ' A' ' 64' ' ' VAL . 83.2 Cg_exo -48.19 -39.56 34.34 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.658 2.238 . . . . 0.0 113.311 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.524 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 89.9 m95 -70.53 -24.45 62.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -57.64 128.95 39.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 111.279 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -73.87 137.49 43.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.555 ' O ' HG21 ' A' ' 24' ' ' VAL . 27.0 m -134.7 132.52 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.03 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.4 m -87.35 113.56 23.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.71 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.52 HG21 ' N ' ' A' ' 27' ' ' ARG . 77.8 mt -75.22 139.45 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.955 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.588 ' HD2' ' O ' ' A' ' 58' ' ' SER . 27.4 tpt180 -147.25 133.15 19.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.291 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -169.14 -132.77 1.48 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.634 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -147.26 134.84 20.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 111.341 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.468 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 75.7 m-20 61.0 41.08 14.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.548 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.571 HD11 ' N ' ' A' ' 31' ' ' LEU . 10.0 mp -83.08 46.86 1.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.031 0.443 . . . . 0.0 110.389 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.35 121.8 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.462 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.1 p -87.56 39.08 0.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.835 0.35 . . . . 0.0 111.182 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.03 146.25 5.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.445 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.38 -40.94 81.31 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.603 2.202 . . . . 0.0 112.024 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.2 p -59.91 -40.23 88.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.183 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -58.16 -45.08 88.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.658 HD21 ' N ' ' A' ' 39' ' ' ILE . 1.5 tt -61.29 133.93 56.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.81 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.658 ' N ' HD21 ' A' ' 38' ' ' LEU . 26.5 pt -142.84 -44.54 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.435 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -102.9 136.05 12.64 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.677 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.437 ' HG ' ' HB1' ' A' ' 52' ' ' ALA . 1.7 tm? -149.23 128.17 12.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.418 HG22 ' C ' ' A' ' 46' ' ' HIS . 95.7 m -161.41 135.93 7.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.229 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.4 mt -129.87 130.45 66.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.373 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 63.5 m 56.13 40.64 30.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.631 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.28 29.04 73.29 Favored Glycine 0 CA--C 1.518 0.229 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.878 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.418 ' C ' HG22 ' A' ' 42' ' ' THR . 81.9 t60 -130.92 131.42 44.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.73 0.3 . . . . 0.0 110.871 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.519 HD21 ' N ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -66.32 132.86 49.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.632 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.519 ' N ' HD21 ' A' ' 47' ' ' ASN . 72.2 m -152.36 38.42 0.56 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.982 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.25 -42.44 59.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.26 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -53.83 -40.74 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.65 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.471 HG23 ' NE ' ' A' ' 63' ' ' ARG . 62.4 p -79.76 -35.04 39.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.598 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.547 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -54.4 135.01 45.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.633 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.65 132.85 51.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.662 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -70.41 151.79 44.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.059 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.6 mmt -142.95 -44.3 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.924 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.5 p -166.05 -166.09 0.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.749 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.02 30.63 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.266 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.588 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 79.0 p 179.04 37.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.031 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -164.76 131.82 3.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.983 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.44 HD12 HD13 ' A' ' 38' ' ' LEU . 72.4 mt -150.72 115.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.4 t -79.93 130.39 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.272 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 53.7 t -170.35 151.9 3.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.025 0.44 . . . . 0.0 111.432 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.524 ' NH1' ' HZ3' ' A' ' 21' ' ' TRP . 39.3 ptt180 -84.05 130.02 34.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.201 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 20' ' ' PRO . 4.9 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 111.61 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.23 0 N-CA-C 112.358 -0.297 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.454 ' OD1' HD12 ' A' ' 75' ' ' ILE . 9.7 t0 -81.13 134.74 35.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.741 0.305 . . . . 0.0 111.015 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.544 HG23 HG23 ' A' ' 10' ' ' VAL . 67.6 mt -85.67 131.75 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.33 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.454 HD12 ' OD1' ' A' ' 73' ' ' ASP . 50.5 mm -134.08 135.9 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 0.0 111.359 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.685 ' H ' ' HA2' ' A' ' 84' ' ' GLY . 99.6 t -141.56 116.98 5.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.811 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.4 m -82.07 146.19 29.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.423 HG22 ' HG2' ' A' ' 8' ' ' PRO . 75.3 p -141.54 139.85 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.17 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 32.1 mmmt -57.1 -51.09 70.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.7 t -65.69 -53.48 40.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.004 0.431 . . . . 0.0 110.544 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.77 -123.06 0.26 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.238 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.55 -139.11 2.58 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.188 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.84 131.97 48.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.616 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.685 ' HA2' ' H ' ' A' ' 76' ' ' VAL . . . -62.41 152.95 43.9 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.691 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 63.0 p -147.93 142.61 26.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.711 0.291 . . . . 0.0 110.713 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.588 ' HG ' ' HB ' ' A' ' 10' ' ' VAL . 42.7 t -160.81 128.16 4.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.948 0.404 . . . . 0.0 111.319 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -74.57 -30.42 61.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.447 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.532 HG21 ' OG ' ' A' ' 86' ' ' SER . 33.0 m -83.79 152.84 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.238 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 m -138.84 141.27 38.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.822 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.473 ' CD2' HG13 ' A' ' 64' ' ' VAL . 41.7 t80 -85.9 127.7 34.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.324 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -82.69 88.24 6.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.243 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 18' ' ' GLY . 35.4 tp -64.6 127.27 30.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.2 mt -92.19 136.17 33.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.218 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -72.16 130.6 86.15 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.693 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo . . . . . 0 C--N 1.346 0.421 0 C-N-CA 122.643 2.229 . . . . 0.0 112.957 -179.695 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.473 0.178 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.34 136.42 63.86 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.482 2.121 . . . . 0.0 112.156 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.534 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 50.2 Cg_exo -53.92 134.23 58.44 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.492 2.128 . . . . 0.0 112.091 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 85' ' ' THR . 1.3 tm? -119.71 130.44 55.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.497 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.591 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 90.5 t -101.92 137.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.744 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.428 ' N ' HG11 ' A' ' 10' ' ' VAL . 39.6 p -151.38 48.3 0.82 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.197 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.15 144.81 6.36 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.021 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.431 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.6 tt -164.8 130.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 110.722 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.817 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -67.33 -59.62 6.98 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.672 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.817 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 83.0 Cg_endo -89.52 125.1 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.06 1.84 . . . . 0.0 112.421 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -86.02 -18.62 32.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.623 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -156.15 138.46 14.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.238 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.8 148.71 7.03 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.561 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 19' ' ' ILE . 40.6 pt -51.82 157.51 1.97 Allowed Pre-proline 0 CA--C 1.531 0.25 0 CA-C-O 120.573 0.225 . . . . 0.0 111.065 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.616 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 84.8 Cg_exo -47.6 -37.5 26.92 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.713 2.276 . . . . 0.0 113.41 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -76.81 -22.4 53.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.425 ' OG1' HG12 ' A' ' 19' ' ' ILE . 96.1 m -52.01 130.88 30.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.796 0.331 . . . . 0.0 111.093 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -65.26 139.05 58.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.406 HG23 HG21 ' A' ' 64' ' ' VAL . 34.1 m -141.2 125.64 17.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.6 m -93.46 116.71 29.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.545 HG23 HD22 ' A' ' 31' ' ' LEU . 55.7 mt -76.54 138.47 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.702 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.432 ' N ' HG21 ' A' ' 26' ' ' ILE . 43.2 mmm-85 -140.39 130.39 24.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.301 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.36 -133.85 1.65 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.629 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -147.61 132.63 18.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.799 0.333 . . . . 0.0 111.111 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 57.5 41.25 26.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.333 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.545 HD22 HG23 ' A' ' 26' ' ' ILE . 10.5 mp -70.35 -36.22 74.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.733 0.301 . . . . 0.0 110.68 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.86 130.93 1.62 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.559 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 37' ' ' ASP . 81.8 p -65.24 -39.31 92.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.731 0.301 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.461 ' HA3' ' CZ2' ' A' ' 54' ' ' TRP . . . -164.52 -161.18 13.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.778 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.56 -49.25 7.61 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.723 2.282 . . . . 0.0 112.64 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.5 p -62.93 -38.84 92.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.53 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.407 ' HB2' ' OG1' ' A' ' 33' ' ' THR . 8.3 t70 -55.75 -51.67 66.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.18 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.687 HD13 HD12 ' A' ' 60' ' ' ILE . 1.4 tt -70.2 134.27 47.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.571 ' N ' HD21 ' A' ' 38' ' ' LEU . 43.1 pt -145.2 -37.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.195 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.439 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -113.69 142.68 17.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.813 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.463 ' O ' HG21 ' A' ' 42' ' ' THR . 1.1 tm? -149.57 130.78 14.55 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.609 HG21 ' HA ' ' A' ' 47' ' ' ASN . 18.5 p -151.88 145.99 25.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.147 0.498 . . . . 0.0 111.888 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 69.8 mt -134.77 118.9 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.238 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 65.0 m 74.91 -38.01 0.37 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.523 0.514 . . . . 0.0 110.53 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.79 -36.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.104 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -77.19 131.07 38.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 110.853 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.609 ' HA ' HG21 ' A' ' 42' ' ' THR . 14.9 p-10 -74.86 144.91 43.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.894 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.9 m -146.77 43.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 2.3 tm? -66.15 -45.99 79.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.709 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -49.19 -41.78 37.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.588 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.6 p -80.54 -35.42 34.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.408 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.28 134.93 56.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.845 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -127.1 134.37 50.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.63 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.461 ' CZ2' ' HA3' ' A' ' 34' ' ' GLY . 81.7 t90 -73.42 152.98 40.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.4 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.6 mmt -145.64 -46.25 0.21 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.777 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.418 ' C ' ' H ' ' A' ' 58' ' ' SER . 35.9 t -171.25 177.26 3.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.679 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.13 35.53 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.607 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 56' ' ' SER . 78.1 p -179.31 30.63 0.0 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.868 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -165.38 133.09 3.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.687 HD12 HD13 ' A' ' 38' ' ' LEU . 77.8 mt -151.34 113.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.845 0.355 . . . . 0.0 111.044 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.6 t -82.15 130.72 35.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.182 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.552 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.1 p -170.51 153.56 4.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.754 0.312 . . . . 0.0 111.483 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -84.06 136.57 33.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.882 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.616 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 2.5 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.183 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.419 0 N-CA-C 112.658 -0.177 . . . . 0.0 112.658 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -63.8 132.16 50.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.804 0.335 . . . . 0.0 111.014 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.9 mt -85.46 129.0 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.533 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.403 HG21 ' O ' ' A' ' 84' ' ' GLY . 41.5 mm -132.76 142.09 43.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.266 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.633 ' H ' ' HA2' ' A' ' 84' ' ' GLY . 6.6 p -141.31 122.52 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.94 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.7 m -87.22 147.7 25.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.37 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.1 p -140.7 140.83 34.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.805 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -51.49 -48.75 62.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 82.2 p -68.98 -46.19 68.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.94 -129.52 0.05 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.885 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.03 -39.29 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.052 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -168.38 129.51 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.633 ' HA2' ' H ' ' A' ' 76' ' ' VAL . . . -67.67 154.22 52.98 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.204 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 63.3 p -144.22 140.0 29.03 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.591 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 42.9 t -154.06 136.41 14.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.99 0.424 . . . . 0.0 111.832 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.9 p -92.71 37.33 1.01 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.173 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.482 HG21 ' OG ' ' A' ' 86' ' ' SER . 33.4 m -148.45 146.61 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.9 m -135.11 136.2 41.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.006 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -86.01 133.84 33.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.557 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -85.24 125.51 32.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.494 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.546 ' N ' HD21 ' A' ' 92' ' ' LEU . 3.5 mm? -85.33 133.88 34.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.843 0.354 . . . . 0.0 111.29 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.0 mt -108.16 134.22 51.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.614 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -65.52 124.28 86.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.659 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo . . . . . 0 C--N 1.349 0.588 0 C-N-CA 122.321 2.014 . . . . 0.0 112.356 179.959 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.618 0.247 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.62 142.93 91.56 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.478 2.119 . . . . 0.0 112.085 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 15.7 Cg_endo -57.32 137.96 84.02 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.614 2.209 . . . . 0.0 112.38 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -124.88 124.22 41.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.284 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.462 ' HA ' ' HA2' ' A' ' 28' ' ' GLY . 68.3 t -86.93 136.88 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.088 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.411 ' N ' HG11 ' A' ' 10' ' ' VAL . 23.3 p -152.52 45.48 0.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.872 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.67 144.17 6.48 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.206 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.482 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.1 tt -161.16 128.85 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.684 0.278 . . . . 0.0 110.489 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.601 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.6 t -61.96 -57.74 22.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.489 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 85.7 Cg_endo -75.95 -156.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.84 1.693 . . . . 0.0 111.804 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -168.96 -30.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.457 . . . . 0.0 110.34 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.4 130.87 11.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.285 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.444 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 177.03 152.32 9.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.846 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.432 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 35.6 pt -52.22 162.73 0.81 Allowed Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 122.338 0.255 . . . . 0.0 111.461 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.521 ' O ' HG21 ' A' ' 64' ' ' VAL . 86.6 Cg_exo -49.84 -43.92 38.82 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.957 2.438 . . . . 0.0 113.942 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.37 -5.57 29.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.432 ' HG1' ' N ' ' A' ' 19' ' ' ILE . 99.2 m -67.93 127.81 34.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.757 0.313 . . . . 0.0 111.121 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -72.53 138.62 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.36 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 62' ' ' CYS . 34.6 m -136.03 127.04 43.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 111.337 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.9 m -87.14 125.46 34.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.275 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.534 HD13 ' SG ' ' A' ' 62' ' ' CYS . 58.8 mt -85.96 139.19 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.909 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.406 ' HG3' HH11 ' A' ' 27' ' ' ARG . 44.0 mmm-85 -143.13 130.78 21.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.268 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -169.59 -131.52 1.33 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.598 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -143.69 134.43 25.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.952 0.406 . . . . 0.0 111.698 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.6 m-80 59.88 43.5 14.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.664 178.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.45 ' HB3' HD13 ' A' ' 60' ' ' ILE . 9.1 mp -83.42 51.09 1.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.947 0.403 . . . . 0.0 110.39 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.13 124.8 0.34 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.532 -179.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.7 p -87.58 38.84 0.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 111.343 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 166.75 146.43 4.85 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.626 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.22 -45.77 32.9 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.639 2.226 . . . . 0.0 112.049 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 p -60.59 -37.82 82.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.873 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.433 ' OD1' ' HB3' ' A' ' 79' ' ' LYS . 39.1 t70 -58.2 -41.88 84.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.075 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.584 HD13 HD12 ' A' ' 60' ' ' ILE . 1.8 tt -66.62 75.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.138 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' A' ' 79' ' ' LYS . 34.8 pt -76.59 -40.63 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.183 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.418 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -121.76 142.73 15.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.412 -179.018 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.417 ' O ' HG21 ' A' ' 42' ' ' THR . 3.3 tm? -150.0 132.96 16.14 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.417 HG21 ' O ' ' A' ' 41' ' ' LEU . 60.9 p -147.52 127.52 13.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.903 0.383 . . . . 0.0 111.837 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.444 HD12 ' SG ' ' A' ' 62' ' ' CYS . 72.7 mt -108.19 124.86 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.022 178.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 67.4 m 54.54 41.25 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.021 0.439 . . . . 0.0 110.459 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.57 34.38 89.75 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.747 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -131.31 132.01 44.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.594 0.235 . . . . 0.0 110.538 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -63.3 131.05 47.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.714 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.0 m -154.46 37.58 0.43 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.2 tm? -72.77 -45.6 57.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 110.32 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.74 -40.22 72.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.167 -179.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.0 p -80.05 -37.47 33.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.992 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.555 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.61 133.9 56.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.351 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.92 131.91 51.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.759 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -69.9 151.55 45.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.958 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.0 mmt -142.07 -44.99 0.34 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.02 179.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.485 ' HG ' ' H ' ' A' ' 59' ' ' LYS . 79.6 p -163.34 -164.95 0.99 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.662 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.45 35.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.4 ' O ' HD21 ' A' ' 31' ' ' LEU . 80.8 p -178.96 -43.37 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.364 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.485 ' H ' ' HG ' ' A' ' 56' ' ' SER . 41.0 ttmt -77.63 133.31 38.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.494 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.584 HD12 HD13 ' A' ' 38' ' ' LEU . 68.6 mt -151.33 111.81 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.387 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.5 t -80.23 125.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.956 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.555 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.0 p -170.72 131.57 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -87.82 140.4 29.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 20' ' ' PRO . 33.4 m . . . . . 0 CA--C 1.534 0.343 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.629 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.333 -0.307 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.32 135.85 42.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.773 0.32 . . . . 0.0 110.821 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.2 mt -85.67 92.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.176 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -86.67 139.66 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.172 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.408 ' O ' HG11 ' A' ' 76' ' ' VAL . 7.5 p -141.36 125.46 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.813 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.4 m -95.95 144.14 26.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.406 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.9 p -126.48 141.02 52.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.876 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.559 ' HA ' HD12 ' A' ' 39' ' ' ILE . 23.5 tptm -56.98 -48.93 77.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.899 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -67.66 -55.35 13.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.53 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.39 -124.71 0.69 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.178 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.51 -143.32 3.78 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.099 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.75 117.94 13.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 110.58 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.3 -149.92 25.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.522 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.8 p -155.22 -169.21 3.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.66 0.267 . . . . 0.0 110.542 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.0 p -170.85 128.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.913 0.387 . . . . 0.0 111.319 179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.5 p -76.27 -34.28 59.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.37 178.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 m -84.66 146.32 6.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.345 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -134.96 134.62 40.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.714 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -89.33 136.67 32.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.664 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -102.55 123.28 46.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.442 179.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 mp -85.28 132.08 34.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 0.0 111.4 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 18' ' ' GLY . 84.2 mt -90.67 138.09 31.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.242 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -67.45 135.41 93.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.368 179.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo . . . . . 0 C--N 1.344 0.29 0 C-N-CA 122.394 2.063 . . . . 0.0 112.151 179.928 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.709 0.29 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.39 138.53 39.23 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.522 2.148 . . . . 0.0 112.13 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.442 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 16.9 Cg_endo -58.31 127.73 25.89 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.48 2.12 . . . . 0.0 112.066 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 85' ' ' THR . 64.4 tp -109.91 117.38 33.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.107 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.549 ' HA ' ' HA2' ' A' ' 28' ' ' GLY . 89.7 t -83.22 131.31 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.776 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.517 HG21 ' O ' ' A' ' 10' ' ' VAL . 73.8 p -149.04 47.9 0.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.032 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.04 147.51 8.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.178 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.56 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.8 tt -161.18 130.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.587 0.232 . . . . 0.0 110.655 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.847 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 44.3 t -63.51 -59.26 12.29 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.31 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.847 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 7.3 Cg_exo -71.29 -147.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.93 1.754 . . . . 0.0 111.748 179.032 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -176.4 -25.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.945 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -162.69 129.49 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.129 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.48 155.07 13.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.728 -179.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.0 pt -51.14 159.75 0.99 Allowed Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.692 0.282 . . . . 0.0 111.382 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.597 ' O ' HG21 ' A' ' 64' ' ' VAL . 86.5 Cg_exo -48.28 -48.28 17.33 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.978 2.452 . . . . 0.0 113.96 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -65.85 -5.69 9.82 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.4 m -67.28 126.17 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 111.071 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.669 ' HZ2' ' HB3' ' A' ' 23' ' ' LYS . 6.1 ttpm? -71.41 133.19 45.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.618 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.48 ' CG1' ' HG2' ' A' ' 15' ' ' PRO . 34.4 m -131.79 126.1 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 111.007 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.2 m -83.73 125.55 32.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.25 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.519 HG21 ' N ' ' A' ' 27' ' ' ARG . 48.7 mt -82.12 139.21 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.835 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.519 ' N ' HG21 ' A' ' 26' ' ' ILE . 23.2 mmm180 -146.51 132.95 19.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.312 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -169.21 -130.47 1.2 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.391 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -147.31 132.98 18.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 71.5 m-80 61.07 42.55 12.34 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.615 178.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 mp -83.13 49.06 1.47 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.939 0.399 . . . . 0.0 110.664 178.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.3 122.73 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.558 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -91.74 42.44 1.1 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.921 0.391 . . . . 0.0 111.177 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.53 146.44 5.52 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.711 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.9 -42.92 62.61 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.588 2.192 . . . . 0.0 111.901 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.3 p -61.96 -32.65 73.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.995 179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -77.84 45.73 0.53 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.048 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 tt -162.1 55.44 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.131 0.491 . . . . 0.0 110.005 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.0 pt -66.54 -37.86 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.323 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.41 138.95 15.34 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.9 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -148.42 134.06 18.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.786 0.327 . . . . 0.0 110.134 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.512 HG21 ' HA ' ' A' ' 47' ' ' ASN . 19.4 p -147.13 147.16 30.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.463 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.546 ' C ' ' H ' ' A' ' 45' ' ' GLY . 75.0 mt -128.8 116.19 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.788 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 69.1 m 70.68 -30.46 0.2 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.982 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.38 -44.18 0.31 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.621 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -80.45 139.48 36.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.856 0.36 . . . . 0.0 111.237 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.512 ' HA ' HG21 ' A' ' 42' ' ' THR . 5.3 m120 -60.85 143.53 54.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.965 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.8 m -145.5 39.09 1.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.599 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.6 tp -70.94 -43.4 68.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.136 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -55.91 -41.24 74.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.157 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.3 p -79.87 -34.34 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.793 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 61' ' ' VAL . . . -58.48 134.17 56.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.285 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -126.27 122.06 34.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.389 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -70.81 147.15 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.586 ' HE2' HG22 ' A' ' 61' ' ' VAL . 56.3 mtt -149.22 -41.36 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.15 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.579 ' HG ' ' HB3' ' A' ' 59' ' ' LYS . 78.6 p -157.47 175.18 14.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.69 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.75 42.03 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.358 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.509 ' HG ' ' H ' ' A' ' 28' ' ' GLY . 43.8 t -175.93 -40.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.077 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.579 ' HB3' ' HG ' ' A' ' 56' ' ' SER . 41.2 ttmt -85.53 133.23 34.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.231 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 74.9 mt -150.72 115.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.648 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.586 HG22 ' HE2' ' A' ' 55' ' ' MET . 64.3 t -82.01 124.15 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.947 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 22.6 p -171.19 132.01 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.917 0.389 . . . . 0.0 111.26 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.618 ' HG2' ' HA ' ' A' ' 23' ' ' LYS . 98.3 mtt180 -85.93 140.68 30.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.139 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 20' ' ' PRO . 34.6 m . . . . . 0 CA--C 1.535 0.372 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.547 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.896 -0.082 . . . . 0.0 112.896 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.8 127.87 34.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.694 0.283 . . . . 0.0 110.856 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.405 HG21 ' N ' ' A' ' 75' ' ' ILE . 65.2 mt -85.81 135.68 24.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.689 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.455 HD11 ' O ' ' A' ' 84' ' ' GLY . 50.4 mm -134.16 139.65 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 111.153 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.6 122.81 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.72 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.7 m -92.02 143.37 26.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.298 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.9 p -134.41 136.56 43.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.056 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -57.61 -47.67 81.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.182 -179.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 88.5 p -64.73 -54.8 25.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.658 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.7 -123.21 1.57 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.421 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.8 -139.03 2.54 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.996 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.57 ' NZ ' ' HB2' ' A' ' 83' ' ' LYS . 4.8 ttmp? -62.45 126.57 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 110.794 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.455 ' O ' HD11 ' A' ' 75' ' ' ILE . . . -81.74 134.69 13.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.802 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 79.8 p -99.31 145.54 27.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.553 0.215 . . . . 0.0 110.684 179.498 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.0 p -141.8 122.05 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.333 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.6 p -93.08 32.97 1.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.399 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.0 m -150.94 150.79 13.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.605 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.0 p -142.99 134.85 26.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.966 0.412 . . . . 0.0 111.217 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -85.67 128.16 34.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.817 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -85.0 121.03 27.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.562 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.8 mp -89.98 128.16 36.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.864 0.364 . . . . 0.0 111.293 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 82.7 mt -85.51 141.51 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.735 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.06 134.42 95.79 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.876 179.848 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--N 1.347 0.492 0 C-N-CA 122.528 2.152 . . . . 0.0 112.555 -179.926 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.631 0.253 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.91 143.93 74.83 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.526 2.15 . . . . 0.0 111.99 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 67.4 Cg_exo -50.7 142.49 31.82 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.584 2.189 . . . . 0.0 112.43 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' A' ' 85' ' ' THR . 63.2 tp -142.9 98.39 3.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.871 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.532 ' HA ' ' HA2' ' A' ' 28' ' ' GLY . 59.6 t -73.01 134.09 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.018 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.6 p -148.88 44.67 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.994 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.81 142.77 5.31 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.776 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.508 HG12 ' HD2' ' A' ' 15' ' ' PRO . 18.1 tt -164.67 131.33 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.743 0.306 . . . . 0.0 110.931 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.794 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -68.05 -58.28 8.03 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.855 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.794 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 92.0 Cg_endo -92.18 123.8 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.329 2.019 . . . . 0.0 112.262 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -81.72 -20.66 38.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.498 ' HG3' HD13 ' A' ' 93' ' ' LEU . 11.0 pt-20 -157.48 138.71 13.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 111.409 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.45 151.76 9.76 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.419 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.494 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 38.4 pt -52.14 163.66 0.68 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.671 0.236 . . . . 0.0 111.15 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.65 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 76.4 Cg_exo -49.08 -47.0 23.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.533 2.155 . . . . 0.0 113.944 -178.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -72.68 -14.65 61.62 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.8 m -55.11 122.52 11.17 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.599 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.747 ' HE2' HG12 ' A' ' 61' ' ' VAL . 61.0 tttm -61.0 136.44 58.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.578 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.495 ' O ' HG21 ' A' ' 24' ' ' VAL . 34.8 m -137.01 122.12 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.099 0.476 . . . . 0.0 111.129 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.0 m -83.84 113.5 20.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.523 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.9 mt -79.13 138.61 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.053 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.492 ' O ' HG11 ' A' ' 10' ' ' VAL . 20.6 mmt85 -144.92 129.44 17.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.276 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -170.62 -134.93 1.83 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.617 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -150.31 133.79 16.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.915 0.388 . . . . 0.0 111.422 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 57.87 41.9 24.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.069 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.6 mp -67.52 -38.51 84.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.74 0.305 . . . . 0.0 110.879 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.04 132.64 1.99 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.699 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.0 p -62.12 -35.69 79.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.44 172.48 39.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.375 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.47 -44.59 45.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.605 2.204 . . . . 0.0 112.273 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.8 p -62.74 -39.27 93.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.092 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.516 ' HA ' ' HD3' ' A' ' 79' ' ' LYS . 8.0 t70 -57.66 -40.63 79.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.034 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 tt -75.28 66.75 1.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.265 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.3 pt -73.27 -33.71 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.96 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -126.3 140.54 12.14 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.531 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 75' ' ' ILE . 53.9 tp -148.72 144.17 26.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.731 0.301 . . . . 0.0 110.57 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.451 HG21 ' HA ' ' A' ' 47' ' ' ASN . 11.5 p -161.33 142.15 11.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.286 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.48 ' C ' ' H ' ' A' ' 45' ' ' GLY . 63.9 mt -127.12 115.51 41.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.72 178.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 48.2 t 74.04 -35.79 0.32 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.695 -178.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.97 -36.15 0.28 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.509 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -77.69 139.82 39.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.899 0.381 . . . . 0.0 111.558 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.451 ' HA ' HG21 ' A' ' 42' ' ' THR . 45.0 t30 -66.73 151.92 46.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.962 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.46 ' SG ' HG13 ' A' ' 43' ' ' ILE . 3.0 p -159.66 45.11 0.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.367 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.9 tp -88.34 -46.24 9.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.568 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -54.8 -39.76 68.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.871 -179.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.3 p -80.25 -38.15 31.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.789 0.328 . . . . 0.0 111.681 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -60.01 135.99 57.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.016 0.436 . . . . 0.0 111.709 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -123.13 127.85 49.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.591 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 66.4 t90 -69.29 146.09 52.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.421 ' HB3' ' HE1' ' A' ' 55' ' ' MET . 87.5 mtp -143.44 -42.23 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.702 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 58' ' ' SER . 81.2 p -167.11 164.31 15.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.301 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.93 27.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.497 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.8 m -167.33 27.27 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.816 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.5 ttmt -164.92 130.14 2.64 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.926 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.476 HG22 HD11 ' A' ' 60' ' ' ILE . 72.4 mt -151.16 118.84 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.747 HG12 ' HE2' ' A' ' 23' ' ' LYS . 92.2 t -90.15 129.22 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.003 179.053 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.554 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 30.2 p -170.54 151.5 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.322 . . . . 0.0 111.492 -179.144 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.2 134.44 34.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.275 179.136 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.65 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.759 -179.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.217 -0.353 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.5 ' OD1' HD12 ' A' ' 75' ' ' ILE . 9.4 t0 -161.46 127.8 3.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.861 0.362 . . . . 0.0 110.604 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.53 92.54 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.02 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.5 HD12 ' OD1' ' A' ' 73' ' ' ASP . 44.3 mm -84.18 139.36 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.742 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.429 ' N ' HG21 ' A' ' 75' ' ' ILE . 46.0 t -141.31 114.3 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.856 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.1 m -81.31 144.3 31.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.913 0.387 . . . . 0.0 111.526 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.2 p -136.8 135.07 37.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.69 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.516 ' HD3' ' HA ' ' A' ' 37' ' ' ASP . 28.3 mtpp -52.74 -47.19 67.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.855 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.8 m -68.33 -48.54 64.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.055 0.455 . . . . 0.0 110.112 179.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.27 -121.96 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.542 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.58 -33.9 0.04 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.4 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -168.89 125.07 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 0.0 110.556 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.09 130.61 9.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.93 -0.653 . . . . 0.0 113.132 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 75.7 p -100.99 147.17 26.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.574 0.226 . . . . 0.0 110.767 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.2 p -149.95 126.96 11.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.051 0.453 . . . . 0.0 111.37 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.7 p -78.85 -30.33 45.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.017 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.8 m -83.68 141.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.212 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.7 m -121.69 142.98 49.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.582 ' CE2' HG23 ' A' ' 64' ' ' VAL . 63.1 t80 -97.91 106.98 19.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.234 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 57.4 tttm -70.31 117.41 11.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.215 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.4 tp -80.62 132.39 35.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.742 -178.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.498 HD13 ' HG3' ' A' ' 17' ' ' GLU . 84.0 mt -102.78 131.69 49.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.189 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -73.1 131.57 83.39 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.773 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo . . . . . 0 C--N 1.347 0.455 0 C-N-CA 122.581 2.187 . . . . 0.0 112.727 -179.824 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.629 0.252 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.78 146.75 95.16 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.673 2.248 . . . . 0.0 112.069 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 13.6 Cg_endo -57.17 123.28 13.45 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.424 2.083 . . . . 0.0 112.212 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.5 tp -103.27 121.2 42.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.97 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 62.4 t -95.31 136.48 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 t -169.51 51.11 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.078 0.466 . . . . 0.0 111.305 -179.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.93 143.41 7.27 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.418 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.507 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.4 tt -160.05 130.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.713 0.292 . . . . 0.0 110.967 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.775 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.9 t -66.39 -58.73 9.71 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.607 179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 67.9 Cg_endo -89.22 115.56 0.7 Allowed 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.146 1.897 . . . . 0.0 112.102 179.377 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -99.1 27.55 5.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.923 0.392 . . . . 0.0 110.632 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 178.61 131.03 0.07 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.454 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.97 150.59 6.77 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.786 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.436 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.3 pt -57.0 162.34 3.89 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.473 0.178 . . . . 0.0 111.057 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.586 ' O ' HG21 ' A' ' 64' ' ' VAL . 85.7 Cg_exo -48.96 -46.68 24.23 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.978 2.452 . . . . 0.0 114.019 -178.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.464 ' O ' ' HD2' ' A' ' 63' ' ' ARG . 94.6 m95 -69.99 -5.96 29.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.4 m -72.96 127.56 32.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 110.818 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -74.38 125.29 28.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.809 179.904 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.454 HG23 HG12 ' A' ' 64' ' ' VAL . 23.7 m -108.38 127.6 64.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.084 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.455 HG22 ' HE2' ' A' ' 59' ' ' LYS . 90.4 m -78.87 119.49 22.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.332 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 61.8 mt -85.28 140.73 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.411 179.255 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -146.55 136.74 23.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.342 . . . . 0.0 110.872 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.99 -128.42 1.04 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.413 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -143.96 129.58 19.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.0 111.266 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.5 m-80 58.66 47.56 12.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.108 179.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.55 HD11 ' N ' ' A' ' 31' ' ' LEU . 9.8 mp -81.18 53.21 1.97 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.868 0.366 . . . . 0.0 111.02 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.453 ' HA3' ' OD2' ' A' ' 37' ' ' ASP . . . 83.86 135.32 2.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.796 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 77.7 p -62.98 -40.77 98.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.656 0.265 . . . . 0.0 111.376 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.562 ' HA3' ' CE2' ' A' ' 54' ' ' TRP . . . -161.35 -159.46 10.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.932 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -65.85 -48.22 3.11 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.728 2.285 . . . . 0.0 112.528 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -60.31 -39.52 87.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.695 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 38.8 t70 -63.19 -47.08 84.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.616 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.599 HD21 ' N ' ' A' ' 39' ' ' ILE . 2.3 tt -66.96 129.16 38.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.773 179.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.599 ' N ' HD21 ' A' ' 38' ' ' LEU . 29.7 pt -137.23 -44.68 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.22 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -98.67 136.59 12.78 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.309 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.499 ' O ' HG21 ' A' ' 42' ' ' THR . 1.9 tm? -149.43 132.41 16.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 110.195 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.499 HG21 ' O ' ' A' ' 41' ' ' LEU . 16.5 p -151.62 148.79 28.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.489 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.477 ' C ' ' H ' ' A' ' 45' ' ' GLY . 77.2 mt -133.14 114.33 21.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.584 179.14 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 66.7 m 73.36 -38.56 0.41 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 123.488 0.493 . . . . 0.0 110.545 -178.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 171.45 -41.97 0.18 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.631 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -78.75 135.74 37.2 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.841 0.353 . . . . 0.0 111.14 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.443 ' HA ' HG21 ' A' ' 42' ' ' THR . 4.9 m120 -61.21 141.62 57.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.2 m -139.98 38.43 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.564 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.5 tp -71.51 -43.77 65.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.353 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -53.57 -42.94 68.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.477 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.3 p -80.47 -37.83 31.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.714 0.292 . . . . 0.0 111.443 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.424 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -60.47 129.17 40.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.032 0.444 . . . . 0.0 111.66 -179.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -126.67 132.1 51.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.213 179.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.562 ' CE2' ' HA3' ' A' ' 34' ' ' GLY . 54.3 t90 -63.99 149.89 46.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.376 . . . . 0.0 111.019 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 93.4 mmm -143.78 -45.88 0.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.632 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 58' ' ' SER . 70.8 m -163.63 162.06 24.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.474 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.48 36.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.35 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 56' ' ' SER . 78.1 p -175.24 20.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.153 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.1 tttm -165.19 131.68 2.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.487 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.455 HG22 HD11 ' A' ' 60' ' ' ILE . 74.3 mt -147.53 122.2 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.792 0.33 . . . . 0.0 110.998 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.4 t -83.82 133.76 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.941 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 29.9 p -170.53 132.92 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.352 . . . . 0.0 110.919 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.581 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 77.6 mtm180 -85.0 134.62 34.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.586 HG21 ' O ' ' A' ' 20' ' ' PRO . 27.8 m . . . . . 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.399 179.343 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.88 128.53 36.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 111.413 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.443 ' O ' HD12 ' A' ' 75' ' ' ILE . 66.8 mt -85.91 137.21 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.732 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.534 HG21 ' N ' ' A' ' 76' ' ' VAL . 48.4 mm -134.22 142.23 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.917 0.389 . . . . 0.0 111.388 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.534 ' N ' HG21 ' A' ' 75' ' ' ILE . 7.7 p -140.82 128.74 23.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.636 179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 24.6 m -102.22 140.13 36.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.42 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.6 p -122.01 149.31 43.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.5 mmmm -51.18 -51.4 54.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.204 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.0 m -69.92 -54.47 13.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.627 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.74 -131.03 2.59 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.28 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 77' ' ' THR . . . -171.83 -143.04 3.92 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.851 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -67.69 117.79 10.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 110.688 179.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.77 -133.42 2.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.735 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 86' ' ' SER . 0.0 OUTLIER -160.21 -176.64 5.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.002 0.43 . . . . 0.0 110.946 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.62 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 79.4 p -169.27 123.88 0.83 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.527 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.409 ' O ' HG11 ' A' ' 88' ' ' VAL . 81.1 p -95.03 33.55 1.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.185 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 87' ' ' THR . 20.3 m -152.18 152.8 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.537 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.0 p -143.93 141.96 30.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.049 0.452 . . . . 0.0 111.209 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -85.0 131.94 34.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.25 -179.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.578 ' HB3' ' NZ ' ' A' ' 91' ' ' LYS . 6.0 ttpm? -81.58 120.78 25.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.657 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.71 130.93 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.823 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 79.8 mt -107.0 145.2 32.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.233 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -61.26 131.73 92.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.778 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 C--N 1.346 0.406 0 C-N-CA 122.584 2.19 . . . . 0.0 112.406 -179.956 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.428 ' NE2' ' N ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.648 0.261 . . . . 0.0 110.986 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.03 145.91 83.37 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.749 2.3 . . . . 0.0 112.265 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 52.6 Cg_exo -54.08 138.86 71.36 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.534 2.156 . . . . 0.0 112.342 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 85' ' ' THR . 5.6 tt -133.74 111.77 10.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.323 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.61 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 83.9 t -83.75 140.51 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.918 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 t -162.68 46.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.028 0.442 . . . . 0.0 110.793 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.1 142.3 5.96 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.858 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.514 HG12 ' HD2' ' A' ' 15' ' ' PRO . 13.2 tt -164.07 128.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.659 0.266 . . . . 0.0 110.457 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.77 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 45.9 t -63.62 -58.64 14.39 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.83 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 94.0 Cg_endo -89.47 107.29 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.21 1.94 . . . . 0.0 112.188 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -91.03 26.41 2.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 110.587 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 179.5 130.01 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.287 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.467 ' N ' HD13 ' A' ' 93' ' ' LEU . . . 166.99 148.19 5.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.568 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.0 pt -52.2 154.01 4.47 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.537 0.208 . . . . 0.0 110.786 179.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.59 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 84.2 Cg_exo -47.26 -37.6 24.56 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.018 2.478 . . . . 0.0 113.792 -178.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -73.44 -23.32 60.09 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 m -57.99 128.55 37.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 110.964 -179.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.87 129.84 41.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.538 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.554 HG11 ' HG2' ' A' ' 15' ' ' PRO . 26.8 m -121.4 125.1 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 111.013 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.509 HG22 ' NZ ' ' A' ' 59' ' ' LYS . 99.4 m -75.84 116.89 17.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.921 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 61.5 mt -83.04 136.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.67 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.459 ' HD2' ' O ' ' A' ' 58' ' ' SER . 29.3 tpt180 -141.49 133.41 27.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.334 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.45 -134.04 1.69 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.48 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -150.25 132.24 15.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.944 0.402 . . . . 0.0 111.281 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.468 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 72.3 m-80 59.3 46.47 12.69 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.673 178.807 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.465 HD21 HD13 ' A' ' 60' ' ' ILE . 8.4 mp -81.78 52.15 1.86 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 110.694 178.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.06 126.69 0.14 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.419 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.7 p -90.77 42.27 1.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.694 0.283 . . . . 0.0 111.563 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.52 145.81 5.0 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.792 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 -46.38 27.61 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.394 2.063 . . . . 0.0 111.709 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.5 t -62.05 -36.06 80.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.072 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.14 -36.18 67.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.563 HD13 HD11 ' A' ' 60' ' ' ILE . 1.4 tt -75.57 61.09 1.28 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.488 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.441 ' O ' HD23 ' A' ' 49' ' ' LEU . 30.7 pt -68.98 -40.1 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.435 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.402 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -110.48 139.75 15.61 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.957 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.445 ' O ' HG21 ' A' ' 42' ' ' THR . 3.0 tm? -148.26 132.06 17.01 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.445 HG21 ' O ' ' A' ' 41' ' ' LEU . 24.0 p -150.51 140.94 22.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.162 0.506 . . . . 0.0 111.843 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.3 mt -137.4 125.79 33.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.573 178.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.531 ' SG ' HD22 ' A' ' 92' ' ' LEU . 69.2 m 58.43 37.98 25.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.163 0.506 . . . . 0.0 110.1 -179.004 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.89 25.31 71.88 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.958 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -131.85 125.33 31.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.54 0.209 . . . . 0.0 110.521 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -63.11 138.17 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.324 . . . . 0.0 110.633 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.0 m -148.84 39.38 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.684 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 39' ' ' ILE . 58.3 tp -69.69 -44.55 70.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.266 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.66 -44.16 57.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.297 -179.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.431 HG23 HH21 ' A' ' 63' ' ' ARG . 71.8 p -80.77 -37.83 29.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 111.134 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.576 ' HB1' ' HG ' ' A' ' 62' ' ' CYS . . . -60.44 130.31 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.718 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -126.82 129.36 48.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.514 179.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 80.8 t90 -64.57 145.92 55.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.618 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.3 mmm -140.14 -45.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.526 ' C ' ' H ' ' A' ' 58' ' ' SER . 65.7 m -164.05 160.27 21.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.65 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.39 27.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.838 0.352 . . . . 0.0 111.396 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.3 m -168.03 19.49 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.833 179.341 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.509 ' NZ ' HG22 ' A' ' 25' ' ' THR . 62.3 tttp -165.19 130.8 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.511 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.563 HD11 HD13 ' A' ' 38' ' ' LEU . 68.5 mt -148.84 119.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.952 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.32 134.71 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.555 179.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.576 ' HG ' ' HB1' ' A' ' 52' ' ' ALA . 45.9 t -170.67 152.84 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.277 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.431 HH21 HG23 ' A' ' 51' ' ' THR . 84.3 mtm180 -83.79 135.25 34.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.001 179.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.59 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.625 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.407 ' C ' ' HB3' ' A' ' 89' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.81 -0.116 . . . . 0.0 112.81 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -66.06 130.69 44.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.708 0.289 . . . . 0.0 111.129 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.476 HD11 HG13 ' A' ' 10' ' ' VAL . 68.8 mt -85.06 131.61 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.355 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 74' ' ' ILE . 39.9 mm -127.4 139.93 50.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.402 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -139.63 120.94 15.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.624 179.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.9 m -94.07 142.47 27.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.2 p -136.92 136.57 38.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -55.96 -50.62 70.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.018 -179.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.0 m -67.52 -54.59 18.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.323 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.21 -125.22 0.46 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.108 179.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.55 -141.69 3.22 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.469 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -63.9 128.99 38.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.82 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.11 128.31 8.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.775 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 81.4 p -103.63 148.55 25.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.626 0.25 . . . . 0.0 110.829 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.61 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 40.4 t -154.48 127.82 8.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 111.661 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.4 p -77.55 -32.98 54.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.423 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.6 m -84.47 148.66 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.494 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.407 ' HB3' ' C ' ' A' ' 72' ' ' GLY . 19.3 m -139.29 140.35 37.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.549 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -85.05 131.74 34.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.35 -179.532 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -84.34 122.27 28.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.595 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.534 HD12 HG13 ' A' ' 64' ' ' VAL . 3.4 mm? -78.59 131.64 36.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.241 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 18' ' ' GLY . 73.6 mt -108.27 137.45 46.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.585 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -61.62 128.58 90.36 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.812 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo . . . . . 0 C--N 1.347 0.468 0 C-N-CA 122.537 2.158 . . . . 0.0 112.45 -179.796 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.769 0.319 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.4 mmt -58.34 132.87 54.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.511 ' HE ' ' HB3' ' A' ' 80' ' ' SER . 72.1 mtm-85 -62.85 123.2 17.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -76.4 140.51 68.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.196 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.98 144.79 99.43 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.521 2.147 . . . . 0.0 111.888 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.506 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 54.2 Cg_exo -51.41 118.47 4.39 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.317 2.011 . . . . 0.0 112.4 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.5 tp -99.41 131.27 45.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 85.1 t -116.6 135.91 55.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.672 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -168.82 52.47 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.098 0.475 . . . . 0.0 111.34 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.93 143.53 8.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.579 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.539 HG12 ' HD2' ' A' ' 15' ' ' PRO . 12.7 tt -161.36 131.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.564 0.221 . . . . 0.0 110.782 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.678 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 43.8 t -62.3 -60.23 10.65 Favored Pre-proline 0 CA--C 1.531 0.218 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.132 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 84.8 Cg_endo -79.71 -160.14 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.875 1.717 . . . . 0.0 111.742 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -173.22 21.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.761 0.315 . . . . 0.0 110.967 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 177.78 127.45 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.3 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.09 153.03 7.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.886 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.405 ' N ' ' HG1' ' A' ' 22' ' ' THR . 34.7 pt -53.92 159.65 2.65 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.435 0.16 . . . . 0.0 110.922 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.673 ' O ' HG21 ' A' ' 64' ' ' VAL . 75.8 Cg_exo -51.41 -40.75 61.94 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.64 2.227 . . . . 0.0 113.392 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.486 ' HE3' HH11 ' A' ' 63' ' ' ARG . 78.6 m95 -69.56 -5.35 23.79 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.405 ' HG1' ' N ' ' A' ' 19' ' ' ILE . 94.0 m -66.96 132.23 47.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 111.314 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -70.31 138.74 51.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.69 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.539 ' O ' HG21 ' A' ' 24' ' ' VAL . 35.2 m -145.9 128.55 9.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.96 0.409 . . . . 0.0 111.06 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.583 HG23 ' HE ' ' A' ' 27' ' ' ARG . 84.3 m -87.13 120.99 28.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.474 HG21 ' N ' ' A' ' 27' ' ' ARG . 62.8 mt -79.79 139.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.115 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.583 ' HE ' HG23 ' A' ' 25' ' ' THR . 19.2 mmt85 -137.33 134.74 36.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.33 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.05 -136.25 2.24 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.871 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -152.16 134.42 15.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.972 0.415 . . . . 0.0 111.497 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 60.63 42.0 14.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.603 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 9.1 mp -83.85 50.47 1.82 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 110.399 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.48 126.56 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.31 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.9 p -94.97 43.51 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 0.0 111.252 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.41 142.74 4.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.707 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.2 -42.26 58.6 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.595 2.196 . . . . 0.0 112.044 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.3 p -62.96 -38.68 92.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.955 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -56.56 -37.33 70.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.976 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.491 HD22 HD21 ' A' ' 41' ' ' LEU . 1.4 tt -75.46 62.8 1.4 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.466 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 40' ' ' GLY . 35.9 pt -69.25 -41.24 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.495 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.443 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -110.41 137.87 14.54 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.957 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.503 ' O ' HG21 ' A' ' 42' ' ' THR . 2.3 tm? -149.05 128.96 13.4 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.503 HG21 ' O ' ' A' ' 41' ' ' LEU . 12.2 p -152.08 138.41 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.148 0.499 . . . . 0.0 111.864 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.631 ' HB ' ' H ' ' A' ' 65' ' ' GLY . 71.4 mt -127.53 127.36 68.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.364 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 71.2 m 58.14 36.03 25.55 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.24 -26.71 1.81 Allowed Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.768 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.439 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 78.2 t60 -76.3 135.06 39.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.786 0.327 . . . . 0.0 111.337 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.551 HD21 ' H ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -73.23 136.22 44.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.659 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.551 ' H ' HD21 ' A' ' 47' ' ' ASN . 72.7 m -152.47 41.87 0.63 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.728 0.299 . . . . 0.0 111.292 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.3 tp -71.38 -43.16 67.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.124 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.31 -41.92 51.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.605 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.4 p -80.3 -36.51 34.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.379 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.89 133.66 55.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.712 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -126.9 130.94 51.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.615 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -70.59 146.5 50.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.056 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.8 mmt -136.36 -52.4 0.72 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.643 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.0 m -160.52 -172.61 3.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.462 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.48 41.67 0.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.205 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 t -175.27 -47.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.753 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.546 ' HZ1' ' HE ' ' A' ' 27' ' ' ARG . 25.0 ttmm -87.8 136.23 33.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.866 0.365 . . . . 0.0 111.638 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -150.51 117.17 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.529 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.5 t -85.04 124.17 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.968 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.8 p -170.93 143.82 2.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 0.0 111.238 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.486 HH11 ' HE3' ' A' ' 21' ' ' TRP . 99.2 mtt180 -84.23 132.51 34.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.331 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 20' ' ' PRO . 16.1 m -59.39 127.65 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.198 0.523 . . . . 0.0 111.635 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.631 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . -70.53 155.5 52.99 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.826 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -51.49 143.74 11.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.804 0.335 . . . . 0.0 110.828 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.516 ' HB1' HD11 ' A' ' 92' ' ' LEU . . . -60.15 144.65 49.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.229 0.538 . . . . 0.0 111.998 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -147.84 -43.9 0.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.528 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -76.15 -123.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.203 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -170.41 42.82 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.747 0.308 . . . . 0.0 111.144 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.482 ' HE2' ' HG ' ' A' ' 89' ' ' SER . 24.1 tptm -164.55 -46.44 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.856 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.88 44.82 2.78 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.159 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -75.5 129.57 37.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.752 0.311 . . . . 0.0 110.94 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 74' ' ' ILE . 65.1 mt -86.6 92.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.996 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.457 HG21 ' N ' ' A' ' 76' ' ' VAL . 47.3 mm -86.52 139.78 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.205 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.457 ' N ' HG21 ' A' ' 75' ' ' ILE . 60.9 t -139.6 113.44 6.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.2 m -81.87 144.28 31.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.496 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.0 p -141.32 134.95 30.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.718 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -59.24 -44.98 92.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.102 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.511 ' HB3' ' HE ' ' A' ' 5' ' ' ARG . 50.9 m -61.61 -42.88 99.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.979 0.418 . . . . 0.0 110.068 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.77 -118.15 3.25 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.081 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 -142.42 3.39 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.398 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -70.65 130.98 43.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.873 0.368 . . . . 0.0 110.963 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.48 136.81 15.98 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.67 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.7 p -98.92 140.17 33.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.662 0.268 . . . . 0.0 110.507 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 39.7 t -129.32 128.78 43.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.977 0.418 . . . . 0.0 111.727 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.2 p -75.4 -35.92 60.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.991 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.8 m -85.27 159.41 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.22 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.482 ' HG ' ' HE2' ' A' ' 71' ' ' LYS . 66.9 m -146.35 137.13 24.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -86.15 129.01 34.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.427 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HE3' HD23 ' A' ' 93' ' ' LEU . 38.8 ttpt -83.36 117.92 23.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.265 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.516 HD11 ' HB1' ' A' ' 67' ' ' ALA . 86.5 mt -83.02 128.46 34.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 111.286 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.426 HD23 ' HE3' ' A' ' 91' ' ' LYS . 80.3 mt -99.62 144.16 29.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.892 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -57.93 139.09 83.06 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.88 134.75 42.47 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.666 2.244 . . . . 0.0 112.939 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -74.66 118.74 17.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.536 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.0 tptp . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.795 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.554 0.216 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.4 mtt -61.99 137.67 58.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.84 0.352 . . . . 0.0 111.093 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.1 mtm-85 -61.99 124.93 22.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.03 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -75.72 142.54 73.72 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.093 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.24 145.56 96.1 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.509 2.139 . . . . 0.0 111.82 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.72 118.71 3.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.401 2.068 . . . . 0.0 112.317 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -98.52 117.79 33.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.646 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 58.8 t -96.1 139.52 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.908 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 t -171.05 48.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 111.205 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.74 139.32 5.59 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.027 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.453 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 15.6 tt -165.03 132.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.75 0.31 . . . . 0.0 110.629 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.796 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.9 t -68.41 -59.35 6.06 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.135 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.796 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 68.1 Cg_endo -92.94 121.98 0.48 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.247 1.965 . . . . 0.0 112.961 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -96.71 29.62 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.528 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 179.73 132.24 0.09 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.395 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.483 ' O ' HD13 ' A' ' 92' ' ' LEU . . . 171.92 143.38 4.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.095 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.537 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 35.2 pt -59.14 165.06 3.91 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 120.38 0.134 . . . . 0.0 111.083 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 19' ' ' ILE . 95.7 Cg_exo -46.27 -41.89 22.16 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.927 2.418 . . . . 0.0 113.61 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -77.22 -17.42 58.49 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.402 ' OG1' HG12 ' A' ' 19' ' ' ILE . 80.9 m -56.89 131.48 49.71 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.68 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -73.63 139.84 45.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.566 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.731 HG23 HG11 ' A' ' 64' ' ' VAL . 35.0 m -139.55 128.25 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 111.075 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.6 m -89.2 118.3 28.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.55 HG23 HD22 ' A' ' 31' ' ' LEU . 62.1 mt -85.74 138.98 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.425 ' N ' HG21 ' A' ' 26' ' ' ILE . 97.7 mtt180 -143.16 137.34 28.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.82 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -172.98 -129.32 1.14 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.722 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -146.75 136.37 23.03 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 110.939 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 61.65 40.02 13.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.87 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.55 HD22 HG23 ' A' ' 26' ' ' ILE . 10.7 mp -82.95 50.55 1.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 110.707 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.79 132.5 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.501 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.3 p -60.14 -34.34 73.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.697 0.284 . . . . 0.0 111.037 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 54' ' ' TRP . . . -158.93 -161.43 11.11 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.825 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.86 -43.61 1.67 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.634 2.223 . . . . 0.0 112.7 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.5 p -57.23 -40.92 78.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.287 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.34 -36.77 84.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.0 tp -75.82 62.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.15 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.4 pt -69.16 -36.13 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.114 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -126.71 139.85 11.56 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.781 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.487 ' O ' HG21 ' A' ' 42' ' ' THR . 58.4 tp -150.0 151.78 33.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.683 0.278 . . . . 0.0 110.685 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.487 HG21 ' O ' ' A' ' 41' ' ' LEU . 3.1 p -149.72 141.46 23.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.29 0.567 . . . . 0.0 111.975 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.6 mt -137.83 130.69 41.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.246 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 83.3 m 52.83 30.49 9.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.404 . . . . 0.0 110.101 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.1 -38.66 3.19 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.987 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.546 ' HE2' ' HA2' ' A' ' 65' ' ' GLY . 30.8 p-80 -86.5 140.5 29.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 117.457 0.628 . . . . 0.0 111.781 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -60.86 145.22 50.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.534 ' O ' ' HB1' ' A' ' 52' ' ' ALA . 81.4 m -149.72 38.03 0.75 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.9 tp -71.57 -47.09 57.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.618 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.599 HD13 HG22 ' A' ' 51' ' ' THR . 3.3 pp -58.49 -34.96 71.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.514 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.599 HG22 HD13 ' A' ' 50' ' ' LEU . 22.0 p -80.45 -38.28 30.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.941 0.4 . . . . 0.0 110.891 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 48' ' ' CYS . . . -68.62 135.5 51.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.168 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -126.77 128.73 47.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.017 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.54 ' CE2' ' HA3' ' A' ' 34' ' ' GLY . 78.6 t90 -61.73 150.08 37.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.914 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.4 mmm -143.12 -44.11 0.29 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.575 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 67.4 m -161.09 160.72 30.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.028 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.76 -30.36 32.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.559 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.9 m -126.21 36.94 4.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.241 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 60.0 tttm -165.02 132.62 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.4 mt -150.43 122.89 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.7 t -82.98 129.45 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.242 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.9 p -170.47 136.67 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 111.569 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 59.3 mtt85 -85.18 138.15 32.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.584 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.731 HG11 HG23 ' A' ' 24' ' ' VAL . 31.7 m -66.63 -143.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.673 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.546 ' HA2' ' HE2' ' A' ' 46' ' ' HIS . . . 175.81 -141.97 5.87 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.499 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -65.88 136.86 56.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.885 0.374 . . . . 0.0 111.378 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.08 55.72 1.86 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.386 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -52.21 -42.05 63.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.877 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -70.86 -127.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.294 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -148.94 -53.9 0.18 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.813 0.34 . . . . 0.0 110.653 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -91.69 -47.38 7.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.104 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.65 43.96 0.48 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.296 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.85 130.14 42.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.131 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.4 mt -97.42 128.39 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.319 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.82 138.0 49.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.418 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.3 t -124.81 129.1 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.633 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 40' ' ' GLY . 88.0 m -97.71 138.31 35.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.403 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.1 p -135.41 140.32 44.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.155 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.539 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 7.2 mtpm? -56.56 -46.72 80.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.779 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.401 ' HG ' ' N ' ' A' ' 81' ' ' GLY . 79.7 p -65.56 -53.59 39.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.092 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.401 ' N ' ' HG ' ' A' ' 80' ' ' SER . . . -88.52 -124.41 2.24 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.099 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.7 -142.71 3.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.088 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.57 ' HB3' ' NZ ' ' A' ' 83' ' ' LYS . 5.9 ttpm? -71.53 123.29 22.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.715 0.293 . . . . 0.0 110.514 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.91 -160.55 36.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.746 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.0 p -154.97 -169.84 3.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.68 0.276 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.62 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 41.0 t -170.99 127.81 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.916 0.389 . . . . 0.0 111.318 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 82.5 p -72.53 -34.05 67.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.14 0.495 . . . . 0.0 110.084 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.458 HG21 ' OG ' ' A' ' 86' ' ' SER . 35.3 m -84.9 173.62 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.377 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.8 p -157.41 135.6 11.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.712 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.508 ' CD2' HG12 ' A' ' 64' ' ' VAL . 53.4 t80 -85.4 127.03 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.184 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.64 ' HZ2' ' HB3' ' A' ' 91' ' ' LYS . 5.7 ttpm? -83.88 119.86 25.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.952 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 20' ' ' PRO . 26.6 tp -85.19 131.14 34.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.244 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.63 136.28 35.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.777 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -63.49 137.92 97.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.31 133.92 52.33 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.493 2.129 . . . . 0.0 112.421 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -71.05 76.96 0.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.737 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.963 -179.703 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.0 t60 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.728 0.299 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -175.15 139.49 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.71 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -171.16 57.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.708 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -60.6 131.85 91.01 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.924 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.23 144.03 82.98 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.656 2.237 . . . . 0.0 112.473 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.573 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 14.4 Cg_endo -57.34 141.32 94.74 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.744 2.296 . . . . 0.0 112.196 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.562 HD21 HG21 ' A' ' 11' ' ' THR . 4.4 tt -141.0 121.9 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 0.0 110.435 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.496 ' HA ' ' HA2' ' A' ' 28' ' ' GLY . 98.5 t -84.61 134.61 26.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.712 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.562 HG21 HD21 ' A' ' 9' ' ' LEU . 34.3 p -153.7 47.26 0.64 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.862 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.95 143.22 6.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.854 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.502 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 14.5 tt -160.53 130.35 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.713 0.292 . . . . 0.0 110.448 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.798 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 52.0 m -63.95 -59.55 11.07 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.155 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.798 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 91.4 Cg_endo -89.56 128.06 1.7 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.232 1.955 . . . . 0.0 112.69 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.3 25.05 11.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 0.0 110.242 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 177.57 131.3 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.547 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.25 149.56 5.82 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.445 -0.884 . . . . 0.0 112.8 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 93' ' ' LEU . 35.3 pt -57.16 157.48 11.75 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.437 0.161 . . . . 0.0 110.868 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.561 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 85.8 Cg_exo -48.69 -39.88 38.26 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.874 2.382 . . . . 0.0 113.576 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.91 -20.49 61.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.9 m -56.75 131.41 49.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 111.144 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -65.98 135.94 55.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.426 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.573 HG13 ' HG2' ' A' ' 15' ' ' PRO . 33.4 m -134.36 129.42 53.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.39 . . . . 0.0 111.216 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.4 m -85.58 122.78 30.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.011 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 63.8 mt -83.3 137.42 20.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.028 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' O ' HG11 ' A' ' 10' ' ' VAL . 44.5 mmm-85 -143.89 133.37 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.668 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -169.13 -134.45 1.73 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.527 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 67.8 mm-40 -142.96 128.64 19.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.391 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.573 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 63.7 m-80 52.63 41.47 31.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.139 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.489 HD22 HG23 ' A' ' 26' ' ' ILE . 10.0 mp -60.11 -39.47 86.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.745 0.307 . . . . 0.0 111.047 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.02 132.15 1.97 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.647 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.8 p -64.68 -36.42 84.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 0.0 111.212 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.34 174.52 37.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.424 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.49 -43.46 55.19 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.427 2.085 . . . . 0.0 112.087 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -61.04 -40.88 95.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.014 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 64.7 t0 -59.06 -48.66 80.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.663 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.694 HD13 HD12 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -71.18 128.31 35.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.962 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.534 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 38.4 pt -143.57 -39.94 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.945 0.402 . . . . 0.0 110.673 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.443 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -105.49 133.33 11.53 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.482 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.0 tp -150.25 149.39 30.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.689 0.28 . . . . 0.0 110.337 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.2 m -159.41 140.34 12.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 111.508 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.08 126.53 37.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.337 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 77.4 m 54.82 38.98 31.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.992 0.425 . . . . 0.0 110.545 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.35 27.99 71.61 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.427 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -131.0 132.91 45.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.685 0.279 . . . . 0.0 110.824 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.481 HD21 ' H ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -67.03 133.5 50.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.705 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.481 ' H ' HD21 ' A' ' 47' ' ' ASN . 74.4 m -152.18 40.03 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.96 0.409 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 3.3 tm? -81.52 -43.29 18.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.874 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -53.59 -38.75 64.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.818 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.9 p -79.88 -37.43 34.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.699 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.529 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.34 135.74 57.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.974 0.416 . . . . 0.0 112.025 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -126.45 132.35 51.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.359 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -66.29 151.78 46.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.412 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.486 ' HE2' HG13 ' A' ' 61' ' ' VAL . 55.0 mtt -149.83 -42.77 0.13 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.76 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 58' ' ' SER . 86.9 p -169.13 169.65 9.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.533 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.83 34.39 0.1 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.529 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 56' ' ' SER . 78.4 p -177.99 30.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.911 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.6 ttmt -165.04 130.12 2.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.791 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.694 HD12 HD13 ' A' ' 38' ' ' LEU . 72.3 mt -150.67 122.56 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.0 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.486 HG13 ' HE2' ' A' ' 55' ' ' MET . 9.0 p -88.33 132.93 32.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.522 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.529 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 26.7 p -170.89 156.32 4.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.035 0.445 . . . . 0.0 111.4 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.01 134.93 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.2 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.561 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.5 t -59.07 134.19 24.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.122 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . -70.16 -123.35 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.293 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.744 ' HG3' ' HE3' ' A' ' 68' ' ' LYS . 20.4 pt20 -165.73 136.55 3.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.773 0.32 . . . . 0.0 110.5 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.577 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -49.71 131.87 21.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.893 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.744 ' HE3' ' HG3' ' A' ' 66' ' ' GLN . 35.0 mmtp -132.11 -50.01 0.94 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.585 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -77.58 -63.07 1.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.555 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.545 ' OD1' ' HG3' ' A' ' 71' ' ' LYS . 1.2 p30 -179.57 -47.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.047 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.545 ' HG3' ' OD1' ' A' ' 70' ' ' ASP . 29.5 mtpp -97.95 -126.68 0.16 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.524 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 44' ' ' CYS . . . -179.1 44.27 0.08 OUTLIER Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.466 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -61.99 132.14 51.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.37 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.8 mt -85.45 92.5 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.165 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.453 HG21 ' N ' ' A' ' 76' ' ' VAL . 49.9 mm -91.08 145.63 7.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.153 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.453 ' N ' HG21 ' A' ' 75' ' ' ILE . 7.3 p -140.42 128.51 24.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.101 0.477 . . . . 0.0 111.058 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 m -100.63 143.78 30.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.239 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.4 p -130.59 140.76 50.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.583 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 8.0 mtpm? -56.94 -47.99 79.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.248 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 61.4 m -64.75 -54.81 25.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.946 0.403 . . . . 0.0 110.561 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.32 -125.03 1.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.127 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.43 -140.78 3.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.995 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.3 117.76 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.753 0.311 . . . . 0.0 110.375 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.439 ' O ' HG21 ' A' ' 85' ' ' THR . . . -75.65 -149.16 2.32 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.935 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 40.6 p -155.84 150.73 26.33 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.49 0.316 . . . . 0.0 110.392 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -157.26 127.61 6.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.968 0.413 . . . . 0.0 111.175 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.3 p -107.58 40.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.806 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.69 149.1 15.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.352 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 t -140.11 137.36 34.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.691 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -85.25 129.95 34.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.131 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -77.51 125.18 28.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.395 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.558 HD23 HG13 ' A' ' 64' ' ' VAL . 92.3 mt -92.49 124.55 36.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.163 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 19' ' ' ILE . 79.3 mt -89.47 135.25 33.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.641 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 53.3 mtmt -64.21 133.07 95.51 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.056 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 31.8 Cg_exo -60.04 130.48 34.73 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.538 2.159 . . . . 0.0 112.171 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -74.19 115.09 13.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.354 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.616 ' NZ ' ' HB2' ' A' ' 97' ' ' LYS . 9.7 mtmp? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.93 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.6 m170 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.503 0.192 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 85.0 mtp 56.57 47.2 19.04 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.855 0.36 . . . . 0.0 111.146 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.413 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 54.5 ttp180 -62.05 144.59 55.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -59.14 135.9 88.04 Favored Pre-proline 0 N--CA 1.453 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.62 146.29 44.32 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.612 2.208 . . . . 0.0 112.436 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 8.9 Cg_endo -50.62 144.68 24.84 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.982 2.455 . . . . 0.0 112.383 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -141.68 119.95 12.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.208 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.533 ' HA ' ' HA2' ' A' ' 28' ' ' GLY . 92.7 t -77.37 134.66 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.618 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.501 HG21 ' O ' ' A' ' 10' ' ' VAL . 61.3 p -148.0 44.51 1.07 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.206 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.34 145.12 5.65 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.063 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.7 tt -164.57 128.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.64 0.257 . . . . 0.0 110.44 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.815 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 48.0 t -67.14 -60.06 6.56 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.66 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.815 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 68.1 Cg_endo -91.99 114.38 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.149 1.899 . . . . 0.0 112.18 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -92.93 30.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 0.0 110.499 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 178.08 131.21 0.07 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.446 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.8 144.6 4.27 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.067 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 93' ' ' LEU . 41.3 pt -59.42 161.54 10.2 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 121.969 0.107 . . . . 0.0 110.967 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.593 ' HA ' HG12 ' A' ' 64' ' ' VAL . 79.3 Cg_exo -47.92 -37.2 28.79 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.572 2.181 . . . . 0.0 113.036 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.09 -27.87 62.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.8 m -56.5 128.58 36.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 0.0 111.581 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.08 136.86 50.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.544 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 24' ' ' VAL . 29.4 m -135.85 121.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.947 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.543 HG22 ' HZ1' ' A' ' 59' ' ' LYS . 66.6 m -80.85 116.87 21.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.767 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 55.5 mt -77.42 141.22 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.555 HH11 ' HB2' ' A' ' 59' ' ' LYS . 25.8 mmm180 -146.9 131.01 17.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.411 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -170.28 -130.78 1.25 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.638 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -146.52 135.87 22.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 111.244 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.5 m-20 61.87 38.05 14.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.356 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 10.2 mp -84.14 51.01 1.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.951 0.405 . . . . 0.0 110.392 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 57' ' ' ALA . . . 70.87 118.78 0.04 OUTLIER Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.192 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.5 p -90.03 41.52 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 111.365 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.31 151.67 7.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.686 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.78 -43.07 62.72 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.473 2.115 . . . . 0.0 111.724 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.511 ' O ' ' HE2' ' A' ' 79' ' ' LYS . 2.5 t -61.79 -35.51 78.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.597 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.458 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 1.4 m-20 -51.93 -48.85 64.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.454 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.95 127.42 32.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.134 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.424 HG22 ' HD2' ' A' ' 79' ' ' LYS . 36.6 pt -147.26 20.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.094 0.474 . . . . 0.0 110.786 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 176.94 139.34 3.22 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.907 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 75' ' ' ILE . 18.1 tp -149.63 146.38 27.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.885 0.374 . . . . 0.0 111.023 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.44 HG21 ' O ' ' A' ' 41' ' ' LEU . 20.5 p -151.15 134.47 16.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.181 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.513 ' HB ' ' H ' ' A' ' 65' ' ' GLY . 64.7 mt -134.51 125.19 46.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.857 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.613 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 66.2 m 56.71 36.43 27.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.09 0.471 . . . . 0.0 109.991 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.99 33.69 87.93 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.891 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.495 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 80.4 t60 -130.78 131.27 44.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.713 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.512 HD21 ' N ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -67.7 131.78 46.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.638 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.512 ' N ' HD21 ' A' ' 47' ' ' ASN . 71.8 m -153.09 39.01 0.51 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.88 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 69.3 tp -73.96 -47.07 40.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.286 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -52.3 -40.36 61.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.631 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.6 p -80.35 -33.37 37.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.292 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -52.74 134.4 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.767 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -126.67 130.24 50.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.669 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -71.95 147.43 46.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 96.1 mmm -138.89 -48.37 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 58' ' ' SER . 69.5 m -160.55 -175.03 4.76 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.645 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -78.52 36.23 0.25 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.983 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 31' ' ' LEU . 79.8 p -177.29 -43.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.754 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.555 ' HB2' HH11 ' A' ' 27' ' ' ARG . 24.6 ttmm -84.87 131.25 34.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.047 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.0 mt -149.97 113.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.682 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.2 t -82.81 130.82 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.431 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.4 p -170.41 160.28 7.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.0 111.199 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -83.65 126.17 32.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.805 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 20' ' ' PRO . 2.3 p -62.96 131.5 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.161 0.505 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.513 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . -71.7 144.82 37.54 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.835 -0.621 . . . . 0.0 113.147 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.529 ' HG3' ' HE2' ' A' ' 68' ' ' LYS . 19.9 pt20 -59.78 145.3 45.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.638 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.613 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -55.35 134.8 50.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.294 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.529 ' HE2' ' HG3' ' A' ' 66' ' ' GLN . 74.9 mmtt -135.28 -48.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.7 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -77.95 -118.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.192 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -152.61 -44.09 0.1 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.837 0.351 . . . . 0.0 110.706 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.588 ' HB2' ' NZ ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -75.59 -48.57 21.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.261 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.55 43.28 6.2 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.189 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -74.76 140.19 43.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.838 0.352 . . . . 0.0 111.3 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.459 ' O ' HD12 ' A' ' 75' ' ' ILE . 76.9 mt -85.11 136.89 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.525 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.536 ' O ' HD13 ' A' ' 41' ' ' LEU . 49.8 mm -133.43 139.07 49.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.927 0.394 . . . . 0.0 111.624 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.444 ' N ' HG21 ' A' ' 75' ' ' ILE . 7.4 p -135.35 126.87 45.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.69 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.7 m -96.73 138.8 33.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.712 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 82' ' ' GLY . 56.7 p -151.95 142.4 22.59 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.465 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.651 ' HD3' ' H ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -54.68 -30.49 55.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.665 0.269 . . . . 0.0 111.353 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -61.73 -57.19 12.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.608 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.45 -45.42 0.92 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.719 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 78' ' ' THR . . . 75.35 120.98 0.12 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.866 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.8 tttm 47.82 65.08 1.38 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.821 0.343 . . . . 0.0 111.047 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.419 ' HA2' ' HG2' ' A' ' 8' ' ' PRO . . . -64.88 -138.88 0.02 OUTLIER Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.88 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.6 p -151.06 -168.35 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.887 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.4 p -169.09 129.64 1.12 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 61.8 p -93.62 29.21 2.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.101 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 m -154.57 140.72 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 71' ' ' LYS . 79.0 p -120.2 140.52 51.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.537 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -89.35 129.95 35.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.621 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -88.33 123.68 33.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.242 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.429 HD22 HG23 ' A' ' 64' ' ' VAL . 93.2 mt -88.02 130.64 34.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.079 0.466 . . . . 0.0 111.974 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 19' ' ' ILE . 84.0 mt -88.69 140.7 29.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.723 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.46 128.03 92.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.651 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.99 127.35 25.96 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.511 2.14 . . . . 0.0 112.604 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.18 117.85 16.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.391 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.612 ' NZ ' ' HB3' ' A' ' 97' ' ' LYS . 5.6 ttpm? . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.1 m170 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.76 0.314 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.434 ' HB2' ' HE1' ' A' ' 4' ' ' MET . 4.7 ppp? -172.9 139.9 0.89 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.601 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.466 ' HG3' HH11 ' A' ' 5' ' ' ARG . 58.7 mtt85 -64.54 128.18 34.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -63.59 137.18 97.02 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.003 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -56.99 149.42 62.12 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.632 2.222 . . . . 0.0 112.242 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.469 ' HD3' ' H ' ' A' ' 82' ' ' GLY . 65.6 Cg_exo -51.9 137.09 52.48 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.54 2.16 . . . . 0.0 112.168 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 85' ' ' THR . 3.3 tt -133.78 117.87 17.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.354 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.533 ' HA ' ' HA2' ' A' ' 28' ' ' GLY . 95.2 t -82.17 135.82 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.184 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.455 HG21 ' O ' ' A' ' 10' ' ' VAL . 80.7 p -147.01 41.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.798 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.29 148.49 7.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.713 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.51 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.1 tt -160.36 132.76 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.763 0.315 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.795 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 45.4 t -66.43 -59.9 7.56 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.661 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.795 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 86.4 Cg_endo -89.87 119.01 0.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.041 1.827 . . . . 0.0 112.389 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -77.54 -20.56 53.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.411 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.502 ' OE1' HD12 ' A' ' 93' ' ' LEU . 15.4 pt-20 -157.07 139.88 15.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.03 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.53 147.57 8.58 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.654 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 37.4 pt -55.16 161.91 2.34 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-O 120.547 0.213 . . . . 0.0 111.362 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.618 ' O ' HG21 ' A' ' 64' ' ' VAL . 85.2 Cg_exo -47.52 -46.17 21.21 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.089 2.526 . . . . 0.0 114.097 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -73.11 -8.29 55.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 m -70.04 128.09 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.992 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 28.5 mtpp -75.65 124.02 26.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.549 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.553 HG23 HG12 ' A' ' 64' ' ' VAL . 30.7 m -113.03 121.25 64.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.966 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.5 m -78.4 118.77 20.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.038 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 62.3 mt -80.63 137.07 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.738 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 58' ' ' SER . 28.3 tpt180 -139.28 126.28 21.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.268 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -167.89 -132.91 1.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.613 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -146.96 137.88 23.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.852 0.358 . . . . 0.0 111.325 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.442 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 72.8 m-80 63.84 41.77 6.54 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.369 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.444 HD11 ' N ' ' A' ' 31' ' ' LEU . 8.8 mp -90.08 46.38 1.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.991 0.424 . . . . 0.0 110.265 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.21 120.34 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.185 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.1 p -91.88 42.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.678 0.275 . . . . 0.0 111.195 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.72 147.76 6.13 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.705 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.13 -45.17 42.65 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.519 2.146 . . . . 0.0 111.716 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 t -62.45 -36.59 82.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.158 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -55.55 -46.09 77.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.975 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.83 134.22 52.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.017 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.434 HG13 ' N ' ' A' ' 40' ' ' GLY . 30.2 pt -140.74 -42.5 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.317 . . . . 0.0 111.219 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.434 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -111.17 136.87 13.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.405 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -147.59 127.41 13.49 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.6 p -152.95 142.02 21.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.514 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 43' ' ' ILE . 70.1 mt -137.37 124.76 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.867 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.643 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 78.0 m 58.24 38.69 26.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 110.156 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.559 ' O ' ' HD3' ' A' ' 68' ' ' LYS . . . 62.44 33.35 86.08 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.877 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -131.12 133.46 45.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.771 0.32 . . . . 0.0 110.8 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.501 HD21 ' N ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -66.48 131.29 45.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.468 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.501 ' N ' HD21 ' A' ' 47' ' ' ASN . 74.1 m -151.7 36.58 0.57 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.861 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.9 tp -75.72 -44.74 40.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.731 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.36 -39.33 69.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.9 p -79.93 -38.1 33.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.151 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -61.2 132.72 54.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.39 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -126.5 133.97 51.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.777 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -64.97 147.17 53.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.252 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 93.8 mmm -145.26 -42.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.407 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.752 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 54.7 m -161.59 157.47 24.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.911 0.386 . . . . 0.0 111.099 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 31' ' ' LEU . . . -50.39 -27.57 6.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.419 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.524 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 54.0 m -133.3 42.11 3.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.371 . . . . 0.0 110.719 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.752 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 60.5 tttm -164.5 128.14 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.868 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -149.97 118.07 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.489 ' CG1' ' HE3' ' A' ' 23' ' ' LYS . 50.1 t -84.46 130.46 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.553 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.527 ' O ' HG21 ' A' ' 24' ' ' VAL . 27.4 p -170.07 131.67 1.03 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.791 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 22.3 ptt-85 -84.96 138.32 32.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.873 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.618 HG21 ' O ' ' A' ' 20' ' ' PRO . 21.3 m -66.2 -145.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.724 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . -178.79 -40.82 0.07 OUTLIER Glycine 0 C--N 1.334 0.44 0 C-N-CA 119.7 -1.238 . . . . 0.0 113.753 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.509 HE21 ' HD2' ' A' ' 68' ' ' LYS . 15.2 pt20 -171.35 131.48 0.76 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.125 0.462 . . . . 0.0 111.588 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.643 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -83.87 64.77 8.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.586 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.559 ' HD3' ' O ' ' A' ' 45' ' ' GLY . 57.4 mtpt -50.02 -45.84 52.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.955 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -71.16 -131.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.313 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -145.02 -48.89 0.24 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.866 0.365 . . . . 0.0 110.591 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.653 ' HZ1' ' HB3' ' A' ' 89' ' ' SER . 63.1 tttm -74.28 -47.53 34.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.138 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.06 45.49 3.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.472 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' OD1' ' HD3' ' A' ' 71' ' ' LYS . 1.6 m-20 -70.21 134.87 48.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.686 0.279 . . . . 0.0 111.179 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.2 mt -85.42 134.15 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.474 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.8 mm -132.97 133.98 58.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.145 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.71 ' H ' ' HA2' ' A' ' 84' ' ' GLY . 53.4 t -141.51 114.37 4.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.825 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.405 ' O ' HG21 ' A' ' 78' ' ' THR . 36.0 m -81.0 142.17 33.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.522 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.405 HG21 ' O ' ' A' ' 77' ' ' THR . 72.5 p -141.93 140.19 32.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.86 0.362 . . . . 0.0 111.426 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.3 mmmm -57.02 -50.69 71.96 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.074 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.0 m -65.07 -53.33 47.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.974 0.416 . . . . 0.0 110.346 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.37 -123.33 0.5 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.148 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.469 ' H ' ' HD3' ' A' ' 8' ' ' PRO . . . -169.44 -141.15 3.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.195 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -62.11 130.08 43.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 110.748 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.71 ' HA2' ' H ' ' A' ' 76' ' ' VAL . . . -69.69 150.05 48.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.083 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 47.3 p -149.09 145.99 27.5 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.53 ' HG ' ' HB ' ' A' ' 10' ' ' VAL . 48.1 t -158.29 134.13 9.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.11 0.481 . . . . 0.0 111.965 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -77.18 -33.41 56.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.517 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -83.74 139.08 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.371 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.653 ' HB3' ' HZ1' ' A' ' 71' ' ' LYS . 83.1 p -120.38 140.27 51.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -86.22 132.75 33.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.721 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.506 ' HD3' HD22 ' A' ' 93' ' ' LEU . 31.7 ttmt -83.27 123.96 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.359 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.527 HD21 ' HB1' ' A' ' 67' ' ' ALA . 56.4 tp -99.06 121.11 40.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.871 0.367 . . . . 0.0 110.734 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 60.4 mt -96.39 139.6 32.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.651 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 61.1 pttt -59.84 134.57 89.72 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.417 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.523 ' HG3' ' HD2' ' A' ' 20' ' ' PRO . 48.1 Cg_exo -58.13 133.26 54.28 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.869 2.379 . . . . 0.0 112.806 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.57 117.85 20.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.651 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.909 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.9 m170 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.678 0.275 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.4 tpt 57.66 51.75 9.08 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.73 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -58.54 135.88 57.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.053 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -62.0 135.47 94.73 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.342 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.27 145.7 73.07 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.449 2.1 . . . . 0.0 111.796 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HG2' ' HA3' ' A' ' 84' ' ' GLY . 11.6 Cg_endo -55.93 120.88 8.99 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.367 2.045 . . . . 0.0 112.036 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.441 ' O ' HD21 ' A' ' 9' ' ' LEU . 5.7 tt -102.65 100.81 10.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.477 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.665 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 59.5 t -84.0 136.76 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.596 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -169.14 51.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.522 . . . . 0.0 111.188 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.03 141.48 7.01 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.417 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.526 HG12 ' HD2' ' A' ' 15' ' ' PRO . 13.9 tt -164.78 130.71 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.448 0.166 . . . . 0.0 110.662 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.754 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.3 t -59.97 -61.44 7.9 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.919 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 85.9 Cg_endo -83.91 -159.96 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.8 1.667 . . . . 0.0 111.104 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -175.25 24.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.111 0.482 . . . . 0.0 110.41 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -179.33 127.33 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.155 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 165.47 151.35 6.62 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.847 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.426 HG21 ' O ' ' A' ' 93' ' ' LEU . 33.7 pt -52.45 161.42 1.08 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.49 0.186 . . . . 0.0 110.986 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.627 ' O ' HG21 ' A' ' 64' ' ' VAL . 73.7 Cg_exo -50.47 -40.72 53.81 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.694 2.263 . . . . 0.0 113.562 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.505 ' HE3' HH11 ' A' ' 63' ' ' ARG . 84.5 m95 -73.86 -5.8 43.25 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -64.96 129.47 39.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.362 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.07 137.27 51.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.586 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.417 ' O ' HG21 ' A' ' 24' ' ' VAL . 34.6 m -144.84 130.59 14.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.973 0.416 . . . . 0.0 110.975 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.521 HG22 ' HZ3' ' A' ' 59' ' ' LYS . 91.6 m -87.67 117.46 26.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.949 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.444 HG21 ' N ' ' A' ' 27' ' ' ARG . 64.1 mt -80.38 137.91 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.754 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.604 ' NH1' ' HB2' ' A' ' 59' ' ' LYS . 25.9 mmm180 -139.72 137.59 35.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.949 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.14 -135.54 2.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.368 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 55.9 mm-40 -151.24 138.06 18.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.825 0.345 . . . . 0.0 111.286 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 76.1 m-20 62.59 38.79 12.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.288 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 mp -81.67 51.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.872 0.368 . . . . 0.0 111.063 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.419 ' HA3' ' OD2' ' A' ' 37' ' ' ASP . . . 76.5 134.56 0.56 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.893 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.5 p -59.75 -35.38 74.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.617 0.246 . . . . 0.0 111.314 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.572 ' HA3' ' CE2' ' A' ' 54' ' ' TRP . . . -168.24 -159.22 13.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.123 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.21 -46.36 15.63 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.954 2.436 . . . . 0.0 112.792 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 p -60.65 -41.22 94.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.511 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.419 ' OD2' ' HA3' ' A' ' 32' ' ' GLY . 64.9 t0 -66.33 -48.09 71.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.819 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.63 130.75 44.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.989 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.436 HG13 ' N ' ' A' ' 40' ' ' GLY . 25.0 pt -149.36 -43.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.436 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -93.94 52.54 2.25 Favored Glycine 0 CA--C 1.51 -0.24 0 C-N-CA 120.494 -0.86 . . . . 0.0 114.149 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.595 ' O ' HG21 ' A' ' 42' ' ' THR . 2.7 tm? -70.23 127.25 32.14 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.595 HG21 ' O ' ' A' ' 41' ' ' LEU . 6.9 p -155.58 144.96 20.98 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.153 0.502 . . . . 0.0 111.987 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 64' ' ' VAL . 80.7 mt -137.66 123.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.527 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.401 ' SG ' HD22 ' A' ' 92' ' ' LEU . 60.3 m 57.64 36.37 26.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.099 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.46 -36.36 2.95 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.637 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -72.87 131.94 42.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.02 0.41 . . . . 0.0 111.398 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -72.56 141.78 48.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 76.4 m -149.2 42.56 0.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.519 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 41' ' ' LEU . 33.0 tp -69.18 -44.47 72.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.19 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 pp -63.94 -34.48 78.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.173 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.3 p -79.92 -38.17 33.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.821 0.343 . . . . 0.0 111.281 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -66.21 137.88 57.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.934 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -126.32 128.48 47.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.247 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.572 ' CE2' ' HA3' ' A' ' 34' ' ' GLY . 82.0 t90 -65.4 149.77 49.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.225 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 93.4 mmm -142.6 -43.81 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.444 ' C ' ' H ' ' A' ' 58' ' ' SER . 48.7 m -155.83 178.02 10.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.674 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.2 37.21 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 56' ' ' SER . 80.7 p -178.81 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.176 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.604 ' HB2' ' NH1' ' A' ' 27' ' ' ARG . 63.0 tttp -83.96 132.52 34.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.5 mt -148.62 115.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.668 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.2 t -84.55 122.75 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.681 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 41.9 t -171.02 146.11 2.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.036 0.446 . . . . 0.0 111.179 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.505 HH11 ' HE3' ' A' ' 21' ' ' TRP . 98.9 mtt180 -85.19 134.09 34.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.207 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.627 HG21 ' O ' ' A' ' 20' ' ' PRO . 19.4 m -55.72 136.67 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.599 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.531 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . -66.29 -125.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.618 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -142.89 143.45 32.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.86 0.362 . . . . 0.0 110.882 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.87 134.88 42.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.793 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -144.71 -41.39 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.612 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.451 ' N ' HD21 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -174.48 153.54 1.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.658 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 69' ' ' ASN . 1.5 m-20 73.87 -40.77 0.47 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.653 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 69' ' ' ASN . 83.4 tttt 64.34 124.28 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.858 ' HA2' ' HB2' ' A' ' 89' ' ' SER . . . 75.39 -33.28 1.14 Allowed Glycine 0 CA--C 1.517 0.217 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.957 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -45.16 127.49 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.373 . . . . 0.0 111.586 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.0 mt -115.47 117.93 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.134 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.472 HG21 ' N ' ' A' ' 76' ' ' VAL . 3.1 mp -120.98 137.5 54.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.37 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.665 ' H ' ' HA2' ' A' ' 84' ' ' GLY . 3.8 p -141.76 103.58 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.829 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -77.31 131.94 38.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.657 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 82.4 p -123.15 142.32 51.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.091 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -50.78 -48.04 59.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.5 m -69.44 -48.48 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.981 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.83 -128.52 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.615 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.4 -40.99 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.344 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -169.72 127.45 0.91 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.76 0.314 . . . . 0.0 110.631 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.665 ' HA2' ' H ' ' A' ' 76' ' ' VAL . . . -74.02 145.5 35.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.967 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 84' ' ' GLY . 69.1 p -143.58 138.63 29.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.597 0.237 . . . . 0.0 110.52 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.665 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 45.2 t -133.13 129.81 38.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.019 0.438 . . . . 0.0 111.493 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.6 p -74.02 -32.43 63.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.573 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.412 HG21 ' OG ' ' A' ' 86' ' ' SER . 33.8 m -83.88 176.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.372 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.858 ' HB2' ' HA2' ' A' ' 72' ' ' GLY . 72.5 p -157.44 133.2 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -85.62 127.32 34.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.815 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -85.04 122.31 29.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 110.607 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.401 HD22 ' SG ' ' A' ' 44' ' ' CYS . 2.9 mm? -82.21 129.73 34.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.929 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.47 ' HG ' ' N ' ' A' ' 18' ' ' GLY . 80.2 mt -100.59 138.94 36.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.6 139.48 96.0 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.039 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.38 133.68 28.92 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.518 2.145 . . . . 0.0 112.045 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.96 76.48 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.133 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.4 pttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.92 -179.834 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.552 0.215 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.5 ttt -62.24 134.54 56.66 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.752 0.31 . . . . 0.0 110.68 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.425 ' HG3' ' HG ' ' A' ' 80' ' ' SER . 38.8 mmt180 -59.82 134.8 57.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.004 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.643 ' NE2' ' H ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -64.98 136.46 96.8 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.023 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.22 144.28 95.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.614 2.21 . . . . 0.0 112.153 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 51.8 Cg_exo -51.86 133.49 45.63 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.524 2.149 . . . . 0.0 112.185 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' A' ' 85' ' ' THR . 3.3 tt -123.56 118.0 26.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.236 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.484 ' O ' HG21 ' A' ' 11' ' ' THR . 62.8 t -81.34 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.285 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 10' ' ' VAL . 71.4 p -147.0 45.2 1.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.033 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.0 147.51 6.92 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.206 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 15' ' ' PRO . 16.3 tt -160.98 130.42 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.728 0.299 . . . . 0.0 110.499 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.813 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.9 t -68.76 -58.2 7.05 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.685 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.813 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 68.8 Cg_endo -93.03 115.14 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.278 1.985 . . . . 0.0 112.592 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.509 ' N ' HD21 ' A' ' 16' ' ' ASN . 0.0 OUTLIER -96.96 27.79 3.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 0.0 110.61 179.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -179.67 130.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.17 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.532 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 171.88 146.03 5.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.828 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.451 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 29.1 pt -54.17 162.81 1.4 Allowed Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 120.486 0.184 . . . . 0.0 111.28 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.599 ' O ' HG11 ' A' ' 64' ' ' VAL . 85.2 Cg_exo -48.16 -37.87 31.79 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.822 2.348 . . . . 0.0 113.653 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -77.71 -15.71 58.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -60.64 124.71 21.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.678 0.275 . . . . 0.0 111.195 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 25.5 pttm -77.18 127.08 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 0.0 110.431 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.6 m -109.45 125.64 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.556 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 84.9 m -72.42 120.88 18.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.82 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.512 HD13 ' SG ' ' A' ' 62' ' ' CYS . 65.5 mt -80.96 139.01 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.002 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 58' ' ' SER . 27.8 tpt180 -147.42 127.3 13.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.894 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -169.17 -134.58 1.75 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.959 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -149.5 137.55 20.5 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.921 0.391 . . . . 0.0 111.579 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 73.6 m-20 60.61 40.6 16.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.578 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.474 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.2 mp -84.49 53.5 2.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.863 0.363 . . . . 0.0 110.597 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.51 129.32 0.43 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.539 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.4 p -97.91 42.56 1.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 0.0 111.369 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.97 142.21 3.98 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.699 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.53 ' HG3' ' CE3' ' A' ' 54' ' ' TRP . 36.0 Cg_exo -56.56 -47.25 24.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.519 2.146 . . . . 0.0 112.116 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.4 p -65.28 -33.97 77.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.421 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.607 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -51.29 -42.88 61.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.997 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.47 HD21 ' N ' ' A' ' 39' ' ' ILE . 1.2 tt -65.92 127.12 30.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.48 HG13 ' N ' ' A' ' 40' ' ' GLY . 32.9 pt -134.43 -44.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 111.32 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.48 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -100.86 136.46 12.71 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.463 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.482 ' O ' HG21 ' A' ' 42' ' ' THR . 2.2 tm? -148.8 126.67 11.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.518 HG23 ' HA ' ' A' ' 47' ' ' ASN . 7.1 p -155.34 141.75 18.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.161 0.505 . . . . 0.0 111.873 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 76.5 mt -129.97 124.0 57.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.401 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.527 ' HA ' HD21 ' A' ' 69' ' ' ASN . 63.0 m 55.4 39.45 31.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.11 -32.92 2.23 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.894 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -72.53 129.75 39.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 0.0 111.127 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.518 ' HA ' HG23 ' A' ' 42' ' ' THR . 5.4 m120 -70.44 140.41 51.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.844 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.1 m -150.39 40.36 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 41' ' ' LEU . 57.4 tp -72.38 -43.88 63.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.321 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -56.39 -38.63 71.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.4 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.0 p -79.84 -36.43 36.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.352 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.537 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -59.63 132.98 55.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.561 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -126.92 126.46 43.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.537 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.53 ' CE3' ' HG3' ' A' ' 35' ' ' PRO . 79.6 t90 -69.44 152.85 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.326 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 49.1 mtt -147.56 -44.38 0.17 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.025 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 58' ' ' SER . 79.2 p -169.58 173.57 6.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.637 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.93 37.31 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.524 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.471 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 79.0 p -176.68 24.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.087 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 59.4 tttp -165.31 128.83 2.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.138 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.4 mt -152.2 119.55 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.655 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.37 134.15 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.616 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.8 p -169.57 146.2 3.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.845 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.655 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 68.3 mtt-85 -84.03 131.64 34.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.599 HG11 ' O ' ' A' ' 20' ' ' PRO . 8.4 p -67.78 -137.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.085 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.501 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 168.94 -140.78 6.34 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.003 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.473 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 3.0 pt20 -87.72 138.47 31.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 0.0 111.471 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.02 66.25 3.61 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.461 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.473 ' HG3' ' HG3' ' A' ' 66' ' ' GLN . 57.7 mtpt -51.8 -43.32 63.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.811 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.527 HD21 ' HA ' ' A' ' 44' ' ' CYS . 76.8 m-20 -69.02 -124.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.771 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -163.4 38.73 0.09 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.81 0.338 . . . . 0.0 110.943 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 89' ' ' SER . 38.8 ttmt -171.03 -43.32 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.606 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.51 ' HA3' ' SG ' ' A' ' 44' ' ' CYS . . . 97.67 47.37 2.14 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.843 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -73.24 130.93 41.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 111.328 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.452 ' O ' HD11 ' A' ' 75' ' ' ILE . 70.4 mt -85.59 135.2 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.226 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.452 HD11 ' O ' ' A' ' 74' ' ' ILE . 40.0 mm -131.55 137.02 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.798 0.332 . . . . 0.0 111.703 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.4 t -141.53 117.84 6.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.937 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -86.05 147.33 26.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.347 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.9 p -139.44 143.7 37.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.4 mmmm -53.97 -55.06 30.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.365 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.425 ' HG ' ' HG3' ' A' ' 5' ' ' ARG . 48.1 t -67.65 -55.43 13.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.002 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.28 -128.65 0.38 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.644 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 -137.3 2.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.999 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -65.12 121.4 14.64 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.5 126.78 8.74 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.893 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 73.1 p -99.43 144.05 28.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.404 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 80.9 p -131.98 126.79 34.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.581 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.9 p -91.65 35.75 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.604 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.49 156.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.67 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 71' ' ' LYS . 84.5 p -138.53 134.63 34.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.946 0.403 . . . . 0.0 111.192 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -86.06 131.42 34.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.347 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -83.93 124.79 31.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.062 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 65' ' ' GLY . 89.2 mt -90.0 127.71 36.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 111.647 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 18' ' ' GLY . 78.3 mt -92.56 139.98 30.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.372 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -56.52 126.89 71.31 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.949 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -53.45 137.75 65.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.869 2.379 . . . . 0.0 112.922 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -70.47 117.89 12.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.881 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.834 -179.838 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.7 m80 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.823 0.344 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.413 ' N ' ' SD ' ' A' ' 4' ' ' MET . 3.2 mpp? -64.42 -45.93 85.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.784 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.549 HH12 ' HB3' ' A' ' 80' ' ' SER . 14.4 tpp85 -62.89 128.29 35.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.434 ' H ' ' CD ' ' A' ' 6' ' ' GLN . 3.2 pm0 -77.23 129.52 77.7 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.055 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.71 148.59 36.94 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.755 2.303 . . . . 0.0 112.375 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.48 142.85 99.58 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.635 2.223 . . . . 0.0 112.054 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.53 HD11 ' C ' ' A' ' 9' ' ' LEU . 3.3 tm? -140.38 119.83 13.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.499 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.585 HG23 HG23 ' A' ' 74' ' ' ILE . 47.1 t -83.58 142.55 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.986 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.446 ' N ' HG11 ' A' ' 10' ' ' VAL . 6.3 t -167.99 49.02 0.05 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.037 0.446 . . . . 0.0 111.363 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.13 138.5 3.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.698 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.506 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.7 tt -165.24 130.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 0.0 110.604 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.805 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.6 t -65.46 -59.38 9.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.692 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 83.7 Cg_endo -90.58 111.72 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.164 1.909 . . . . 0.0 112.155 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -89.33 26.81 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.595 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 176.22 132.25 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.261 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.73 144.22 4.64 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.905 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.421 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 33.1 pt -56.7 160.77 5.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.496 0.189 . . . . 0.0 111.02 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.59 ' HA ' HG12 ' A' ' 64' ' ' VAL . 84.8 Cg_exo -47.07 -45.15 22.02 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.812 2.342 . . . . 0.0 113.544 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -67.2 -22.43 65.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.2 m -62.61 128.21 34.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.136 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 24.7 ttmm -73.83 138.18 44.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.622 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.484 ' O ' HG21 ' A' ' 24' ' ' VAL . 35.0 m -132.23 125.28 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.002 0.43 . . . . 0.0 111.032 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -85.57 118.8 25.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.097 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.4 mt -83.92 137.16 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.431 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -147.66 135.76 21.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.827 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.93 -126.6 0.85 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.21 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -145.18 134.85 23.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.329 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 60.97 42.21 13.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.079 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.571 HD11 ' N ' ' A' ' 31' ' ' LEU . 10.7 mp -83.91 54.93 3.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.964 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.21 134.19 1.9 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.76 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.6 p -67.4 -40.81 85.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.63 0.252 . . . . 0.0 111.62 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.545 ' HA3' ' CZ2' ' A' ' 54' ' ' TRP . . . -156.52 -177.92 30.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.755 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.85 -40.27 79.94 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.638 2.225 . . . . 0.0 112.042 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.8 p -59.95 -41.35 91.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.983 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.512 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 37.7 t70 -66.82 -46.88 73.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.898 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.468 ' O ' HG21 ' A' ' 39' ' ' ILE . 3.4 tm? -69.85 129.0 38.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.923 0.392 . . . . 0.0 110.347 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.478 ' O ' HD23 ' A' ' 49' ' ' LEU . 49.8 pt -147.96 -23.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.422 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.91 128.72 6.98 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.848 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' ' 52' ' ' ALA . 31.4 tp -150.41 147.15 27.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.64 0.257 . . . . 0.0 110.558 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.407 HG22 ' C ' ' A' ' 46' ' ' HIS . 98.2 m -161.69 129.28 4.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.396 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.8 mt -105.34 130.52 56.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.449 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 79.7 m 69.26 -66.42 0.26 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.53 0.519 . . . . 0.0 110.971 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.65 26.13 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.493 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' C ' HG22 ' A' ' 42' ' ' THR . 83.1 t60 -132.18 135.76 46.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.585 0.231 . . . . 0.0 110.707 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -59.29 136.83 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.772 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.404 ' O ' ' HB1' ' A' ' 52' ' ' ALA . 77.7 m -151.45 36.28 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.102 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 39' ' ' ILE . 49.5 tp -70.3 -44.69 67.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.964 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -54.12 -40.77 67.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.049 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.3 p -80.38 -32.67 37.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.04 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.15 133.27 55.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.087 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' O ' HG21 ' A' ' 60' ' ' ILE . 43.8 tt0 -127.14 127.1 44.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.129 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.545 ' CZ2' ' HA3' ' A' ' 34' ' ' GLY . 43.4 t90 -67.4 149.09 50.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 110.702 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 94.5 mmm -143.26 -43.13 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.096 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 58' ' ' SER . 32.2 t -166.86 172.84 9.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.846 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.58 25.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.641 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 56' ' ' SER . 66.8 m -167.78 21.35 0.03 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.696 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.641 ' HB2' ' HZ3' ' A' ' 59' ' ' LYS . 5.0 ttmp? -165.1 134.87 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.411 HG21 ' O ' ' A' ' 53' ' ' GLU . 79.3 mt -146.86 121.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -80.89 125.7 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.513 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.1 p -170.42 140.56 1.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.021 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 84.4 mtm180 -84.33 136.79 33.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.634 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 20' ' ' PRO . 4.8 p -54.29 137.73 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.395 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.74 -62.0 4.07 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.801 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -178.6 -138.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.399 -0.222 . . . . 0.0 110.399 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.61 48.03 1.84 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.723 0.297 . . . . 0.0 111.098 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -51.79 -46.32 64.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.174 0.511 . . . . 0.0 110.069 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.538 ' N ' HD21 ' A' ' 69' ' ' ASN . 1.8 m120 -87.39 151.55 22.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.422 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.597 ' OD1' ' HG3' ' A' ' 71' ' ' LYS . 1.2 p30 -56.24 -44.81 79.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.021 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.597 ' HG3' ' OD1' ' A' ' 70' ' ' ASP . 97.1 mttt -86.78 -125.58 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.437 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.51 40.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.311 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -62.76 130.91 47.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.585 HG23 HG23 ' A' ' 10' ' ' VAL . 71.8 mt -85.3 131.58 33.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.468 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.0 mm -128.88 139.55 51.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.229 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.78 121.65 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.8 m -98.09 133.9 41.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.509 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 81.6 p -118.52 142.21 47.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.178 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 37' ' ' ASP . 29.4 mtpp -54.02 -44.88 71.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.633 0.254 . . . . 0.0 110.982 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB3' HH12 ' A' ' 5' ' ' ARG . 49.9 m -66.81 -47.13 72.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.984 0.421 . . . . 0.0 109.957 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.42 -132.53 1.69 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.47 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . 172.81 67.41 0.05 OUTLIER Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.247 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 82' ' ' GLY . 59.2 tttm 67.98 109.28 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.881 0.372 . . . . 0.0 110.439 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.06 -134.32 6.44 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.856 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.4 p -145.99 -168.26 2.94 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.578 0.227 . . . . 0.0 110.626 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.406 ' HA ' HD23 ' A' ' 9' ' ' LEU . 78.4 p -169.47 125.35 0.86 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 111.151 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.9 p -90.53 28.37 1.5 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.708 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 m -153.58 149.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.999 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.8 m -134.56 134.86 41.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -85.5 127.67 34.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -81.08 117.15 21.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.553 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 93' ' ' LEU . 1.5 tm? -81.16 128.47 33.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.523 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 92' ' ' LEU . 80.8 mt -99.65 133.51 43.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.845 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -68.05 134.1 91.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.661 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.45 129.95 37.43 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.368 2.046 . . . . 0.0 112.349 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -79.85 119.29 22.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.674 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.869 179.899 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.407 ' H1 ' HH12 ' A' ' 5' ' ' ARG . 21.2 t-80 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.79 0.328 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 4' ' ' MET . 27.8 ttt -79.67 44.76 0.64 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.078 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.567 ' HA ' ' NE ' ' A' ' 5' ' ' ARG . 12.9 mmp_? -68.79 129.63 40.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.612 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -67.34 133.25 93.17 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.01 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.82 146.59 66.24 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.658 2.239 . . . . 0.0 112.206 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.478 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 18.0 Cg_endo -58.31 129.61 33.62 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.596 2.198 . . . . 0.0 112.3 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 85' ' ' THR . 63.2 tp -113.33 119.84 39.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.071 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 27' ' ' ARG . 69.7 t -85.29 132.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.069 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.9 p -151.57 47.91 0.81 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.51 144.57 6.43 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.869 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.555 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 13.0 tt -158.95 131.01 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.859 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 53.2 m -60.88 -60.69 9.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.565 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.859 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 3.7 Cg_exo -75.83 -150.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.954 1.769 . . . . 0.0 111.796 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.508 ' OD1' ' HG2' ' A' ' 17' ' ' GLU . 5.3 p30 -173.94 -22.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.024 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.508 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 16.2 pt-20 -159.51 129.38 5.52 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.685 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.69 159.81 16.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.56 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.6 pt -51.64 156.75 2.14 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.613 0.244 . . . . 0.0 111.03 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.578 ' O ' HG21 ' A' ' 64' ' ' VAL . 75.8 Cg_exo -51.88 -41.07 65.16 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.742 2.295 . . . . 0.0 113.496 -179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -70.67 -5.79 32.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -64.02 131.0 46.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.998 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.425 ' O ' HG11 ' A' ' 24' ' ' VAL . 17.3 tppt? -65.99 136.97 56.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.283 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.498 ' O ' HG21 ' A' ' 24' ' ' VAL . 26.3 m -141.45 131.34 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.007 0.432 . . . . 0.0 111.309 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.418 ' HB ' ' OG ' ' A' ' 14' ' ' SER . 99.7 m -90.3 122.53 33.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.479 HG21 ' N ' ' A' ' 27' ' ' ARG . 64.1 mt -79.41 141.5 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.782 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.495 ' O ' HG11 ' A' ' 10' ' ' VAL . 12.2 tpt180 -147.56 131.39 17.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.318 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -170.87 -135.62 1.95 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.663 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 67.0 mm-40 -145.93 135.86 23.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.842 0.353 . . . . 0.0 111.44 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.478 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 72.8 m-80 61.59 40.59 13.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.351 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 mp -83.57 49.05 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.704 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.72 124.24 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.476 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.8 p -88.29 39.25 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.763 0.316 . . . . 0.0 111.362 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.36 147.47 5.07 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.594 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.92 -41.6 62.54 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.334 2.023 . . . . 0.0 111.77 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.9 p -61.17 -34.67 75.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.771 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.94 46.09 0.56 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.815 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.51 HD21 ' N ' ' A' ' 39' ' ' ILE . 1.9 tt -157.4 121.9 4.35 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.51 ' N ' HD21 ' A' ' 38' ' ' LEU . 29.0 pt -144.21 33.16 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.989 0.423 . . . . 0.0 111.424 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.04 128.5 1.48 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.39 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.566 HD12 ' N ' ' A' ' 42' ' ' THR . 1.2 tm? -150.56 134.0 16.4 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.566 ' N ' HD12 ' A' ' 41' ' ' LEU . 94.0 m -158.33 128.08 5.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.079 0.466 . . . . 0.0 111.746 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.587 HG23 ' H ' ' A' ' 65' ' ' GLY . 41.1 mm -115.72 126.09 73.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.387 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.653 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 69.7 m 57.68 45.79 18.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.789 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.49 ' O ' ' HD2' ' A' ' 68' ' ' LYS . . . 61.94 11.65 32.2 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.975 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -116.07 133.12 56.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.328 . . . . 0.0 111.026 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.13 133.29 54.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.987 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.1 m -153.35 39.01 0.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.669 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.1 tp -72.27 -41.97 66.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.459 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.419 HD13 HG22 ' A' ' 51' ' ' THR . 3.9 pp -58.07 -33.51 69.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.501 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.419 HG22 HD13 ' A' ' 50' ' ' LEU . 20.3 p -80.03 -37.7 33.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.766 0.317 . . . . 0.0 110.99 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -59.82 131.13 49.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.735 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -127.21 127.58 44.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.262 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -65.62 141.53 58.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.739 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 95.3 mmm -132.23 -42.65 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.139 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 m -160.93 -166.34 1.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.998 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.04 -7.53 54.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.478 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.4 m -156.23 47.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.078 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 87.3 tttt -164.44 129.11 2.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.9 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.427 HD12 HD13 ' A' ' 38' ' ' LEU . 76.2 mt -150.21 126.91 2.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.968 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 89.1 t -84.58 127.89 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.535 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.554 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.5 p -170.67 145.09 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.815 0.34 . . . . 0.0 111.198 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -84.63 131.63 34.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.341 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 20' ' ' PRO . 15.3 m -61.39 124.9 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.421 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.587 ' H ' HG23 ' A' ' 43' ' ' ILE . . . -74.39 151.28 43.2 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.683 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -52.43 140.75 21.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.749 0.309 . . . . 0.0 110.64 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.653 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -59.71 121.24 11.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.263 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.49 ' HD2' ' O ' ' A' ' 45' ' ' GLY . 52.5 tttp -87.85 -53.69 4.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.45 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -92.77 -74.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.9 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -160.01 -54.19 0.06 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -78.34 -126.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.143 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 44' ' ' CYS . . . 171.67 48.69 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.53 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -57.87 132.16 52.55 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.01 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.4 mt -86.77 121.18 37.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.748 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.9 mm -111.62 138.97 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.307 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.0 t -141.39 110.64 2.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.901 0.382 . . . . 0.0 111.095 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.7 m -79.73 143.39 34.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.823 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.5 p -136.86 139.74 41.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.893 0.377 . . . . 0.0 111.369 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -56.78 -47.43 80.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.055 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.7 m -67.25 -52.83 36.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.607 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 -125.14 2.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.068 -0.586 . . . . 0.0 112.411 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 -134.97 1.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.18 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -60.58 125.46 23.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 0.0 110.524 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.404 ' HA3' ' HG2' ' A' ' 8' ' ' PRO . . . -72.92 130.7 14.48 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.217 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 74.3 p -100.47 147.47 25.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.586 0.232 . . . . 0.0 110.773 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -159.88 125.74 4.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.32 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.48 ' O ' HG11 ' A' ' 88' ' ' VAL . 81.7 p -99.0 40.73 1.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.522 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.48 HG11 ' O ' ' A' ' 87' ' ' THR . 28.4 m -147.97 157.34 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.798 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.2 p -150.74 139.24 20.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -84.83 127.24 34.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.163 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -72.4 120.26 17.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.338 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.405 ' HA ' HD21 ' A' ' 92' ' ' LEU . 92.9 mt -90.19 128.95 36.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.285 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.1 mt -105.55 140.11 39.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.631 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -58.51 140.22 84.76 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.9 129.1 32.46 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.534 2.156 . . . . 0.0 112.598 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -82.93 119.15 24.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.495 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.1 pttt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.946 -179.787 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.847 0.356 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -58.32 130.89 48.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.086 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.46 ' HA ' ' NE ' ' A' ' 5' ' ' ARG . 3.6 mmp_? -75.62 135.84 40.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.786 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.64 ' NE2' ' H ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -72.47 133.02 83.22 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.975 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.72 141.78 38.32 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.51 2.14 . . . . 0.0 112.407 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 16.6 Cg_endo -57.57 143.46 94.65 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.735 2.29 . . . . 0.0 112.288 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -132.12 122.47 25.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.248 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.501 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 63.7 t -83.04 137.65 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.624 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.448 HG21 ' O ' ' A' ' 10' ' ' VAL . 68.9 p -148.94 45.6 1.0 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.94 146.34 6.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.126 -1.035 . . . . 0.0 113.449 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 13' ' ' ILE . 14.1 tt -163.59 128.32 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.677 0.275 . . . . 0.0 110.308 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.847 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 59.1 m -68.48 -60.05 5.21 Favored Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.717 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.847 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 70.1 Cg_endo -95.24 106.74 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.399 2.066 . . . . 0.0 112.157 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -91.07 32.31 1.03 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.562 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 179.31 128.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.36 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.03 149.45 6.23 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.593 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.3 pt -54.01 160.07 2.49 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.538 0.209 . . . . 0.0 111.04 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.523 ' O ' HG21 ' A' ' 64' ' ' VAL . 86.1 Cg_exo -49.26 -38.65 42.26 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.889 2.393 . . . . 0.0 113.651 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -75.8 -14.5 60.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 m -63.58 127.92 33.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 111.536 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 54.1 mtmt -74.97 134.65 41.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.324 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.718 HG23 HG12 ' A' ' 64' ' ' VAL . 28.4 m -123.41 128.57 74.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.941 0.4 . . . . 0.0 111.339 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.6 m -73.67 117.05 14.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.764 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 60' ' ' ILE . 67.9 mt -86.99 136.08 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.063 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.45 ' HE ' ' HG3' ' A' ' 59' ' ' LYS . 21.0 mmt85 -146.5 134.96 21.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.601 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -170.03 -130.99 1.27 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.466 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -146.49 132.48 19.21 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.855 0.36 . . . . 0.0 111.343 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.517 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.1 m-80 61.27 41.76 12.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.136 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mp -81.86 53.33 2.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.978 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.99 134.32 1.22 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.639 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 p -66.47 -37.47 85.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.665 0.269 . . . . 0.0 111.537 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 54' ' ' TRP . . . -154.79 -174.4 24.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.008 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.77 -43.93 15.0 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.737 2.291 . . . . 0.0 112.567 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.0 p -56.36 -40.63 74.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.828 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -66.28 -36.86 84.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.736 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.2 tp -74.61 63.06 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.5 pt -73.0 -37.14 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.158 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -113.51 142.27 17.36 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.037 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.418 ' O ' HG21 ' A' ' 42' ' ' THR . 3.0 tm? -149.62 134.71 18.06 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.545 HG21 ' HA ' ' A' ' 47' ' ' ASN . 18.5 p -150.31 151.16 32.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.079 0.466 . . . . 0.0 111.832 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.521 HD11 ' HA ' ' A' ' 64' ' ' VAL . 77.2 mt -136.15 117.49 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.328 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 85.3 m 73.78 -38.3 0.4 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.468 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 168.33 -40.1 0.22 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.962 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -80.24 140.68 36.14 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.92 0.39 . . . . 0.0 111.763 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.545 ' HA ' HG21 ' A' ' 42' ' ' THR . 39.3 t30 -59.8 144.59 48.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.965 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.5 m -149.96 38.28 0.74 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.08 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.8 tp -73.84 -47.67 36.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.237 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.418 ' HG ' ' N ' ' A' ' 51' ' ' THR . 2.3 pt? -48.41 -44.44 35.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.727 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.746 HG23 ' HE ' ' A' ' 63' ' ' ARG . 52.9 p -80.12 -37.87 32.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.722 0.296 . . . . 0.0 111.349 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -60.23 137.16 58.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.491 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -126.76 130.72 50.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.506 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.422 ' CE2' ' HA3' ' A' ' 34' ' ' GLY . 55.7 t90 -66.53 150.83 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.223 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.599 ' HG3' ' HZ1' ' A' ' 59' ' ' LYS . 23.8 mmt -141.2 -47.49 0.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.902 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 58' ' ' SER . 35.2 t -166.41 -175.1 3.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.401 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.73 38.23 0.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.756 0.312 . . . . 0.0 111.169 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 56' ' ' SER . 80.4 p -175.87 -43.54 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.599 ' HZ1' ' HG3' ' A' ' 55' ' ' MET . 61.9 tttm -82.87 131.94 35.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.227 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 77.2 mt -151.78 105.92 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.598 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.484 HG11 ' O ' ' A' ' 61' ' ' VAL . 8.8 p -80.25 130.67 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.825 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 31.7 t -170.82 141.33 1.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 111.407 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.746 ' HE ' HG23 ' A' ' 51' ' ' THR . 40.1 ptt180 -85.35 131.88 34.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.392 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.718 HG12 HG23 ' A' ' 24' ' ' VAL . 27.0 m -66.68 -149.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.732 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.523 ' O ' HD23 ' A' ' 92' ' ' LEU . . . -178.64 -142.22 4.7 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.634 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -77.23 -143.13 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.09 124.27 0.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 110.972 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.551 ' HB3' ' NZ ' ' A' ' 68' ' ' LYS . 3.3 mmmp? -71.09 -52.33 20.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -71.83 -82.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.772 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 64.1 t0 179.7 -47.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.69 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.678 ' HZ1' ' HB3' ' A' ' 89' ' ' SER . 25.6 ttpp -68.71 -116.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.794 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.8 46.72 0.05 OUTLIER Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.717 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.554 ' HB2' ' HZ2' ' A' ' 71' ' ' LYS . 63.9 t0 -63.81 128.63 36.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.928 0.394 . . . . 0.0 111.219 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.76 130.74 35.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.326 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 85' ' ' THR . 34.5 mm -134.19 145.77 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 111.449 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.2 p -139.55 128.36 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.833 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.5 m -93.61 143.79 25.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.403 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.8 p -137.0 137.42 39.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.605 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 7.5 mtpm? -55.65 -48.26 75.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.4 m -65.87 -55.46 16.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.928 0.394 . . . . 0.0 110.382 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.0 -123.64 0.72 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.161 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.82 -143.04 3.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.005 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.404 ' HE2' ' CG2' ' A' ' 75' ' ' ILE . 19.7 tptm -69.18 109.72 4.21 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.94 -161.25 7.28 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.181 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.437 ' HA ' HD11 ' A' ' 75' ' ' ILE . 44.0 p -154.29 -169.03 3.11 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.427 0.291 . . . . 0.0 110.451 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.533 ' OG ' HG21 ' A' ' 88' ' ' VAL . 45.4 t -171.16 131.86 0.8 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.755 0.312 . . . . 0.0 111.243 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.7 p -90.49 31.68 1.01 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.78 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.533 HG21 ' OG ' ' A' ' 86' ' ' SER . 27.4 m -152.03 142.48 15.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.922 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.678 ' HB3' ' HZ1' ' A' ' 71' ' ' LYS . 77.3 p -125.07 133.72 52.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.72 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -85.77 128.08 34.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -82.48 123.13 28.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.572 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 65' ' ' GLY . 82.8 mt -81.84 128.8 34.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.152 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.1 mt -98.89 133.38 43.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.724 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 31.0 mmmt -74.37 134.74 76.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 51.9 Cg_exo -55.85 130.75 42.06 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.53 2.153 . . . . 0.0 112.352 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -75.22 115.97 15.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.682 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.3 tttm . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.912 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.844 0.354 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 93.0 mmm -57.36 138.42 54.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.742 ' HD3' ' HB3' ' A' ' 80' ' ' SER . 99.5 mtt180 -145.74 45.39 1.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.771 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -60.25 145.53 85.66 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.225 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.68 141.08 76.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.626 2.217 . . . . 0.0 112.289 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.52 137.98 82.66 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.515 2.143 . . . . 0.0 112.148 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 85' ' ' THR . 3.5 tt -130.39 113.25 14.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.107 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.542 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 90.3 t -81.01 135.69 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.421 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 10' ' ' VAL . 80.7 p -146.67 42.5 1.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.14 144.74 5.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.75 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.521 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.0 tt -163.07 130.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.62 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.813 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 50.4 m -65.64 -58.94 10.3 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.068 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.813 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 90.9 Cg_endo -95.0 119.99 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.575 2.183 . . . . 0.0 112.478 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -92.92 21.17 5.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.887 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 178.64 135.58 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.655 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 167.35 145.44 4.5 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.94 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.498 HG21 ' O ' ' A' ' 93' ' ' LEU . 33.4 pt -54.97 159.79 3.51 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 110.723 -0.103 . . . . 0.0 110.723 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.638 ' O ' HG21 ' A' ' 64' ' ' VAL . 73.7 Cg_exo -48.67 -39.93 38.11 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.574 2.183 . . . . 0.0 113.099 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.404 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 60.4 m95 -69.92 -21.19 63.31 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.6 m -60.94 129.83 43.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 111.452 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -70.34 140.59 52.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.422 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.613 HG23 HG11 ' A' ' 64' ' ' VAL . 19.6 m -136.66 133.15 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.2 m -88.13 110.59 20.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.782 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 26' ' ' ILE . 59.6 mt -75.95 138.8 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.466 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.533 ' O ' HG11 ' A' ' 10' ' ' VAL . 22.2 tpp180 -147.11 128.99 15.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.385 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -170.77 -136.22 2.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.62 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -148.57 138.41 22.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.941 0.4 . . . . 0.0 111.197 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 62.92 41.18 8.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.289 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.8 mp -85.47 52.07 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.495 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.85 125.14 0.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.305 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -91.92 39.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.753 0.311 . . . . 0.0 111.493 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.54 144.74 4.37 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.599 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.88 -43.5 58.74 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.491 2.128 . . . . 0.0 111.997 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.8 p -61.75 -37.48 84.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.193 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -57.1 -44.1 82.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.484 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.421 ' C ' HD21 ' A' ' 38' ' ' LEU . 1.2 tt -73.9 67.74 1.26 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.74 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.49 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 26.6 pt -75.92 -39.53 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.675 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -114.31 139.17 15.42 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.219 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 42' ' ' THR . 3.0 tm? -150.13 130.11 13.44 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.536 ' N ' HD12 ' A' ' 41' ' ' LEU . 36.2 p -151.61 137.08 17.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 111.748 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.522 HD11 ' HA ' ' A' ' 64' ' ' VAL . 69.1 mt -125.28 126.13 70.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.648 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.595 ' SG ' HD22 ' A' ' 92' ' ' LEU . 69.5 m 58.19 38.37 26.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.018 0.437 . . . . 0.0 110.335 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.406 ' HA2' ' OD1' ' A' ' 69' ' ' ASN . . . 64.07 34.28 89.49 Favored Glycine 0 C--N 1.331 0.285 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.171 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -131.34 133.38 45.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 0.0 110.556 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -68.56 132.94 47.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.051 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.0 m -154.64 36.67 0.41 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.628 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 3.3 tm? -77.51 -46.09 23.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.774 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -52.72 -39.73 62.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.053 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.497 HG23 ' NE ' ' A' ' 63' ' ' ARG . 67.8 p -80.48 -35.67 34.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -55.13 138.37 44.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.514 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -126.07 130.69 51.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.806 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -80.36 150.6 29.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.4 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.9 mtt -147.71 -44.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.482 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 t -165.52 176.42 8.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.447 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.18 43.37 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.219 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.7 p -172.31 -42.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.135 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -93.71 130.64 39.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 111.166 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.1 mt -150.33 111.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.666 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 66.2 t -84.39 125.94 40.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.887 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 31.6 p -170.87 151.22 3.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.051 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.497 ' NE ' HG23 ' A' ' 51' ' ' THR . 39.0 ptt180 -83.94 132.37 34.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.501 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.638 HG21 ' O ' ' A' ' 20' ' ' PRO . 6.5 m -60.06 130.02 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.856 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.4 154.59 50.59 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.579 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -49.82 149.64 2.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.541 0.21 . . . . 0.0 110.576 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.442 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . . . -73.47 59.19 0.59 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.967 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.517 ' HD3' ' C ' ' A' ' 68' ' ' LYS . 12.6 tmtt? -55.45 -47.81 75.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.06 0.457 . . . . 0.0 109.78 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.406 ' OD1' ' HA2' ' A' ' 45' ' ' GLY . 4.8 m120 -83.07 -125.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.802 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -161.19 -40.24 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.789 0.328 . . . . 0.0 110.768 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 89' ' ' SER . 40.1 ttmt -60.27 -42.48 95.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.772 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.413 ' HA3' ' SG ' ' A' ' 44' ' ' CYS . . . 75.1 37.35 43.26 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.655 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.08 136.8 41.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.686 0.279 . . . . 0.0 110.449 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.6 mt -84.95 92.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.007 0.432 . . . . 0.0 110.935 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.8 mm -81.88 137.77 20.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.635 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.2 t -141.54 106.77 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.119 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.0 m -82.16 143.55 31.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.505 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.2 p -141.04 134.8 30.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.519 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.546 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 7.6 mtpm? -55.53 -43.57 75.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.794 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.742 ' HB3' ' HD3' ' A' ' 5' ' ' ARG . 53.8 m -64.43 -48.97 73.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.241 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.46 -121.33 4.85 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.164 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.42 -141.28 3.09 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.182 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.19 127.97 34.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 110.854 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.3 132.38 12.04 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.0 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 78.7 p -99.1 146.18 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.545 0.212 . . . . 0.0 110.64 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.546 ' HG ' HG21 ' A' ' 88' ' ' VAL . 47.5 t -149.37 132.06 15.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.982 0.42 . . . . 0.0 111.583 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.6 p -72.05 -33.49 68.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.746 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.546 HG21 ' HG ' ' A' ' 86' ' ' SER . 35.4 m -83.54 139.43 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.401 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 71' ' ' LYS . 78.1 p -123.62 138.68 54.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.744 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -88.26 130.06 35.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -90.43 125.07 35.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.532 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.595 HD22 ' SG ' ' A' ' 44' ' ' CYS . 3.2 mm? -85.25 124.42 31.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 111.046 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.498 ' O ' HG21 ' A' ' 19' ' ' ILE . 80.7 mt -87.24 136.1 33.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.785 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -64.91 131.62 95.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.369 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.94 127.24 25.25 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.419 2.08 . . . . 0.0 112.319 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.57 111.47 4.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.949 179.766 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.1 m170 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.5 mmm -68.2 -137.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.789 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -62.85 137.12 58.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.752 0.31 . . . . 0.0 111.065 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -60.33 137.8 91.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.054 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.34 142.79 99.57 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.755 2.303 . . . . 0.0 112.216 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.19 129.73 36.87 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.515 2.144 . . . . 0.0 112.275 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.7 tp -115.01 108.19 16.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 57.4 t -84.82 137.02 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.454 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 t -166.73 51.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.204 0.526 . . . . 0.0 111.414 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.33 136.77 4.13 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.392 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.531 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.4 tt -165.29 131.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.703 0.287 . . . . 0.0 110.622 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.793 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.6 t -69.35 -58.46 5.97 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.627 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 88.3 Cg_endo -93.24 113.18 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.364 2.043 . . . . 0.0 112.614 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.47 ' N ' HD21 ' A' ' 16' ' ' ASN . 0.0 OUTLIER -95.81 31.65 2.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.897 0.38 . . . . 0.0 110.863 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -179.45 129.34 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.358 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.512 ' N ' HD13 ' A' ' 93' ' ' LEU . . . 166.07 146.9 5.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.988 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 39.6 pt -53.43 160.39 1.86 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.342 0.115 . . . . 0.0 110.949 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.573 ' O ' HG21 ' A' ' 64' ' ' VAL . 89.3 Cg_exo -48.08 -38.8 32.89 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.622 2.215 . . . . 0.0 113.11 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.59 ' O ' ' HD2' ' A' ' 63' ' ' ARG . 97.4 m95 -72.76 -21.03 61.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.6 m -56.22 127.98 33.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.076 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.406 ' HE2' HG12 ' A' ' 61' ' ' VAL . 60.6 tttm -70.28 142.34 52.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.79 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.832 HG23 HG11 ' A' ' 64' ' ' VAL . 34.6 m -139.82 126.46 23.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 111.091 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 62.1 m -83.55 87.85 7.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.76 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.8 mm -54.69 133.8 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.758 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.47 ' O ' HG11 ' A' ' 10' ' ' VAL . 45.2 mmm-85 -140.44 137.29 33.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -168.12 -134.11 1.66 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.196 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -150.57 135.58 17.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 111.237 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 61.65 41.72 11.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.227 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 mp -82.79 51.24 1.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.865 0.364 . . . . 0.0 110.411 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.41 123.45 0.19 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.212 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.7 p -92.29 42.47 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.741 0.305 . . . . 0.0 111.352 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.63 143.75 4.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.653 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HG3' ' CE3' ' A' ' 54' ' ' TRP . 32.2 Cg_exo -57.3 -46.09 30.47 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.456 2.104 . . . . 0.0 111.749 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 t -62.48 -36.36 82.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.157 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.443 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 28.3 m-20 -53.7 -45.46 70.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.672 HD21 ' N ' ' A' ' 39' ' ' ILE . 1.4 tt -68.76 131.11 44.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.076 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.672 ' N ' HD21 ' A' ' 38' ' ' LEU . 30.0 pt -138.4 -44.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.593 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.467 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -104.55 135.82 12.71 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.216 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.535 ' O ' HG21 ' A' ' 42' ' ' THR . 0.2 OUTLIER -146.32 121.0 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.535 HG21 ' O ' ' A' ' 41' ' ' LEU . 33.3 p -153.13 134.82 14.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.179 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.511 HD11 ' HA ' ' A' ' 64' ' ' VAL . 76.0 mt -105.38 111.22 33.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.044 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.493 ' SG ' ' HA3' ' A' ' 72' ' ' GLY . 34.5 t 73.91 -37.8 0.38 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.748 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 171.9 -32.39 0.13 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.528 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -73.58 135.73 43.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.921 0.391 . . . . 0.0 111.459 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.525 ' HA ' HG21 ' A' ' 42' ' ' THR . 43.2 t30 -71.35 138.39 49.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.844 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.2 m -151.89 40.4 0.64 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.965 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.2 tp -74.28 -44.39 52.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.57 -42.71 55.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.497 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.1 p -80.31 -35.26 35.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 111.204 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.577 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.77 131.2 50.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.983 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -127.11 129.99 48.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.335 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.428 ' CE3' ' HG3' ' A' ' 35' ' ' PRO . 67.2 t90 -73.35 148.35 43.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.076 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.3 mtt -148.76 -44.01 0.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.317 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 58' ' ' SER . 64.7 m -160.62 169.97 21.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.727 0.298 . . . . 0.0 110.884 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.78 32.8 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.344 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 56' ' ' SER . 79.8 p -177.85 34.42 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.544 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -164.58 131.23 3.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.8 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.484 HD12 HD13 ' A' ' 38' ' ' LEU . 71.4 mt -150.1 118.81 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 70.5 t -83.7 125.37 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.5 p -170.43 148.24 3.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.826 0.346 . . . . 0.0 111.015 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.59 ' HD2' ' O ' ' A' ' 21' ' ' TRP . 37.6 mmt-85 -84.01 131.18 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.126 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.832 HG11 HG23 ' A' ' 24' ' ' VAL . 10.4 m -54.81 128.42 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.189 0.519 . . . . 0.0 112.131 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.44 -105.54 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.502 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.629 ' HG3' ' HZ1' ' A' ' 68' ' ' LYS . 25.1 pt20 -162.57 138.96 7.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.721 0.296 . . . . 0.0 110.774 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.432 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . . . -61.51 96.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.405 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.629 ' HZ1' ' HG3' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -73.58 -43.76 58.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.457 ' N ' HD21 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -170.17 171.82 6.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.861 0.362 . . . . 0.0 111.695 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 69' ' ' ASN . 1.5 m-20 74.87 -62.55 0.45 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.227 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt 177.26 -46.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.982 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.493 ' HA3' ' SG ' ' A' ' 44' ' ' CYS . . . 146.35 38.66 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.554 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -66.36 139.38 58.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.727 0.298 . . . . 0.0 110.958 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.2 mt -84.32 135.27 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.584 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.458 HD11 ' O ' ' A' ' 84' ' ' GLY . 46.1 mm -128.66 137.51 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.899 0.38 . . . . 0.0 111.72 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t -141.4 117.5 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.896 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.9 m -87.56 140.69 29.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.975 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.6 p -134.59 137.0 43.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.996 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 37' ' ' ASP . 28.9 mtpp -60.1 -46.27 90.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.3 m -65.11 -52.43 55.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.056 0.455 . . . . 0.0 110.159 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.72 -121.8 2.46 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.063 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.36 -142.19 3.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.355 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.461 ' C ' ' HD2' ' A' ' 83' ' ' LYS . 3.5 tmmm? -66.73 125.25 25.25 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.458 ' O ' HD11 ' A' ' 75' ' ' ILE . . . -79.45 131.31 10.5 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.061 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.7 p -99.27 148.24 24.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.642 0.258 . . . . 0.0 110.431 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.55 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 78.9 p -149.23 130.31 14.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 111.817 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 74.0 p -81.51 -31.74 32.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.376 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 m -84.22 148.31 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.205 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.0 p -138.97 135.25 34.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.797 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -85.64 133.34 34.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.538 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -88.45 123.71 33.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.403 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.438 ' HA ' HD11 ' A' ' 92' ' ' LEU . 3.2 mm? -80.13 128.27 33.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.056 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.512 HD13 ' N ' ' A' ' 18' ' ' GLY . 75.8 mt -101.45 135.97 42.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.002 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -67.69 140.97 94.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.62 134.74 63.77 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.447 2.098 . . . . 0.0 112.284 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -68.68 79.73 0.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.303 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.4 pttt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.928 179.89 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.453 ' H2 ' ' HD1' ' A' ' 3' ' ' HIS . 15.2 m80 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.65 0.262 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 92.3 mmm -71.43 -145.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.811 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.431 ' HD2' ' OG ' ' A' ' 80' ' ' SER . 99.0 mtt180 63.49 134.92 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.983 0.421 . . . . 0.0 111.27 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -64.24 134.34 95.93 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.17 147.46 94.05 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.614 2.209 . . . . 0.0 112.241 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.09 143.36 18.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.571 2.181 . . . . 0.0 112.331 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 85' ' ' THR . 46.7 tp -135.93 111.57 9.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 58.8 t -78.36 130.0 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.791 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.483 HG21 ' O ' ' A' ' 10' ' ' VAL . 76.5 p -150.92 47.8 0.85 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.093 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.4 145.22 6.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.292 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.477 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.4 tt -164.35 128.18 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.31 . . . . 0.0 110.397 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.779 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.0 t -64.98 -58.26 13.31 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.861 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 79.8 Cg_endo -91.27 110.84 0.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.28 1.987 . . . . 0.0 112.397 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -90.31 24.41 2.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.943 0.402 . . . . 0.0 110.166 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -179.31 132.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.169 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.407 ' N ' HD13 ' A' ' 93' ' ' LEU . . . 172.17 145.84 5.1 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.852 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.482 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.9 pt -55.67 164.18 1.7 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 120.407 0.146 . . . . 0.0 110.707 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 19' ' ' ILE . 81.4 Cg_exo -47.7 -53.73 6.14 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.605 2.204 . . . . 0.0 113.966 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.412 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 80.2 m95 -68.31 -8.87 43.53 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.439 ' OG1' HG12 ' A' ' 19' ' ' ILE . 73.1 m -62.29 127.29 30.63 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.079 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.423 ' HD3' HG12 ' A' ' 61' ' ' VAL . 40.8 ttmt -69.43 131.63 45.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.36 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.456 HG13 ' HG2' ' A' ' 15' ' ' PRO . 34.0 m -125.94 127.78 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.978 0.418 . . . . 0.0 110.999 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.8 m -81.33 118.5 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 63.7 mt -79.74 138.49 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.775 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -147.21 136.94 22.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.346 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -170.17 -132.08 1.41 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.673 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -146.94 131.38 17.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.318 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 60.63 41.85 14.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.166 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.416 HD11 ' N ' ' A' ' 31' ' ' LEU . 10.5 mp -81.97 52.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.959 0.409 . . . . 0.0 110.841 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.81 121.44 0.04 OUTLIER Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.404 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.0 p -93.4 41.18 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.0 144.13 5.38 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.464 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HA ' ' CG ' ' A' ' 54' ' ' TRP . 51.3 Cg_exo -54.26 -43.04 62.23 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.538 2.159 . . . . 0.0 112.089 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.8 p -64.01 -35.69 81.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 28.6 m-20 -52.18 -49.06 64.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.005 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.12 132.46 47.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.33 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.546 ' O ' HD12 ' A' ' 49' ' ' LEU . 35.5 pt -147.97 -24.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.998 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.94 137.21 12.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.58 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.555 ' O ' HG21 ' A' ' 42' ' ' THR . 0.2 OUTLIER -149.64 131.67 15.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.555 HG21 ' O ' ' A' ' 41' ' ' LEU . 5.7 p -153.7 141.73 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.134 0.493 . . . . 0.0 111.657 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -135.97 123.23 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.168 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 78.9 m 58.41 40.1 24.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.941 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.02 -32.74 1.73 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.183 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -70.71 133.06 46.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 111.356 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -74.62 143.94 44.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.73 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.5 p -154.12 46.31 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 110.793 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 39' ' ' ILE . 60.2 tp -72.95 -48.9 32.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.58 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.439 HD13 HG22 ' A' ' 51' ' ' THR . 4.1 pp -62.24 -30.37 71.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.599 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.793 HG23 ' HE ' ' A' ' 63' ' ' ARG . 41.3 p -79.92 -38.39 32.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.903 0.383 . . . . 0.0 110.91 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.488 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -64.22 138.08 58.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.67 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.37 127.39 45.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.08 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.423 ' CG ' ' HA ' ' A' ' 35' ' ' PRO . 31.1 t90 -63.78 143.57 57.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.111 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 94.0 mmm -132.95 -51.17 0.9 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.718 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.2 m -161.2 -172.15 3.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.62 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.31 39.17 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.276 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.2 t -178.4 -43.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.7 tttm -86.81 134.05 33.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.483 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 75.3 mt -151.24 120.29 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.571 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.423 HG12 ' HD3' ' A' ' 23' ' ' LYS . 61.7 t -88.22 132.39 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 25.9 t -170.57 141.4 1.89 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.197 0.522 . . . . 0.0 111.545 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.793 ' HE ' HG23 ' A' ' 51' ' ' THR . 39.7 ptt180 -85.37 140.44 30.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.711 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t -59.74 -42.63 89.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.647 0.737 . . . . 0.0 110.758 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.21 -49.92 2.3 Favored Glycine 0 C--N 1.314 -0.648 0 CA-C-N 114.321 -1.308 . . . . 0.0 113.149 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -174.92 -143.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.864 0.332 . . . . 0.0 110.738 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -172.95 135.46 0.62 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.776 0.322 . . . . 0.0 111.112 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 68' ' ' LYS . 1.4 tmtp? -117.88 -43.54 2.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.328 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -65.77 -119.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.697 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -167.61 -48.1 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.724 0.297 . . . . 0.0 110.723 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 89' ' ' SER . 0.0 OUTLIER -70.06 -46.52 64.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.701 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.07 44.48 5.36 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.723 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -71.41 131.87 43.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 110.886 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.6 mt -85.6 100.33 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.085 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.48 HD11 ' O ' ' A' ' 84' ' ' GLY . 42.3 mm -98.6 138.97 21.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.99 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.52 120.17 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.0 111.288 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.1 m -90.87 145.87 24.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.271 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.4 p -140.49 142.93 35.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.953 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 32.2 mmmt -51.77 -49.12 63.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.231 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.431 ' OG ' ' HD2' ' A' ' 5' ' ' ARG . 47.4 t -67.0 -47.41 71.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.88 -127.81 0.19 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.819 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.12 -39.77 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.851 -0.499 . . . . 0.0 111.851 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -168.06 121.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.48 ' O ' HD11 ' A' ' 75' ' ' ILE . . . -79.98 127.05 7.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.368 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.445 ' O ' HD13 ' A' ' 9' ' ' LEU . 81.7 p -99.69 144.63 28.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.539 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 66.5 p -143.36 124.19 14.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.101 0.477 . . . . 0.0 111.794 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.7 p -81.02 -28.69 35.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.245 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.62 141.89 14.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.287 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.564 ' HB2' ' O ' ' A' ' 71' ' ' LYS . 74.1 p -129.77 139.26 51.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.958 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -85.74 129.44 34.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.39 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.41 114.55 20.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.093 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 47.0 tp -78.86 131.07 36.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 111.406 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 18' ' ' GLY . 78.4 mt -98.82 141.27 31.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.764 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -61.92 123.32 77.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.015 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.98 134.06 19.13 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.421 2.081 . . . . 0.0 111.987 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -69.34 77.46 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.507 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.821 179.685 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.8 m170 . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.87 0.367 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.2 ttt -59.4 -51.77 68.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.234 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.478 ' HD2' ' N ' ' A' ' 5' ' ' ARG . 0.3 OUTLIER -71.03 129.13 38.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.062 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -78.57 136.22 59.86 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.18 139.15 85.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.57 2.18 . . . . 0.0 112.267 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -52.8 147.1 33.15 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.82 2.347 . . . . 0.0 112.625 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.553 HD11 ' OG1' ' A' ' 85' ' ' THR . 59.8 tp -149.97 112.24 4.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.741 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.538 ' O ' HG21 ' A' ' 11' ' ' THR . 57.3 t -79.02 131.5 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.538 HG21 ' O ' ' A' ' 10' ' ' VAL . 76.2 p -147.76 44.22 1.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.43 146.41 6.49 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.778 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.5 tt -161.45 129.66 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.762 0.315 . . . . 0.0 110.629 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.812 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 49.5 m -68.89 -59.88 4.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.805 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.812 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 72.2 Cg_endo -92.49 121.95 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.364 2.042 . . . . 0.0 112.077 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -105.78 28.51 7.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.881 0.372 . . . . 0.0 110.832 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -179.99 129.53 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.436 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.462 ' HA3' HD13 ' A' ' 93' ' ' LEU . . . 164.25 148.15 5.34 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.583 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.0 pt -51.62 158.56 1.5 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.481 0.181 . . . . 0.0 110.767 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.627 ' O ' HG21 ' A' ' 64' ' ' VAL . 73.4 Cg_exo -50.08 -41.67 48.3 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.656 2.237 . . . . 0.0 113.322 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -70.12 -8.97 53.94 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.9 m -67.93 126.9 30.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.765 0.317 . . . . 0.0 110.927 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.684 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 4.9 ttmp? -71.02 134.03 46.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.071 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.587 HG11 ' HG2' ' A' ' 15' ' ' PRO . 34.7 m -124.37 127.24 73.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 0.0 111.542 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.408 ' HB ' ' HG ' ' A' ' 14' ' ' SER . 85.1 m -78.54 102.33 7.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.563 HD13 ' SG ' ' A' ' 62' ' ' CYS . 70.7 mt -69.83 139.73 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.09 0.471 . . . . 0.0 111.403 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -144.11 130.95 20.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.205 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -169.31 -133.17 1.54 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.623 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -150.16 136.8 19.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.914 0.388 . . . . 0.0 111.325 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 61.94 39.05 13.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.508 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 mp -84.98 53.1 2.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.0 110.63 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.08 129.65 1.46 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.509 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.9 p -69.31 -36.63 77.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.76 0.314 . . . . 0.0 111.455 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.441 ' HA3' ' CZ2' ' A' ' 54' ' ' TRP . . . -150.86 174.84 30.07 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.517 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.28 -43.86 54.58 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.795 2.33 . . . . 0.0 112.486 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.3 t -58.56 -40.12 82.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.19 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.02 -46.79 85.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.156 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.62 HD21 ' N ' ' A' ' 39' ' ' ILE . 1.3 tt -59.71 129.73 43.33 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.62 ' N ' HD21 ' A' ' 38' ' ' LEU . 39.6 pt -141.95 -44.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.439 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.509 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -102.55 133.81 11.54 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.628 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.538 ' O ' HG21 ' A' ' 42' ' ' THR . 2.4 tm? -149.48 127.3 11.79 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.538 HG21 ' O ' ' A' ' 41' ' ' LEU . 11.8 p -155.87 140.82 17.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.525 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.557 HD12 ' SG ' ' A' ' 62' ' ' CYS . 73.3 mt -126.03 123.77 64.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.596 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.583 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 58.9 m 57.37 36.35 27.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.058 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.89 -31.66 3.05 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.055 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.534 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 79.6 t60 -73.7 133.18 43.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.854 0.359 . . . . 0.0 111.408 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.431 ' HA ' HG21 ' A' ' 42' ' ' THR . 42.0 t30 -69.2 138.3 53.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.7 m -151.04 39.27 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 110.7 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.3 tp -75.06 -43.19 54.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.107 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -52.21 -41.61 62.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.281 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.0 p -80.29 -34.62 36.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.175 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 61' ' ' VAL . . . -58.06 131.02 49.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.566 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -126.61 132.31 51.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.573 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.441 ' CZ2' ' HA3' ' A' ' 34' ' ' GLY . 77.0 t90 -68.31 144.84 54.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.196 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.7 mmt -132.65 -47.78 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.663 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.6 p -168.54 -157.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.635 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.37 32.32 1.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.355 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.7 p -179.98 37.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.278 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -164.88 129.62 2.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.102 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.4 mt -151.23 111.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.698 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -84.51 130.25 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.349 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.563 ' SG ' HD13 ' A' ' 26' ' ' ILE . 26.4 p -170.97 150.98 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.042 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -84.01 129.79 34.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.627 HG21 ' O ' ' A' ' 20' ' ' PRO . 14.3 m -65.72 134.65 29.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.102 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 46' ' ' HIS . . . -72.61 -125.49 0.08 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.442 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 24.9 pt20 -140.53 137.79 34.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.734 0.302 . . . . 0.0 110.576 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.583 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -49.74 134.04 20.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.852 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 66' ' ' GLN . 29.4 mtpp -151.3 -41.39 0.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.381 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -63.54 -53.36 53.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.267 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -173.74 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.427 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -147.34 -56.25 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.814 0.34 . . . . 0.0 111.01 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.414 ' HA3' ' SG ' ' A' ' 44' ' ' CYS . . . 163.01 43.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.328 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -64.14 131.58 47.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.861 0.362 . . . . 0.0 111.083 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.479 HG23 HG22 ' A' ' 10' ' ' VAL . 74.4 mt -85.36 135.43 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.522 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.4 ' N ' HG21 ' A' ' 74' ' ' ILE . 47.9 mm -134.55 133.82 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 0.0 111.713 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.0 t -141.55 118.66 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.22 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.4 m -98.68 131.88 44.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.555 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.1 p -99.48 146.29 26.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.844 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.61 ' HA ' HD12 ' A' ' 39' ' ' ILE . 56.5 tptt -58.57 -49.19 78.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.773 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 81.9 p -70.33 -54.43 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.76 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.53 -127.05 0.35 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.42 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.4 -137.25 2.18 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.17 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -65.17 126.12 27.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.7 0.286 . . . . 0.0 110.569 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.527 ' O ' HG21 ' A' ' 85' ' ' THR . . . -80.28 -150.19 6.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.154 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.553 ' OG1' HD11 ' A' ' 9' ' ' LEU . 21.5 p -158.09 151.59 23.44 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.706 0.402 . . . . 0.0 110.624 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.3 p -158.66 121.34 3.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.917 0.389 . . . . 0.0 111.431 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.427 ' O ' HG11 ' A' ' 88' ' ' VAL . 82.6 p -96.07 37.56 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.436 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.427 HG11 ' O ' ' A' ' 87' ' ' THR . 27.6 m -150.56 157.44 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.744 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.5 p -146.0 136.23 23.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -85.45 130.44 34.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.863 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -82.19 120.83 25.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.659 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.422 HD22 ' SG ' ' A' ' 44' ' ' CYS . 3.3 mm? -83.91 126.96 33.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.018 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.462 HD13 ' HA3' ' A' ' 18' ' ' GLY . 76.9 mt -94.6 134.94 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.823 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -67.01 129.21 94.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.956 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.83 133.81 50.01 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.65 2.234 . . . . 0.0 112.471 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -73.05 112.84 9.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.634 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.939 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.5 t60 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 121.127 0.489 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.8 ptp -160.41 135.52 7.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.745 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.548 ' HA ' ' NE ' ' A' ' 5' ' ' ARG . 4.4 mmp_? 65.31 130.67 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.193 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -63.63 136.94 96.94 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.847 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.15 138.01 78.89 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.543 2.162 . . . . 0.0 112.054 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HG2' ' HA3' ' A' ' 84' ' ' GLY . 14.1 Cg_endo -55.94 134.11 62.11 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.703 2.269 . . . . 0.0 112.331 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.422 HD11 ' O ' ' A' ' 85' ' ' THR . 64.8 tp -120.03 117.65 28.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.018 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.54 ' HB ' ' HG ' ' A' ' 86' ' ' SER . 94.8 t -83.29 132.92 30.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.841 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.529 HG21 ' O ' ' A' ' 10' ' ' VAL . 63.0 p -151.34 48.86 0.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.042 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.3 144.83 6.9 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.01 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.637 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.1 tt -163.01 131.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.579 0.228 . . . . 0.0 110.645 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.837 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 48.4 t -63.22 -59.18 12.87 Favored Pre-proline 0 C--N 1.331 -0.239 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.349 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.837 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 10.3 Cg_exo -70.7 -148.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.945 1.763 . . . . 0.0 112.035 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -175.4 -23.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.351 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.7 133.94 4.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.832 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.404 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 169.69 160.07 17.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.409 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.484 HG21 ' O ' ' A' ' 93' ' ' LEU . 30.6 pt -50.87 154.68 2.33 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.561 0.22 . . . . 0.0 111.009 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.597 ' O ' HG11 ' A' ' 64' ' ' VAL . 71.1 Cg_exo -50.18 -41.88 48.44 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.902 2.402 . . . . 0.0 113.807 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -70.51 -5.89 32.18 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -66.08 132.09 47.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.808 0.337 . . . . 0.0 111.227 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HE3' ' CG1' ' A' ' 61' ' ' VAL . 87.2 tttt -67.26 137.35 56.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.479 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.487 ' O ' HG21 ' A' ' 24' ' ' VAL . 35.9 m -140.98 127.23 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.977 0.417 . . . . 0.0 111.015 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.1 m -80.85 121.21 25.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.097 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 26' ' ' ILE . 68.0 mt -84.3 135.83 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.726 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -146.2 134.51 21.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.726 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -169.07 -132.58 1.46 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.58 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -146.09 132.88 20.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.873 0.368 . . . . 0.0 111.352 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 59.11 43.57 17.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.189 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 mp -83.31 47.88 1.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.829 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.47 125.24 0.06 OUTLIER Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.531 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.9 p -92.35 42.87 1.11 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.616 0.246 . . . . 0.0 111.211 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.05 144.81 4.78 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.752 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 10.5 Cg_endo -53.82 -42.87 62.9 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.686 2.258 . . . . 0.0 112.162 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.6 t -60.98 -37.03 81.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.954 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.57 -38.51 69.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.135 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.4 tp -76.31 60.41 1.53 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 0.0 110.914 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.479 ' O ' HD23 ' A' ' 49' ' ' LEU . 22.6 pt -69.12 -40.06 80.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.318 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.07 138.21 12.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.885 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.551 ' O ' HG21 ' A' ' 42' ' ' THR . 3.1 tm? -149.77 127.8 11.93 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.551 HG21 ' O ' ' A' ' 41' ' ' LEU . 39.3 p -151.53 136.73 17.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.976 0.417 . . . . 0.0 111.64 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.404 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 51.6 mm -107.65 105.62 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.911 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 38.0 t 58.28 45.22 17.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.731 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.14 -38.66 3.14 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.569 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.416 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 79.9 t60 -68.38 129.02 38.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.908 0.354 . . . . 0.0 111.141 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.479 ' HA ' HG21 ' A' ' 42' ' ' THR . 13.6 p-10 -73.62 140.76 46.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.603 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.508 ' O ' ' HB1' ' A' ' 52' ' ' ALA . 75.2 m -150.25 40.12 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.764 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 39' ' ' ILE . 61.6 tp -72.88 -49.36 30.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.224 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -54.08 -39.46 66.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.499 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.664 HG23 HH21 ' A' ' 63' ' ' ARG . 68.1 p -80.11 -38.11 32.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.576 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.547 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -62.5 130.44 45.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.847 0.356 . . . . 0.0 111.686 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -126.85 130.87 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.605 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.425 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 86.9 t90 -65.93 149.76 49.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.979 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.42 ' HE1' ' HB3' ' A' ' 55' ' ' MET . 94.9 mmm -142.37 -42.9 0.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.766 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 58' ' ' SER . 33.2 t -170.63 173.97 5.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.857 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.83 33.43 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.283 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 56' ' ' SER . 80.6 p -178.61 23.68 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.588 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -165.67 131.27 2.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.743 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.6 mt -149.43 120.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.008 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.4 ' CG1' ' HE3' ' A' ' 23' ' ' LYS . 57.4 t -81.82 126.33 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.471 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 52.7 t -171.08 149.71 2.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 0.0 111.138 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.664 HH21 HG23 ' A' ' 51' ' ' THR . 83.5 mtm180 -84.66 131.43 34.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.308 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.597 HG11 ' O ' ' A' ' 20' ' ' PRO . 5.5 p -56.64 136.57 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.065 0.459 . . . . 0.0 111.576 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.404 ' HA2' ' HB ' ' A' ' 43' ' ' ILE . . . -69.01 -127.19 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.603 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -146.45 140.62 26.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 0.0 110.637 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 71' ' ' LYS . . . -68.52 74.1 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.239 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 46' ' ' HIS . 68.0 mttm -64.36 -49.49 71.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.769 0.319 . . . . 0.0 110.86 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -68.4 -63.83 0.98 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 64.7 t0 179.42 -60.67 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.973 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.552 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 36.6 ttpt -75.24 -114.58 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.646 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 44' ' ' CYS . . . 173.24 47.55 0.05 OUTLIER Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.193 -1.003 . . . . 0.0 113.2 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -64.22 132.67 51.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.77 0.319 . . . . 0.0 111.042 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.5 92.48 3.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.817 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.416 HG22 ' HD3' ' A' ' 83' ' ' LYS . 44.5 mm -81.03 138.58 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.195 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.53 113.51 3.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.936 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.5 m -84.47 142.23 30.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.722 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.3 p -137.73 135.52 36.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.047 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -59.29 -46.72 87.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.004 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.9 p -64.42 -52.83 56.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.03 0.443 . . . . 0.0 110.331 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 -120.97 2.13 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.193 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.76 -140.77 2.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.117 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.449 ' C ' ' HD2' ' A' ' 83' ' ' LYS . 4.3 tmmm? -67.38 127.12 31.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.36 . . . . 0.0 110.169 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.445 ' HA3' ' HG2' ' A' ' 8' ' ' PRO . . . -78.15 130.64 10.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.346 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.422 ' O ' HD11 ' A' ' 9' ' ' LEU . 79.3 p -108.15 144.66 35.25 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.54 ' HG ' ' HB ' ' A' ' 10' ' ' VAL . 41.3 t -151.31 131.12 13.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.093 0.473 . . . . 0.0 111.875 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.8 p -78.17 -28.39 48.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.781 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.9 m -83.15 153.76 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.362 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.0 p -148.97 138.65 21.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.724 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -85.2 131.56 34.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.439 ' HD2' HD22 ' A' ' 93' ' ' LEU . 5.8 tmtt? -79.39 119.1 21.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.013 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.534 HD12 HG23 ' A' ' 64' ' ' VAL . 3.2 mm? -84.61 109.67 18.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 110.54 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.484 ' O ' HG21 ' A' ' 19' ' ' ILE . 54.9 mt -85.86 136.68 33.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.955 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -65.51 137.11 96.4 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.168 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.72 132.79 24.13 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.441 2.094 . . . . 0.0 112.469 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -73.16 77.42 1.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.697 -179.886 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.836 0.35 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.7 mtt -78.91 43.55 0.51 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.304 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.409 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 72.3 mtm-85 56.69 51.83 10.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.0 0.429 . . . . 0.0 111.347 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -59.41 141.9 87.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.051 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -57.11 150.7 55.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.79 2.327 . . . . 0.0 112.308 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 82.1 Cg_exo -48.57 143.07 16.78 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.705 2.27 . . . . 0.0 112.746 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 85' ' ' THR . 4.9 tt -145.03 111.34 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.747 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' A' ' 28' ' ' GLY . 66.3 t -81.92 137.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.005 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.455 HG22 HD21 ' A' ' 9' ' ' LEU . 30.1 p -154.26 44.52 0.55 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.624 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.46 143.8 6.09 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.845 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.509 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.8 tt -164.47 129.47 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.0 110.51 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.825 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -65.22 -59.39 9.93 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.942 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.825 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 72.8 Cg_endo -94.86 118.89 0.26 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.447 2.098 . . . . 0.0 112.169 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -100.22 30.61 3.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.73 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 179.0 129.39 0.07 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.571 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.421 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . 165.09 152.29 6.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.738 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.424 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 31.9 pt -56.12 162.54 2.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.48 0.181 . . . . 0.0 111.11 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.594 ' HB3' ' C ' ' A' ' 65' ' ' GLY . 87.2 Cg_exo -49.23 -46.31 26.42 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.881 2.388 . . . . 0.0 113.768 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -71.4 -4.97 29.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.1 m -63.33 126.99 29.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.845 0.355 . . . . 0.0 110.986 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.465 ' HD2' ' CG1' ' A' ' 61' ' ' VAL . 17.2 tppt? -67.13 136.31 54.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.148 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.505 HG11 ' HG2' ' A' ' 15' ' ' PRO . 31.6 m -140.59 131.67 29.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.036 0.445 . . . . 0.0 111.51 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.431 HG22 ' NZ ' ' A' ' 59' ' ' LYS . 94.9 m -89.75 116.28 27.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.549 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.577 HD13 ' HG ' ' A' ' 62' ' ' CYS . 57.3 mt -74.61 141.13 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.187 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 27' ' ' ARG . 11.9 tpt180 -147.48 130.75 16.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.997 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -170.56 -122.61 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.733 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -162.19 134.23 5.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.963 0.411 . . . . 0.0 111.598 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 60.86 40.21 16.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.86 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.6 mp -70.31 -41.96 72.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.609 0.242 . . . . 0.0 111.233 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.93 135.47 2.36 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.803 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.9 p -62.7 -39.75 94.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.798 0.332 . . . . 0.0 110.902 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.512 ' HA3' ' CE2' ' A' ' 54' ' ' TRP . . . -165.32 -164.11 20.04 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.66 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.28 -47.11 6.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.779 2.319 . . . . 0.0 112.514 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.516 ' O ' HG21 ' A' ' 39' ' ' ILE . 67.2 p -60.12 -40.91 91.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.379 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.703 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 36.5 t70 -62.65 -41.53 99.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.346 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 tt -78.33 62.15 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.947 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.516 HG21 ' O ' ' A' ' 36' ' ' THR . 27.2 pt -68.96 -41.79 82.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.19 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.414 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -112.21 140.61 16.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.098 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -146.89 134.85 21.4 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.629 HG21 ' HA ' ' A' ' 47' ' ' ASN . 14.1 p -150.36 149.82 30.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.101 0.477 . . . . 0.0 111.546 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.607 HD12 ' SG ' ' A' ' 62' ' ' CYS . 71.1 mt -135.75 116.56 18.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.484 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.747 ' HA ' ' HB2' ' A' ' 70' ' ' ASP . 65.4 m 72.82 -35.2 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.813 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 166.11 -41.08 0.27 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.026 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.641 ' HE2' ' HA2' ' A' ' 65' ' ' GLY . 27.5 p-80 -80.67 138.48 36.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.959 0.409 . . . . 0.0 111.705 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.629 ' HA ' HG21 ' A' ' 42' ' ' THR . 42.2 t30 -60.68 141.51 56.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.679 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.3 m -143.76 38.15 1.34 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.846 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.55 -42.25 68.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -57.52 -42.41 82.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.58 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.8 p -80.19 -38.19 31.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.691 0.282 . . . . 0.0 111.351 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -63.09 132.9 53.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.333 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -126.38 127.39 45.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.552 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.512 ' CE2' ' HA3' ' A' ' 34' ' ' GLY . 75.2 t90 -67.46 149.97 49.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 90.4 mtp -146.04 -41.3 0.21 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.731 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.466 ' C ' ' H ' ' A' ' 58' ' ' SER . 33.8 t -165.38 173.86 10.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.685 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.34 21.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.489 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.3 m -167.72 35.31 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.884 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' NZ ' HG22 ' A' ' 25' ' ' THR . 55.0 tttp -165.09 127.95 2.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.867 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.441 HD13 HD21 ' A' ' 31' ' ' LEU . 73.9 mt -150.82 125.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.158 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 60.8 t -93.4 128.12 45.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.564 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.607 ' SG ' HD12 ' A' ' 43' ' ' ILE . 23.0 p -171.11 157.82 5.31 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.073 0.463 . . . . 0.0 111.772 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -84.59 134.76 34.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.857 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.543 HG22 ' HA ' ' A' ' 20' ' ' PRO . 18.0 m -67.84 -26.67 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.404 0.621 . . . . 0.0 111.338 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.641 ' HA2' ' HE2' ' A' ' 46' ' ' HIS . . . 53.9 -158.05 5.33 Favored Glycine 0 C--N 1.315 -0.587 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.734 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -74.62 -140.85 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.492 0.187 . . . . 0.0 111.192 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 71' ' ' LYS . . . -165.43 158.85 16.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.715 0.293 . . . . 0.0 111.013 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -140.56 -42.77 0.4 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.686 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -134.78 -59.61 0.8 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.885 0.374 . . . . 0.0 111.238 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.747 ' HB2' ' HA ' ' A' ' 44' ' ' CYS . 57.0 m-20 -60.28 -39.55 87.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.546 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HA ' ' HB3' ' A' ' 67' ' ' ALA . 9.2 ptpp? 45.46 27.59 0.4 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.764 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.618 ' HA2' ' HB3' ' A' ' 89' ' ' SER . . . 161.26 -41.07 0.41 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.369 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.725 ' HB2' ' HB3' ' A' ' 70' ' ' ASP . 27.0 m-20 -61.43 120.31 10.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.806 0.336 . . . . 0.0 111.026 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.403 ' O ' HD11 ' A' ' 75' ' ' ILE . 69.8 mt -85.99 128.67 39.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.35 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.403 HD11 ' O ' ' A' ' 74' ' ' ILE . 37.0 mm -127.32 142.02 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.926 0.393 . . . . 0.0 111.484 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.778 ' H ' ' HA2' ' A' ' 84' ' ' GLY . 58.4 t -140.65 122.71 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.57 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.3 m -86.48 141.75 28.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.115 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.4 p -136.08 136.01 39.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.804 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.703 ' HE2' ' HA ' ' A' ' 37' ' ' ASP . 48.3 mtmt -57.16 -46.91 82.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 5' ' ' ARG . 50.0 m -68.4 -53.12 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.083 0.468 . . . . 0.0 110.258 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.74 -123.37 0.67 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.189 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.63 -140.78 2.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.325 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -63.31 132.42 51.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.949 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.778 ' HA2' ' H ' ' A' ' 76' ' ' VAL . . . -68.11 159.48 51.34 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.946 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 74.2 p -143.37 145.67 32.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.9 p -157.14 131.51 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 0.0 111.698 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 65.3 p -79.2 -33.06 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.538 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.1 m -84.24 158.6 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.396 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.618 ' HB3' ' HA2' ' A' ' 72' ' ' GLY . 31.4 m -148.88 139.99 23.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.075 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.511 ' CE2' HG23 ' A' ' 64' ' ' VAL . 68.2 t80 -85.51 133.58 34.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.045 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 92' ' ' LEU . 5.5 tmtt? -80.76 121.41 25.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.299 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.52 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 94.0 mt -84.82 109.12 17.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 110.202 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.434 HD22 ' HD2' ' A' ' 91' ' ' LYS . 50.0 mt -83.64 138.0 33.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.342 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -62.61 141.59 96.86 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.287 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -53.07 133.93 54.0 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.729 2.286 . . . . 0.0 112.503 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -68.53 115.08 7.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.472 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.314 -0.851 . . . . 0.0 110.955 -179.826 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.91 0.386 . . . . 0.0 111.623 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.2 tpt -170.42 -43.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.658 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -58.85 131.78 51.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.693 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -60.53 139.47 92.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.133 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.21 144.34 98.83 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.754 2.302 . . . . 0.0 112.13 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.526 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 10.3 Cg_endo -54.18 115.86 2.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.533 2.155 . . . . 0.0 112.109 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.5 tp -90.62 98.37 11.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.196 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.477 ' HB ' ' CB ' ' A' ' 86' ' ' SER . 60.3 t -79.92 135.42 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.273 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 t -167.76 52.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.183 0.516 . . . . 0.0 111.271 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.06 137.67 4.79 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.483 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.521 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.8 tt -165.15 128.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.709 0.29 . . . . 0.0 110.624 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.797 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.3 t -66.54 -57.92 11.23 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.626 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.797 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 98.2 Cg_endo -91.47 110.54 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.336 2.024 . . . . 0.0 112.15 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.473 ' N ' HD21 ' A' ' 16' ' ' ASN . 1.8 m120 -88.49 26.79 1.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.728 0.299 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 179.82 130.16 0.09 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.521 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.494 ' O ' HD11 ' A' ' 92' ' ' LEU . . . 169.05 143.08 3.72 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.472 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.427 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.6 pt -53.14 161.31 1.34 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.434 0.159 . . . . 0.0 111.214 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.605 ' N ' HD13 ' A' ' 92' ' ' LEU . 88.8 Cg_exo -47.79 -43.48 28.95 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.79 2.327 . . . . 0.0 113.75 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -68.56 -20.66 64.55 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.7 m -59.48 129.1 40.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 111.003 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.554 ' HB3' ' NZ ' ' A' ' 23' ' ' LYS . 6.1 ttpm? -71.56 143.34 49.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.016 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.561 HG23 HG12 ' A' ' 64' ' ' VAL . 34.8 m -140.27 131.03 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.99 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.1 m -90.33 87.39 6.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.431 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.566 HD13 ' SG ' ' A' ' 62' ' ' CYS . 69.8 mt -60.77 137.3 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.572 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' A' ' 58' ' ' SER . 75.9 ttt180 -148.07 140.44 24.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.963 0.411 . . . . 0.0 111.054 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -167.07 -127.61 0.92 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.298 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -150.4 137.21 19.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.921 0.391 . . . . 0.0 111.214 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 72.4 m-80 64.82 32.49 10.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.496 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.526 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 9.2 mp -83.27 48.93 1.46 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.951 0.405 . . . . 0.0 110.607 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.58 121.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.597 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -89.54 41.02 1.02 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.729 0.299 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.4 146.42 5.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.733 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.21 -43.18 61.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.52 2.146 . . . . 0.0 112.07 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.5 p -59.01 -40.7 85.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.775 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 78' ' ' THR . 55.6 m-20 -58.07 -32.31 67.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.671 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.489 ' C ' HD21 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -76.91 58.09 1.42 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.34 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.9 pt -66.52 -22.49 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.915 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.13 141.94 10.66 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.426 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 42' ' ' THR . 2.9 tm? -149.78 130.4 14.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.48 ' N ' HD12 ' A' ' 41' ' ' LEU . 81.4 m -161.4 127.62 3.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 111.782 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.472 HD11 HG11 ' A' ' 64' ' ' VAL . 76.9 mt -100.56 129.75 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.588 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.548 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 48.8 t 65.47 -72.74 0.07 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.249 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.7 30.77 0.12 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.427 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.603 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 84.5 t60 -131.08 128.42 40.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 110.805 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -63.1 134.5 56.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 71.4 m -152.67 39.69 0.56 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.682 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.91 -46.23 45.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.385 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -55.5 -37.88 68.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.221 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.6 p -79.94 -36.91 35.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.93 134.97 56.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.243 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -126.18 129.08 48.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.804 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 87.3 t90 -70.52 145.21 51.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.093 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.6 mmt -132.63 -48.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.771 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.9 m -161.74 -161.78 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.702 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.97 32.86 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.253 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.61 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 83.4 p -178.77 35.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.247 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.563 ' NZ ' ' HB2' ' A' ' 59' ' ' LYS . 5.1 ttmp? -165.41 135.4 3.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.338 . . . . 0.0 111.078 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.6 mt -150.61 120.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.77 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 51.5 t -90.35 127.59 42.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.629 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.566 ' SG ' HD13 ' A' ' 26' ' ' ILE . 27.6 p -170.55 154.63 4.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.15 133.65 34.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.66 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.598 HG21 ' O ' ' A' ' 20' ' ' PRO . 11.5 m -62.15 130.98 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.934 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 46' ' ' HIS . . . -81.13 163.79 45.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.419 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -48.95 137.35 12.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 111.015 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.548 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . . . -75.95 66.16 2.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.438 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -59.42 -46.25 89.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.916 0.388 . . . . 0.0 110.354 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.538 ' HB2' ' HG ' ' A' ' 44' ' ' CYS . 3.6 m120 -67.92 -147.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.749 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.518 ' O ' ' HG2' ' A' ' 71' ' ' LYS . 55.2 m-20 -154.62 31.9 0.41 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.392 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 30.2 mmtp -158.5 30.63 0.23 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.599 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 33.85 42.15 0.22 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.441 -0.409 . . . . 0.0 113.523 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -65.62 121.94 16.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.524 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.5 mt -97.68 131.23 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.376 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.414 ' HA ' HD11 ' A' ' 75' ' ' ILE . 48.3 mm -134.22 140.19 46.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.458 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 p -140.85 125.68 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.78 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.627 ' HA ' ' H ' ' A' ' 83' ' ' LYS . 15.9 m -90.77 139.96 30.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.718 ' H ' ' HA3' ' A' ' 82' ' ' GLY . 73.8 p -147.41 143.86 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.118 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -54.02 -33.88 58.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.055 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.8 m -63.44 -49.41 73.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.703 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.77 -48.46 0.23 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.759 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.718 ' HA3' ' H ' ' A' ' 78' ' ' THR . . . 75.8 127.19 0.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.873 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.627 ' H ' ' HA ' ' A' ' 77' ' ' THR . 61.7 tttm 51.67 56.93 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 110.995 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.49 -138.4 0.05 OUTLIER Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.848 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.0 p -149.98 -168.2 3.04 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.723 0.297 . . . . 0.0 110.817 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.553 ' HG ' HG21 ' A' ' 88' ' ' VAL . 45.4 t -167.76 129.3 1.49 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.257 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 77.0 p -92.91 37.84 1.02 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.231 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.553 HG21 ' HG ' ' A' ' 86' ' ' SER . 29.6 m -150.73 139.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.88 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.0 m -118.97 127.99 53.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.164 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.459 ' CD2' HG13 ' A' ' 64' ' ' VAL . 44.3 t80 -89.31 124.06 34.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.979 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -85.06 91.7 8.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.12 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.605 HD13 ' N ' ' A' ' 20' ' ' PRO . 31.6 tp -65.14 128.39 35.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.249 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 18' ' ' GLY . 80.5 mt -80.41 137.0 36.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.072 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.616 ' HZ3' ' HB2' ' A' ' 94' ' ' LYS . 4.8 ttmp? -64.15 134.7 96.04 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.0 131.08 44.28 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.487 2.125 . . . . 0.0 112.57 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -73.3 117.01 14.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.111 -179.966 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.4 m80 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.713 0.292 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.8 mmt -66.26 129.78 40.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.774 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.507 ' NH1' HG22 ' A' ' 33' ' ' THR . 36.2 ttm180 -70.27 136.45 49.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.887 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -60.61 136.39 92.49 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.91 139.66 80.79 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.552 2.168 . . . . 0.0 112.234 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.518 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 17.3 Cg_endo -58.16 123.2 13.11 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.58 2.187 . . . . 0.0 112.168 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -94.17 122.0 36.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.553 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 62.1 t -99.6 140.53 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.432 ' N ' HG11 ' A' ' 10' ' ' VAL . 6.4 t -166.99 50.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 111.348 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.71 140.53 5.74 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.695 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.502 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.3 tt -164.42 131.18 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.722 0.296 . . . . 0.0 110.507 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.833 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.8 t -66.39 -59.13 8.88 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.931 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.833 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 88.7 Cg_endo -96.08 119.87 0.21 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.652 2.235 . . . . 0.0 112.137 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -94.69 29.51 2.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 110.713 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 179.06 133.78 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.602 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.46 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 167.07 146.95 5.07 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.947 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.487 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 37.2 pt -55.78 159.24 5.46 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 110.736 -0.098 . . . . 0.0 110.736 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.605 ' HA ' HG22 ' A' ' 64' ' ' VAL . 3.7 Cg_endo -48.25 -41.9 34.22 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.708 2.272 . . . . 0.0 113.22 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -67.87 -23.06 65.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.444 ' HG1' ' N ' ' A' ' 19' ' ' ILE . 94.7 m -54.43 127.98 29.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.042 0.449 . . . . 0.0 111.659 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.443 ' HE3' HG12 ' A' ' 61' ' ' VAL . 86.8 tttt -73.04 140.2 47.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.445 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.591 HG23 HG12 ' A' ' 64' ' ' VAL . 30.3 m -141.69 132.91 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.908 0.385 . . . . 0.0 111.362 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.0 m -87.61 118.55 27.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.528 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.454 HG21 ' N ' ' A' ' 27' ' ' ARG . 63.5 mt -80.34 140.41 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.032 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.454 ' N ' HG21 ' A' ' 26' ' ' ILE . 25.1 mmm180 -141.38 135.63 30.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.682 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.24 -134.7 2.0 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.662 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -149.14 136.66 20.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 111.282 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.518 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.0 m-20 63.28 36.4 11.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.33 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.524 HD11 ' N ' ' A' ' 31' ' ' LEU . 9.1 mp -82.6 61.04 5.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.944 0.402 . . . . 0.0 110.503 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.96 121.27 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.124 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.507 HG22 ' NH1' ' A' ' 5' ' ' ARG . 34.3 p -92.18 33.67 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.817 0.341 . . . . 0.0 111.244 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.8 149.95 5.93 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.498 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.15 -45.04 41.71 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.525 2.15 . . . . 0.0 111.876 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 t -64.19 -38.14 89.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.231 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 56.7 m-20 -54.61 -54.24 44.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.756 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.99 127.15 30.17 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.443 ' O ' HD23 ' A' ' 49' ' ' LEU . 41.9 pt -138.31 -25.81 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.694 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.85 142.26 13.35 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.133 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' A' ' 52' ' ' ALA . 1.8 tm? -149.57 131.61 15.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.435 HG21 ' O ' ' A' ' 41' ' ' LEU . 3.4 p -151.66 146.43 25.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.161 0.505 . . . . 0.0 111.623 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.494 ' HB ' ' H ' ' A' ' 65' ' ' GLY . 80.5 mt -137.53 123.41 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.683 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 80.0 m 57.41 39.54 28.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.259 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.18 -31.29 1.82 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.549 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -73.5 131.09 41.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.829 0.347 . . . . 0.0 111.278 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -72.35 140.36 48.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.5 m -150.71 39.86 0.72 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.772 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 39' ' ' ILE . 60.8 tp -70.97 -42.57 69.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.364 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -51.13 -43.16 61.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.446 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.0 p -80.31 -32.1 38.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.327 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.525 ' HB2' ' HG ' ' A' ' 41' ' ' LEU . . . -56.4 131.27 47.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.774 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -127.12 131.96 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.198 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.428 ' CH2' ' HA ' ' A' ' 56' ' ' SER . 65.2 t90 -72.1 146.77 47.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.355 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.509 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 22.1 mmt -133.82 -50.24 0.83 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.066 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.428 ' HA ' ' CH2' ' A' ' 54' ' ' TRP . 78.0 p -169.18 -156.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.703 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -96.01 30.98 2.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.147 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.7 p -178.76 31.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.057 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 55' ' ' MET . 63.0 tttm -165.05 128.39 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.8 mt -151.66 114.6 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.882 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.443 HG12 ' HE3' ' A' ' 23' ' ' LYS . 90.7 t -80.3 131.87 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.084 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.4 p -169.08 155.02 6.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.992 0.425 . . . . 0.0 111.405 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -83.99 126.22 32.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.288 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.605 HG22 ' HA ' ' A' ' 20' ' ' PRO . 5.2 m -62.92 125.68 19.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.077 0.465 . . . . 0.0 111.103 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.494 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . -72.39 151.19 46.36 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.668 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -47.57 149.09 1.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.559 0.219 . . . . 0.0 110.839 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.47 63.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.744 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 23.6 tptm -58.63 -51.57 69.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.96 0.41 . . . . 0.0 110.449 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -75.17 -122.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.487 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.95 -36.38 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.711 0.291 . . . . 0.0 110.683 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -66.97 -42.36 85.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.402 ' HA3' ' SG ' ' A' ' 44' ' ' CYS . . . 75.85 36.45 42.01 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.406 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.28 137.27 38.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.702 0.287 . . . . 0.0 111.055 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.07 127.78 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.227 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.484 HD11 ' O ' ' A' ' 84' ' ' GLY . 40.5 mm -128.1 138.41 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.899 0.381 . . . . 0.0 111.304 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -139.8 119.06 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.678 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 58.2 m -89.07 130.01 35.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.532 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 64.4 p -107.83 143.48 36.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.615 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 53.1 tptt -56.32 -43.79 79.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 110.369 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.501 ' HG ' ' HD2' ' A' ' 5' ' ' ARG . 87.2 p -73.06 -56.83 4.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.65 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.2 -125.42 2.02 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.587 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 77' ' ' THR . . . -160.54 -139.63 2.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.398 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.611 ' HZ2' ' HB3' ' A' ' 83' ' ' LYS . 9.0 mtpm? -64.34 126.06 26.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.897 0.379 . . . . 0.0 111.343 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' HD11 ' A' ' 75' ' ' ILE . . . -79.9 143.42 25.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.403 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.2 p -98.63 139.2 34.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.678 0.275 . . . . 0.0 110.995 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.52 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 63.5 p -136.26 132.27 35.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.418 . . . . 0.0 111.299 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -81.04 -32.16 34.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.922 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.6 m -84.18 176.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.322 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.5 m -156.88 138.11 13.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.644 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.458 ' CD2' HG13 ' A' ' 64' ' ' VAL . 52.3 t80 -88.85 132.48 34.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.431 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -91.99 122.3 34.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.276 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.41 HD11 ' HA ' ' A' ' 92' ' ' LEU . 3.7 mm? -84.49 127.02 33.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.948 0.404 . . . . 0.0 111.168 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.46 ' HG ' ' N ' ' A' ' 18' ' ' GLY . 77.9 mt -91.38 138.27 31.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.709 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.599 ' NZ ' ' HB3' ' A' ' 94' ' ' LYS . 3.3 mmmp? -59.21 129.84 86.65 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.546 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.405 ' HA ' HG23 ' A' ' 19' ' ' ILE . 53.2 Cg_exo -54.25 129.15 33.09 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.52 2.147 . . . . 0.0 112.56 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -83.27 119.99 25.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.685 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.3 pttt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.922 -179.894 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.631 0.253 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.407 ' HB3' ' HE1' ' A' ' 4' ' ' MET . 18.5 ptp -61.7 132.98 54.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 110.525 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.556 ' HA ' ' NE ' ' A' ' 5' ' ' ARG . 4.8 mmp_? -64.69 136.51 57.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.329 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.475 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 4.8 tp60 -62.46 130.32 93.25 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.631 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.475 ' HD2' ' OE1' ' A' ' 6' ' ' GLN . 61.9 Cg_exo -52.01 146.32 30.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.427 2.084 . . . . 0.0 112.222 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 51.2 Cg_exo -54.91 129.46 35.38 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.52 2.147 . . . . 0.0 112.244 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 85' ' ' THR . 59.6 tp -114.92 109.29 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.63 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.588 ' HB ' ' HG ' ' A' ' 86' ' ' SER . 61.2 t -74.76 129.72 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.743 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.526 HG21 ' O ' ' A' ' 10' ' ' VAL . 68.6 p -148.32 46.3 1.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.096 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.18 141.56 4.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.201 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.439 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 14.7 tt -164.66 129.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.714 0.292 . . . . 0.0 110.304 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.789 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.8 t -66.12 -58.64 10.33 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.167 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 90.2 Cg_endo -88.88 124.23 1.51 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.121 1.881 . . . . 0.0 112.881 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.81 26.28 6.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.072 0.463 . . . . 0.0 110.125 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 177.66 131.8 0.06 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.585 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.546 ' O ' HD13 ' A' ' 92' ' ' LEU . . . 169.06 141.58 3.26 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.006 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.461 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 37.6 pt -57.44 162.85 4.05 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 122.066 0.146 . . . . 0.0 111.012 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.585 ' HA ' HG22 ' A' ' 64' ' ' VAL . 83.2 Cg_exo -48.19 -39.56 34.34 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.658 2.238 . . . . 0.0 113.311 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.524 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 89.9 m95 -70.53 -24.45 62.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -57.64 128.95 39.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 111.279 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -73.87 137.49 43.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.555 ' O ' HG21 ' A' ' 24' ' ' VAL . 27.0 m -134.7 132.52 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.03 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.4 m -87.35 113.56 23.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.71 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.52 HG21 ' N ' ' A' ' 27' ' ' ARG . 77.8 mt -75.22 139.45 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.955 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.588 ' HD2' ' O ' ' A' ' 58' ' ' SER . 27.4 tpt180 -147.25 133.15 19.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.291 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -169.14 -132.77 1.48 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.634 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -147.26 134.84 20.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 111.341 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.468 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 75.7 m-20 61.0 41.08 14.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.548 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.571 HD11 ' N ' ' A' ' 31' ' ' LEU . 10.0 mp -83.08 46.86 1.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.031 0.443 . . . . 0.0 110.389 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.35 121.8 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.462 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.1 p -87.56 39.08 0.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.835 0.35 . . . . 0.0 111.182 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.03 146.25 5.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.445 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.38 -40.94 81.31 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.603 2.202 . . . . 0.0 112.024 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.2 p -59.91 -40.23 88.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.183 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -58.16 -45.08 88.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.658 HD21 ' N ' ' A' ' 39' ' ' ILE . 1.5 tt -61.29 133.93 56.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.81 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.658 ' N ' HD21 ' A' ' 38' ' ' LEU . 26.5 pt -142.84 -44.54 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.435 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -102.9 136.05 12.64 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.677 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.437 ' HG ' ' HB1' ' A' ' 52' ' ' ALA . 1.7 tm? -149.23 128.17 12.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.418 HG22 ' C ' ' A' ' 46' ' ' HIS . 95.7 m -161.41 135.93 7.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.229 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.501 ' HB ' ' H ' ' A' ' 65' ' ' GLY . 73.4 mt -129.87 130.45 66.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.373 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.642 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 63.5 m 56.13 40.64 30.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.631 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' A' ' 68' ' ' LYS . . . 63.28 29.04 73.29 Favored Glycine 0 CA--C 1.518 0.229 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.878 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.486 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 81.9 t60 -130.92 131.42 44.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.73 0.3 . . . . 0.0 110.871 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.519 HD21 ' N ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -66.32 132.86 49.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.632 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.519 ' N ' HD21 ' A' ' 47' ' ' ASN . 72.2 m -152.36 38.42 0.56 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.982 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.25 -42.44 59.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.26 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -53.83 -40.74 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.65 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.471 HG23 ' NE ' ' A' ' 63' ' ' ARG . 62.4 p -79.76 -35.04 39.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.598 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.547 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -54.4 135.01 45.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.633 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.65 132.85 51.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.662 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -70.41 151.79 44.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.059 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.6 mmt -142.95 -44.3 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.924 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.5 p -166.05 -166.09 0.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.749 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.02 30.63 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.266 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.588 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 79.0 p 179.04 37.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.031 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -164.76 131.82 3.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.983 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.44 HD12 HD13 ' A' ' 38' ' ' LEU . 72.4 mt -150.72 115.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.4 t -79.93 130.39 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.272 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 53.7 t -170.35 151.9 3.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.025 0.44 . . . . 0.0 111.432 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.524 ' NH1' ' HZ3' ' A' ' 21' ' ' TRP . 39.3 ptt180 -84.05 130.02 34.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.201 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 20' ' ' PRO . 4.9 m -58.71 127.79 18.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 111.61 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.501 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . -72.49 150.21 44.76 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.035 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -52.45 137.53 29.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.924 0.392 . . . . 0.0 110.831 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.642 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -64.81 134.24 53.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.771 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.432 ' HD2' ' O ' ' A' ' 45' ' ' GLY . 99.5 mttt -136.13 -46.06 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.348 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -72.9 -130.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.477 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -166.25 48.59 0.08 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.06 0.457 . . . . 0.0 110.623 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 89' ' ' SER . 4.7 tppp? -157.6 -41.38 0.07 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.828 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.96 40.71 34.75 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.358 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.454 ' OD1' HD12 ' A' ' 75' ' ' ILE . 9.7 t0 -81.13 134.74 35.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.741 0.305 . . . . 0.0 111.015 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.544 HG23 HG23 ' A' ' 10' ' ' VAL . 67.6 mt -85.67 131.75 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.33 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.454 HD12 ' OD1' ' A' ' 73' ' ' ASP . 50.5 mm -134.08 135.9 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 0.0 111.359 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.685 ' H ' ' HA2' ' A' ' 84' ' ' GLY . 99.6 t -141.56 116.98 5.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.811 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.4 m -82.07 146.19 29.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.423 HG22 ' HG2' ' A' ' 8' ' ' PRO . 75.3 p -141.54 139.85 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.17 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 32.1 mmmt -57.1 -51.09 70.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.7 t -65.69 -53.48 40.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.004 0.431 . . . . 0.0 110.544 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.77 -123.06 0.26 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.238 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.55 -139.11 2.58 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.188 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.84 131.97 48.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.616 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.685 ' HA2' ' H ' ' A' ' 76' ' ' VAL . . . -62.41 152.95 43.9 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.691 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 63.0 p -147.93 142.61 26.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.711 0.291 . . . . 0.0 110.713 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.588 ' HG ' ' HB ' ' A' ' 10' ' ' VAL . 42.7 t -160.81 128.16 4.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.948 0.404 . . . . 0.0 111.319 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -74.57 -30.42 61.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.447 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.532 HG21 ' OG ' ' A' ' 86' ' ' SER . 33.0 m -83.79 152.84 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.238 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 71' ' ' LYS . 48.0 m -138.84 141.27 38.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.822 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.473 ' CD2' HG13 ' A' ' 64' ' ' VAL . 41.7 t80 -85.9 127.7 34.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.324 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -82.69 88.24 6.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.243 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 18' ' ' GLY . 35.4 tp -64.6 127.27 30.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.2 mt -92.19 136.17 33.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.218 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -72.16 130.6 86.15 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.693 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -53.36 133.65 53.87 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.643 2.229 . . . . 0.0 112.957 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.78 129.56 51.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.662 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.818 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.98 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.1 m80 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.843 0.354 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.408 ' HB2' ' HE1' ' A' ' 4' ' ' MET . 65.7 mtm -79.57 45.54 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.428 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -174.7 131.68 0.34 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.898 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -70.36 127.14 92.38 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.691 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.34 136.42 63.86 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.482 2.121 . . . . 0.0 112.156 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.534 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 50.2 Cg_exo -53.92 134.23 58.44 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.492 2.128 . . . . 0.0 112.091 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 85' ' ' THR . 1.3 tm? -119.71 130.44 55.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.497 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.591 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 90.5 t -101.92 137.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.744 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.428 ' N ' HG11 ' A' ' 10' ' ' VAL . 39.6 p -151.38 48.3 0.82 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.197 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.15 144.81 6.36 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.021 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.431 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.6 tt -164.8 130.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 110.722 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.817 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -67.33 -59.62 6.98 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.672 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.817 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 83.0 Cg_endo -89.52 125.1 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.06 1.84 . . . . 0.0 112.421 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -86.02 -18.62 32.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.623 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -156.15 138.46 14.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.238 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.8 148.71 7.03 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.561 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 19' ' ' ILE . 40.6 pt -51.82 157.51 1.97 Allowed Pre-proline 0 CA--C 1.531 0.25 0 CA-C-O 120.573 0.225 . . . . 0.0 111.065 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.616 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 84.8 Cg_exo -47.6 -37.5 26.92 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.713 2.276 . . . . 0.0 113.41 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -76.81 -22.4 53.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.425 ' OG1' HG12 ' A' ' 19' ' ' ILE . 96.1 m -52.01 130.88 30.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.796 0.331 . . . . 0.0 111.093 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -65.26 139.05 58.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.406 HG23 HG21 ' A' ' 64' ' ' VAL . 34.1 m -141.2 125.64 17.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.6 m -93.46 116.71 29.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.545 HG23 HD22 ' A' ' 31' ' ' LEU . 55.7 mt -76.54 138.47 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.702 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.432 ' N ' HG21 ' A' ' 26' ' ' ILE . 43.2 mmm-85 -140.39 130.39 24.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.301 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.36 -133.85 1.65 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.629 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -147.61 132.63 18.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.799 0.333 . . . . 0.0 111.111 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 57.5 41.25 26.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.333 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.545 HD22 HG23 ' A' ' 26' ' ' ILE . 10.5 mp -70.35 -36.22 74.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.733 0.301 . . . . 0.0 110.68 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.86 130.93 1.62 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.559 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 37' ' ' ASP . 81.8 p -65.24 -39.31 92.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.731 0.301 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.461 ' HA3' ' CZ2' ' A' ' 54' ' ' TRP . . . -164.52 -161.18 13.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.778 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.56 -49.25 7.61 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.723 2.282 . . . . 0.0 112.64 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.5 p -62.93 -38.84 92.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.53 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.407 ' HB2' ' OG1' ' A' ' 33' ' ' THR . 8.3 t70 -55.75 -51.67 66.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.18 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.687 HD13 HD12 ' A' ' 60' ' ' ILE . 1.4 tt -70.2 134.27 47.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.571 ' N ' HD21 ' A' ' 38' ' ' LEU . 43.1 pt -145.2 -37.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.195 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.439 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -113.69 142.68 17.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.813 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.463 ' O ' HG21 ' A' ' 42' ' ' THR . 1.1 tm? -149.57 130.78 14.55 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.609 HG21 ' HA ' ' A' ' 47' ' ' ASN . 18.5 p -151.88 145.99 25.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.147 0.498 . . . . 0.0 111.888 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 69.8 mt -134.77 118.9 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.238 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 65.0 m 74.91 -38.01 0.37 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.523 0.514 . . . . 0.0 110.53 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.79 -36.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.104 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -77.19 131.07 38.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 110.853 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.609 ' HA ' HG21 ' A' ' 42' ' ' THR . 14.9 p-10 -74.86 144.91 43.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.894 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.9 m -146.77 43.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 2.3 tm? -66.15 -45.99 79.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.709 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -49.19 -41.78 37.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.588 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.6 p -80.54 -35.42 34.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.408 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.28 134.93 56.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.845 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -127.1 134.37 50.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.63 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.461 ' CZ2' ' HA3' ' A' ' 34' ' ' GLY . 81.7 t90 -73.42 152.98 40.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.4 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.6 mmt -145.64 -46.25 0.21 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.777 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.418 ' C ' ' H ' ' A' ' 58' ' ' SER . 35.9 t -171.25 177.26 3.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.679 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.13 35.53 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.607 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 56' ' ' SER . 78.1 p -179.31 30.63 0.0 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.868 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -165.38 133.09 3.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.687 HD12 HD13 ' A' ' 38' ' ' LEU . 77.8 mt -151.34 113.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.845 0.355 . . . . 0.0 111.044 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.6 t -82.15 130.72 35.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.182 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.552 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.1 p -170.51 153.56 4.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.754 0.312 . . . . 0.0 111.483 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -84.06 136.57 33.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.882 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.616 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 2.5 t -54.0 135.73 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.183 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.9 -119.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.224 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.14 143.26 10.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.573 0.225 . . . . 0.0 110.5 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.48 140.47 5.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.62 -47.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.904 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -174.87 173.99 2.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.197 0.523 . . . . 0.0 111.555 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 72' ' ' GLY . 58.0 t0 47.02 40.57 9.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.274 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 71' ' ' LYS . 4.0 mptp? 62.59 -71.72 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.59 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 44' ' ' CYS . . . 175.83 43.1 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.658 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -63.8 132.16 50.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.804 0.335 . . . . 0.0 111.014 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.9 mt -85.46 129.0 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.533 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.403 HG21 ' O ' ' A' ' 84' ' ' GLY . 41.5 mm -132.76 142.09 43.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.266 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.633 ' H ' ' HA2' ' A' ' 84' ' ' GLY . 6.6 p -141.31 122.52 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.94 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.7 m -87.22 147.7 25.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.37 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.1 p -140.7 140.83 34.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.805 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -51.49 -48.75 62.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 82.2 p -68.98 -46.19 68.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.94 -129.52 0.05 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.885 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.03 -39.29 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.052 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -168.38 129.51 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.633 ' HA2' ' H ' ' A' ' 76' ' ' VAL . . . -67.67 154.22 52.98 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.204 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 63.3 p -144.22 140.0 29.03 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.591 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 42.9 t -154.06 136.41 14.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.99 0.424 . . . . 0.0 111.832 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.9 p -92.71 37.33 1.01 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.173 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.482 HG21 ' OG ' ' A' ' 86' ' ' SER . 33.4 m -148.45 146.61 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.9 m -135.11 136.2 41.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.006 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -86.01 133.84 33.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.557 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -85.24 125.51 32.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.494 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.546 ' N ' HD21 ' A' ' 92' ' ' LEU . 3.5 mm? -85.33 133.88 34.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.843 0.354 . . . . 0.0 111.29 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.0 mt -108.16 134.22 51.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.614 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -65.52 124.28 86.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.659 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.07 132.74 33.01 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.321 2.014 . . . . 0.0 112.356 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -110.76 102.78 11.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.833 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.337 -0.839 . . . . 0.0 110.936 179.959 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.756 0.312 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 41.3 tpp -173.75 135.27 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.937 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -62.12 106.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.998 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -83.56 140.29 41.34 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.19 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.62 142.93 91.56 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.478 2.119 . . . . 0.0 112.085 179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 15.7 Cg_endo -57.32 137.96 84.02 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.614 2.209 . . . . 0.0 112.38 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -124.88 124.22 41.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.284 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.462 ' HA ' ' HA2' ' A' ' 28' ' ' GLY . 68.3 t -86.93 136.88 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.088 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.411 ' N ' HG11 ' A' ' 10' ' ' VAL . 23.3 p -152.52 45.48 0.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.872 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.67 144.17 6.48 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.206 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.482 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.1 tt -161.16 128.85 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.684 0.278 . . . . 0.0 110.489 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.601 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.6 t -61.96 -57.74 22.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.489 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 85.7 Cg_endo -75.95 -156.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.84 1.693 . . . . 0.0 111.804 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -168.96 -30.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.457 . . . . 0.0 110.34 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.4 130.87 11.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.285 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.444 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 177.03 152.32 9.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.846 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.432 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 35.6 pt -52.22 162.73 0.81 Allowed Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 122.338 0.255 . . . . 0.0 111.461 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.59 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 86.6 Cg_exo -49.84 -43.92 38.82 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.957 2.438 . . . . 0.0 113.942 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.37 -5.57 29.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.432 ' HG1' ' N ' ' A' ' 19' ' ' ILE . 99.2 m -67.93 127.81 34.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.757 0.313 . . . . 0.0 111.121 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -72.53 138.62 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.36 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 62' ' ' CYS . 34.6 m -136.03 127.04 43.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 111.337 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.9 m -87.14 125.46 34.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.275 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.534 HD13 ' SG ' ' A' ' 62' ' ' CYS . 58.8 mt -85.96 139.19 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.909 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.406 ' HG3' HH11 ' A' ' 27' ' ' ARG . 44.0 mmm-85 -143.13 130.78 21.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.268 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -169.59 -131.52 1.33 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.598 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -143.69 134.43 25.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.952 0.406 . . . . 0.0 111.698 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.6 m-80 59.88 43.5 14.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.664 178.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.45 ' HB3' HD13 ' A' ' 60' ' ' ILE . 9.1 mp -83.42 51.09 1.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.947 0.403 . . . . 0.0 110.39 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.13 124.8 0.34 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.532 -179.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.7 p -87.58 38.84 0.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 111.343 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 166.75 146.43 4.85 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.626 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.22 -45.77 32.9 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.639 2.226 . . . . 0.0 112.049 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 p -60.59 -37.82 82.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.873 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.433 ' OD1' ' HB3' ' A' ' 79' ' ' LYS . 39.1 t70 -58.2 -41.88 84.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.075 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.584 HD13 HD12 ' A' ' 60' ' ' ILE . 1.8 tt -66.62 75.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.138 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' A' ' 79' ' ' LYS . 34.8 pt -76.59 -40.63 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.183 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.418 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -121.76 142.73 15.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.412 -179.018 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.417 ' O ' HG21 ' A' ' 42' ' ' THR . 3.3 tm? -150.0 132.96 16.14 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.417 HG21 ' O ' ' A' ' 41' ' ' LEU . 60.9 p -147.52 127.52 13.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.903 0.383 . . . . 0.0 111.837 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.444 HD12 ' SG ' ' A' ' 62' ' ' CYS . 72.7 mt -108.19 124.86 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.022 178.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.641 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 67.4 m 54.54 41.25 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.021 0.439 . . . . 0.0 110.459 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.57 34.38 89.75 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.747 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -131.31 132.01 44.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.594 0.235 . . . . 0.0 110.538 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -63.3 131.05 47.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.714 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.0 m -154.46 37.58 0.43 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.2 tm? -72.77 -45.6 57.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 110.32 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.74 -40.22 72.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.167 -179.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.0 p -80.05 -37.47 33.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.992 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.555 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.61 133.9 56.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.351 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.92 131.91 51.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.759 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -69.9 151.55 45.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.958 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.0 mmt -142.07 -44.99 0.34 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.02 179.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.485 ' HG ' ' H ' ' A' ' 59' ' ' LYS . 79.6 p -163.34 -164.95 0.99 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.662 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.45 35.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.4 ' O ' HD21 ' A' ' 31' ' ' LEU . 80.8 p -178.96 -43.37 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.364 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.485 ' H ' ' HG ' ' A' ' 56' ' ' SER . 41.0 ttmt -77.63 133.31 38.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.494 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.584 HD12 HD13 ' A' ' 38' ' ' LEU . 68.6 mt -151.33 111.81 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.387 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.5 t -80.23 125.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.956 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.555 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.0 p -170.72 131.57 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -87.82 140.4 29.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 20' ' ' PRO . 33.4 m -67.3 -147.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.629 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.59 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . 176.06 -40.74 0.11 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.562 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -174.31 136.66 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.954 0.377 . . . . 0.0 111.422 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.641 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -79.6 61.69 3.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.247 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 68' ' ' LYS . 12.1 tmtt? -48.96 -43.31 39.75 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.878 0.37 . . . . 0.0 110.042 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -65.65 -107.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.344 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -173.04 -50.81 0.02 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.766 0.317 . . . . 0.0 110.613 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -76.62 -38.32 54.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.8 37.55 5.46 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.333 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.32 135.85 42.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.773 0.32 . . . . 0.0 110.821 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.2 mt -85.67 92.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.176 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -86.67 139.66 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.172 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.408 ' O ' HG11 ' A' ' 76' ' ' VAL . 7.5 p -141.36 125.46 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.813 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.4 m -95.95 144.14 26.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.406 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.9 p -126.48 141.02 52.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.876 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.559 ' HA ' HD12 ' A' ' 39' ' ' ILE . 23.5 tptm -56.98 -48.93 77.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.899 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -67.66 -55.35 13.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.53 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.39 -124.71 0.69 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.178 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.51 -143.32 3.78 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.099 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.75 117.94 13.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 110.58 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.3 -149.92 25.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.522 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.8 p -155.22 -169.21 3.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.66 0.267 . . . . 0.0 110.542 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.0 p -170.85 128.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.913 0.387 . . . . 0.0 111.319 179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.5 p -76.27 -34.28 59.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.37 178.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 m -84.66 146.32 6.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.345 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -134.96 134.62 40.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.714 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -89.33 136.67 32.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.664 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -102.55 123.28 46.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.442 179.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 mp -85.28 132.08 34.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 0.0 111.4 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 18' ' ' GLY . 84.2 mt -90.67 138.09 31.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.242 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -67.45 135.41 93.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.368 179.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -57.24 128.73 30.84 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.394 2.063 . . . . 0.0 112.151 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.36 113.91 9.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.668 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.847 179.864 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.8 m170 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.791 0.329 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' A' ' 4' ' ' MET . 1.6 pmm? -61.75 136.8 58.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.636 ' HB3' ' HA3' ' A' ' 81' ' ' GLY . 22.2 tpp180 -61.61 135.01 57.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.638 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -60.99 130.06 90.9 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.998 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.39 138.53 39.23 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.522 2.148 . . . . 0.0 112.13 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.442 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 16.9 Cg_endo -58.31 127.73 25.89 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.48 2.12 . . . . 0.0 112.066 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 85' ' ' THR . 64.4 tp -109.91 117.38 33.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.107 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.549 ' HA ' ' HA2' ' A' ' 28' ' ' GLY . 89.7 t -83.22 131.31 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.776 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.517 HG21 ' O ' ' A' ' 10' ' ' VAL . 73.8 p -149.04 47.9 0.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.032 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.04 147.51 8.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.178 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.56 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.8 tt -161.18 130.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.587 0.232 . . . . 0.0 110.655 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.847 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 44.3 t -63.51 -59.26 12.29 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.31 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.847 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 7.3 Cg_exo -71.29 -147.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.93 1.754 . . . . 0.0 111.748 179.032 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -176.4 -25.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.945 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -162.69 129.49 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.129 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.48 155.07 13.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.728 -179.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.0 pt -51.14 159.75 0.99 Allowed Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.692 0.282 . . . . 0.0 111.382 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.603 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 86.5 Cg_exo -48.28 -48.28 17.33 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.978 2.452 . . . . 0.0 113.96 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -65.85 -5.69 9.82 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.4 m -67.28 126.17 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 111.071 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.669 ' HZ2' ' HB3' ' A' ' 23' ' ' LYS . 6.1 ttpm? -71.41 133.19 45.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.618 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.48 ' CG1' ' HG2' ' A' ' 15' ' ' PRO . 34.4 m -131.79 126.1 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 111.007 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.2 m -83.73 125.55 32.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.25 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.519 HG21 ' N ' ' A' ' 27' ' ' ARG . 48.7 mt -82.12 139.21 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.835 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.519 ' N ' HG21 ' A' ' 26' ' ' ILE . 23.2 mmm180 -146.51 132.95 19.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.312 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -169.21 -130.47 1.2 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.391 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -147.31 132.98 18.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 71.5 m-80 61.07 42.55 12.34 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.615 178.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.9 mp -83.13 49.06 1.47 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.939 0.399 . . . . 0.0 110.664 178.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.3 122.73 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.558 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -91.74 42.44 1.1 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.921 0.391 . . . . 0.0 111.177 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.53 146.44 5.52 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.711 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.9 -42.92 62.61 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.588 2.192 . . . . 0.0 111.901 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.3 p -61.96 -32.65 73.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.995 179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -77.84 45.73 0.53 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.048 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 tt -162.1 55.44 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.131 0.491 . . . . 0.0 110.005 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.0 pt -66.54 -37.86 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.323 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.41 138.95 15.34 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.9 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -148.42 134.06 18.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.786 0.327 . . . . 0.0 110.134 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.512 HG21 ' HA ' ' A' ' 47' ' ' ASN . 19.4 p -147.13 147.16 30.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.463 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.546 ' C ' ' H ' ' A' ' 45' ' ' GLY . 75.0 mt -128.8 116.19 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.788 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.652 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 69.1 m 70.68 -30.46 0.2 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.982 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.38 -44.18 0.31 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.621 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -80.45 139.48 36.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.856 0.36 . . . . 0.0 111.237 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.512 ' HA ' HG21 ' A' ' 42' ' ' THR . 5.3 m120 -60.85 143.53 54.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.965 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.8 m -145.5 39.09 1.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.599 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.6 tp -70.94 -43.4 68.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.136 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -55.91 -41.24 74.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.157 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.3 p -79.87 -34.34 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.793 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 61' ' ' VAL . . . -58.48 134.17 56.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.285 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -126.27 122.06 34.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.389 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -70.81 147.15 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.586 ' HE2' HG22 ' A' ' 61' ' ' VAL . 56.3 mtt -149.22 -41.36 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.15 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.579 ' HG ' ' HB3' ' A' ' 59' ' ' LYS . 78.6 p -157.47 175.18 14.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.69 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.75 42.03 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.358 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.509 ' HG ' ' H ' ' A' ' 28' ' ' GLY . 43.8 t -175.93 -40.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.077 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.579 ' HB3' ' HG ' ' A' ' 56' ' ' SER . 41.2 ttmt -85.53 133.23 34.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.231 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 74.9 mt -150.72 115.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.648 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.586 HG22 ' HE2' ' A' ' 55' ' ' MET . 64.3 t -82.01 124.15 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.947 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 22.6 p -171.19 132.01 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.917 0.389 . . . . 0.0 111.26 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.618 ' HG2' ' HA ' ' A' ' 23' ' ' LYS . 98.3 mtt180 -85.93 140.68 30.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.139 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 20' ' ' PRO . 34.6 m -66.76 -149.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.547 179.525 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.603 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . 179.69 -48.03 0.08 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.653 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -177.53 137.67 0.21 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.23 0.515 . . . . 0.0 111.842 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.652 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -70.25 145.47 51.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.16 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.457 ' HB2' ' HA2' ' A' ' 45' ' ' GLY . 29.0 mtpp -147.17 -46.32 0.17 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.418 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -62.74 -46.49 87.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.561 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -169.17 -40.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.616 0.246 . . . . 0.0 111.35 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.588 ' HB3' ' NZ ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -160.11 -42.66 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.372 -179.746 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.84 39.9 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.896 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.8 127.87 34.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.694 0.283 . . . . 0.0 110.856 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.405 HG21 ' N ' ' A' ' 75' ' ' ILE . 65.2 mt -85.81 135.68 24.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.689 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.455 HD11 ' O ' ' A' ' 84' ' ' GLY . 50.4 mm -134.16 139.65 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 111.153 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.6 122.81 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.72 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.7 m -92.02 143.37 26.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.298 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.9 p -134.41 136.56 43.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.056 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -57.61 -47.67 81.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.182 -179.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 88.5 p -64.73 -54.8 25.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.658 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.636 ' HA3' ' HB3' ' A' ' 5' ' ' ARG . . . -86.7 -123.21 1.57 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.421 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.8 -139.03 2.54 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.996 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.57 ' NZ ' ' HB2' ' A' ' 83' ' ' LYS . 4.8 ttmp? -62.45 126.57 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 110.794 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.455 ' O ' HD11 ' A' ' 75' ' ' ILE . . . -81.74 134.69 13.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.802 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 79.8 p -99.31 145.54 27.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.553 0.215 . . . . 0.0 110.684 179.498 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.0 p -141.8 122.05 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.333 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.6 p -93.08 32.97 1.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.399 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.0 m -150.94 150.79 13.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.605 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.0 p -142.99 134.85 26.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.966 0.412 . . . . 0.0 111.217 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -85.67 128.16 34.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.817 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -85.0 121.03 27.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.562 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.8 mp -89.98 128.16 36.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.864 0.364 . . . . 0.0 111.293 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 82.7 mt -85.51 141.51 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.735 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.06 134.42 95.79 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.876 179.848 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.47 132.74 53.96 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.528 2.152 . . . . 0.0 112.555 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -72.09 115.05 10.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.559 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.8 pttt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.001 -179.888 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.823 0.344 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.569 ' HG3' ' H ' ' A' ' 5' ' ' ARG . 40.9 tpp -71.43 -131.86 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.42 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.569 ' H ' ' HG3' ' A' ' 4' ' ' MET . 1.0 OUTLIER 52.45 42.97 31.4 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.865 0.364 . . . . 0.0 110.964 179.84 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -64.57 133.13 95.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.041 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.91 143.93 74.83 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.526 2.15 . . . . 0.0 111.99 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 67.4 Cg_exo -50.7 142.49 31.82 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.584 2.189 . . . . 0.0 112.43 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' A' ' 85' ' ' THR . 63.2 tp -142.9 98.39 3.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.871 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.532 ' HA ' ' HA2' ' A' ' 28' ' ' GLY . 59.6 t -73.01 134.09 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.018 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.6 p -148.88 44.67 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.994 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.81 142.77 5.31 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.776 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.508 HG12 ' HD2' ' A' ' 15' ' ' PRO . 18.1 tt -164.67 131.33 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.743 0.306 . . . . 0.0 110.931 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.794 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -68.05 -58.28 8.03 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.855 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.794 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 92.0 Cg_endo -92.18 123.8 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.329 2.019 . . . . 0.0 112.262 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -81.72 -20.66 38.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.498 ' HG3' HD13 ' A' ' 93' ' ' LEU . 11.0 pt-20 -157.48 138.71 13.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 111.409 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.45 151.76 9.76 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.419 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.494 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 38.4 pt -52.14 163.66 0.68 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.671 0.236 . . . . 0.0 111.15 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.65 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 76.4 Cg_exo -49.08 -47.0 23.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.533 2.155 . . . . 0.0 113.944 -178.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -72.68 -14.65 61.62 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.8 m -55.11 122.52 11.17 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.599 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.747 ' HE2' HG12 ' A' ' 61' ' ' VAL . 61.0 tttm -61.0 136.44 58.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.578 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.495 ' O ' HG21 ' A' ' 24' ' ' VAL . 34.8 m -137.01 122.12 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.099 0.476 . . . . 0.0 111.129 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.0 m -83.84 113.5 20.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.523 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.9 mt -79.13 138.61 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.053 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.492 ' O ' HG11 ' A' ' 10' ' ' VAL . 20.6 mmt85 -144.92 129.44 17.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.276 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 10' ' ' VAL . . . -170.62 -134.93 1.83 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.617 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -150.31 133.79 16.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.915 0.388 . . . . 0.0 111.422 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 57.87 41.9 24.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.069 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.489 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.6 mp -67.52 -38.51 84.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.74 0.305 . . . . 0.0 110.879 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.04 132.64 1.99 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.699 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.0 p -62.12 -35.69 79.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.44 172.48 39.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.375 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.47 -44.59 45.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.605 2.204 . . . . 0.0 112.273 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.8 p -62.74 -39.27 93.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.092 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.516 ' HA ' ' HD3' ' A' ' 79' ' ' LYS . 8.0 t70 -57.66 -40.63 79.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.034 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 tt -75.28 66.75 1.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.265 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.3 pt -73.27 -33.71 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.96 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -126.3 140.54 12.14 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.531 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 75' ' ' ILE . 53.9 tp -148.72 144.17 26.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.731 0.301 . . . . 0.0 110.57 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.451 HG21 ' HA ' ' A' ' 47' ' ' ASN . 11.5 p -161.33 142.15 11.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.286 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.48 ' C ' ' H ' ' A' ' 45' ' ' GLY . 63.9 mt -127.12 115.51 41.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.72 178.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 48.2 t 74.04 -35.79 0.32 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.695 -178.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.97 -36.15 0.28 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.509 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.438 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 83.4 t60 -77.69 139.82 39.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.899 0.381 . . . . 0.0 111.558 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.451 ' HA ' HG21 ' A' ' 42' ' ' THR . 45.0 t30 -66.73 151.92 46.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.962 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.46 ' SG ' HG13 ' A' ' 43' ' ' ILE . 3.0 p -159.66 45.11 0.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.367 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.9 tp -88.34 -46.24 9.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.568 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -54.8 -39.76 68.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.871 -179.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.3 p -80.25 -38.15 31.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.789 0.328 . . . . 0.0 111.681 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -60.01 135.99 57.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.016 0.436 . . . . 0.0 111.709 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -123.13 127.85 49.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.591 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 66.4 t90 -69.29 146.09 52.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.421 ' HB3' ' HE1' ' A' ' 55' ' ' MET . 87.5 mtp -143.44 -42.23 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.702 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 58' ' ' SER . 81.2 p -167.11 164.31 15.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.301 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.93 27.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.497 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.8 m -167.33 27.27 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.816 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.5 ttmt -164.92 130.14 2.64 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.926 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.476 HG22 HD11 ' A' ' 60' ' ' ILE . 72.4 mt -151.16 118.84 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.747 HG12 ' HE2' ' A' ' 23' ' ' LYS . 92.2 t -90.15 129.22 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.003 179.053 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.554 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 30.2 p -170.54 151.5 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.322 . . . . 0.0 111.492 -179.144 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.2 134.44 34.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.275 179.136 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.65 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t -57.29 128.47 17.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.759 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 46' ' ' HIS . . . -83.8 61.4 4.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.938 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.471 ' HA ' ' HG3' ' A' ' 20' ' ' PRO . 19.3 pt20 43.07 -141.39 0.15 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 122.249 0.219 . . . . 0.0 111.31 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.09 119.78 5.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.954 0.407 . . . . 0.0 111.167 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.405 ' H ' ' HG ' ' A' ' 44' ' ' CYS . 14.4 mmmm -81.69 -35.07 30.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.779 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -139.02 -129.27 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.6 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -150.97 48.61 0.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.16 0.505 . . . . 0.0 110.3 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.598 ' HB2' ' NZ ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -82.95 -42.55 17.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.284 -179.805 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.72 72.05 0.75 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.217 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.559 ' HB3' ' HE3' ' A' ' 71' ' ' LYS . 9.4 t0 -161.46 127.8 3.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.861 0.362 . . . . 0.0 110.604 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.53 92.54 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.02 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.5 HD12 ' OD1' ' A' ' 73' ' ' ASP . 44.3 mm -84.18 139.36 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.742 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.429 ' N ' HG21 ' A' ' 75' ' ' ILE . 46.0 t -141.31 114.3 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.856 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.1 m -81.31 144.3 31.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.913 0.387 . . . . 0.0 111.526 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.2 p -136.8 135.07 37.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.69 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.516 ' HD3' ' HA ' ' A' ' 37' ' ' ASP . 28.3 mtpp -52.74 -47.19 67.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.855 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.8 m -68.33 -48.54 64.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.055 0.455 . . . . 0.0 110.112 179.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.27 -121.96 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.542 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.58 -33.9 0.04 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.4 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -168.89 125.07 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 0.0 110.556 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.09 130.61 9.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.93 -0.653 . . . . 0.0 113.132 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 75.7 p -100.99 147.17 26.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.574 0.226 . . . . 0.0 110.767 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.2 p -149.95 126.96 11.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.051 0.453 . . . . 0.0 111.37 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.7 p -78.85 -30.33 45.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.017 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.8 m -83.68 141.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.212 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.7 m -121.69 142.98 49.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.582 ' CE2' HG23 ' A' ' 64' ' ' VAL . 63.1 t80 -97.91 106.98 19.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.234 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 57.4 tttm -70.31 117.41 11.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.215 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.4 tp -80.62 132.39 35.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.742 -178.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.498 HD13 ' HG3' ' A' ' 17' ' ' GLU . 84.0 mt -102.78 131.69 49.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.189 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -73.1 131.57 83.39 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.773 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -57.52 131.48 44.72 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.581 2.187 . . . . 0.0 112.727 -179.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -72.92 115.59 12.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.518 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.1 tptt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.959 -179.902 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.445 ' O ' ' HB3' ' A' ' 4' ' ' MET . 47.5 m170 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.547 0.213 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.445 ' HB3' ' O ' ' A' ' 3' ' ' HIS . 48.2 tpp 73.56 -41.08 0.48 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.682 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -168.97 140.65 2.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 110.764 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -59.28 133.51 88.05 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.085 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.78 146.75 95.16 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.673 2.248 . . . . 0.0 112.069 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 13.6 Cg_endo -57.17 123.28 13.45 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.424 2.083 . . . . 0.0 112.212 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.5 tp -103.27 121.2 42.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.97 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 62.4 t -95.31 136.48 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 t -169.51 51.11 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.078 0.466 . . . . 0.0 111.305 -179.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.93 143.41 7.27 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.418 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.507 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.4 tt -160.05 130.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.713 0.292 . . . . 0.0 110.967 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.775 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.9 t -66.39 -58.73 9.71 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.607 179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 67.9 Cg_endo -89.22 115.56 0.7 Allowed 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.146 1.897 . . . . 0.0 112.102 179.377 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -99.1 27.55 5.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.923 0.392 . . . . 0.0 110.632 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 178.61 131.03 0.07 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.454 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.97 150.59 6.77 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.786 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.436 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.3 pt -57.0 162.34 3.89 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.473 0.178 . . . . 0.0 111.057 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.586 ' O ' HG21 ' A' ' 64' ' ' VAL . 85.7 Cg_exo -48.96 -46.68 24.23 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.978 2.452 . . . . 0.0 114.019 -178.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.464 ' O ' ' HD2' ' A' ' 63' ' ' ARG . 94.6 m95 -69.99 -5.96 29.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.4 m -72.96 127.56 32.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 110.818 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -74.38 125.29 28.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.809 179.904 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.454 HG23 HG12 ' A' ' 64' ' ' VAL . 23.7 m -108.38 127.6 64.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.084 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.455 HG22 ' HE2' ' A' ' 59' ' ' LYS . 90.4 m -78.87 119.49 22.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.332 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 61.8 mt -85.28 140.73 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.411 179.255 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -146.55 136.74 23.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.342 . . . . 0.0 110.872 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.99 -128.42 1.04 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.413 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -143.96 129.58 19.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.0 111.266 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.5 m-80 58.66 47.56 12.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.108 179.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.55 HD11 ' N ' ' A' ' 31' ' ' LEU . 9.8 mp -81.18 53.21 1.97 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.868 0.366 . . . . 0.0 111.02 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.453 ' HA3' ' OD2' ' A' ' 37' ' ' ASP . . . 83.86 135.32 2.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.796 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 77.7 p -62.98 -40.77 98.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.656 0.265 . . . . 0.0 111.376 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.562 ' HA3' ' CE2' ' A' ' 54' ' ' TRP . . . -161.35 -159.46 10.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.932 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -65.85 -48.22 3.11 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.728 2.285 . . . . 0.0 112.528 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -60.31 -39.52 87.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.695 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 38.8 t70 -63.19 -47.08 84.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.616 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.599 HD21 ' N ' ' A' ' 39' ' ' ILE . 2.3 tt -66.96 129.16 38.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.773 179.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.599 ' N ' HD21 ' A' ' 38' ' ' LEU . 29.7 pt -137.23 -44.68 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.22 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -98.67 136.59 12.78 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.309 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.499 ' O ' HG21 ' A' ' 42' ' ' THR . 1.9 tm? -149.43 132.41 16.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 110.195 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.499 HG21 ' O ' ' A' ' 41' ' ' LEU . 16.5 p -151.62 148.79 28.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.489 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.477 ' C ' ' H ' ' A' ' 45' ' ' GLY . 77.2 mt -133.14 114.33 21.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.584 179.14 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.61 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 66.7 m 73.36 -38.56 0.41 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 123.488 0.493 . . . . 0.0 110.545 -178.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 171.45 -41.97 0.18 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.631 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.825 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 25.2 p-80 -78.75 135.74 37.2 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.841 0.353 . . . . 0.0 111.14 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.443 ' HA ' HG21 ' A' ' 42' ' ' THR . 4.9 m120 -61.21 141.62 57.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.2 m -139.98 38.43 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.564 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.5 tp -71.51 -43.77 65.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.353 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -53.57 -42.94 68.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.477 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.3 p -80.47 -37.83 31.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.714 0.292 . . . . 0.0 111.443 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.424 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -60.47 129.17 40.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.032 0.444 . . . . 0.0 111.66 -179.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -126.67 132.1 51.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.213 179.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.562 ' CE2' ' HA3' ' A' ' 34' ' ' GLY . 54.3 t90 -63.99 149.89 46.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.376 . . . . 0.0 111.019 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 93.4 mmm -143.78 -45.88 0.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.632 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 58' ' ' SER . 70.8 m -163.63 162.06 24.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.474 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.48 36.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.35 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 56' ' ' SER . 78.1 p -175.24 20.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.153 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.1 tttm -165.19 131.68 2.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.487 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.455 HG22 HD11 ' A' ' 60' ' ' ILE . 74.3 mt -147.53 122.2 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.792 0.33 . . . . 0.0 110.998 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.4 t -83.82 133.76 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.941 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 29.9 p -170.53 132.92 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.352 . . . . 0.0 110.919 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.581 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 77.6 mtm180 -85.0 134.62 34.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.586 HG21 ' O ' ' A' ' 20' ' ' PRO . 27.8 m -70.94 -148.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.399 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . 179.81 -52.91 0.09 OUTLIER Glycine 0 C--N 1.335 0.476 0 C-N-CA 119.88 -1.152 . . . . 0.0 113.494 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -177.17 136.85 0.21 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.101 0.45 . . . . 0.0 111.745 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.61 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -83.52 123.4 29.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.784 179.128 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.825 ' HE3' ' HB3' ' A' ' 46' ' ' HIS . 99.3 mttt -83.14 -54.48 5.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.409 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -67.04 -68.32 0.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.847 -179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 64.8 t0 177.09 -51.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.306 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.47 ' HD3' ' OD1' ' A' ' 73' ' ' ASP . 49.9 tttp -76.69 -121.4 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.293 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.84 46.55 0.05 OUTLIER Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.538 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.47 ' OD1' ' HD3' ' A' ' 71' ' ' LYS . 1.6 m-20 -63.88 128.53 36.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 111.413 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.443 ' O ' HD12 ' A' ' 75' ' ' ILE . 66.8 mt -85.91 137.21 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.732 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.534 HG21 ' N ' ' A' ' 76' ' ' VAL . 48.4 mm -134.22 142.23 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.917 0.389 . . . . 0.0 111.388 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.534 ' N ' HG21 ' A' ' 75' ' ' ILE . 7.7 p -140.82 128.74 23.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.636 179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 24.6 m -102.22 140.13 36.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.42 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.6 p -122.01 149.31 43.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.5 mmmm -51.18 -51.4 54.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.204 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.0 m -69.92 -54.47 13.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.627 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.74 -131.03 2.59 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.28 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 77' ' ' THR . . . -171.83 -143.04 3.92 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.851 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -67.69 117.79 10.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 110.688 179.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.77 -133.42 2.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.735 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 86' ' ' SER . 0.0 OUTLIER -160.21 -176.64 5.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.002 0.43 . . . . 0.0 110.946 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.62 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 79.4 p -169.27 123.88 0.83 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.527 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.409 ' O ' HG11 ' A' ' 88' ' ' VAL . 81.1 p -95.03 33.55 1.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.185 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 87' ' ' THR . 20.3 m -152.18 152.8 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.537 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.0 p -143.93 141.96 30.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.049 0.452 . . . . 0.0 111.209 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -85.0 131.94 34.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.25 -179.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.578 ' HB3' ' NZ ' ' A' ' 91' ' ' LYS . 6.0 ttpm? -81.58 120.78 25.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.657 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.71 130.93 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.823 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 79.8 mt -107.0 145.2 32.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.233 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -61.26 131.73 92.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.778 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.97 135.48 41.09 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.584 2.19 . . . . 0.0 112.406 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -70.5 77.18 0.57 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.124 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.774 179.958 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.417 ' NE2' ' HG2' ' A' ' 4' ' ' MET . 18.9 p-80 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.71 0.29 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.417 ' HG2' ' NE2' ' A' ' 3' ' ' HIS . 92.9 mmm -69.95 -145.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.287 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -175.76 134.16 0.28 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.478 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.428 ' NE2' ' N ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -141.02 141.48 24.12 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.986 -179.716 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.03 145.91 83.37 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.749 2.3 . . . . 0.0 112.265 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 52.6 Cg_exo -54.08 138.86 71.36 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.534 2.156 . . . . 0.0 112.342 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 85' ' ' THR . 5.6 tt -133.74 111.77 10.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.323 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.61 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 83.9 t -83.75 140.51 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.918 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 t -162.68 46.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.028 0.442 . . . . 0.0 110.793 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.1 142.3 5.96 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.858 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.514 HG12 ' HD2' ' A' ' 15' ' ' PRO . 13.2 tt -164.07 128.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.659 0.266 . . . . 0.0 110.457 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.77 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 45.9 t -63.62 -58.64 14.39 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.83 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 94.0 Cg_endo -89.47 107.29 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.21 1.94 . . . . 0.0 112.188 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -91.03 26.41 2.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 110.587 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 179.5 130.01 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.287 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.467 ' N ' HD13 ' A' ' 93' ' ' LEU . . . 166.99 148.19 5.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.568 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.0 pt -52.2 154.01 4.47 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.537 0.208 . . . . 0.0 110.786 179.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.59 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 84.2 Cg_exo -47.26 -37.6 24.56 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.018 2.478 . . . . 0.0 113.792 -178.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -73.44 -23.32 60.09 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 m -57.99 128.55 37.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 110.964 -179.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.87 129.84 41.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.538 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.554 HG11 ' HG2' ' A' ' 15' ' ' PRO . 26.8 m -121.4 125.1 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 111.013 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.509 HG22 ' NZ ' ' A' ' 59' ' ' LYS . 99.4 m -75.84 116.89 17.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.921 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 61.5 mt -83.04 136.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.67 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.459 ' HD2' ' O ' ' A' ' 58' ' ' SER . 29.3 tpt180 -141.49 133.41 27.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.334 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.45 -134.04 1.69 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.48 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -150.25 132.24 15.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.944 0.402 . . . . 0.0 111.281 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.468 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 72.3 m-80 59.3 46.47 12.69 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.673 178.807 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.465 HD21 HD13 ' A' ' 60' ' ' ILE . 8.4 mp -81.78 52.15 1.86 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 110.694 178.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.06 126.69 0.14 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.419 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.7 p -90.77 42.27 1.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.694 0.283 . . . . 0.0 111.563 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.52 145.81 5.0 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.792 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 -46.38 27.61 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.394 2.063 . . . . 0.0 111.709 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.5 t -62.05 -36.06 80.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.072 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.14 -36.18 67.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.563 HD13 HD11 ' A' ' 60' ' ' ILE . 1.4 tt -75.57 61.09 1.28 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.488 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.441 ' O ' HD23 ' A' ' 49' ' ' LEU . 30.7 pt -68.98 -40.1 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.435 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -110.48 139.75 15.61 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.957 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.445 ' O ' HG21 ' A' ' 42' ' ' THR . 3.0 tm? -148.26 132.06 17.01 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.445 HG21 ' O ' ' A' ' 41' ' ' LEU . 24.0 p -150.51 140.94 22.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.162 0.506 . . . . 0.0 111.843 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.3 mt -137.4 125.79 33.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.573 178.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.531 ' SG ' HD22 ' A' ' 92' ' ' LEU . 69.2 m 58.43 37.98 25.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.163 0.506 . . . . 0.0 110.1 -179.004 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.89 25.31 71.88 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.958 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -131.85 125.33 31.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.54 0.209 . . . . 0.0 110.521 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -63.11 138.17 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.324 . . . . 0.0 110.633 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.0 m -148.84 39.38 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.684 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 39' ' ' ILE . 58.3 tp -69.69 -44.55 70.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.266 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.66 -44.16 57.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.297 -179.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.431 HG23 HH21 ' A' ' 63' ' ' ARG . 71.8 p -80.77 -37.83 29.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 111.134 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.576 ' HB1' ' HG ' ' A' ' 62' ' ' CYS . . . -60.44 130.31 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.718 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -126.82 129.36 48.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.514 179.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 80.8 t90 -64.57 145.92 55.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.618 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.3 mmm -140.14 -45.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.526 ' C ' ' H ' ' A' ' 58' ' ' SER . 65.7 m -164.05 160.27 21.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.65 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.39 27.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.838 0.352 . . . . 0.0 111.396 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.3 m -168.03 19.49 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.833 179.341 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.509 ' NZ ' HG22 ' A' ' 25' ' ' THR . 62.3 tttp -165.19 130.8 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.511 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.563 HD11 HD13 ' A' ' 38' ' ' LEU . 68.5 mt -148.84 119.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.952 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.32 134.71 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.555 179.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.576 ' HG ' ' HB1' ' A' ' 52' ' ' ALA . 45.9 t -170.67 152.84 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.277 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.431 HH21 HG23 ' A' ' 51' ' ' THR . 84.3 mtm180 -83.79 135.25 34.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.001 179.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.59 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t -56.64 135.82 20.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.625 -178.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.29 -110.3 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.929 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -165.9 139.29 4.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.562 0.22 . . . . 0.0 110.477 179.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -61.51 78.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.031 -179.195 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -66.75 -50.81 61.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.746 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -77.84 -71.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.833 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 t70 178.29 -47.18 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.118 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -78.22 -122.78 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.825 -179.81 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.407 ' C ' ' HB3' ' A' ' 89' ' ' SER . . . 178.39 40.92 0.07 OUTLIER Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.81 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -66.06 130.69 44.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.708 0.289 . . . . 0.0 111.129 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.476 HD11 HG13 ' A' ' 10' ' ' VAL . 68.8 mt -85.06 131.61 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.355 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 74' ' ' ILE . 39.9 mm -127.4 139.93 50.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.402 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -139.63 120.94 15.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.624 179.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.9 m -94.07 142.47 27.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.2 p -136.92 136.57 38.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -55.96 -50.62 70.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.018 -179.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.0 m -67.52 -54.59 18.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.323 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.21 -125.22 0.46 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.108 179.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.55 -141.69 3.22 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.469 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -63.9 128.99 38.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.82 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.11 128.31 8.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.775 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 81.4 p -103.63 148.55 25.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.626 0.25 . . . . 0.0 110.829 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.61 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 40.4 t -154.48 127.82 8.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 111.661 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.4 p -77.55 -32.98 54.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.423 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.6 m -84.47 148.66 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.494 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.407 ' HB3' ' C ' ' A' ' 72' ' ' GLY . 19.3 m -139.29 140.35 37.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.549 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -85.05 131.74 34.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.35 -179.532 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -84.34 122.27 28.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.595 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.534 HD12 HG13 ' A' ' 64' ' ' VAL . 3.4 mm? -78.59 131.64 36.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.241 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 18' ' ' GLY . 73.6 mt -108.27 137.45 46.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.585 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -61.62 128.58 90.36 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.812 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.54 131.48 44.7 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.537 2.158 . . . . 0.0 112.45 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.1 114.81 10.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.416 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.3 pttt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.88 -179.973 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.576 0.226 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.98 144.79 99.43 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.521 2.147 . . . . 0.0 111.888 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 54.2 Cg_exo -51.41 118.47 4.39 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.317 2.011 . . . . 0.0 112.4 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.5 tp -99.41 131.27 45.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.645 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 85.1 t -116.6 135.91 55.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.672 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -168.82 52.47 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.098 0.475 . . . . 0.0 111.34 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.93 143.53 8.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.579 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.544 HG12 ' HD2' ' A' ' 15' ' ' PRO . 12.7 tt -161.36 131.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.564 0.221 . . . . 0.0 110.782 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.697 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 43.8 t -62.3 -60.23 10.65 Favored Pre-proline 0 CA--C 1.531 0.218 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.132 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 84.8 Cg_endo -79.71 -160.14 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.875 1.717 . . . . 0.0 111.742 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -173.22 21.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.761 0.315 . . . . 0.0 110.967 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.413 ' HB2' HD11 ' A' ' 93' ' ' LEU . 22.8 pt-20 177.78 127.45 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.3 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 164.09 153.03 7.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.886 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 93' ' ' LEU . 34.7 pt -53.92 159.65 2.65 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.435 0.16 . . . . 0.0 110.922 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.841 ' HA ' HG23 ' A' ' 64' ' ' VAL . 75.8 Cg_exo -51.41 -40.75 61.94 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.64 2.227 . . . . 0.0 113.392 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.495 ' HE3' HH11 ' A' ' 63' ' ' ARG . 78.6 m95 -69.56 -5.35 23.79 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.0 m -66.96 132.23 47.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 111.314 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.56 ' HD2' HG13 ' A' ' 61' ' ' VAL . 17.6 tppt? -70.31 138.74 51.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.69 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.576 HG12 ' HG3' ' A' ' 15' ' ' PRO . 35.2 m -145.9 128.55 9.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.96 0.409 . . . . 0.0 111.06 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 84.3 m -87.13 120.99 28.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.8 mt -79.79 139.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.115 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HE ' ' HZ3' ' A' ' 59' ' ' LYS . 19.2 mmt85 -137.33 134.74 36.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.33 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.05 -136.25 2.24 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.871 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -152.16 134.42 15.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.972 0.415 . . . . 0.0 111.497 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.9 m120 60.63 42.0 14.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.603 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.527 HD13 ' HA ' ' A' ' 58' ' ' SER . 9.1 mp -83.85 50.47 1.82 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 110.399 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.48 126.56 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.31 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.9 p -94.97 43.51 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 0.0 111.252 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.41 142.74 4.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.707 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.2 -42.26 58.6 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.595 2.196 . . . . 0.0 112.044 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.3 p -62.96 -38.68 92.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.955 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -56.56 -37.33 70.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.976 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.575 HD21 HD23 ' A' ' 41' ' ' LEU . 1.4 tt -75.46 62.8 1.4 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.466 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.464 HG13 ' N ' ' A' ' 40' ' ' GLY . 35.9 pt -69.25 -41.24 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.495 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -110.41 137.87 14.54 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.957 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.602 HD13 ' N ' ' A' ' 42' ' ' THR . 2.3 tm? -149.05 128.96 13.4 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.605 HG22 ' HA ' ' A' ' 47' ' ' ASN . 12.2 p -152.08 138.41 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.148 0.499 . . . . 0.0 111.864 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.516 HG21 ' HA ' ' A' ' 64' ' ' VAL . 71.4 mt -127.53 127.36 68.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.364 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.477 ' SG ' HD11 ' A' ' 92' ' ' LEU . 71.2 m 58.14 36.03 25.55 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.24 -26.71 1.81 Allowed Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.768 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -76.3 135.06 39.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.786 0.327 . . . . 0.0 111.337 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.605 ' HA ' HG22 ' A' ' 42' ' ' THR . 50.5 t-20 -73.23 136.22 44.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.659 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.7 m -152.47 41.87 0.63 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.728 0.299 . . . . 0.0 111.292 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.3 tp -71.38 -43.16 67.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.124 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -50.31 -41.92 51.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.605 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.422 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 72.4 p -80.3 -36.51 34.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.379 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.89 133.66 55.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.712 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -126.9 130.94 51.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.615 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -70.59 146.5 50.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.056 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.8 mmt -136.36 -52.4 0.72 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.643 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.0 m -160.52 -172.61 3.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.462 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.48 41.67 0.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.205 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.527 ' HA ' HD13 ' A' ' 31' ' ' LEU . 47.9 t -175.27 -47.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.753 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.618 ' HZ3' ' HE ' ' A' ' 27' ' ' ARG . 25.0 ttmm -87.8 136.23 33.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.866 0.365 . . . . 0.0 111.638 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -150.51 117.17 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.529 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.56 HG13 ' HD2' ' A' ' 23' ' ' LYS . 57.5 t -85.04 124.17 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.968 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.8 p -170.93 143.82 2.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 0.0 111.238 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.495 HH11 ' HE3' ' A' ' 21' ' ' TRP . 99.2 mtt180 -84.23 132.51 34.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.331 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.841 HG23 ' HA ' ' A' ' 20' ' ' PRO . 16.1 m . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.198 0.523 . . . . 0.0 111.635 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.31 0 CA-C-O 120.457 -0.079 . . . . 0.0 113.159 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -75.5 129.57 37.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.752 0.311 . . . . 0.0 110.94 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.1 mt -86.6 92.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.996 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.3 mm -86.52 139.78 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.205 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.9 t -139.6 113.44 6.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.2 m -81.87 144.28 31.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.496 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.0 p -141.32 134.95 30.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.718 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -59.24 -44.98 92.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.102 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.9 m -61.61 -42.88 99.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.979 0.418 . . . . 0.0 110.068 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.77 -118.15 3.25 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.081 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 -142.42 3.39 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.398 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -70.65 130.98 43.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.873 0.368 . . . . 0.0 110.963 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.48 136.81 15.98 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.67 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.7 p -98.92 140.17 33.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.662 0.268 . . . . 0.0 110.507 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.645 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 39.7 t -129.32 128.78 43.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.977 0.418 . . . . 0.0 111.727 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.2 p -75.4 -35.92 60.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.991 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.8 m -85.27 159.41 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.22 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.9 m -146.35 137.13 24.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' A' ' 64' ' ' VAL . 46.4 t80 -86.15 129.01 34.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.427 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.457 ' HE3' HD21 ' A' ' 93' ' ' LEU . 38.8 ttpt -83.36 117.92 23.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.265 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.477 HD11 ' SG ' ' A' ' 44' ' ' CYS . 86.5 mt -83.02 128.46 34.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 111.286 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.47 HD12 ' HA2' ' A' ' 18' ' ' GLY . 80.3 mt -99.62 144.16 29.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.892 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -57.93 139.09 83.06 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo . . . . . 0 C--N 1.348 0.517 0 C-N-CA 122.666 2.244 . . . . 0.0 112.939 -179.633 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 . . . . . 0 CA--C 1.529 0.151 0 CA-C-O 120.567 0.223 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.24 145.56 96.1 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.509 2.139 . . . . 0.0 111.82 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.72 118.71 3.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.401 2.068 . . . . 0.0 112.317 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.529 HD13 ' C ' ' A' ' 9' ' ' LEU . 3.4 tm? -98.52 117.79 33.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.646 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 58.8 t -96.1 139.52 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.908 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 t -171.05 48.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 111.205 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.74 139.32 5.59 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.027 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.458 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.6 tt -165.03 132.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.75 0.31 . . . . 0.0 110.629 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.81 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.9 t -68.41 -59.35 6.06 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.135 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.85 ' HG2' HG12 ' A' ' 24' ' ' VAL . 68.1 Cg_endo -92.94 121.98 0.48 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.247 1.965 . . . . 0.0 112.961 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -96.71 29.62 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.528 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.546 ' HB2' HD11 ' A' ' 93' ' ' LEU . 23.3 pt-20 179.73 132.24 0.09 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.395 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 171.92 143.38 4.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.095 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.558 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 35.2 pt -59.14 165.06 3.91 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 120.38 0.134 . . . . 0.0 111.083 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.671 ' HA ' HG23 ' A' ' 64' ' ' VAL . 95.7 Cg_exo -46.27 -41.89 22.16 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.927 2.418 . . . . 0.0 113.61 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -77.22 -17.42 58.49 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.426 ' OG1' HG12 ' A' ' 19' ' ' ILE . 80.9 m -56.89 131.48 49.71 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.68 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -73.63 139.84 45.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.566 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.85 HG12 ' HG2' ' A' ' 15' ' ' PRO . 35.0 m -139.55 128.25 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 111.075 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.6 m -89.2 118.3 28.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.1 mt -85.74 138.98 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -143.16 137.34 28.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.82 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -172.98 -129.32 1.14 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.722 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -146.75 136.37 23.03 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 110.939 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 61.65 40.02 13.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.87 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 mp -82.95 50.55 1.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 110.707 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.79 132.5 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.501 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.3 p -60.14 -34.34 73.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.697 0.284 . . . . 0.0 111.037 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.546 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -158.93 -161.43 11.11 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.825 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.86 -43.61 1.67 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.634 2.223 . . . . 0.0 112.7 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.5 p -57.23 -40.92 78.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.287 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.34 -36.77 84.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.0 tp -75.82 62.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.15 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.646 HD13 ' HG2' ' A' ' 79' ' ' LYS . 32.4 pt -69.16 -36.13 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.114 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.468 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -126.71 139.85 11.56 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.781 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.4 tp -150.0 151.78 33.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.683 0.278 . . . . 0.0 110.685 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.1 p -149.72 141.46 23.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.29 0.567 . . . . 0.0 111.975 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.6 mt -137.83 130.69 41.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.246 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.407 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 83.3 m 52.83 30.49 9.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.404 . . . . 0.0 110.101 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.1 -38.66 3.19 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.987 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' CE1' ' HB2' ' A' ' 44' ' ' CYS . 30.8 p-80 -86.5 140.5 29.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 117.457 0.628 . . . . 0.0 111.781 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -60.86 145.22 50.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.4 m -149.72 38.03 0.75 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.9 tp -71.57 -47.09 57.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.618 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 51' ' ' THR . 3.3 pp -58.49 -34.96 71.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.514 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.731 ' N ' HD12 ' A' ' 50' ' ' LEU . 22.0 p -80.45 -38.28 30.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.941 0.4 . . . . 0.0 110.891 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -68.62 135.5 51.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.168 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -126.77 128.73 47.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.017 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.546 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 78.6 t90 -61.73 150.08 37.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.914 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.699 ' HG3' HG23 ' A' ' 61' ' ' VAL . 92.4 mmm -143.12 -44.11 0.29 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 67.4 m -161.09 160.72 30.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.028 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.76 -30.36 32.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.559 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.9 m -126.21 36.94 4.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.241 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 60.0 tttm -165.02 132.62 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.4 mt -150.43 122.89 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.699 HG23 ' HG3' ' A' ' 55' ' ' MET . 65.7 t -82.98 129.45 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.242 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.9 p -170.47 136.67 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 111.569 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 59.3 mtt85 -85.18 138.15 32.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.584 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.671 HG23 ' HA ' ' A' ' 20' ' ' PRO . 31.7 m . . . . . 0 CA--C 1.533 0.319 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.673 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.296 -0.322 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.85 130.14 42.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.131 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.4 mt -97.42 128.39 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.319 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.82 138.0 49.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.418 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.3 t -124.81 129.1 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.633 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 40' ' ' GLY . 88.0 m -97.71 138.31 35.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.403 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.1 p -135.41 140.32 44.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.155 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.646 ' HG2' HD13 ' A' ' 39' ' ' ILE . 7.2 mtpm? -56.56 -46.72 80.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.779 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.7 p -65.56 -53.59 39.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.092 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.52 -124.41 2.24 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.099 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.7 -142.71 3.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.088 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.575 ' NZ ' ' HB3' ' A' ' 83' ' ' LYS . 5.9 ttpm? -71.53 123.29 22.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.715 0.293 . . . . 0.0 110.514 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.91 -160.55 36.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.746 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.0 p -154.97 -169.84 3.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.68 0.276 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.612 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 41.0 t -170.99 127.81 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.916 0.389 . . . . 0.0 111.318 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 82.5 p -72.53 -34.05 67.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.14 0.495 . . . . 0.0 110.084 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.9 173.62 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.377 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.8 p -157.41 135.6 11.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.712 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.518 ' CD2' HG11 ' A' ' 64' ' ' VAL . 53.4 t80 -85.4 127.03 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.184 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.598 ' HB3' ' NZ ' ' A' ' 91' ' ' LYS . 5.7 ttpm? -83.88 119.86 25.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.952 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' A' ' 20' ' ' PRO . 26.6 tp -85.19 131.14 34.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.244 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 17' ' ' GLU . 79.6 mt -94.63 136.28 35.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.777 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -63.49 137.92 97.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 C--N 1.346 0.439 0 C-N-CA 122.493 2.129 . . . . 0.0 112.421 -179.955 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 32.8 tp60 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.53 0.205 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 6' ' ' GLN . 46.5 Cg_exo -56.23 144.03 82.98 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.656 2.237 . . . . 0.0 112.473 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.57 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 14.4 Cg_endo -57.34 141.32 94.74 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.744 2.296 . . . . 0.0 112.196 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 85' ' ' THR . 4.4 tt -141.0 121.9 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 0.0 110.435 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.528 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 98.5 t -84.61 134.61 26.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.712 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.565 HG23 HD22 ' A' ' 9' ' ' LEU . 34.3 p -153.7 47.26 0.64 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.862 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.95 143.22 6.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.854 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.501 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 14.5 tt -160.53 130.35 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.713 0.292 . . . . 0.0 110.448 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.804 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 52.0 m -63.95 -59.55 11.07 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.155 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.804 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 91.4 Cg_endo -89.56 128.06 1.7 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.232 1.955 . . . . 0.0 112.69 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -105.3 25.05 11.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 0.0 110.242 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 177.57 131.3 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.547 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.25 149.56 5.82 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.445 -0.884 . . . . 0.0 112.8 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 93' ' ' LEU . 35.3 pt -57.16 157.48 11.75 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.437 0.161 . . . . 0.0 110.868 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.639 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 85.8 Cg_exo -48.69 -39.88 38.26 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.874 2.382 . . . . 0.0 113.576 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.408 ' HZ3' HH11 ' A' ' 63' ' ' ARG . 97.0 m95 -71.91 -20.49 61.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.9 m -56.75 131.41 49.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 111.144 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -65.98 135.94 55.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.426 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.57 HG12 ' HG2' ' A' ' 15' ' ' PRO . 33.4 m -134.36 129.42 53.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.39 . . . . 0.0 111.216 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.4 m -85.58 122.78 30.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.011 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.736 HD12 ' HB ' ' A' ' 60' ' ' ILE . 63.8 mt -83.3 137.42 20.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.028 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.491 ' O ' HG13 ' A' ' 10' ' ' VAL . 44.5 mmm-85 -143.89 133.37 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.668 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.13 -134.45 1.73 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.527 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -142.96 128.64 19.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.391 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.57 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 63.7 m-80 52.63 41.47 31.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.139 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.412 HD21 HG22 ' A' ' 26' ' ' ILE . 10.0 mp -60.11 -39.47 86.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.745 0.307 . . . . 0.0 111.047 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.02 132.15 1.97 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.647 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.8 p -64.68 -36.42 84.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 0.0 111.212 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.34 174.52 37.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.424 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.49 -43.46 55.19 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.427 2.085 . . . . 0.0 112.087 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -61.04 -40.88 95.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.014 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.496 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 64.7 t0 -59.06 -48.66 80.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.663 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.441 HD11 HD13 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -71.18 128.31 35.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.962 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.535 HD13 ' HG2' ' A' ' 79' ' ' LYS . 38.4 pt -143.57 -39.94 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.945 0.402 . . . . 0.0 110.673 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -105.49 133.33 11.53 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.482 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.405 ' HB2' HD23 ' A' ' 49' ' ' LEU . 24.0 tp -150.25 149.39 30.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.689 0.28 . . . . 0.0 110.337 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.2 m -159.41 140.34 12.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 111.508 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.08 126.53 37.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.337 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.442 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 77.4 m 54.82 38.98 31.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.992 0.425 . . . . 0.0 110.545 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.35 27.99 71.61 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.427 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -131.0 132.91 45.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.685 0.279 . . . . 0.0 110.824 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -67.03 133.5 50.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.705 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.4 m -152.18 40.03 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.96 0.409 . . . . 0.0 110.86 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 3.3 tm? -81.52 -43.29 18.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.874 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.454 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -53.59 -38.75 64.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.818 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.9 p -79.88 -37.43 34.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.699 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.34 135.74 57.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.974 0.416 . . . . 0.0 112.025 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -126.45 132.35 51.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.359 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -66.29 151.78 46.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.412 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 55.0 mtt -149.83 -42.77 0.13 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.76 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 58' ' ' SER . 86.9 p -169.13 169.65 9.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.533 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.83 34.39 0.1 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.529 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 56' ' ' SER . 78.4 p -177.99 30.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.911 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.6 ttmt -165.04 130.12 2.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.791 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.736 ' HB ' HD12 ' A' ' 26' ' ' ILE . 72.3 mt -150.67 122.56 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.0 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 9.0 p -88.33 132.93 32.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.522 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 26.7 p -170.89 156.32 4.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.035 0.445 . . . . 0.0 111.4 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.408 HH11 ' HZ3' ' A' ' 21' ' ' TRP . 98.9 mtt180 -84.01 134.93 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.2 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.639 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.5 t . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.122 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -61.99 132.14 51.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.37 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.8 mt -85.45 92.5 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.165 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.9 mm -91.08 145.63 7.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.153 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.42 128.51 24.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.101 0.477 . . . . 0.0 111.058 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 m -100.63 143.78 30.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.239 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.4 p -130.59 140.76 50.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.562 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 8.0 mtpm? -56.94 -47.99 79.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.248 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 61.4 m -64.75 -54.81 25.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.946 0.403 . . . . 0.0 110.561 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.32 -125.03 1.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.127 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.43 -140.78 3.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.995 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.3 117.76 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.753 0.311 . . . . 0.0 110.375 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.65 -149.16 2.32 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.935 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 40.6 p -155.84 150.73 26.33 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.49 0.316 . . . . 0.0 110.392 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -157.26 127.61 6.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.968 0.413 . . . . 0.0 111.175 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.3 p -107.58 40.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.806 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.69 149.1 15.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.352 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 t -140.11 137.36 34.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.691 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.544 ' HD2' HG11 ' A' ' 64' ' ' VAL . 63.4 t80 -85.25 129.95 34.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.131 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -77.51 125.18 28.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.395 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.3 mt -92.49 124.55 36.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.163 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 19' ' ' ILE . 79.3 mt -89.47 135.25 33.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.641 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 53.3 mtmt -64.21 133.07 95.51 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.056 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 31.8 Cg_exo . . . . . 0 C--N 1.347 0.467 0 C-N-CA 122.538 2.159 . . . . 0.0 112.171 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.474 0.178 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.62 146.29 44.32 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.612 2.208 . . . . 0.0 112.436 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HG2' ' HA3' ' A' ' 84' ' ' GLY . 8.9 Cg_endo -50.62 144.68 24.84 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.982 2.455 . . . . 0.0 112.383 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.534 HD21 HG23 ' A' ' 87' ' ' THR . 2.1 tm? -141.68 119.95 12.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.208 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.565 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 92.7 t -77.37 134.66 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.618 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.459 HG23 HD12 ' A' ' 9' ' ' LEU . 61.3 p -148.0 44.51 1.07 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.206 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.34 145.12 5.65 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.063 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.7 tt -164.57 128.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.64 0.257 . . . . 0.0 110.44 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.829 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 48.0 t -67.14 -60.06 6.56 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.66 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.829 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 68.1 Cg_endo -91.99 114.38 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.149 1.899 . . . . 0.0 112.18 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -92.93 30.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 0.0 110.499 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.516 ' HB2' HD21 ' A' ' 93' ' ' LEU . 15.3 pt-20 178.08 131.21 0.07 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.446 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.8 144.6 4.27 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.067 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 93' ' ' LEU . 41.3 pt -59.42 161.54 10.2 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 121.969 0.107 . . . . 0.0 110.967 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.926 ' HA ' HG13 ' A' ' 64' ' ' VAL . 79.3 Cg_exo -47.92 -37.2 28.79 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.572 2.181 . . . . 0.0 113.036 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.09 -27.87 62.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.8 m -56.5 128.58 36.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 0.0 111.581 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.08 136.86 50.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.544 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.775 HG12 ' HG2' ' A' ' 15' ' ' PRO . 29.4 m -135.85 121.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.947 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.6 m -80.85 116.87 21.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.767 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 55.5 mt -77.42 141.22 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.581 HH11 ' HB2' ' A' ' 59' ' ' LYS . 25.8 mmm180 -146.9 131.01 17.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.411 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.28 -130.78 1.25 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.638 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -146.52 135.87 22.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 111.244 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.5 m-20 61.87 38.05 14.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.356 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.503 HD22 ' O ' ' A' ' 58' ' ' SER . 10.2 mp -84.14 51.01 1.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.951 0.405 . . . . 0.0 110.392 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 57' ' ' ALA . . . 70.87 118.78 0.04 OUTLIER Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.192 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.5 p -90.03 41.52 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 111.365 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.31 151.67 7.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.686 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.78 -43.07 62.72 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.473 2.115 . . . . 0.0 111.724 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.511 ' O ' ' HE2' ' A' ' 79' ' ' LYS . 2.5 t -61.79 -35.51 78.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.597 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.497 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 1.4 m-20 -51.93 -48.85 64.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.454 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.95 127.42 32.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.134 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.524 HD13 ' HD2' ' A' ' 79' ' ' LYS . 36.6 pt -147.26 20.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.094 0.474 . . . . 0.0 110.786 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 176.94 139.34 3.22 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.907 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 75' ' ' ILE . 18.1 tp -149.63 146.38 27.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.885 0.374 . . . . 0.0 111.023 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.408 ' OG1' ' HB ' ' A' ' 75' ' ' ILE . 20.5 p -151.15 134.47 16.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.181 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.684 HG21 HG23 ' A' ' 64' ' ' VAL . 64.7 mt -134.51 125.19 46.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.857 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 66.2 m 56.71 36.43 27.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.09 0.471 . . . . 0.0 109.991 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.99 33.69 87.93 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.891 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -130.78 131.27 44.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.713 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -67.7 131.78 46.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.638 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 71.8 m -153.09 39.01 0.51 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.88 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 69.3 tp -73.96 -47.07 40.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.286 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.466 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -52.3 -40.36 61.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.631 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.6 p -80.35 -33.37 37.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.292 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.571 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -52.74 134.4 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.767 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -126.67 130.24 50.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.669 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -71.95 147.43 46.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 96.1 mmm -138.89 -48.37 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.5 m -160.55 -175.03 4.76 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.645 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -78.52 36.23 0.25 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.983 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.503 ' O ' HD22 ' A' ' 31' ' ' LEU . 79.8 p -177.29 -43.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.754 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.581 ' HB2' HH11 ' A' ' 27' ' ' ARG . 24.6 ttmm -84.87 131.25 34.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.047 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.0 mt -149.97 113.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.682 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.432 HG23 ' HG3' ' A' ' 55' ' ' MET . 43.2 t -82.81 130.82 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.431 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.571 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.4 p -170.41 160.28 7.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.0 111.199 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -83.65 126.17 32.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.805 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.926 HG13 ' HA ' ' A' ' 20' ' ' PRO . 2.3 p . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.161 0.505 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.235 0 N-CA-C 112.189 -0.364 . . . . 0.0 112.189 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -74.76 140.19 43.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.838 0.352 . . . . 0.0 111.3 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.42 ' O ' HD13 ' A' ' 75' ' ' ILE . 76.9 mt -85.11 136.89 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.525 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.42 HD13 ' O ' ' A' ' 74' ' ' ILE . 49.8 mm -133.43 139.07 49.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.927 0.394 . . . . 0.0 111.624 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.35 126.87 45.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.69 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.7 m -96.73 138.8 33.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.712 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 82' ' ' GLY . 56.7 p -151.95 142.4 22.59 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.465 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.694 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -54.68 -30.49 55.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.665 0.269 . . . . 0.0 111.353 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -61.73 -57.19 12.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.608 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.45 -45.42 0.92 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.719 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 78' ' ' THR . . . 75.35 120.98 0.12 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.866 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.8 tttm 47.82 65.08 1.38 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.821 0.343 . . . . 0.0 111.047 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.425 ' HA3' ' HG2' ' A' ' 8' ' ' PRO . . . -64.88 -138.88 0.02 OUTLIER Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.88 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.6 p -151.06 -168.35 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.887 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.4 p -169.09 129.64 1.12 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.534 HG23 HD21 ' A' ' 9' ' ' LEU . 61.8 p -93.62 29.21 2.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.101 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 m -154.57 140.72 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.0 p -120.2 140.52 51.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.522 ' CD2' HG21 ' A' ' 64' ' ' VAL . 45.0 t80 -89.35 129.95 35.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.621 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -88.33 123.68 33.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.242 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.413 HD21 ' CG2' ' A' ' 64' ' ' VAL . 93.2 mt -88.02 130.64 34.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.079 0.466 . . . . 0.0 111.974 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.549 ' O ' HG22 ' A' ' 19' ' ' ILE . 84.0 mt -88.69 140.7 29.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.723 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.46 128.03 92.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.651 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 C--N 1.347 0.454 0 C-N-CA 122.511 2.14 . . . . 0.0 112.604 -179.84 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.407 ' HG3' ' HD2' ' A' ' 7' ' ' PRO . 65.5 tt0 . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.517 0.198 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.407 ' HD2' ' HG3' ' A' ' 6' ' ' GLN . 16.9 Cg_endo -56.99 149.42 62.12 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.632 2.222 . . . . 0.0 112.242 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HD3' ' H ' ' A' ' 82' ' ' GLY . 65.6 Cg_exo -51.9 137.09 52.48 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.54 2.16 . . . . 0.0 112.168 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 85' ' ' THR . 3.3 tt -133.78 117.87 17.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.354 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.565 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 95.2 t -82.17 135.82 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.184 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.447 HG23 HD22 ' A' ' 9' ' ' LEU . 80.7 p -147.01 41.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.798 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.29 148.49 7.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.713 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.519 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.1 tt -160.36 132.76 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.763 0.315 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.811 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 45.4 t -66.43 -59.9 7.56 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.661 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.811 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 86.4 Cg_endo -89.87 119.01 0.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.041 1.827 . . . . 0.0 112.389 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -77.54 -20.56 53.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.411 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.463 ' OE1' HD11 ' A' ' 93' ' ' LEU . 15.4 pt-20 -157.07 139.88 15.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.03 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.53 147.57 8.58 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.654 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 37.4 pt -55.16 161.91 2.34 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-O 120.547 0.213 . . . . 0.0 111.362 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.881 ' HA ' HG23 ' A' ' 64' ' ' VAL . 85.2 Cg_exo -47.52 -46.17 21.21 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.089 2.526 . . . . 0.0 114.097 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -73.11 -8.29 55.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 m -70.04 128.09 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.992 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 28.5 mtpp -75.65 124.02 26.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.549 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.726 HG12 ' HG2' ' A' ' 15' ' ' PRO . 30.7 m -113.03 121.25 64.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.966 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.5 m -78.4 118.77 20.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.038 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.3 mt -80.63 137.07 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.738 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 58' ' ' SER . 28.3 tpt180 -139.28 126.28 21.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.268 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -167.89 -132.91 1.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.613 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -146.96 137.88 23.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.852 0.358 . . . . 0.0 111.325 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 72.8 m-80 63.84 41.77 6.54 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.369 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 8.8 mp -90.08 46.38 1.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.991 0.424 . . . . 0.0 110.265 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.21 120.34 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.185 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.1 p -91.88 42.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.678 0.275 . . . . 0.0 111.195 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.72 147.76 6.13 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.705 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.13 -45.17 42.65 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.519 2.146 . . . . 0.0 111.716 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 t -62.45 -36.59 82.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.158 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -55.55 -46.09 77.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.975 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -65.83 134.22 52.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.017 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.476 ' N ' HD23 ' A' ' 38' ' ' LEU . 30.2 pt -140.74 -42.5 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.317 . . . . 0.0 111.219 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.455 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -111.17 136.87 13.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.405 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.58 HD13 ' N ' ' A' ' 42' ' ' THR . 1.5 tm? -147.59 127.41 13.49 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.58 ' N ' HD13 ' A' ' 41' ' ' LEU . 22.6 p -152.95 142.02 21.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.514 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.609 HG21 HG12 ' A' ' 64' ' ' VAL . 70.1 mt -137.37 124.76 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.867 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 78.0 m 58.24 38.69 26.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 110.156 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.44 33.35 86.08 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.877 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -131.12 133.46 45.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.771 0.32 . . . . 0.0 110.8 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -66.48 131.29 45.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.468 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.1 m -151.7 36.58 0.57 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.861 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.9 tp -75.72 -44.74 40.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.731 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -55.36 -39.33 69.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.9 p -79.93 -38.1 33.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.151 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -61.2 132.72 54.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.39 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -126.5 133.97 51.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.777 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -64.97 147.17 53.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.252 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 93.8 mmm -145.26 -42.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.407 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.764 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 54.7 m -161.59 157.47 24.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.911 0.386 . . . . 0.0 111.099 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 31' ' ' LEU . . . -50.39 -27.57 6.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.419 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.545 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 54.0 m -133.3 42.11 3.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.371 . . . . 0.0 110.719 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.764 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 60.5 tttm -164.5 128.14 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.868 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -149.97 118.07 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.506 ' CG1' ' HE3' ' A' ' 23' ' ' LYS . 50.1 t -84.46 130.46 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.553 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.547 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.4 p -170.07 131.67 1.03 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.791 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 22.3 ptt-85 -84.96 138.32 32.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.873 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.881 HG23 ' HA ' ' A' ' 20' ' ' PRO . 21.3 m . . . . . 0 CA--C 1.537 0.463 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.724 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.21 134.87 48.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.686 0.279 . . . . 0.0 111.179 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.559 ' O ' HD13 ' A' ' 75' ' ' ILE . 68.2 mt -85.42 134.15 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.474 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.559 HD13 ' O ' ' A' ' 74' ' ' ILE . 37.8 mm -132.97 133.98 58.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.145 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.739 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 53.4 t -141.51 114.37 4.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.825 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.0 m -81.0 142.17 33.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.522 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.5 p -141.93 140.19 32.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.86 0.362 . . . . 0.0 111.426 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.3 mmmm -57.02 -50.69 71.96 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.074 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.0 m -65.07 -53.33 47.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.974 0.416 . . . . 0.0 110.346 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.37 -123.33 0.5 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.148 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.507 ' H ' ' HD3' ' A' ' 8' ' ' PRO . . . -169.44 -141.15 3.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.195 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -62.11 130.08 43.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 110.748 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.739 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -69.69 150.05 48.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.083 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 47.3 p -149.09 145.99 27.5 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.535 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 48.1 t -158.29 134.13 9.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.11 0.481 . . . . 0.0 111.965 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -77.18 -33.41 56.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.517 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -83.74 139.08 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.371 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -120.38 140.27 51.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -86.22 132.75 33.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.721 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.494 ' HD3' HD21 ' A' ' 93' ' ' LEU . 31.7 ttmt -83.27 123.96 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.359 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.429 HD13 HG21 ' A' ' 64' ' ' VAL . 56.4 tp -99.06 121.11 40.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.871 0.367 . . . . 0.0 110.734 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 60.4 mt -96.39 139.6 32.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.651 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 61.1 pttt -59.84 134.57 89.72 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.417 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.531 ' HG3' ' HD2' ' A' ' 20' ' ' PRO . 48.1 Cg_exo . . . . . 0 C--N 1.347 0.479 0 C-N-CA 122.869 2.379 . . . . 0.0 112.806 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.631 0.253 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.27 145.7 73.07 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.449 2.1 . . . . 0.0 111.796 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.538 ' HG2' ' HA2' ' A' ' 84' ' ' GLY . 11.6 Cg_endo -55.93 120.88 8.99 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.367 2.045 . . . . 0.0 112.036 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 9' ' ' LEU . 5.7 tt -102.65 100.81 10.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.477 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.662 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 59.5 t -84.0 136.76 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.596 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -169.14 51.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.522 . . . . 0.0 111.188 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.03 141.48 7.01 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.417 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.534 HG12 ' HD2' ' A' ' 15' ' ' PRO . 13.9 tt -164.78 130.71 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.448 0.166 . . . . 0.0 110.662 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.771 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.3 t -59.97 -61.44 7.9 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.919 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 85.9 Cg_endo -83.91 -159.96 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.8 1.667 . . . . 0.0 111.104 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -175.25 24.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.111 0.482 . . . . 0.0 110.41 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HB2' HD11 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -179.33 127.33 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.155 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.479 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 165.47 151.35 6.62 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.847 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.403 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 33.7 pt -52.45 161.42 1.08 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.49 0.186 . . . . 0.0 110.986 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.757 ' HA ' HG23 ' A' ' 64' ' ' VAL . 73.7 Cg_exo -50.47 -40.72 53.81 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.694 2.263 . . . . 0.0 113.562 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.516 ' HE3' HH11 ' A' ' 63' ' ' ARG . 84.5 m95 -73.86 -5.8 43.25 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -64.96 129.47 39.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.362 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.07 137.27 51.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.586 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.493 HG21 HG13 ' A' ' 64' ' ' VAL . 34.6 m -144.84 130.59 14.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.973 0.416 . . . . 0.0 110.975 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.6 m -87.67 117.46 26.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.949 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.1 mt -80.38 137.91 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.754 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.611 ' NH1' ' HB2' ' A' ' 59' ' ' LYS . 25.9 mmm180 -139.72 137.59 35.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.949 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.14 -135.54 2.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.368 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 55.9 mm-40 -151.24 138.06 18.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.825 0.345 . . . . 0.0 111.286 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 29.9 m120 62.59 38.79 12.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.288 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.566 HD23 HD12 ' A' ' 60' ' ' ILE . 9.5 mp -81.67 51.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.872 0.368 . . . . 0.0 111.063 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.429 ' HA2' ' OD2' ' A' ' 37' ' ' ASP . . . 76.5 134.56 0.56 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.893 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.5 p -59.75 -35.38 74.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.617 0.246 . . . . 0.0 111.314 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.58 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -168.24 -159.22 13.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.123 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.21 -46.36 15.63 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.954 2.436 . . . . 0.0 112.792 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 p -60.65 -41.22 94.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.511 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.429 ' OD2' ' HA2' ' A' ' 32' ' ' GLY . 64.9 t0 -66.33 -48.09 71.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.819 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.6 tt -64.63 130.75 44.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.989 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.504 ' N ' HD23 ' A' ' 38' ' ' LEU . 25.0 pt -149.36 -43.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.457 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -93.94 52.54 2.25 Favored Glycine 0 CA--C 1.51 -0.24 0 C-N-CA 120.494 -0.86 . . . . 0.0 114.149 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.554 HD13 ' N ' ' A' ' 42' ' ' THR . 2.7 tm? -70.23 127.25 32.14 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.69 HG22 ' HA ' ' A' ' 47' ' ' ASN . 6.9 p -155.58 144.96 20.98 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.153 0.502 . . . . 0.0 111.987 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.7 mt -137.66 123.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.527 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.458 ' HG ' ' N ' ' A' ' 72' ' ' GLY . 60.3 m 57.64 36.37 26.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.099 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.46 -36.36 2.95 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.637 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -72.87 131.94 42.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.02 0.41 . . . . 0.0 111.398 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.69 ' HA ' HG22 ' A' ' 42' ' ' THR . 16.2 p-10 -72.56 141.78 48.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.433 ' C ' HD12 ' A' ' 41' ' ' LEU . 76.4 m -149.2 42.56 0.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.519 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 41' ' ' LEU . 33.0 tp -69.18 -44.47 72.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.19 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 51' ' ' THR . 3.6 pp -63.94 -34.48 78.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.173 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.729 ' N ' HD12 ' A' ' 50' ' ' LEU . 20.3 p -79.92 -38.17 33.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.821 0.343 . . . . 0.0 111.281 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -66.21 137.88 57.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.934 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -126.32 128.48 47.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.247 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.58 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 82.0 t90 -65.4 149.77 49.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.225 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.44 ' HG3' HG23 ' A' ' 61' ' ' VAL . 93.4 mmm -142.6 -43.81 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 58' ' ' SER . 48.7 m -155.83 178.02 10.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.674 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.2 37.21 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.564 ' O ' HD22 ' A' ' 31' ' ' LEU . 80.7 p -178.81 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.176 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.611 ' HB2' ' NH1' ' A' ' 27' ' ' ARG . 63.0 tttp -83.96 132.52 34.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.566 HD12 HD23 ' A' ' 31' ' ' LEU . 74.5 mt -148.62 115.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.668 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.44 HG23 ' HG3' ' A' ' 55' ' ' MET . 40.2 t -84.55 122.75 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.681 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 41.9 t -171.02 146.11 2.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.036 0.446 . . . . 0.0 111.179 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.516 HH11 ' HE3' ' A' ' 21' ' ' TRP . 98.9 mtt180 -85.19 134.09 34.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.207 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.757 HG23 ' HA ' ' A' ' 20' ' ' PRO . 19.4 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.599 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.871 ' HA3' ' HB2' ' A' ' 89' ' ' SER . . . . . . . . 0 CA--C 1.517 0.217 0 N-CA-C 113.957 0.343 . . . . 0.0 113.957 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -45.16 127.49 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.373 . . . . 0.0 111.586 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.508 ' C ' HD12 ' A' ' 75' ' ' ILE . 68.0 mt -115.47 117.93 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.134 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.809 HG21 ' HE3' ' A' ' 83' ' ' LYS . 3.1 mp -120.98 137.5 54.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.37 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.725 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 3.8 p -141.76 103.58 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.829 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -77.31 131.94 38.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.657 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 82.4 p -123.15 142.32 51.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.091 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -50.78 -48.04 59.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.5 m -69.44 -48.48 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.981 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.83 -128.52 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.615 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.4 -40.99 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.344 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.809 ' HE3' HG21 ' A' ' 75' ' ' ILE . 49.6 tptt -169.72 127.45 0.91 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.76 0.314 . . . . 0.0 110.631 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.725 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -74.02 145.5 35.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.967 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.1 p -143.58 138.63 29.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.597 0.237 . . . . 0.0 110.52 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.662 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 45.2 t -133.13 129.81 38.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.019 0.438 . . . . 0.0 111.493 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.6 p -74.02 -32.43 63.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.573 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -83.88 176.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.372 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.871 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 72.5 p -157.44 133.2 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.649 ' CD2' HG11 ' A' ' 64' ' ' VAL . 69.0 t80 -85.62 127.32 34.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.815 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -85.04 122.31 29.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 110.607 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.522 ' N ' HD22 ' A' ' 92' ' ' LEU . 2.9 mm? -82.21 129.73 34.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.929 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.479 HD12 ' HA2' ' A' ' 18' ' ' GLY . 80.2 mt -100.59 138.94 36.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.6 139.48 96.0 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.039 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.518 2.145 . . . . 0.0 112.045 179.64 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.599 0.238 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.22 144.28 95.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.614 2.21 . . . . 0.0 112.153 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 51.8 Cg_exo -51.86 133.49 45.63 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.524 2.149 . . . . 0.0 112.185 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.55 HD22 HG23 ' A' ' 11' ' ' THR . 3.3 tt -123.56 118.0 26.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.236 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.514 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 62.8 t -81.34 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.285 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.55 HG23 HD22 ' A' ' 9' ' ' LEU . 71.4 p -147.0 45.2 1.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.033 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.407 ' C ' ' HB3' ' A' ' 27' ' ' ARG . . . 178.0 147.51 6.92 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.206 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.51 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.3 tt -160.98 130.42 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.728 0.299 . . . . 0.0 110.499 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.823 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.9 t -68.76 -58.2 7.05 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.685 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.823 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 68.8 Cg_endo -93.03 115.14 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.278 1.985 . . . . 0.0 112.592 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -96.96 27.79 3.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 0.0 110.61 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HB2' HD21 ' A' ' 93' ' ' LEU . 23.8 pt-20 -179.67 130.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.17 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.537 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 171.88 146.03 5.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.828 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.471 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 29.1 pt -54.17 162.81 1.4 Allowed Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 120.486 0.184 . . . . 0.0 111.28 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 19' ' ' ILE . 85.2 Cg_exo -48.16 -37.87 31.79 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.822 2.348 . . . . 0.0 113.653 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -77.71 -15.71 58.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -60.64 124.71 21.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.678 0.275 . . . . 0.0 111.195 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 25.5 pttm -77.18 127.08 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 0.0 110.431 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.799 HG12 ' HG2' ' A' ' 15' ' ' PRO . 16.6 m -109.45 125.64 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.556 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 84.9 m -72.42 120.88 18.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.82 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.511 HD12 ' HB ' ' A' ' 60' ' ' ILE . 65.5 mt -80.96 139.01 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.002 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 58' ' ' SER . 27.8 tpt180 -147.42 127.3 13.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.894 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.17 -134.58 1.75 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.959 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -149.5 137.55 20.5 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.921 0.391 . . . . 0.0 111.579 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 73.6 m-20 60.61 40.6 16.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.578 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.499 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.2 mp -84.49 53.5 2.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.863 0.363 . . . . 0.0 110.597 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.51 129.32 0.43 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.539 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.4 p -97.91 42.56 1.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 0.0 111.369 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.97 142.21 3.98 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.699 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.528 ' HG3' ' CE3' ' A' ' 54' ' ' TRP . 36.0 Cg_exo -56.56 -47.25 24.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.519 2.146 . . . . 0.0 112.116 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.4 p -65.28 -33.97 77.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.421 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -51.29 -42.88 61.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.997 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.2 tt -65.92 127.12 30.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 40' ' ' GLY . 32.9 pt -134.43 -44.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 111.32 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.5 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -100.86 136.46 12.71 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.463 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.555 HD13 ' N ' ' A' ' 42' ' ' THR . 2.2 tm? -148.8 126.67 11.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 47' ' ' ASN . 7.1 p -155.34 141.75 18.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.161 0.505 . . . . 0.0 111.873 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.8 HG21 HG23 ' A' ' 64' ' ' VAL . 76.5 mt -129.97 124.0 57.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.401 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.528 ' SG ' ' HA2' ' A' ' 72' ' ' GLY . 63.0 m 55.4 39.45 31.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.11 -32.92 2.23 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.894 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -72.53 129.75 39.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 0.0 111.127 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.663 ' HA ' HG22 ' A' ' 42' ' ' THR . 5.4 m120 -70.44 140.41 51.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.844 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.429 ' C ' HD12 ' A' ' 41' ' ' LEU . 75.1 m -150.39 40.36 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.4 tp -72.38 -43.88 63.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.321 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.434 ' H ' HD23 ' A' ' 50' ' ' LEU . 2.6 pt? -56.39 -38.63 71.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.4 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.0 p -79.84 -36.43 36.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.352 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -59.63 132.98 55.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.561 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -126.92 126.46 43.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.537 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.528 ' CE3' ' HG3' ' A' ' 35' ' ' PRO . 79.6 t90 -69.44 152.85 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.326 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 49.1 mtt -147.56 -44.38 0.17 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.025 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.2 p -169.58 173.57 6.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.637 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.93 37.31 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.524 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.491 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 79.0 p -176.68 24.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.087 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 59.4 tttp -165.31 128.83 2.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.138 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' HB ' HD12 ' A' ' 26' ' ' ILE . 73.4 mt -152.2 119.55 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.655 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.37 134.15 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.616 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.544 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.8 p -169.57 146.2 3.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.845 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.672 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 68.3 mtt-85 -84.03 131.64 34.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.8 HG23 HG21 ' A' ' 43' ' ' ILE . 8.4 p . . . . . 0 CA--C 1.54 0.582 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.085 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.528 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . . . . . . 0 CA--C 1.518 0.244 0 N-CA-C 112.843 -0.103 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -73.24 130.93 41.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 111.328 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.502 ' O ' HD13 ' A' ' 75' ' ' ILE . 70.4 mt -85.59 135.2 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.226 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.502 HD13 ' O ' ' A' ' 74' ' ' ILE . 40.0 mm -131.55 137.02 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.798 0.332 . . . . 0.0 111.703 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.4 t -141.53 117.84 6.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.937 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -86.05 147.33 26.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.347 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.9 p -139.44 143.7 37.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.4 mmmm -53.97 -55.06 30.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.365 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.1 t -67.65 -55.43 13.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.002 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.28 -128.65 0.38 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.644 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 -137.3 2.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.999 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -65.12 121.4 14.64 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.5 126.78 8.74 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.893 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 73.1 p -99.43 144.05 28.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.412 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 80.9 p -131.98 126.79 34.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.581 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.9 p -91.65 35.75 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.604 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.49 156.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.67 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.5 p -138.53 134.63 34.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.946 0.403 . . . . 0.0 111.192 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.651 ' HE2' HG11 ' A' ' 64' ' ' VAL . 39.3 t80 -86.06 131.42 34.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.347 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -83.93 124.79 31.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.062 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.2 mt -90.0 127.71 36.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 111.647 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 18' ' ' GLY . 78.3 mt -92.56 139.98 30.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.372 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -56.52 126.89 71.31 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.949 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo . . . . . 0 C--N 1.347 0.496 0 C-N-CA 122.869 2.379 . . . . 0.0 112.922 -179.854 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 120.663 0.268 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.71 148.59 36.94 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.755 2.303 . . . . 0.0 112.375 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.48 142.85 99.58 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.635 2.223 . . . . 0.0 112.054 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.518 HD13 ' C ' ' A' ' 9' ' ' LEU . 3.3 tm? -140.38 119.83 13.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.499 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.1 t -83.58 142.55 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.986 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 t -167.99 49.02 0.05 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.037 0.446 . . . . 0.0 111.363 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.13 138.5 3.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.698 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.518 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.7 tt -165.24 130.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 0.0 110.604 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.818 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.6 t -65.46 -59.38 9.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.692 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.818 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 83.7 Cg_endo -90.58 111.72 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.164 1.909 . . . . 0.0 112.155 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -89.33 26.81 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.595 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 176.22 132.25 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.261 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.73 144.22 4.64 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.905 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.429 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 33.1 pt -56.7 160.77 5.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.496 0.189 . . . . 0.0 111.02 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.744 ' HA ' HG13 ' A' ' 64' ' ' VAL . 84.8 Cg_exo -47.07 -45.15 22.02 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.812 2.342 . . . . 0.0 113.544 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -67.2 -22.43 65.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.2 m -62.61 128.21 34.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.136 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 24.7 ttmm -73.83 138.18 44.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.622 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.691 HG12 ' HG2' ' A' ' 15' ' ' PRO . 35.0 m -132.23 125.28 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.002 0.43 . . . . 0.0 111.032 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -85.57 118.8 25.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.097 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.4 mt -83.92 137.16 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.431 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -147.66 135.76 21.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.827 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.93 -126.6 0.85 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.21 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -145.18 134.85 23.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.329 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 60.97 42.21 13.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.079 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 mp -83.91 54.93 3.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.964 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.21 134.19 1.9 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.76 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.6 p -67.4 -40.81 85.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.63 0.252 . . . . 0.0 111.62 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.552 ' HA2' ' CZ2' ' A' ' 54' ' ' TRP . . . -156.52 -177.92 30.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.755 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.85 -40.27 79.94 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.638 2.225 . . . . 0.0 112.042 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.8 p -59.95 -41.35 91.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.983 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 37.7 t70 -66.82 -46.88 73.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.898 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.511 ' C ' HD13 ' A' ' 38' ' ' LEU . 3.4 tm? -69.85 129.0 38.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.923 0.392 . . . . 0.0 110.347 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.501 HD13 ' HG2' ' A' ' 79' ' ' LYS . 49.8 pt -147.96 -23.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.422 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.91 128.72 6.98 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.848 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' A' ' 52' ' ' ALA . 31.4 tp -150.41 147.15 27.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.64 0.257 . . . . 0.0 110.558 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 46' ' ' HIS . 98.2 m -161.69 129.28 4.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.396 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.514 HD11 ' SG ' ' A' ' 62' ' ' CYS . 70.8 mt -105.34 130.52 56.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.449 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 79.7 m 69.26 -66.42 0.26 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.53 0.519 . . . . 0.0 110.971 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.65 26.13 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.493 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.56 ' O ' HG23 ' A' ' 42' ' ' THR . 83.1 t60 -132.18 135.76 46.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.585 0.231 . . . . 0.0 110.707 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -59.29 136.83 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.772 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.7 m -151.45 36.28 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.102 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 49.5 tp -70.3 -44.69 67.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.964 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.451 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -54.12 -40.77 67.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.049 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.3 p -80.38 -32.67 37.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.04 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.15 133.27 55.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.087 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -127.14 127.1 44.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.129 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.552 ' CZ2' ' HA2' ' A' ' 34' ' ' GLY . 43.4 t90 -67.4 149.09 50.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 110.702 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.688 ' HG3' HG23 ' A' ' 61' ' ' VAL . 94.5 mmm -143.26 -43.13 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.2 t -166.86 172.84 9.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.846 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.58 25.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.641 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.8 m -167.78 21.35 0.03 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.696 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.579 ' HB2' ' NZ ' ' A' ' 59' ' ' LYS . 5.0 ttmp? -165.1 134.87 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.3 mt -146.86 121.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.688 HG23 ' HG3' ' A' ' 55' ' ' MET . 60.7 t -80.89 125.7 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.513 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.1 p -170.42 140.56 1.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.021 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 84.4 mtm180 -84.33 136.79 33.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.634 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.744 HG13 ' HA ' ' A' ' 20' ' ' PRO . 4.8 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.395 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.311 -0.315 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -62.76 130.91 47.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 71.8 mt -85.3 131.58 33.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.468 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.0 mm -128.88 139.55 51.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.229 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.78 121.65 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.8 m -98.09 133.9 41.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.509 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 81.6 p -118.52 142.21 47.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.178 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 37' ' ' ASP . 29.4 mtpp -54.02 -44.88 71.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.633 0.254 . . . . 0.0 110.982 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.9 m -66.81 -47.13 72.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.984 0.421 . . . . 0.0 109.957 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.42 -132.53 1.69 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.47 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . 172.81 67.41 0.05 OUTLIER Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.247 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 82' ' ' GLY . 59.2 tttm 67.98 109.28 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.881 0.372 . . . . 0.0 110.439 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.06 -134.32 6.44 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.856 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.427 ' OG1' HD23 ' A' ' 9' ' ' LEU . 74.4 p -145.99 -168.26 2.94 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.578 0.227 . . . . 0.0 110.626 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 78.4 p -169.47 125.35 0.86 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 111.151 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.9 p -90.53 28.37 1.5 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.708 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 m -153.58 149.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.999 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.8 m -134.56 134.86 41.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -85.5 127.67 34.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -81.08 117.15 21.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.553 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.586 HD13 ' N ' ' A' ' 93' ' ' LEU . 1.5 tm? -81.16 128.47 33.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.523 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.586 ' N ' HD13 ' A' ' 92' ' ' LEU . 80.8 mt -99.65 133.51 43.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.845 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -68.05 134.1 91.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.661 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--N 1.347 0.484 0 C-N-CA 122.368 2.046 . . . . 0.0 112.349 -179.995 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.651 0.263 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.82 146.59 66.24 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.658 2.239 . . . . 0.0 112.206 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 18.0 Cg_endo -58.31 129.61 33.62 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.596 2.198 . . . . 0.0 112.3 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 85' ' ' THR . 63.2 tp -113.33 119.84 39.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.071 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.43 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 69.7 t -85.29 132.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.069 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.9 p -151.57 47.91 0.81 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.51 144.57 6.43 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.869 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.567 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 13.0 tt -158.95 131.01 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.882 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 53.2 m -60.88 -60.69 9.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.565 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 1.001 ' HG2' HG12 ' A' ' 24' ' ' VAL . 3.7 Cg_exo -75.83 -150.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.954 1.769 . . . . 0.0 111.796 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.515 ' OD1' ' HG2' ' A' ' 17' ' ' GLU . 5.3 p30 -173.94 -22.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.024 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.515 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 16.2 pt-20 -159.51 129.38 5.52 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.685 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 169.69 159.81 16.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.56 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.405 HG21 ' HA ' ' A' ' 95' ' ' PRO . 35.6 pt -51.64 156.75 2.14 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.613 0.244 . . . . 0.0 111.03 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.853 ' HA ' HG23 ' A' ' 64' ' ' VAL . 75.8 Cg_exo -51.88 -41.07 65.16 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.742 2.295 . . . . 0.0 113.496 -179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -70.67 -5.79 32.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -64.02 131.0 46.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.998 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.736 ' HD2' HG13 ' A' ' 61' ' ' VAL . 17.3 tppt? -65.99 136.97 56.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.283 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.001 HG12 ' HG2' ' A' ' 15' ' ' PRO . 26.3 m -141.45 131.34 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.007 0.432 . . . . 0.0 111.309 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.416 ' HB ' ' OG ' ' A' ' 14' ' ' SER . 99.7 m -90.3 122.53 33.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.663 HD12 ' HB ' ' A' ' 60' ' ' ILE . 64.1 mt -79.41 141.5 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.782 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.403 ' HG2' HH11 ' A' ' 27' ' ' ARG . 12.2 tpt180 -147.56 131.39 17.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.318 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.87 -135.62 1.95 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.663 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 67.0 mm-40 -145.93 135.86 23.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.842 0.353 . . . . 0.0 111.44 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.474 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 72.8 m-80 61.59 40.59 13.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.351 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 mp -83.57 49.05 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.704 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.72 124.24 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.476 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.8 p -88.29 39.25 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.763 0.316 . . . . 0.0 111.362 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.36 147.47 5.07 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.594 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.92 -41.6 62.54 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.334 2.023 . . . . 0.0 111.77 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.9 p -61.17 -34.67 75.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.771 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.94 46.09 0.56 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.815 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 40' ' ' GLY . 1.9 tt -157.4 121.9 4.35 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.409 HD13 ' CD ' ' A' ' 79' ' ' LYS . 29.0 pt -144.21 33.16 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.989 0.423 . . . . 0.0 111.424 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.453 ' H ' HD23 ' A' ' 38' ' ' LEU . . . -174.04 128.5 1.48 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.39 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.685 HD13 ' N ' ' A' ' 42' ' ' THR . 1.2 tm? -150.56 134.0 16.4 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.685 ' N ' HD13 ' A' ' 41' ' ' LEU . 94.0 m -158.33 128.08 5.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.079 0.466 . . . . 0.0 111.746 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.651 HG21 ' HA ' ' A' ' 64' ' ' VAL . 41.1 mm -115.72 126.09 73.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.387 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.468 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 69.7 m 57.68 45.79 18.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.789 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.94 11.65 32.2 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.975 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.479 ' C ' HG23 ' A' ' 42' ' ' THR . 82.1 t60 -116.07 133.12 56.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.328 . . . . 0.0 111.026 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.13 133.29 54.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.987 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.1 m -153.35 39.01 0.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.669 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.1 tp -72.27 -41.97 66.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.459 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 51' ' ' THR . 3.9 pp -58.07 -33.51 69.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.501 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.7 ' N ' HD12 ' A' ' 50' ' ' LEU . 20.3 p -80.03 -37.7 33.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.766 0.317 . . . . 0.0 110.99 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.577 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -59.82 131.13 49.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.735 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -127.21 127.58 44.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.262 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -65.62 141.53 58.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.739 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 95.3 mmm -132.23 -42.65 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.139 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 m -160.93 -166.34 1.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.998 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.04 -7.53 54.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.478 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.4 m -156.23 47.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.078 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 87.3 tttt -164.44 129.11 2.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.9 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.663 ' HB ' HD12 ' A' ' 26' ' ' ILE . 76.2 mt -150.21 126.91 2.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.968 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.736 HG13 ' HD2' ' A' ' 23' ' ' LYS . 89.1 t -84.58 127.89 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.535 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.5 p -170.67 145.09 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.815 0.34 . . . . 0.0 111.198 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -84.63 131.63 34.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.341 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.853 HG23 ' HA ' ' A' ' 20' ' ' PRO . 15.3 m . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.421 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.405 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -57.87 132.16 52.55 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.01 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.4 mt -86.77 121.18 37.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.748 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.9 mm -111.62 138.97 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.307 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.458 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 62.0 t -141.39 110.64 2.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.901 0.382 . . . . 0.0 111.095 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.7 m -79.73 143.39 34.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.823 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.5 p -136.86 139.74 41.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.893 0.377 . . . . 0.0 111.369 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.409 ' CD ' HD13 ' A' ' 39' ' ' ILE . 32.0 mmmt -56.78 -47.43 80.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.055 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.7 m -67.25 -52.83 36.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.607 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 -125.14 2.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.068 -0.586 . . . . 0.0 112.411 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 -134.97 1.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.18 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -60.58 125.46 23.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 0.0 110.524 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.458 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -72.92 130.7 14.48 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.217 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 74.3 p -100.47 147.47 25.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.586 0.232 . . . . 0.0 110.773 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -159.88 125.74 4.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.32 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.7 p -99.0 40.73 1.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.522 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.4 m -147.97 157.34 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.798 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.2 p -150.74 139.24 20.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.542 ' CE2' HG21 ' A' ' 64' ' ' VAL . 68.9 t80 -84.83 127.24 34.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.163 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -72.4 120.26 17.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.338 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.9 mt -90.19 128.95 36.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.285 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.411 HD12 ' HA2' ' A' ' 18' ' ' GLY . 67.1 mt -105.55 140.11 39.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.631 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -58.51 140.22 84.76 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.405 ' HA ' HG21 ' A' ' 19' ' ' ILE . 52.0 Cg_exo . . . . . 0 C--N 1.347 0.496 0 C-N-CA 122.534 2.156 . . . . 0.0 112.598 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 . . . . . 0 CA--C 1.527 0.096 0 CA-C-O 120.524 0.202 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.72 141.78 38.32 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.51 2.14 . . . . 0.0 112.407 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 16.6 Cg_endo -57.57 143.46 94.65 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.735 2.29 . . . . 0.0 112.288 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 10' ' ' VAL . 1.9 tm? -132.12 122.47 25.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.248 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.511 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 63.7 t -83.04 137.65 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.624 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.409 HG23 HD12 ' A' ' 9' ' ' LEU . 68.9 p -148.94 45.6 1.0 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.94 146.34 6.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.126 -1.035 . . . . 0.0 113.449 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.1 tt -163.59 128.32 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.677 0.275 . . . . 0.0 110.308 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.869 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 59.1 m -68.48 -60.05 5.21 Favored Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.717 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.919 ' HG2' HG12 ' A' ' 24' ' ' VAL . 70.1 Cg_endo -95.24 106.74 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.399 2.066 . . . . 0.0 112.157 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -91.07 32.31 1.03 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.562 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 179.31 128.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.36 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 169.03 149.45 6.23 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.593 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.3 pt -54.01 160.07 2.49 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.538 0.209 . . . . 0.0 111.04 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.632 ' HA ' HG23 ' A' ' 64' ' ' VAL . 86.1 Cg_exo -49.26 -38.65 42.26 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.889 2.393 . . . . 0.0 113.651 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -75.8 -14.5 60.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 m -63.58 127.92 33.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 111.536 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 54.1 mtmt -74.97 134.65 41.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.324 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.919 HG12 ' HG2' ' A' ' 15' ' ' PRO . 28.4 m -123.41 128.57 74.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.941 0.4 . . . . 0.0 111.339 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.6 m -73.67 117.05 14.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.764 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 60' ' ' ILE . 67.9 mt -86.99 136.08 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.063 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.478 ' HE ' ' HG3' ' A' ' 59' ' ' LYS . 21.0 mmt85 -146.5 134.96 21.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.601 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.03 -130.99 1.27 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.466 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -146.49 132.48 19.21 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.855 0.36 . . . . 0.0 111.343 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.519 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.1 m-80 61.27 41.76 12.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.136 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.587 HD22 ' O ' ' A' ' 58' ' ' SER . 10.0 mp -81.86 53.33 2.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.978 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.99 134.32 1.22 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.639 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 p -66.47 -37.47 85.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.665 0.269 . . . . 0.0 111.537 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.42 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -154.79 -174.4 24.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.008 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.77 -43.93 15.0 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.737 2.291 . . . . 0.0 112.567 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.0 p -56.36 -40.63 74.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.828 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 79' ' ' LYS . 37.7 t70 -66.28 -36.86 84.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.736 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.2 tp -74.61 63.06 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.513 ' O ' HD22 ' A' ' 49' ' ' LEU . 32.5 pt -73.0 -37.14 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.158 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -113.51 142.27 17.36 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.037 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.646 HD13 ' N ' ' A' ' 42' ' ' THR . 3.0 tm? -149.62 134.71 18.06 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.646 ' N ' HD13 ' A' ' 41' ' ' LEU . 18.5 p -150.31 151.16 32.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.079 0.466 . . . . 0.0 111.832 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 77.2 mt -136.15 117.49 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.328 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 85.3 m 73.78 -38.3 0.4 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.468 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 168.33 -40.1 0.22 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.962 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -80.24 140.68 36.14 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.92 0.39 . . . . 0.0 111.763 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.541 ' HA ' HG22 ' A' ' 42' ' ' THR . 15.1 t-20 -59.8 144.59 48.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.965 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.5 m -149.96 38.28 0.74 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.08 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.513 HD22 ' O ' ' A' ' 39' ' ' ILE . 52.8 tp -73.84 -47.67 36.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.237 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.492 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.3 pt? -48.41 -44.44 35.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.727 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.674 HG21 ' HE ' ' A' ' 63' ' ' ARG . 52.9 p -80.12 -37.87 32.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.722 0.296 . . . . 0.0 111.349 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -60.23 137.16 58.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.491 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -126.76 130.72 50.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.506 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.42 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 55.7 t90 -66.53 150.83 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.223 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.8 mmt -141.2 -47.49 0.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.902 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.2 t -166.41 -175.1 3.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.401 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.73 38.23 0.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.756 0.312 . . . . 0.0 111.169 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.587 ' O ' HD22 ' A' ' 31' ' ' LEU . 80.4 p -175.87 -43.54 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.478 ' HG3' ' HE ' ' A' ' 27' ' ' ARG . 61.9 tttm -82.87 131.94 35.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.227 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 77.2 mt -151.78 105.92 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.598 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -80.25 130.67 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.825 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 31.7 t -170.82 141.33 1.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 111.407 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.674 ' HE ' HG21 ' A' ' 51' ' ' THR . 40.1 ptt180 -85.35 131.88 34.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.392 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.632 HG23 ' HA ' ' A' ' 20' ' ' PRO . 27.0 m . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.732 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.191 0 N-CA-C 112.717 -0.153 . . . . 0.0 112.717 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -63.81 128.63 36.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.928 0.394 . . . . 0.0 111.219 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.528 ' O ' HD13 ' A' ' 75' ' ' ILE . 68.5 mt -85.76 130.74 35.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.326 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.882 HG21 ' HE2' ' A' ' 83' ' ' LYS . 34.5 mm -134.19 145.77 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 111.449 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.2 p -139.55 128.36 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.833 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.5 m -93.61 143.79 25.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.403 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.8 p -137.0 137.42 39.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.541 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 7.5 mtpm? -55.65 -48.26 75.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.4 m -65.87 -55.46 16.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.928 0.394 . . . . 0.0 110.382 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.0 -123.64 0.72 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.161 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.82 -143.04 3.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.005 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.882 ' HE2' HG21 ' A' ' 75' ' ' ILE . 19.7 tptm -69.18 109.72 4.21 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.94 -161.25 7.28 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.181 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.43 ' HA ' ' CD1' ' A' ' 75' ' ' ILE . 44.0 p -154.29 -169.03 3.11 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.427 0.291 . . . . 0.0 110.451 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.511 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 45.4 t -171.16 131.86 0.8 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.755 0.312 . . . . 0.0 111.243 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.7 p -90.49 31.68 1.01 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.78 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.4 m -152.03 142.48 15.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.922 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.3 p -125.07 133.72 52.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.72 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.506 ' CE2' HG21 ' A' ' 64' ' ' VAL . 69.5 t80 -85.77 128.08 34.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.866 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -82.48 123.13 28.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.572 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.8 mt -81.84 128.8 34.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.152 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.47 HD12 ' HA2' ' A' ' 18' ' ' GLY . 79.1 mt -98.89 133.38 43.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.724 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 31.0 mmmt -74.37 134.74 76.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 51.9 Cg_exo . . . . . 0 C--N 1.346 0.429 0 C-N-CA 122.53 2.153 . . . . 0.0 112.352 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.622 0.249 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.451 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 50.9 Cg_exo -54.68 141.08 76.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.626 2.217 . . . . 0.0 112.289 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 48.0 Cg_exo -56.52 137.98 82.66 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.515 2.143 . . . . 0.0 112.148 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 85' ' ' THR . 3.5 tt -130.39 113.25 14.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.107 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.555 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 90.3 t -81.01 135.69 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.421 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.7 p -146.67 42.5 1.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.14 144.74 5.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.75 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.536 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.0 tt -163.07 130.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.62 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.827 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 50.4 m -65.64 -58.94 10.3 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.068 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.827 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 90.9 Cg_endo -95.0 119.99 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.575 2.183 . . . . 0.0 112.478 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -92.92 21.17 5.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.887 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 178.64 135.58 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.655 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.403 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 167.35 145.44 4.5 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.94 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 93' ' ' LEU . 33.4 pt -54.97 159.79 3.51 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 110.723 -0.103 . . . . 0.0 110.723 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.908 ' HA ' HG23 ' A' ' 64' ' ' VAL . 73.7 Cg_exo -48.67 -39.93 38.11 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.574 2.183 . . . . 0.0 113.099 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.406 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 60.4 m95 -69.92 -21.19 63.31 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.6 m -60.94 129.83 43.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 111.452 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.549 ' HD2' HG13 ' A' ' 61' ' ' VAL . 4.5 tppp? -70.34 140.59 52.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.422 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.702 HG12 ' HG2' ' A' ' 15' ' ' PRO . 19.6 m -136.66 133.15 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.2 m -88.13 110.59 20.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.782 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.406 HD11 ' SG ' ' A' ' 62' ' ' CYS . 59.6 mt -75.95 138.8 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.466 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.517 ' O ' HG13 ' A' ' 10' ' ' VAL . 22.2 tpp180 -147.11 128.99 15.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.385 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.77 -136.22 2.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.62 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -148.57 138.41 22.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.941 0.4 . . . . 0.0 111.197 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 62.92 41.18 8.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.289 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.576 HD23 HD12 ' A' ' 60' ' ' ILE . 9.8 mp -85.47 52.07 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.495 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.85 125.14 0.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.305 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -91.92 39.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.753 0.311 . . . . 0.0 111.493 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.54 144.74 4.37 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.599 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.88 -43.5 58.74 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.491 2.128 . . . . 0.0 111.997 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.8 p -61.75 -37.48 84.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.193 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 32.7 m-20 -57.1 -44.1 82.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.484 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.445 HD11 HD13 ' A' ' 60' ' ' ILE . 1.2 tt -73.9 67.74 1.26 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.74 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.509 HD13 ' HG2' ' A' ' 79' ' ' LYS . 26.6 pt -75.92 -39.53 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.675 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -114.31 139.17 15.42 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.219 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.576 HD13 ' N ' ' A' ' 42' ' ' THR . 3.0 tm? -150.13 130.11 13.44 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.576 ' N ' HD13 ' A' ' 41' ' ' LEU . 36.2 p -151.61 137.08 17.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 111.748 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.1 mt -125.28 126.13 70.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.648 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.508 ' SG ' HD21 ' A' ' 92' ' ' LEU . 69.5 m 58.19 38.37 26.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.018 0.437 . . . . 0.0 110.335 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.07 34.28 89.49 Favored Glycine 0 C--N 1.331 0.285 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.171 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -131.34 133.38 45.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 0.0 110.556 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.491 ' HA ' HG22 ' A' ' 42' ' ' THR . 45.7 t30 -68.56 132.94 47.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.051 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.0 m -154.64 36.67 0.41 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.628 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 3.3 tm? -77.51 -46.09 23.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.774 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.451 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -52.72 -39.73 62.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.053 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.615 HG21 ' NE ' ' A' ' 63' ' ' ARG . 67.8 p -80.48 -35.67 34.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -55.13 138.37 44.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.514 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -126.07 130.69 51.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.806 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -80.36 150.6 29.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.4 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.9 mtt -147.71 -44.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.482 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 t -165.52 176.42 8.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.447 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.18 43.37 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.219 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.508 ' HA ' HD13 ' A' ' 31' ' ' LEU . 79.7 p -172.31 -42.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.135 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -93.71 130.64 39.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 111.166 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.576 HD12 HD23 ' A' ' 31' ' ' LEU . 80.1 mt -150.33 111.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.666 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.549 HG13 ' HD2' ' A' ' 23' ' ' LYS . 66.2 t -84.39 125.94 40.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.887 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 31.6 p -170.87 151.22 3.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.051 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.615 ' NE ' HG21 ' A' ' 51' ' ' THR . 39.0 ptt180 -83.94 132.37 34.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.501 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.908 HG23 ' HA ' ' A' ' 20' ' ' PRO . 6.5 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.856 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.428 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.384 0 N-CA-C 112.655 -0.178 . . . . 0.0 112.655 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.08 136.8 41.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.686 0.279 . . . . 0.0 110.449 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.6 mt -84.95 92.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.007 0.432 . . . . 0.0 110.935 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.8 mm -81.88 137.77 20.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.635 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.2 t -141.54 106.77 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.119 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.0 m -82.16 143.55 31.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.505 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.2 p -141.04 134.8 30.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.519 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.555 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 7.6 mtpm? -55.53 -43.57 75.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.794 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.8 m -64.43 -48.97 73.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.241 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.46 -121.33 4.85 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.164 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.42 -141.28 3.09 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.182 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.19 127.97 34.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 110.854 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.3 132.38 12.04 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.0 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 78.7 p -99.1 146.18 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.545 0.212 . . . . 0.0 110.64 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.555 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 47.5 t -149.37 132.06 15.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.982 0.42 . . . . 0.0 111.583 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.6 p -72.05 -33.49 68.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.746 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.54 139.43 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.401 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.1 p -123.62 138.68 54.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.744 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.484 ' CD2' HG11 ' A' ' 64' ' ' VAL . 54.2 t80 -88.26 130.06 35.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -90.43 125.07 35.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.532 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.508 HD21 ' SG ' ' A' ' 44' ' ' CYS . 3.2 mm? -85.25 124.42 31.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 111.046 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 19' ' ' ILE . 80.7 mt -87.24 136.1 33.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.785 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -64.91 131.62 95.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.369 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 C--N 1.345 0.373 0 C-N-CA 122.419 2.08 . . . . 0.0 112.319 -179.745 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.662 0.268 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.0 Cg_endo -59.34 142.79 99.57 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.755 2.303 . . . . 0.0 112.216 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 51.8 Cg_exo -55.19 129.73 36.87 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.515 2.144 . . . . 0.0 112.275 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.7 tp -115.01 108.19 16.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 57.4 t -84.82 137.02 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.454 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 t -166.73 51.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.204 0.526 . . . . 0.0 111.414 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.33 136.77 4.13 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.392 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.539 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.4 tt -165.29 131.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.703 0.287 . . . . 0.0 110.622 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.804 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.6 t -69.35 -58.46 5.97 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.627 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.872 ' HG2' HG12 ' A' ' 24' ' ' VAL . 88.3 Cg_endo -93.24 113.18 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.364 2.043 . . . . 0.0 112.614 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -95.81 31.65 2.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.897 0.38 . . . . 0.0 110.863 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.688 ' HB2' HD11 ' A' ' 93' ' ' LEU . 15.9 pt-20 -179.45 129.34 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.358 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.07 146.9 5.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.988 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 39.6 pt -53.43 160.39 1.86 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.342 0.115 . . . . 0.0 110.949 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.893 ' HA ' HG23 ' A' ' 64' ' ' VAL . 89.3 Cg_exo -48.08 -38.8 32.89 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.622 2.215 . . . . 0.0 113.11 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.593 ' O ' ' HD2' ' A' ' 63' ' ' ARG . 97.4 m95 -72.76 -21.03 61.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.6 m -56.22 127.98 33.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.076 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.552 ' HE2' HG13 ' A' ' 61' ' ' VAL . 60.6 tttm -70.28 142.34 52.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.79 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.872 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.6 m -139.82 126.46 23.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 111.091 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 62.1 m -83.55 87.85 7.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.76 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.652 HD12 HD13 ' A' ' 74' ' ' ILE . 49.8 mm -54.69 133.8 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.758 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 25' ' ' THR . 45.2 mmm-85 -140.44 137.29 33.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -168.12 -134.11 1.66 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.196 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -150.57 135.58 17.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 111.237 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 61.65 41.72 11.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.227 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 mp -82.79 51.24 1.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.865 0.364 . . . . 0.0 110.411 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.41 123.45 0.19 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.212 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.7 p -92.29 42.47 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.741 0.305 . . . . 0.0 111.352 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.63 143.75 4.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.653 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.427 ' HG3' ' CE3' ' A' ' 54' ' ' TRP . 32.2 Cg_exo -57.3 -46.09 30.47 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.456 2.104 . . . . 0.0 111.749 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 t -62.48 -36.36 82.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.157 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 28.3 m-20 -53.7 -45.46 70.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.623 HD21 HD23 ' A' ' 41' ' ' LEU . 1.4 tt -68.76 131.11 44.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.076 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.51 ' N ' HD23 ' A' ' 38' ' ' LEU . 30.0 pt -138.4 -44.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.593 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.489 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -104.55 135.82 12.71 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.216 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.623 HD23 HD21 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -146.32 121.0 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.828 HG22 ' HA ' ' A' ' 47' ' ' ASN . 33.3 p -153.13 134.82 14.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.179 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 45' ' ' GLY . 76.0 mt -105.38 111.22 33.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.044 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.493 ' SG ' ' HA2' ' A' ' 72' ' ' GLY . 34.5 t 73.91 -37.8 0.38 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.748 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 171.9 -32.39 0.13 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.528 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -73.58 135.73 43.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.921 0.391 . . . . 0.0 111.459 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.828 ' HA ' HG22 ' A' ' 42' ' ' THR . 43.2 t30 -71.35 138.39 49.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.844 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.2 m -151.89 40.4 0.64 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.965 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.2 tp -74.28 -44.39 52.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.472 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.4 pt? -50.57 -42.71 55.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.497 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.418 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 59.1 p -80.31 -35.26 35.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 111.204 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.585 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.77 131.2 50.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.983 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -127.11 129.99 48.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.335 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.427 ' CE3' ' HG3' ' A' ' 35' ' ' PRO . 67.2 t90 -73.35 148.35 43.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.076 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.3 mtt -148.76 -44.01 0.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.317 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.445 ' C ' ' H ' ' A' ' 58' ' ' SER . 64.7 m -160.62 169.97 21.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.727 0.298 . . . . 0.0 110.884 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.78 32.8 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.344 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 56' ' ' SER . 79.8 p -177.85 34.42 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.544 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -164.58 131.23 3.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.8 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.4 mt -150.1 118.81 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.552 HG13 ' HE2' ' A' ' 23' ' ' LYS . 70.5 t -83.7 125.37 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.585 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.5 p -170.43 148.24 3.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.826 0.346 . . . . 0.0 111.015 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.593 ' HD2' ' O ' ' A' ' 21' ' ' TRP . 37.6 mmt-85 -84.01 131.18 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.126 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.893 HG23 ' HA ' ' A' ' 20' ' ' PRO . 10.4 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.189 0.519 . . . . 0.0 112.131 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.493 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.452 -0.246 0 N-CA-C 112.554 -0.219 . . . . 0.0 112.554 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -66.36 139.38 58.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.727 0.298 . . . . 0.0 110.958 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.652 HD13 HD12 ' A' ' 26' ' ' ILE . 72.2 mt -84.32 135.27 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.584 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.55 HD12 ' HD3' ' A' ' 83' ' ' LYS . 46.1 mm -128.66 137.51 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.899 0.38 . . . . 0.0 111.72 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t -141.4 117.5 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.896 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.9 m -87.56 140.69 29.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.975 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.6 p -134.59 137.0 43.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.996 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 37' ' ' ASP . 28.9 mtpp -60.1 -46.27 90.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.3 m -65.11 -52.43 55.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.056 0.455 . . . . 0.0 110.159 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.72 -121.8 2.46 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.063 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.36 -142.19 3.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.355 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.55 ' HD3' HD12 ' A' ' 75' ' ' ILE . 3.5 tmmm? -66.73 125.25 25.25 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 83' ' ' LYS . . . -79.45 131.31 10.5 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.061 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.7 p -99.27 148.24 24.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.642 0.258 . . . . 0.0 110.431 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.581 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 78.9 p -149.23 130.31 14.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 111.817 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 74.0 p -81.51 -31.74 32.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.376 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 m -84.22 148.31 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.205 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.0 p -138.97 135.25 34.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.797 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.476 ' CD2' HG11 ' A' ' 64' ' ' VAL . 86.6 t80 -85.64 133.34 34.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.538 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -88.45 123.71 33.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.403 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.492 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -80.13 128.27 33.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.056 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 17' ' ' GLU . 75.8 mt -101.45 135.97 42.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.002 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -67.69 140.97 94.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 C--N 1.346 0.437 0 C-N-CA 122.447 2.098 . . . . 0.0 112.284 -179.886 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.609 0.242 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.17 147.46 94.05 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.614 2.209 . . . . 0.0 112.241 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.09 143.36 18.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.571 2.181 . . . . 0.0 112.331 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 85' ' ' THR . 46.7 tp -135.93 111.57 9.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.568 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 58.8 t -78.36 130.0 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.791 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.427 ' H ' ' HA2' ' A' ' 28' ' ' GLY . 76.5 p -150.92 47.8 0.85 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.093 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.4 145.22 6.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.292 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.486 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.4 tt -164.35 128.18 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.31 . . . . 0.0 110.397 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.793 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.0 t -64.98 -58.26 13.31 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.861 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 79.8 Cg_endo -91.27 110.84 0.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.28 1.987 . . . . 0.0 112.397 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.411 ' OD1' HG23 ' A' ' 13' ' ' ILE . 50.5 m-80 -90.31 24.41 2.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.943 0.402 . . . . 0.0 110.166 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HB2' HD11 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -179.31 132.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.169 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.17 145.84 5.1 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.852 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.512 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.9 pt -55.67 164.18 1.7 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 120.407 0.146 . . . . 0.0 110.707 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 81.4 Cg_exo -47.7 -53.73 6.14 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.605 2.204 . . . . 0.0 113.966 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.416 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 80.2 m95 -68.31 -8.87 43.53 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.465 ' OG1' HG12 ' A' ' 19' ' ' ILE . 73.1 m -62.29 127.29 30.63 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.079 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -69.43 131.63 45.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.36 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.602 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.0 m -125.94 127.78 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.978 0.418 . . . . 0.0 110.999 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.8 m -81.33 118.5 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 60' ' ' ILE . 63.7 mt -79.74 138.49 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.775 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.423 ' O ' HG13 ' A' ' 10' ' ' VAL . 27.1 mmm180 -147.21 136.94 22.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.346 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.17 -132.08 1.41 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.673 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -146.94 131.38 17.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.318 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.9 m120 60.63 41.85 14.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.166 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.453 HD22 ' O ' ' A' ' 58' ' ' SER . 10.5 mp -81.97 52.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.959 0.409 . . . . 0.0 110.841 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.81 121.44 0.04 OUTLIER Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.404 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.0 p -93.4 41.18 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.0 144.13 5.38 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.464 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HA ' ' CG ' ' A' ' 54' ' ' TRP . 51.3 Cg_exo -54.26 -43.04 62.23 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.538 2.159 . . . . 0.0 112.089 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.8 p -64.01 -35.69 81.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 28.6 m-20 -52.18 -49.06 64.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.005 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.47 ' C ' HD13 ' A' ' 38' ' ' LEU . 3.5 tm? -67.12 132.46 47.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.33 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.433 ' N ' HD13 ' A' ' 38' ' ' LEU . 35.5 pt -147.97 -24.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.998 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.94 137.21 12.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.58 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.784 HD12 ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -149.64 131.67 15.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 47' ' ' ASN . 5.7 p -153.7 141.73 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.134 0.493 . . . . 0.0 111.657 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -135.97 123.23 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.168 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 78.9 m 58.41 40.1 24.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.941 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.02 -32.74 1.73 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.183 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -70.71 133.06 46.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 111.356 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.617 ' HA ' HG22 ' A' ' 42' ' ' THR . 15.0 p-10 -74.62 143.94 44.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.73 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.784 ' SG ' HD12 ' A' ' 41' ' ' LEU . 7.5 p -154.12 46.31 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 110.793 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.2 tp -72.95 -48.9 32.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.58 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 51' ' ' THR . 4.1 pp -62.24 -30.37 71.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.599 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.629 ' N ' HD12 ' A' ' 50' ' ' LEU . 41.3 p -79.92 -38.39 32.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.903 0.383 . . . . 0.0 110.91 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.501 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -64.22 138.08 58.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.67 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.37 127.39 45.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.08 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.41 ' CG ' ' HA ' ' A' ' 35' ' ' PRO . 31.1 t90 -63.78 143.57 57.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.111 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 94.0 mmm -132.95 -51.17 0.9 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.718 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.2 m -161.2 -172.15 3.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.62 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.31 39.17 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.276 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.453 ' O ' HD22 ' A' ' 31' ' ' LEU . 40.2 t -178.4 -43.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.7 tttm -86.81 134.05 33.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.483 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 75.3 mt -151.24 120.29 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.571 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.22 132.39 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.064 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 25.9 t -170.57 141.4 1.89 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.197 0.522 . . . . 0.0 111.545 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.552 ' HE ' HG21 ' A' ' 51' ' ' THR . 39.7 ptt180 -85.37 140.44 30.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.711 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.532 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t . . . . . 0 CA--C 1.515 -0.371 0 CA-C-O 121.647 0.737 . . . . 0.0 110.758 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.723 -0.151 . . . . 0.0 112.723 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -71.41 131.87 43.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 110.886 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.6 mt -85.6 100.33 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.085 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.3 mm -98.6 138.97 21.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.99 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.52 120.17 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.0 111.288 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.1 m -90.87 145.87 24.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.271 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.4 p -140.49 142.93 35.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.953 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 32.2 mmmt -51.77 -49.12 63.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.231 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.4 t -67.0 -47.41 71.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.88 -127.81 0.19 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.819 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.12 -39.77 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.851 -0.499 . . . . 0.0 111.851 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -168.06 121.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.98 127.05 7.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.368 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.558 ' O ' HD12 ' A' ' 9' ' ' LEU . 81.7 p -99.69 144.63 28.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.568 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 66.5 p -143.36 124.19 14.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.101 0.477 . . . . 0.0 111.794 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.7 p -81.02 -28.69 35.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.245 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.62 141.89 14.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.287 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.1 p -129.77 139.26 51.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.958 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -85.74 129.44 34.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.39 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.41 114.55 20.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.093 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 47.0 tp -78.86 131.07 36.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 111.406 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 17' ' ' GLU . 78.4 mt -98.82 141.27 31.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.764 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -61.92 123.32 77.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.015 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo . . . . . 0 C--N 1.348 0.545 0 C-N-CA 122.421 2.081 . . . . 0.0 111.987 179.612 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.437 0.161 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 17.9 Cg_endo -60.18 139.15 85.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.57 2.18 . . . . 0.0 112.267 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 59.7 Cg_exo -52.8 147.1 33.15 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.82 2.347 . . . . 0.0 112.625 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 85' ' ' THR . 59.8 tp -149.97 112.24 4.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.741 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.49 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 57.3 t -79.02 131.5 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.2 p -147.76 44.22 1.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.43 146.41 6.49 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.778 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.5 tt -161.45 129.66 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.762 0.315 . . . . 0.0 110.629 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.843 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 49.5 m -68.89 -59.88 4.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.805 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.843 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 72.2 Cg_endo -92.49 121.95 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.364 2.042 . . . . 0.0 112.077 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -105.78 28.51 7.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.881 0.372 . . . . 0.0 110.832 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -179.99 129.53 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.436 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.456 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 164.25 148.15 5.34 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.583 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.0 pt -51.62 158.56 1.5 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.481 0.181 . . . . 0.0 110.767 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.785 ' HA ' HG23 ' A' ' 64' ' ' VAL . 73.4 Cg_exo -50.08 -41.67 48.3 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.656 2.237 . . . . 0.0 113.322 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -70.12 -8.97 53.94 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.9 m -67.93 126.9 30.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.765 0.317 . . . . 0.0 110.927 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.583 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 4.9 ttmp? -71.02 134.03 46.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.071 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.734 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.7 m -124.37 127.24 73.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 0.0 111.542 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.1 m -78.54 102.33 7.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.7 mt -69.83 139.73 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.09 0.471 . . . . 0.0 111.403 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -144.11 130.95 20.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.205 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.31 -133.17 1.54 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.623 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -150.16 136.8 19.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.914 0.388 . . . . 0.0 111.325 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.7 m120 61.94 39.05 13.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.508 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 mp -84.98 53.1 2.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.0 110.63 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.08 129.65 1.46 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.509 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.9 p -69.31 -36.63 77.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.76 0.314 . . . . 0.0 111.455 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.445 ' HA2' ' CZ2' ' A' ' 54' ' ' TRP . . . -150.86 174.84 30.07 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.517 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.28 -43.86 54.58 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.795 2.33 . . . . 0.0 112.486 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.3 t -58.56 -40.12 82.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.19 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.02 -46.79 85.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.156 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.3 tt -59.71 129.73 43.33 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.573 HG21 ' HD3' ' A' ' 79' ' ' LYS . 39.6 pt -141.95 -44.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.439 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.528 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -102.55 133.81 11.54 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.628 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 42' ' ' THR . 2.4 tm? -149.48 127.3 11.79 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.748 HG22 ' HA ' ' A' ' 47' ' ' ASN . 11.8 p -155.87 140.82 17.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.525 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.594 HD11 ' SG ' ' A' ' 62' ' ' CYS . 73.3 mt -126.03 123.77 64.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.596 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.432 ' SG ' ' HA2' ' A' ' 72' ' ' GLY . 58.9 m 57.37 36.35 27.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.058 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.89 -31.66 3.05 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.055 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -73.7 133.18 43.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.854 0.359 . . . . 0.0 111.408 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.748 ' HA ' HG22 ' A' ' 42' ' ' THR . 42.0 t30 -69.2 138.3 53.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.7 m -151.04 39.27 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 110.7 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.3 tp -75.06 -43.19 54.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.107 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.454 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -52.21 -41.61 62.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.281 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.408 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 68.0 p -80.29 -34.62 36.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.175 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 61' ' ' VAL . . . -58.06 131.02 49.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.566 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.424 ' HB3' HG23 ' A' ' 61' ' ' VAL . 17.8 tp10 -126.61 132.31 51.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.573 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.445 ' CZ2' ' HA2' ' A' ' 34' ' ' GLY . 77.0 t90 -68.31 144.84 54.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.196 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.7 mmt -132.65 -47.78 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.663 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.6 p -168.54 -157.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.635 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.37 32.32 1.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.355 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.7 p -179.98 37.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.278 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -164.88 129.62 2.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.102 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.4 mt -151.23 111.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.698 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -84.51 130.25 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.349 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.594 ' SG ' HD11 ' A' ' 43' ' ' ILE . 26.4 p -170.97 150.98 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.042 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -84.01 129.79 34.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.785 HG23 ' HA ' ' A' ' 20' ' ' PRO . 14.3 m . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.102 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.432 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.328 -0.309 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -64.14 131.58 47.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.861 0.362 . . . . 0.0 111.083 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.4 mt -85.36 135.43 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.522 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.9 mm -134.55 133.82 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 0.0 111.713 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.418 HG22 HD22 ' A' ' 41' ' ' LEU . 60.0 t -141.55 118.66 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.22 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.4 m -98.68 131.88 44.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.555 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.1 p -99.48 146.29 26.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.844 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.573 ' HD3' HG21 ' A' ' 39' ' ' ILE . 56.5 tptt -58.57 -49.19 78.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.773 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 81.9 p -70.33 -54.43 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.76 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.53 -127.05 0.35 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.42 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.4 -137.25 2.18 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.17 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -65.17 126.12 27.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.7 0.286 . . . . 0.0 110.569 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.28 -150.19 6.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.154 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 21.5 p -158.09 151.59 23.44 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.706 0.402 . . . . 0.0 110.624 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.3 p -158.66 121.34 3.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.917 0.389 . . . . 0.0 111.431 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 82.6 p -96.07 37.56 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.436 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.6 m -150.56 157.44 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.744 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.5 p -146.0 136.23 23.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.572 ' CE2' HG21 ' A' ' 64' ' ' VAL . 65.4 t80 -85.45 130.44 34.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.863 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -82.19 120.83 25.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.659 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.486 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.3 mm? -83.91 126.96 33.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.018 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.456 HD12 ' HA2' ' A' ' 18' ' ' GLY . 76.9 mt -94.6 134.94 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.823 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 47.5 mmtm -67.01 129.21 94.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.956 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 31.2 Cg_exo . . . . . 0 C--N 1.347 0.481 0 C-N-CA 122.65 2.234 . . . . 0.0 112.471 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.597 0.237 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.15 138.01 78.89 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.543 2.162 . . . . 0.0 112.054 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HG2' ' HA2' ' A' ' 84' ' ' GLY . 14.1 Cg_endo -55.94 134.11 62.11 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.703 2.269 . . . . 0.0 112.331 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 85' ' ' THR . 64.8 tp -120.03 117.65 28.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.018 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.535 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 94.8 t -83.29 132.92 30.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.841 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.0 p -151.34 48.86 0.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.042 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.3 144.83 6.9 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.01 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.655 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.1 tt -163.01 131.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.579 0.228 . . . . 0.0 110.645 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.846 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 48.4 t -63.22 -59.18 12.87 Favored Pre-proline 0 C--N 1.331 -0.239 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.349 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.924 ' HG2' HG12 ' A' ' 24' ' ' VAL . 10.3 Cg_exo -70.7 -148.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.945 1.763 . . . . 0.0 112.035 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -175.4 -23.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.351 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.7 133.94 4.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.832 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 169.69 160.07 17.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.409 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 30.6 pt -50.87 154.68 2.33 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.561 0.22 . . . . 0.0 111.009 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.18 -41.88 48.44 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.902 2.402 . . . . 0.0 113.807 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -70.51 -5.89 32.18 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -66.08 132.09 47.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.808 0.337 . . . . 0.0 111.227 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.581 ' HE3' HG13 ' A' ' 61' ' ' VAL . 87.2 tttt -67.26 137.35 56.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.479 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.924 HG12 ' HG2' ' A' ' 15' ' ' PRO . 35.9 m -140.98 127.23 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.977 0.417 . . . . 0.0 111.015 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.1 m -80.85 121.21 25.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.097 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.0 mt -84.3 135.83 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.726 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 10' ' ' VAL . 83.0 mtm180 -146.2 134.51 21.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.726 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.07 -132.58 1.46 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.58 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -146.09 132.88 20.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.873 0.368 . . . . 0.0 111.352 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 59.11 43.57 17.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.189 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 mp -83.31 47.88 1.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.829 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.47 125.24 0.06 OUTLIER Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.531 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.9 p -92.35 42.87 1.11 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.616 0.246 . . . . 0.0 111.211 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.05 144.81 4.78 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.752 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 10.5 Cg_endo -53.82 -42.87 62.9 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.686 2.258 . . . . 0.0 112.162 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.6 t -60.98 -37.03 81.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.954 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.57 -38.51 69.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.135 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.4 tp -76.31 60.41 1.53 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 0.0 110.914 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.46 HD13 ' HG2' ' A' ' 79' ' ' LYS . 22.6 pt -69.12 -40.06 80.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.318 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.07 138.21 12.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.885 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.53 HD13 ' N ' ' A' ' 42' ' ' THR . 3.1 tm? -149.77 127.8 11.93 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.903 HG22 ' HA ' ' A' ' 47' ' ' ASN . 39.3 p -151.53 136.73 17.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.976 0.417 . . . . 0.0 111.64 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.539 HG21 HG23 ' A' ' 64' ' ' VAL . 51.6 mm -107.65 105.62 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.911 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.419 ' HB2' ' HA2' ' A' ' 72' ' ' GLY . 38.0 t 58.28 45.22 17.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.731 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.14 -38.66 3.14 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.569 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -68.38 129.02 38.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.908 0.354 . . . . 0.0 111.141 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.903 ' HA ' HG22 ' A' ' 42' ' ' THR . 13.6 p-10 -73.62 140.76 46.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.603 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.2 m -150.25 40.12 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.764 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.6 tp -72.88 -49.36 30.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.224 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.448 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -54.08 -39.46 66.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.499 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.1 p -80.11 -38.11 32.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.576 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -62.5 130.44 45.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.847 0.356 . . . . 0.0 111.686 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 60' ' ' ILE . 44.9 tp10 -126.85 130.87 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.605 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 86.9 t90 -65.93 149.76 49.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.979 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.458 ' HG3' HG23 ' A' ' 61' ' ' VAL . 94.9 mmm -142.37 -42.9 0.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.766 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 t -170.63 173.97 5.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.857 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.83 33.43 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.283 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.6 p -178.61 23.68 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.588 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -165.67 131.27 2.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.743 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 53' ' ' GLU . 75.6 mt -149.43 120.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.008 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.581 HG13 ' HE3' ' A' ' 23' ' ' LYS . 57.4 t -81.82 126.33 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.471 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 52.7 t -171.08 149.71 2.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 0.0 111.138 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -84.66 131.43 34.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.308 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.539 HG23 HG21 ' A' ' 43' ' ' ILE . 5.5 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.065 0.459 . . . . 0.0 111.576 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 44' ' ' CYS . . . . . . . . 0 CA--C 1.518 0.231 0 CA-C-O 120.368 -0.129 . . . . 0.0 113.2 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -64.22 132.67 51.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.77 0.319 . . . . 0.0 111.042 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.442 HG23 ' CD1' ' A' ' 43' ' ' ILE . 68.5 mt -85.5 92.48 3.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.817 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.5 mm -81.03 138.58 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.195 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.53 113.51 3.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.936 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.5 m -84.47 142.23 30.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.722 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.3 p -137.73 135.52 36.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.047 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HG2' HD13 ' A' ' 39' ' ' ILE . 28.2 mtpp -59.29 -46.72 87.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.004 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.9 p -64.42 -52.83 56.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.03 0.443 . . . . 0.0 110.331 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 -120.97 2.13 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.193 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.76 -140.77 2.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.117 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.439 ' HD2' ' C ' ' A' ' 83' ' ' LYS . 4.3 tmmm? -67.38 127.12 31.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.36 . . . . 0.0 110.169 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.459 ' HA2' ' HG2' ' A' ' 8' ' ' PRO . . . -78.15 130.64 10.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.346 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.428 HG22 ' HE3' ' A' ' 83' ' ' LYS . 79.3 p -108.15 144.66 35.25 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.535 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 41.3 t -151.31 131.12 13.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.093 0.473 . . . . 0.0 111.875 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.8 p -78.17 -28.39 48.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.781 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.9 m -83.15 153.76 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.362 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.0 p -148.97 138.65 21.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.724 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 64' ' ' VAL . 67.2 t80 -85.2 131.56 34.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.68 ' HD2' HD23 ' A' ' 93' ' ' LEU . 5.8 tmtt? -79.39 119.1 21.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.013 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.476 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -84.61 109.67 18.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 110.54 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.68 HD23 ' HD2' ' A' ' 91' ' ' LYS . 54.9 mt -85.86 136.68 33.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.955 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -65.51 137.11 96.4 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.168 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--N 1.346 0.439 0 C-N-CA 122.441 2.094 . . . . 0.0 112.469 179.843 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.514 0.197 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -57.11 150.7 55.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.79 2.327 . . . . 0.0 112.308 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.543 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 82.1 Cg_exo -48.57 143.07 16.78 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.705 2.27 . . . . 0.0 112.746 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 85' ' ' THR . 4.9 tt -145.03 111.34 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.747 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.512 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 66.3 t -81.92 137.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.005 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.422 HG23 ' CD2' ' A' ' 9' ' ' LEU . 30.1 p -154.26 44.52 0.55 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.624 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.46 143.8 6.09 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.845 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.527 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.8 tt -164.47 129.47 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.0 110.51 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.824 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -65.22 -59.39 9.93 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.942 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.944 ' HG2' HG12 ' A' ' 24' ' ' VAL . 72.8 Cg_endo -94.86 118.89 0.26 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.447 2.098 . . . . 0.0 112.169 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -100.22 30.61 3.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.73 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.592 ' HB2' HD11 ' A' ' 93' ' ' LEU . 11.3 pt-20 179.0 129.39 0.07 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.571 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . 165.09 152.29 6.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.738 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.441 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 31.9 pt -56.12 162.54 2.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.48 0.181 . . . . 0.0 111.11 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.567 ' HA ' HG23 ' A' ' 64' ' ' VAL . 87.2 Cg_exo -49.23 -46.31 26.42 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.881 2.388 . . . . 0.0 113.768 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -71.4 -4.97 29.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.1 m -63.33 126.99 29.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.845 0.355 . . . . 0.0 110.986 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.484 ' HD2' HG13 ' A' ' 61' ' ' VAL . 17.2 tppt? -67.13 136.31 54.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.148 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.944 HG12 ' HG2' ' A' ' 15' ' ' PRO . 31.6 m -140.59 131.67 29.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.036 0.445 . . . . 0.0 111.51 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.9 m -89.75 116.28 27.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.549 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.44 HD11 ' SG ' ' A' ' 62' ' ' CYS . 57.3 mt -74.61 141.13 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.187 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 27' ' ' ARG . 11.9 tpt180 -147.48 130.75 16.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.997 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.56 -122.61 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.733 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.424 ' OE2' HD13 ' A' ' 9' ' ' LEU . 20.5 pt-20 -162.19 134.23 5.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.963 0.411 . . . . 0.0 111.598 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 60.86 40.21 16.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.86 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.543 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.6 mp -70.31 -41.96 72.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.609 0.242 . . . . 0.0 111.233 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.93 135.47 2.36 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.803 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.9 p -62.7 -39.75 94.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.798 0.332 . . . . 0.0 110.902 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.513 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -165.32 -164.11 20.04 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.66 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.28 -47.11 6.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.779 2.319 . . . . 0.0 112.514 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 39' ' ' ILE . 67.2 p -60.12 -40.91 91.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.379 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.732 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 36.5 t70 -62.65 -41.53 99.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.346 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.433 HD11 HD13 ' A' ' 60' ' ' ILE . 1.3 tt -78.33 62.15 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.947 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.638 HD13 ' HG2' ' A' ' 79' ' ' LYS . 27.2 pt -68.96 -41.79 82.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.19 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.433 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -112.21 140.61 16.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.098 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.627 HD13 ' N ' ' A' ' 42' ' ' THR . 3.4 tm? -146.89 134.85 21.4 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.627 ' N ' HD13 ' A' ' 41' ' ' LEU . 14.1 p -150.36 149.82 30.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.101 0.477 . . . . 0.0 111.546 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.712 HG21 ' HA ' ' A' ' 64' ' ' VAL . 71.1 mt -135.75 116.56 18.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.484 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 65.4 m 72.82 -35.2 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.813 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 166.11 -41.08 0.27 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.026 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -80.67 138.48 36.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.959 0.409 . . . . 0.0 111.705 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.493 ' HA ' HG22 ' A' ' 42' ' ' THR . 42.2 t30 -60.68 141.51 56.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.679 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.3 m -143.76 38.15 1.34 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.846 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.55 -42.25 68.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.466 ' H ' HD23 ' A' ' 50' ' ' LEU . 2.6 pt? -57.52 -42.41 82.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.58 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.514 HG21 ' NE ' ' A' ' 63' ' ' ARG . 55.8 p -80.19 -38.19 31.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.691 0.282 . . . . 0.0 111.351 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -63.09 132.9 53.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.333 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -126.38 127.39 45.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.552 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.513 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 75.2 t90 -67.46 149.97 49.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.512 ' SD ' HG23 ' A' ' 61' ' ' VAL . 90.4 mtp -146.04 -41.3 0.21 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.731 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 58' ' ' SER . 33.8 t -165.38 173.86 10.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.685 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.34 21.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.489 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.3 m -167.72 35.31 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.884 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -165.09 127.95 2.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.867 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.433 HD13 HD11 ' A' ' 38' ' ' LEU . 73.9 mt -150.82 125.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.158 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.512 HG23 ' SD ' ' A' ' 55' ' ' MET . 60.8 t -93.4 128.12 45.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.564 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.658 ' SG ' HD11 ' A' ' 43' ' ' ILE . 23.0 p -171.11 157.82 5.31 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.073 0.463 . . . . 0.0 111.772 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.514 ' NE ' HG21 ' A' ' 51' ' ' THR . 40.3 ptt180 -84.59 134.76 34.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.857 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.712 ' HA ' HG21 ' A' ' 43' ' ' ILE . 18.0 m . . . . . 0 CA--C 1.516 -0.352 0 CA-C-O 121.404 0.621 . . . . 0.0 111.338 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.631 ' HA3' ' HB3' ' A' ' 89' ' ' SER . . . . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -61.43 120.31 10.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.806 0.336 . . . . 0.0 111.026 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.498 ' O ' HD13 ' A' ' 75' ' ' ILE . 69.8 mt -85.99 128.67 39.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.35 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.947 HG21 ' HE3' ' A' ' 83' ' ' LYS . 37.0 mm -127.32 142.02 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.926 0.393 . . . . 0.0 111.484 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.819 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 58.4 t -140.65 122.71 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.57 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.3 m -86.48 141.75 28.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.115 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.4 p -136.08 136.01 39.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.804 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.732 ' HE2' ' HA ' ' A' ' 37' ' ' ASP . 48.3 mtmt -57.16 -46.91 82.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.0 m -68.4 -53.12 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.083 0.468 . . . . 0.0 110.258 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.74 -123.37 0.67 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.189 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.63 -140.78 2.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.325 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.947 ' HE3' HG21 ' A' ' 75' ' ' ILE . 51.1 tptt -63.31 132.42 51.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.949 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.819 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -68.11 159.48 51.34 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.946 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 74.2 p -143.37 145.67 32.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.9 p -157.14 131.51 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 0.0 111.698 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 65.3 p -79.2 -33.06 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.538 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.1 m -84.24 158.6 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.396 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.631 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 31.4 m -148.88 139.99 23.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.075 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.548 ' CD2' HG11 ' A' ' 64' ' ' VAL . 68.2 t80 -85.51 133.58 34.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.045 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.705 ' HD2' HD23 ' A' ' 93' ' ' LEU . 5.5 tmtt? -80.76 121.41 25.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.299 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.54 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 94.0 mt -84.82 109.12 17.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 110.202 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.705 HD23 ' HD2' ' A' ' 91' ' ' LYS . 50.0 mt -83.64 138.0 33.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.342 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -62.61 141.59 96.86 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.287 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo . . . . . 0 C--N 1.348 0.503 0 C-N-CA 122.729 2.286 . . . . 0.0 112.503 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.664 0.269 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.21 144.34 98.83 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.754 2.302 . . . . 0.0 112.13 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.56 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 10.3 Cg_endo -54.18 115.86 2.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.533 2.155 . . . . 0.0 112.109 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.5 tp -90.62 98.37 11.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.196 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.489 HG22 HD21 ' A' ' 31' ' ' LEU . 60.3 t -79.92 135.42 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.273 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 t -167.76 52.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.183 0.516 . . . . 0.0 111.271 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.06 137.67 4.79 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.483 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.531 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.8 tt -165.15 128.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.709 0.29 . . . . 0.0 110.624 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.807 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.3 t -66.54 -57.92 11.23 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.626 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.864 ' HG2' HG12 ' A' ' 24' ' ' VAL . 98.2 Cg_endo -91.47 110.54 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.336 2.024 . . . . 0.0 112.15 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.463 ' OD1' HG23 ' A' ' 13' ' ' ILE . 13.7 m-20 -88.49 26.79 1.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.728 0.299 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 179.82 130.16 0.09 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.521 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.592 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 169.05 143.08 3.72 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.472 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.439 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.6 pt -53.14 161.31 1.34 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.434 0.159 . . . . 0.0 111.214 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.913 ' HA ' HG23 ' A' ' 64' ' ' VAL . 88.8 Cg_exo -47.79 -43.48 28.95 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.79 2.327 . . . . 0.0 113.75 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -68.56 -20.66 64.55 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.7 m -59.48 129.1 40.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 111.003 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.562 ' NZ ' ' HB3' ' A' ' 23' ' ' LYS . 6.1 ttpm? -71.56 143.34 49.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.016 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.864 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.8 m -140.27 131.03 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.99 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.1 m -90.33 87.39 6.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.431 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 43' ' ' ILE . 69.8 mt -60.77 137.3 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.572 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' A' ' 58' ' ' SER . 75.9 ttt180 -148.07 140.44 24.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.963 0.411 . . . . 0.0 111.054 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -167.07 -127.61 0.92 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.298 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -150.4 137.21 19.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.921 0.391 . . . . 0.0 111.214 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.484 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 72.4 m-80 64.82 32.49 10.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.496 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 9.2 mp -83.27 48.93 1.46 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.951 0.405 . . . . 0.0 110.607 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.58 121.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.597 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.409 HG22 ' HB2' ' A' ' 57' ' ' ALA . 81.7 p -89.54 41.02 1.02 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.729 0.299 . . . . 0.0 111.126 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.4 146.42 5.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.733 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.21 -43.18 61.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.52 2.146 . . . . 0.0 112.07 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.5 p -59.01 -40.7 85.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.775 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 78' ' ' THR . 55.6 m-20 -58.07 -32.31 67.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.671 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 41' ' ' LEU . 1.0 OUTLIER -76.91 58.09 1.42 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.34 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.9 pt -66.52 -22.49 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.915 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.13 141.94 10.66 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.426 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.585 HD13 ' N ' ' A' ' 42' ' ' THR . 2.9 tm? -149.78 130.4 14.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 46' ' ' HIS . 81.4 m -161.4 127.62 3.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 111.782 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 26' ' ' ILE . 76.9 mt -100.56 129.75 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.588 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 48.8 t 65.47 -72.74 0.07 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.249 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.7 30.77 0.12 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.427 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.647 ' O ' HG23 ' A' ' 42' ' ' THR . 35.3 t-80 -131.08 128.42 40.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 110.805 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -63.1 134.5 56.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 71.4 m -152.67 39.69 0.56 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.682 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.91 -46.23 45.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.385 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.433 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.6 pt? -55.5 -37.88 68.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.221 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.6 p -79.94 -36.91 35.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.54 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.93 134.97 56.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.243 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -126.18 129.08 48.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.804 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 87.3 t90 -70.52 145.21 51.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.093 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.6 mmt -132.63 -48.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.771 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.9 m -161.74 -161.78 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.702 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB2' HG22 ' A' ' 33' ' ' THR . . . -91.97 32.86 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.253 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.621 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 83.4 p -178.77 35.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.247 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.571 ' HB2' ' NZ ' ' A' ' 59' ' ' LYS . 5.1 ttmp? -165.41 135.4 3.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.338 . . . . 0.0 111.078 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.408 HD13 HD11 ' A' ' 38' ' ' LEU . 80.6 mt -150.61 120.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.77 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 51.5 t -90.35 127.59 42.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.629 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.6 p -170.55 154.63 4.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.15 133.65 34.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.66 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.913 HG23 ' HA ' ' A' ' 20' ' ' PRO . 11.5 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.934 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 N-CA-C 113.523 0.169 . . . . 0.0 113.523 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -65.62 121.94 16.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.524 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.5 mt -97.68 131.23 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.376 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.3 mm -134.22 140.19 46.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.458 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 p -140.85 125.68 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.78 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.643 ' HA ' ' H ' ' A' ' 83' ' ' LYS . 15.9 m -90.77 139.96 30.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.724 ' H ' ' HA2' ' A' ' 82' ' ' GLY . 73.8 p -147.41 143.86 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.118 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.428 ' HG2' ' HA ' ' A' ' 37' ' ' ASP . 14.5 mmmm -54.02 -33.88 58.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.055 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.8 m -63.44 -49.41 73.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.703 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.77 -48.46 0.23 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.759 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.724 ' HA2' ' H ' ' A' ' 78' ' ' THR . . . 75.8 127.19 0.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.873 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.643 ' H ' ' HA ' ' A' ' 77' ' ' THR . 61.7 tttm 51.67 56.93 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 110.995 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.49 -138.4 0.05 OUTLIER Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.848 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.0 p -149.98 -168.2 3.04 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.723 0.297 . . . . 0.0 110.817 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.488 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 45.4 t -167.76 129.3 1.49 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.257 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 77.0 p -92.91 37.84 1.02 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.231 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.6 m -150.73 139.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.88 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.0 m -118.97 127.99 53.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.164 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 64' ' ' VAL . 44.3 t80 -89.31 124.06 34.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.979 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -85.06 91.7 8.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.12 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.879 HD21 ' HG3' ' A' ' 20' ' ' PRO . 31.6 tp -65.14 128.39 35.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.249 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.482 HD12 ' HA2' ' A' ' 18' ' ' GLY . 80.5 mt -80.41 137.0 36.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.072 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.575 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 4.8 ttmp? -64.15 134.7 96.04 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 51.9 Cg_exo . . . . . 0 C--N 1.347 0.459 0 C-N-CA 122.487 2.125 . . . . 0.0 112.57 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.605 0.241 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.91 139.66 80.79 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.552 2.168 . . . . 0.0 112.234 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 17.3 Cg_endo -58.16 123.2 13.11 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.58 2.187 . . . . 0.0 112.168 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 9' ' ' LEU . 3.0 tm? -94.17 122.0 36.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.553 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 62.1 t -99.6 140.53 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -166.99 50.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 111.348 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.71 140.53 5.74 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.695 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.513 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.3 tt -164.42 131.18 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.722 0.296 . . . . 0.0 110.507 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.835 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.8 t -66.39 -59.13 8.88 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.931 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.837 ' HG2' HG12 ' A' ' 24' ' ' VAL . 88.7 Cg_endo -96.08 119.87 0.21 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.652 2.235 . . . . 0.0 112.137 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -94.69 29.51 2.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 110.713 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.47 ' HB2' HD21 ' A' ' 93' ' ' LEU . 12.2 pt-20 179.06 133.78 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.602 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.461 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 167.07 146.95 5.07 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.947 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.465 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 37.2 pt -55.78 159.24 5.46 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 110.736 -0.098 . . . . 0.0 110.736 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.799 ' HA ' HG23 ' A' ' 64' ' ' VAL . 3.7 Cg_endo -48.25 -41.9 34.22 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.708 2.272 . . . . 0.0 113.22 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -67.87 -23.06 65.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.7 m -54.43 127.98 29.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.042 0.449 . . . . 0.0 111.659 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.412 ' HE3' ' CG1' ' A' ' 61' ' ' VAL . 86.8 tttt -73.04 140.2 47.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.445 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.837 HG12 ' HG2' ' A' ' 15' ' ' PRO . 30.3 m -141.69 132.91 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.908 0.385 . . . . 0.0 111.362 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.0 m -87.61 118.55 27.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.528 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.46 HD11 ' SG ' ' A' ' 62' ' ' CYS . 63.5 mt -80.34 140.41 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.032 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -141.38 135.63 30.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.682 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.24 -134.7 2.0 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.662 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -149.14 136.66 20.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 111.282 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.0 m-20 63.28 36.4 11.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.33 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 mp -82.6 61.04 5.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.944 0.402 . . . . 0.0 110.503 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.96 121.27 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.124 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.3 p -92.18 33.67 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.817 0.341 . . . . 0.0 111.244 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.8 149.95 5.93 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.498 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.15 -45.04 41.71 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.525 2.15 . . . . 0.0 111.876 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 t -64.19 -38.14 89.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.231 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 56.7 m-20 -54.61 -54.24 44.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.756 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.476 ' C ' HD13 ' A' ' 38' ' ' LEU . 3.2 tm? -60.99 127.15 30.17 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.586 HG21 ' HD3' ' A' ' 79' ' ' LYS . 41.9 pt -138.31 -25.81 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.694 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.85 142.26 13.35 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.133 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.644 HD13 ' N ' ' A' ' 42' ' ' THR . 1.8 tm? -149.57 131.61 15.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.674 HG22 ' HA ' ' A' ' 47' ' ' ASN . 3.4 p -151.66 146.43 25.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.161 0.505 . . . . 0.0 111.623 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 64' ' ' VAL . 80.5 mt -137.53 123.41 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.683 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.419 ' SG ' ' HA2' ' A' ' 72' ' ' GLY . 80.0 m 57.41 39.54 28.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.259 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.18 -31.29 1.82 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.549 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -73.5 131.09 41.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.829 0.347 . . . . 0.0 111.278 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.674 ' HA ' HG22 ' A' ' 42' ' ' THR . 5.4 m120 -72.35 140.36 48.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.5 m -150.71 39.86 0.72 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.772 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 tp -70.97 -42.57 69.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.364 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.469 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -51.13 -43.16 61.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.446 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.421 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 60.0 p -80.31 -32.1 38.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.327 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -56.4 131.27 47.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.774 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -127.12 131.96 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.198 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.436 ' CH2' ' HA ' ' A' ' 56' ' ' SER . 65.2 t90 -72.1 146.77 47.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.355 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.516 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 22.1 mmt -133.82 -50.24 0.83 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.066 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.436 ' HA ' ' CH2' ' A' ' 54' ' ' TRP . 78.0 p -169.18 -156.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.703 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -96.01 30.98 2.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.147 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.7 p -178.76 31.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.057 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 55' ' ' MET . 63.0 tttm -165.05 128.39 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.413 ' HB ' HD12 ' A' ' 26' ' ' ILE . 63.8 mt -151.66 114.6 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.882 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.412 ' CG1' ' HE3' ' A' ' 23' ' ' LYS . 90.7 t -80.3 131.87 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.084 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.491 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.4 p -169.08 155.02 6.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.992 0.425 . . . . 0.0 111.405 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -83.99 126.22 32.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.288 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 20' ' ' PRO . 5.2 m . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.077 0.465 . . . . 0.0 111.103 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.453 -0.212 0 N-CA-C 112.406 -0.277 . . . . 0.0 112.406 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.28 137.27 38.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.702 0.287 . . . . 0.0 111.055 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.07 127.78 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.227 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.5 mm -128.1 138.41 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.899 0.381 . . . . 0.0 111.304 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -139.8 119.06 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.678 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 58.2 m -89.07 130.01 35.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.532 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 64.4 p -107.83 143.48 36.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.615 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.586 ' HD3' HG21 ' A' ' 39' ' ' ILE . 53.1 tptt -56.32 -43.79 79.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 110.369 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 87.2 p -73.06 -56.83 4.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.65 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.2 -125.42 2.02 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.587 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' THR . . . -160.54 -139.63 2.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.398 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.527 ' NZ ' ' HB3' ' A' ' 83' ' ' LYS . 9.0 mtpm? -64.34 126.06 26.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.897 0.379 . . . . 0.0 111.343 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.9 143.42 25.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.403 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.2 p -98.63 139.2 34.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.678 0.275 . . . . 0.0 110.995 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.546 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 63.5 p -136.26 132.27 35.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.418 . . . . 0.0 111.299 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -81.04 -32.16 34.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.922 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.6 m -84.18 176.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.322 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.5 m -156.88 138.11 13.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.644 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.511 ' CE2' HG21 ' A' ' 64' ' ' VAL . 52.3 t80 -88.85 132.48 34.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.431 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -91.99 122.3 34.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.276 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.428 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.7 mm? -84.49 127.02 33.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.948 0.404 . . . . 0.0 111.168 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 17' ' ' GLU . 77.9 mt -91.38 138.27 31.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.709 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.591 ' NZ ' ' HB3' ' A' ' 94' ' ' LYS . 3.3 mmmp? -59.21 129.84 86.65 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.546 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.52 2.147 . . . . 0.0 112.56 -179.714 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.505 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 4.8 tp60 . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.505 ' HD2' ' OE1' ' A' ' 6' ' ' GLN . 61.9 Cg_exo -52.01 146.32 30.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.427 2.084 . . . . 0.0 112.222 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 51.2 Cg_exo -54.91 129.46 35.38 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.52 2.147 . . . . 0.0 112.244 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 85' ' ' THR . 59.6 tp -114.92 109.29 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.63 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.56 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 61.2 t -74.76 129.72 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.743 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.6 p -148.32 46.3 1.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.096 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.18 141.56 4.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.201 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.445 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.7 tt -164.66 129.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.714 0.292 . . . . 0.0 110.304 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.804 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.8 t -66.12 -58.64 10.33 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.167 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.804 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 90.2 Cg_endo -88.88 124.23 1.51 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.121 1.881 . . . . 0.0 112.881 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -99.81 26.28 6.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.072 0.463 . . . . 0.0 110.125 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.636 ' HB2' HD11 ' A' ' 93' ' ' LEU . 23.7 pt-20 177.66 131.8 0.06 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.585 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 169.06 141.58 3.26 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.006 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.473 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 37.6 pt -57.44 162.85 4.05 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 122.066 0.146 . . . . 0.0 111.012 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.954 ' HA ' HG23 ' A' ' 64' ' ' VAL . 83.2 Cg_exo -48.19 -39.56 34.34 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.658 2.238 . . . . 0.0 113.311 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.52 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 89.9 m95 -70.53 -24.45 62.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -57.64 128.95 39.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 111.279 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -73.87 137.49 43.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.635 HG12 ' HG2' ' A' ' 15' ' ' PRO . 27.0 m -134.7 132.52 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.03 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.4 m -87.35 113.56 23.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.71 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 77.8 mt -75.22 139.45 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.955 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.602 ' HD2' ' O ' ' A' ' 58' ' ' SER . 27.4 tpt180 -147.25 133.15 19.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.291 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.14 -132.77 1.48 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.634 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 51.7 mt-10 -147.26 134.84 20.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 111.341 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.461 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 75.7 m-20 61.0 41.08 14.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.548 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 58' ' ' SER . 10.0 mp -83.08 46.86 1.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.031 0.443 . . . . 0.0 110.389 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.35 121.8 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.462 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.505 HG22 ' HB2' ' A' ' 57' ' ' ALA . 80.1 p -87.56 39.08 0.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.835 0.35 . . . . 0.0 111.182 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.03 146.25 5.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.445 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.38 -40.94 81.31 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.603 2.202 . . . . 0.0 112.024 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.2 p -59.91 -40.23 88.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.183 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -58.16 -45.08 88.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.583 HD11 HD13 ' A' ' 60' ' ' ILE . 1.5 tt -61.29 133.93 56.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.81 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.527 ' N ' HD23 ' A' ' 38' ' ' LEU . 26.5 pt -142.84 -44.54 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -102.9 136.05 12.64 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.677 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 42' ' ' THR . 1.7 tm? -149.23 128.17 12.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.607 ' N ' HD13 ' A' ' 41' ' ' LEU . 95.7 m -161.41 135.93 7.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.229 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.4 mt -129.87 130.45 66.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.373 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 63.5 m 56.13 40.64 30.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.631 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.28 29.04 73.29 Favored Glycine 0 CA--C 1.518 0.229 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.878 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.451 ' C ' HG23 ' A' ' 42' ' ' THR . 29.1 t-80 -130.92 131.42 44.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.73 0.3 . . . . 0.0 110.871 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -66.32 132.86 49.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.632 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.2 m -152.36 38.42 0.56 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.982 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.25 -42.44 59.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.26 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.455 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -53.83 -40.74 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.65 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.727 HG21 ' NE ' ' A' ' 63' ' ' ARG . 62.4 p -79.76 -35.04 39.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.598 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.532 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -54.4 135.01 45.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.633 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.65 132.85 51.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.662 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -70.41 151.79 44.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.059 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.6 mmt -142.95 -44.3 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.924 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.5 p -166.05 -166.09 0.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.749 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 33' ' ' THR . . . -88.02 30.63 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.266 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.602 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 79.0 p 179.04 37.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.031 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.9 ttmt -164.76 131.82 3.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.983 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.583 HD13 HD11 ' A' ' 38' ' ' LEU . 72.4 mt -150.72 115.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.4 t -79.93 130.39 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.272 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 53.7 t -170.35 151.9 3.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.025 0.44 . . . . 0.0 111.432 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.727 ' NE ' HG21 ' A' ' 51' ' ' THR . 39.3 ptt180 -84.05 130.02 34.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.201 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.954 HG23 ' HA ' ' A' ' 20' ' ' PRO . 4.9 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 111.61 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.23 0 N-CA-C 112.358 -0.297 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.13 134.74 35.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.741 0.305 . . . . 0.0 111.015 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.448 ' O ' HD13 ' A' ' 75' ' ' ILE . 67.6 mt -85.67 131.75 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.33 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 84' ' ' GLY . 50.5 mm -134.08 135.9 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 0.0 111.359 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.728 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 99.6 t -141.56 116.98 5.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.811 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.4 m -82.07 146.19 29.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.3 p -141.54 139.85 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.17 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.513 ' HD2' HD13 ' A' ' 39' ' ' ILE . 32.1 mmmt -57.1 -51.09 70.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.7 t -65.69 -53.48 40.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.004 0.431 . . . . 0.0 110.544 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.77 -123.06 0.26 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.238 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.55 -139.11 2.58 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.188 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.84 131.97 48.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.616 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.728 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -62.41 152.95 43.9 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.691 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 63.0 p -147.93 142.61 26.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.711 0.291 . . . . 0.0 110.713 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.533 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 42.7 t -160.81 128.16 4.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.948 0.404 . . . . 0.0 111.319 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -74.57 -30.42 61.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.447 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.0 m -83.79 152.84 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.238 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 m -138.84 141.27 38.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.822 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.526 ' CD2' HG11 ' A' ' 64' ' ' VAL . 41.7 t80 -85.9 127.7 34.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.324 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -82.69 88.24 6.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.243 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.784 HD21 ' HG3' ' A' ' 20' ' ' PRO . 35.4 tp -64.6 127.27 30.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 17' ' ' GLU . 81.2 mt -92.19 136.17 33.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.218 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -72.16 130.6 86.15 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.693 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo . . . . . 0 C--N 1.346 0.421 0 C-N-CA 122.643 2.229 . . . . 0.0 112.957 -179.695 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.473 0.178 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.34 136.42 63.86 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.482 2.121 . . . . 0.0 112.156 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 50.2 Cg_exo -53.92 134.23 58.44 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.492 2.128 . . . . 0.0 112.091 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.672 HD13 ' N ' ' A' ' 10' ' ' VAL . 1.3 tm? -119.71 130.44 55.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.497 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.672 ' N ' HD13 ' A' ' 9' ' ' LEU . 90.5 t -101.92 137.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.744 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.52 HG23 HD12 ' A' ' 9' ' ' LEU . 39.6 p -151.38 48.3 0.82 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.197 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.15 144.81 6.36 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.021 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.442 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.6 tt -164.8 130.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 110.722 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.831 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -67.33 -59.62 6.98 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.672 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.831 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 83.0 Cg_endo -89.52 125.1 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.06 1.84 . . . . 0.0 112.421 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -86.02 -18.62 32.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.623 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HB2' HD11 ' A' ' 93' ' ' LEU . 11.3 pt-20 -156.15 138.46 14.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.238 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.539 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 175.8 148.71 7.03 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.561 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.448 HG12 ' OG1' ' A' ' 22' ' ' THR . 40.6 pt -51.82 157.51 1.97 Allowed Pre-proline 0 CA--C 1.531 0.25 0 CA-C-O 120.573 0.225 . . . . 0.0 111.065 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.691 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 84.8 Cg_exo -47.6 -37.5 26.92 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.713 2.276 . . . . 0.0 113.41 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -76.81 -22.4 53.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 64' ' ' VAL . 96.1 m -52.01 130.88 30.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.796 0.331 . . . . 0.0 111.093 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -65.26 139.05 58.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.682 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.1 m -141.2 125.64 17.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.6 m -93.46 116.71 29.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 55.7 mt -76.54 138.47 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.702 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 10' ' ' VAL . 43.2 mmm-85 -140.39 130.39 24.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.301 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.36 -133.85 1.65 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.629 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -147.61 132.63 18.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.799 0.333 . . . . 0.0 111.111 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 57.5 41.25 26.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.333 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.563 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.5 mp -70.35 -36.22 74.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.733 0.301 . . . . 0.0 110.68 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.86 130.93 1.62 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.559 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.415 ' OG1' ' HB2' ' A' ' 37' ' ' ASP . 81.8 p -65.24 -39.31 92.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.731 0.301 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.467 ' HA2' ' CZ2' ' A' ' 54' ' ' TRP . . . -164.52 -161.18 13.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.778 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.56 -49.25 7.61 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.723 2.282 . . . . 0.0 112.64 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.5 p -62.93 -38.84 92.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.53 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.415 ' HB2' ' OG1' ' A' ' 33' ' ' THR . 8.3 t70 -55.75 -51.67 66.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.18 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.4 tt -70.2 134.27 47.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.552 ' N ' HD23 ' A' ' 38' ' ' LEU . 43.1 pt -145.2 -37.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.195 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.46 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -113.69 142.68 17.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.813 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 42' ' ' THR . 1.1 tm? -149.57 130.78 14.55 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.621 ' N ' HD13 ' A' ' 41' ' ' LEU . 18.5 p -151.88 145.99 25.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.147 0.498 . . . . 0.0 111.888 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 69.8 mt -134.77 118.9 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.238 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.477 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 65.0 m 74.91 -38.01 0.37 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.523 0.514 . . . . 0.0 110.53 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.79 -36.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.104 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -77.19 131.07 38.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 110.853 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.606 ' HA ' HG22 ' A' ' 42' ' ' THR . 14.9 p-10 -74.86 144.91 43.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.894 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.9 m -146.77 43.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 49' ' ' LEU . 2.3 tm? -66.15 -45.99 79.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.709 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.485 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.4 pt? -49.19 -41.78 37.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.588 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.6 p -80.54 -35.42 34.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.408 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.28 134.93 56.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.845 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -127.1 134.37 50.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.63 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.467 ' CZ2' ' HA2' ' A' ' 34' ' ' GLY . 81.7 t90 -73.42 152.98 40.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.4 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.6 mmt -145.64 -46.25 0.21 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.777 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.9 t -171.25 177.26 3.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.679 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.13 35.53 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.607 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.1 p -179.31 30.63 0.0 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.868 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.6 ttmt -165.38 133.09 3.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.894 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.8 mt -151.34 113.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.845 0.355 . . . . 0.0 111.044 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.6 t -82.15 130.72 35.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.182 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.574 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.1 p -170.51 153.56 4.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.754 0.312 . . . . 0.0 111.483 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -84.06 136.57 33.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.882 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.691 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 2.5 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.183 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.419 0 N-CA-C 112.658 -0.177 . . . . 0.0 112.658 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -63.8 132.16 50.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.804 0.335 . . . . 0.0 111.014 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.517 ' O ' HD13 ' A' ' 75' ' ' ILE . 67.9 mt -85.46 129.0 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.533 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 74' ' ' ILE . 41.5 mm -132.76 142.09 43.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.266 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.686 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 6.6 p -141.31 122.52 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.94 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.7 m -87.22 147.7 25.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.37 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.1 p -140.7 140.83 34.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.805 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.548 ' HD2' HD13 ' A' ' 39' ' ' ILE . 14.3 mmmm -51.49 -48.75 62.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 82.2 p -68.98 -46.19 68.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.94 -129.52 0.05 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.885 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.03 -39.29 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.052 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -168.38 129.51 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.686 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -67.67 154.22 52.98 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.204 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 63.3 p -144.22 140.0 29.03 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.608 ' OG ' HG22 ' A' ' 88' ' ' VAL . 42.9 t -154.06 136.41 14.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.99 0.424 . . . . 0.0 111.832 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.9 p -92.71 37.33 1.01 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.173 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.608 HG22 ' OG ' ' A' ' 86' ' ' SER . 33.4 m -148.45 146.61 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.9 m -135.11 136.2 41.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.006 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -86.01 133.84 33.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.557 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -85.24 125.51 32.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.494 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.451 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.5 mm? -85.33 133.88 34.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.843 0.354 . . . . 0.0 111.29 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.539 HD12 ' HA2' ' A' ' 18' ' ' GLY . 80.0 mt -108.16 134.22 51.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.614 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -65.52 124.28 86.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.659 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo . . . . . 0 C--N 1.349 0.588 0 C-N-CA 122.321 2.014 . . . . 0.0 112.356 179.959 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.618 0.247 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HB2' ' HA2' ' A' ' 84' ' ' GLY . 28.9 Cg_endo -62.62 142.93 91.56 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.478 2.119 . . . . 0.0 112.085 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 15.7 Cg_endo -57.32 137.96 84.02 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.614 2.209 . . . . 0.0 112.38 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.488 ' CD1' HG23 ' A' ' 11' ' ' THR . 2.4 tm? -124.88 124.22 41.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.284 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.498 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 68.3 t -86.93 136.88 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.088 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.488 HG23 ' CD1' ' A' ' 9' ' ' LEU . 23.3 p -152.52 45.48 0.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.872 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.67 144.17 6.48 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.206 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.483 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.1 tt -161.16 128.85 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.684 0.278 . . . . 0.0 110.489 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.621 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.6 t -61.96 -57.74 22.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.489 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 85.7 Cg_endo -75.95 -156.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.84 1.693 . . . . 0.0 111.804 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -168.96 -30.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.457 . . . . 0.0 110.34 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HB2' HD21 ' A' ' 93' ' ' LEU . 11.6 pt-20 -153.4 130.87 11.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.285 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.449 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 177.03 152.32 9.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.846 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.446 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 35.6 pt -52.22 162.73 0.81 Allowed Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 122.338 0.255 . . . . 0.0 111.461 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.637 ' HA ' HG23 ' A' ' 64' ' ' VAL . 86.6 Cg_exo -49.84 -43.92 38.82 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.957 2.438 . . . . 0.0 113.942 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.37 -5.57 29.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.2 m -67.93 127.81 34.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.757 0.313 . . . . 0.0 111.121 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HD2' HG13 ' A' ' 61' ' ' VAL . 39.7 ttpt -72.53 138.62 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.36 179.483 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.613 HG12 ' HG3' ' A' ' 15' ' ' PRO . 34.6 m -136.03 127.04 43.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 111.337 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.9 m -87.14 125.46 34.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.275 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 58.8 mt -85.96 139.19 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.909 179.546 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.486 ' O ' HG13 ' A' ' 10' ' ' VAL . 44.0 mmm-85 -143.13 130.78 21.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.268 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.59 -131.52 1.33 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.598 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -143.69 134.43 25.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.952 0.406 . . . . 0.0 111.698 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.6 m-80 59.88 43.5 14.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.664 178.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.575 HD22 ' O ' ' A' ' 58' ' ' SER . 9.1 mp -83.42 51.09 1.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.947 0.403 . . . . 0.0 110.39 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.13 124.8 0.34 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.532 -179.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.7 p -87.58 38.84 0.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 111.343 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 166.75 146.43 4.85 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.626 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.22 -45.77 32.9 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.639 2.226 . . . . 0.0 112.049 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 p -60.59 -37.82 82.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.873 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' A' ' 79' ' ' LYS . 39.1 t70 -58.2 -41.88 84.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.075 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.467 HD11 HD13 ' A' ' 60' ' ' ILE . 1.8 tt -66.62 75.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.138 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.508 HG21 ' HD3' ' A' ' 79' ' ' LYS . 34.8 pt -76.59 -40.63 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.183 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.437 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -121.76 142.73 15.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.412 -179.018 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.591 HD13 ' N ' ' A' ' 42' ' ' THR . 3.3 tm? -150.0 132.96 16.14 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.31 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.591 ' N ' HD13 ' A' ' 41' ' ' LEU . 60.9 p -147.52 127.52 13.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.903 0.383 . . . . 0.0 111.837 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.875 HG21 HG12 ' A' ' 64' ' ' VAL . 72.7 mt -108.19 124.86 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.022 178.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 67.4 m 54.54 41.25 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.021 0.439 . . . . 0.0 110.459 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.57 34.38 89.75 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.747 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -131.31 132.01 44.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.594 0.235 . . . . 0.0 110.538 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.42 ' HA ' HG22 ' A' ' 42' ' ' THR . 22.6 t-20 -63.3 131.05 47.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.714 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.0 m -154.46 37.58 0.43 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 49' ' ' LEU . 2.2 tm? -72.77 -45.6 57.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 110.32 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.449 ' H ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -55.74 -40.22 72.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.167 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.0 p -80.05 -37.47 33.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.992 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.581 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.61 133.9 56.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.351 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.92 131.91 51.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.759 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -69.9 151.55 45.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.958 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.0 mmt -142.07 -44.99 0.34 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.02 179.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.6 p -163.34 -164.95 0.99 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.662 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.45 35.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.575 ' O ' HD22 ' A' ' 31' ' ' LEU . 80.8 p -178.96 -43.37 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.364 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -77.63 133.31 38.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.494 -179.437 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.467 HD13 HD11 ' A' ' 38' ' ' LEU . 68.6 mt -151.33 111.81 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.387 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.411 HG13 ' HD2' ' A' ' 23' ' ' LYS . 60.5 t -80.23 125.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.627 ' SG ' HD11 ' A' ' 43' ' ' ILE . 29.0 p -170.72 131.57 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -87.82 140.4 29.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.875 HG12 HG21 ' A' ' 43' ' ' ILE . 33.4 m . . . . . 0 CA--C 1.534 0.343 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.629 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.333 -0.307 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.32 135.85 42.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.773 0.32 . . . . 0.0 110.821 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.2 mt -85.67 92.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.176 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.475 ' N ' HD12 ' A' ' 75' ' ' ILE . 1.9 mp -86.67 139.66 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.172 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.559 HG23 HD23 ' A' ' 41' ' ' LEU . 7.5 p -141.36 125.46 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.813 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.4 m -95.95 144.14 26.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.406 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.9 p -126.48 141.02 52.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.876 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.508 ' HD3' HG21 ' A' ' 39' ' ' ILE . 23.5 tptm -56.98 -48.93 77.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.899 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -67.66 -55.35 13.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.53 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.39 -124.71 0.69 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.178 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.51 -143.32 3.78 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.099 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.75 117.94 13.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 110.58 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 7' ' ' PRO . . . -92.3 -149.92 25.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.522 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.8 p -155.22 -169.21 3.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.66 0.267 . . . . 0.0 110.542 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.0 p -170.85 128.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.913 0.387 . . . . 0.0 111.319 179.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.5 p -76.27 -34.28 59.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.37 178.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 m -84.66 146.32 6.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.345 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -134.96 134.62 40.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.714 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -89.33 136.67 32.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.664 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -102.55 123.28 46.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.442 179.224 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.502 HD12 ' N ' ' A' ' 92' ' ' LEU . 6.4 mp -85.28 132.08 34.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 0.0 111.4 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 17' ' ' GLU . 84.2 mt -90.67 138.09 31.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.242 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 37.6 mtmm -67.45 135.41 93.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.368 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 44.1 Cg_exo . . . . . 0 C--N 1.344 0.29 0 C-N-CA 122.394 2.063 . . . . 0.0 112.151 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.709 0.29 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.39 138.53 39.23 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.522 2.148 . . . . 0.0 112.13 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 16.9 Cg_endo -58.31 127.73 25.89 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.48 2.12 . . . . 0.0 112.066 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 85' ' ' THR . 64.4 tp -109.91 117.38 33.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.107 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.58 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 89.7 t -83.22 131.31 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.776 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.8 p -149.04 47.9 0.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.032 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.04 147.51 8.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.178 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.577 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.8 tt -161.18 130.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.587 0.232 . . . . 0.0 110.655 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.855 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 44.3 t -63.51 -59.26 12.29 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.31 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.968 ' HG2' HG12 ' A' ' 24' ' ' VAL . 7.3 Cg_exo -71.29 -147.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.93 1.754 . . . . 0.0 111.748 179.032 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -176.4 -25.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.945 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -162.69 129.49 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.129 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 177.48 155.07 13.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.728 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.0 pt -51.14 159.75 0.99 Allowed Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.692 0.282 . . . . 0.0 111.382 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.6 ' HA ' HG23 ' A' ' 64' ' ' VAL . 86.5 Cg_exo -48.28 -48.28 17.33 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.978 2.452 . . . . 0.0 113.96 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -65.85 -5.69 9.82 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.4 m -67.28 126.17 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 111.071 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.625 ' HA ' ' HG2' ' A' ' 63' ' ' ARG . 6.1 ttpm? -71.41 133.19 45.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.618 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.968 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.4 m -131.79 126.1 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 111.007 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.2 m -83.73 125.55 32.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.25 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 60' ' ' ILE . 48.7 mt -82.12 139.21 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.835 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 10' ' ' VAL . 23.2 mmm180 -146.51 132.95 19.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.312 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.21 -130.47 1.2 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.391 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -147.31 132.98 18.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 32.9 m120 61.07 42.55 12.34 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.615 178.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 58' ' ' SER . 8.9 mp -83.13 49.06 1.47 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.939 0.399 . . . . 0.0 110.664 178.713 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.3 122.73 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.558 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -91.74 42.44 1.1 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.921 0.391 . . . . 0.0 111.177 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.53 146.44 5.52 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.711 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.9 -42.92 62.61 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.588 2.192 . . . . 0.0 111.901 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.3 p -61.96 -32.65 73.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.995 179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -77.84 45.73 0.53 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.048 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.465 HD21 HD23 ' A' ' 41' ' ' LEU . 1.3 tt -162.1 55.44 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.131 0.491 . . . . 0.0 110.005 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.0 pt -66.54 -37.86 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.323 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.41 138.95 15.34 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.9 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.645 HD13 ' N ' ' A' ' 42' ' ' THR . 2.9 tm? -148.42 134.06 18.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.786 0.327 . . . . 0.0 110.134 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.645 ' N ' HD13 ' A' ' 41' ' ' LEU . 19.4 p -147.13 147.16 30.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.463 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.655 HG21 HG12 ' A' ' 64' ' ' VAL . 75.0 mt -128.8 116.19 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.788 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 69.1 m 70.68 -30.46 0.2 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.982 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.38 -44.18 0.31 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.621 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -80.45 139.48 36.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.856 0.36 . . . . 0.0 111.237 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.442 ' HA ' HG22 ' A' ' 42' ' ' THR . 5.3 m120 -60.85 143.53 54.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.965 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.8 m -145.5 39.09 1.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.599 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.6 tp -70.94 -43.4 68.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.136 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.453 ' H ' HD23 ' A' ' 50' ' ' LEU . 2.6 pt? -55.91 -41.24 74.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.157 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.3 p -79.87 -34.34 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.793 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 61' ' ' VAL . . . -58.48 134.17 56.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.285 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -126.27 122.06 34.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.389 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -70.81 147.15 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 56.3 mtt -149.22 -41.36 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.15 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.6 p -157.47 175.18 14.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.69 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.75 42.03 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.358 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.506 ' O ' HD22 ' A' ' 31' ' ' LEU . 43.8 t -175.93 -40.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.077 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -85.53 133.23 34.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.231 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 74.9 mt -150.72 115.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.648 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 64.3 t -82.01 124.15 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.947 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.653 ' SG ' HD11 ' A' ' 43' ' ' ILE . 22.6 p -171.19 132.01 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.917 0.389 . . . . 0.0 111.26 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.625 ' HG2' ' HA ' ' A' ' 23' ' ' LYS . 98.3 mtt180 -85.93 140.68 30.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.139 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.655 HG12 HG21 ' A' ' 43' ' ' ILE . 34.6 m . . . . . 0 CA--C 1.535 0.372 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.547 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.896 -0.082 . . . . 0.0 112.896 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.8 127.87 34.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.694 0.283 . . . . 0.0 110.856 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.465 ' O ' HD13 ' A' ' 75' ' ' ILE . 65.2 mt -85.81 135.68 24.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.689 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 74' ' ' ILE . 50.4 mm -134.16 139.65 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 111.153 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.6 122.81 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.72 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.7 m -92.02 143.37 26.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.298 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.9 p -134.41 136.56 43.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.056 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -57.61 -47.67 81.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.182 -179.649 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 88.5 p -64.73 -54.8 25.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.658 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.7 -123.21 1.57 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.421 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.8 -139.03 2.54 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.996 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.576 ' NZ ' ' HB2' ' A' ' 83' ' ' LYS . 4.8 ttmp? -62.45 126.57 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 110.794 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.74 134.69 13.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.802 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 79.8 p -99.31 145.54 27.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.553 0.215 . . . . 0.0 110.684 179.498 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.0 p -141.8 122.05 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.333 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.6 p -93.08 32.97 1.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.399 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.0 m -150.94 150.79 13.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.605 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.0 p -142.99 134.85 26.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.966 0.412 . . . . 0.0 111.217 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.5 ' HD2' HG11 ' A' ' 64' ' ' VAL . 60.1 t80 -85.67 128.16 34.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.817 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -85.0 121.03 27.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.562 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 92' ' ' LEU . 6.8 mp -89.98 128.16 36.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.864 0.364 . . . . 0.0 111.293 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.425 HD12 ' HA2' ' A' ' 18' ' ' GLY . 82.7 mt -85.51 141.51 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.735 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.41 ' N ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.06 134.42 95.79 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.876 179.848 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--N 1.347 0.492 0 C-N-CA 122.528 2.152 . . . . 0.0 112.555 -179.926 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.631 0.253 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.91 143.93 74.83 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.526 2.15 . . . . 0.0 111.99 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.497 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 67.4 Cg_exo -50.7 142.49 31.82 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.584 2.189 . . . . 0.0 112.43 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 85' ' ' THR . 63.2 tp -142.9 98.39 3.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.871 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.566 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 59.6 t -73.01 134.09 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.018 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.6 p -148.88 44.67 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.994 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.81 142.77 5.31 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.776 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.515 HG12 ' HD2' ' A' ' 15' ' ' PRO . 18.1 tt -164.67 131.33 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.743 0.306 . . . . 0.0 110.931 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.796 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -68.05 -58.28 8.03 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.855 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.819 ' HG2' HG12 ' A' ' 24' ' ' VAL . 92.0 Cg_endo -92.18 123.8 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.329 2.019 . . . . 0.0 112.262 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -81.72 -20.66 38.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 91' ' ' LYS . 11.0 pt-20 -157.48 138.71 13.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 111.409 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.454 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 178.45 151.76 9.76 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.419 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.517 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 38.4 pt -52.14 163.66 0.68 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.671 0.236 . . . . 0.0 111.15 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.727 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 76.4 Cg_exo -49.08 -47.0 23.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.533 2.155 . . . . 0.0 113.944 -178.657 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -72.68 -14.65 61.62 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.601 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.423 ' OG1' HG12 ' A' ' 19' ' ' ILE . 99.8 m -55.11 122.52 11.17 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.599 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -61.0 136.44 58.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.578 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.819 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.8 m -137.01 122.12 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.099 0.476 . . . . 0.0 111.129 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.0 m -83.84 113.5 20.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.523 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.611 HD12 ' HB ' ' A' ' 60' ' ' ILE . 62.9 mt -79.13 138.61 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.053 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.436 ' O ' HG13 ' A' ' 10' ' ' VAL . 20.6 mmt85 -144.92 129.44 17.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.276 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.62 -134.93 1.83 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.617 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 5.6 mm-40 -150.31 133.79 16.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.915 0.388 . . . . 0.0 111.422 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 57.87 41.9 24.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.069 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.497 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.6 mp -67.52 -38.51 84.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.74 0.305 . . . . 0.0 110.879 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.04 132.64 1.99 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.699 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.0 p -62.12 -35.69 79.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.44 172.48 39.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.375 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.47 -44.59 45.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.605 2.204 . . . . 0.0 112.273 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.8 p -62.74 -39.27 93.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.092 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.536 ' HA ' ' HD3' ' A' ' 79' ' ' LYS . 8.0 t70 -57.66 -40.63 79.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.034 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 tt -75.28 66.75 1.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.265 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.416 ' O ' HD22 ' A' ' 49' ' ' LEU . 36.3 pt -73.27 -33.71 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.96 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -126.3 140.54 12.14 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.531 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 48' ' ' CYS . 53.9 tp -148.72 144.17 26.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.731 0.301 . . . . 0.0 110.57 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 41' ' ' LEU . 11.5 p -161.33 142.15 11.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.286 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.455 HG13 ' SG ' ' A' ' 48' ' ' CYS . 63.9 mt -127.12 115.51 41.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.72 178.671 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 48.2 t 74.04 -35.79 0.32 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.695 -178.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.97 -36.15 0.28 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.509 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -77.69 139.82 39.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.899 0.381 . . . . 0.0 111.558 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -66.73 151.92 46.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.962 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.567 ' O ' HD23 ' A' ' 41' ' ' LEU . 3.0 p -159.66 45.11 0.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.367 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 39' ' ' ILE . 52.9 tp -88.34 -46.24 9.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.568 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.434 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -54.8 -39.76 68.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.871 -179.025 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.3 p -80.25 -38.15 31.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.789 0.328 . . . . 0.0 111.681 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.565 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -60.01 135.99 57.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.016 0.436 . . . . 0.0 111.709 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -123.13 127.85 49.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.591 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 66.4 t90 -69.29 146.09 52.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.473 ' SD ' HG23 ' A' ' 61' ' ' VAL . 87.5 mtp -143.44 -42.23 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.702 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.492 ' C ' ' H ' ' A' ' 58' ' ' SER . 81.2 p -167.11 164.31 15.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.301 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.93 27.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.497 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.8 m -167.33 27.27 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.816 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.5 ttmt -164.92 130.14 2.64 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.926 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.611 ' HB ' HD12 ' A' ' 26' ' ' ILE . 72.4 mt -151.16 118.84 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.473 HG23 ' SD ' ' A' ' 55' ' ' MET . 92.2 t -90.15 129.22 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.003 179.053 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 30.2 p -170.54 151.5 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.322 . . . . 0.0 111.492 -179.144 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.2 134.44 34.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.275 179.136 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.727 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.759 -179.483 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.217 -0.353 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -161.46 127.8 3.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.861 0.362 . . . . 0.0 110.604 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.53 92.54 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.02 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.3 mm -84.18 139.36 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.742 -179.556 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 41' ' ' LEU . 46.0 t -141.31 114.3 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.856 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.1 m -81.31 144.3 31.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.913 0.387 . . . . 0.0 111.526 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.2 p -136.8 135.07 37.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.69 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.536 ' HD3' ' HA ' ' A' ' 37' ' ' ASP . 28.3 mtpp -52.74 -47.19 67.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.855 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.8 m -68.33 -48.54 64.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.055 0.455 . . . . 0.0 110.112 179.103 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.27 -121.96 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.542 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.58 -33.9 0.04 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.4 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -168.89 125.07 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 0.0 110.556 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.09 130.61 9.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.93 -0.653 . . . . 0.0 113.132 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 75.7 p -100.99 147.17 26.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.574 0.226 . . . . 0.0 110.767 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.2 p -149.95 126.96 11.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.051 0.453 . . . . 0.0 111.37 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.7 p -78.85 -30.33 45.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.017 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.8 m -83.68 141.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.212 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.7 m -121.69 142.98 49.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.478 ' CE2' HG21 ' A' ' 64' ' ' VAL . 63.1 t80 -97.91 106.98 19.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.234 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 57.4 tttm -70.31 117.41 11.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.215 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.51 HD11 ' CD ' ' A' ' 20' ' ' PRO . 45.4 tp -80.62 132.39 35.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.742 -178.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.415 HD11 ' HG3' ' A' ' 17' ' ' GLU . 84.0 mt -102.78 131.69 49.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.189 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 60.2 mttp -73.1 131.57 83.39 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.773 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 49.2 Cg_exo . . . . . 0 C--N 1.347 0.455 0 C-N-CA 122.581 2.187 . . . . 0.0 112.727 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.629 0.252 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.78 146.75 95.16 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.673 2.248 . . . . 0.0 112.069 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 13.6 Cg_endo -57.17 123.28 13.45 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.424 2.083 . . . . 0.0 112.212 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.5 tp -103.27 121.2 42.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.97 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 62.4 t -95.31 136.48 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 t -169.51 51.11 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.078 0.466 . . . . 0.0 111.305 -179.565 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.93 143.41 7.27 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.418 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.511 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.4 tt -160.05 130.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.713 0.292 . . . . 0.0 110.967 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.787 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.9 t -66.39 -58.73 9.71 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.607 179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 67.9 Cg_endo -89.22 115.56 0.7 Allowed 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.146 1.897 . . . . 0.0 112.102 179.377 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -99.1 27.55 5.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.923 0.392 . . . . 0.0 110.632 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' A' ' 93' ' ' LEU . 11.7 pt-20 178.61 131.03 0.07 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.454 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.97 150.59 6.77 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.786 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.443 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.3 pt -57.0 162.34 3.89 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.473 0.178 . . . . 0.0 111.057 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.666 ' HA ' HG23 ' A' ' 64' ' ' VAL . 85.7 Cg_exo -48.96 -46.68 24.23 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.978 2.452 . . . . 0.0 114.019 -178.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' O ' ' HD2' ' A' ' 63' ' ' ARG . 94.6 m95 -69.99 -5.96 29.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.869 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.4 m -72.96 127.56 32.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 110.818 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -74.38 125.29 28.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.809 179.904 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.542 HG12 ' HG2' ' A' ' 15' ' ' PRO . 23.7 m -108.38 127.6 64.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.084 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.4 m -78.87 119.49 22.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.332 -179.679 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 61.8 mt -85.28 140.73 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.411 179.255 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -146.55 136.74 23.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.342 . . . . 0.0 110.872 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.99 -128.42 1.04 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.413 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -143.96 129.58 19.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.0 111.266 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.491 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.5 m-80 58.66 47.56 12.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.108 179.261 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.8 mp -81.18 53.21 1.97 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.868 0.366 . . . . 0.0 111.02 179.194 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 37' ' ' ASP . . . 83.86 135.32 2.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.796 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 77.7 p -62.98 -40.77 98.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.656 0.265 . . . . 0.0 111.376 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -161.35 -159.46 10.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.932 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -65.85 -48.22 3.11 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.728 2.285 . . . . 0.0 112.528 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -60.31 -39.52 87.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.695 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 38.8 t70 -63.19 -47.08 84.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.616 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 39' ' ' ILE . 2.3 tt -66.96 129.16 38.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.773 179.696 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.587 HD13 ' HD2' ' A' ' 79' ' ' LYS . 29.7 pt -137.23 -44.68 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.22 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.485 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -98.67 136.59 12.78 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.309 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.655 HD13 ' N ' ' A' ' 42' ' ' THR . 1.9 tm? -149.43 132.41 16.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 110.195 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.655 ' N ' HD13 ' A' ' 41' ' ' LEU . 16.5 p -151.62 148.79 28.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.489 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.884 HG21 HG12 ' A' ' 64' ' ' VAL . 77.2 mt -133.14 114.33 21.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.584 179.14 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 66.7 m 73.36 -38.56 0.41 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 123.488 0.493 . . . . 0.0 110.545 -178.866 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 171.45 -41.97 0.18 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.631 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -78.75 135.74 37.2 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.841 0.353 . . . . 0.0 111.14 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.523 ' HA ' HG22 ' A' ' 42' ' ' THR . 4.9 m120 -61.21 141.62 57.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.2 m -139.98 38.43 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.564 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 39' ' ' ILE . 53.5 tp -71.51 -43.77 65.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.353 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.443 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -53.57 -42.94 68.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.477 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.3 p -80.47 -37.83 31.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.714 0.292 . . . . 0.0 111.443 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -60.47 129.17 40.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.032 0.444 . . . . 0.0 111.66 -179.647 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -126.67 132.1 51.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.213 179.278 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.564 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 54.3 t90 -63.99 149.89 46.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.376 . . . . 0.0 111.019 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 93.4 mmm -143.78 -45.88 0.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.632 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 58' ' ' SER . 70.8 m -163.63 162.06 24.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.474 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.48 36.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.35 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 56' ' ' SER . 78.1 p -175.24 20.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.153 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.1 tttm -165.19 131.68 2.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.487 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.3 mt -147.53 122.2 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.792 0.33 . . . . 0.0 110.998 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.4 t -83.82 133.76 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.941 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.529 ' SG ' HD11 ' A' ' 43' ' ' ILE . 29.9 p -170.53 132.92 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.352 . . . . 0.0 110.919 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 77.6 mtm180 -85.0 134.62 34.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.884 HG12 HG21 ' A' ' 43' ' ' ILE . 27.8 m . . . . . 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.399 179.343 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.88 128.53 36.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 111.413 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.406 ' O ' HD13 ' A' ' 75' ' ' ILE . 66.8 mt -85.91 137.21 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.732 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.406 HD13 ' O ' ' A' ' 74' ' ' ILE . 48.4 mm -134.22 142.23 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.917 0.389 . . . . 0.0 111.388 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.82 128.74 23.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.636 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.565 HG23 ' HA2' ' A' ' 82' ' ' GLY . 24.6 m -102.22 140.13 36.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.42 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.6 p -122.01 149.31 43.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.587 ' HD2' HD13 ' A' ' 39' ' ' ILE . 14.5 mmmm -51.18 -51.4 54.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.204 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.0 m -69.92 -54.47 13.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.627 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.74 -131.03 2.59 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.28 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.565 ' HA2' HG23 ' A' ' 77' ' ' THR . . . -171.83 -143.04 3.92 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.851 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -67.69 117.79 10.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 110.688 179.624 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.77 -133.42 2.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.735 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 86' ' ' SER . 0.0 OUTLIER -160.21 -176.64 5.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.002 0.43 . . . . 0.0 110.946 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.649 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 79.4 p -169.27 123.88 0.83 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.527 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.1 p -95.03 33.55 1.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.185 178.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.3 m -152.18 152.8 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.537 -179.627 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.0 p -143.93 141.96 30.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.049 0.452 . . . . 0.0 111.209 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -85.0 131.94 34.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.25 -179.679 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.745 ' HE2' HD21 ' A' ' 93' ' ' LEU . 6.0 ttpm? -81.58 120.78 25.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.657 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.466 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -81.71 130.93 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.823 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.745 HD21 ' HE2' ' A' ' 91' ' ' LYS . 79.8 mt -107.0 145.2 32.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.233 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -61.26 131.73 92.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.778 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 C--N 1.346 0.406 0 C-N-CA 122.584 2.19 . . . . 0.0 112.406 -179.956 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.648 0.261 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 13.7 Cg_endo -57.03 145.91 83.37 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.749 2.3 . . . . 0.0 112.265 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 52.6 Cg_exo -54.08 138.86 71.36 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.534 2.156 . . . . 0.0 112.342 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 85' ' ' THR . 5.6 tt -133.74 111.77 10.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.323 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 83.9 t -83.75 140.51 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.918 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 t -162.68 46.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.028 0.442 . . . . 0.0 110.793 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.1 142.3 5.96 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.858 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.524 HG12 ' HD2' ' A' ' 15' ' ' PRO . 13.2 tt -164.07 128.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.659 0.266 . . . . 0.0 110.457 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.781 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 45.9 t -63.62 -58.64 14.39 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.83 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 94.0 Cg_endo -89.47 107.29 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.21 1.94 . . . . 0.0 112.188 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -91.03 26.41 2.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 110.587 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' A' ' 93' ' ' LEU . 12.4 pt-20 179.5 130.01 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.287 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.459 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 166.99 148.19 5.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.568 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.0 pt -52.2 154.01 4.47 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.537 0.208 . . . . 0.0 110.786 179.72 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.677 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 84.2 Cg_exo -47.26 -37.6 24.56 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.018 2.478 . . . . 0.0 113.792 -178.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -73.44 -23.32 60.09 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 m -57.99 128.55 37.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 110.964 -179.773 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.87 129.84 41.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.538 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.702 HG12 ' HG2' ' A' ' 15' ' ' PRO . 26.8 m -121.4 125.1 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 111.013 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.4 m -75.84 116.89 17.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.921 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 61.5 mt -83.04 136.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.67 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 58' ' ' SER . 29.3 tpt180 -141.49 133.41 27.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.334 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.45 -134.04 1.69 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.48 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -150.25 132.24 15.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.944 0.402 . . . . 0.0 111.281 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.456 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 72.3 m-80 59.3 46.47 12.69 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.673 178.807 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.4 mp -81.78 52.15 1.86 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 110.694 178.797 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.06 126.69 0.14 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.419 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.7 p -90.77 42.27 1.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.694 0.283 . . . . 0.0 111.563 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.52 145.81 5.0 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.792 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 -46.38 27.61 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.394 2.063 . . . . 0.0 111.709 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.5 t -62.05 -36.06 80.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.072 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.14 -36.18 67.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 tt -75.57 61.09 1.28 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.488 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.593 HD13 ' HG2' ' A' ' 79' ' ' LYS . 30.7 pt -68.98 -40.1 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.435 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.422 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -110.48 139.75 15.61 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.957 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 42' ' ' THR . 3.0 tm? -148.26 132.06 17.01 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.626 ' N ' HD13 ' A' ' 41' ' ' LEU . 24.0 p -150.51 140.94 22.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.162 0.506 . . . . 0.0 111.843 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.3 mt -137.4 125.79 33.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.573 178.991 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.522 ' SG ' HD21 ' A' ' 92' ' ' LEU . 69.2 m 58.43 37.98 25.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.163 0.506 . . . . 0.0 110.1 -179.004 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.89 25.31 71.88 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.958 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -131.85 125.33 31.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.54 0.209 . . . . 0.0 110.521 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -63.11 138.17 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.324 . . . . 0.0 110.633 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.0 m -148.84 39.38 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.684 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 39' ' ' ILE . 58.3 tp -69.69 -44.55 70.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.266 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.463 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.4 pt? -50.66 -44.16 57.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.297 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.457 HG23 ' HG ' ' A' ' 50' ' ' LEU . 71.8 p -80.77 -37.83 29.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 111.134 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -60.44 130.31 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.718 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -126.82 129.36 48.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.514 179.404 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 80.8 t90 -64.57 145.92 55.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.618 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.3 mmm -140.14 -45.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 58' ' ' SER . 65.7 m -164.05 160.27 21.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.65 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.39 27.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.838 0.352 . . . . 0.0 111.396 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.3 m -168.03 19.49 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.833 179.341 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.3 tttp -165.19 130.8 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.511 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 68.5 mt -148.84 119.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.952 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.32 134.71 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.555 179.323 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 45.9 t -170.67 152.84 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.277 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -83.79 135.25 34.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.001 179.366 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.677 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.625 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.81 -0.116 . . . . 0.0 112.81 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -66.06 130.69 44.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.708 0.289 . . . . 0.0 111.129 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.422 ' O ' HD13 ' A' ' 75' ' ' ILE . 68.8 mt -85.06 131.61 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.355 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 74' ' ' ILE . 39.9 mm -127.4 139.93 50.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.402 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -139.63 120.94 15.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.624 179.558 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.9 m -94.07 142.47 27.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.2 p -136.92 136.57 38.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.593 ' HG2' HD13 ' A' ' 39' ' ' ILE . 28.3 mtpp -55.96 -50.62 70.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.018 -179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.0 m -67.52 -54.59 18.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.323 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.21 -125.22 0.46 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.108 179.385 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.55 -141.69 3.22 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.469 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -63.9 128.99 38.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.82 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.11 128.31 8.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.775 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 81.4 p -103.63 148.55 25.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.626 0.25 . . . . 0.0 110.829 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.608 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 40.4 t -154.48 127.82 8.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 111.661 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.4 p -77.55 -32.98 54.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.423 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.6 m -84.47 148.66 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.494 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.3 m -139.29 140.35 37.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.549 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.416 ' CD2' HG11 ' A' ' 64' ' ' VAL . 62.3 t80 -85.05 131.74 34.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.35 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.461 ' HE3' HD21 ' A' ' 93' ' ' LEU . 38.9 ttpt -84.34 122.27 28.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.595 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.522 HD21 ' SG ' ' A' ' 44' ' ' CYS . 3.4 mm? -78.59 131.64 36.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.241 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 17' ' ' GLU . 73.6 mt -108.27 137.45 46.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.585 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 62.0 tttp -61.62 128.58 90.36 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.812 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 47.8 Cg_exo . . . . . 0 C--N 1.347 0.468 0 C-N-CA 122.537 2.158 . . . . 0.0 112.45 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.769 0.319 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.4 mmt -58.34 132.87 54.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.55 ' HE ' ' HB3' ' A' ' 80' ' ' SER . 72.1 mtm-85 -62.85 123.2 17.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -76.4 140.51 68.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.196 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.98 144.79 99.43 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.521 2.147 . . . . 0.0 111.888 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 54.2 Cg_exo -51.41 118.47 4.39 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.317 2.011 . . . . 0.0 112.4 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.5 tp -99.41 131.27 45.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.645 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 85.1 t -116.6 135.91 55.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.672 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -168.82 52.47 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.098 0.475 . . . . 0.0 111.34 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.93 143.53 8.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.579 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.544 HG12 ' HD2' ' A' ' 15' ' ' PRO . 12.7 tt -161.36 131.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.564 0.221 . . . . 0.0 110.782 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.697 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 43.8 t -62.3 -60.23 10.65 Favored Pre-proline 0 CA--C 1.531 0.218 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.132 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 84.8 Cg_endo -79.71 -160.14 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.875 1.717 . . . . 0.0 111.742 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -173.22 21.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.761 0.315 . . . . 0.0 110.967 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.413 ' HB2' HD11 ' A' ' 93' ' ' LEU . 22.8 pt-20 177.78 127.45 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.3 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 164.09 153.03 7.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.886 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 93' ' ' LEU . 34.7 pt -53.92 159.65 2.65 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.435 0.16 . . . . 0.0 110.922 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.841 ' HA ' HG23 ' A' ' 64' ' ' VAL . 75.8 Cg_exo -51.41 -40.75 61.94 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.64 2.227 . . . . 0.0 113.392 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.495 ' HE3' HH11 ' A' ' 63' ' ' ARG . 78.6 m95 -69.56 -5.35 23.79 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.0 m -66.96 132.23 47.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 111.314 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.56 ' HD2' HG13 ' A' ' 61' ' ' VAL . 17.6 tppt? -70.31 138.74 51.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.69 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.576 HG12 ' HG3' ' A' ' 15' ' ' PRO . 35.2 m -145.9 128.55 9.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.96 0.409 . . . . 0.0 111.06 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 84.3 m -87.13 120.99 28.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.8 mt -79.79 139.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.115 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HE ' ' HZ3' ' A' ' 59' ' ' LYS . 19.2 mmt85 -137.33 134.74 36.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.33 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.05 -136.25 2.24 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.871 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -152.16 134.42 15.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.972 0.415 . . . . 0.0 111.497 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.9 m120 60.63 42.0 14.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.603 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.527 HD13 ' HA ' ' A' ' 58' ' ' SER . 9.1 mp -83.85 50.47 1.82 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 110.399 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.48 126.56 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.31 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.9 p -94.97 43.51 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 0.0 111.252 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.41 142.74 4.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.707 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.2 -42.26 58.6 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.595 2.196 . . . . 0.0 112.044 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.3 p -62.96 -38.68 92.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.955 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -56.56 -37.33 70.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.976 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.575 HD21 HD23 ' A' ' 41' ' ' LEU . 1.4 tt -75.46 62.8 1.4 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.466 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.464 HG13 ' N ' ' A' ' 40' ' ' GLY . 35.9 pt -69.25 -41.24 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.495 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -110.41 137.87 14.54 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.957 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.602 HD13 ' N ' ' A' ' 42' ' ' THR . 2.3 tm? -149.05 128.96 13.4 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.605 HG22 ' HA ' ' A' ' 47' ' ' ASN . 12.2 p -152.08 138.41 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.148 0.499 . . . . 0.0 111.864 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.663 ' HB ' ' H ' ' A' ' 65' ' ' GLY . 71.4 mt -127.53 127.36 68.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.364 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.477 ' SG ' HD11 ' A' ' 92' ' ' LEU . 71.2 m 58.14 36.03 25.55 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.24 -26.71 1.81 Allowed Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.768 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.442 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 25.5 t-80 -76.3 135.06 39.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.786 0.327 . . . . 0.0 111.337 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.605 ' HA ' HG22 ' A' ' 42' ' ' THR . 50.5 t-20 -73.23 136.22 44.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.659 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.7 m -152.47 41.87 0.63 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.728 0.299 . . . . 0.0 111.292 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.3 tp -71.38 -43.16 67.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.124 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -50.31 -41.92 51.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.605 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.422 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 72.4 p -80.3 -36.51 34.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.379 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.89 133.66 55.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.712 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -126.9 130.94 51.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.615 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -70.59 146.5 50.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.056 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.8 mmt -136.36 -52.4 0.72 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.643 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.0 m -160.52 -172.61 3.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.462 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.48 41.67 0.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.205 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.527 ' HA ' HD13 ' A' ' 31' ' ' LEU . 47.9 t -175.27 -47.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.753 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.618 ' HZ3' ' HE ' ' A' ' 27' ' ' ARG . 25.0 ttmm -87.8 136.23 33.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.866 0.365 . . . . 0.0 111.638 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -150.51 117.17 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.529 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.56 HG13 ' HD2' ' A' ' 23' ' ' LYS . 57.5 t -85.04 124.17 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.968 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.8 p -170.93 143.82 2.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 0.0 111.238 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.495 HH11 ' HE3' ' A' ' 21' ' ' TRP . 99.2 mtt180 -84.23 132.51 34.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.331 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.841 HG23 ' HA ' ' A' ' 20' ' ' PRO . 16.1 m -59.39 127.65 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.198 0.523 . . . . 0.0 111.635 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.663 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . -70.53 155.5 52.99 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.826 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.414 ' HG2' ' CG ' ' A' ' 46' ' ' HIS . 17.8 pt20 -51.49 143.74 11.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.804 0.335 . . . . 0.0 110.828 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.873 ' HB2' HD12 ' A' ' 92' ' ' LEU . . . -60.15 144.65 49.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.229 0.538 . . . . 0.0 111.998 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -147.84 -43.9 0.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.528 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -76.15 -123.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.203 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -170.41 42.82 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.747 0.308 . . . . 0.0 111.144 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 89' ' ' SER . 24.1 tptm -164.55 -46.44 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.856 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.88 44.82 2.78 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.159 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -75.5 129.57 37.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.752 0.311 . . . . 0.0 110.94 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.1 mt -86.6 92.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.996 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.3 mm -86.52 139.78 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.205 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.9 t -139.6 113.44 6.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.2 m -81.87 144.28 31.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.496 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.0 p -141.32 134.95 30.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.718 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -59.24 -44.98 92.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.102 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.55 ' HB3' ' HE ' ' A' ' 5' ' ' ARG . 50.9 m -61.61 -42.88 99.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.979 0.418 . . . . 0.0 110.068 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.77 -118.15 3.25 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.081 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 -142.42 3.39 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.398 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -70.65 130.98 43.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.873 0.368 . . . . 0.0 110.963 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.48 136.81 15.98 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.67 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.7 p -98.92 140.17 33.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.662 0.268 . . . . 0.0 110.507 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.645 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 39.7 t -129.32 128.78 43.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.977 0.418 . . . . 0.0 111.727 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.2 p -75.4 -35.92 60.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.991 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.8 m -85.27 159.41 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.22 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 71' ' ' LYS . 66.9 m -146.35 137.13 24.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' A' ' 64' ' ' VAL . 46.4 t80 -86.15 129.01 34.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.427 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.457 ' HE3' HD21 ' A' ' 93' ' ' LEU . 38.8 ttpt -83.36 117.92 23.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.265 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.873 HD12 ' HB2' ' A' ' 67' ' ' ALA . 86.5 mt -83.02 128.46 34.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 111.286 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.47 HD12 ' HA2' ' A' ' 18' ' ' GLY . 80.3 mt -99.62 144.16 29.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.892 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -57.93 139.09 83.06 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.88 134.75 42.47 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.666 2.244 . . . . 0.0 112.939 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -74.66 118.74 17.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.536 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.0 tptp . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.795 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.554 0.216 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.4 mtt -61.99 137.67 58.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.84 0.352 . . . . 0.0 111.093 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.1 mtm-85 -61.99 124.93 22.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.03 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -75.72 142.54 73.72 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.093 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.24 145.56 96.1 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.509 2.139 . . . . 0.0 111.82 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.72 118.71 3.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.401 2.068 . . . . 0.0 112.317 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.529 HD13 ' C ' ' A' ' 9' ' ' LEU . 3.4 tm? -98.52 117.79 33.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.646 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 58.8 t -96.1 139.52 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.908 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 t -171.05 48.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 111.205 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.74 139.32 5.59 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.027 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.458 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.6 tt -165.03 132.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.75 0.31 . . . . 0.0 110.629 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.81 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.9 t -68.41 -59.35 6.06 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.135 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.85 ' HG2' HG12 ' A' ' 24' ' ' VAL . 68.1 Cg_endo -92.94 121.98 0.48 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.247 1.965 . . . . 0.0 112.961 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -96.71 29.62 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.528 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.546 ' HB2' HD11 ' A' ' 93' ' ' LEU . 23.3 pt-20 179.73 132.24 0.09 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.395 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 171.92 143.38 4.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.095 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.558 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 35.2 pt -59.14 165.06 3.91 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 120.38 0.134 . . . . 0.0 111.083 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.671 ' HA ' HG23 ' A' ' 64' ' ' VAL . 95.7 Cg_exo -46.27 -41.89 22.16 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.927 2.418 . . . . 0.0 113.61 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -77.22 -17.42 58.49 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.426 ' OG1' HG12 ' A' ' 19' ' ' ILE . 80.9 m -56.89 131.48 49.71 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.68 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -73.63 139.84 45.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.566 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.85 HG12 ' HG2' ' A' ' 15' ' ' PRO . 35.0 m -139.55 128.25 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 111.075 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.6 m -89.2 118.3 28.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.1 mt -85.74 138.98 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -143.16 137.34 28.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.82 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -172.98 -129.32 1.14 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.722 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -146.75 136.37 23.03 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 110.939 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 61.65 40.02 13.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.87 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 mp -82.95 50.55 1.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 110.707 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.79 132.5 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.501 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.3 p -60.14 -34.34 73.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.697 0.284 . . . . 0.0 111.037 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.546 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -158.93 -161.43 11.11 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.825 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.86 -43.61 1.67 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.634 2.223 . . . . 0.0 112.7 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.5 p -57.23 -40.92 78.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.287 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.34 -36.77 84.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.0 tp -75.82 62.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.15 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.646 HD13 ' HG2' ' A' ' 79' ' ' LYS . 32.4 pt -69.16 -36.13 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.114 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.468 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -126.71 139.85 11.56 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.781 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.4 tp -150.0 151.78 33.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.683 0.278 . . . . 0.0 110.685 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.1 p -149.72 141.46 23.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.29 0.567 . . . . 0.0 111.975 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.6 mt -137.83 130.69 41.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.246 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.407 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 83.3 m 52.83 30.49 9.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.404 . . . . 0.0 110.101 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.1 -38.66 3.19 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.987 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.479 ' NE2' ' HA3' ' A' ' 65' ' ' GLY . 30.8 p-80 -86.5 140.5 29.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 117.457 0.628 . . . . 0.0 111.781 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -60.86 145.22 50.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.4 m -149.72 38.03 0.75 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.9 tp -71.57 -47.09 57.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.618 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 51' ' ' THR . 3.3 pp -58.49 -34.96 71.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.514 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.731 ' N ' HD12 ' A' ' 50' ' ' LEU . 22.0 p -80.45 -38.28 30.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.941 0.4 . . . . 0.0 110.891 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -68.62 135.5 51.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.168 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -126.77 128.73 47.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.017 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.546 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 78.6 t90 -61.73 150.08 37.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.914 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.699 ' HG3' HG23 ' A' ' 61' ' ' VAL . 92.4 mmm -143.12 -44.11 0.29 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 67.4 m -161.09 160.72 30.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.028 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.76 -30.36 32.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.559 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.9 m -126.21 36.94 4.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.241 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 60.0 tttm -165.02 132.62 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.4 mt -150.43 122.89 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.699 HG23 ' HG3' ' A' ' 55' ' ' MET . 65.7 t -82.98 129.45 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.242 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.9 p -170.47 136.67 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 111.569 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 59.3 mtt85 -85.18 138.15 32.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.584 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.671 HG23 ' HA ' ' A' ' 20' ' ' PRO . 31.7 m -66.63 -143.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.673 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.479 ' HA3' ' NE2' ' A' ' 46' ' ' HIS . . . 175.81 -141.97 5.87 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.499 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -65.88 136.86 56.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.885 0.374 . . . . 0.0 111.378 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.461 ' HB2' HD23 ' A' ' 92' ' ' LEU . . . -79.08 55.72 1.86 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.386 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -52.21 -42.05 63.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.877 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -70.86 -127.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.294 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -148.94 -53.9 0.18 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.813 0.34 . . . . 0.0 110.653 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -91.69 -47.38 7.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.104 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.65 43.96 0.48 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.296 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.85 130.14 42.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.131 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.4 mt -97.42 128.39 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.319 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.82 138.0 49.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.418 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.3 t -124.81 129.1 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.633 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 40' ' ' GLY . 88.0 m -97.71 138.31 35.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.403 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.1 p -135.41 140.32 44.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.155 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.646 ' HG2' HD13 ' A' ' 39' ' ' ILE . 7.2 mtpm? -56.56 -46.72 80.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.779 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.7 p -65.56 -53.59 39.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.092 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.52 -124.41 2.24 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.099 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.7 -142.71 3.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.088 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.575 ' NZ ' ' HB3' ' A' ' 83' ' ' LYS . 5.9 ttpm? -71.53 123.29 22.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.715 0.293 . . . . 0.0 110.514 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.91 -160.55 36.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.746 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.0 p -154.97 -169.84 3.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.68 0.276 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.612 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 41.0 t -170.99 127.81 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.916 0.389 . . . . 0.0 111.318 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 82.5 p -72.53 -34.05 67.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.14 0.495 . . . . 0.0 110.084 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.9 173.62 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.377 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.8 p -157.41 135.6 11.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.712 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.518 ' CD2' HG11 ' A' ' 64' ' ' VAL . 53.4 t80 -85.4 127.03 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.184 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.598 ' HB3' ' NZ ' ' A' ' 91' ' ' LYS . 5.7 ttpm? -83.88 119.86 25.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.952 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' A' ' 20' ' ' PRO . 26.6 tp -85.19 131.14 34.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.244 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 17' ' ' GLU . 79.6 mt -94.63 136.28 35.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.777 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -63.49 137.92 97.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.31 133.92 52.33 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.493 2.129 . . . . 0.0 112.421 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -71.05 76.96 0.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.737 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.963 -179.703 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.728 0.299 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -175.15 139.49 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.71 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -171.16 57.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.708 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 32.8 tp60 -60.6 131.85 91.01 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.924 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 6' ' ' GLN . 46.5 Cg_exo -56.23 144.03 82.98 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.656 2.237 . . . . 0.0 112.473 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.57 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 14.4 Cg_endo -57.34 141.32 94.74 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.744 2.296 . . . . 0.0 112.196 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 85' ' ' THR . 4.4 tt -141.0 121.9 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 0.0 110.435 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.528 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 98.5 t -84.61 134.61 26.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.712 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.565 HG23 HD22 ' A' ' 9' ' ' LEU . 34.3 p -153.7 47.26 0.64 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.862 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.95 143.22 6.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.854 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.501 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 14.5 tt -160.53 130.35 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.713 0.292 . . . . 0.0 110.448 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.804 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 52.0 m -63.95 -59.55 11.07 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.155 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.804 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 91.4 Cg_endo -89.56 128.06 1.7 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.232 1.955 . . . . 0.0 112.69 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -105.3 25.05 11.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 0.0 110.242 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 177.57 131.3 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.547 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.25 149.56 5.82 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.445 -0.884 . . . . 0.0 112.8 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 93' ' ' LEU . 35.3 pt -57.16 157.48 11.75 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.437 0.161 . . . . 0.0 110.868 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.639 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 85.8 Cg_exo -48.69 -39.88 38.26 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.874 2.382 . . . . 0.0 113.576 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.408 ' HZ3' HH11 ' A' ' 63' ' ' ARG . 97.0 m95 -71.91 -20.49 61.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.9 m -56.75 131.41 49.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 111.144 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -65.98 135.94 55.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.426 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.57 HG12 ' HG2' ' A' ' 15' ' ' PRO . 33.4 m -134.36 129.42 53.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.39 . . . . 0.0 111.216 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.4 m -85.58 122.78 30.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.011 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.736 HD12 ' HB ' ' A' ' 60' ' ' ILE . 63.8 mt -83.3 137.42 20.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.028 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.491 ' O ' HG13 ' A' ' 10' ' ' VAL . 44.5 mmm-85 -143.89 133.37 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.668 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.13 -134.45 1.73 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.527 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -142.96 128.64 19.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.391 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.57 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 63.7 m-80 52.63 41.47 31.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.139 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.412 HD21 HG22 ' A' ' 26' ' ' ILE . 10.0 mp -60.11 -39.47 86.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.745 0.307 . . . . 0.0 111.047 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.02 132.15 1.97 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.647 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.8 p -64.68 -36.42 84.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 0.0 111.212 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.34 174.52 37.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.424 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.49 -43.46 55.19 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.427 2.085 . . . . 0.0 112.087 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -61.04 -40.88 95.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.014 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.496 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 64.7 t0 -59.06 -48.66 80.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.663 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.441 HD11 HD13 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -71.18 128.31 35.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.962 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.535 HD13 ' HG2' ' A' ' 79' ' ' LYS . 38.4 pt -143.57 -39.94 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.945 0.402 . . . . 0.0 110.673 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -105.49 133.33 11.53 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.482 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.405 ' HB2' HD23 ' A' ' 49' ' ' LEU . 24.0 tp -150.25 149.39 30.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.689 0.28 . . . . 0.0 110.337 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.2 m -159.41 140.34 12.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 111.508 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.08 126.53 37.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.337 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.601 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 77.4 m 54.82 38.98 31.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.992 0.425 . . . . 0.0 110.545 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.35 27.99 71.61 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.427 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -131.0 132.91 45.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.685 0.279 . . . . 0.0 110.824 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -67.03 133.5 50.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.705 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.4 m -152.18 40.03 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.96 0.409 . . . . 0.0 110.86 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 3.3 tm? -81.52 -43.29 18.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.874 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.454 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -53.59 -38.75 64.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.818 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.9 p -79.88 -37.43 34.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.699 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.34 135.74 57.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.974 0.416 . . . . 0.0 112.025 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -126.45 132.35 51.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.359 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -66.29 151.78 46.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.412 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 55.0 mtt -149.83 -42.77 0.13 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.76 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 58' ' ' SER . 86.9 p -169.13 169.65 9.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.533 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.83 34.39 0.1 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.529 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 56' ' ' SER . 78.4 p -177.99 30.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.911 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.6 ttmt -165.04 130.12 2.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.791 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.736 ' HB ' HD12 ' A' ' 26' ' ' ILE . 72.3 mt -150.67 122.56 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.0 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 9.0 p -88.33 132.93 32.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.522 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 26.7 p -170.89 156.32 4.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.035 0.445 . . . . 0.0 111.4 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.408 HH11 ' HZ3' ' A' ' 21' ' ' TRP . 98.9 mtt180 -84.01 134.93 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.2 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.639 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.5 t -59.07 134.19 24.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.122 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . -70.16 -123.35 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.293 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.745 ' HG3' ' HE3' ' A' ' 68' ' ' LYS . 20.4 pt20 -165.73 136.55 3.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.773 0.32 . . . . 0.0 110.5 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.601 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -49.71 131.87 21.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.893 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.745 ' HE3' ' HG3' ' A' ' 66' ' ' GLN . 35.0 mmtp -132.11 -50.01 0.94 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.585 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -77.58 -63.07 1.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.555 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.545 ' OD1' ' HG3' ' A' ' 71' ' ' LYS . 1.2 p30 -179.57 -47.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.047 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.545 ' HG3' ' OD1' ' A' ' 70' ' ' ASP . 29.5 mtpp -97.95 -126.68 0.16 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.524 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 44' ' ' CYS . . . -179.1 44.27 0.08 OUTLIER Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.466 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -61.99 132.14 51.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.37 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.8 mt -85.45 92.5 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.165 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.9 mm -91.08 145.63 7.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.153 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.42 128.51 24.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.101 0.477 . . . . 0.0 111.058 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 m -100.63 143.78 30.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.239 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.4 p -130.59 140.76 50.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.562 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 8.0 mtpm? -56.94 -47.99 79.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.248 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 61.4 m -64.75 -54.81 25.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.946 0.403 . . . . 0.0 110.561 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.32 -125.03 1.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.127 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.43 -140.78 3.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.995 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.3 117.76 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.753 0.311 . . . . 0.0 110.375 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.65 -149.16 2.32 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.935 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 40.6 p -155.84 150.73 26.33 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.49 0.316 . . . . 0.0 110.392 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -157.26 127.61 6.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.968 0.413 . . . . 0.0 111.175 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.3 p -107.58 40.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.806 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.69 149.1 15.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.352 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 t -140.11 137.36 34.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.691 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.544 ' HD2' HG11 ' A' ' 64' ' ' VAL . 63.4 t80 -85.25 129.95 34.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.131 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -77.51 125.18 28.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.395 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.3 mt -92.49 124.55 36.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.163 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 19' ' ' ILE . 79.3 mt -89.47 135.25 33.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.641 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 53.3 mtmt -64.21 133.07 95.51 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.056 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 31.8 Cg_exo -60.04 130.48 34.73 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.538 2.159 . . . . 0.0 112.171 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -74.19 115.09 13.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.354 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.62 ' HB2' ' NZ ' ' A' ' 97' ' ' LYS . 9.7 mtmp? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.93 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.6 m170 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.503 0.192 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 85.0 mtp 56.57 47.2 19.04 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.855 0.36 . . . . 0.0 111.146 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.412 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 54.5 ttp180 -62.05 144.59 55.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -59.14 135.9 88.04 Favored Pre-proline 0 N--CA 1.453 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.62 146.29 44.32 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.612 2.208 . . . . 0.0 112.436 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HG2' ' HA3' ' A' ' 84' ' ' GLY . 8.9 Cg_endo -50.62 144.68 24.84 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.982 2.455 . . . . 0.0 112.383 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.534 HD21 HG23 ' A' ' 87' ' ' THR . 2.1 tm? -141.68 119.95 12.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.208 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.565 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 92.7 t -77.37 134.66 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.618 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.459 HG23 HD12 ' A' ' 9' ' ' LEU . 61.3 p -148.0 44.51 1.07 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.206 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.34 145.12 5.65 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.063 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.7 tt -164.57 128.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.64 0.257 . . . . 0.0 110.44 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.829 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 48.0 t -67.14 -60.06 6.56 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.66 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.829 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 68.1 Cg_endo -91.99 114.38 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.149 1.899 . . . . 0.0 112.18 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -92.93 30.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 0.0 110.499 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.516 ' HB2' HD21 ' A' ' 93' ' ' LEU . 15.3 pt-20 178.08 131.21 0.07 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.446 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.8 144.6 4.27 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.067 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 93' ' ' LEU . 41.3 pt -59.42 161.54 10.2 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 121.969 0.107 . . . . 0.0 110.967 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.926 ' HA ' HG13 ' A' ' 64' ' ' VAL . 79.3 Cg_exo -47.92 -37.2 28.79 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.572 2.181 . . . . 0.0 113.036 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.09 -27.87 62.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.8 m -56.5 128.58 36.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 0.0 111.581 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.08 136.86 50.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.544 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.775 HG12 ' HG2' ' A' ' 15' ' ' PRO . 29.4 m -135.85 121.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.947 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.6 m -80.85 116.87 21.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.767 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 55.5 mt -77.42 141.22 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.581 HH11 ' HB2' ' A' ' 59' ' ' LYS . 25.8 mmm180 -146.9 131.01 17.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.411 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.28 -130.78 1.25 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.638 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -146.52 135.87 22.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 111.244 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.5 m-20 61.87 38.05 14.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.356 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.503 HD22 ' O ' ' A' ' 58' ' ' SER . 10.2 mp -84.14 51.01 1.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.951 0.405 . . . . 0.0 110.392 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 57' ' ' ALA . . . 70.87 118.78 0.04 OUTLIER Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.192 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.5 p -90.03 41.52 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 111.365 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.31 151.67 7.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.686 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.78 -43.07 62.72 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.473 2.115 . . . . 0.0 111.724 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.511 ' O ' ' HE2' ' A' ' 79' ' ' LYS . 2.5 t -61.79 -35.51 78.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.597 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.497 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 1.4 m-20 -51.93 -48.85 64.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.454 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.95 127.42 32.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.134 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.524 HD13 ' HD2' ' A' ' 79' ' ' LYS . 36.6 pt -147.26 20.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.094 0.474 . . . . 0.0 110.786 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 176.94 139.34 3.22 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.907 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 75' ' ' ILE . 18.1 tp -149.63 146.38 27.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.885 0.374 . . . . 0.0 111.023 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.408 ' OG1' ' HB ' ' A' ' 75' ' ' ILE . 20.5 p -151.15 134.47 16.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.181 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.684 HG21 HG23 ' A' ' 64' ' ' VAL . 64.7 mt -134.51 125.19 46.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.857 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.645 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 66.2 m 56.71 36.43 27.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.09 0.471 . . . . 0.0 109.991 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.99 33.69 87.93 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.891 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.515 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 31.0 t-80 -130.78 131.27 44.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.713 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -67.7 131.78 46.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.638 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 71.8 m -153.09 39.01 0.51 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.88 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 69.3 tp -73.96 -47.07 40.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.286 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.466 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -52.3 -40.36 61.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.631 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.6 p -80.35 -33.37 37.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.292 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.571 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -52.74 134.4 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.767 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -126.67 130.24 50.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.669 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -71.95 147.43 46.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 96.1 mmm -138.89 -48.37 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.5 m -160.55 -175.03 4.76 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.645 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -78.52 36.23 0.25 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.983 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.503 ' O ' HD22 ' A' ' 31' ' ' LEU . 79.8 p -177.29 -43.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.754 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.581 ' HB2' HH11 ' A' ' 27' ' ' ARG . 24.6 ttmm -84.87 131.25 34.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.047 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.0 mt -149.97 113.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.682 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.432 HG23 ' HG3' ' A' ' 55' ' ' MET . 43.2 t -82.81 130.82 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.431 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.571 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.4 p -170.41 160.28 7.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.0 111.199 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -83.65 126.17 32.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.805 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.926 HG13 ' HA ' ' A' ' 20' ' ' PRO . 2.3 p -62.96 131.5 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.161 0.505 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.576 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . -71.7 144.82 37.54 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.835 -0.621 . . . . 0.0 113.147 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.546 ' HG3' ' HE2' ' A' ' 68' ' ' LYS . 5.3 pt20 -59.78 145.3 45.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.638 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.805 ' HB2' HD12 ' A' ' 92' ' ' LEU . . . -55.35 134.8 50.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.294 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.546 ' HE2' ' HG3' ' A' ' 66' ' ' GLN . 74.9 mmtt -135.28 -48.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.7 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -77.95 -118.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.192 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -152.61 -44.09 0.1 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.837 0.351 . . . . 0.0 110.706 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.578 ' NZ ' ' HB2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -75.59 -48.57 21.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.261 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.55 43.28 6.2 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.189 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -74.76 140.19 43.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.838 0.352 . . . . 0.0 111.3 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.42 ' O ' HD13 ' A' ' 75' ' ' ILE . 76.9 mt -85.11 136.89 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.525 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.42 HD13 ' O ' ' A' ' 74' ' ' ILE . 49.8 mm -133.43 139.07 49.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.927 0.394 . . . . 0.0 111.624 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.35 126.87 45.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.69 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.7 m -96.73 138.8 33.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.712 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 82' ' ' GLY . 56.7 p -151.95 142.4 22.59 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.465 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.694 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -54.68 -30.49 55.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.665 0.269 . . . . 0.0 111.353 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -61.73 -57.19 12.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.608 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.45 -45.42 0.92 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.719 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 78' ' ' THR . . . 75.35 120.98 0.12 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.866 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.8 tttm 47.82 65.08 1.38 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.821 0.343 . . . . 0.0 111.047 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.425 ' HA3' ' HG2' ' A' ' 8' ' ' PRO . . . -64.88 -138.88 0.02 OUTLIER Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.88 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.6 p -151.06 -168.35 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.887 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.4 p -169.09 129.64 1.12 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.534 HG23 HD21 ' A' ' 9' ' ' LEU . 61.8 p -93.62 29.21 2.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.101 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 m -154.57 140.72 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 71' ' ' LYS . 79.0 p -120.2 140.52 51.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.537 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.522 ' CD2' HG21 ' A' ' 64' ' ' VAL . 45.0 t80 -89.35 129.95 35.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.621 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -88.33 123.68 33.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.242 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.805 HD12 ' HB2' ' A' ' 67' ' ' ALA . 93.2 mt -88.02 130.64 34.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.079 0.466 . . . . 0.0 111.974 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.549 ' O ' HG22 ' A' ' 19' ' ' ILE . 84.0 mt -88.69 140.7 29.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.723 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.46 128.03 92.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.651 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.99 127.35 25.96 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.511 2.14 . . . . 0.0 112.604 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.18 117.85 16.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.391 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.616 ' NZ ' ' HB3' ' A' ' 97' ' ' LYS . 5.6 ttpm? . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.1 m170 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.76 0.314 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -172.9 139.9 0.89 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.601 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.469 ' HG3' HH11 ' A' ' 5' ' ' ARG . 58.7 mtt85 -64.54 128.18 34.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.407 ' HG3' ' HD2' ' A' ' 7' ' ' PRO . 65.5 tt0 -63.59 137.18 97.02 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.003 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.407 ' HD2' ' HG3' ' A' ' 6' ' ' GLN . 16.9 Cg_endo -56.99 149.42 62.12 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.632 2.222 . . . . 0.0 112.242 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HD3' ' H ' ' A' ' 82' ' ' GLY . 65.6 Cg_exo -51.9 137.09 52.48 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.54 2.16 . . . . 0.0 112.168 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 85' ' ' THR . 3.3 tt -133.78 117.87 17.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.354 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.565 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 95.2 t -82.17 135.82 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.184 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.447 HG23 HD22 ' A' ' 9' ' ' LEU . 80.7 p -147.01 41.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.798 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.29 148.49 7.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.713 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.519 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.1 tt -160.36 132.76 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.763 0.315 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.811 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 45.4 t -66.43 -59.9 7.56 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.661 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.811 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 86.4 Cg_endo -89.87 119.01 0.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.041 1.827 . . . . 0.0 112.389 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -77.54 -20.56 53.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.411 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' OE1' HD11 ' A' ' 93' ' ' LEU . 15.4 pt-20 -157.07 139.88 15.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.03 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.53 147.57 8.58 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.654 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 37.4 pt -55.16 161.91 2.34 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-O 120.547 0.213 . . . . 0.0 111.362 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.881 ' HA ' HG23 ' A' ' 64' ' ' VAL . 85.2 Cg_exo -47.52 -46.17 21.21 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.089 2.526 . . . . 0.0 114.097 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -73.11 -8.29 55.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 m -70.04 128.09 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.992 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 28.5 mtpp -75.65 124.02 26.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.549 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.726 HG12 ' HG2' ' A' ' 15' ' ' PRO . 30.7 m -113.03 121.25 64.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.966 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.5 m -78.4 118.77 20.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.038 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.3 mt -80.63 137.07 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.738 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 58' ' ' SER . 28.3 tpt180 -139.28 126.28 21.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.268 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -167.89 -132.91 1.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.613 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -146.96 137.88 23.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.852 0.358 . . . . 0.0 111.325 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 72.8 m-80 63.84 41.77 6.54 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.369 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 8.8 mp -90.08 46.38 1.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.991 0.424 . . . . 0.0 110.265 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.21 120.34 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.185 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.1 p -91.88 42.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.678 0.275 . . . . 0.0 111.195 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.72 147.76 6.13 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.705 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.13 -45.17 42.65 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.519 2.146 . . . . 0.0 111.716 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 t -62.45 -36.59 82.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.158 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -55.55 -46.09 77.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.975 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -65.83 134.22 52.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.017 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.476 ' N ' HD23 ' A' ' 38' ' ' LEU . 30.2 pt -140.74 -42.5 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.317 . . . . 0.0 111.219 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.455 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -111.17 136.87 13.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.405 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.58 HD13 ' N ' ' A' ' 42' ' ' THR . 1.5 tm? -147.59 127.41 13.49 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.58 ' N ' HD13 ' A' ' 41' ' ' LEU . 22.6 p -152.95 142.02 21.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.514 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.609 HG21 HG12 ' A' ' 64' ' ' VAL . 70.1 mt -137.37 124.76 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.867 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.663 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 78.0 m 58.24 38.69 26.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 110.156 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.57 ' O ' ' HD3' ' A' ' 68' ' ' LYS . . . 62.44 33.35 86.08 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.877 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -131.12 133.46 45.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.771 0.32 . . . . 0.0 110.8 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -66.48 131.29 45.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.468 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.1 m -151.7 36.58 0.57 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.861 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.9 tp -75.72 -44.74 40.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.731 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -55.36 -39.33 69.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.9 p -79.93 -38.1 33.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.151 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -61.2 132.72 54.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.39 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -126.5 133.97 51.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.777 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -64.97 147.17 53.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.252 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 93.8 mmm -145.26 -42.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.407 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.764 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 54.7 m -161.59 157.47 24.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.911 0.386 . . . . 0.0 111.099 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 31' ' ' LEU . . . -50.39 -27.57 6.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.419 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.545 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 54.0 m -133.3 42.11 3.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.371 . . . . 0.0 110.719 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.764 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 60.5 tttm -164.5 128.14 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.868 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -149.97 118.07 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.506 ' CG1' ' HE3' ' A' ' 23' ' ' LYS . 50.1 t -84.46 130.46 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.553 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.547 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.4 p -170.07 131.67 1.03 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.791 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 22.3 ptt-85 -84.96 138.32 32.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.873 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.881 HG23 ' HA ' ' A' ' 20' ' ' PRO . 21.3 m -66.2 -145.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.724 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . -178.79 -40.82 0.07 OUTLIER Glycine 0 C--N 1.334 0.44 0 C-N-CA 119.7 -1.238 . . . . 0.0 113.753 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -171.35 131.48 0.76 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.125 0.462 . . . . 0.0 111.588 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.663 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -83.87 64.77 8.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.586 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 45' ' ' GLY . 57.4 mtpt -50.02 -45.84 52.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.955 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -71.16 -131.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.313 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -145.02 -48.89 0.24 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.866 0.365 . . . . 0.0 110.591 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 89' ' ' SER . 63.1 tttm -74.28 -47.53 34.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.138 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.06 45.49 3.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.472 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.21 134.87 48.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.686 0.279 . . . . 0.0 111.179 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.559 ' O ' HD13 ' A' ' 75' ' ' ILE . 68.2 mt -85.42 134.15 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.474 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.559 HD13 ' O ' ' A' ' 74' ' ' ILE . 37.8 mm -132.97 133.98 58.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.145 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.739 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 53.4 t -141.51 114.37 4.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.825 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.0 m -81.0 142.17 33.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.522 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.5 p -141.93 140.19 32.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.86 0.362 . . . . 0.0 111.426 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.3 mmmm -57.02 -50.69 71.96 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.074 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.0 m -65.07 -53.33 47.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.974 0.416 . . . . 0.0 110.346 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.37 -123.33 0.5 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.148 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.507 ' H ' ' HD3' ' A' ' 8' ' ' PRO . . . -169.44 -141.15 3.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.195 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -62.11 130.08 43.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 110.748 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.739 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -69.69 150.05 48.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.083 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 47.3 p -149.09 145.99 27.5 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.535 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 48.1 t -158.29 134.13 9.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.11 0.481 . . . . 0.0 111.965 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -77.18 -33.41 56.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.517 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -83.74 139.08 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.371 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 71' ' ' LYS . 83.1 p -120.38 140.27 51.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -86.22 132.75 33.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.721 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.494 ' HD3' HD21 ' A' ' 93' ' ' LEU . 31.7 ttmt -83.27 123.96 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.359 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.429 HD13 HG21 ' A' ' 64' ' ' VAL . 56.4 tp -99.06 121.11 40.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.871 0.367 . . . . 0.0 110.734 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 60.4 mt -96.39 139.6 32.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.651 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 61.1 pttt -59.84 134.57 89.72 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.417 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.531 ' HG3' ' HD2' ' A' ' 20' ' ' PRO . 48.1 Cg_exo -58.13 133.26 54.28 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.869 2.379 . . . . 0.0 112.806 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.57 117.85 20.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.651 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.909 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.9 m170 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.678 0.275 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.4 tpt 57.66 51.75 9.08 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.73 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -58.54 135.88 57.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.053 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -62.0 135.47 94.73 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.342 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.27 145.7 73.07 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.449 2.1 . . . . 0.0 111.796 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.538 ' HG2' ' HA2' ' A' ' 84' ' ' GLY . 11.6 Cg_endo -55.93 120.88 8.99 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.367 2.045 . . . . 0.0 112.036 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 9' ' ' LEU . 5.7 tt -102.65 100.81 10.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.477 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.662 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 59.5 t -84.0 136.76 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.596 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -169.14 51.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.522 . . . . 0.0 111.188 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.03 141.48 7.01 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.417 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.534 HG12 ' HD2' ' A' ' 15' ' ' PRO . 13.9 tt -164.78 130.71 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.448 0.166 . . . . 0.0 110.662 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.771 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.3 t -59.97 -61.44 7.9 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.919 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 85.9 Cg_endo -83.91 -159.96 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.8 1.667 . . . . 0.0 111.104 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -175.25 24.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.111 0.482 . . . . 0.0 110.41 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HB2' HD11 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -179.33 127.33 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.155 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.479 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 165.47 151.35 6.62 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.847 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.403 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 33.7 pt -52.45 161.42 1.08 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.49 0.186 . . . . 0.0 110.986 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.757 ' HA ' HG23 ' A' ' 64' ' ' VAL . 73.7 Cg_exo -50.47 -40.72 53.81 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.694 2.263 . . . . 0.0 113.562 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.516 ' HE3' HH11 ' A' ' 63' ' ' ARG . 84.5 m95 -73.86 -5.8 43.25 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -64.96 129.47 39.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.362 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.07 137.27 51.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.586 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.493 HG21 HG13 ' A' ' 64' ' ' VAL . 34.6 m -144.84 130.59 14.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.973 0.416 . . . . 0.0 110.975 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.6 m -87.67 117.46 26.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.949 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.1 mt -80.38 137.91 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.754 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.611 ' NH1' ' HB2' ' A' ' 59' ' ' LYS . 25.9 mmm180 -139.72 137.59 35.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.949 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.14 -135.54 2.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.368 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 55.9 mm-40 -151.24 138.06 18.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.825 0.345 . . . . 0.0 111.286 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 29.9 m120 62.59 38.79 12.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.288 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.566 HD23 HD12 ' A' ' 60' ' ' ILE . 9.5 mp -81.67 51.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.872 0.368 . . . . 0.0 111.063 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.429 ' HA2' ' OD2' ' A' ' 37' ' ' ASP . . . 76.5 134.56 0.56 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.893 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.5 p -59.75 -35.38 74.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.617 0.246 . . . . 0.0 111.314 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.58 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -168.24 -159.22 13.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.123 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.21 -46.36 15.63 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.954 2.436 . . . . 0.0 112.792 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 p -60.65 -41.22 94.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.511 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.429 ' OD2' ' HA2' ' A' ' 32' ' ' GLY . 64.9 t0 -66.33 -48.09 71.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.819 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.6 tt -64.63 130.75 44.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.989 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.504 ' N ' HD23 ' A' ' 38' ' ' LEU . 25.0 pt -149.36 -43.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.457 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -93.94 52.54 2.25 Favored Glycine 0 CA--C 1.51 -0.24 0 C-N-CA 120.494 -0.86 . . . . 0.0 114.149 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.554 HD13 ' N ' ' A' ' 42' ' ' THR . 2.7 tm? -70.23 127.25 32.14 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.69 HG22 ' HA ' ' A' ' 47' ' ' ASN . 6.9 p -155.58 144.96 20.98 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.153 0.502 . . . . 0.0 111.987 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.7 mt -137.66 123.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.527 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 60.3 m 57.64 36.37 26.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.099 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.46 -36.36 2.95 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.637 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -72.87 131.94 42.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.02 0.41 . . . . 0.0 111.398 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.69 ' HA ' HG22 ' A' ' 42' ' ' THR . 16.2 p-10 -72.56 141.78 48.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.433 ' C ' HD12 ' A' ' 41' ' ' LEU . 76.4 m -149.2 42.56 0.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.519 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 41' ' ' LEU . 33.0 tp -69.18 -44.47 72.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.19 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 51' ' ' THR . 3.6 pp -63.94 -34.48 78.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.173 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.729 ' N ' HD12 ' A' ' 50' ' ' LEU . 20.3 p -79.92 -38.17 33.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.821 0.343 . . . . 0.0 111.281 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -66.21 137.88 57.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.934 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -126.32 128.48 47.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.247 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.58 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 82.0 t90 -65.4 149.77 49.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.225 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.44 ' HG3' HG23 ' A' ' 61' ' ' VAL . 93.4 mmm -142.6 -43.81 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 58' ' ' SER . 48.7 m -155.83 178.02 10.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.674 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.2 37.21 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.564 ' O ' HD22 ' A' ' 31' ' ' LEU . 80.7 p -178.81 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.176 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.611 ' HB2' ' NH1' ' A' ' 27' ' ' ARG . 63.0 tttp -83.96 132.52 34.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.566 HD12 HD23 ' A' ' 31' ' ' LEU . 74.5 mt -148.62 115.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.668 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.44 HG23 ' HG3' ' A' ' 55' ' ' MET . 40.2 t -84.55 122.75 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.681 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 41.9 t -171.02 146.11 2.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.036 0.446 . . . . 0.0 111.179 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.516 HH11 ' HE3' ' A' ' 21' ' ' TRP . 98.9 mtt180 -85.19 134.09 34.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.207 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.757 HG23 ' HA ' ' A' ' 20' ' ' PRO . 19.4 m -55.72 136.67 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.599 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . -66.29 -125.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.618 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -142.89 143.45 32.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.86 0.362 . . . . 0.0 110.882 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.87 134.88 42.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.793 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -144.71 -41.39 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.612 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 53.4 p-10 -174.48 153.54 1.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.658 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 69' ' ' ASN . 1.5 m-20 73.87 -40.77 0.47 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.653 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 69' ' ' ASN . 83.4 tttt 64.34 124.28 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.871 ' HA3' ' HB2' ' A' ' 89' ' ' SER . . . 75.39 -33.28 1.14 Allowed Glycine 0 CA--C 1.517 0.217 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.957 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -45.16 127.49 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.373 . . . . 0.0 111.586 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.508 ' C ' HD12 ' A' ' 75' ' ' ILE . 68.0 mt -115.47 117.93 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.134 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.809 HG21 ' HE3' ' A' ' 83' ' ' LYS . 3.1 mp -120.98 137.5 54.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.37 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.725 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 3.8 p -141.76 103.58 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.829 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -77.31 131.94 38.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.657 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 82.4 p -123.15 142.32 51.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.091 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -50.78 -48.04 59.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.5 m -69.44 -48.48 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.981 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.83 -128.52 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.615 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.4 -40.99 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.344 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.809 ' HE3' HG21 ' A' ' 75' ' ' ILE . 49.6 tptt -169.72 127.45 0.91 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.76 0.314 . . . . 0.0 110.631 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.725 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -74.02 145.5 35.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.967 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.1 p -143.58 138.63 29.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.597 0.237 . . . . 0.0 110.52 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.662 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 45.2 t -133.13 129.81 38.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.019 0.438 . . . . 0.0 111.493 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.6 p -74.02 -32.43 63.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.573 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -83.88 176.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.372 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.871 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 72.5 p -157.44 133.2 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.649 ' CD2' HG11 ' A' ' 64' ' ' VAL . 69.0 t80 -85.62 127.32 34.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.815 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -85.04 122.31 29.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 110.607 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.522 ' N ' HD22 ' A' ' 92' ' ' LEU . 2.9 mm? -82.21 129.73 34.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.929 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.479 HD12 ' HA2' ' A' ' 18' ' ' GLY . 80.2 mt -100.59 138.94 36.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.6 139.48 96.0 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.039 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.38 133.68 28.92 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.518 2.145 . . . . 0.0 112.045 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.96 76.48 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.133 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.4 pttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.92 -179.834 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.552 0.215 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.5 ttt -62.24 134.54 56.66 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.752 0.31 . . . . 0.0 110.68 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -59.82 134.8 57.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.004 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -64.98 136.46 96.8 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.023 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.22 144.28 95.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.614 2.21 . . . . 0.0 112.153 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 51.8 Cg_exo -51.86 133.49 45.63 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.524 2.149 . . . . 0.0 112.185 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.55 HD22 HG23 ' A' ' 11' ' ' THR . 3.3 tt -123.56 118.0 26.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.236 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.514 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 62.8 t -81.34 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.285 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.55 HG23 HD22 ' A' ' 9' ' ' LEU . 71.4 p -147.0 45.2 1.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.033 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' C ' ' HB3' ' A' ' 27' ' ' ARG . . . 178.0 147.51 6.92 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.206 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.51 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.3 tt -160.98 130.42 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.728 0.299 . . . . 0.0 110.499 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.823 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.9 t -68.76 -58.2 7.05 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.685 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.823 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 68.8 Cg_endo -93.03 115.14 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.278 1.985 . . . . 0.0 112.592 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -96.96 27.79 3.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 0.0 110.61 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HB2' HD21 ' A' ' 93' ' ' LEU . 23.8 pt-20 -179.67 130.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.17 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.537 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 171.88 146.03 5.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.828 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.471 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 29.1 pt -54.17 162.81 1.4 Allowed Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 120.486 0.184 . . . . 0.0 111.28 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 19' ' ' ILE . 85.2 Cg_exo -48.16 -37.87 31.79 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.822 2.348 . . . . 0.0 113.653 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -77.71 -15.71 58.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -60.64 124.71 21.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.678 0.275 . . . . 0.0 111.195 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 25.5 pttm -77.18 127.08 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 0.0 110.431 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.799 HG12 ' HG2' ' A' ' 15' ' ' PRO . 16.6 m -109.45 125.64 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.556 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 84.9 m -72.42 120.88 18.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.82 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.511 HD12 ' HB ' ' A' ' 60' ' ' ILE . 65.5 mt -80.96 139.01 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.002 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 58' ' ' SER . 27.8 tpt180 -147.42 127.3 13.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.894 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.17 -134.58 1.75 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.959 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -149.5 137.55 20.5 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.921 0.391 . . . . 0.0 111.579 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 73.6 m-20 60.61 40.6 16.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.578 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.499 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.2 mp -84.49 53.5 2.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.863 0.363 . . . . 0.0 110.597 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.51 129.32 0.43 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.539 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.4 p -97.91 42.56 1.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 0.0 111.369 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.97 142.21 3.98 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.699 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.528 ' HG3' ' CE3' ' A' ' 54' ' ' TRP . 36.0 Cg_exo -56.56 -47.25 24.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.519 2.146 . . . . 0.0 112.116 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.4 p -65.28 -33.97 77.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.421 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -51.29 -42.88 61.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.997 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.2 tt -65.92 127.12 30.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 40' ' ' GLY . 32.9 pt -134.43 -44.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 111.32 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.5 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -100.86 136.46 12.71 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.463 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.555 HD13 ' N ' ' A' ' 42' ' ' THR . 2.2 tm? -148.8 126.67 11.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 47' ' ' ASN . 7.1 p -155.34 141.75 18.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.161 0.505 . . . . 0.0 111.873 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.8 HG21 HG23 ' A' ' 64' ' ' VAL . 76.5 mt -129.97 124.0 57.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.401 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.528 ' SG ' ' HA2' ' A' ' 72' ' ' GLY . 63.0 m 55.4 39.45 31.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.11 -32.92 2.23 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.894 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -72.53 129.75 39.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 0.0 111.127 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.663 ' HA ' HG22 ' A' ' 42' ' ' THR . 5.4 m120 -70.44 140.41 51.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.844 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.429 ' C ' HD12 ' A' ' 41' ' ' LEU . 75.1 m -150.39 40.36 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.4 tp -72.38 -43.88 63.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.321 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.434 ' H ' HD23 ' A' ' 50' ' ' LEU . 2.6 pt? -56.39 -38.63 71.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.4 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.0 p -79.84 -36.43 36.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.352 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -59.63 132.98 55.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.561 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -126.92 126.46 43.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.537 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.528 ' CE3' ' HG3' ' A' ' 35' ' ' PRO . 79.6 t90 -69.44 152.85 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.326 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 49.1 mtt -147.56 -44.38 0.17 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.025 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.2 p -169.58 173.57 6.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.637 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.93 37.31 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.524 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.491 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 79.0 p -176.68 24.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.087 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 59.4 tttp -165.31 128.83 2.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.138 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' HB ' HD12 ' A' ' 26' ' ' ILE . 73.4 mt -152.2 119.55 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.655 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.37 134.15 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.616 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.544 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.8 p -169.57 146.2 3.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.845 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.672 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 68.3 mtt-85 -84.03 131.64 34.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.8 HG23 HG21 ' A' ' 43' ' ' ILE . 8.4 p -67.78 -137.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.085 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.686 ' H ' HG22 ' A' ' 64' ' ' VAL . . . 168.94 -140.78 6.34 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.003 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.504 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 20.0 pt20 -87.72 138.47 31.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 0.0 111.471 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.631 ' HB2' HD12 ' A' ' 92' ' ' LEU . . . -78.02 66.25 3.61 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.461 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.504 ' HG3' ' HG3' ' A' ' 66' ' ' GLN . 57.7 mtpt -51.8 -43.32 63.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.811 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -69.02 -124.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.771 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -163.4 38.73 0.09 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.81 0.338 . . . . 0.0 110.943 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 89' ' ' SER . 38.8 ttmt -171.03 -43.32 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.606 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.528 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . 97.67 47.37 2.14 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.843 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -73.24 130.93 41.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 111.328 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.502 ' O ' HD13 ' A' ' 75' ' ' ILE . 70.4 mt -85.59 135.2 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.226 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.502 HD13 ' O ' ' A' ' 74' ' ' ILE . 40.0 mm -131.55 137.02 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.798 0.332 . . . . 0.0 111.703 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.4 t -141.53 117.84 6.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.937 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -86.05 147.33 26.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.347 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.9 p -139.44 143.7 37.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.4 mmmm -53.97 -55.06 30.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.365 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.1 t -67.65 -55.43 13.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.002 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.28 -128.65 0.38 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.644 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 -137.3 2.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.999 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -65.12 121.4 14.64 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.5 126.78 8.74 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.893 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 73.1 p -99.43 144.05 28.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.412 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 80.9 p -131.98 126.79 34.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.581 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.9 p -91.65 35.75 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.604 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.49 156.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.67 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.533 ' HB2' ' O ' ' A' ' 71' ' ' LYS . 84.5 p -138.53 134.63 34.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.946 0.403 . . . . 0.0 111.192 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.651 ' HE2' HG11 ' A' ' 64' ' ' VAL . 39.3 t80 -86.06 131.42 34.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.347 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -83.93 124.79 31.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.062 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.631 HD12 ' HB2' ' A' ' 67' ' ' ALA . 89.2 mt -90.0 127.71 36.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 111.647 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 18' ' ' GLY . 78.3 mt -92.56 139.98 30.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.372 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -56.52 126.89 71.31 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.949 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -53.45 137.75 65.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.869 2.379 . . . . 0.0 112.922 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -70.47 117.89 12.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.881 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.834 -179.838 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.7 m80 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.823 0.344 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.413 ' N ' ' SD ' ' A' ' 4' ' ' MET . 3.2 mpp? -64.42 -45.93 85.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.784 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.572 HH12 ' HB3' ' A' ' 80' ' ' SER . 14.4 tpp85 -62.89 128.29 35.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.52 ' CD ' ' H ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -77.23 129.52 77.7 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.055 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.71 148.59 36.94 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.755 2.303 . . . . 0.0 112.375 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.48 142.85 99.58 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.635 2.223 . . . . 0.0 112.054 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.518 HD13 ' C ' ' A' ' 9' ' ' LEU . 3.3 tm? -140.38 119.83 13.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.499 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.1 t -83.58 142.55 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.986 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 t -167.99 49.02 0.05 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.037 0.446 . . . . 0.0 111.363 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.13 138.5 3.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.698 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.518 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.7 tt -165.24 130.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 0.0 110.604 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.818 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.6 t -65.46 -59.38 9.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.692 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.818 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 83.7 Cg_endo -90.58 111.72 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.164 1.909 . . . . 0.0 112.155 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -89.33 26.81 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.595 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 176.22 132.25 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.261 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.73 144.22 4.64 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.905 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.429 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 33.1 pt -56.7 160.77 5.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.496 0.189 . . . . 0.0 111.02 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.744 ' HA ' HG13 ' A' ' 64' ' ' VAL . 84.8 Cg_exo -47.07 -45.15 22.02 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.812 2.342 . . . . 0.0 113.544 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -67.2 -22.43 65.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.2 m -62.61 128.21 34.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.136 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 24.7 ttmm -73.83 138.18 44.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.622 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.691 HG12 ' HG2' ' A' ' 15' ' ' PRO . 35.0 m -132.23 125.28 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.002 0.43 . . . . 0.0 111.032 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -85.57 118.8 25.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.097 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.4 mt -83.92 137.16 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.431 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -147.66 135.76 21.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.827 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.93 -126.6 0.85 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.21 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -145.18 134.85 23.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.329 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 60.97 42.21 13.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.079 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 mp -83.91 54.93 3.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.964 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.21 134.19 1.9 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.76 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.6 p -67.4 -40.81 85.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.63 0.252 . . . . 0.0 111.62 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.552 ' HA2' ' CZ2' ' A' ' 54' ' ' TRP . . . -156.52 -177.92 30.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.755 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.85 -40.27 79.94 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.638 2.225 . . . . 0.0 112.042 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.8 p -59.95 -41.35 91.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.983 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 37.7 t70 -66.82 -46.88 73.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.898 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.511 ' C ' HD13 ' A' ' 38' ' ' LEU . 3.4 tm? -69.85 129.0 38.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.923 0.392 . . . . 0.0 110.347 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.501 HD13 ' HG2' ' A' ' 79' ' ' LYS . 49.8 pt -147.96 -23.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.422 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.91 128.72 6.98 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.848 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' A' ' 52' ' ' ALA . 31.4 tp -150.41 147.15 27.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.64 0.257 . . . . 0.0 110.558 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 46' ' ' HIS . 98.2 m -161.69 129.28 4.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.396 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.514 HD11 ' SG ' ' A' ' 62' ' ' CYS . 70.8 mt -105.34 130.52 56.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.449 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 79.7 m 69.26 -66.42 0.26 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.53 0.519 . . . . 0.0 110.971 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.65 26.13 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.493 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.56 ' O ' HG23 ' A' ' 42' ' ' THR . 83.1 t60 -132.18 135.76 46.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.585 0.231 . . . . 0.0 110.707 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -59.29 136.83 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.772 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.7 m -151.45 36.28 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.102 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 49.5 tp -70.3 -44.69 67.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.964 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.451 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -54.12 -40.77 67.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.049 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.3 p -80.38 -32.67 37.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.04 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.15 133.27 55.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.087 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -127.14 127.1 44.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.129 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.552 ' CZ2' ' HA2' ' A' ' 34' ' ' GLY . 43.4 t90 -67.4 149.09 50.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 110.702 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.688 ' HG3' HG23 ' A' ' 61' ' ' VAL . 94.5 mmm -143.26 -43.13 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.2 t -166.86 172.84 9.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.846 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.58 25.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.641 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.8 m -167.78 21.35 0.03 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.696 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.579 ' HB2' ' NZ ' ' A' ' 59' ' ' LYS . 5.0 ttmp? -165.1 134.87 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.3 mt -146.86 121.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.688 HG23 ' HG3' ' A' ' 55' ' ' MET . 60.7 t -80.89 125.7 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.513 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.1 p -170.42 140.56 1.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.021 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 84.4 mtm180 -84.33 136.79 33.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.634 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.744 HG13 ' HA ' ' A' ' 20' ' ' PRO . 4.8 p -54.29 137.73 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.395 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.74 -62.0 4.07 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.801 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' C ' ' HG ' ' A' ' 92' ' ' LEU . 11.3 pt20 -178.6 -138.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.399 -0.222 . . . . 0.0 110.399 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.615 ' HB2' ' CB ' ' A' ' 92' ' ' LEU . . . -139.61 48.03 1.84 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.723 0.297 . . . . 0.0 111.098 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -51.79 -46.32 64.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.174 0.511 . . . . 0.0 110.069 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -87.39 151.55 22.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.422 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.606 ' OD1' ' HG3' ' A' ' 71' ' ' LYS . 1.2 p30 -56.24 -44.81 79.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.021 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.606 ' HG3' ' OD1' ' A' ' 70' ' ' ASP . 97.1 mttt -86.78 -125.58 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.437 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.51 40.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.311 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -62.76 130.91 47.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 71.8 mt -85.3 131.58 33.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.468 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.0 mm -128.88 139.55 51.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.229 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.78 121.65 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.8 m -98.09 133.9 41.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.509 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 81.6 p -118.52 142.21 47.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.178 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 37' ' ' ASP . 29.4 mtpp -54.02 -44.88 71.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.633 0.254 . . . . 0.0 110.982 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.572 ' HB3' HH12 ' A' ' 5' ' ' ARG . 49.9 m -66.81 -47.13 72.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.984 0.421 . . . . 0.0 109.957 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.42 -132.53 1.69 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.47 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . 172.81 67.41 0.05 OUTLIER Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.247 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 82' ' ' GLY . 59.2 tttm 67.98 109.28 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.881 0.372 . . . . 0.0 110.439 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.06 -134.32 6.44 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.856 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.427 ' OG1' HD23 ' A' ' 9' ' ' LEU . 74.4 p -145.99 -168.26 2.94 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.578 0.227 . . . . 0.0 110.626 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 78.4 p -169.47 125.35 0.86 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 111.151 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.9 p -90.53 28.37 1.5 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.708 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 m -153.58 149.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.999 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.8 m -134.56 134.86 41.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -85.5 127.67 34.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -81.08 117.15 21.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.553 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.615 ' CB ' ' HB2' ' A' ' 67' ' ' ALA . 1.5 tm? -81.16 128.47 33.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.523 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.586 ' N ' HD13 ' A' ' 92' ' ' LEU . 80.8 mt -99.65 133.51 43.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.845 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -68.05 134.1 91.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.661 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.45 129.95 37.43 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.368 2.046 . . . . 0.0 112.349 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -79.85 119.29 22.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.674 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.869 179.899 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.79 0.328 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.462 ' O ' ' HG2' ' A' ' 4' ' ' MET . 27.8 ttt -79.67 44.76 0.64 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.078 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.572 ' NE ' ' HA ' ' A' ' 5' ' ' ARG . 12.9 mmp_? -68.79 129.63 40.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.612 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -67.34 133.25 93.17 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.01 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.82 146.59 66.24 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.658 2.239 . . . . 0.0 112.206 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 18.0 Cg_endo -58.31 129.61 33.62 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.596 2.198 . . . . 0.0 112.3 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 85' ' ' THR . 63.2 tp -113.33 119.84 39.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.071 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.43 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 69.7 t -85.29 132.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.069 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.9 p -151.57 47.91 0.81 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.51 144.57 6.43 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.869 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.567 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 13.0 tt -158.95 131.01 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.882 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 53.2 m -60.88 -60.69 9.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.565 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 1.001 ' HG2' HG12 ' A' ' 24' ' ' VAL . 3.7 Cg_exo -75.83 -150.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.954 1.769 . . . . 0.0 111.796 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.515 ' OD1' ' HG2' ' A' ' 17' ' ' GLU . 5.3 p30 -173.94 -22.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.024 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.515 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 16.2 pt-20 -159.51 129.38 5.52 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.685 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 169.69 159.81 16.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.56 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.405 HG21 ' HA ' ' A' ' 95' ' ' PRO . 35.6 pt -51.64 156.75 2.14 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.613 0.244 . . . . 0.0 111.03 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.853 ' HA ' HG23 ' A' ' 64' ' ' VAL . 75.8 Cg_exo -51.88 -41.07 65.16 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.742 2.295 . . . . 0.0 113.496 -179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -70.67 -5.79 32.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -64.02 131.0 46.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.998 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.736 ' HD2' HG13 ' A' ' 61' ' ' VAL . 17.3 tppt? -65.99 136.97 56.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.283 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.001 HG12 ' HG2' ' A' ' 15' ' ' PRO . 26.3 m -141.45 131.34 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.007 0.432 . . . . 0.0 111.309 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.416 ' HB ' ' OG ' ' A' ' 14' ' ' SER . 99.7 m -90.3 122.53 33.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.663 HD12 ' HB ' ' A' ' 60' ' ' ILE . 64.1 mt -79.41 141.5 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.782 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.403 ' HG2' HH11 ' A' ' 27' ' ' ARG . 12.2 tpt180 -147.56 131.39 17.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.318 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.87 -135.62 1.95 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.663 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 67.0 mm-40 -145.93 135.86 23.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.842 0.353 . . . . 0.0 111.44 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.474 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 72.8 m-80 61.59 40.59 13.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.351 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 mp -83.57 49.05 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.704 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.72 124.24 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.476 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.8 p -88.29 39.25 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.763 0.316 . . . . 0.0 111.362 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.36 147.47 5.07 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.594 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.92 -41.6 62.54 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.334 2.023 . . . . 0.0 111.77 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.9 p -61.17 -34.67 75.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.771 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.94 46.09 0.56 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.815 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 40' ' ' GLY . 1.9 tt -157.4 121.9 4.35 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.409 HD13 ' CD ' ' A' ' 79' ' ' LYS . 29.0 pt -144.21 33.16 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.989 0.423 . . . . 0.0 111.424 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.453 ' H ' HD23 ' A' ' 38' ' ' LEU . . . -174.04 128.5 1.48 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.39 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.685 HD13 ' N ' ' A' ' 42' ' ' THR . 1.2 tm? -150.56 134.0 16.4 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.685 ' N ' HD13 ' A' ' 41' ' ' LEU . 94.0 m -158.33 128.08 5.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.079 0.466 . . . . 0.0 111.746 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.651 HG21 ' HA ' ' A' ' 64' ' ' VAL . 41.1 mm -115.72 126.09 73.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.387 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.676 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 69.7 m 57.68 45.79 18.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.789 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.508 ' O ' ' HD2' ' A' ' 68' ' ' LYS . . . 61.94 11.65 32.2 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.975 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.479 ' C ' HG23 ' A' ' 42' ' ' THR . 82.1 t60 -116.07 133.12 56.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.328 . . . . 0.0 111.026 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.13 133.29 54.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.987 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.1 m -153.35 39.01 0.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.669 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.1 tp -72.27 -41.97 66.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.459 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 51' ' ' THR . 3.9 pp -58.07 -33.51 69.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.501 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.7 ' N ' HD12 ' A' ' 50' ' ' LEU . 20.3 p -80.03 -37.7 33.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.766 0.317 . . . . 0.0 110.99 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.577 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -59.82 131.13 49.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.735 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -127.21 127.58 44.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.262 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -65.62 141.53 58.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.739 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 95.3 mmm -132.23 -42.65 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.139 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 m -160.93 -166.34 1.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.998 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.04 -7.53 54.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.478 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.4 m -156.23 47.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.078 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 87.3 tttt -164.44 129.11 2.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.9 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.663 ' HB ' HD12 ' A' ' 26' ' ' ILE . 76.2 mt -150.21 126.91 2.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.968 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.736 HG13 ' HD2' ' A' ' 23' ' ' LYS . 89.1 t -84.58 127.89 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.535 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.5 p -170.67 145.09 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.815 0.34 . . . . 0.0 111.198 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -84.63 131.63 34.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.341 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.853 HG23 ' HA ' ' A' ' 20' ' ' PRO . 15.3 m -61.39 124.9 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.421 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.406 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . -74.39 151.28 43.2 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.683 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -52.43 140.75 21.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.749 0.309 . . . . 0.0 110.64 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.676 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -59.71 121.24 11.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.263 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HD2' ' O ' ' A' ' 45' ' ' GLY . 52.5 tttp -87.85 -53.69 4.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.45 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -92.77 -74.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.9 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -160.01 -54.19 0.06 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -78.34 -126.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.143 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 44' ' ' CYS . . . 171.67 48.69 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.53 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -57.87 132.16 52.55 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.01 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.4 mt -86.77 121.18 37.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.748 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.9 mm -111.62 138.97 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.307 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.458 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 62.0 t -141.39 110.64 2.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.901 0.382 . . . . 0.0 111.095 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.7 m -79.73 143.39 34.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.823 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.5 p -136.86 139.74 41.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.893 0.377 . . . . 0.0 111.369 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.409 ' CD ' HD13 ' A' ' 39' ' ' ILE . 32.0 mmmt -56.78 -47.43 80.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.055 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.7 m -67.25 -52.83 36.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.607 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 -125.14 2.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.068 -0.586 . . . . 0.0 112.411 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 -134.97 1.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.18 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -60.58 125.46 23.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 0.0 110.524 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.458 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -72.92 130.7 14.48 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.217 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 74.3 p -100.47 147.47 25.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.586 0.232 . . . . 0.0 110.773 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -159.88 125.74 4.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.32 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.7 p -99.0 40.73 1.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.522 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.4 m -147.97 157.34 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.798 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.2 p -150.74 139.24 20.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.542 ' CE2' HG21 ' A' ' 64' ' ' VAL . 68.9 t80 -84.83 127.24 34.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.163 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -72.4 120.26 17.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.338 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' A' ' 67' ' ' ALA . 92.9 mt -90.19 128.95 36.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.285 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.411 HD12 ' HA2' ' A' ' 18' ' ' GLY . 67.1 mt -105.55 140.11 39.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.631 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -58.51 140.22 84.76 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.405 ' HA ' HG21 ' A' ' 19' ' ' ILE . 52.0 Cg_exo -53.9 129.1 32.46 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.534 2.156 . . . . 0.0 112.598 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -82.93 119.15 24.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.495 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.1 pttt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.946 -179.787 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.847 0.356 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -58.32 130.89 48.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.086 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.458 ' NE ' ' HA ' ' A' ' 5' ' ' ARG . 3.6 mmp_? -75.62 135.84 40.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.786 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -72.47 133.02 83.22 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.975 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.72 141.78 38.32 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.51 2.14 . . . . 0.0 112.407 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 16.6 Cg_endo -57.57 143.46 94.65 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.735 2.29 . . . . 0.0 112.288 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 10' ' ' VAL . 1.9 tm? -132.12 122.47 25.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.248 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.511 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 63.7 t -83.04 137.65 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.624 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.409 HG23 HD12 ' A' ' 9' ' ' LEU . 68.9 p -148.94 45.6 1.0 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.94 146.34 6.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.126 -1.035 . . . . 0.0 113.449 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.1 tt -163.59 128.32 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.677 0.275 . . . . 0.0 110.308 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.869 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 59.1 m -68.48 -60.05 5.21 Favored Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.717 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.919 ' HG2' HG12 ' A' ' 24' ' ' VAL . 70.1 Cg_endo -95.24 106.74 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.399 2.066 . . . . 0.0 112.157 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -91.07 32.31 1.03 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.562 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 179.31 128.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.36 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 169.03 149.45 6.23 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.593 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.3 pt -54.01 160.07 2.49 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.538 0.209 . . . . 0.0 111.04 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.632 ' HA ' HG23 ' A' ' 64' ' ' VAL . 86.1 Cg_exo -49.26 -38.65 42.26 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.889 2.393 . . . . 0.0 113.651 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -75.8 -14.5 60.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 m -63.58 127.92 33.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 111.536 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 54.1 mtmt -74.97 134.65 41.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.324 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.919 HG12 ' HG2' ' A' ' 15' ' ' PRO . 28.4 m -123.41 128.57 74.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.941 0.4 . . . . 0.0 111.339 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.6 m -73.67 117.05 14.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.764 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 60' ' ' ILE . 67.9 mt -86.99 136.08 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.063 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.478 ' HE ' ' HG3' ' A' ' 59' ' ' LYS . 21.0 mmt85 -146.5 134.96 21.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.601 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.03 -130.99 1.27 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.466 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -146.49 132.48 19.21 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.855 0.36 . . . . 0.0 111.343 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.519 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.1 m-80 61.27 41.76 12.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.136 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.587 HD22 ' O ' ' A' ' 58' ' ' SER . 10.0 mp -81.86 53.33 2.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.978 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.99 134.32 1.22 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.639 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 p -66.47 -37.47 85.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.665 0.269 . . . . 0.0 111.537 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.42 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -154.79 -174.4 24.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.008 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.77 -43.93 15.0 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.737 2.291 . . . . 0.0 112.567 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.0 p -56.36 -40.63 74.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.828 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 79' ' ' LYS . 37.7 t70 -66.28 -36.86 84.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.736 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.2 tp -74.61 63.06 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.513 ' O ' HD22 ' A' ' 49' ' ' LEU . 32.5 pt -73.0 -37.14 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.158 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -113.51 142.27 17.36 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.037 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.646 HD13 ' N ' ' A' ' 42' ' ' THR . 3.0 tm? -149.62 134.71 18.06 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.646 ' N ' HD13 ' A' ' 41' ' ' LEU . 18.5 p -150.31 151.16 32.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.079 0.466 . . . . 0.0 111.832 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 77.2 mt -136.15 117.49 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.328 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 85.3 m 73.78 -38.3 0.4 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.468 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 168.33 -40.1 0.22 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.962 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -80.24 140.68 36.14 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.92 0.39 . . . . 0.0 111.763 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.541 ' HA ' HG22 ' A' ' 42' ' ' THR . 15.1 t-20 -59.8 144.59 48.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.965 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.5 m -149.96 38.28 0.74 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.08 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.513 HD22 ' O ' ' A' ' 39' ' ' ILE . 52.8 tp -73.84 -47.67 36.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.237 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.492 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.3 pt? -48.41 -44.44 35.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.727 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.674 HG21 ' HE ' ' A' ' 63' ' ' ARG . 52.9 p -80.12 -37.87 32.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.722 0.296 . . . . 0.0 111.349 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -60.23 137.16 58.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.491 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -126.76 130.72 50.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.506 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.42 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 55.7 t90 -66.53 150.83 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.223 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.8 mmt -141.2 -47.49 0.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.902 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.2 t -166.41 -175.1 3.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.401 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.73 38.23 0.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.756 0.312 . . . . 0.0 111.169 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.587 ' O ' HD22 ' A' ' 31' ' ' LEU . 80.4 p -175.87 -43.54 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.478 ' HG3' ' HE ' ' A' ' 27' ' ' ARG . 61.9 tttm -82.87 131.94 35.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.227 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 77.2 mt -151.78 105.92 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.598 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -80.25 130.67 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.825 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 31.7 t -170.82 141.33 1.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 111.407 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.674 ' HE ' HG21 ' A' ' 51' ' ' THR . 40.1 ptt180 -85.35 131.88 34.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.392 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.632 HG23 ' HA ' ' A' ' 20' ' ' PRO . 27.0 m -66.68 -149.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.732 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.51 ' C ' ' HB3' ' A' ' 20' ' ' PRO . . . -178.64 -142.22 4.7 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.634 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -77.23 -143.13 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.09 124.27 0.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 110.972 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.54 ' NZ ' ' HB3' ' A' ' 68' ' ' LYS . 3.3 mmmp? -71.09 -52.33 20.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -71.83 -82.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.772 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 64.1 t0 179.7 -47.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.69 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.613 ' HZ3' ' HB3' ' A' ' 89' ' ' SER . 25.6 ttpp -68.71 -116.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.794 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.8 46.72 0.05 OUTLIER Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.717 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.6 ' HB2' ' HZ1' ' A' ' 71' ' ' LYS . 63.9 t0 -63.81 128.63 36.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.928 0.394 . . . . 0.0 111.219 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.528 ' O ' HD13 ' A' ' 75' ' ' ILE . 68.5 mt -85.76 130.74 35.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.326 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.882 HG21 ' HE2' ' A' ' 83' ' ' LYS . 34.5 mm -134.19 145.77 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 111.449 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.2 p -139.55 128.36 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.833 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.5 m -93.61 143.79 25.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.403 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.8 p -137.0 137.42 39.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.541 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 7.5 mtpm? -55.65 -48.26 75.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.4 m -65.87 -55.46 16.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.928 0.394 . . . . 0.0 110.382 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.0 -123.64 0.72 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.161 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.82 -143.04 3.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.005 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.882 ' HE2' HG21 ' A' ' 75' ' ' ILE . 19.7 tptm -69.18 109.72 4.21 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.94 -161.25 7.28 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.181 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.43 ' HA ' ' CD1' ' A' ' 75' ' ' ILE . 44.0 p -154.29 -169.03 3.11 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.427 0.291 . . . . 0.0 110.451 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.511 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 45.4 t -171.16 131.86 0.8 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.755 0.312 . . . . 0.0 111.243 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.7 p -90.49 31.68 1.01 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.78 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.4 m -152.03 142.48 15.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.922 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.613 ' HB3' ' HZ3' ' A' ' 71' ' ' LYS . 77.3 p -125.07 133.72 52.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.72 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.506 ' CE2' HG21 ' A' ' 64' ' ' VAL . 69.5 t80 -85.77 128.08 34.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.866 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -82.48 123.13 28.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.572 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.8 mt -81.84 128.8 34.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.152 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.47 HD12 ' HA2' ' A' ' 18' ' ' GLY . 79.1 mt -98.89 133.38 43.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.724 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 31.0 mmmt -74.37 134.74 76.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 51.9 Cg_exo -55.85 130.75 42.06 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.53 2.153 . . . . 0.0 112.352 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -75.22 115.97 15.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.682 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.3 tttm . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.912 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.844 0.354 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 93.0 mmm -57.36 138.42 54.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.728 ' HD3' ' HB3' ' A' ' 80' ' ' SER . 99.5 mtt180 -145.74 45.39 1.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.771 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -60.25 145.53 85.66 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.225 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.451 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 50.9 Cg_exo -54.68 141.08 76.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.626 2.217 . . . . 0.0 112.289 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 48.0 Cg_exo -56.52 137.98 82.66 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.515 2.143 . . . . 0.0 112.148 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 85' ' ' THR . 3.5 tt -130.39 113.25 14.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.107 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.555 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 90.3 t -81.01 135.69 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.421 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.7 p -146.67 42.5 1.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.14 144.74 5.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.75 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.536 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.0 tt -163.07 130.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.62 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.827 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 50.4 m -65.64 -58.94 10.3 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.068 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.827 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 90.9 Cg_endo -95.0 119.99 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.575 2.183 . . . . 0.0 112.478 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -92.92 21.17 5.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.887 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 178.64 135.58 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.655 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.403 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 167.35 145.44 4.5 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.94 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 93' ' ' LEU . 33.4 pt -54.97 159.79 3.51 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 110.723 -0.103 . . . . 0.0 110.723 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.908 ' HA ' HG23 ' A' ' 64' ' ' VAL . 73.7 Cg_exo -48.67 -39.93 38.11 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.574 2.183 . . . . 0.0 113.099 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.406 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 60.4 m95 -69.92 -21.19 63.31 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.6 m -60.94 129.83 43.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 111.452 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.549 ' HD2' HG13 ' A' ' 61' ' ' VAL . 4.5 tppp? -70.34 140.59 52.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.422 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.702 HG12 ' HG2' ' A' ' 15' ' ' PRO . 19.6 m -136.66 133.15 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.2 m -88.13 110.59 20.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.782 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.406 HD11 ' SG ' ' A' ' 62' ' ' CYS . 59.6 mt -75.95 138.8 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.466 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.517 ' O ' HG13 ' A' ' 10' ' ' VAL . 22.2 tpp180 -147.11 128.99 15.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.385 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.77 -136.22 2.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.62 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -148.57 138.41 22.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.941 0.4 . . . . 0.0 111.197 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 62.92 41.18 8.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.289 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.576 HD23 HD12 ' A' ' 60' ' ' ILE . 9.8 mp -85.47 52.07 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.495 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.85 125.14 0.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.305 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -91.92 39.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.753 0.311 . . . . 0.0 111.493 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.54 144.74 4.37 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.599 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.88 -43.5 58.74 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.491 2.128 . . . . 0.0 111.997 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.8 p -61.75 -37.48 84.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.193 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 32.7 m-20 -57.1 -44.1 82.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.484 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.445 HD11 HD13 ' A' ' 60' ' ' ILE . 1.2 tt -73.9 67.74 1.26 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.74 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.509 HD13 ' HG2' ' A' ' 79' ' ' LYS . 26.6 pt -75.92 -39.53 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.675 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -114.31 139.17 15.42 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.219 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.576 HD13 ' N ' ' A' ' 42' ' ' THR . 3.0 tm? -150.13 130.11 13.44 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.576 ' N ' HD13 ' A' ' 41' ' ' LEU . 36.2 p -151.61 137.08 17.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 111.748 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.438 ' HB ' ' H ' ' A' ' 65' ' ' GLY . 69.1 mt -125.28 126.13 70.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.648 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.508 ' SG ' HD21 ' A' ' 92' ' ' LEU . 69.5 m 58.19 38.37 26.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.018 0.437 . . . . 0.0 110.335 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.408 ' HA3' ' OD1' ' A' ' 69' ' ' ASN . . . 64.07 34.28 89.49 Favored Glycine 0 C--N 1.331 0.285 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.171 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -131.34 133.38 45.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 0.0 110.556 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.491 ' HA ' HG22 ' A' ' 42' ' ' THR . 45.7 t30 -68.56 132.94 47.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.051 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.0 m -154.64 36.67 0.41 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.628 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 3.3 tm? -77.51 -46.09 23.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.774 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.451 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -52.72 -39.73 62.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.053 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.615 HG21 ' NE ' ' A' ' 63' ' ' ARG . 67.8 p -80.48 -35.67 34.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -55.13 138.37 44.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.514 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -126.07 130.69 51.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.806 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -80.36 150.6 29.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.4 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.9 mtt -147.71 -44.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.482 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 t -165.52 176.42 8.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.447 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.18 43.37 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.219 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.508 ' HA ' HD13 ' A' ' 31' ' ' LEU . 79.7 p -172.31 -42.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.135 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -93.71 130.64 39.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 111.166 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.576 HD12 HD23 ' A' ' 31' ' ' LEU . 80.1 mt -150.33 111.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.666 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.549 HG13 ' HD2' ' A' ' 23' ' ' LYS . 66.2 t -84.39 125.94 40.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.887 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 31.6 p -170.87 151.22 3.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.051 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.615 ' NE ' HG21 ' A' ' 51' ' ' THR . 39.0 ptt180 -83.94 132.37 34.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.501 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.908 HG23 ' HA ' ' A' ' 20' ' ' PRO . 6.5 m -60.06 130.02 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.856 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.438 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . -72.4 154.59 50.59 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.579 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -49.82 149.64 2.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.541 0.21 . . . . 0.0 110.576 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . . . -73.47 59.19 0.59 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.967 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.525 ' C ' ' HD3' ' A' ' 68' ' ' LYS . 12.6 tmtt? -55.45 -47.81 75.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.06 0.457 . . . . 0.0 109.78 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.408 ' OD1' ' HA3' ' A' ' 45' ' ' GLY . 4.8 m120 -83.07 -125.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.802 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -161.19 -40.24 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.789 0.328 . . . . 0.0 110.768 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 89' ' ' SER . 40.1 ttmt -60.27 -42.48 95.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.772 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.428 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . 75.1 37.35 43.26 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.655 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.08 136.8 41.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.686 0.279 . . . . 0.0 110.449 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.6 mt -84.95 92.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.007 0.432 . . . . 0.0 110.935 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.8 mm -81.88 137.77 20.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.635 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.2 t -141.54 106.77 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.119 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.0 m -82.16 143.55 31.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.505 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.2 p -141.04 134.8 30.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.519 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.555 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 7.6 mtpm? -55.53 -43.57 75.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.794 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.728 ' HB3' ' HD3' ' A' ' 5' ' ' ARG . 53.8 m -64.43 -48.97 73.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.241 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.46 -121.33 4.85 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.164 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.42 -141.28 3.09 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.182 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.19 127.97 34.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 110.854 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.3 132.38 12.04 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.0 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 78.7 p -99.1 146.18 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.545 0.212 . . . . 0.0 110.64 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.555 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 47.5 t -149.37 132.06 15.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.982 0.42 . . . . 0.0 111.583 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.6 p -72.05 -33.49 68.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.746 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.54 139.43 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.401 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 71' ' ' LYS . 78.1 p -123.62 138.68 54.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.744 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.484 ' CD2' HG11 ' A' ' 64' ' ' VAL . 54.2 t80 -88.26 130.06 35.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -90.43 125.07 35.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.532 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.508 HD21 ' SG ' ' A' ' 44' ' ' CYS . 3.2 mm? -85.25 124.42 31.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 111.046 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 19' ' ' ILE . 80.7 mt -87.24 136.1 33.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.785 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -64.91 131.62 95.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.369 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.94 127.24 25.25 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.419 2.08 . . . . 0.0 112.319 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.57 111.47 4.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.949 179.766 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.1 m170 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.5 mmm -68.2 -137.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.789 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -62.85 137.12 58.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.752 0.31 . . . . 0.0 111.065 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -60.33 137.8 91.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.054 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.0 Cg_endo -59.34 142.79 99.57 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.755 2.303 . . . . 0.0 112.216 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 51.8 Cg_exo -55.19 129.73 36.87 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.515 2.144 . . . . 0.0 112.275 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.7 tp -115.01 108.19 16.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 57.4 t -84.82 137.02 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.454 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 t -166.73 51.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.204 0.526 . . . . 0.0 111.414 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.33 136.77 4.13 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.392 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.539 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.4 tt -165.29 131.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.703 0.287 . . . . 0.0 110.622 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.804 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.6 t -69.35 -58.46 5.97 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.627 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.872 ' HG2' HG12 ' A' ' 24' ' ' VAL . 88.3 Cg_endo -93.24 113.18 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.364 2.043 . . . . 0.0 112.614 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -95.81 31.65 2.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.897 0.38 . . . . 0.0 110.863 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.688 ' HB2' HD11 ' A' ' 93' ' ' LEU . 15.9 pt-20 -179.45 129.34 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.358 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.07 146.9 5.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.988 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 39.6 pt -53.43 160.39 1.86 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.342 0.115 . . . . 0.0 110.949 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.893 ' HA ' HG23 ' A' ' 64' ' ' VAL . 89.3 Cg_exo -48.08 -38.8 32.89 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.622 2.215 . . . . 0.0 113.11 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.593 ' O ' ' HD2' ' A' ' 63' ' ' ARG . 97.4 m95 -72.76 -21.03 61.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.6 m -56.22 127.98 33.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.076 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.552 ' HE2' HG13 ' A' ' 61' ' ' VAL . 60.6 tttm -70.28 142.34 52.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.79 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.872 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.6 m -139.82 126.46 23.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 111.091 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 62.1 m -83.55 87.85 7.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.76 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.652 HD12 HD13 ' A' ' 74' ' ' ILE . 49.8 mm -54.69 133.8 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.758 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 25' ' ' THR . 45.2 mmm-85 -140.44 137.29 33.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -168.12 -134.11 1.66 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.196 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -150.57 135.58 17.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 111.237 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 61.65 41.72 11.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.227 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 mp -82.79 51.24 1.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.865 0.364 . . . . 0.0 110.411 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.41 123.45 0.19 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.212 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.7 p -92.29 42.47 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.741 0.305 . . . . 0.0 111.352 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.63 143.75 4.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.653 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.427 ' HG3' ' CE3' ' A' ' 54' ' ' TRP . 32.2 Cg_exo -57.3 -46.09 30.47 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.456 2.104 . . . . 0.0 111.749 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 t -62.48 -36.36 82.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.157 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 28.3 m-20 -53.7 -45.46 70.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.623 HD21 HD23 ' A' ' 41' ' ' LEU . 1.4 tt -68.76 131.11 44.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.076 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.51 ' N ' HD23 ' A' ' 38' ' ' LEU . 30.0 pt -138.4 -44.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.593 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.489 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -104.55 135.82 12.71 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.216 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.623 HD23 HD21 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -146.32 121.0 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.828 HG22 ' HA ' ' A' ' 47' ' ' ASN . 33.3 p -153.13 134.82 14.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.179 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 45' ' ' GLY . 76.0 mt -105.38 111.22 33.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.044 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.493 ' SG ' ' HA2' ' A' ' 72' ' ' GLY . 34.5 t 73.91 -37.8 0.38 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.748 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.443 ' HA3' ' HG3' ' A' ' 68' ' ' LYS . . . 171.9 -32.39 0.13 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.528 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -73.58 135.73 43.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.921 0.391 . . . . 0.0 111.459 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.828 ' HA ' HG22 ' A' ' 42' ' ' THR . 43.2 t30 -71.35 138.39 49.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.844 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.2 m -151.89 40.4 0.64 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.965 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.2 tp -74.28 -44.39 52.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.472 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.4 pt? -50.57 -42.71 55.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.497 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.418 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 59.1 p -80.31 -35.26 35.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 111.204 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.585 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.77 131.2 50.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.983 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -127.11 129.99 48.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.335 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.427 ' CE3' ' HG3' ' A' ' 35' ' ' PRO . 67.2 t90 -73.35 148.35 43.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.076 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.3 mtt -148.76 -44.01 0.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.317 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.445 ' C ' ' H ' ' A' ' 58' ' ' SER . 64.7 m -160.62 169.97 21.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.727 0.298 . . . . 0.0 110.884 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.78 32.8 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.344 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 56' ' ' SER . 79.8 p -177.85 34.42 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.544 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -164.58 131.23 3.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.8 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.4 mt -150.1 118.81 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.552 HG13 ' HE2' ' A' ' 23' ' ' LYS . 70.5 t -83.7 125.37 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.585 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.5 p -170.43 148.24 3.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.826 0.346 . . . . 0.0 111.015 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.593 ' HD2' ' O ' ' A' ' 21' ' ' TRP . 37.6 mmt-85 -84.01 131.18 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.126 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.893 HG23 ' HA ' ' A' ' 20' ' ' PRO . 10.4 m -54.81 128.42 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.189 0.519 . . . . 0.0 112.131 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.44 -105.54 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.502 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.674 ' HG3' ' HZ2' ' A' ' 68' ' ' LYS . 25.1 pt20 -162.57 138.96 7.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.721 0.296 . . . . 0.0 110.774 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.746 ' HB2' HD23 ' A' ' 92' ' ' LEU . . . -61.51 96.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.405 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.674 ' HZ2' ' HG3' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -73.58 -43.76 58.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 42.7 p-10 -170.17 171.82 6.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.861 0.362 . . . . 0.0 111.695 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 69' ' ' ASN . 1.5 m-20 74.87 -62.55 0.45 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.227 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt 177.26 -46.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.982 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.493 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . 146.35 38.66 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.554 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -66.36 139.38 58.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.727 0.298 . . . . 0.0 110.958 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.652 HD13 HD12 ' A' ' 26' ' ' ILE . 72.2 mt -84.32 135.27 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.584 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.55 HD12 ' HD3' ' A' ' 83' ' ' LYS . 46.1 mm -128.66 137.51 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.899 0.38 . . . . 0.0 111.72 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t -141.4 117.5 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.896 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.9 m -87.56 140.69 29.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.975 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.6 p -134.59 137.0 43.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.996 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 37' ' ' ASP . 28.9 mtpp -60.1 -46.27 90.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.3 m -65.11 -52.43 55.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.056 0.455 . . . . 0.0 110.159 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.72 -121.8 2.46 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.063 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.36 -142.19 3.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.355 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.55 ' HD3' HD12 ' A' ' 75' ' ' ILE . 3.5 tmmm? -66.73 125.25 25.25 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 83' ' ' LYS . . . -79.45 131.31 10.5 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.061 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.7 p -99.27 148.24 24.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.642 0.258 . . . . 0.0 110.431 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.581 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 78.9 p -149.23 130.31 14.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 111.817 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 74.0 p -81.51 -31.74 32.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.376 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 m -84.22 148.31 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.205 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.0 p -138.97 135.25 34.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.797 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.476 ' CD2' HG11 ' A' ' 64' ' ' VAL . 86.6 t80 -85.64 133.34 34.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.538 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -88.45 123.71 33.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.403 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 67' ' ' ALA . 3.2 mm? -80.13 128.27 33.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.056 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 17' ' ' GLU . 75.8 mt -101.45 135.97 42.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.002 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -67.69 140.97 94.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.62 134.74 63.77 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.447 2.098 . . . . 0.0 112.284 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -68.68 79.73 0.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.303 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.4 pttt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.928 179.89 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.2 m80 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.65 0.262 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 92.3 mmm -71.43 -145.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.811 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.449 ' HD2' ' OG ' ' A' ' 80' ' ' SER . 99.0 mtt180 63.49 134.92 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.983 0.421 . . . . 0.0 111.27 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -64.24 134.34 95.93 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.17 147.46 94.05 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.614 2.209 . . . . 0.0 112.241 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.09 143.36 18.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.571 2.181 . . . . 0.0 112.331 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 85' ' ' THR . 46.7 tp -135.93 111.57 9.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.568 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 58.8 t -78.36 130.0 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.791 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.427 ' H ' ' HA2' ' A' ' 28' ' ' GLY . 76.5 p -150.92 47.8 0.85 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.093 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.4 145.22 6.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.292 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.486 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.4 tt -164.35 128.18 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.31 . . . . 0.0 110.397 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.793 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.0 t -64.98 -58.26 13.31 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.861 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 79.8 Cg_endo -91.27 110.84 0.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.28 1.987 . . . . 0.0 112.397 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.411 ' OD1' HG23 ' A' ' 13' ' ' ILE . 50.5 m-80 -90.31 24.41 2.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.943 0.402 . . . . 0.0 110.166 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HB2' HD11 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -179.31 132.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.169 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.17 145.84 5.1 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.852 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.512 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.9 pt -55.67 164.18 1.7 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 120.407 0.146 . . . . 0.0 110.707 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 81.4 Cg_exo -47.7 -53.73 6.14 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.605 2.204 . . . . 0.0 113.966 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.416 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 80.2 m95 -68.31 -8.87 43.53 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.465 ' OG1' HG12 ' A' ' 19' ' ' ILE . 73.1 m -62.29 127.29 30.63 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.079 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -69.43 131.63 45.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.36 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.602 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.0 m -125.94 127.78 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.978 0.418 . . . . 0.0 110.999 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.8 m -81.33 118.5 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 60' ' ' ILE . 63.7 mt -79.74 138.49 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.775 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.423 ' O ' HG13 ' A' ' 10' ' ' VAL . 27.1 mmm180 -147.21 136.94 22.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.346 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.17 -132.08 1.41 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.673 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -146.94 131.38 17.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.318 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.9 m120 60.63 41.85 14.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.166 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.453 HD22 ' O ' ' A' ' 58' ' ' SER . 10.5 mp -81.97 52.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.959 0.409 . . . . 0.0 110.841 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.81 121.44 0.04 OUTLIER Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.404 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.0 p -93.4 41.18 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.0 144.13 5.38 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.464 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HA ' ' CG ' ' A' ' 54' ' ' TRP . 51.3 Cg_exo -54.26 -43.04 62.23 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.538 2.159 . . . . 0.0 112.089 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.8 p -64.01 -35.69 81.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 28.6 m-20 -52.18 -49.06 64.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.005 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.47 ' C ' HD13 ' A' ' 38' ' ' LEU . 3.5 tm? -67.12 132.46 47.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.33 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.433 ' N ' HD13 ' A' ' 38' ' ' LEU . 35.5 pt -147.97 -24.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.998 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.94 137.21 12.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.58 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.784 HD12 ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -149.64 131.67 15.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 47' ' ' ASN . 5.7 p -153.7 141.73 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.134 0.493 . . . . 0.0 111.657 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -135.97 123.23 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.168 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 78.9 m 58.41 40.1 24.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.941 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.02 -32.74 1.73 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.183 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -70.71 133.06 46.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 111.356 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.617 ' HA ' HG22 ' A' ' 42' ' ' THR . 15.0 p-10 -74.62 143.94 44.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.73 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.784 ' SG ' HD12 ' A' ' 41' ' ' LEU . 7.5 p -154.12 46.31 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 110.793 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.2 tp -72.95 -48.9 32.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.58 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 51' ' ' THR . 4.1 pp -62.24 -30.37 71.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.599 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.629 ' N ' HD12 ' A' ' 50' ' ' LEU . 41.3 p -79.92 -38.39 32.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.903 0.383 . . . . 0.0 110.91 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.501 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -64.22 138.08 58.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.67 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.37 127.39 45.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.08 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.41 ' CG ' ' HA ' ' A' ' 35' ' ' PRO . 31.1 t90 -63.78 143.57 57.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.111 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 94.0 mmm -132.95 -51.17 0.9 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.718 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.2 m -161.2 -172.15 3.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.62 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.31 39.17 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.276 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.453 ' O ' HD22 ' A' ' 31' ' ' LEU . 40.2 t -178.4 -43.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.7 tttm -86.81 134.05 33.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.483 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 75.3 mt -151.24 120.29 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.571 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.22 132.39 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.064 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 25.9 t -170.57 141.4 1.89 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.197 0.522 . . . . 0.0 111.545 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.552 ' HE ' HG21 ' A' ' 51' ' ' THR . 39.7 ptt180 -85.37 140.44 30.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.711 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.532 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t -59.74 -42.63 89.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.647 0.737 . . . . 0.0 110.758 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.404 ' C ' ' HB3' ' A' ' 20' ' ' PRO . . . 75.21 -49.92 2.3 Favored Glycine 0 C--N 1.314 -0.648 0 CA-C-N 114.321 -1.308 . . . . 0.0 113.149 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -174.92 -143.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.864 0.332 . . . . 0.0 110.738 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.487 ' HB2' HD22 ' A' ' 92' ' ' LEU . . . -172.95 135.46 0.62 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.776 0.322 . . . . 0.0 111.112 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.522 ' O ' ' HD3' ' A' ' 68' ' ' LYS . 1.4 tmtp? -117.88 -43.54 2.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.328 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -65.77 -119.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.697 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -167.61 -48.1 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.724 0.297 . . . . 0.0 110.723 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 89' ' ' SER . 0.0 OUTLIER -70.06 -46.52 64.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.701 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.07 44.48 5.36 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.723 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -71.41 131.87 43.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 110.886 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.6 mt -85.6 100.33 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.085 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.3 mm -98.6 138.97 21.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.99 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.52 120.17 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.0 111.288 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.1 m -90.87 145.87 24.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.271 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.4 p -140.49 142.93 35.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.953 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 32.2 mmmt -51.77 -49.12 63.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.231 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.449 ' OG ' ' HD2' ' A' ' 5' ' ' ARG . 47.4 t -67.0 -47.41 71.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.88 -127.81 0.19 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.819 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.12 -39.77 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.851 -0.499 . . . . 0.0 111.851 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -168.06 121.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.98 127.05 7.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.368 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.558 ' O ' HD12 ' A' ' 9' ' ' LEU . 81.7 p -99.69 144.63 28.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.568 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 66.5 p -143.36 124.19 14.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.101 0.477 . . . . 0.0 111.794 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.7 p -81.02 -28.69 35.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.245 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.62 141.89 14.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.287 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.575 ' HB2' ' O ' ' A' ' 71' ' ' LYS . 74.1 p -129.77 139.26 51.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.958 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -85.74 129.44 34.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.39 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.41 114.55 20.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.093 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.487 HD22 ' HB2' ' A' ' 67' ' ' ALA . 47.0 tp -78.86 131.07 36.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 111.406 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 17' ' ' GLU . 78.4 mt -98.82 141.27 31.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.764 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -61.92 123.32 77.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.015 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.98 134.06 19.13 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.421 2.081 . . . . 0.0 111.987 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -69.34 77.46 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.507 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.821 179.685 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.8 m170 . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.87 0.367 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.2 ttt -59.4 -51.77 68.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.234 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.488 ' HD2' ' N ' ' A' ' 5' ' ' ARG . 0.3 OUTLIER -71.03 129.13 38.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.062 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -78.57 136.22 59.86 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 17.9 Cg_endo -60.18 139.15 85.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.57 2.18 . . . . 0.0 112.267 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 59.7 Cg_exo -52.8 147.1 33.15 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.82 2.347 . . . . 0.0 112.625 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 85' ' ' THR . 59.8 tp -149.97 112.24 4.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.741 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.49 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 57.3 t -79.02 131.5 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.2 p -147.76 44.22 1.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.43 146.41 6.49 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.778 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.5 tt -161.45 129.66 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.762 0.315 . . . . 0.0 110.629 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.843 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 49.5 m -68.89 -59.88 4.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.805 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.843 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 72.2 Cg_endo -92.49 121.95 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.364 2.042 . . . . 0.0 112.077 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -105.78 28.51 7.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.881 0.372 . . . . 0.0 110.832 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -179.99 129.53 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.436 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.456 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 164.25 148.15 5.34 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.583 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.0 pt -51.62 158.56 1.5 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.481 0.181 . . . . 0.0 110.767 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.785 ' HA ' HG23 ' A' ' 64' ' ' VAL . 73.4 Cg_exo -50.08 -41.67 48.3 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.656 2.237 . . . . 0.0 113.322 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -70.12 -8.97 53.94 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.9 m -67.93 126.9 30.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.765 0.317 . . . . 0.0 110.927 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.583 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 4.9 ttmp? -71.02 134.03 46.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.071 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.734 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.7 m -124.37 127.24 73.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 0.0 111.542 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.1 m -78.54 102.33 7.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.7 mt -69.83 139.73 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.09 0.471 . . . . 0.0 111.403 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -144.11 130.95 20.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.205 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.31 -133.17 1.54 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.623 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -150.16 136.8 19.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.914 0.388 . . . . 0.0 111.325 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.7 m120 61.94 39.05 13.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.508 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 mp -84.98 53.1 2.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.0 110.63 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.08 129.65 1.46 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.509 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.9 p -69.31 -36.63 77.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.76 0.314 . . . . 0.0 111.455 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.445 ' HA2' ' CZ2' ' A' ' 54' ' ' TRP . . . -150.86 174.84 30.07 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.517 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.28 -43.86 54.58 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.795 2.33 . . . . 0.0 112.486 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.3 t -58.56 -40.12 82.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.19 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.02 -46.79 85.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.156 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.3 tt -59.71 129.73 43.33 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.573 HG21 ' HD3' ' A' ' 79' ' ' LYS . 39.6 pt -141.95 -44.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.439 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.528 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -102.55 133.81 11.54 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.628 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 42' ' ' THR . 2.4 tm? -149.48 127.3 11.79 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.748 HG22 ' HA ' ' A' ' 47' ' ' ASN . 11.8 p -155.87 140.82 17.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.525 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.594 HD11 ' SG ' ' A' ' 62' ' ' CYS . 73.3 mt -126.03 123.77 64.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.596 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.601 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 58.9 m 57.37 36.35 27.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.058 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.89 -31.66 3.05 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.055 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.553 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 27.3 t-80 -73.7 133.18 43.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.854 0.359 . . . . 0.0 111.408 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.748 ' HA ' HG22 ' A' ' 42' ' ' THR . 42.0 t30 -69.2 138.3 53.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.7 m -151.04 39.27 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 110.7 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.3 tp -75.06 -43.19 54.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.107 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.454 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -52.21 -41.61 62.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.281 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.408 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 68.0 p -80.29 -34.62 36.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.175 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 61' ' ' VAL . . . -58.06 131.02 49.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.566 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.424 ' HB3' HG23 ' A' ' 61' ' ' VAL . 17.8 tp10 -126.61 132.31 51.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.573 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.445 ' CZ2' ' HA2' ' A' ' 34' ' ' GLY . 77.0 t90 -68.31 144.84 54.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.196 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.7 mmt -132.65 -47.78 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.663 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.6 p -168.54 -157.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.635 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.37 32.32 1.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.355 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.7 p -179.98 37.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.278 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -164.88 129.62 2.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.102 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.4 mt -151.23 111.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.698 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -84.51 130.25 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.349 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.594 ' SG ' HD11 ' A' ' 43' ' ' ILE . 26.4 p -170.97 150.98 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.042 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -84.01 129.79 34.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.785 HG23 ' HA ' ' A' ' 20' ' ' PRO . 14.3 m -65.72 134.65 29.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.102 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 46' ' ' HIS . . . -72.61 -125.49 0.08 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.442 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.441 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 24.9 pt20 -140.53 137.79 34.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.734 0.302 . . . . 0.0 110.576 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.601 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -49.74 134.04 20.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.852 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 66' ' ' GLN . 29.4 mtpp -151.3 -41.39 0.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.381 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -63.54 -53.36 53.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.267 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -173.74 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.427 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -147.34 -56.25 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.814 0.34 . . . . 0.0 111.01 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.432 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . 163.01 43.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.328 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -64.14 131.58 47.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.861 0.362 . . . . 0.0 111.083 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.4 mt -85.36 135.43 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.522 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.9 mm -134.55 133.82 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 0.0 111.713 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.418 HG22 HD22 ' A' ' 41' ' ' LEU . 60.0 t -141.55 118.66 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.22 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.4 m -98.68 131.88 44.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.555 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.1 p -99.48 146.29 26.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.844 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.573 ' HD3' HG21 ' A' ' 39' ' ' ILE . 56.5 tptt -58.57 -49.19 78.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.773 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 81.9 p -70.33 -54.43 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.76 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.53 -127.05 0.35 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.42 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.4 -137.25 2.18 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.17 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -65.17 126.12 27.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.7 0.286 . . . . 0.0 110.569 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.28 -150.19 6.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.154 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 21.5 p -158.09 151.59 23.44 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.706 0.402 . . . . 0.0 110.624 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.3 p -158.66 121.34 3.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.917 0.389 . . . . 0.0 111.431 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 82.6 p -96.07 37.56 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.436 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.6 m -150.56 157.44 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.744 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.5 p -146.0 136.23 23.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.572 ' CE2' HG21 ' A' ' 64' ' ' VAL . 65.4 t80 -85.45 130.44 34.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.863 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -82.19 120.83 25.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.659 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.486 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.3 mm? -83.91 126.96 33.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.018 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.456 HD12 ' HA2' ' A' ' 18' ' ' GLY . 76.9 mt -94.6 134.94 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.823 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 47.5 mmtm -67.01 129.21 94.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.956 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 31.2 Cg_exo -60.83 133.81 50.01 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.65 2.234 . . . . 0.0 112.471 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -73.05 112.84 9.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.634 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.939 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.5 t60 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 121.127 0.489 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.8 ptp -160.41 135.52 7.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.745 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.551 ' NE ' ' HA ' ' A' ' 5' ' ' ARG . 4.4 mmp_? 65.31 130.67 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.193 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -63.63 136.94 96.94 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.847 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.15 138.01 78.89 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.543 2.162 . . . . 0.0 112.054 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HG2' ' HA2' ' A' ' 84' ' ' GLY . 14.1 Cg_endo -55.94 134.11 62.11 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.703 2.269 . . . . 0.0 112.331 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 85' ' ' THR . 64.8 tp -120.03 117.65 28.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.018 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.535 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 94.8 t -83.29 132.92 30.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.841 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.0 p -151.34 48.86 0.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.042 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.3 144.83 6.9 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.01 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.655 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.1 tt -163.01 131.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.579 0.228 . . . . 0.0 110.645 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.846 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 48.4 t -63.22 -59.18 12.87 Favored Pre-proline 0 C--N 1.331 -0.239 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.349 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.924 ' HG2' HG12 ' A' ' 24' ' ' VAL . 10.3 Cg_exo -70.7 -148.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.945 1.763 . . . . 0.0 112.035 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -175.4 -23.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.351 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.7 133.94 4.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.832 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 169.69 160.07 17.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.409 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 30.6 pt -50.87 154.68 2.33 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.561 0.22 . . . . 0.0 111.009 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.18 -41.88 48.44 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.902 2.402 . . . . 0.0 113.807 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -70.51 -5.89 32.18 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -66.08 132.09 47.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.808 0.337 . . . . 0.0 111.227 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.581 ' HE3' HG13 ' A' ' 61' ' ' VAL . 87.2 tttt -67.26 137.35 56.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.479 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.924 HG12 ' HG2' ' A' ' 15' ' ' PRO . 35.9 m -140.98 127.23 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.977 0.417 . . . . 0.0 111.015 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.1 m -80.85 121.21 25.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.097 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.0 mt -84.3 135.83 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.726 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 10' ' ' VAL . 83.0 mtm180 -146.2 134.51 21.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.726 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.07 -132.58 1.46 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.58 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -146.09 132.88 20.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.873 0.368 . . . . 0.0 111.352 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 59.11 43.57 17.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.189 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 mp -83.31 47.88 1.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.829 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.47 125.24 0.06 OUTLIER Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.531 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.9 p -92.35 42.87 1.11 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.616 0.246 . . . . 0.0 111.211 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.05 144.81 4.78 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.752 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 10.5 Cg_endo -53.82 -42.87 62.9 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.686 2.258 . . . . 0.0 112.162 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.6 t -60.98 -37.03 81.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.954 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.57 -38.51 69.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.135 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.4 tp -76.31 60.41 1.53 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 0.0 110.914 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.46 HD13 ' HG2' ' A' ' 79' ' ' LYS . 22.6 pt -69.12 -40.06 80.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.318 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.07 138.21 12.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.885 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.53 HD13 ' N ' ' A' ' 42' ' ' THR . 3.1 tm? -149.77 127.8 11.93 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.903 HG22 ' HA ' ' A' ' 47' ' ' ASN . 39.3 p -151.53 136.73 17.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.976 0.417 . . . . 0.0 111.64 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.539 HG21 HG23 ' A' ' 64' ' ' VAL . 51.6 mm -107.65 105.62 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.911 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 38.0 t 58.28 45.22 17.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.731 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.14 -38.66 3.14 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.569 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 79.9 t60 -68.38 129.02 38.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.908 0.354 . . . . 0.0 111.141 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.903 ' HA ' HG22 ' A' ' 42' ' ' THR . 13.6 p-10 -73.62 140.76 46.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.603 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.2 m -150.25 40.12 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.764 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.6 tp -72.88 -49.36 30.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.224 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.448 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -54.08 -39.46 66.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.499 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.1 p -80.11 -38.11 32.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.576 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -62.5 130.44 45.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.847 0.356 . . . . 0.0 111.686 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 60' ' ' ILE . 44.9 tp10 -126.85 130.87 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.605 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 86.9 t90 -65.93 149.76 49.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.979 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.458 ' HG3' HG23 ' A' ' 61' ' ' VAL . 94.9 mmm -142.37 -42.9 0.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.766 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 t -170.63 173.97 5.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.857 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.83 33.43 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.283 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.6 p -178.61 23.68 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.588 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -165.67 131.27 2.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.743 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 53' ' ' GLU . 75.6 mt -149.43 120.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.008 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.581 HG13 ' HE3' ' A' ' 23' ' ' LYS . 57.4 t -81.82 126.33 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.471 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 52.7 t -171.08 149.71 2.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 0.0 111.138 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -84.66 131.43 34.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.308 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.539 HG23 HG21 ' A' ' 43' ' ' ILE . 5.5 p -56.64 136.57 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.065 0.459 . . . . 0.0 111.576 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.408 ' HA3' ' HB ' ' A' ' 43' ' ' ILE . . . -69.01 -127.19 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.603 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -146.45 140.62 26.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 0.0 110.637 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.553 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . . . -68.52 74.1 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.239 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 46' ' ' HIS . 68.0 mttm -64.36 -49.49 71.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.769 0.319 . . . . 0.0 110.86 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -68.4 -63.83 0.98 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 64.7 t0 179.42 -60.67 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.973 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -75.24 -114.58 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.646 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 44' ' ' CYS . . . 173.24 47.55 0.05 OUTLIER Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.193 -1.003 . . . . 0.0 113.2 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -64.22 132.67 51.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.77 0.319 . . . . 0.0 111.042 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.442 HG23 ' CD1' ' A' ' 43' ' ' ILE . 68.5 mt -85.5 92.48 3.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.817 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.5 mm -81.03 138.58 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.195 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.53 113.51 3.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.936 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.5 m -84.47 142.23 30.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.722 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.3 p -137.73 135.52 36.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.047 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HG2' HD13 ' A' ' 39' ' ' ILE . 28.2 mtpp -59.29 -46.72 87.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.004 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.9 p -64.42 -52.83 56.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.03 0.443 . . . . 0.0 110.331 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 -120.97 2.13 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.193 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.76 -140.77 2.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.117 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.439 ' HD2' ' C ' ' A' ' 83' ' ' LYS . 4.3 tmmm? -67.38 127.12 31.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.36 . . . . 0.0 110.169 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.459 ' HA2' ' HG2' ' A' ' 8' ' ' PRO . . . -78.15 130.64 10.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.346 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.428 HG22 ' HE3' ' A' ' 83' ' ' LYS . 79.3 p -108.15 144.66 35.25 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.535 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 41.3 t -151.31 131.12 13.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.093 0.473 . . . . 0.0 111.875 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.8 p -78.17 -28.39 48.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.781 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.9 m -83.15 153.76 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.362 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.0 p -148.97 138.65 21.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.724 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 64' ' ' VAL . 67.2 t80 -85.2 131.56 34.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.68 ' HD2' HD23 ' A' ' 93' ' ' LEU . 5.8 tmtt? -79.39 119.1 21.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.013 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.476 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -84.61 109.67 18.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 110.54 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.68 HD23 ' HD2' ' A' ' 91' ' ' LYS . 54.9 mt -85.86 136.68 33.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.955 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -65.51 137.11 96.4 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.168 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.72 132.79 24.13 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.441 2.094 . . . . 0.0 112.469 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -73.16 77.42 1.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.697 -179.886 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.836 0.35 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.7 mtt -78.91 43.55 0.51 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.304 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.425 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 72.3 mtm-85 56.69 51.83 10.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.0 0.429 . . . . 0.0 111.347 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -59.41 141.9 87.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.051 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -57.11 150.7 55.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.79 2.327 . . . . 0.0 112.308 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.543 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 82.1 Cg_exo -48.57 143.07 16.78 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.705 2.27 . . . . 0.0 112.746 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 85' ' ' THR . 4.9 tt -145.03 111.34 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.747 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.512 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 66.3 t -81.92 137.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.005 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.422 HG23 ' CD2' ' A' ' 9' ' ' LEU . 30.1 p -154.26 44.52 0.55 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.624 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.46 143.8 6.09 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.845 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.527 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.8 tt -164.47 129.47 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.0 110.51 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.824 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -65.22 -59.39 9.93 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.942 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.944 ' HG2' HG12 ' A' ' 24' ' ' VAL . 72.8 Cg_endo -94.86 118.89 0.26 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.447 2.098 . . . . 0.0 112.169 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -100.22 30.61 3.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.73 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.592 ' HB2' HD11 ' A' ' 93' ' ' LEU . 11.3 pt-20 179.0 129.39 0.07 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.571 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . 165.09 152.29 6.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.738 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.441 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 31.9 pt -56.12 162.54 2.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.48 0.181 . . . . 0.0 111.11 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.599 ' HB3' ' C ' ' A' ' 65' ' ' GLY . 87.2 Cg_exo -49.23 -46.31 26.42 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.881 2.388 . . . . 0.0 113.768 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -71.4 -4.97 29.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.1 m -63.33 126.99 29.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.845 0.355 . . . . 0.0 110.986 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.484 ' HD2' HG13 ' A' ' 61' ' ' VAL . 17.2 tppt? -67.13 136.31 54.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.148 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.944 HG12 ' HG2' ' A' ' 15' ' ' PRO . 31.6 m -140.59 131.67 29.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.036 0.445 . . . . 0.0 111.51 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.9 m -89.75 116.28 27.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.549 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.44 HD11 ' SG ' ' A' ' 62' ' ' CYS . 57.3 mt -74.61 141.13 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.187 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 27' ' ' ARG . 11.9 tpt180 -147.48 130.75 16.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.997 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.56 -122.61 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.733 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.424 ' OE2' HD13 ' A' ' 9' ' ' LEU . 20.5 pt-20 -162.19 134.23 5.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.963 0.411 . . . . 0.0 111.598 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 60.86 40.21 16.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.86 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.543 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.6 mp -70.31 -41.96 72.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.609 0.242 . . . . 0.0 111.233 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.93 135.47 2.36 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.803 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.9 p -62.7 -39.75 94.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.798 0.332 . . . . 0.0 110.902 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.513 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -165.32 -164.11 20.04 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.66 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.28 -47.11 6.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.779 2.319 . . . . 0.0 112.514 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 39' ' ' ILE . 67.2 p -60.12 -40.91 91.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.379 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.732 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 36.5 t70 -62.65 -41.53 99.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.346 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.433 HD11 HD13 ' A' ' 60' ' ' ILE . 1.3 tt -78.33 62.15 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.947 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.638 HD13 ' HG2' ' A' ' 79' ' ' LYS . 27.2 pt -68.96 -41.79 82.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.19 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.433 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -112.21 140.61 16.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.098 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.627 HD13 ' N ' ' A' ' 42' ' ' THR . 3.4 tm? -146.89 134.85 21.4 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.627 ' N ' HD13 ' A' ' 41' ' ' LEU . 14.1 p -150.36 149.82 30.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.101 0.477 . . . . 0.0 111.546 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.712 HG21 ' HA ' ' A' ' 64' ' ' VAL . 71.1 mt -135.75 116.56 18.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.484 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.771 ' HA ' ' HB2' ' A' ' 70' ' ' ASP . 65.4 m 72.82 -35.2 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.813 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 166.11 -41.08 0.27 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.026 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.474 ' H ' ' HD1' ' A' ' 46' ' ' HIS . 27.5 p-80 -80.67 138.48 36.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.959 0.409 . . . . 0.0 111.705 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.493 ' HA ' HG22 ' A' ' 42' ' ' THR . 42.2 t30 -60.68 141.51 56.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.679 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.3 m -143.76 38.15 1.34 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.846 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.55 -42.25 68.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.466 ' H ' HD23 ' A' ' 50' ' ' LEU . 2.6 pt? -57.52 -42.41 82.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.58 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.514 HG21 ' NE ' ' A' ' 63' ' ' ARG . 55.8 p -80.19 -38.19 31.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.691 0.282 . . . . 0.0 111.351 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -63.09 132.9 53.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.333 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -126.38 127.39 45.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.552 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.513 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 75.2 t90 -67.46 149.97 49.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.512 ' SD ' HG23 ' A' ' 61' ' ' VAL . 90.4 mtp -146.04 -41.3 0.21 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.731 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 58' ' ' SER . 33.8 t -165.38 173.86 10.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.685 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.34 21.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.489 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.3 m -167.72 35.31 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.884 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -165.09 127.95 2.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.867 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.433 HD13 HD11 ' A' ' 38' ' ' LEU . 73.9 mt -150.82 125.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.158 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.512 HG23 ' SD ' ' A' ' 55' ' ' MET . 60.8 t -93.4 128.12 45.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.564 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.658 ' SG ' HD11 ' A' ' 43' ' ' ILE . 23.0 p -171.11 157.82 5.31 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.073 0.463 . . . . 0.0 111.772 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.514 ' NE ' HG21 ' A' ' 51' ' ' THR . 40.3 ptt180 -84.59 134.76 34.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.857 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.712 ' HA ' HG21 ' A' ' 43' ' ' ILE . 18.0 m -67.84 -26.67 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.404 0.621 . . . . 0.0 111.338 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.599 ' C ' ' HB3' ' A' ' 20' ' ' PRO . . . 53.9 -158.05 5.33 Favored Glycine 0 C--N 1.315 -0.587 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.734 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -74.62 -140.85 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.492 0.187 . . . . 0.0 111.192 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 71' ' ' LYS . . . -165.43 158.85 16.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.715 0.293 . . . . 0.0 111.013 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -140.56 -42.77 0.4 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.686 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -134.78 -59.61 0.8 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.885 0.374 . . . . 0.0 111.238 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.771 ' HB2' ' HA ' ' A' ' 44' ' ' CYS . 57.0 m-20 -60.28 -39.55 87.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.546 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.583 ' HA ' ' HB1' ' A' ' 67' ' ' ALA . 9.2 ptpp? 45.46 27.59 0.4 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.764 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.631 ' HA3' ' HB3' ' A' ' 89' ' ' SER . . . 161.26 -41.07 0.41 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.369 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.718 ' HB2' ' HB3' ' A' ' 70' ' ' ASP . 27.0 m-20 -61.43 120.31 10.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.806 0.336 . . . . 0.0 111.026 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.498 ' O ' HD13 ' A' ' 75' ' ' ILE . 69.8 mt -85.99 128.67 39.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.35 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.947 HG21 ' HE3' ' A' ' 83' ' ' LYS . 37.0 mm -127.32 142.02 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.926 0.393 . . . . 0.0 111.484 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.819 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 58.4 t -140.65 122.71 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.57 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.3 m -86.48 141.75 28.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.115 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.4 p -136.08 136.01 39.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.804 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.732 ' HE2' ' HA ' ' A' ' 37' ' ' ASP . 48.3 mtmt -57.16 -46.91 82.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 5' ' ' ARG . 50.0 m -68.4 -53.12 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.083 0.468 . . . . 0.0 110.258 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.74 -123.37 0.67 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.189 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.63 -140.78 2.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.325 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.947 ' HE3' HG21 ' A' ' 75' ' ' ILE . 51.1 tptt -63.31 132.42 51.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.949 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.819 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -68.11 159.48 51.34 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.946 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 74.2 p -143.37 145.67 32.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.9 p -157.14 131.51 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 0.0 111.698 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 65.3 p -79.2 -33.06 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.538 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.1 m -84.24 158.6 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.396 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.631 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 31.4 m -148.88 139.99 23.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.075 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.548 ' CD2' HG11 ' A' ' 64' ' ' VAL . 68.2 t80 -85.51 133.58 34.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.045 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.705 ' HD2' HD23 ' A' ' 93' ' ' LEU . 5.5 tmtt? -80.76 121.41 25.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.299 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.54 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 94.0 mt -84.82 109.12 17.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 110.202 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.705 HD23 ' HD2' ' A' ' 91' ' ' LYS . 50.0 mt -83.64 138.0 33.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.342 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -62.61 141.59 96.86 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.287 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -53.07 133.93 54.0 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.729 2.286 . . . . 0.0 112.503 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -68.53 115.08 7.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.472 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.314 -0.851 . . . . 0.0 110.955 -179.826 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.91 0.386 . . . . 0.0 111.623 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.2 tpt -170.42 -43.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.658 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.403 ' HG2' ' HB3' ' A' ' 80' ' ' SER . 22.3 tpp180 -58.85 131.78 51.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.693 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -60.53 139.47 92.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.133 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.21 144.34 98.83 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.754 2.302 . . . . 0.0 112.13 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.56 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 10.3 Cg_endo -54.18 115.86 2.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.533 2.155 . . . . 0.0 112.109 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.5 tp -90.62 98.37 11.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.196 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.489 HG22 HD21 ' A' ' 31' ' ' LEU . 60.3 t -79.92 135.42 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.273 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 t -167.76 52.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.183 0.516 . . . . 0.0 111.271 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.06 137.67 4.79 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.483 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.531 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.8 tt -165.15 128.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.709 0.29 . . . . 0.0 110.624 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.807 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.3 t -66.54 -57.92 11.23 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.626 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.864 ' HG2' HG12 ' A' ' 24' ' ' VAL . 98.2 Cg_endo -91.47 110.54 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.336 2.024 . . . . 0.0 112.15 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.463 ' OD1' HG23 ' A' ' 13' ' ' ILE . 13.7 m-20 -88.49 26.79 1.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.728 0.299 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 179.82 130.16 0.09 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.521 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.592 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 169.05 143.08 3.72 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.472 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.439 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.6 pt -53.14 161.31 1.34 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.434 0.159 . . . . 0.0 111.214 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.913 ' HA ' HG23 ' A' ' 64' ' ' VAL . 88.8 Cg_exo -47.79 -43.48 28.95 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.79 2.327 . . . . 0.0 113.75 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -68.56 -20.66 64.55 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.7 m -59.48 129.1 40.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 111.003 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.562 ' NZ ' ' HB3' ' A' ' 23' ' ' LYS . 6.1 ttpm? -71.56 143.34 49.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.016 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.864 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.8 m -140.27 131.03 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.99 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.1 m -90.33 87.39 6.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.431 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 43' ' ' ILE . 69.8 mt -60.77 137.3 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.572 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' A' ' 58' ' ' SER . 75.9 ttt180 -148.07 140.44 24.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.963 0.411 . . . . 0.0 111.054 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -167.07 -127.61 0.92 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.298 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -150.4 137.21 19.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.921 0.391 . . . . 0.0 111.214 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.484 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 72.4 m-80 64.82 32.49 10.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.496 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 9.2 mp -83.27 48.93 1.46 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.951 0.405 . . . . 0.0 110.607 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.58 121.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.597 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.409 HG22 ' HB2' ' A' ' 57' ' ' ALA . 81.7 p -89.54 41.02 1.02 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.729 0.299 . . . . 0.0 111.126 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.4 146.42 5.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.733 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.21 -43.18 61.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.52 2.146 . . . . 0.0 112.07 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.5 p -59.01 -40.7 85.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.775 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 78' ' ' THR . 55.6 m-20 -58.07 -32.31 67.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.671 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 41' ' ' LEU . 1.0 OUTLIER -76.91 58.09 1.42 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.34 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.9 pt -66.52 -22.49 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.915 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.13 141.94 10.66 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.426 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.585 HD13 ' N ' ' A' ' 42' ' ' THR . 2.9 tm? -149.78 130.4 14.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 46' ' ' HIS . 81.4 m -161.4 127.62 3.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 111.782 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 26' ' ' ILE . 76.9 mt -100.56 129.75 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.588 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.572 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 48.8 t 65.47 -72.74 0.07 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.249 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.7 30.77 0.12 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.427 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.647 ' O ' HG23 ' A' ' 42' ' ' THR . 35.3 t-80 -131.08 128.42 40.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 110.805 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -63.1 134.5 56.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 71.4 m -152.67 39.69 0.56 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.682 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.91 -46.23 45.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.385 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.433 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.6 pt? -55.5 -37.88 68.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.221 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.6 p -79.94 -36.91 35.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.54 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.93 134.97 56.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.243 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -126.18 129.08 48.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.804 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 87.3 t90 -70.52 145.21 51.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.093 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.6 mmt -132.63 -48.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.771 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.9 m -161.74 -161.78 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.702 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB2' HG22 ' A' ' 33' ' ' THR . . . -91.97 32.86 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.253 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.621 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 83.4 p -178.77 35.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.247 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.571 ' HB2' ' NZ ' ' A' ' 59' ' ' LYS . 5.1 ttmp? -165.41 135.4 3.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.338 . . . . 0.0 111.078 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.408 HD13 HD11 ' A' ' 38' ' ' LEU . 80.6 mt -150.61 120.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.77 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 51.5 t -90.35 127.59 42.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.629 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.6 p -170.55 154.63 4.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.15 133.65 34.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.66 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.913 HG23 ' HA ' ' A' ' 20' ' ' PRO . 11.5 m -62.15 130.98 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.934 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.624 ' HA3' ' HB3' ' A' ' 46' ' ' HIS . . . -81.13 163.79 45.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.419 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -48.95 137.35 12.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 111.015 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.572 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . . . -75.95 66.16 2.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.438 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -59.42 -46.25 89.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.916 0.388 . . . . 0.0 110.354 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.4 ' HB3' ' H ' ' A' ' 70' ' ' ASP . 52.4 m-20 -67.92 -147.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.749 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 71' ' ' LYS . 55.2 m-20 -154.62 31.9 0.41 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.392 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 30.2 mmtp -158.5 30.63 0.23 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.599 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 33.85 42.15 0.22 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.441 -0.409 . . . . 0.0 113.523 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -65.62 121.94 16.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.524 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.5 mt -97.68 131.23 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.376 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.3 mm -134.22 140.19 46.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.458 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 p -140.85 125.68 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.78 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.643 ' HA ' ' H ' ' A' ' 83' ' ' LYS . 15.9 m -90.77 139.96 30.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.724 ' H ' ' HA2' ' A' ' 82' ' ' GLY . 73.8 p -147.41 143.86 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.118 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.428 ' HG2' ' HA ' ' A' ' 37' ' ' ASP . 14.5 mmmm -54.02 -33.88 58.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.055 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.403 ' HB3' ' HG2' ' A' ' 5' ' ' ARG . 49.8 m -63.44 -49.41 73.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.703 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.77 -48.46 0.23 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.759 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.724 ' HA2' ' H ' ' A' ' 78' ' ' THR . . . 75.8 127.19 0.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.873 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.643 ' H ' ' HA ' ' A' ' 77' ' ' THR . 61.7 tttm 51.67 56.93 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 110.995 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.49 -138.4 0.05 OUTLIER Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.848 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.0 p -149.98 -168.2 3.04 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.723 0.297 . . . . 0.0 110.817 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.488 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 45.4 t -167.76 129.3 1.49 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.257 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 77.0 p -92.91 37.84 1.02 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.231 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.6 m -150.73 139.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.88 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.0 m -118.97 127.99 53.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.164 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 64' ' ' VAL . 44.3 t80 -89.31 124.06 34.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.979 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -85.06 91.7 8.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.12 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.879 HD21 ' HG3' ' A' ' 20' ' ' PRO . 31.6 tp -65.14 128.39 35.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.249 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.482 HD12 ' HA2' ' A' ' 18' ' ' GLY . 80.5 mt -80.41 137.0 36.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.072 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.575 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 4.8 ttmp? -64.15 134.7 96.04 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 51.9 Cg_exo -55.0 131.08 44.28 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.487 2.125 . . . . 0.0 112.57 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -73.3 117.01 14.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.111 -179.966 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.4 m80 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.713 0.292 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.8 mmt -66.26 129.78 40.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.774 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -70.27 136.45 49.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.887 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -60.61 136.39 92.49 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.91 139.66 80.79 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.552 2.168 . . . . 0.0 112.234 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 17.3 Cg_endo -58.16 123.2 13.11 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.58 2.187 . . . . 0.0 112.168 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 9' ' ' LEU . 3.0 tm? -94.17 122.0 36.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.553 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 62.1 t -99.6 140.53 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -166.99 50.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 111.348 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.71 140.53 5.74 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.695 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.513 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.3 tt -164.42 131.18 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.722 0.296 . . . . 0.0 110.507 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.835 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.8 t -66.39 -59.13 8.88 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.931 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.837 ' HG2' HG12 ' A' ' 24' ' ' VAL . 88.7 Cg_endo -96.08 119.87 0.21 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.652 2.235 . . . . 0.0 112.137 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -94.69 29.51 2.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 110.713 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.47 ' HB2' HD21 ' A' ' 93' ' ' LEU . 12.2 pt-20 179.06 133.78 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.602 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.461 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 167.07 146.95 5.07 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.947 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.465 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 37.2 pt -55.78 159.24 5.46 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 110.736 -0.098 . . . . 0.0 110.736 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.799 ' HA ' HG23 ' A' ' 64' ' ' VAL . 3.7 Cg_endo -48.25 -41.9 34.22 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.708 2.272 . . . . 0.0 113.22 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -67.87 -23.06 65.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.7 m -54.43 127.98 29.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.042 0.449 . . . . 0.0 111.659 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.412 ' HE3' ' CG1' ' A' ' 61' ' ' VAL . 86.8 tttt -73.04 140.2 47.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.445 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.837 HG12 ' HG2' ' A' ' 15' ' ' PRO . 30.3 m -141.69 132.91 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.908 0.385 . . . . 0.0 111.362 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.0 m -87.61 118.55 27.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.528 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.46 HD11 ' SG ' ' A' ' 62' ' ' CYS . 63.5 mt -80.34 140.41 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.032 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -141.38 135.63 30.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.682 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.24 -134.7 2.0 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.662 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -149.14 136.66 20.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 111.282 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.0 m-20 63.28 36.4 11.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.33 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 mp -82.6 61.04 5.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.944 0.402 . . . . 0.0 110.503 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.96 121.27 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.124 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.3 p -92.18 33.67 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.817 0.341 . . . . 0.0 111.244 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.8 149.95 5.93 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.498 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.15 -45.04 41.71 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.525 2.15 . . . . 0.0 111.876 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 t -64.19 -38.14 89.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.231 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 56.7 m-20 -54.61 -54.24 44.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.756 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.476 ' C ' HD13 ' A' ' 38' ' ' LEU . 3.2 tm? -60.99 127.15 30.17 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.586 HG21 ' HD3' ' A' ' 79' ' ' LYS . 41.9 pt -138.31 -25.81 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.694 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.85 142.26 13.35 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.133 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.644 HD13 ' N ' ' A' ' 42' ' ' THR . 1.8 tm? -149.57 131.61 15.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.674 HG22 ' HA ' ' A' ' 47' ' ' ASN . 3.4 p -151.66 146.43 25.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.161 0.505 . . . . 0.0 111.623 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.577 ' HB ' ' H ' ' A' ' 65' ' ' GLY . 80.5 mt -137.53 123.41 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.683 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 80.0 m 57.41 39.54 28.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.259 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.18 -31.29 1.82 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.549 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -73.5 131.09 41.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.829 0.347 . . . . 0.0 111.278 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.674 ' HA ' HG22 ' A' ' 42' ' ' THR . 5.4 m120 -72.35 140.36 48.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.5 m -150.71 39.86 0.72 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.772 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 tp -70.97 -42.57 69.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.364 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.469 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -51.13 -43.16 61.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.446 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.421 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 60.0 p -80.31 -32.1 38.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.327 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -56.4 131.27 47.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.774 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -127.12 131.96 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.198 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.436 ' CH2' ' HA ' ' A' ' 56' ' ' SER . 65.2 t90 -72.1 146.77 47.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.355 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.516 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 22.1 mmt -133.82 -50.24 0.83 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.066 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.436 ' HA ' ' CH2' ' A' ' 54' ' ' TRP . 78.0 p -169.18 -156.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.703 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -96.01 30.98 2.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.147 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.7 p -178.76 31.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.057 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 55' ' ' MET . 63.0 tttm -165.05 128.39 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.413 ' HB ' HD12 ' A' ' 26' ' ' ILE . 63.8 mt -151.66 114.6 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.882 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.412 ' CG1' ' HE3' ' A' ' 23' ' ' LYS . 90.7 t -80.3 131.87 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.084 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.491 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.4 p -169.08 155.02 6.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.992 0.425 . . . . 0.0 111.405 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -83.99 126.22 32.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.288 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 20' ' ' PRO . 5.2 m -62.92 125.68 19.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.077 0.465 . . . . 0.0 111.103 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.577 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . -72.39 151.19 46.36 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.668 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -47.57 149.09 1.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.559 0.219 . . . . 0.0 110.839 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.47 63.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.744 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 23.6 tptm -58.63 -51.57 69.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.96 0.41 . . . . 0.0 110.449 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -75.17 -122.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.487 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.95 -36.38 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.711 0.291 . . . . 0.0 110.683 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -66.97 -42.36 85.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . 75.85 36.45 42.01 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.406 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.28 137.27 38.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.702 0.287 . . . . 0.0 111.055 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.07 127.78 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.227 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.5 mm -128.1 138.41 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.899 0.381 . . . . 0.0 111.304 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -139.8 119.06 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.678 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 58.2 m -89.07 130.01 35.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.532 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 64.4 p -107.83 143.48 36.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.615 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.586 ' HD3' HG21 ' A' ' 39' ' ' ILE . 53.1 tptt -56.32 -43.79 79.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 110.369 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 87.2 p -73.06 -56.83 4.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.65 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.2 -125.42 2.02 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.587 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' THR . . . -160.54 -139.63 2.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.398 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.527 ' NZ ' ' HB3' ' A' ' 83' ' ' LYS . 9.0 mtpm? -64.34 126.06 26.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.897 0.379 . . . . 0.0 111.343 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.9 143.42 25.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.403 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.2 p -98.63 139.2 34.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.678 0.275 . . . . 0.0 110.995 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.546 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 63.5 p -136.26 132.27 35.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.418 . . . . 0.0 111.299 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -81.04 -32.16 34.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.922 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.6 m -84.18 176.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.322 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.5 m -156.88 138.11 13.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.644 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.511 ' CE2' HG21 ' A' ' 64' ' ' VAL . 52.3 t80 -88.85 132.48 34.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.431 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -91.99 122.3 34.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.276 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.428 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.7 mm? -84.49 127.02 33.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.948 0.404 . . . . 0.0 111.168 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 17' ' ' GLU . 77.9 mt -91.38 138.27 31.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.709 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.591 ' NZ ' ' HB3' ' A' ' 94' ' ' LYS . 3.3 mmmp? -59.21 129.84 86.65 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.546 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.25 129.15 33.09 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.52 2.147 . . . . 0.0 112.56 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -83.27 119.99 25.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.685 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.3 pttt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.922 -179.894 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.631 0.253 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 18.5 ptp -61.7 132.98 54.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 110.525 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.554 ' NE ' ' HA ' ' A' ' 5' ' ' ARG . 4.8 mmp_? -64.69 136.51 57.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.329 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.505 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 4.8 tp60 -62.46 130.32 93.25 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.631 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.505 ' HD2' ' OE1' ' A' ' 6' ' ' GLN . 61.9 Cg_exo -52.01 146.32 30.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.427 2.084 . . . . 0.0 112.222 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 51.2 Cg_exo -54.91 129.46 35.38 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.52 2.147 . . . . 0.0 112.244 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 85' ' ' THR . 59.6 tp -114.92 109.29 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.63 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.56 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 61.2 t -74.76 129.72 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.743 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.6 p -148.32 46.3 1.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.096 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.18 141.56 4.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.201 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.445 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.7 tt -164.66 129.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.714 0.292 . . . . 0.0 110.304 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.804 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.8 t -66.12 -58.64 10.33 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.167 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.804 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 90.2 Cg_endo -88.88 124.23 1.51 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.121 1.881 . . . . 0.0 112.881 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -99.81 26.28 6.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.072 0.463 . . . . 0.0 110.125 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.636 ' HB2' HD11 ' A' ' 93' ' ' LEU . 23.7 pt-20 177.66 131.8 0.06 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.585 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 169.06 141.58 3.26 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.006 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.473 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 37.6 pt -57.44 162.85 4.05 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 122.066 0.146 . . . . 0.0 111.012 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.954 ' HA ' HG23 ' A' ' 64' ' ' VAL . 83.2 Cg_exo -48.19 -39.56 34.34 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.658 2.238 . . . . 0.0 113.311 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.52 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 89.9 m95 -70.53 -24.45 62.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -57.64 128.95 39.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 111.279 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -73.87 137.49 43.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.635 HG12 ' HG2' ' A' ' 15' ' ' PRO . 27.0 m -134.7 132.52 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.03 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.4 m -87.35 113.56 23.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.71 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 77.8 mt -75.22 139.45 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.955 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.602 ' HD2' ' O ' ' A' ' 58' ' ' SER . 27.4 tpt180 -147.25 133.15 19.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.291 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.14 -132.77 1.48 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.634 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 51.7 mt-10 -147.26 134.84 20.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 111.341 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.461 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 75.7 m-20 61.0 41.08 14.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.548 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 58' ' ' SER . 10.0 mp -83.08 46.86 1.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.031 0.443 . . . . 0.0 110.389 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.35 121.8 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.462 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.505 HG22 ' HB2' ' A' ' 57' ' ' ALA . 80.1 p -87.56 39.08 0.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.835 0.35 . . . . 0.0 111.182 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.03 146.25 5.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.445 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.38 -40.94 81.31 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.603 2.202 . . . . 0.0 112.024 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.2 p -59.91 -40.23 88.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.183 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -58.16 -45.08 88.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.583 HD11 HD13 ' A' ' 60' ' ' ILE . 1.5 tt -61.29 133.93 56.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.81 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.527 ' N ' HD23 ' A' ' 38' ' ' LEU . 26.5 pt -142.84 -44.54 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -102.9 136.05 12.64 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.677 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 42' ' ' THR . 1.7 tm? -149.23 128.17 12.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.607 ' N ' HD13 ' A' ' 41' ' ' LEU . 95.7 m -161.41 135.93 7.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.229 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.56 ' HB ' ' H ' ' A' ' 65' ' ' GLY . 73.4 mt -129.87 130.45 66.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.373 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.67 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 63.5 m 56.13 40.64 30.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.631 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.446 ' O ' ' HD2' ' A' ' 68' ' ' LYS . . . 63.28 29.04 73.29 Favored Glycine 0 CA--C 1.518 0.229 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.878 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.502 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 29.1 t-80 -130.92 131.42 44.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.73 0.3 . . . . 0.0 110.871 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -66.32 132.86 49.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.632 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.2 m -152.36 38.42 0.56 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.982 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.25 -42.44 59.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.26 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.455 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -53.83 -40.74 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.65 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.727 HG21 ' NE ' ' A' ' 63' ' ' ARG . 62.4 p -79.76 -35.04 39.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.598 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.532 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -54.4 135.01 45.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.633 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.65 132.85 51.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.662 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -70.41 151.79 44.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.059 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.6 mmt -142.95 -44.3 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.924 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.5 p -166.05 -166.09 0.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.749 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 33' ' ' THR . . . -88.02 30.63 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.266 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.602 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 79.0 p 179.04 37.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.031 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.9 ttmt -164.76 131.82 3.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.983 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.583 HD13 HD11 ' A' ' 38' ' ' LEU . 72.4 mt -150.72 115.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.4 t -79.93 130.39 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.272 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 53.7 t -170.35 151.9 3.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.025 0.44 . . . . 0.0 111.432 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.727 ' NE ' HG21 ' A' ' 51' ' ' THR . 39.3 ptt180 -84.05 130.02 34.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.201 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.954 HG23 ' HA ' ' A' ' 20' ' ' PRO . 4.9 m -58.71 127.79 18.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 111.61 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.56 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . -72.49 150.21 44.76 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.035 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -52.45 137.53 29.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.924 0.392 . . . . 0.0 110.831 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.67 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -64.81 134.24 53.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.771 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.446 ' HD2' ' O ' ' A' ' 45' ' ' GLY . 99.5 mttt -136.13 -46.06 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.348 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -72.9 -130.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.477 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -166.25 48.59 0.08 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.06 0.457 . . . . 0.0 110.623 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 89' ' ' SER . 4.7 tppp? -157.6 -41.38 0.07 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.828 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.96 40.71 34.75 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.358 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.13 134.74 35.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.741 0.305 . . . . 0.0 111.015 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.448 ' O ' HD13 ' A' ' 75' ' ' ILE . 67.6 mt -85.67 131.75 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.33 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 84' ' ' GLY . 50.5 mm -134.08 135.9 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 0.0 111.359 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.728 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 99.6 t -141.56 116.98 5.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.811 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.4 m -82.07 146.19 29.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.3 p -141.54 139.85 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.17 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.513 ' HD2' HD13 ' A' ' 39' ' ' ILE . 32.1 mmmt -57.1 -51.09 70.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.7 t -65.69 -53.48 40.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.004 0.431 . . . . 0.0 110.544 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.77 -123.06 0.26 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.238 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.55 -139.11 2.58 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.188 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.84 131.97 48.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.616 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.728 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -62.41 152.95 43.9 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.691 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 63.0 p -147.93 142.61 26.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.711 0.291 . . . . 0.0 110.713 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.533 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 42.7 t -160.81 128.16 4.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.948 0.404 . . . . 0.0 111.319 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -74.57 -30.42 61.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.447 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.0 m -83.79 152.84 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.238 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 71' ' ' LYS . 48.0 m -138.84 141.27 38.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.822 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.526 ' CD2' HG11 ' A' ' 64' ' ' VAL . 41.7 t80 -85.9 127.7 34.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.324 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -82.69 88.24 6.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.243 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.784 HD21 ' HG3' ' A' ' 20' ' ' PRO . 35.4 tp -64.6 127.27 30.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 17' ' ' GLU . 81.2 mt -92.19 136.17 33.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.218 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -72.16 130.6 86.15 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.693 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -53.36 133.65 53.87 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.643 2.229 . . . . 0.0 112.957 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.78 129.56 51.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.662 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.813 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.98 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.1 m80 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.843 0.354 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.7 mtm -79.57 45.54 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.428 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -174.7 131.68 0.34 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.898 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -70.36 127.14 92.38 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.691 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.34 136.42 63.86 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.482 2.121 . . . . 0.0 112.156 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 50.2 Cg_exo -53.92 134.23 58.44 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.492 2.128 . . . . 0.0 112.091 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.672 HD13 ' N ' ' A' ' 10' ' ' VAL . 1.3 tm? -119.71 130.44 55.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.497 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.672 ' N ' HD13 ' A' ' 9' ' ' LEU . 90.5 t -101.92 137.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.744 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.52 HG23 HD12 ' A' ' 9' ' ' LEU . 39.6 p -151.38 48.3 0.82 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.197 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.15 144.81 6.36 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.021 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.442 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.6 tt -164.8 130.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 110.722 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.831 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -67.33 -59.62 6.98 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.672 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.831 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 83.0 Cg_endo -89.52 125.1 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.06 1.84 . . . . 0.0 112.421 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -86.02 -18.62 32.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.623 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HB2' HD11 ' A' ' 93' ' ' LEU . 11.3 pt-20 -156.15 138.46 14.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.238 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.539 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 175.8 148.71 7.03 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.561 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.448 HG12 ' OG1' ' A' ' 22' ' ' THR . 40.6 pt -51.82 157.51 1.97 Allowed Pre-proline 0 CA--C 1.531 0.25 0 CA-C-O 120.573 0.225 . . . . 0.0 111.065 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.691 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 84.8 Cg_exo -47.6 -37.5 26.92 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.713 2.276 . . . . 0.0 113.41 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -76.81 -22.4 53.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 64' ' ' VAL . 96.1 m -52.01 130.88 30.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.796 0.331 . . . . 0.0 111.093 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -65.26 139.05 58.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.682 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.1 m -141.2 125.64 17.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.6 m -93.46 116.71 29.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 55.7 mt -76.54 138.47 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.702 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 10' ' ' VAL . 43.2 mmm-85 -140.39 130.39 24.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.301 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.36 -133.85 1.65 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.629 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -147.61 132.63 18.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.799 0.333 . . . . 0.0 111.111 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 57.5 41.25 26.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.333 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.563 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.5 mp -70.35 -36.22 74.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.733 0.301 . . . . 0.0 110.68 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.86 130.93 1.62 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.559 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.415 ' OG1' ' HB2' ' A' ' 37' ' ' ASP . 81.8 p -65.24 -39.31 92.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.731 0.301 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.467 ' HA2' ' CZ2' ' A' ' 54' ' ' TRP . . . -164.52 -161.18 13.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.778 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.56 -49.25 7.61 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.723 2.282 . . . . 0.0 112.64 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.5 p -62.93 -38.84 92.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.53 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.415 ' HB2' ' OG1' ' A' ' 33' ' ' THR . 8.3 t70 -55.75 -51.67 66.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.18 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.4 tt -70.2 134.27 47.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.552 ' N ' HD23 ' A' ' 38' ' ' LEU . 43.1 pt -145.2 -37.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.195 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.46 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -113.69 142.68 17.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.813 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 42' ' ' THR . 1.1 tm? -149.57 130.78 14.55 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.621 ' N ' HD13 ' A' ' 41' ' ' LEU . 18.5 p -151.88 145.99 25.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.147 0.498 . . . . 0.0 111.888 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 69.8 mt -134.77 118.9 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.238 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.477 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 65.0 m 74.91 -38.01 0.37 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.523 0.514 . . . . 0.0 110.53 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.79 -36.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.104 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -77.19 131.07 38.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 110.853 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.606 ' HA ' HG22 ' A' ' 42' ' ' THR . 14.9 p-10 -74.86 144.91 43.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.894 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.9 m -146.77 43.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 49' ' ' LEU . 2.3 tm? -66.15 -45.99 79.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.709 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.485 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.4 pt? -49.19 -41.78 37.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.588 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.6 p -80.54 -35.42 34.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.408 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.28 134.93 56.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.845 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -127.1 134.37 50.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.63 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.467 ' CZ2' ' HA2' ' A' ' 34' ' ' GLY . 81.7 t90 -73.42 152.98 40.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.4 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.6 mmt -145.64 -46.25 0.21 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.777 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.9 t -171.25 177.26 3.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.679 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.13 35.53 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.607 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.1 p -179.31 30.63 0.0 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.868 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.6 ttmt -165.38 133.09 3.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.894 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.8 mt -151.34 113.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.845 0.355 . . . . 0.0 111.044 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.6 t -82.15 130.72 35.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.182 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.574 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.1 p -170.51 153.56 4.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.754 0.312 . . . . 0.0 111.483 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -84.06 136.57 33.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.882 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.691 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 2.5 t -54.0 135.73 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.183 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . -66.9 -119.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.224 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.14 143.26 10.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.573 0.225 . . . . 0.0 110.5 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.48 140.47 5.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -154.62 -47.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.904 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -174.87 173.99 2.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.197 0.523 . . . . 0.0 111.555 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 72' ' ' GLY . 58.0 t0 47.02 40.57 9.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.274 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 71' ' ' LYS . 4.0 mptp? 62.59 -71.72 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.59 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 44' ' ' CYS . . . 175.83 43.1 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.658 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -63.8 132.16 50.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.804 0.335 . . . . 0.0 111.014 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.517 ' O ' HD13 ' A' ' 75' ' ' ILE . 67.9 mt -85.46 129.0 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.533 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 74' ' ' ILE . 41.5 mm -132.76 142.09 43.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.266 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.686 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 6.6 p -141.31 122.52 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.94 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.7 m -87.22 147.7 25.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.37 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.1 p -140.7 140.83 34.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.805 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.548 ' HD2' HD13 ' A' ' 39' ' ' ILE . 14.3 mmmm -51.49 -48.75 62.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 82.2 p -68.98 -46.19 68.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.94 -129.52 0.05 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.885 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.03 -39.29 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.052 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -168.38 129.51 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.686 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -67.67 154.22 52.98 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.204 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 63.3 p -144.22 140.0 29.03 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.608 ' OG ' HG22 ' A' ' 88' ' ' VAL . 42.9 t -154.06 136.41 14.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.99 0.424 . . . . 0.0 111.832 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.9 p -92.71 37.33 1.01 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.173 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.608 HG22 ' OG ' ' A' ' 86' ' ' SER . 33.4 m -148.45 146.61 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.9 m -135.11 136.2 41.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.006 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -86.01 133.84 33.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.557 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -85.24 125.51 32.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.494 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.451 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.5 mm? -85.33 133.88 34.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.843 0.354 . . . . 0.0 111.29 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.539 HD12 ' HA2' ' A' ' 18' ' ' GLY . 80.0 mt -108.16 134.22 51.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.614 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -65.52 124.28 86.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.659 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.07 132.74 33.01 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.321 2.014 . . . . 0.0 112.356 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -110.76 102.78 11.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.833 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.337 -0.839 . . . . 0.0 110.936 179.959 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.756 0.312 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 41.3 tpp -173.75 135.27 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.937 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -62.12 106.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.998 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -83.56 140.29 41.34 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.19 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HB2' ' HA2' ' A' ' 84' ' ' GLY . 28.9 Cg_endo -62.62 142.93 91.56 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.478 2.119 . . . . 0.0 112.085 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 15.7 Cg_endo -57.32 137.96 84.02 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.614 2.209 . . . . 0.0 112.38 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.488 ' CD1' HG23 ' A' ' 11' ' ' THR . 2.4 tm? -124.88 124.22 41.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.284 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.498 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 68.3 t -86.93 136.88 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.088 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.488 HG23 ' CD1' ' A' ' 9' ' ' LEU . 23.3 p -152.52 45.48 0.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.872 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.67 144.17 6.48 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.206 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.483 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.1 tt -161.16 128.85 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.684 0.278 . . . . 0.0 110.489 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.621 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.6 t -61.96 -57.74 22.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.489 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 85.7 Cg_endo -75.95 -156.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.84 1.693 . . . . 0.0 111.804 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -168.96 -30.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.457 . . . . 0.0 110.34 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HB2' HD21 ' A' ' 93' ' ' LEU . 11.6 pt-20 -153.4 130.87 11.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.285 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.449 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 177.03 152.32 9.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.846 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.446 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 35.6 pt -52.22 162.73 0.81 Allowed Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 122.338 0.255 . . . . 0.0 111.461 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.637 ' HA ' HG23 ' A' ' 64' ' ' VAL . 86.6 Cg_exo -49.84 -43.92 38.82 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.957 2.438 . . . . 0.0 113.942 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.37 -5.57 29.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.2 m -67.93 127.81 34.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.757 0.313 . . . . 0.0 111.121 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HD2' HG13 ' A' ' 61' ' ' VAL . 39.7 ttpt -72.53 138.62 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.36 179.483 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.613 HG12 ' HG3' ' A' ' 15' ' ' PRO . 34.6 m -136.03 127.04 43.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 111.337 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.9 m -87.14 125.46 34.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.275 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 58.8 mt -85.96 139.19 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.909 179.546 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.486 ' O ' HG13 ' A' ' 10' ' ' VAL . 44.0 mmm-85 -143.13 130.78 21.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.268 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.59 -131.52 1.33 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.598 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -143.69 134.43 25.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.952 0.406 . . . . 0.0 111.698 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.6 m-80 59.88 43.5 14.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.664 178.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.575 HD22 ' O ' ' A' ' 58' ' ' SER . 9.1 mp -83.42 51.09 1.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.947 0.403 . . . . 0.0 110.39 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.13 124.8 0.34 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.532 -179.532 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.7 p -87.58 38.84 0.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 111.343 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 166.75 146.43 4.85 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.626 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.22 -45.77 32.9 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.639 2.226 . . . . 0.0 112.049 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 p -60.59 -37.82 82.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.873 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' A' ' 79' ' ' LYS . 39.1 t70 -58.2 -41.88 84.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.075 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.467 HD11 HD13 ' A' ' 60' ' ' ILE . 1.8 tt -66.62 75.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.138 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.508 HG21 ' HD3' ' A' ' 79' ' ' LYS . 34.8 pt -76.59 -40.63 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.183 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.437 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -121.76 142.73 15.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.412 -179.018 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.591 HD13 ' N ' ' A' ' 42' ' ' THR . 3.3 tm? -150.0 132.96 16.14 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.31 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.591 ' N ' HD13 ' A' ' 41' ' ' LEU . 60.9 p -147.52 127.52 13.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.903 0.383 . . . . 0.0 111.837 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.875 HG21 HG12 ' A' ' 64' ' ' VAL . 72.7 mt -108.19 124.86 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.022 178.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.666 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 67.4 m 54.54 41.25 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.021 0.439 . . . . 0.0 110.459 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.57 34.38 89.75 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.747 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -131.31 132.01 44.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.594 0.235 . . . . 0.0 110.538 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.42 ' HA ' HG22 ' A' ' 42' ' ' THR . 22.6 t-20 -63.3 131.05 47.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.714 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.0 m -154.46 37.58 0.43 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 49' ' ' LEU . 2.2 tm? -72.77 -45.6 57.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 110.32 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.449 ' H ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -55.74 -40.22 72.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.167 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.0 p -80.05 -37.47 33.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.992 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.581 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.61 133.9 56.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.351 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.92 131.91 51.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.759 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -69.9 151.55 45.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.958 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.0 mmt -142.07 -44.99 0.34 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.02 179.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.6 p -163.34 -164.95 0.99 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.662 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.45 35.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.575 ' O ' HD22 ' A' ' 31' ' ' LEU . 80.8 p -178.96 -43.37 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.364 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -77.63 133.31 38.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.494 -179.437 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.467 HD13 HD11 ' A' ' 38' ' ' LEU . 68.6 mt -151.33 111.81 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.387 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.411 HG13 ' HD2' ' A' ' 23' ' ' LYS . 60.5 t -80.23 125.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.627 ' SG ' HD11 ' A' ' 43' ' ' ILE . 29.0 p -170.72 131.57 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -87.82 140.4 29.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.875 HG12 HG21 ' A' ' 43' ' ' ILE . 33.4 m -67.3 -147.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.629 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.611 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . 176.06 -40.74 0.11 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.562 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -174.31 136.66 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.954 0.377 . . . . 0.0 111.422 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.666 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -79.6 61.69 3.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.247 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.529 ' O ' ' HD3' ' A' ' 68' ' ' LYS . 12.1 tmtt? -48.96 -43.31 39.75 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.878 0.37 . . . . 0.0 110.042 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -65.65 -107.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.344 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -173.04 -50.81 0.02 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.766 0.317 . . . . 0.0 110.613 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -76.62 -38.32 54.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.8 37.55 5.46 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.333 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.32 135.85 42.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.773 0.32 . . . . 0.0 110.821 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.2 mt -85.67 92.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.176 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.475 ' N ' HD12 ' A' ' 75' ' ' ILE . 1.9 mp -86.67 139.66 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.172 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.559 HG23 HD23 ' A' ' 41' ' ' LEU . 7.5 p -141.36 125.46 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.813 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.4 m -95.95 144.14 26.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.406 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.9 p -126.48 141.02 52.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.876 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.508 ' HD3' HG21 ' A' ' 39' ' ' ILE . 23.5 tptm -56.98 -48.93 77.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.899 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -67.66 -55.35 13.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.53 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.39 -124.71 0.69 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.178 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.51 -143.32 3.78 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.099 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.75 117.94 13.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 110.58 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 7' ' ' PRO . . . -92.3 -149.92 25.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.522 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.8 p -155.22 -169.21 3.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.66 0.267 . . . . 0.0 110.542 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.0 p -170.85 128.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.913 0.387 . . . . 0.0 111.319 179.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.5 p -76.27 -34.28 59.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.37 178.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 m -84.66 146.32 6.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.345 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -134.96 134.62 40.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.714 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -89.33 136.67 32.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.664 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -102.55 123.28 46.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.442 179.224 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.502 HD12 ' N ' ' A' ' 92' ' ' LEU . 6.4 mp -85.28 132.08 34.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 0.0 111.4 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 17' ' ' GLU . 84.2 mt -90.67 138.09 31.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.242 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 37.6 mtmm -67.45 135.41 93.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.368 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 44.1 Cg_exo -57.24 128.73 30.84 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.394 2.063 . . . . 0.0 112.151 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.36 113.91 9.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.668 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.847 179.864 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.8 m170 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.791 0.329 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' A' ' 4' ' ' MET . 1.6 pmm? -61.75 136.8 58.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.655 ' HB3' ' HA2' ' A' ' 81' ' ' GLY . 22.2 tpp180 -61.61 135.01 57.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.638 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -60.99 130.06 90.9 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.998 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.39 138.53 39.23 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.522 2.148 . . . . 0.0 112.13 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 16.9 Cg_endo -58.31 127.73 25.89 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.48 2.12 . . . . 0.0 112.066 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 85' ' ' THR . 64.4 tp -109.91 117.38 33.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.107 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.58 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 89.7 t -83.22 131.31 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.776 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.8 p -149.04 47.9 0.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.032 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.04 147.51 8.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.178 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.577 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.8 tt -161.18 130.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.587 0.232 . . . . 0.0 110.655 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.855 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 44.3 t -63.51 -59.26 12.29 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.31 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.968 ' HG2' HG12 ' A' ' 24' ' ' VAL . 7.3 Cg_exo -71.29 -147.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.93 1.754 . . . . 0.0 111.748 179.032 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -176.4 -25.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.945 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -162.69 129.49 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.129 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 177.48 155.07 13.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.728 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.0 pt -51.14 159.75 0.99 Allowed Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.692 0.282 . . . . 0.0 111.382 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.62 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 86.5 Cg_exo -48.28 -48.28 17.33 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.978 2.452 . . . . 0.0 113.96 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -65.85 -5.69 9.82 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.4 m -67.28 126.17 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 111.071 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.625 ' HA ' ' HG2' ' A' ' 63' ' ' ARG . 6.1 ttpm? -71.41 133.19 45.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.618 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.968 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.4 m -131.79 126.1 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 111.007 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.2 m -83.73 125.55 32.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.25 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 60' ' ' ILE . 48.7 mt -82.12 139.21 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.835 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 10' ' ' VAL . 23.2 mmm180 -146.51 132.95 19.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.312 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.21 -130.47 1.2 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.391 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -147.31 132.98 18.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 32.9 m120 61.07 42.55 12.34 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.615 178.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 58' ' ' SER . 8.9 mp -83.13 49.06 1.47 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.939 0.399 . . . . 0.0 110.664 178.713 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.3 122.73 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.558 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -91.74 42.44 1.1 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.921 0.391 . . . . 0.0 111.177 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.53 146.44 5.52 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.711 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.9 -42.92 62.61 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.588 2.192 . . . . 0.0 111.901 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.3 p -61.96 -32.65 73.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.995 179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -77.84 45.73 0.53 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.048 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.465 HD21 HD23 ' A' ' 41' ' ' LEU . 1.3 tt -162.1 55.44 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.131 0.491 . . . . 0.0 110.005 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.0 pt -66.54 -37.86 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.323 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.41 138.95 15.34 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.9 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.645 HD13 ' N ' ' A' ' 42' ' ' THR . 2.9 tm? -148.42 134.06 18.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.786 0.327 . . . . 0.0 110.134 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.645 ' N ' HD13 ' A' ' 41' ' ' LEU . 19.4 p -147.13 147.16 30.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.463 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.655 HG21 HG12 ' A' ' 64' ' ' VAL . 75.0 mt -128.8 116.19 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.788 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.678 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 69.1 m 70.68 -30.46 0.2 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.982 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.38 -44.18 0.31 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.621 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -80.45 139.48 36.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.856 0.36 . . . . 0.0 111.237 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.442 ' HA ' HG22 ' A' ' 42' ' ' THR . 5.3 m120 -60.85 143.53 54.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.965 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.8 m -145.5 39.09 1.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.599 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.6 tp -70.94 -43.4 68.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.136 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.453 ' H ' HD23 ' A' ' 50' ' ' LEU . 2.6 pt? -55.91 -41.24 74.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.157 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.3 p -79.87 -34.34 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.793 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 61' ' ' VAL . . . -58.48 134.17 56.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.285 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -126.27 122.06 34.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.389 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -70.81 147.15 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 56.3 mtt -149.22 -41.36 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.15 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.6 p -157.47 175.18 14.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.69 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.75 42.03 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.358 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.506 ' O ' HD22 ' A' ' 31' ' ' LEU . 43.8 t -175.93 -40.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.077 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -85.53 133.23 34.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.231 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 74.9 mt -150.72 115.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.648 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 64.3 t -82.01 124.15 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.947 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.653 ' SG ' HD11 ' A' ' 43' ' ' ILE . 22.6 p -171.19 132.01 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.917 0.389 . . . . 0.0 111.26 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.625 ' HG2' ' HA ' ' A' ' 23' ' ' LYS . 98.3 mtt180 -85.93 140.68 30.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.139 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.655 HG12 HG21 ' A' ' 43' ' ' ILE . 34.6 m -66.76 -149.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.547 179.525 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.62 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . 179.69 -48.03 0.08 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.653 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -177.53 137.67 0.21 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.23 0.515 . . . . 0.0 111.842 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.678 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -70.25 145.47 51.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.16 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.475 ' HB2' ' HA3' ' A' ' 45' ' ' GLY . 29.0 mtpp -147.17 -46.32 0.17 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.418 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -62.74 -46.49 87.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.561 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -169.17 -40.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.616 0.246 . . . . 0.0 111.35 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.595 ' HB3' ' NZ ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -160.11 -42.66 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.372 -179.746 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.84 39.9 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.896 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.8 127.87 34.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.694 0.283 . . . . 0.0 110.856 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.465 ' O ' HD13 ' A' ' 75' ' ' ILE . 65.2 mt -85.81 135.68 24.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.689 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 74' ' ' ILE . 50.4 mm -134.16 139.65 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 111.153 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.6 122.81 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.72 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.7 m -92.02 143.37 26.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.298 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.9 p -134.41 136.56 43.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.056 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -57.61 -47.67 81.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.182 -179.649 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 88.5 p -64.73 -54.8 25.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.658 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.655 ' HA2' ' HB3' ' A' ' 5' ' ' ARG . . . -86.7 -123.21 1.57 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.421 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.8 -139.03 2.54 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.996 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.576 ' NZ ' ' HB2' ' A' ' 83' ' ' LYS . 4.8 ttmp? -62.45 126.57 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 110.794 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.74 134.69 13.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.802 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 79.8 p -99.31 145.54 27.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.553 0.215 . . . . 0.0 110.684 179.498 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.0 p -141.8 122.05 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.333 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.6 p -93.08 32.97 1.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.399 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.0 m -150.94 150.79 13.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.605 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.0 p -142.99 134.85 26.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.966 0.412 . . . . 0.0 111.217 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.5 ' HD2' HG11 ' A' ' 64' ' ' VAL . 60.1 t80 -85.67 128.16 34.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.817 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -85.0 121.03 27.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.562 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 92' ' ' LEU . 6.8 mp -89.98 128.16 36.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.864 0.364 . . . . 0.0 111.293 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.425 HD12 ' HA2' ' A' ' 18' ' ' GLY . 82.7 mt -85.51 141.51 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.735 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.41 ' N ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.06 134.42 95.79 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.876 179.848 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.47 132.74 53.96 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.528 2.152 . . . . 0.0 112.555 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -72.09 115.05 10.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.559 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.8 pttt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.001 -179.888 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.823 0.344 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.556 ' HG3' ' H ' ' A' ' 5' ' ' ARG . 40.9 tpp -71.43 -131.86 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.42 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.556 ' H ' ' HG3' ' A' ' 4' ' ' MET . 1.0 OUTLIER 52.45 42.97 31.4 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.865 0.364 . . . . 0.0 110.964 179.84 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -64.57 133.13 95.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.041 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.91 143.93 74.83 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.526 2.15 . . . . 0.0 111.99 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.497 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 67.4 Cg_exo -50.7 142.49 31.82 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.584 2.189 . . . . 0.0 112.43 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 85' ' ' THR . 63.2 tp -142.9 98.39 3.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.871 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.566 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 59.6 t -73.01 134.09 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.018 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.6 p -148.88 44.67 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.994 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.81 142.77 5.31 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.776 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.515 HG12 ' HD2' ' A' ' 15' ' ' PRO . 18.1 tt -164.67 131.33 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.743 0.306 . . . . 0.0 110.931 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.796 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -68.05 -58.28 8.03 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.855 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.819 ' HG2' HG12 ' A' ' 24' ' ' VAL . 92.0 Cg_endo -92.18 123.8 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.329 2.019 . . . . 0.0 112.262 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -81.72 -20.66 38.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 91' ' ' LYS . 11.0 pt-20 -157.48 138.71 13.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 111.409 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.454 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 178.45 151.76 9.76 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.419 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.517 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 38.4 pt -52.14 163.66 0.68 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.671 0.236 . . . . 0.0 111.15 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.727 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 76.4 Cg_exo -49.08 -47.0 23.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.533 2.155 . . . . 0.0 113.944 -178.657 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -72.68 -14.65 61.62 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.601 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.423 ' OG1' HG12 ' A' ' 19' ' ' ILE . 99.8 m -55.11 122.52 11.17 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.599 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -61.0 136.44 58.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.578 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.819 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.8 m -137.01 122.12 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.099 0.476 . . . . 0.0 111.129 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.0 m -83.84 113.5 20.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.523 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.611 HD12 ' HB ' ' A' ' 60' ' ' ILE . 62.9 mt -79.13 138.61 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.053 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.436 ' O ' HG13 ' A' ' 10' ' ' VAL . 20.6 mmt85 -144.92 129.44 17.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.276 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.62 -134.93 1.83 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.617 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 5.6 mm-40 -150.31 133.79 16.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.915 0.388 . . . . 0.0 111.422 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 57.87 41.9 24.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.069 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.497 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.6 mp -67.52 -38.51 84.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.74 0.305 . . . . 0.0 110.879 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.04 132.64 1.99 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.699 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.0 p -62.12 -35.69 79.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.44 172.48 39.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.375 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.47 -44.59 45.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.605 2.204 . . . . 0.0 112.273 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.8 p -62.74 -39.27 93.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.092 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.536 ' HA ' ' HD3' ' A' ' 79' ' ' LYS . 8.0 t70 -57.66 -40.63 79.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.034 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 tt -75.28 66.75 1.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.265 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.416 ' O ' HD22 ' A' ' 49' ' ' LEU . 36.3 pt -73.27 -33.71 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.96 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -126.3 140.54 12.14 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.531 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 48' ' ' CYS . 53.9 tp -148.72 144.17 26.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.731 0.301 . . . . 0.0 110.57 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 41' ' ' LEU . 11.5 p -161.33 142.15 11.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.286 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.455 HG13 ' SG ' ' A' ' 48' ' ' CYS . 63.9 mt -127.12 115.51 41.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.72 178.671 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 48.2 t 74.04 -35.79 0.32 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.695 -178.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.97 -36.15 0.28 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.509 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.45 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 83.4 t60 -77.69 139.82 39.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.899 0.381 . . . . 0.0 111.558 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -66.73 151.92 46.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.962 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.567 ' O ' HD23 ' A' ' 41' ' ' LEU . 3.0 p -159.66 45.11 0.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.367 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 39' ' ' ILE . 52.9 tp -88.34 -46.24 9.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.568 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.434 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -54.8 -39.76 68.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.871 -179.025 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.3 p -80.25 -38.15 31.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.789 0.328 . . . . 0.0 111.681 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.565 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -60.01 135.99 57.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.016 0.436 . . . . 0.0 111.709 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -123.13 127.85 49.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.591 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 66.4 t90 -69.29 146.09 52.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.473 ' SD ' HG23 ' A' ' 61' ' ' VAL . 87.5 mtp -143.44 -42.23 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.702 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.492 ' C ' ' H ' ' A' ' 58' ' ' SER . 81.2 p -167.11 164.31 15.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.301 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.93 27.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.497 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.8 m -167.33 27.27 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.816 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.5 ttmt -164.92 130.14 2.64 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.926 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.611 ' HB ' HD12 ' A' ' 26' ' ' ILE . 72.4 mt -151.16 118.84 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.473 HG23 ' SD ' ' A' ' 55' ' ' MET . 92.2 t -90.15 129.22 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.003 179.053 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 30.2 p -170.54 151.5 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.322 . . . . 0.0 111.492 -179.144 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.2 134.44 34.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.275 179.136 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.727 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t -57.29 128.47 17.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.759 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 46' ' ' HIS . . . -83.8 61.4 4.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.938 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.495 ' H ' ' HB3' ' A' ' 20' ' ' PRO . 19.3 pt20 43.07 -141.39 0.15 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 122.249 0.219 . . . . 0.0 111.31 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.09 119.78 5.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.954 0.407 . . . . 0.0 111.167 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.69 -35.07 30.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.779 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -139.02 -129.27 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.6 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -150.97 48.61 0.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.16 0.505 . . . . 0.0 110.3 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.604 ' NZ ' ' HB2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -82.95 -42.55 17.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.284 -179.805 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.72 72.05 0.75 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.217 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.58 ' HB3' ' HE3' ' A' ' 71' ' ' LYS . 9.4 t0 -161.46 127.8 3.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.861 0.362 . . . . 0.0 110.604 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.53 92.54 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.02 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.3 mm -84.18 139.36 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.742 -179.556 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 41' ' ' LEU . 46.0 t -141.31 114.3 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.856 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.1 m -81.31 144.3 31.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.913 0.387 . . . . 0.0 111.526 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.2 p -136.8 135.07 37.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.69 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.536 ' HD3' ' HA ' ' A' ' 37' ' ' ASP . 28.3 mtpp -52.74 -47.19 67.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.855 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.8 m -68.33 -48.54 64.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.055 0.455 . . . . 0.0 110.112 179.103 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.27 -121.96 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.542 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.58 -33.9 0.04 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.4 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -168.89 125.07 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 0.0 110.556 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.09 130.61 9.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.93 -0.653 . . . . 0.0 113.132 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 75.7 p -100.99 147.17 26.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.574 0.226 . . . . 0.0 110.767 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.2 p -149.95 126.96 11.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.051 0.453 . . . . 0.0 111.37 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.7 p -78.85 -30.33 45.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.017 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.8 m -83.68 141.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.212 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.7 m -121.69 142.98 49.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.478 ' CE2' HG21 ' A' ' 64' ' ' VAL . 63.1 t80 -97.91 106.98 19.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.234 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 57.4 tttm -70.31 117.41 11.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.215 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.51 HD11 ' CD ' ' A' ' 20' ' ' PRO . 45.4 tp -80.62 132.39 35.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.742 -178.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.415 HD11 ' HG3' ' A' ' 17' ' ' GLU . 84.0 mt -102.78 131.69 49.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.189 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 60.2 mttp -73.1 131.57 83.39 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.773 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 49.2 Cg_exo -57.52 131.48 44.72 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.581 2.187 . . . . 0.0 112.727 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -72.92 115.59 12.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.518 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.1 tptt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.959 -179.902 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.456 ' O ' ' HB3' ' A' ' 4' ' ' MET . 47.5 m170 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.547 0.213 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.456 ' HB3' ' O ' ' A' ' 3' ' ' HIS . 48.2 tpp 73.56 -41.08 0.48 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.682 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -168.97 140.65 2.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 110.764 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -59.28 133.51 88.05 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.085 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.78 146.75 95.16 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.673 2.248 . . . . 0.0 112.069 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 13.6 Cg_endo -57.17 123.28 13.45 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.424 2.083 . . . . 0.0 112.212 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.5 tp -103.27 121.2 42.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.97 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 62.4 t -95.31 136.48 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 t -169.51 51.11 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.078 0.466 . . . . 0.0 111.305 -179.565 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.93 143.41 7.27 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.418 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.511 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.4 tt -160.05 130.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.713 0.292 . . . . 0.0 110.967 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.787 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.9 t -66.39 -58.73 9.71 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.607 179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 67.9 Cg_endo -89.22 115.56 0.7 Allowed 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.146 1.897 . . . . 0.0 112.102 179.377 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -99.1 27.55 5.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.923 0.392 . . . . 0.0 110.632 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' A' ' 93' ' ' LEU . 11.7 pt-20 178.61 131.03 0.07 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.454 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.97 150.59 6.77 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.786 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.443 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.3 pt -57.0 162.34 3.89 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.473 0.178 . . . . 0.0 111.057 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.666 ' HA ' HG23 ' A' ' 64' ' ' VAL . 85.7 Cg_exo -48.96 -46.68 24.23 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.978 2.452 . . . . 0.0 114.019 -178.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' O ' ' HD2' ' A' ' 63' ' ' ARG . 94.6 m95 -69.99 -5.96 29.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.869 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.4 m -72.96 127.56 32.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 110.818 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -74.38 125.29 28.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.809 179.904 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG12 ' HG2' ' A' ' 15' ' ' PRO . 23.7 m -108.38 127.6 64.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.084 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.4 m -78.87 119.49 22.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.332 -179.679 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 61.8 mt -85.28 140.73 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.411 179.255 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -146.55 136.74 23.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.342 . . . . 0.0 110.872 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.99 -128.42 1.04 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.413 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -143.96 129.58 19.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.0 111.266 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.491 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.5 m-80 58.66 47.56 12.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.108 179.261 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.8 mp -81.18 53.21 1.97 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.868 0.366 . . . . 0.0 111.02 179.194 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 37' ' ' ASP . . . 83.86 135.32 2.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.796 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 77.7 p -62.98 -40.77 98.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.656 0.265 . . . . 0.0 111.376 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -161.35 -159.46 10.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.932 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -65.85 -48.22 3.11 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.728 2.285 . . . . 0.0 112.528 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -60.31 -39.52 87.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.695 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 38.8 t70 -63.19 -47.08 84.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.616 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 39' ' ' ILE . 2.3 tt -66.96 129.16 38.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.773 179.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.587 HD13 ' HD2' ' A' ' 79' ' ' LYS . 29.7 pt -137.23 -44.68 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.22 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.485 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -98.67 136.59 12.78 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.309 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.655 HD13 ' N ' ' A' ' 42' ' ' THR . 1.9 tm? -149.43 132.41 16.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 110.195 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.655 ' N ' HD13 ' A' ' 41' ' ' LEU . 16.5 p -151.62 148.79 28.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.489 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.884 HG21 HG12 ' A' ' 64' ' ' VAL . 77.2 mt -133.14 114.33 21.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.584 179.14 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.625 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 66.7 m 73.36 -38.56 0.41 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 123.488 0.493 . . . . 0.0 110.545 -178.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 171.45 -41.97 0.18 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.631 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.846 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 25.2 p-80 -78.75 135.74 37.2 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.841 0.353 . . . . 0.0 111.14 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.523 ' HA ' HG22 ' A' ' 42' ' ' THR . 4.9 m120 -61.21 141.62 57.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.2 m -139.98 38.43 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.564 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 39' ' ' ILE . 53.5 tp -71.51 -43.77 65.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.353 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.443 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.5 pt? -53.57 -42.94 68.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.477 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.3 p -80.47 -37.83 31.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.714 0.292 . . . . 0.0 111.443 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -60.47 129.17 40.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.032 0.444 . . . . 0.0 111.66 -179.647 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -126.67 132.1 51.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.213 179.278 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.564 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 54.3 t90 -63.99 149.89 46.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.376 . . . . 0.0 111.019 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 93.4 mmm -143.78 -45.88 0.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.632 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 58' ' ' SER . 70.8 m -163.63 162.06 24.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.474 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.48 36.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.35 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 56' ' ' SER . 78.1 p -175.24 20.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.153 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.1 tttm -165.19 131.68 2.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.487 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.3 mt -147.53 122.2 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.792 0.33 . . . . 0.0 110.998 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.4 t -83.82 133.76 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.941 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.529 ' SG ' HD11 ' A' ' 43' ' ' ILE . 29.9 p -170.53 132.92 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.352 . . . . 0.0 110.919 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 77.6 mtm180 -85.0 134.62 34.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.884 HG12 HG21 ' A' ' 43' ' ' ILE . 27.8 m -70.94 -148.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.399 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . 179.81 -52.91 0.09 OUTLIER Glycine 0 C--N 1.335 0.476 0 C-N-CA 119.88 -1.152 . . . . 0.0 113.494 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -177.17 136.85 0.21 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.101 0.45 . . . . 0.0 111.745 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.625 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -83.52 123.4 29.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.784 179.128 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.846 ' HE3' ' HB3' ' A' ' 46' ' ' HIS . 99.3 mttt -83.14 -54.48 5.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.409 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 73.1 m-20 -67.04 -68.32 0.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.847 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 69' ' ' ASN . 64.8 t0 177.09 -51.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.306 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HD3' ' OD1' ' A' ' 73' ' ' ASP . 49.9 tttp -76.69 -121.4 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.293 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.84 46.55 0.05 OUTLIER Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.538 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.48 ' OD1' ' HD3' ' A' ' 71' ' ' LYS . 1.6 m-20 -63.88 128.53 36.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 111.413 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.406 ' O ' HD13 ' A' ' 75' ' ' ILE . 66.8 mt -85.91 137.21 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.732 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.406 HD13 ' O ' ' A' ' 74' ' ' ILE . 48.4 mm -134.22 142.23 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.917 0.389 . . . . 0.0 111.388 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.82 128.74 23.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.636 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.565 HG23 ' HA2' ' A' ' 82' ' ' GLY . 24.6 m -102.22 140.13 36.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.42 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.6 p -122.01 149.31 43.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.587 ' HD2' HD13 ' A' ' 39' ' ' ILE . 14.5 mmmm -51.18 -51.4 54.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.204 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.0 m -69.92 -54.47 13.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.627 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.74 -131.03 2.59 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.28 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.565 ' HA2' HG23 ' A' ' 77' ' ' THR . . . -171.83 -143.04 3.92 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.851 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -67.69 117.79 10.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 110.688 179.624 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.77 -133.42 2.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.735 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 86' ' ' SER . 0.0 OUTLIER -160.21 -176.64 5.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.002 0.43 . . . . 0.0 110.946 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.649 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 79.4 p -169.27 123.88 0.83 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.527 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.1 p -95.03 33.55 1.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.185 178.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.3 m -152.18 152.8 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.537 -179.627 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.0 p -143.93 141.96 30.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.049 0.452 . . . . 0.0 111.209 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -85.0 131.94 34.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.25 -179.679 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.745 ' HE2' HD21 ' A' ' 93' ' ' LEU . 6.0 ttpm? -81.58 120.78 25.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.657 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.466 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -81.71 130.93 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.823 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.745 HD21 ' HE2' ' A' ' 91' ' ' LYS . 79.8 mt -107.0 145.2 32.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.233 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -61.26 131.73 92.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.778 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.97 135.48 41.09 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.584 2.19 . . . . 0.0 112.406 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -70.5 77.18 0.57 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.124 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.774 179.958 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.428 ' NE2' ' HG2' ' A' ' 4' ' ' MET . 18.9 p-80 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.71 0.29 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.428 ' HG2' ' NE2' ' A' ' 3' ' ' HIS . 92.9 mmm -69.95 -145.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.287 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.408 ' H ' ' HB3' ' A' ' 4' ' ' MET . 56.1 ttp180 -175.76 134.16 0.28 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.478 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -141.02 141.48 24.12 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.986 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 13.7 Cg_endo -57.03 145.91 83.37 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.749 2.3 . . . . 0.0 112.265 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 52.6 Cg_exo -54.08 138.86 71.36 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.534 2.156 . . . . 0.0 112.342 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 85' ' ' THR . 5.6 tt -133.74 111.77 10.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.323 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 83.9 t -83.75 140.51 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.918 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 t -162.68 46.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.028 0.442 . . . . 0.0 110.793 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.1 142.3 5.96 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.858 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.524 HG12 ' HD2' ' A' ' 15' ' ' PRO . 13.2 tt -164.07 128.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.659 0.266 . . . . 0.0 110.457 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.781 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 45.9 t -63.62 -58.64 14.39 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.83 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 94.0 Cg_endo -89.47 107.29 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.21 1.94 . . . . 0.0 112.188 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -91.03 26.41 2.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 110.587 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' A' ' 93' ' ' LEU . 12.4 pt-20 179.5 130.01 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.287 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.459 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 166.99 148.19 5.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.568 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.0 pt -52.2 154.01 4.47 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.537 0.208 . . . . 0.0 110.786 179.72 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.677 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 84.2 Cg_exo -47.26 -37.6 24.56 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.018 2.478 . . . . 0.0 113.792 -178.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -73.44 -23.32 60.09 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 m -57.99 128.55 37.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 110.964 -179.773 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.87 129.84 41.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.538 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.702 HG12 ' HG2' ' A' ' 15' ' ' PRO . 26.8 m -121.4 125.1 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 111.013 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.4 m -75.84 116.89 17.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.921 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 61.5 mt -83.04 136.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.67 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 58' ' ' SER . 29.3 tpt180 -141.49 133.41 27.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.334 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.45 -134.04 1.69 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.48 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -150.25 132.24 15.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.944 0.402 . . . . 0.0 111.281 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.456 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 72.3 m-80 59.3 46.47 12.69 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.673 178.807 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.4 mp -81.78 52.15 1.86 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 110.694 178.797 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.06 126.69 0.14 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.419 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.7 p -90.77 42.27 1.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.694 0.283 . . . . 0.0 111.563 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.52 145.81 5.0 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.792 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 -46.38 27.61 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.394 2.063 . . . . 0.0 111.709 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.5 t -62.05 -36.06 80.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.072 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.14 -36.18 67.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 tt -75.57 61.09 1.28 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.488 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.593 HD13 ' HG2' ' A' ' 79' ' ' LYS . 30.7 pt -68.98 -40.1 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.435 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.422 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -110.48 139.75 15.61 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.957 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 42' ' ' THR . 3.0 tm? -148.26 132.06 17.01 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.626 ' N ' HD13 ' A' ' 41' ' ' LEU . 24.0 p -150.51 140.94 22.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.162 0.506 . . . . 0.0 111.843 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.3 mt -137.4 125.79 33.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.573 178.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.522 ' SG ' HD21 ' A' ' 92' ' ' LEU . 69.2 m 58.43 37.98 25.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.163 0.506 . . . . 0.0 110.1 -179.004 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.89 25.31 71.88 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.958 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -131.85 125.33 31.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.54 0.209 . . . . 0.0 110.521 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -63.11 138.17 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.324 . . . . 0.0 110.633 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.0 m -148.84 39.38 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.684 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 39' ' ' ILE . 58.3 tp -69.69 -44.55 70.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.266 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.463 ' N ' HD23 ' A' ' 50' ' ' LEU . 2.4 pt? -50.66 -44.16 57.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.297 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.457 HG23 ' HG ' ' A' ' 50' ' ' LEU . 71.8 p -80.77 -37.83 29.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 111.134 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -60.44 130.31 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.718 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -126.82 129.36 48.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.514 179.404 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 80.8 t90 -64.57 145.92 55.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.618 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.3 mmm -140.14 -45.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 58' ' ' SER . 65.7 m -164.05 160.27 21.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.65 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.39 27.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.838 0.352 . . . . 0.0 111.396 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.3 m -168.03 19.49 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.833 179.341 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.3 tttp -165.19 130.8 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.511 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 68.5 mt -148.84 119.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.952 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.32 134.71 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.555 179.323 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 45.9 t -170.67 152.84 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.277 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -83.79 135.25 34.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.001 179.366 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.677 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t -56.64 135.82 20.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.625 -178.679 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.29 -110.3 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.929 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -165.9 139.29 4.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.562 0.22 . . . . 0.0 110.477 179.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.461 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -61.51 78.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.031 -179.195 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -66.75 -50.81 61.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.746 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -77.84 -71.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.833 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 t70 178.29 -47.18 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.118 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -78.22 -122.78 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.825 -179.81 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.39 40.92 0.07 OUTLIER Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.81 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -66.06 130.69 44.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.708 0.289 . . . . 0.0 111.129 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.422 ' O ' HD13 ' A' ' 75' ' ' ILE . 68.8 mt -85.06 131.61 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.355 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 74' ' ' ILE . 39.9 mm -127.4 139.93 50.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.402 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -139.63 120.94 15.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.624 179.558 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.9 m -94.07 142.47 27.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.2 p -136.92 136.57 38.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.593 ' HG2' HD13 ' A' ' 39' ' ' ILE . 28.3 mtpp -55.96 -50.62 70.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.018 -179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.0 m -67.52 -54.59 18.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.323 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.21 -125.22 0.46 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.108 179.385 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.55 -141.69 3.22 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.469 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -63.9 128.99 38.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.82 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.11 128.31 8.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.775 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 81.4 p -103.63 148.55 25.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.626 0.25 . . . . 0.0 110.829 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.608 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 40.4 t -154.48 127.82 8.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 111.661 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.4 p -77.55 -32.98 54.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.423 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.6 m -84.47 148.66 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.494 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.3 m -139.29 140.35 37.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.549 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.416 ' CD2' HG11 ' A' ' 64' ' ' VAL . 62.3 t80 -85.05 131.74 34.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.35 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.461 ' HE3' HD21 ' A' ' 93' ' ' LEU . 38.9 ttpt -84.34 122.27 28.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.595 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.522 HD21 ' SG ' ' A' ' 44' ' ' CYS . 3.4 mm? -78.59 131.64 36.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.241 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 17' ' ' GLU . 73.6 mt -108.27 137.45 46.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.585 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 62.0 tttp -61.62 128.58 90.36 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.812 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 47.8 Cg_exo -57.54 131.48 44.7 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.537 2.158 . . . . 0.0 112.45 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.1 114.81 10.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.416 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.3 pttt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.88 -179.973 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.576 0.226 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.98 144.79 99.43 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.521 2.147 . . . . 0.0 111.888 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 54.2 Cg_exo -51.41 118.47 4.39 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.317 2.011 . . . . 0.0 112.4 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.5 tp -99.41 131.27 45.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.645 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 85.1 t -116.6 135.91 55.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.672 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -168.82 52.47 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.098 0.475 . . . . 0.0 111.34 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.93 143.53 8.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.579 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.544 HG12 ' HD2' ' A' ' 15' ' ' PRO . 12.7 tt -161.36 131.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.564 0.221 . . . . 0.0 110.782 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.697 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 43.8 t -62.3 -60.23 10.65 Favored Pre-proline 0 CA--C 1.531 0.218 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.132 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 84.8 Cg_endo -79.71 -160.14 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.875 1.717 . . . . 0.0 111.742 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -173.22 21.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.761 0.315 . . . . 0.0 110.967 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.413 ' HB2' HD11 ' A' ' 93' ' ' LEU . 22.8 pt-20 177.78 127.45 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.3 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 164.09 153.03 7.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.886 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 93' ' ' LEU . 34.7 pt -53.92 159.65 2.65 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.435 0.16 . . . . 0.0 110.922 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.841 ' HA ' HG23 ' A' ' 64' ' ' VAL . 75.8 Cg_exo -51.41 -40.75 61.94 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.64 2.227 . . . . 0.0 113.392 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.495 ' HE3' HH11 ' A' ' 63' ' ' ARG . 78.6 m95 -69.56 -5.35 23.79 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.0 m -66.96 132.23 47.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 111.314 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.56 ' HD2' HG13 ' A' ' 61' ' ' VAL . 17.6 tppt? -70.31 138.74 51.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.69 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.576 HG12 ' HG3' ' A' ' 15' ' ' PRO . 35.2 m -145.9 128.55 9.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.96 0.409 . . . . 0.0 111.06 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 84.3 m -87.13 120.99 28.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.8 mt -79.79 139.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.115 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HE ' ' HZ3' ' A' ' 59' ' ' LYS . 19.2 mmt85 -137.33 134.74 36.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.33 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.05 -136.25 2.24 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.871 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -152.16 134.42 15.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.972 0.415 . . . . 0.0 111.497 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 60.63 42.0 14.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.603 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.527 HD13 ' HA ' ' A' ' 58' ' ' SER . 9.1 mp -83.85 50.47 1.82 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 110.399 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.48 126.56 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.31 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.9 p -94.97 43.51 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 0.0 111.252 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.41 142.74 4.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.707 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.2 -42.26 58.6 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.595 2.196 . . . . 0.0 112.044 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.3 p -62.96 -38.68 92.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.955 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -56.56 -37.33 70.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.976 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.575 HD21 HD23 ' A' ' 41' ' ' LEU . 1.4 tt -75.46 62.8 1.4 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.466 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.464 HG13 ' N ' ' A' ' 40' ' ' GLY . 35.9 pt -69.25 -41.24 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.495 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -110.41 137.87 14.54 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.957 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.602 HD13 ' N ' ' A' ' 42' ' ' THR . 2.3 tm? -149.05 128.96 13.4 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.605 HG22 ' HA ' ' A' ' 47' ' ' ASN . 12.2 p -152.08 138.41 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.148 0.499 . . . . 0.0 111.864 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.516 HG21 ' HA ' ' A' ' 64' ' ' VAL . 71.4 mt -127.53 127.36 68.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.364 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.477 ' SG ' HD11 ' A' ' 92' ' ' LEU . 71.2 m 58.14 36.03 25.55 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.24 -26.71 1.81 Allowed Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.768 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -76.3 135.06 39.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.786 0.327 . . . . 0.0 111.337 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.605 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.8 OUTLIER -73.23 136.22 44.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.659 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.564 ' H ' HD22 ' A' ' 47' ' ' ASN . 72.7 m -152.47 41.87 0.63 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.728 0.299 . . . . 0.0 111.292 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.3 tp -71.38 -43.16 67.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.124 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -50.31 -41.92 51.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.605 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.422 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 72.4 p -80.3 -36.51 34.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.379 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.89 133.66 55.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.712 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -126.9 130.94 51.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.615 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -70.59 146.5 50.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.056 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.8 mmt -136.36 -52.4 0.72 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.643 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.0 m -160.52 -172.61 3.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.462 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.48 41.67 0.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.205 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.527 ' HA ' HD13 ' A' ' 31' ' ' LEU . 47.9 t -175.27 -47.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.753 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.618 ' HZ3' ' HE ' ' A' ' 27' ' ' ARG . 25.0 ttmm -87.8 136.23 33.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.866 0.365 . . . . 0.0 111.638 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -150.51 117.17 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.529 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.56 HG13 ' HD2' ' A' ' 23' ' ' LYS . 57.5 t -85.04 124.17 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.968 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.8 p -170.93 143.82 2.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 0.0 111.238 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.495 HH11 ' HE3' ' A' ' 21' ' ' TRP . 99.2 mtt180 -84.23 132.51 34.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.331 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.841 HG23 ' HA ' ' A' ' 20' ' ' PRO . 16.1 m . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.198 0.523 . . . . 0.0 111.635 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.31 0 CA-C-O 120.457 -0.079 . . . . 0.0 113.159 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -75.5 129.57 37.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.752 0.311 . . . . 0.0 110.94 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.1 mt -86.6 92.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.996 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.3 mm -86.52 139.78 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.205 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.9 t -139.6 113.44 6.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.2 m -81.87 144.28 31.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.496 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.0 p -141.32 134.95 30.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.718 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -59.24 -44.98 92.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.102 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.9 m -61.61 -42.88 99.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.979 0.418 . . . . 0.0 110.068 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.77 -118.15 3.25 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.081 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 -142.42 3.39 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.398 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -70.65 130.98 43.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.873 0.368 . . . . 0.0 110.963 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.48 136.81 15.98 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.67 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.7 p -98.92 140.17 33.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.662 0.268 . . . . 0.0 110.507 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.645 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 39.7 t -129.32 128.78 43.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.977 0.418 . . . . 0.0 111.727 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.2 p -75.4 -35.92 60.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.991 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.8 m -85.27 159.41 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.22 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.9 m -146.35 137.13 24.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' A' ' 64' ' ' VAL . 46.4 t80 -86.15 129.01 34.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.427 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.457 ' HE3' HD21 ' A' ' 93' ' ' LEU . 38.8 ttpt -83.36 117.92 23.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.265 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.477 HD11 ' SG ' ' A' ' 44' ' ' CYS . 86.5 mt -83.02 128.46 34.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 111.286 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.47 HD12 ' HA2' ' A' ' 18' ' ' GLY . 80.3 mt -99.62 144.16 29.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.892 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -57.93 139.09 83.06 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo . . . . . 0 C--N 1.348 0.517 0 C-N-CA 122.666 2.244 . . . . 0.0 112.939 -179.633 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 . . . . . 0 CA--C 1.529 0.151 0 CA-C-O 120.567 0.223 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.24 145.56 96.1 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.509 2.139 . . . . 0.0 111.82 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.72 118.71 3.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.401 2.068 . . . . 0.0 112.317 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.529 HD13 ' C ' ' A' ' 9' ' ' LEU . 3.4 tm? -98.52 117.79 33.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.646 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 58.8 t -96.1 139.52 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.908 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 t -171.05 48.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 111.205 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.74 139.32 5.59 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.027 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.458 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.6 tt -165.03 132.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.75 0.31 . . . . 0.0 110.629 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.81 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.9 t -68.41 -59.35 6.06 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.135 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.85 ' HG2' HG12 ' A' ' 24' ' ' VAL . 68.1 Cg_endo -92.94 121.98 0.48 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.247 1.965 . . . . 0.0 112.961 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -96.71 29.62 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.528 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.546 ' HB2' HD11 ' A' ' 93' ' ' LEU . 23.3 pt-20 179.73 132.24 0.09 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.395 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 171.92 143.38 4.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.095 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.558 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 35.2 pt -59.14 165.06 3.91 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 120.38 0.134 . . . . 0.0 111.083 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.671 ' HA ' HG23 ' A' ' 64' ' ' VAL . 95.7 Cg_exo -46.27 -41.89 22.16 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.927 2.418 . . . . 0.0 113.61 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -77.22 -17.42 58.49 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.426 ' OG1' HG12 ' A' ' 19' ' ' ILE . 80.9 m -56.89 131.48 49.71 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.68 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -73.63 139.84 45.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.566 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.85 HG12 ' HG2' ' A' ' 15' ' ' PRO . 35.0 m -139.55 128.25 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 111.075 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.6 m -89.2 118.3 28.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.1 mt -85.74 138.98 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -143.16 137.34 28.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.82 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -172.98 -129.32 1.14 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.722 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -146.75 136.37 23.03 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 110.939 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 61.65 40.02 13.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.87 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 mp -82.95 50.55 1.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 110.707 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.79 132.5 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.501 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.3 p -60.14 -34.34 73.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.697 0.284 . . . . 0.0 111.037 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.546 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -158.93 -161.43 11.11 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.825 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.86 -43.61 1.67 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.634 2.223 . . . . 0.0 112.7 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.5 p -57.23 -40.92 78.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.287 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.34 -36.77 84.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.0 tp -75.82 62.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.15 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.646 HD13 ' HG2' ' A' ' 79' ' ' LYS . 32.4 pt -69.16 -36.13 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.114 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.468 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -126.71 139.85 11.56 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.781 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.4 tp -150.0 151.78 33.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.683 0.278 . . . . 0.0 110.685 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.1 p -149.72 141.46 23.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.29 0.567 . . . . 0.0 111.975 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.6 mt -137.83 130.69 41.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.246 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.407 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 83.3 m 52.83 30.49 9.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.404 . . . . 0.0 110.101 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.1 -38.66 3.19 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.987 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' CE1' ' HB2' ' A' ' 44' ' ' CYS . 30.8 p-80 -86.5 140.5 29.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 117.457 0.628 . . . . 0.0 111.781 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -60.86 145.22 50.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.4 m -149.72 38.03 0.75 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.9 tp -71.57 -47.09 57.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.618 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 51' ' ' THR . 3.3 pp -58.49 -34.96 71.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.514 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.731 ' N ' HD12 ' A' ' 50' ' ' LEU . 22.0 p -80.45 -38.28 30.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.941 0.4 . . . . 0.0 110.891 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -68.62 135.5 51.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.168 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -126.77 128.73 47.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.017 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.546 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 78.6 t90 -61.73 150.08 37.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.914 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.699 ' HG3' HG23 ' A' ' 61' ' ' VAL . 92.4 mmm -143.12 -44.11 0.29 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 67.4 m -161.09 160.72 30.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.028 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.76 -30.36 32.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.559 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.9 m -126.21 36.94 4.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.241 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 60.0 tttm -165.02 132.62 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.4 mt -150.43 122.89 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.699 HG23 ' HG3' ' A' ' 55' ' ' MET . 65.7 t -82.98 129.45 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.242 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.9 p -170.47 136.67 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 111.569 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 59.3 mtt85 -85.18 138.15 32.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.584 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.671 HG23 ' HA ' ' A' ' 20' ' ' PRO . 31.7 m . . . . . 0 CA--C 1.533 0.319 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.673 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.296 -0.322 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.85 130.14 42.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.131 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.4 mt -97.42 128.39 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.319 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.82 138.0 49.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.418 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.3 t -124.81 129.1 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.633 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 40' ' ' GLY . 88.0 m -97.71 138.31 35.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.403 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.1 p -135.41 140.32 44.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.155 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.646 ' HG2' HD13 ' A' ' 39' ' ' ILE . 7.2 mtpm? -56.56 -46.72 80.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.779 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.7 p -65.56 -53.59 39.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.092 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.52 -124.41 2.24 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.099 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.7 -142.71 3.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.088 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.575 ' HB3' ' NZ ' ' A' ' 83' ' ' LYS . 5.9 ttpm? -71.53 123.29 22.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.715 0.293 . . . . 0.0 110.514 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.91 -160.55 36.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.746 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.0 p -154.97 -169.84 3.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.68 0.276 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.612 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 41.0 t -170.99 127.81 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.916 0.389 . . . . 0.0 111.318 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 82.5 p -72.53 -34.05 67.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.14 0.495 . . . . 0.0 110.084 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.9 173.62 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.377 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.8 p -157.41 135.6 11.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.712 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.518 ' CD2' HG11 ' A' ' 64' ' ' VAL . 53.4 t80 -85.4 127.03 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.184 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.598 ' HB3' ' NZ ' ' A' ' 91' ' ' LYS . 5.7 ttpm? -83.88 119.86 25.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.952 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' A' ' 20' ' ' PRO . 26.6 tp -85.19 131.14 34.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.244 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 17' ' ' GLU . 79.6 mt -94.63 136.28 35.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.777 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -63.49 137.92 97.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 C--N 1.346 0.439 0 C-N-CA 122.493 2.129 . . . . 0.0 112.421 -179.955 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 2.5 tp-100 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.53 0.205 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 6' ' ' GLN . 46.5 Cg_exo -56.23 144.03 82.98 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.656 2.237 . . . . 0.0 112.473 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.57 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 14.4 Cg_endo -57.34 141.32 94.74 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.744 2.296 . . . . 0.0 112.196 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 85' ' ' THR . 4.4 tt -141.0 121.9 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 0.0 110.435 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.528 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 98.5 t -84.61 134.61 26.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.712 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.565 HG23 HD22 ' A' ' 9' ' ' LEU . 34.3 p -153.7 47.26 0.64 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.862 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.95 143.22 6.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.854 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.501 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 14.5 tt -160.53 130.35 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.713 0.292 . . . . 0.0 110.448 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.804 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 52.0 m -63.95 -59.55 11.07 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.155 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.804 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 91.4 Cg_endo -89.56 128.06 1.7 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.232 1.955 . . . . 0.0 112.69 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.3 25.05 11.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 0.0 110.242 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 177.57 131.3 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.547 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.25 149.56 5.82 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.445 -0.884 . . . . 0.0 112.8 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 93' ' ' LEU . 35.3 pt -57.16 157.48 11.75 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.437 0.161 . . . . 0.0 110.868 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.639 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 85.8 Cg_exo -48.69 -39.88 38.26 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.874 2.382 . . . . 0.0 113.576 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.408 ' HZ3' HH11 ' A' ' 63' ' ' ARG . 97.0 m95 -71.91 -20.49 61.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.9 m -56.75 131.41 49.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 111.144 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -65.98 135.94 55.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.426 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.57 HG12 ' HG2' ' A' ' 15' ' ' PRO . 33.4 m -134.36 129.42 53.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.39 . . . . 0.0 111.216 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.4 m -85.58 122.78 30.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.011 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.736 HD12 ' HB ' ' A' ' 60' ' ' ILE . 63.8 mt -83.3 137.42 20.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.028 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.491 ' O ' HG13 ' A' ' 10' ' ' VAL . 44.5 mmm-85 -143.89 133.37 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.668 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.13 -134.45 1.73 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.527 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -142.96 128.64 19.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.391 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.57 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 63.7 m-80 52.63 41.47 31.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.139 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.412 HD21 HG22 ' A' ' 26' ' ' ILE . 10.0 mp -60.11 -39.47 86.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.745 0.307 . . . . 0.0 111.047 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.02 132.15 1.97 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.647 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.8 p -64.68 -36.42 84.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 0.0 111.212 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.34 174.52 37.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.424 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.49 -43.46 55.19 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.427 2.085 . . . . 0.0 112.087 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -61.04 -40.88 95.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.014 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.496 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 64.7 t0 -59.06 -48.66 80.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.663 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.441 HD11 HD13 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -71.18 128.31 35.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.962 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.535 HD13 ' HG2' ' A' ' 79' ' ' LYS . 38.4 pt -143.57 -39.94 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.945 0.402 . . . . 0.0 110.673 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -105.49 133.33 11.53 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.482 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.405 ' HB2' HD23 ' A' ' 49' ' ' LEU . 24.0 tp -150.25 149.39 30.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.689 0.28 . . . . 0.0 110.337 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.2 m -159.41 140.34 12.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 111.508 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.08 126.53 37.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.337 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.442 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 77.4 m 54.82 38.98 31.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.992 0.425 . . . . 0.0 110.545 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.35 27.99 71.61 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.427 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -131.0 132.91 45.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.685 0.279 . . . . 0.0 110.824 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.5 HD22 ' N ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -67.03 133.5 50.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.705 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.5 ' N ' HD22 ' A' ' 47' ' ' ASN . 74.4 m -152.18 40.03 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.96 0.409 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 3.3 tm? -81.52 -43.29 18.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.874 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -53.59 -38.75 64.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.818 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.9 p -79.88 -37.43 34.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.699 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.34 135.74 57.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.974 0.416 . . . . 0.0 112.025 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -126.45 132.35 51.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.359 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -66.29 151.78 46.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.412 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 55.0 mtt -149.83 -42.77 0.13 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.76 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 58' ' ' SER . 86.9 p -169.13 169.65 9.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.533 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.83 34.39 0.1 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.529 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 56' ' ' SER . 78.4 p -177.99 30.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.911 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.6 ttmt -165.04 130.12 2.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.791 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.736 ' HB ' HD12 ' A' ' 26' ' ' ILE . 72.3 mt -150.67 122.56 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.0 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 9.0 p -88.33 132.93 32.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.522 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 26.7 p -170.89 156.32 4.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.035 0.445 . . . . 0.0 111.4 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.408 HH11 ' HZ3' ' A' ' 21' ' ' TRP . 98.9 mtt180 -84.01 134.93 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.2 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.639 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.5 t . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.122 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -61.99 132.14 51.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.37 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.8 mt -85.45 92.5 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.165 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.9 mm -91.08 145.63 7.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.153 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.42 128.51 24.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.101 0.477 . . . . 0.0 111.058 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 m -100.63 143.78 30.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.239 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.4 p -130.59 140.76 50.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.562 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 8.0 mtpm? -56.94 -47.99 79.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.248 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 61.4 m -64.75 -54.81 25.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.946 0.403 . . . . 0.0 110.561 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.32 -125.03 1.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.127 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.43 -140.78 3.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.995 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.3 117.76 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.753 0.311 . . . . 0.0 110.375 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.65 -149.16 2.32 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.935 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 40.6 p -155.84 150.73 26.33 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.49 0.316 . . . . 0.0 110.392 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -157.26 127.61 6.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.968 0.413 . . . . 0.0 111.175 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.3 p -107.58 40.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.806 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.69 149.1 15.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.352 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 t -140.11 137.36 34.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.691 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.544 ' HD2' HG11 ' A' ' 64' ' ' VAL . 63.4 t80 -85.25 129.95 34.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.131 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -77.51 125.18 28.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.395 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.3 mt -92.49 124.55 36.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.163 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 19' ' ' ILE . 79.3 mt -89.47 135.25 33.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.641 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 53.3 mtmt -64.21 133.07 95.51 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.056 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 31.8 Cg_exo . . . . . 0 C--N 1.347 0.467 0 C-N-CA 122.538 2.159 . . . . 0.0 112.171 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.474 0.178 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.62 146.29 44.32 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.612 2.208 . . . . 0.0 112.436 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HG2' ' HA3' ' A' ' 84' ' ' GLY . 8.9 Cg_endo -50.62 144.68 24.84 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.982 2.455 . . . . 0.0 112.383 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.534 HD21 HG23 ' A' ' 87' ' ' THR . 2.1 tm? -141.68 119.95 12.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.208 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.565 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 92.7 t -77.37 134.66 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.618 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.459 HG23 HD12 ' A' ' 9' ' ' LEU . 61.3 p -148.0 44.51 1.07 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.206 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.34 145.12 5.65 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.063 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.7 tt -164.57 128.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.64 0.257 . . . . 0.0 110.44 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.829 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 48.0 t -67.14 -60.06 6.56 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.66 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.829 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 68.1 Cg_endo -91.99 114.38 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.149 1.899 . . . . 0.0 112.18 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -92.93 30.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 0.0 110.499 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.516 ' HB2' HD21 ' A' ' 93' ' ' LEU . 15.3 pt-20 178.08 131.21 0.07 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.446 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.8 144.6 4.27 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.067 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 93' ' ' LEU . 41.3 pt -59.42 161.54 10.2 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 121.969 0.107 . . . . 0.0 110.967 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.926 ' HA ' HG13 ' A' ' 64' ' ' VAL . 79.3 Cg_exo -47.92 -37.2 28.79 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.572 2.181 . . . . 0.0 113.036 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.09 -27.87 62.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.8 m -56.5 128.58 36.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 0.0 111.581 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.08 136.86 50.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.544 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.775 HG12 ' HG2' ' A' ' 15' ' ' PRO . 29.4 m -135.85 121.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.947 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.6 m -80.85 116.87 21.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.767 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 55.5 mt -77.42 141.22 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.581 HH11 ' HB2' ' A' ' 59' ' ' LYS . 25.8 mmm180 -146.9 131.01 17.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.411 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.28 -130.78 1.25 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.638 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -146.52 135.87 22.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 111.244 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.5 m-20 61.87 38.05 14.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.356 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.503 HD22 ' O ' ' A' ' 58' ' ' SER . 10.2 mp -84.14 51.01 1.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.951 0.405 . . . . 0.0 110.392 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 57' ' ' ALA . . . 70.87 118.78 0.04 OUTLIER Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.192 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.5 p -90.03 41.52 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 111.365 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.31 151.67 7.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.686 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.78 -43.07 62.72 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.473 2.115 . . . . 0.0 111.724 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.511 ' O ' ' HE2' ' A' ' 79' ' ' LYS . 2.5 t -61.79 -35.51 78.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.597 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.497 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 1.4 m-20 -51.93 -48.85 64.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.454 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.95 127.42 32.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.134 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.524 HD13 ' HD2' ' A' ' 79' ' ' LYS . 36.6 pt -147.26 20.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.094 0.474 . . . . 0.0 110.786 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 176.94 139.34 3.22 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.907 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 75' ' ' ILE . 18.1 tp -149.63 146.38 27.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.885 0.374 . . . . 0.0 111.023 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.408 ' OG1' ' HB ' ' A' ' 75' ' ' ILE . 20.5 p -151.15 134.47 16.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.181 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.684 HG21 HG23 ' A' ' 64' ' ' VAL . 64.7 mt -134.51 125.19 46.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.857 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 66.2 m 56.71 36.43 27.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.09 0.471 . . . . 0.0 109.991 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.99 33.69 87.93 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.891 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -130.78 131.27 44.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.713 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -67.7 131.78 46.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.638 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.544 ' N ' HD22 ' A' ' 47' ' ' ASN . 71.8 m -153.09 39.01 0.51 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.88 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 69.3 tp -73.96 -47.07 40.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.286 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -52.3 -40.36 61.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.631 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.6 p -80.35 -33.37 37.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.292 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.571 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -52.74 134.4 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.767 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -126.67 130.24 50.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.669 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -71.95 147.43 46.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 96.1 mmm -138.89 -48.37 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.5 m -160.55 -175.03 4.76 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.645 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -78.52 36.23 0.25 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.983 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.503 ' O ' HD22 ' A' ' 31' ' ' LEU . 79.8 p -177.29 -43.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.754 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.581 ' HB2' HH11 ' A' ' 27' ' ' ARG . 24.6 ttmm -84.87 131.25 34.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.047 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.0 mt -149.97 113.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.682 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.432 HG23 ' HG3' ' A' ' 55' ' ' MET . 43.2 t -82.81 130.82 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.431 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.571 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.4 p -170.41 160.28 7.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.0 111.199 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -83.65 126.17 32.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.805 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.926 HG13 ' HA ' ' A' ' 20' ' ' PRO . 2.3 p . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.161 0.505 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.235 0 N-CA-C 112.189 -0.364 . . . . 0.0 112.189 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -74.76 140.19 43.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.838 0.352 . . . . 0.0 111.3 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.42 ' O ' HD13 ' A' ' 75' ' ' ILE . 76.9 mt -85.11 136.89 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.525 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.42 HD13 ' O ' ' A' ' 74' ' ' ILE . 49.8 mm -133.43 139.07 49.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.927 0.394 . . . . 0.0 111.624 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.35 126.87 45.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.69 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.7 m -96.73 138.8 33.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.712 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 82' ' ' GLY . 56.7 p -151.95 142.4 22.59 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.465 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.694 ' HD3' ' H ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -54.68 -30.49 55.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.665 0.269 . . . . 0.0 111.353 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -61.73 -57.19 12.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.608 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.45 -45.42 0.92 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.719 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 78' ' ' THR . . . 75.35 120.98 0.12 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.866 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.8 tttm 47.82 65.08 1.38 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.821 0.343 . . . . 0.0 111.047 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.425 ' HA3' ' HG2' ' A' ' 8' ' ' PRO . . . -64.88 -138.88 0.02 OUTLIER Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.88 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.6 p -151.06 -168.35 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.887 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.4 p -169.09 129.64 1.12 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.534 HG23 HD21 ' A' ' 9' ' ' LEU . 61.8 p -93.62 29.21 2.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.101 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 m -154.57 140.72 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.0 p -120.2 140.52 51.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.537 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.522 ' CD2' HG21 ' A' ' 64' ' ' VAL . 45.0 t80 -89.35 129.95 35.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.621 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -88.33 123.68 33.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.242 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.413 HD21 ' CG2' ' A' ' 64' ' ' VAL . 93.2 mt -88.02 130.64 34.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.079 0.466 . . . . 0.0 111.974 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.549 ' O ' HG22 ' A' ' 19' ' ' ILE . 84.0 mt -88.69 140.7 29.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.723 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.46 128.03 92.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.651 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 C--N 1.347 0.454 0 C-N-CA 122.511 2.14 . . . . 0.0 112.604 -179.84 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.407 ' HG3' ' HD2' ' A' ' 7' ' ' PRO . 8.2 tt0 . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.517 0.198 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.407 ' HD2' ' HG3' ' A' ' 6' ' ' GLN . 16.9 Cg_endo -56.99 149.42 62.12 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.632 2.222 . . . . 0.0 112.242 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HD3' ' H ' ' A' ' 82' ' ' GLY . 65.6 Cg_exo -51.9 137.09 52.48 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.54 2.16 . . . . 0.0 112.168 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 85' ' ' THR . 3.3 tt -133.78 117.87 17.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.354 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.565 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 95.2 t -82.17 135.82 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.184 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.447 HG23 HD22 ' A' ' 9' ' ' LEU . 80.7 p -147.01 41.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.798 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.29 148.49 7.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.713 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.519 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.1 tt -160.36 132.76 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.763 0.315 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.811 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 45.4 t -66.43 -59.9 7.56 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.661 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.811 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 86.4 Cg_endo -89.87 119.01 0.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.041 1.827 . . . . 0.0 112.389 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -77.54 -20.56 53.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.411 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.463 ' OE1' HD11 ' A' ' 93' ' ' LEU . 15.4 pt-20 -157.07 139.88 15.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.03 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.53 147.57 8.58 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.654 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 37.4 pt -55.16 161.91 2.34 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-O 120.547 0.213 . . . . 0.0 111.362 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.881 ' HA ' HG23 ' A' ' 64' ' ' VAL . 85.2 Cg_exo -47.52 -46.17 21.21 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.089 2.526 . . . . 0.0 114.097 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -73.11 -8.29 55.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 m -70.04 128.09 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.992 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 28.5 mtpp -75.65 124.02 26.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.549 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.726 HG12 ' HG2' ' A' ' 15' ' ' PRO . 30.7 m -113.03 121.25 64.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.966 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.5 m -78.4 118.77 20.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.038 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.3 mt -80.63 137.07 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.738 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 58' ' ' SER . 28.3 tpt180 -139.28 126.28 21.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.268 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -167.89 -132.91 1.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.613 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -146.96 137.88 23.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.852 0.358 . . . . 0.0 111.325 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 72.8 m-80 63.84 41.77 6.54 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.369 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 8.8 mp -90.08 46.38 1.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.991 0.424 . . . . 0.0 110.265 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.21 120.34 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.185 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.1 p -91.88 42.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.678 0.275 . . . . 0.0 111.195 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.72 147.76 6.13 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.705 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.13 -45.17 42.65 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.519 2.146 . . . . 0.0 111.716 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 t -62.45 -36.59 82.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.158 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -55.55 -46.09 77.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.975 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -65.83 134.22 52.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.017 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.476 ' N ' HD23 ' A' ' 38' ' ' LEU . 30.2 pt -140.74 -42.5 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.317 . . . . 0.0 111.219 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.455 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -111.17 136.87 13.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.405 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.58 HD13 ' N ' ' A' ' 42' ' ' THR . 1.5 tm? -147.59 127.41 13.49 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.58 ' N ' HD13 ' A' ' 41' ' ' LEU . 22.6 p -152.95 142.02 21.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.514 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.609 HG21 HG12 ' A' ' 64' ' ' VAL . 70.1 mt -137.37 124.76 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.867 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 78.0 m 58.24 38.69 26.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 110.156 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.44 33.35 86.08 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.877 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -131.12 133.46 45.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.771 0.32 . . . . 0.0 110.8 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.532 HD22 ' N ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -66.48 131.29 45.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.468 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.532 ' N ' HD22 ' A' ' 47' ' ' ASN . 74.1 m -151.7 36.58 0.57 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.861 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.9 tp -75.72 -44.74 40.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.731 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 50' ' ' LEU . 2.5 pt? -55.36 -39.33 69.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.9 p -79.93 -38.1 33.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.151 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -61.2 132.72 54.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.39 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -126.5 133.97 51.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.777 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -64.97 147.17 53.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.252 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 93.8 mmm -145.26 -42.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.407 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.764 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 54.7 m -161.59 157.47 24.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.911 0.386 . . . . 0.0 111.099 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 31' ' ' LEU . . . -50.39 -27.57 6.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.419 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.545 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 54.0 m -133.3 42.11 3.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.371 . . . . 0.0 110.719 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.764 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 60.5 tttm -164.5 128.14 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.868 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -149.97 118.07 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.506 ' CG1' ' HE3' ' A' ' 23' ' ' LYS . 50.1 t -84.46 130.46 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.553 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.547 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.4 p -170.07 131.67 1.03 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.791 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 22.3 ptt-85 -84.96 138.32 32.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.873 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.881 HG23 ' HA ' ' A' ' 20' ' ' PRO . 21.3 m . . . . . 0 CA--C 1.537 0.463 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.724 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.21 134.87 48.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.686 0.279 . . . . 0.0 111.179 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.559 ' O ' HD13 ' A' ' 75' ' ' ILE . 68.2 mt -85.42 134.15 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.474 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.559 HD13 ' O ' ' A' ' 74' ' ' ILE . 37.8 mm -132.97 133.98 58.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.145 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.739 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 53.4 t -141.51 114.37 4.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.825 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.0 m -81.0 142.17 33.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.522 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.5 p -141.93 140.19 32.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.86 0.362 . . . . 0.0 111.426 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.3 mmmm -57.02 -50.69 71.96 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.074 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.0 m -65.07 -53.33 47.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.974 0.416 . . . . 0.0 110.346 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.37 -123.33 0.5 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.148 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.507 ' H ' ' HD3' ' A' ' 8' ' ' PRO . . . -169.44 -141.15 3.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.195 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -62.11 130.08 43.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 110.748 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.739 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -69.69 150.05 48.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.083 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 47.3 p -149.09 145.99 27.5 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.535 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 48.1 t -158.29 134.13 9.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.11 0.481 . . . . 0.0 111.965 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -77.18 -33.41 56.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.517 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -83.74 139.08 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.371 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -120.38 140.27 51.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -86.22 132.75 33.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.721 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.494 ' HD3' HD21 ' A' ' 93' ' ' LEU . 31.7 ttmt -83.27 123.96 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.359 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.429 HD13 HG21 ' A' ' 64' ' ' VAL . 56.4 tp -99.06 121.11 40.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.871 0.367 . . . . 0.0 110.734 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 60.4 mt -96.39 139.6 32.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.651 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 61.1 pttt -59.84 134.57 89.72 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.417 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.531 ' HG3' ' HD2' ' A' ' 20' ' ' PRO . 48.1 Cg_exo . . . . . 0 C--N 1.347 0.479 0 C-N-CA 122.869 2.379 . . . . 0.0 112.806 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.631 0.253 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.27 145.7 73.07 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.449 2.1 . . . . 0.0 111.796 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.538 ' HG2' ' HA2' ' A' ' 84' ' ' GLY . 11.6 Cg_endo -55.93 120.88 8.99 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.367 2.045 . . . . 0.0 112.036 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 9' ' ' LEU . 5.7 tt -102.65 100.81 10.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.477 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.662 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 59.5 t -84.0 136.76 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.596 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -169.14 51.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.522 . . . . 0.0 111.188 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.03 141.48 7.01 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.417 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.534 HG12 ' HD2' ' A' ' 15' ' ' PRO . 13.9 tt -164.78 130.71 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.448 0.166 . . . . 0.0 110.662 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.771 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.3 t -59.97 -61.44 7.9 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.919 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 85.9 Cg_endo -83.91 -159.96 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.8 1.667 . . . . 0.0 111.104 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -175.25 24.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.111 0.482 . . . . 0.0 110.41 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HB2' HD11 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -179.33 127.33 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.155 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.479 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 165.47 151.35 6.62 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.847 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.403 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 33.7 pt -52.45 161.42 1.08 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.49 0.186 . . . . 0.0 110.986 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.757 ' HA ' HG23 ' A' ' 64' ' ' VAL . 73.7 Cg_exo -50.47 -40.72 53.81 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.694 2.263 . . . . 0.0 113.562 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.516 ' HE3' HH11 ' A' ' 63' ' ' ARG . 84.5 m95 -73.86 -5.8 43.25 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -64.96 129.47 39.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.362 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.07 137.27 51.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.586 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.493 HG21 HG13 ' A' ' 64' ' ' VAL . 34.6 m -144.84 130.59 14.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.973 0.416 . . . . 0.0 110.975 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.6 m -87.67 117.46 26.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.949 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.1 mt -80.38 137.91 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.754 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.611 ' NH1' ' HB2' ' A' ' 59' ' ' LYS . 25.9 mmm180 -139.72 137.59 35.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.949 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.14 -135.54 2.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.368 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 55.9 mm-40 -151.24 138.06 18.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.825 0.345 . . . . 0.0 111.286 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 76.1 m-20 62.59 38.79 12.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.288 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.566 HD23 HD12 ' A' ' 60' ' ' ILE . 9.5 mp -81.67 51.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.872 0.368 . . . . 0.0 111.063 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.429 ' HA2' ' OD2' ' A' ' 37' ' ' ASP . . . 76.5 134.56 0.56 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.893 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.5 p -59.75 -35.38 74.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.617 0.246 . . . . 0.0 111.314 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.58 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -168.24 -159.22 13.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.123 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.21 -46.36 15.63 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.954 2.436 . . . . 0.0 112.792 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 p -60.65 -41.22 94.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.511 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.429 ' OD2' ' HA2' ' A' ' 32' ' ' GLY . 64.9 t0 -66.33 -48.09 71.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.819 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.6 tt -64.63 130.75 44.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.989 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.504 ' N ' HD23 ' A' ' 38' ' ' LEU . 25.0 pt -149.36 -43.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.457 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -93.94 52.54 2.25 Favored Glycine 0 CA--C 1.51 -0.24 0 C-N-CA 120.494 -0.86 . . . . 0.0 114.149 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.554 HD13 ' N ' ' A' ' 42' ' ' THR . 2.7 tm? -70.23 127.25 32.14 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.69 HG22 ' HA ' ' A' ' 47' ' ' ASN . 6.9 p -155.58 144.96 20.98 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.153 0.502 . . . . 0.0 111.987 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.7 mt -137.66 123.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.527 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.458 ' HG ' ' N ' ' A' ' 72' ' ' GLY . 60.3 m 57.64 36.37 26.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.099 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.46 -36.36 2.95 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.637 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -72.87 131.94 42.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.02 0.41 . . . . 0.0 111.398 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.69 ' HA ' HG22 ' A' ' 42' ' ' THR . 16.2 p-10 -72.56 141.78 48.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.433 ' C ' HD12 ' A' ' 41' ' ' LEU . 76.4 m -149.2 42.56 0.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.519 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 41' ' ' LEU . 33.0 tp -69.18 -44.47 72.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.19 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 51' ' ' THR . 3.6 pp -63.94 -34.48 78.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.173 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.729 ' N ' HD12 ' A' ' 50' ' ' LEU . 20.3 p -79.92 -38.17 33.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.821 0.343 . . . . 0.0 111.281 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -66.21 137.88 57.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.934 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -126.32 128.48 47.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.247 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.58 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 82.0 t90 -65.4 149.77 49.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.225 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.44 ' HG3' HG23 ' A' ' 61' ' ' VAL . 93.4 mmm -142.6 -43.81 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 58' ' ' SER . 48.7 m -155.83 178.02 10.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.674 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.2 37.21 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.564 ' O ' HD22 ' A' ' 31' ' ' LEU . 80.7 p -178.81 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.176 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.611 ' HB2' ' NH1' ' A' ' 27' ' ' ARG . 63.0 tttp -83.96 132.52 34.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.566 HD12 HD23 ' A' ' 31' ' ' LEU . 74.5 mt -148.62 115.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.668 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.44 HG23 ' HG3' ' A' ' 55' ' ' MET . 40.2 t -84.55 122.75 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.681 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 41.9 t -171.02 146.11 2.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.036 0.446 . . . . 0.0 111.179 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.516 HH11 ' HE3' ' A' ' 21' ' ' TRP . 98.9 mtt180 -85.19 134.09 34.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.207 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.757 HG23 ' HA ' ' A' ' 20' ' ' PRO . 19.4 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.599 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.871 ' HA3' ' HB2' ' A' ' 89' ' ' SER . . . . . . . . 0 CA--C 1.517 0.217 0 N-CA-C 113.957 0.343 . . . . 0.0 113.957 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -45.16 127.49 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.373 . . . . 0.0 111.586 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.508 ' C ' HD12 ' A' ' 75' ' ' ILE . 68.0 mt -115.47 117.93 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.134 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.809 HG21 ' HE3' ' A' ' 83' ' ' LYS . 3.1 mp -120.98 137.5 54.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.37 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.725 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 3.8 p -141.76 103.58 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.829 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -77.31 131.94 38.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.657 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 82.4 p -123.15 142.32 51.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.091 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -50.78 -48.04 59.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.5 m -69.44 -48.48 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.981 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.83 -128.52 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.615 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.4 -40.99 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.344 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.809 ' HE3' HG21 ' A' ' 75' ' ' ILE . 49.6 tptt -169.72 127.45 0.91 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.76 0.314 . . . . 0.0 110.631 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.725 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -74.02 145.5 35.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.967 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.1 p -143.58 138.63 29.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.597 0.237 . . . . 0.0 110.52 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.662 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 45.2 t -133.13 129.81 38.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.019 0.438 . . . . 0.0 111.493 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.6 p -74.02 -32.43 63.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.573 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -83.88 176.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.372 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.871 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 72.5 p -157.44 133.2 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.649 ' CD2' HG11 ' A' ' 64' ' ' VAL . 69.0 t80 -85.62 127.32 34.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.815 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -85.04 122.31 29.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 110.607 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.522 ' N ' HD22 ' A' ' 92' ' ' LEU . 2.9 mm? -82.21 129.73 34.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.929 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.479 HD12 ' HA2' ' A' ' 18' ' ' GLY . 80.2 mt -100.59 138.94 36.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.6 139.48 96.0 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.039 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.518 2.145 . . . . 0.0 112.045 179.64 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.42 HE21 ' HB2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.599 0.238 . . . . 0.0 111.023 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.22 144.28 95.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.614 2.21 . . . . 0.0 112.153 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 51.8 Cg_exo -51.86 133.49 45.63 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.524 2.149 . . . . 0.0 112.185 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.55 HD22 HG23 ' A' ' 11' ' ' THR . 3.3 tt -123.56 118.0 26.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.236 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.514 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 62.8 t -81.34 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.285 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.55 HG23 HD22 ' A' ' 9' ' ' LEU . 71.4 p -147.0 45.2 1.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.033 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.407 ' C ' ' HB3' ' A' ' 27' ' ' ARG . . . 178.0 147.51 6.92 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.206 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.51 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.3 tt -160.98 130.42 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.728 0.299 . . . . 0.0 110.499 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.823 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.9 t -68.76 -58.2 7.05 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.685 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.823 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 68.8 Cg_endo -93.03 115.14 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.278 1.985 . . . . 0.0 112.592 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.531 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -96.96 27.79 3.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 0.0 110.61 179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HB2' HD21 ' A' ' 93' ' ' LEU . 23.8 pt-20 -179.67 130.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.17 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.537 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 171.88 146.03 5.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.828 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.471 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 29.1 pt -54.17 162.81 1.4 Allowed Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 120.486 0.184 . . . . 0.0 111.28 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 19' ' ' ILE . 85.2 Cg_exo -48.16 -37.87 31.79 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.822 2.348 . . . . 0.0 113.653 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -77.71 -15.71 58.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -60.64 124.71 21.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.678 0.275 . . . . 0.0 111.195 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 25.5 pttm -77.18 127.08 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 0.0 110.431 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.799 HG12 ' HG2' ' A' ' 15' ' ' PRO . 16.6 m -109.45 125.64 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.556 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 84.9 m -72.42 120.88 18.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.82 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.511 HD12 ' HB ' ' A' ' 60' ' ' ILE . 65.5 mt -80.96 139.01 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.002 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 58' ' ' SER . 27.8 tpt180 -147.42 127.3 13.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.894 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.17 -134.58 1.75 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.959 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -149.5 137.55 20.5 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.921 0.391 . . . . 0.0 111.579 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 73.6 m-20 60.61 40.6 16.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.578 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.499 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.2 mp -84.49 53.5 2.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.863 0.363 . . . . 0.0 110.597 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.51 129.32 0.43 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.539 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.4 p -97.91 42.56 1.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 0.0 111.369 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.97 142.21 3.98 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.699 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.528 ' HG3' ' CE3' ' A' ' 54' ' ' TRP . 36.0 Cg_exo -56.56 -47.25 24.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.519 2.146 . . . . 0.0 112.116 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.4 p -65.28 -33.97 77.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.421 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -51.29 -42.88 61.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.997 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.2 tt -65.92 127.12 30.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 40' ' ' GLY . 32.9 pt -134.43 -44.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 111.32 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.5 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -100.86 136.46 12.71 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.463 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.555 HD13 ' N ' ' A' ' 42' ' ' THR . 2.2 tm? -148.8 126.67 11.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 47' ' ' ASN . 7.1 p -155.34 141.75 18.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.161 0.505 . . . . 0.0 111.873 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.8 HG21 HG23 ' A' ' 64' ' ' VAL . 76.5 mt -129.97 124.0 57.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.401 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.528 ' SG ' ' HA2' ' A' ' 72' ' ' GLY . 63.0 m 55.4 39.45 31.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.11 -32.92 2.23 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.894 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -72.53 129.75 39.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 0.0 111.127 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.663 ' HA ' HG22 ' A' ' 42' ' ' THR . 5.4 m120 -70.44 140.41 51.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.844 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.429 ' C ' HD12 ' A' ' 41' ' ' LEU . 75.1 m -150.39 40.36 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.4 tp -72.38 -43.88 63.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.321 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 50' ' ' LEU . 2.6 pt? -56.39 -38.63 71.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.4 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.0 p -79.84 -36.43 36.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.352 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -59.63 132.98 55.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.561 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -126.92 126.46 43.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.537 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.528 ' CE3' ' HG3' ' A' ' 35' ' ' PRO . 79.6 t90 -69.44 152.85 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.326 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 49.1 mtt -147.56 -44.38 0.17 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.025 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.2 p -169.58 173.57 6.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.637 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.93 37.31 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.524 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.491 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 79.0 p -176.68 24.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.087 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 59.4 tttp -165.31 128.83 2.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.138 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' HB ' HD12 ' A' ' 26' ' ' ILE . 73.4 mt -152.2 119.55 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.655 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.37 134.15 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.616 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.544 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.8 p -169.57 146.2 3.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.845 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.672 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 68.3 mtt-85 -84.03 131.64 34.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.8 HG23 HG21 ' A' ' 43' ' ' ILE . 8.4 p . . . . . 0 CA--C 1.54 0.582 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.085 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.528 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . . . . . . 0 CA--C 1.518 0.244 0 N-CA-C 112.843 -0.103 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -73.24 130.93 41.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 111.328 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.502 ' O ' HD13 ' A' ' 75' ' ' ILE . 70.4 mt -85.59 135.2 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.226 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.502 HD13 ' O ' ' A' ' 74' ' ' ILE . 40.0 mm -131.55 137.02 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.798 0.332 . . . . 0.0 111.703 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.4 t -141.53 117.84 6.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.937 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -86.05 147.33 26.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.347 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.9 p -139.44 143.7 37.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.4 mmmm -53.97 -55.06 30.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.365 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.1 t -67.65 -55.43 13.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.002 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.28 -128.65 0.38 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.644 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 -137.3 2.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.999 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -65.12 121.4 14.64 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.5 126.78 8.74 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.893 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 73.1 p -99.43 144.05 28.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.412 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 80.9 p -131.98 126.79 34.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.581 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.9 p -91.65 35.75 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.604 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.49 156.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.67 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.5 p -138.53 134.63 34.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.946 0.403 . . . . 0.0 111.192 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.651 ' HE2' HG11 ' A' ' 64' ' ' VAL . 39.3 t80 -86.06 131.42 34.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.347 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -83.93 124.79 31.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.062 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.2 mt -90.0 127.71 36.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 111.647 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 18' ' ' GLY . 78.3 mt -92.56 139.98 30.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.372 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -56.52 126.89 71.31 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.949 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo . . . . . 0 C--N 1.347 0.496 0 C-N-CA 122.869 2.379 . . . . 0.0 112.922 -179.854 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 120.663 0.268 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.71 148.59 36.94 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.755 2.303 . . . . 0.0 112.375 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.48 142.85 99.58 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.635 2.223 . . . . 0.0 112.054 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.518 HD13 ' C ' ' A' ' 9' ' ' LEU . 3.3 tm? -140.38 119.83 13.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.499 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.1 t -83.58 142.55 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.986 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 t -167.99 49.02 0.05 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.037 0.446 . . . . 0.0 111.363 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.13 138.5 3.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.698 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.518 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.7 tt -165.24 130.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 0.0 110.604 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.818 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.6 t -65.46 -59.38 9.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.692 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.818 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 83.7 Cg_endo -90.58 111.72 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.164 1.909 . . . . 0.0 112.155 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -89.33 26.81 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.595 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 176.22 132.25 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.261 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.73 144.22 4.64 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.905 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.429 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 33.1 pt -56.7 160.77 5.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.496 0.189 . . . . 0.0 111.02 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.744 ' HA ' HG13 ' A' ' 64' ' ' VAL . 84.8 Cg_exo -47.07 -45.15 22.02 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.812 2.342 . . . . 0.0 113.544 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -67.2 -22.43 65.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.2 m -62.61 128.21 34.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.136 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 24.7 ttmm -73.83 138.18 44.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.622 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.691 HG12 ' HG2' ' A' ' 15' ' ' PRO . 35.0 m -132.23 125.28 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.002 0.43 . . . . 0.0 111.032 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -85.57 118.8 25.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.097 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.4 mt -83.92 137.16 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.431 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -147.66 135.76 21.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.827 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.93 -126.6 0.85 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.21 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -145.18 134.85 23.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.329 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 60.97 42.21 13.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.079 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 mp -83.91 54.93 3.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.964 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.21 134.19 1.9 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.76 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.6 p -67.4 -40.81 85.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.63 0.252 . . . . 0.0 111.62 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.552 ' HA2' ' CZ2' ' A' ' 54' ' ' TRP . . . -156.52 -177.92 30.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.755 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.85 -40.27 79.94 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.638 2.225 . . . . 0.0 112.042 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.8 p -59.95 -41.35 91.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.983 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 37.7 t70 -66.82 -46.88 73.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.898 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.511 ' C ' HD13 ' A' ' 38' ' ' LEU . 3.4 tm? -69.85 129.0 38.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.923 0.392 . . . . 0.0 110.347 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.501 HD13 ' HG2' ' A' ' 79' ' ' LYS . 49.8 pt -147.96 -23.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.422 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.91 128.72 6.98 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.848 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' A' ' 52' ' ' ALA . 31.4 tp -150.41 147.15 27.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.64 0.257 . . . . 0.0 110.558 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 46' ' ' HIS . 98.2 m -161.69 129.28 4.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.396 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.514 HD11 ' SG ' ' A' ' 62' ' ' CYS . 70.8 mt -105.34 130.52 56.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.449 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 79.7 m 69.26 -66.42 0.26 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.53 0.519 . . . . 0.0 110.971 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.65 26.13 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.493 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.56 ' O ' HG23 ' A' ' 42' ' ' THR . 83.1 t60 -132.18 135.76 46.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.585 0.231 . . . . 0.0 110.707 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -59.29 136.83 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.772 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.7 m -151.45 36.28 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.102 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 49.5 tp -70.3 -44.69 67.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.964 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -54.12 -40.77 67.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.049 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.3 p -80.38 -32.67 37.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.04 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.15 133.27 55.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.087 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -127.14 127.1 44.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.129 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.552 ' CZ2' ' HA2' ' A' ' 34' ' ' GLY . 43.4 t90 -67.4 149.09 50.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 110.702 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.688 ' HG3' HG23 ' A' ' 61' ' ' VAL . 94.5 mmm -143.26 -43.13 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.2 t -166.86 172.84 9.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.846 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.58 25.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.641 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.8 m -167.78 21.35 0.03 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.696 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.579 ' NZ ' ' HB2' ' A' ' 59' ' ' LYS . 5.0 ttmp? -165.1 134.87 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.3 mt -146.86 121.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.688 HG23 ' HG3' ' A' ' 55' ' ' MET . 60.7 t -80.89 125.7 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.513 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.1 p -170.42 140.56 1.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.021 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 84.4 mtm180 -84.33 136.79 33.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.634 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.744 HG13 ' HA ' ' A' ' 20' ' ' PRO . 4.8 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.395 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.311 -0.315 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -62.76 130.91 47.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 71.8 mt -85.3 131.58 33.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.468 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.0 mm -128.88 139.55 51.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.229 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.78 121.65 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.8 m -98.09 133.9 41.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.509 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 81.6 p -118.52 142.21 47.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.178 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 37' ' ' ASP . 29.4 mtpp -54.02 -44.88 71.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.633 0.254 . . . . 0.0 110.982 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.9 m -66.81 -47.13 72.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.984 0.421 . . . . 0.0 109.957 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.42 -132.53 1.69 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.47 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . 172.81 67.41 0.05 OUTLIER Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.247 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 82' ' ' GLY . 59.2 tttm 67.98 109.28 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.881 0.372 . . . . 0.0 110.439 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.06 -134.32 6.44 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.856 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.427 ' OG1' HD23 ' A' ' 9' ' ' LEU . 74.4 p -145.99 -168.26 2.94 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.578 0.227 . . . . 0.0 110.626 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 78.4 p -169.47 125.35 0.86 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 111.151 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.9 p -90.53 28.37 1.5 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.708 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 m -153.58 149.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.999 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.8 m -134.56 134.86 41.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -85.5 127.67 34.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -81.08 117.15 21.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.553 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.586 HD13 ' N ' ' A' ' 93' ' ' LEU . 1.5 tm? -81.16 128.47 33.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.523 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.586 ' N ' HD13 ' A' ' 92' ' ' LEU . 80.8 mt -99.65 133.51 43.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.845 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -68.05 134.1 91.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.661 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--N 1.347 0.484 0 C-N-CA 122.368 2.046 . . . . 0.0 112.349 -179.995 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.651 0.263 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.82 146.59 66.24 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.658 2.239 . . . . 0.0 112.206 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 18.0 Cg_endo -58.31 129.61 33.62 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.596 2.198 . . . . 0.0 112.3 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 85' ' ' THR . 63.2 tp -113.33 119.84 39.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.071 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.43 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 69.7 t -85.29 132.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.069 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.9 p -151.57 47.91 0.81 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.51 144.57 6.43 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.869 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.567 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 13.0 tt -158.95 131.01 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.882 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 53.2 m -60.88 -60.69 9.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.565 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 1.001 ' HG2' HG12 ' A' ' 24' ' ' VAL . 3.7 Cg_exo -75.83 -150.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.954 1.769 . . . . 0.0 111.796 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.515 ' OD1' ' HG2' ' A' ' 17' ' ' GLU . 5.3 p30 -173.94 -22.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.024 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.515 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 16.2 pt-20 -159.51 129.38 5.52 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.685 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 169.69 159.81 16.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.56 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.405 HG21 ' HA ' ' A' ' 95' ' ' PRO . 35.6 pt -51.64 156.75 2.14 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.613 0.244 . . . . 0.0 111.03 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.853 ' HA ' HG23 ' A' ' 64' ' ' VAL . 75.8 Cg_exo -51.88 -41.07 65.16 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.742 2.295 . . . . 0.0 113.496 -179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -70.67 -5.79 32.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -64.02 131.0 46.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.998 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.736 ' HD2' HG13 ' A' ' 61' ' ' VAL . 17.3 tppt? -65.99 136.97 56.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.283 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.001 HG12 ' HG2' ' A' ' 15' ' ' PRO . 26.3 m -141.45 131.34 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.007 0.432 . . . . 0.0 111.309 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.416 ' HB ' ' OG ' ' A' ' 14' ' ' SER . 99.7 m -90.3 122.53 33.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.663 HD12 ' HB ' ' A' ' 60' ' ' ILE . 64.1 mt -79.41 141.5 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.782 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.403 ' HG2' HH11 ' A' ' 27' ' ' ARG . 12.2 tpt180 -147.56 131.39 17.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.318 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.87 -135.62 1.95 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.663 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 67.0 mm-40 -145.93 135.86 23.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.842 0.353 . . . . 0.0 111.44 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.474 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 72.8 m-80 61.59 40.59 13.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.351 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 mp -83.57 49.05 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.704 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.72 124.24 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.476 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.8 p -88.29 39.25 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.763 0.316 . . . . 0.0 111.362 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.36 147.47 5.07 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.594 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.92 -41.6 62.54 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.334 2.023 . . . . 0.0 111.77 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.9 p -61.17 -34.67 75.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.771 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.94 46.09 0.56 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.815 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 40' ' ' GLY . 1.9 tt -157.4 121.9 4.35 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.409 HD13 ' CD ' ' A' ' 79' ' ' LYS . 29.0 pt -144.21 33.16 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.989 0.423 . . . . 0.0 111.424 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.453 ' H ' HD23 ' A' ' 38' ' ' LEU . . . -174.04 128.5 1.48 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.39 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.685 HD13 ' N ' ' A' ' 42' ' ' THR . 1.2 tm? -150.56 134.0 16.4 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.685 ' N ' HD13 ' A' ' 41' ' ' LEU . 94.0 m -158.33 128.08 5.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.079 0.466 . . . . 0.0 111.746 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.651 HG21 ' HA ' ' A' ' 64' ' ' VAL . 41.1 mm -115.72 126.09 73.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.387 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.468 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 69.7 m 57.68 45.79 18.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.789 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.94 11.65 32.2 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.975 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.479 ' C ' HG23 ' A' ' 42' ' ' THR . 82.1 t60 -116.07 133.12 56.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.328 . . . . 0.0 111.026 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.13 133.29 54.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.987 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.1 m -153.35 39.01 0.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.669 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.1 tp -72.27 -41.97 66.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.459 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 51' ' ' THR . 3.9 pp -58.07 -33.51 69.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.501 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.7 ' N ' HD12 ' A' ' 50' ' ' LEU . 20.3 p -80.03 -37.7 33.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.766 0.317 . . . . 0.0 110.99 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.577 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -59.82 131.13 49.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.735 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -127.21 127.58 44.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.262 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -65.62 141.53 58.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.739 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 95.3 mmm -132.23 -42.65 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.139 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 m -160.93 -166.34 1.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.998 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.04 -7.53 54.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.478 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.4 m -156.23 47.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.078 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 87.3 tttt -164.44 129.11 2.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.9 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.663 ' HB ' HD12 ' A' ' 26' ' ' ILE . 76.2 mt -150.21 126.91 2.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.968 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.736 HG13 ' HD2' ' A' ' 23' ' ' LYS . 89.1 t -84.58 127.89 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.535 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.5 p -170.67 145.09 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.815 0.34 . . . . 0.0 111.198 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -84.63 131.63 34.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.341 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.853 HG23 ' HA ' ' A' ' 20' ' ' PRO . 15.3 m . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.421 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.405 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -57.87 132.16 52.55 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.01 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.4 mt -86.77 121.18 37.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.748 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.9 mm -111.62 138.97 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.307 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.458 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 62.0 t -141.39 110.64 2.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.901 0.382 . . . . 0.0 111.095 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.7 m -79.73 143.39 34.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.823 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.5 p -136.86 139.74 41.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.893 0.377 . . . . 0.0 111.369 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.409 ' CD ' HD13 ' A' ' 39' ' ' ILE . 32.0 mmmt -56.78 -47.43 80.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.055 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.7 m -67.25 -52.83 36.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.607 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 -125.14 2.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.068 -0.586 . . . . 0.0 112.411 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 -134.97 1.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.18 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -60.58 125.46 23.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 0.0 110.524 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.458 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -72.92 130.7 14.48 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.217 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 74.3 p -100.47 147.47 25.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.586 0.232 . . . . 0.0 110.773 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -159.88 125.74 4.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.32 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.7 p -99.0 40.73 1.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.522 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.4 m -147.97 157.34 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.798 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.2 p -150.74 139.24 20.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.542 ' CE2' HG21 ' A' ' 64' ' ' VAL . 68.9 t80 -84.83 127.24 34.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.163 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -72.4 120.26 17.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.338 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.9 mt -90.19 128.95 36.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.285 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.411 HD12 ' HA2' ' A' ' 18' ' ' GLY . 67.1 mt -105.55 140.11 39.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.631 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -58.51 140.22 84.76 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.405 ' HA ' HG21 ' A' ' 19' ' ' ILE . 52.0 Cg_exo . . . . . 0 C--N 1.347 0.496 0 C-N-CA 122.534 2.156 . . . . 0.0 112.598 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.096 0 CA-C-O 120.524 0.202 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.72 141.78 38.32 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.51 2.14 . . . . 0.0 112.407 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 16.6 Cg_endo -57.57 143.46 94.65 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.735 2.29 . . . . 0.0 112.288 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 10' ' ' VAL . 1.9 tm? -132.12 122.47 25.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.248 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.511 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 63.7 t -83.04 137.65 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.624 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.409 HG23 HD12 ' A' ' 9' ' ' LEU . 68.9 p -148.94 45.6 1.0 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.94 146.34 6.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.126 -1.035 . . . . 0.0 113.449 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.1 tt -163.59 128.32 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.677 0.275 . . . . 0.0 110.308 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.869 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 59.1 m -68.48 -60.05 5.21 Favored Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.717 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.919 ' HG2' HG12 ' A' ' 24' ' ' VAL . 70.1 Cg_endo -95.24 106.74 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.399 2.066 . . . . 0.0 112.157 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -91.07 32.31 1.03 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.562 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 179.31 128.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.36 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 169.03 149.45 6.23 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.593 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.3 pt -54.01 160.07 2.49 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.538 0.209 . . . . 0.0 111.04 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.632 ' HA ' HG23 ' A' ' 64' ' ' VAL . 86.1 Cg_exo -49.26 -38.65 42.26 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.889 2.393 . . . . 0.0 113.651 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -75.8 -14.5 60.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 m -63.58 127.92 33.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 111.536 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 54.1 mtmt -74.97 134.65 41.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.324 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.919 HG12 ' HG2' ' A' ' 15' ' ' PRO . 28.4 m -123.41 128.57 74.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.941 0.4 . . . . 0.0 111.339 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.6 m -73.67 117.05 14.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.764 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 60' ' ' ILE . 67.9 mt -86.99 136.08 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.063 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.478 ' HE ' ' HG3' ' A' ' 59' ' ' LYS . 21.0 mmt85 -146.5 134.96 21.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.601 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.03 -130.99 1.27 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.466 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -146.49 132.48 19.21 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.855 0.36 . . . . 0.0 111.343 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.519 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.1 m-80 61.27 41.76 12.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.136 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.587 HD22 ' O ' ' A' ' 58' ' ' SER . 10.0 mp -81.86 53.33 2.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.978 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.99 134.32 1.22 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.639 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 p -66.47 -37.47 85.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.665 0.269 . . . . 0.0 111.537 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.42 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -154.79 -174.4 24.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.008 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.77 -43.93 15.0 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.737 2.291 . . . . 0.0 112.567 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.0 p -56.36 -40.63 74.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.828 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 79' ' ' LYS . 37.7 t70 -66.28 -36.86 84.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.736 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.2 tp -74.61 63.06 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.513 ' O ' HD22 ' A' ' 49' ' ' LEU . 32.5 pt -73.0 -37.14 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.158 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -113.51 142.27 17.36 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.037 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.646 HD13 ' N ' ' A' ' 42' ' ' THR . 3.0 tm? -149.62 134.71 18.06 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.646 ' N ' HD13 ' A' ' 41' ' ' LEU . 18.5 p -150.31 151.16 32.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.079 0.466 . . . . 0.0 111.832 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 77.2 mt -136.15 117.49 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.328 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 85.3 m 73.78 -38.3 0.4 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.468 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 168.33 -40.1 0.22 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.962 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -80.24 140.68 36.14 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.92 0.39 . . . . 0.0 111.763 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.541 ' HA ' HG22 ' A' ' 42' ' ' THR . 39.3 t30 -59.8 144.59 48.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.965 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.5 m -149.96 38.28 0.74 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.08 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.513 HD22 ' O ' ' A' ' 39' ' ' ILE . 52.8 tp -73.84 -47.67 36.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.237 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.3 pt? -48.41 -44.44 35.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.727 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.674 HG21 ' HE ' ' A' ' 63' ' ' ARG . 52.9 p -80.12 -37.87 32.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.722 0.296 . . . . 0.0 111.349 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -60.23 137.16 58.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.491 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -126.76 130.72 50.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.506 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.42 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 55.7 t90 -66.53 150.83 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.223 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.8 mmt -141.2 -47.49 0.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.902 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.2 t -166.41 -175.1 3.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.401 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.73 38.23 0.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.756 0.312 . . . . 0.0 111.169 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.587 ' O ' HD22 ' A' ' 31' ' ' LEU . 80.4 p -175.87 -43.54 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.478 ' HG3' ' HE ' ' A' ' 27' ' ' ARG . 61.9 tttm -82.87 131.94 35.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.227 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 77.2 mt -151.78 105.92 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.598 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -80.25 130.67 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.825 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 31.7 t -170.82 141.33 1.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 111.407 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.674 ' HE ' HG21 ' A' ' 51' ' ' THR . 40.1 ptt180 -85.35 131.88 34.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.392 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.632 HG23 ' HA ' ' A' ' 20' ' ' PRO . 27.0 m . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.732 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.191 0 N-CA-C 112.717 -0.153 . . . . 0.0 112.717 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -63.81 128.63 36.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.928 0.394 . . . . 0.0 111.219 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.528 ' O ' HD13 ' A' ' 75' ' ' ILE . 68.5 mt -85.76 130.74 35.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.326 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.882 HG21 ' HE2' ' A' ' 83' ' ' LYS . 34.5 mm -134.19 145.77 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 111.449 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.2 p -139.55 128.36 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.833 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.5 m -93.61 143.79 25.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.403 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.8 p -137.0 137.42 39.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.541 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 7.5 mtpm? -55.65 -48.26 75.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.4 m -65.87 -55.46 16.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.928 0.394 . . . . 0.0 110.382 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.0 -123.64 0.72 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.161 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.82 -143.04 3.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.005 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.882 ' HE2' HG21 ' A' ' 75' ' ' ILE . 19.7 tptm -69.18 109.72 4.21 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.94 -161.25 7.28 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.181 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.43 ' HA ' ' CD1' ' A' ' 75' ' ' ILE . 44.0 p -154.29 -169.03 3.11 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.427 0.291 . . . . 0.0 110.451 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.511 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 45.4 t -171.16 131.86 0.8 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.755 0.312 . . . . 0.0 111.243 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.7 p -90.49 31.68 1.01 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.78 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.4 m -152.03 142.48 15.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.922 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.3 p -125.07 133.72 52.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.72 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.506 ' CE2' HG21 ' A' ' 64' ' ' VAL . 69.5 t80 -85.77 128.08 34.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.866 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -82.48 123.13 28.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.572 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.8 mt -81.84 128.8 34.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.152 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.47 HD12 ' HA2' ' A' ' 18' ' ' GLY . 79.1 mt -98.89 133.38 43.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.724 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 31.0 mmmt -74.37 134.74 76.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 51.9 Cg_exo . . . . . 0 C--N 1.346 0.429 0 C-N-CA 122.53 2.153 . . . . 0.0 112.352 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.622 0.249 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.451 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 50.9 Cg_exo -54.68 141.08 76.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.626 2.217 . . . . 0.0 112.289 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 48.0 Cg_exo -56.52 137.98 82.66 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.515 2.143 . . . . 0.0 112.148 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 85' ' ' THR . 3.5 tt -130.39 113.25 14.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.107 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.555 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 90.3 t -81.01 135.69 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.421 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.7 p -146.67 42.5 1.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.14 144.74 5.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.75 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.536 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.0 tt -163.07 130.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.62 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.827 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 50.4 m -65.64 -58.94 10.3 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.068 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.827 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 90.9 Cg_endo -95.0 119.99 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.575 2.183 . . . . 0.0 112.478 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -92.92 21.17 5.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.887 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 178.64 135.58 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.655 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.403 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 167.35 145.44 4.5 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.94 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 93' ' ' LEU . 33.4 pt -54.97 159.79 3.51 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 110.723 -0.103 . . . . 0.0 110.723 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.908 ' HA ' HG23 ' A' ' 64' ' ' VAL . 73.7 Cg_exo -48.67 -39.93 38.11 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.574 2.183 . . . . 0.0 113.099 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.406 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 60.4 m95 -69.92 -21.19 63.31 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.6 m -60.94 129.83 43.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 111.452 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.549 ' HD2' HG13 ' A' ' 61' ' ' VAL . 4.5 tppp? -70.34 140.59 52.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.422 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.702 HG12 ' HG2' ' A' ' 15' ' ' PRO . 19.6 m -136.66 133.15 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.2 m -88.13 110.59 20.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.782 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.406 HD11 ' SG ' ' A' ' 62' ' ' CYS . 59.6 mt -75.95 138.8 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.466 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.517 ' O ' HG13 ' A' ' 10' ' ' VAL . 22.2 tpp180 -147.11 128.99 15.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.385 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.77 -136.22 2.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.62 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -148.57 138.41 22.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.941 0.4 . . . . 0.0 111.197 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 62.92 41.18 8.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.289 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.576 HD23 HD12 ' A' ' 60' ' ' ILE . 9.8 mp -85.47 52.07 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.495 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.85 125.14 0.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.305 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -91.92 39.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.753 0.311 . . . . 0.0 111.493 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.54 144.74 4.37 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.599 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.88 -43.5 58.74 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.491 2.128 . . . . 0.0 111.997 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.8 p -61.75 -37.48 84.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.193 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 32.7 m-20 -57.1 -44.1 82.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.484 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.445 HD11 HD13 ' A' ' 60' ' ' ILE . 1.2 tt -73.9 67.74 1.26 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.74 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.509 HD13 ' HG2' ' A' ' 79' ' ' LYS . 26.6 pt -75.92 -39.53 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.675 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -114.31 139.17 15.42 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.219 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.576 HD13 ' N ' ' A' ' 42' ' ' THR . 3.0 tm? -150.13 130.11 13.44 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.576 ' N ' HD13 ' A' ' 41' ' ' LEU . 36.2 p -151.61 137.08 17.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 111.748 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.1 mt -125.28 126.13 70.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.648 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.508 ' SG ' HD21 ' A' ' 92' ' ' LEU . 69.5 m 58.19 38.37 26.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.018 0.437 . . . . 0.0 110.335 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.07 34.28 89.49 Favored Glycine 0 C--N 1.331 0.285 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.171 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -131.34 133.38 45.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 0.0 110.556 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.491 ' HA ' HG22 ' A' ' 42' ' ' THR . 45.7 t30 -68.56 132.94 47.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.051 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.0 m -154.64 36.67 0.41 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.628 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 3.3 tm? -77.51 -46.09 23.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.774 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -52.72 -39.73 62.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.053 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.615 HG21 ' NE ' ' A' ' 63' ' ' ARG . 67.8 p -80.48 -35.67 34.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -55.13 138.37 44.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.514 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -126.07 130.69 51.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.806 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -80.36 150.6 29.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.4 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.9 mtt -147.71 -44.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.482 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 t -165.52 176.42 8.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.447 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.18 43.37 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.219 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.508 ' HA ' HD13 ' A' ' 31' ' ' LEU . 79.7 p -172.31 -42.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.135 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -93.71 130.64 39.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 111.166 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.576 HD12 HD23 ' A' ' 31' ' ' LEU . 80.1 mt -150.33 111.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.666 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.549 HG13 ' HD2' ' A' ' 23' ' ' LYS . 66.2 t -84.39 125.94 40.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.887 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 31.6 p -170.87 151.22 3.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.051 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.615 ' NE ' HG21 ' A' ' 51' ' ' THR . 39.0 ptt180 -83.94 132.37 34.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.501 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.908 HG23 ' HA ' ' A' ' 20' ' ' PRO . 6.5 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.856 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.428 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.384 0 N-CA-C 112.655 -0.178 . . . . 0.0 112.655 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.08 136.8 41.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.686 0.279 . . . . 0.0 110.449 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.6 mt -84.95 92.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.007 0.432 . . . . 0.0 110.935 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.8 mm -81.88 137.77 20.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.635 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.2 t -141.54 106.77 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.119 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.0 m -82.16 143.55 31.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.505 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.2 p -141.04 134.8 30.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.519 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.555 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 7.6 mtpm? -55.53 -43.57 75.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.794 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.8 m -64.43 -48.97 73.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.241 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.46 -121.33 4.85 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.164 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.42 -141.28 3.09 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.182 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.19 127.97 34.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 110.854 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.3 132.38 12.04 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.0 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 78.7 p -99.1 146.18 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.545 0.212 . . . . 0.0 110.64 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.555 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 47.5 t -149.37 132.06 15.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.982 0.42 . . . . 0.0 111.583 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.6 p -72.05 -33.49 68.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.746 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.54 139.43 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.401 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.1 p -123.62 138.68 54.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.744 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.484 ' CD2' HG11 ' A' ' 64' ' ' VAL . 54.2 t80 -88.26 130.06 35.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -90.43 125.07 35.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.532 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.508 HD21 ' SG ' ' A' ' 44' ' ' CYS . 3.2 mm? -85.25 124.42 31.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 111.046 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 19' ' ' ILE . 80.7 mt -87.24 136.1 33.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.785 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -64.91 131.62 95.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.369 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 C--N 1.345 0.373 0 C-N-CA 122.419 2.08 . . . . 0.0 112.319 -179.745 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.662 0.268 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.0 Cg_endo -59.34 142.79 99.57 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.755 2.303 . . . . 0.0 112.216 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 51.8 Cg_exo -55.19 129.73 36.87 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.515 2.144 . . . . 0.0 112.275 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.7 tp -115.01 108.19 16.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 57.4 t -84.82 137.02 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.454 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 t -166.73 51.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.204 0.526 . . . . 0.0 111.414 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.33 136.77 4.13 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.392 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.539 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.4 tt -165.29 131.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.703 0.287 . . . . 0.0 110.622 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.804 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.6 t -69.35 -58.46 5.97 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.627 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.872 ' HG2' HG12 ' A' ' 24' ' ' VAL . 88.3 Cg_endo -93.24 113.18 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.364 2.043 . . . . 0.0 112.614 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.505 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -95.81 31.65 2.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.897 0.38 . . . . 0.0 110.863 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.688 ' HB2' HD11 ' A' ' 93' ' ' LEU . 15.9 pt-20 -179.45 129.34 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.358 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.07 146.9 5.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.988 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 39.6 pt -53.43 160.39 1.86 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.342 0.115 . . . . 0.0 110.949 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.893 ' HA ' HG23 ' A' ' 64' ' ' VAL . 89.3 Cg_exo -48.08 -38.8 32.89 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.622 2.215 . . . . 0.0 113.11 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.593 ' O ' ' HD2' ' A' ' 63' ' ' ARG . 97.4 m95 -72.76 -21.03 61.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.6 m -56.22 127.98 33.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.076 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.552 ' HE2' HG13 ' A' ' 61' ' ' VAL . 60.6 tttm -70.28 142.34 52.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.79 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.872 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.6 m -139.82 126.46 23.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 111.091 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 62.1 m -83.55 87.85 7.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.76 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.652 HD12 HD13 ' A' ' 74' ' ' ILE . 49.8 mm -54.69 133.8 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.758 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 25' ' ' THR . 45.2 mmm-85 -140.44 137.29 33.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -168.12 -134.11 1.66 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.196 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -150.57 135.58 17.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 111.237 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 61.65 41.72 11.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.227 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 mp -82.79 51.24 1.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.865 0.364 . . . . 0.0 110.411 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.41 123.45 0.19 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.212 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.7 p -92.29 42.47 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.741 0.305 . . . . 0.0 111.352 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.63 143.75 4.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.653 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.427 ' HG3' ' CE3' ' A' ' 54' ' ' TRP . 32.2 Cg_exo -57.3 -46.09 30.47 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.456 2.104 . . . . 0.0 111.749 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 t -62.48 -36.36 82.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.157 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 28.3 m-20 -53.7 -45.46 70.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.623 HD21 HD23 ' A' ' 41' ' ' LEU . 1.4 tt -68.76 131.11 44.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.076 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.51 ' N ' HD23 ' A' ' 38' ' ' LEU . 30.0 pt -138.4 -44.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.593 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.489 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -104.55 135.82 12.71 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.216 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.623 HD23 HD21 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -146.32 121.0 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.828 HG22 ' HA ' ' A' ' 47' ' ' ASN . 33.3 p -153.13 134.82 14.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.179 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 45' ' ' GLY . 76.0 mt -105.38 111.22 33.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.044 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.493 ' SG ' ' HA2' ' A' ' 72' ' ' GLY . 34.5 t 73.91 -37.8 0.38 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.748 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 171.9 -32.39 0.13 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.528 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -73.58 135.73 43.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.921 0.391 . . . . 0.0 111.459 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.828 ' HA ' HG22 ' A' ' 42' ' ' THR . 43.2 t30 -71.35 138.39 49.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.844 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.2 m -151.89 40.4 0.64 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.965 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.2 tp -74.28 -44.39 52.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.4 pt? -50.57 -42.71 55.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.497 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.418 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 59.1 p -80.31 -35.26 35.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 111.204 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.585 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.77 131.2 50.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.983 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -127.11 129.99 48.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.335 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.427 ' CE3' ' HG3' ' A' ' 35' ' ' PRO . 67.2 t90 -73.35 148.35 43.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.076 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.3 mtt -148.76 -44.01 0.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.317 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.445 ' C ' ' H ' ' A' ' 58' ' ' SER . 64.7 m -160.62 169.97 21.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.727 0.298 . . . . 0.0 110.884 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.78 32.8 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.344 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 56' ' ' SER . 79.8 p -177.85 34.42 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.544 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -164.58 131.23 3.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.8 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.4 mt -150.1 118.81 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.552 HG13 ' HE2' ' A' ' 23' ' ' LYS . 70.5 t -83.7 125.37 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.585 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.5 p -170.43 148.24 3.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.826 0.346 . . . . 0.0 111.015 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.593 ' HD2' ' O ' ' A' ' 21' ' ' TRP . 37.6 mmt-85 -84.01 131.18 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.126 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.893 HG23 ' HA ' ' A' ' 20' ' ' PRO . 10.4 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.189 0.519 . . . . 0.0 112.131 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.493 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.452 -0.246 0 N-CA-C 112.554 -0.219 . . . . 0.0 112.554 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -66.36 139.38 58.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.727 0.298 . . . . 0.0 110.958 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.652 HD13 HD12 ' A' ' 26' ' ' ILE . 72.2 mt -84.32 135.27 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.584 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.55 HD12 ' HD3' ' A' ' 83' ' ' LYS . 46.1 mm -128.66 137.51 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.899 0.38 . . . . 0.0 111.72 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t -141.4 117.5 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.896 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.9 m -87.56 140.69 29.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.975 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.6 p -134.59 137.0 43.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.996 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 37' ' ' ASP . 28.9 mtpp -60.1 -46.27 90.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.3 m -65.11 -52.43 55.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.056 0.455 . . . . 0.0 110.159 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.72 -121.8 2.46 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.063 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.36 -142.19 3.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.355 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.55 ' HD3' HD12 ' A' ' 75' ' ' ILE . 3.5 tmmm? -66.73 125.25 25.25 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 83' ' ' LYS . . . -79.45 131.31 10.5 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.061 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.7 p -99.27 148.24 24.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.642 0.258 . . . . 0.0 110.431 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.581 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 78.9 p -149.23 130.31 14.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 111.817 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 74.0 p -81.51 -31.74 32.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.376 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 m -84.22 148.31 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.205 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.0 p -138.97 135.25 34.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.797 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.476 ' CD2' HG11 ' A' ' 64' ' ' VAL . 86.6 t80 -85.64 133.34 34.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.538 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -88.45 123.71 33.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.403 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.492 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -80.13 128.27 33.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.056 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 17' ' ' GLU . 75.8 mt -101.45 135.97 42.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.002 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -67.69 140.97 94.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 C--N 1.346 0.437 0 C-N-CA 122.447 2.098 . . . . 0.0 112.284 -179.886 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.609 0.242 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.17 147.46 94.05 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.614 2.209 . . . . 0.0 112.241 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.09 143.36 18.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.571 2.181 . . . . 0.0 112.331 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 85' ' ' THR . 46.7 tp -135.93 111.57 9.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.568 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 58.8 t -78.36 130.0 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.791 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.427 ' H ' ' HA2' ' A' ' 28' ' ' GLY . 76.5 p -150.92 47.8 0.85 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.093 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.4 145.22 6.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.292 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.486 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.4 tt -164.35 128.18 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.31 . . . . 0.0 110.397 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.793 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.0 t -64.98 -58.26 13.31 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.861 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 79.8 Cg_endo -91.27 110.84 0.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.28 1.987 . . . . 0.0 112.397 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.411 ' OD1' HG23 ' A' ' 13' ' ' ILE . 50.5 m-80 -90.31 24.41 2.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.943 0.402 . . . . 0.0 110.166 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HB2' HD11 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -179.31 132.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.169 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.17 145.84 5.1 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.852 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.512 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.9 pt -55.67 164.18 1.7 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 120.407 0.146 . . . . 0.0 110.707 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 81.4 Cg_exo -47.7 -53.73 6.14 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.605 2.204 . . . . 0.0 113.966 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.416 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 80.2 m95 -68.31 -8.87 43.53 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.465 ' OG1' HG12 ' A' ' 19' ' ' ILE . 73.1 m -62.29 127.29 30.63 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.079 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -69.43 131.63 45.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.36 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.602 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.0 m -125.94 127.78 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.978 0.418 . . . . 0.0 110.999 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.8 m -81.33 118.5 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 60' ' ' ILE . 63.7 mt -79.74 138.49 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.775 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.423 ' O ' HG13 ' A' ' 10' ' ' VAL . 27.1 mmm180 -147.21 136.94 22.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.346 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.17 -132.08 1.41 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.673 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -146.94 131.38 17.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.318 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 60.63 41.85 14.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.166 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.453 HD22 ' O ' ' A' ' 58' ' ' SER . 10.5 mp -81.97 52.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.959 0.409 . . . . 0.0 110.841 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.81 121.44 0.04 OUTLIER Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.404 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.0 p -93.4 41.18 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.0 144.13 5.38 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.464 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HA ' ' CG ' ' A' ' 54' ' ' TRP . 51.3 Cg_exo -54.26 -43.04 62.23 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.538 2.159 . . . . 0.0 112.089 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.8 p -64.01 -35.69 81.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 28.6 m-20 -52.18 -49.06 64.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.005 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.47 ' C ' HD13 ' A' ' 38' ' ' LEU . 3.5 tm? -67.12 132.46 47.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.33 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.433 ' N ' HD13 ' A' ' 38' ' ' LEU . 35.5 pt -147.97 -24.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.998 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.94 137.21 12.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.58 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.784 HD12 ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -149.64 131.67 15.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 47' ' ' ASN . 5.7 p -153.7 141.73 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.134 0.493 . . . . 0.0 111.657 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -135.97 123.23 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.168 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 78.9 m 58.41 40.1 24.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.941 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.02 -32.74 1.73 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.183 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -70.71 133.06 46.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 111.356 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.617 ' HA ' HG22 ' A' ' 42' ' ' THR . 15.0 p-10 -74.62 143.94 44.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.73 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.784 ' SG ' HD12 ' A' ' 41' ' ' LEU . 7.5 p -154.12 46.31 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 110.793 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.2 tp -72.95 -48.9 32.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.58 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 51' ' ' THR . 4.1 pp -62.24 -30.37 71.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.599 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.629 ' N ' HD12 ' A' ' 50' ' ' LEU . 41.3 p -79.92 -38.39 32.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.903 0.383 . . . . 0.0 110.91 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.501 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -64.22 138.08 58.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.67 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.37 127.39 45.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.08 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.41 ' CG ' ' HA ' ' A' ' 35' ' ' PRO . 31.1 t90 -63.78 143.57 57.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.111 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 94.0 mmm -132.95 -51.17 0.9 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.718 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.2 m -161.2 -172.15 3.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.62 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.31 39.17 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.276 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.453 ' O ' HD22 ' A' ' 31' ' ' LEU . 40.2 t -178.4 -43.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.7 tttm -86.81 134.05 33.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.483 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 75.3 mt -151.24 120.29 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.571 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.22 132.39 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.064 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 25.9 t -170.57 141.4 1.89 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.197 0.522 . . . . 0.0 111.545 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.552 ' HE ' HG21 ' A' ' 51' ' ' THR . 39.7 ptt180 -85.37 140.44 30.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.711 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.532 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t . . . . . 0 CA--C 1.515 -0.371 0 CA-C-O 121.647 0.737 . . . . 0.0 110.758 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.723 -0.151 . . . . 0.0 112.723 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -71.41 131.87 43.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 110.886 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.6 mt -85.6 100.33 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.085 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.3 mm -98.6 138.97 21.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.99 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.52 120.17 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.0 111.288 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.1 m -90.87 145.87 24.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.271 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.4 p -140.49 142.93 35.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.953 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 32.2 mmmt -51.77 -49.12 63.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.231 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.4 t -67.0 -47.41 71.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.88 -127.81 0.19 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.819 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.12 -39.77 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.851 -0.499 . . . . 0.0 111.851 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -168.06 121.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.98 127.05 7.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.368 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.558 ' O ' HD12 ' A' ' 9' ' ' LEU . 81.7 p -99.69 144.63 28.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.568 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 66.5 p -143.36 124.19 14.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.101 0.477 . . . . 0.0 111.794 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.7 p -81.02 -28.69 35.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.245 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.62 141.89 14.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.287 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.1 p -129.77 139.26 51.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.958 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -85.74 129.44 34.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.39 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.41 114.55 20.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.093 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 47.0 tp -78.86 131.07 36.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 111.406 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 17' ' ' GLU . 78.4 mt -98.82 141.27 31.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.764 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -61.92 123.32 77.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.015 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo . . . . . 0 C--N 1.348 0.545 0 C-N-CA 122.421 2.081 . . . . 0.0 111.987 179.612 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.437 0.161 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 17.9 Cg_endo -60.18 139.15 85.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.57 2.18 . . . . 0.0 112.267 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 59.7 Cg_exo -52.8 147.1 33.15 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.82 2.347 . . . . 0.0 112.625 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 85' ' ' THR . 59.8 tp -149.97 112.24 4.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.741 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.49 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 57.3 t -79.02 131.5 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.2 p -147.76 44.22 1.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.43 146.41 6.49 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.778 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.5 tt -161.45 129.66 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.762 0.315 . . . . 0.0 110.629 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.843 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 49.5 m -68.89 -59.88 4.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.805 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.843 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 72.2 Cg_endo -92.49 121.95 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.364 2.042 . . . . 0.0 112.077 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -105.78 28.51 7.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.881 0.372 . . . . 0.0 110.832 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -179.99 129.53 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.436 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.456 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 164.25 148.15 5.34 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.583 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.0 pt -51.62 158.56 1.5 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.481 0.181 . . . . 0.0 110.767 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.785 ' HA ' HG23 ' A' ' 64' ' ' VAL . 73.4 Cg_exo -50.08 -41.67 48.3 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.656 2.237 . . . . 0.0 113.322 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -70.12 -8.97 53.94 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.9 m -67.93 126.9 30.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.765 0.317 . . . . 0.0 110.927 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.583 ' NZ ' ' HB2' ' A' ' 23' ' ' LYS . 4.9 ttmp? -71.02 134.03 46.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.071 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.734 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.7 m -124.37 127.24 73.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 0.0 111.542 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.1 m -78.54 102.33 7.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.7 mt -69.83 139.73 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.09 0.471 . . . . 0.0 111.403 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -144.11 130.95 20.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.205 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.31 -133.17 1.54 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.623 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -150.16 136.8 19.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.914 0.388 . . . . 0.0 111.325 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 61.94 39.05 13.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.508 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 mp -84.98 53.1 2.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.0 110.63 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.08 129.65 1.46 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.509 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.9 p -69.31 -36.63 77.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.76 0.314 . . . . 0.0 111.455 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.445 ' HA2' ' CZ2' ' A' ' 54' ' ' TRP . . . -150.86 174.84 30.07 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.517 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.28 -43.86 54.58 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.795 2.33 . . . . 0.0 112.486 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.3 t -58.56 -40.12 82.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.19 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.02 -46.79 85.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.156 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.3 tt -59.71 129.73 43.33 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.573 HG21 ' HD3' ' A' ' 79' ' ' LYS . 39.6 pt -141.95 -44.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.439 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.528 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -102.55 133.81 11.54 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.628 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 42' ' ' THR . 2.4 tm? -149.48 127.3 11.79 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.748 HG22 ' HA ' ' A' ' 47' ' ' ASN . 11.8 p -155.87 140.82 17.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.525 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.594 HD11 ' SG ' ' A' ' 62' ' ' CYS . 73.3 mt -126.03 123.77 64.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.596 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.432 ' SG ' ' HA2' ' A' ' 72' ' ' GLY . 58.9 m 57.37 36.35 27.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.058 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.89 -31.66 3.05 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.055 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -73.7 133.18 43.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.854 0.359 . . . . 0.0 111.408 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.748 ' HA ' HG22 ' A' ' 42' ' ' THR . 42.0 t30 -69.2 138.3 53.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.7 m -151.04 39.27 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 110.7 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.3 tp -75.06 -43.19 54.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.107 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -52.21 -41.61 62.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.281 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.408 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 68.0 p -80.29 -34.62 36.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.175 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 61' ' ' VAL . . . -58.06 131.02 49.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.566 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.424 ' HB3' HG23 ' A' ' 61' ' ' VAL . 17.8 tp10 -126.61 132.31 51.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.573 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.445 ' CZ2' ' HA2' ' A' ' 34' ' ' GLY . 77.0 t90 -68.31 144.84 54.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.196 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.7 mmt -132.65 -47.78 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.663 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.6 p -168.54 -157.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.635 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.37 32.32 1.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.355 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.7 p -179.98 37.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.278 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -164.88 129.62 2.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.102 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.4 mt -151.23 111.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.698 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -84.51 130.25 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.349 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.594 ' SG ' HD11 ' A' ' 43' ' ' ILE . 26.4 p -170.97 150.98 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.042 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -84.01 129.79 34.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.785 HG23 ' HA ' ' A' ' 20' ' ' PRO . 14.3 m . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.102 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.432 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.328 -0.309 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -64.14 131.58 47.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.861 0.362 . . . . 0.0 111.083 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.4 mt -85.36 135.43 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.522 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.9 mm -134.55 133.82 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 0.0 111.713 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.418 HG22 HD22 ' A' ' 41' ' ' LEU . 60.0 t -141.55 118.66 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.22 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.4 m -98.68 131.88 44.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.555 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.1 p -99.48 146.29 26.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.844 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.573 ' HD3' HG21 ' A' ' 39' ' ' ILE . 56.5 tptt -58.57 -49.19 78.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.773 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 81.9 p -70.33 -54.43 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.76 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.53 -127.05 0.35 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.42 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.4 -137.25 2.18 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.17 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -65.17 126.12 27.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.7 0.286 . . . . 0.0 110.569 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.28 -150.19 6.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.154 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 21.5 p -158.09 151.59 23.44 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.706 0.402 . . . . 0.0 110.624 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.3 p -158.66 121.34 3.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.917 0.389 . . . . 0.0 111.431 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 82.6 p -96.07 37.56 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.436 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.6 m -150.56 157.44 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.744 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.5 p -146.0 136.23 23.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.572 ' CE2' HG21 ' A' ' 64' ' ' VAL . 65.4 t80 -85.45 130.44 34.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.863 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -82.19 120.83 25.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.659 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.486 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.3 mm? -83.91 126.96 33.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.018 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.456 HD12 ' HA2' ' A' ' 18' ' ' GLY . 76.9 mt -94.6 134.94 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.823 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 47.5 mmtm -67.01 129.21 94.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.956 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 31.2 Cg_exo . . . . . 0 C--N 1.347 0.481 0 C-N-CA 122.65 2.234 . . . . 0.0 112.471 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.597 0.237 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.15 138.01 78.89 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.543 2.162 . . . . 0.0 112.054 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HG2' ' HA2' ' A' ' 84' ' ' GLY . 14.1 Cg_endo -55.94 134.11 62.11 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.703 2.269 . . . . 0.0 112.331 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 85' ' ' THR . 64.8 tp -120.03 117.65 28.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.018 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.535 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 94.8 t -83.29 132.92 30.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.841 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.0 p -151.34 48.86 0.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.042 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.3 144.83 6.9 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.01 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.655 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.1 tt -163.01 131.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.579 0.228 . . . . 0.0 110.645 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.846 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 48.4 t -63.22 -59.18 12.87 Favored Pre-proline 0 C--N 1.331 -0.239 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.349 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.924 ' HG2' HG12 ' A' ' 24' ' ' VAL . 10.3 Cg_exo -70.7 -148.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.945 1.763 . . . . 0.0 112.035 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -175.4 -23.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.351 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.7 133.94 4.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.832 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 169.69 160.07 17.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.409 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 30.6 pt -50.87 154.68 2.33 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.561 0.22 . . . . 0.0 111.009 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.18 -41.88 48.44 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.902 2.402 . . . . 0.0 113.807 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -70.51 -5.89 32.18 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -66.08 132.09 47.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.808 0.337 . . . . 0.0 111.227 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.581 ' HE3' HG13 ' A' ' 61' ' ' VAL . 87.2 tttt -67.26 137.35 56.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.479 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.924 HG12 ' HG2' ' A' ' 15' ' ' PRO . 35.9 m -140.98 127.23 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.977 0.417 . . . . 0.0 111.015 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.1 m -80.85 121.21 25.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.097 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.0 mt -84.3 135.83 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.726 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 10' ' ' VAL . 83.0 mtm180 -146.2 134.51 21.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.726 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.07 -132.58 1.46 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.58 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -146.09 132.88 20.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.873 0.368 . . . . 0.0 111.352 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 59.11 43.57 17.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.189 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 mp -83.31 47.88 1.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.829 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.47 125.24 0.06 OUTLIER Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.531 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.9 p -92.35 42.87 1.11 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.616 0.246 . . . . 0.0 111.211 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.05 144.81 4.78 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.752 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 10.5 Cg_endo -53.82 -42.87 62.9 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.686 2.258 . . . . 0.0 112.162 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.6 t -60.98 -37.03 81.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.954 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.57 -38.51 69.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.135 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.4 tp -76.31 60.41 1.53 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 0.0 110.914 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.46 HD13 ' HG2' ' A' ' 79' ' ' LYS . 22.6 pt -69.12 -40.06 80.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.318 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.07 138.21 12.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.885 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.53 HD13 ' N ' ' A' ' 42' ' ' THR . 3.1 tm? -149.77 127.8 11.93 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.903 HG22 ' HA ' ' A' ' 47' ' ' ASN . 39.3 p -151.53 136.73 17.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.976 0.417 . . . . 0.0 111.64 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.539 HG21 HG23 ' A' ' 64' ' ' VAL . 51.6 mm -107.65 105.62 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.911 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.419 ' HB2' ' HA2' ' A' ' 72' ' ' GLY . 38.0 t 58.28 45.22 17.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.731 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.14 -38.66 3.14 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.569 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -68.38 129.02 38.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.908 0.354 . . . . 0.0 111.141 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.903 ' HA ' HG22 ' A' ' 42' ' ' THR . 13.6 p-10 -73.62 140.76 46.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.603 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.2 m -150.25 40.12 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.764 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.6 tp -72.88 -49.36 30.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.224 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -54.08 -39.46 66.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.499 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.1 p -80.11 -38.11 32.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.576 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -62.5 130.44 45.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.847 0.356 . . . . 0.0 111.686 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 60' ' ' ILE . 44.9 tp10 -126.85 130.87 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.605 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 86.9 t90 -65.93 149.76 49.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.979 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.458 ' HG3' HG23 ' A' ' 61' ' ' VAL . 94.9 mmm -142.37 -42.9 0.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.766 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 t -170.63 173.97 5.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.857 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.83 33.43 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.283 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.6 p -178.61 23.68 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.588 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -165.67 131.27 2.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.743 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 53' ' ' GLU . 75.6 mt -149.43 120.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.008 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.581 HG13 ' HE3' ' A' ' 23' ' ' LYS . 57.4 t -81.82 126.33 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.471 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 52.7 t -171.08 149.71 2.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 0.0 111.138 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -84.66 131.43 34.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.308 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.539 HG23 HG21 ' A' ' 43' ' ' ILE . 5.5 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.065 0.459 . . . . 0.0 111.576 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 44' ' ' CYS . . . . . . . . 0 CA--C 1.518 0.231 0 CA-C-O 120.368 -0.129 . . . . 0.0 113.2 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -64.22 132.67 51.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.77 0.319 . . . . 0.0 111.042 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.442 HG23 ' CD1' ' A' ' 43' ' ' ILE . 68.5 mt -85.5 92.48 3.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.817 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.5 mm -81.03 138.58 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.195 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.53 113.51 3.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.936 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.5 m -84.47 142.23 30.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.722 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.3 p -137.73 135.52 36.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.047 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HG2' HD13 ' A' ' 39' ' ' ILE . 28.2 mtpp -59.29 -46.72 87.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.004 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.9 p -64.42 -52.83 56.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.03 0.443 . . . . 0.0 110.331 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 -120.97 2.13 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.193 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.76 -140.77 2.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.117 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.439 ' C ' ' HD2' ' A' ' 83' ' ' LYS . 4.3 tmmm? -67.38 127.12 31.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.36 . . . . 0.0 110.169 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.459 ' HA2' ' HG2' ' A' ' 8' ' ' PRO . . . -78.15 130.64 10.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.346 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.428 HG22 ' HE3' ' A' ' 83' ' ' LYS . 79.3 p -108.15 144.66 35.25 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.535 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 41.3 t -151.31 131.12 13.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.093 0.473 . . . . 0.0 111.875 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.8 p -78.17 -28.39 48.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.781 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.9 m -83.15 153.76 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.362 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.0 p -148.97 138.65 21.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.724 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 64' ' ' VAL . 67.2 t80 -85.2 131.56 34.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.68 ' HD2' HD23 ' A' ' 93' ' ' LEU . 5.8 tmtt? -79.39 119.1 21.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.013 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.476 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -84.61 109.67 18.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 110.54 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.68 HD23 ' HD2' ' A' ' 91' ' ' LYS . 54.9 mt -85.86 136.68 33.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.955 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -65.51 137.11 96.4 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.168 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--N 1.346 0.439 0 C-N-CA 122.441 2.094 . . . . 0.0 112.469 179.843 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.514 0.197 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -57.11 150.7 55.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.79 2.327 . . . . 0.0 112.308 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.543 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 82.1 Cg_exo -48.57 143.07 16.78 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.705 2.27 . . . . 0.0 112.746 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 85' ' ' THR . 4.9 tt -145.03 111.34 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.747 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.512 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 66.3 t -81.92 137.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.005 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.422 HG23 ' CD2' ' A' ' 9' ' ' LEU . 30.1 p -154.26 44.52 0.55 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.624 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.46 143.8 6.09 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.845 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.527 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.8 tt -164.47 129.47 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.0 110.51 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.824 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -65.22 -59.39 9.93 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.942 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.944 ' HG2' HG12 ' A' ' 24' ' ' VAL . 72.8 Cg_endo -94.86 118.89 0.26 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.447 2.098 . . . . 0.0 112.169 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -100.22 30.61 3.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.73 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.592 ' HB2' HD11 ' A' ' 93' ' ' LEU . 11.3 pt-20 179.0 129.39 0.07 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.571 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . 165.09 152.29 6.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.738 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.441 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 31.9 pt -56.12 162.54 2.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.48 0.181 . . . . 0.0 111.11 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.567 ' HA ' HG23 ' A' ' 64' ' ' VAL . 87.2 Cg_exo -49.23 -46.31 26.42 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.881 2.388 . . . . 0.0 113.768 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -71.4 -4.97 29.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.1 m -63.33 126.99 29.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.845 0.355 . . . . 0.0 110.986 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.484 ' HD2' HG13 ' A' ' 61' ' ' VAL . 17.2 tppt? -67.13 136.31 54.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.148 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.944 HG12 ' HG2' ' A' ' 15' ' ' PRO . 31.6 m -140.59 131.67 29.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.036 0.445 . . . . 0.0 111.51 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.9 m -89.75 116.28 27.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.549 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.44 HD11 ' SG ' ' A' ' 62' ' ' CYS . 57.3 mt -74.61 141.13 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.187 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 27' ' ' ARG . 11.9 tpt180 -147.48 130.75 16.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.997 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.56 -122.61 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.733 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.424 ' OE2' HD13 ' A' ' 9' ' ' LEU . 20.5 pt-20 -162.19 134.23 5.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.963 0.411 . . . . 0.0 111.598 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 60.86 40.21 16.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.86 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.543 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.6 mp -70.31 -41.96 72.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.609 0.242 . . . . 0.0 111.233 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.93 135.47 2.36 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.803 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.9 p -62.7 -39.75 94.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.798 0.332 . . . . 0.0 110.902 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.513 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -165.32 -164.11 20.04 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.66 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.28 -47.11 6.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.779 2.319 . . . . 0.0 112.514 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 39' ' ' ILE . 67.2 p -60.12 -40.91 91.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.379 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.732 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 36.5 t70 -62.65 -41.53 99.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.346 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.433 HD11 HD13 ' A' ' 60' ' ' ILE . 1.3 tt -78.33 62.15 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.947 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.638 HD13 ' HG2' ' A' ' 79' ' ' LYS . 27.2 pt -68.96 -41.79 82.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.19 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.433 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -112.21 140.61 16.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.098 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.627 HD13 ' N ' ' A' ' 42' ' ' THR . 3.4 tm? -146.89 134.85 21.4 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.627 ' N ' HD13 ' A' ' 41' ' ' LEU . 14.1 p -150.36 149.82 30.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.101 0.477 . . . . 0.0 111.546 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.712 HG21 ' HA ' ' A' ' 64' ' ' VAL . 71.1 mt -135.75 116.56 18.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.484 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 65.4 m 72.82 -35.2 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.813 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 166.11 -41.08 0.27 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.026 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -80.67 138.48 36.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.959 0.409 . . . . 0.0 111.705 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.493 ' HA ' HG22 ' A' ' 42' ' ' THR . 42.2 t30 -60.68 141.51 56.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.679 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.3 m -143.76 38.15 1.34 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.846 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.55 -42.25 68.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 50' ' ' LEU . 2.6 pt? -57.52 -42.41 82.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.58 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.514 HG21 ' NE ' ' A' ' 63' ' ' ARG . 55.8 p -80.19 -38.19 31.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.691 0.282 . . . . 0.0 111.351 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -63.09 132.9 53.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.333 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -126.38 127.39 45.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.552 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.513 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 75.2 t90 -67.46 149.97 49.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.512 ' SD ' HG23 ' A' ' 61' ' ' VAL . 90.4 mtp -146.04 -41.3 0.21 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.731 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 58' ' ' SER . 33.8 t -165.38 173.86 10.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.685 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.34 21.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.489 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.3 m -167.72 35.31 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.884 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -165.09 127.95 2.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.867 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.433 HD13 HD11 ' A' ' 38' ' ' LEU . 73.9 mt -150.82 125.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.158 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.512 HG23 ' SD ' ' A' ' 55' ' ' MET . 60.8 t -93.4 128.12 45.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.564 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.658 ' SG ' HD11 ' A' ' 43' ' ' ILE . 23.0 p -171.11 157.82 5.31 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.073 0.463 . . . . 0.0 111.772 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.514 ' NE ' HG21 ' A' ' 51' ' ' THR . 40.3 ptt180 -84.59 134.76 34.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.857 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.712 ' HA ' HG21 ' A' ' 43' ' ' ILE . 18.0 m . . . . . 0 CA--C 1.516 -0.352 0 CA-C-O 121.404 0.621 . . . . 0.0 111.338 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.631 ' HA3' ' HB3' ' A' ' 89' ' ' SER . . . . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -61.43 120.31 10.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.806 0.336 . . . . 0.0 111.026 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.498 ' O ' HD13 ' A' ' 75' ' ' ILE . 69.8 mt -85.99 128.67 39.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.35 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.947 HG21 ' HE3' ' A' ' 83' ' ' LYS . 37.0 mm -127.32 142.02 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.926 0.393 . . . . 0.0 111.484 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.819 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 58.4 t -140.65 122.71 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.57 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.3 m -86.48 141.75 28.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.115 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.4 p -136.08 136.01 39.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.804 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.732 ' HE2' ' HA ' ' A' ' 37' ' ' ASP . 48.3 mtmt -57.16 -46.91 82.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.0 m -68.4 -53.12 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.083 0.468 . . . . 0.0 110.258 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.74 -123.37 0.67 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.189 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.63 -140.78 2.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.325 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.947 ' HE3' HG21 ' A' ' 75' ' ' ILE . 51.1 tptt -63.31 132.42 51.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.949 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.819 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -68.11 159.48 51.34 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.946 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 74.2 p -143.37 145.67 32.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.9 p -157.14 131.51 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 0.0 111.698 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 65.3 p -79.2 -33.06 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.538 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.1 m -84.24 158.6 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.396 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.631 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 31.4 m -148.88 139.99 23.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.075 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.548 ' CD2' HG11 ' A' ' 64' ' ' VAL . 68.2 t80 -85.51 133.58 34.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.045 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.705 ' HD2' HD23 ' A' ' 93' ' ' LEU . 5.5 tmtt? -80.76 121.41 25.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.299 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.54 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 94.0 mt -84.82 109.12 17.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 110.202 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.705 HD23 ' HD2' ' A' ' 91' ' ' LYS . 50.0 mt -83.64 138.0 33.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.342 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -62.61 141.59 96.86 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.287 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo . . . . . 0 C--N 1.348 0.503 0 C-N-CA 122.729 2.286 . . . . 0.0 112.503 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.664 0.269 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.21 144.34 98.83 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.754 2.302 . . . . 0.0 112.13 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.56 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 10.3 Cg_endo -54.18 115.86 2.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.533 2.155 . . . . 0.0 112.109 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.5 tp -90.62 98.37 11.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.196 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.489 HG22 HD21 ' A' ' 31' ' ' LEU . 60.3 t -79.92 135.42 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.273 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 t -167.76 52.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.183 0.516 . . . . 0.0 111.271 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.06 137.67 4.79 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.483 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.613 HG23 ' ND2' ' A' ' 16' ' ' ASN . 14.8 tt -165.15 128.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.709 0.29 . . . . 0.0 110.624 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.807 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.3 t -66.54 -57.92 11.23 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.626 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.864 ' HG2' HG12 ' A' ' 24' ' ' VAL . 98.2 Cg_endo -91.47 110.54 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.336 2.024 . . . . 0.0 112.15 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.613 ' ND2' HG23 ' A' ' 13' ' ' ILE . 1.8 m120 -88.49 26.79 1.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.728 0.299 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 179.82 130.16 0.09 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.521 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.592 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 169.05 143.08 3.72 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.472 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.439 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.6 pt -53.14 161.31 1.34 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.434 0.159 . . . . 0.0 111.214 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.913 ' HA ' HG23 ' A' ' 64' ' ' VAL . 88.8 Cg_exo -47.79 -43.48 28.95 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.79 2.327 . . . . 0.0 113.75 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -68.56 -20.66 64.55 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.7 m -59.48 129.1 40.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 111.003 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.562 ' HB3' ' NZ ' ' A' ' 23' ' ' LYS . 6.1 ttpm? -71.56 143.34 49.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.016 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.864 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.8 m -140.27 131.03 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.99 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.1 m -90.33 87.39 6.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.431 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 43' ' ' ILE . 69.8 mt -60.77 137.3 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.572 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' A' ' 58' ' ' SER . 75.9 ttt180 -148.07 140.44 24.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.963 0.411 . . . . 0.0 111.054 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -167.07 -127.61 0.92 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.298 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -150.4 137.21 19.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.921 0.391 . . . . 0.0 111.214 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.484 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 72.4 m-80 64.82 32.49 10.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.496 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 9.2 mp -83.27 48.93 1.46 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.951 0.405 . . . . 0.0 110.607 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.58 121.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.597 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.409 HG22 ' HB2' ' A' ' 57' ' ' ALA . 81.7 p -89.54 41.02 1.02 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.729 0.299 . . . . 0.0 111.126 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.4 146.42 5.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.733 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.21 -43.18 61.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.52 2.146 . . . . 0.0 112.07 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.5 p -59.01 -40.7 85.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.775 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 78' ' ' THR . 55.6 m-20 -58.07 -32.31 67.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.671 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 41' ' ' LEU . 1.0 OUTLIER -76.91 58.09 1.42 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.34 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.9 pt -66.52 -22.49 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.915 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.13 141.94 10.66 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.426 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.585 HD13 ' N ' ' A' ' 42' ' ' THR . 2.9 tm? -149.78 130.4 14.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 46' ' ' HIS . 81.4 m -161.4 127.62 3.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 111.782 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 26' ' ' ILE . 76.9 mt -100.56 129.75 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.588 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 48.8 t 65.47 -72.74 0.07 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.249 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.7 30.77 0.12 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.427 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.647 ' O ' HG23 ' A' ' 42' ' ' THR . 84.5 t60 -131.08 128.42 40.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 110.805 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -63.1 134.5 56.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 71.4 m -152.67 39.69 0.56 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.682 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.91 -46.23 45.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.385 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.433 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.6 pt? -55.5 -37.88 68.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.221 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.6 p -79.94 -36.91 35.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.54 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.93 134.97 56.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.243 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -126.18 129.08 48.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.804 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 87.3 t90 -70.52 145.21 51.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.093 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.6 mmt -132.63 -48.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.771 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.9 m -161.74 -161.78 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.702 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB2' HG22 ' A' ' 33' ' ' THR . . . -91.97 32.86 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.253 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.621 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 83.4 p -178.77 35.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.247 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.571 ' NZ ' ' HB2' ' A' ' 59' ' ' LYS . 5.1 ttmp? -165.41 135.4 3.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.338 . . . . 0.0 111.078 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.408 HD13 HD11 ' A' ' 38' ' ' LEU . 80.6 mt -150.61 120.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.77 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 51.5 t -90.35 127.59 42.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.629 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.6 p -170.55 154.63 4.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.15 133.65 34.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.66 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.913 HG23 ' HA ' ' A' ' 20' ' ' PRO . 11.5 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.934 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 N-CA-C 113.523 0.169 . . . . 0.0 113.523 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -65.62 121.94 16.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.524 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.5 mt -97.68 131.23 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.376 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.3 mm -134.22 140.19 46.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.458 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 p -140.85 125.68 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.78 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.643 ' HA ' ' H ' ' A' ' 83' ' ' LYS . 15.9 m -90.77 139.96 30.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.724 ' H ' ' HA2' ' A' ' 82' ' ' GLY . 73.8 p -147.41 143.86 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.118 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.428 ' HG2' ' HA ' ' A' ' 37' ' ' ASP . 14.5 mmmm -54.02 -33.88 58.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.055 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.8 m -63.44 -49.41 73.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.703 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.77 -48.46 0.23 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.759 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.724 ' HA2' ' H ' ' A' ' 78' ' ' THR . . . 75.8 127.19 0.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.873 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.643 ' H ' ' HA ' ' A' ' 77' ' ' THR . 61.7 tttm 51.67 56.93 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 110.995 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.49 -138.4 0.05 OUTLIER Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.848 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.0 p -149.98 -168.2 3.04 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.723 0.297 . . . . 0.0 110.817 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.488 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 45.4 t -167.76 129.3 1.49 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.257 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 77.0 p -92.91 37.84 1.02 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.231 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.6 m -150.73 139.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.88 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.0 m -118.97 127.99 53.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.164 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 64' ' ' VAL . 44.3 t80 -89.31 124.06 34.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.979 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -85.06 91.7 8.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.12 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.879 HD21 ' HG3' ' A' ' 20' ' ' PRO . 31.6 tp -65.14 128.39 35.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.249 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.482 HD12 ' HA2' ' A' ' 18' ' ' GLY . 80.5 mt -80.41 137.0 36.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.072 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.575 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 4.8 ttmp? -64.15 134.7 96.04 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 51.9 Cg_exo . . . . . 0 C--N 1.347 0.459 0 C-N-CA 122.487 2.125 . . . . 0.0 112.57 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.605 0.241 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.91 139.66 80.79 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.552 2.168 . . . . 0.0 112.234 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 17.3 Cg_endo -58.16 123.2 13.11 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.58 2.187 . . . . 0.0 112.168 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 9' ' ' LEU . 3.0 tm? -94.17 122.0 36.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.553 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 62.1 t -99.6 140.53 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -166.99 50.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 111.348 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.71 140.53 5.74 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.695 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.513 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.3 tt -164.42 131.18 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.722 0.296 . . . . 0.0 110.507 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.835 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.8 t -66.39 -59.13 8.88 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.931 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.837 ' HG2' HG12 ' A' ' 24' ' ' VAL . 88.7 Cg_endo -96.08 119.87 0.21 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.652 2.235 . . . . 0.0 112.137 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -94.69 29.51 2.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 110.713 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.47 ' HB2' HD21 ' A' ' 93' ' ' LEU . 12.2 pt-20 179.06 133.78 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.602 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.461 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 167.07 146.95 5.07 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.947 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.465 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 37.2 pt -55.78 159.24 5.46 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 110.736 -0.098 . . . . 0.0 110.736 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.799 ' HA ' HG23 ' A' ' 64' ' ' VAL . 3.7 Cg_endo -48.25 -41.9 34.22 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.708 2.272 . . . . 0.0 113.22 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -67.87 -23.06 65.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.7 m -54.43 127.98 29.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.042 0.449 . . . . 0.0 111.659 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.412 ' HE3' ' CG1' ' A' ' 61' ' ' VAL . 86.8 tttt -73.04 140.2 47.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.445 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.837 HG12 ' HG2' ' A' ' 15' ' ' PRO . 30.3 m -141.69 132.91 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.908 0.385 . . . . 0.0 111.362 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.0 m -87.61 118.55 27.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.528 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.46 HD11 ' SG ' ' A' ' 62' ' ' CYS . 63.5 mt -80.34 140.41 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.032 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -141.38 135.63 30.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.682 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.24 -134.7 2.0 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.662 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -149.14 136.66 20.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 111.282 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.0 m-20 63.28 36.4 11.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.33 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 mp -82.6 61.04 5.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.944 0.402 . . . . 0.0 110.503 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.96 121.27 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.124 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.3 p -92.18 33.67 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.817 0.341 . . . . 0.0 111.244 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.8 149.95 5.93 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.498 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.15 -45.04 41.71 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.525 2.15 . . . . 0.0 111.876 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 t -64.19 -38.14 89.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.231 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 56.7 m-20 -54.61 -54.24 44.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.756 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.476 ' C ' HD13 ' A' ' 38' ' ' LEU . 3.2 tm? -60.99 127.15 30.17 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.586 HG21 ' HD3' ' A' ' 79' ' ' LYS . 41.9 pt -138.31 -25.81 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.694 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.85 142.26 13.35 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.133 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.644 HD13 ' N ' ' A' ' 42' ' ' THR . 1.8 tm? -149.57 131.61 15.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.674 HG22 ' HA ' ' A' ' 47' ' ' ASN . 3.4 p -151.66 146.43 25.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.161 0.505 . . . . 0.0 111.623 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 64' ' ' VAL . 80.5 mt -137.53 123.41 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.683 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.419 ' SG ' ' HA2' ' A' ' 72' ' ' GLY . 80.0 m 57.41 39.54 28.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.259 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.18 -31.29 1.82 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.549 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -73.5 131.09 41.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.829 0.347 . . . . 0.0 111.278 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.674 ' HA ' HG22 ' A' ' 42' ' ' THR . 5.4 m120 -72.35 140.36 48.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.5 m -150.71 39.86 0.72 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.772 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 tp -70.97 -42.57 69.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.364 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -51.13 -43.16 61.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.446 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.421 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 60.0 p -80.31 -32.1 38.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.327 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -56.4 131.27 47.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.774 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -127.12 131.96 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.198 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.436 ' CH2' ' HA ' ' A' ' 56' ' ' SER . 65.2 t90 -72.1 146.77 47.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.355 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.516 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 22.1 mmt -133.82 -50.24 0.83 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.066 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.436 ' HA ' ' CH2' ' A' ' 54' ' ' TRP . 78.0 p -169.18 -156.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.703 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -96.01 30.98 2.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.147 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.7 p -178.76 31.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.057 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 55' ' ' MET . 63.0 tttm -165.05 128.39 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.413 ' HB ' HD12 ' A' ' 26' ' ' ILE . 63.8 mt -151.66 114.6 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.882 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.412 ' CG1' ' HE3' ' A' ' 23' ' ' LYS . 90.7 t -80.3 131.87 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.084 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.491 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.4 p -169.08 155.02 6.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.992 0.425 . . . . 0.0 111.405 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -83.99 126.22 32.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.288 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 20' ' ' PRO . 5.2 m . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.077 0.465 . . . . 0.0 111.103 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.453 -0.212 0 N-CA-C 112.406 -0.277 . . . . 0.0 112.406 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.28 137.27 38.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.702 0.287 . . . . 0.0 111.055 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.07 127.78 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.227 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.5 mm -128.1 138.41 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.899 0.381 . . . . 0.0 111.304 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -139.8 119.06 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.678 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 58.2 m -89.07 130.01 35.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.532 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 64.4 p -107.83 143.48 36.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.615 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.586 ' HD3' HG21 ' A' ' 39' ' ' ILE . 53.1 tptt -56.32 -43.79 79.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 110.369 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 87.2 p -73.06 -56.83 4.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.65 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.2 -125.42 2.02 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.587 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' THR . . . -160.54 -139.63 2.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.398 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.527 ' HB3' ' NZ ' ' A' ' 83' ' ' LYS . 9.0 mtpm? -64.34 126.06 26.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.897 0.379 . . . . 0.0 111.343 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.9 143.42 25.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.403 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.2 p -98.63 139.2 34.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.678 0.275 . . . . 0.0 110.995 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.546 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 63.5 p -136.26 132.27 35.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.418 . . . . 0.0 111.299 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -81.04 -32.16 34.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.922 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.6 m -84.18 176.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.322 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.5 m -156.88 138.11 13.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.644 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.511 ' CE2' HG21 ' A' ' 64' ' ' VAL . 52.3 t80 -88.85 132.48 34.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.431 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -91.99 122.3 34.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.276 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.428 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.7 mm? -84.49 127.02 33.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.948 0.404 . . . . 0.0 111.168 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 17' ' ' GLU . 77.9 mt -91.38 138.27 31.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.709 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.591 ' NZ ' ' HB3' ' A' ' 94' ' ' LYS . 3.3 mmmp? -59.21 129.84 86.65 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.546 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.52 2.147 . . . . 0.0 112.56 -179.714 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.505 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 4.8 tp60 . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.505 ' HD2' ' OE1' ' A' ' 6' ' ' GLN . 61.9 Cg_exo -52.01 146.32 30.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.427 2.084 . . . . 0.0 112.222 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 51.2 Cg_exo -54.91 129.46 35.38 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.52 2.147 . . . . 0.0 112.244 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 85' ' ' THR . 59.6 tp -114.92 109.29 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.63 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.56 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 61.2 t -74.76 129.72 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.743 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.6 p -148.32 46.3 1.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.096 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.18 141.56 4.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.201 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.445 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.7 tt -164.66 129.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.714 0.292 . . . . 0.0 110.304 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.804 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.8 t -66.12 -58.64 10.33 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.167 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.804 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 90.2 Cg_endo -88.88 124.23 1.51 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.121 1.881 . . . . 0.0 112.881 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.81 26.28 6.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.072 0.463 . . . . 0.0 110.125 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.636 ' HB2' HD11 ' A' ' 93' ' ' LEU . 23.7 pt-20 177.66 131.8 0.06 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.585 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 169.06 141.58 3.26 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.006 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.473 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 37.6 pt -57.44 162.85 4.05 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 122.066 0.146 . . . . 0.0 111.012 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.954 ' HA ' HG23 ' A' ' 64' ' ' VAL . 83.2 Cg_exo -48.19 -39.56 34.34 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.658 2.238 . . . . 0.0 113.311 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.52 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 89.9 m95 -70.53 -24.45 62.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -57.64 128.95 39.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 111.279 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -73.87 137.49 43.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.635 HG12 ' HG2' ' A' ' 15' ' ' PRO . 27.0 m -134.7 132.52 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.03 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.4 m -87.35 113.56 23.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.71 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 77.8 mt -75.22 139.45 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.955 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.602 ' HD2' ' O ' ' A' ' 58' ' ' SER . 27.4 tpt180 -147.25 133.15 19.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.291 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.14 -132.77 1.48 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.634 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 51.7 mt-10 -147.26 134.84 20.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 111.341 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.461 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 75.7 m-20 61.0 41.08 14.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.548 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 58' ' ' SER . 10.0 mp -83.08 46.86 1.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.031 0.443 . . . . 0.0 110.389 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.35 121.8 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.462 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.505 HG22 ' HB2' ' A' ' 57' ' ' ALA . 80.1 p -87.56 39.08 0.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.835 0.35 . . . . 0.0 111.182 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.03 146.25 5.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.445 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.38 -40.94 81.31 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.603 2.202 . . . . 0.0 112.024 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.2 p -59.91 -40.23 88.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.183 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -58.16 -45.08 88.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.583 HD11 HD13 ' A' ' 60' ' ' ILE . 1.5 tt -61.29 133.93 56.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.81 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.527 ' N ' HD23 ' A' ' 38' ' ' LEU . 26.5 pt -142.84 -44.54 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -102.9 136.05 12.64 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.677 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 42' ' ' THR . 1.7 tm? -149.23 128.17 12.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.607 ' N ' HD13 ' A' ' 41' ' ' LEU . 95.7 m -161.41 135.93 7.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.229 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.4 mt -129.87 130.45 66.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.373 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 63.5 m 56.13 40.64 30.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.631 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.28 29.04 73.29 Favored Glycine 0 CA--C 1.518 0.229 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.878 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.451 ' C ' HG23 ' A' ' 42' ' ' THR . 81.9 t60 -130.92 131.42 44.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.73 0.3 . . . . 0.0 110.871 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.552 HD22 ' N ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -66.32 132.86 49.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.632 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.552 ' N ' HD22 ' A' ' 47' ' ' ASN . 72.2 m -152.36 38.42 0.56 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.982 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.25 -42.44 59.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.26 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -53.83 -40.74 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.65 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.727 HG21 ' NE ' ' A' ' 63' ' ' ARG . 62.4 p -79.76 -35.04 39.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.598 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.532 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -54.4 135.01 45.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.633 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.65 132.85 51.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.662 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -70.41 151.79 44.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.059 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.6 mmt -142.95 -44.3 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.924 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.5 p -166.05 -166.09 0.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.749 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 33' ' ' THR . . . -88.02 30.63 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.266 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.602 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 79.0 p 179.04 37.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.031 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.9 ttmt -164.76 131.82 3.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.983 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.583 HD13 HD11 ' A' ' 38' ' ' LEU . 72.4 mt -150.72 115.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.4 t -79.93 130.39 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.272 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 53.7 t -170.35 151.9 3.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.025 0.44 . . . . 0.0 111.432 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.727 ' NE ' HG21 ' A' ' 51' ' ' THR . 39.3 ptt180 -84.05 130.02 34.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.201 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.954 HG23 ' HA ' ' A' ' 20' ' ' PRO . 4.9 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 111.61 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.23 0 N-CA-C 112.358 -0.297 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.13 134.74 35.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.741 0.305 . . . . 0.0 111.015 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.448 ' O ' HD13 ' A' ' 75' ' ' ILE . 67.6 mt -85.67 131.75 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.33 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 84' ' ' GLY . 50.5 mm -134.08 135.9 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 0.0 111.359 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.728 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 99.6 t -141.56 116.98 5.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.811 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.4 m -82.07 146.19 29.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.3 p -141.54 139.85 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.17 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.513 ' HD2' HD13 ' A' ' 39' ' ' ILE . 32.1 mmmt -57.1 -51.09 70.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.7 t -65.69 -53.48 40.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.004 0.431 . . . . 0.0 110.544 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.77 -123.06 0.26 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.238 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.55 -139.11 2.58 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.188 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.84 131.97 48.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.616 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.728 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -62.41 152.95 43.9 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.691 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 63.0 p -147.93 142.61 26.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.711 0.291 . . . . 0.0 110.713 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.533 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 42.7 t -160.81 128.16 4.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.948 0.404 . . . . 0.0 111.319 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -74.57 -30.42 61.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.447 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.0 m -83.79 152.84 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.238 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 m -138.84 141.27 38.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.822 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.526 ' CD2' HG11 ' A' ' 64' ' ' VAL . 41.7 t80 -85.9 127.7 34.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.324 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -82.69 88.24 6.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.243 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.784 HD21 ' HG3' ' A' ' 20' ' ' PRO . 35.4 tp -64.6 127.27 30.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 17' ' ' GLU . 81.2 mt -92.19 136.17 33.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.218 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -72.16 130.6 86.15 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.693 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo . . . . . 0 C--N 1.346 0.421 0 C-N-CA 122.643 2.229 . . . . 0.0 112.957 -179.695 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.473 0.178 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.34 136.42 63.86 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.482 2.121 . . . . 0.0 112.156 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 50.2 Cg_exo -53.92 134.23 58.44 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.492 2.128 . . . . 0.0 112.091 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.672 HD13 ' N ' ' A' ' 10' ' ' VAL . 1.3 tm? -119.71 130.44 55.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.497 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.672 ' N ' HD13 ' A' ' 9' ' ' LEU . 90.5 t -101.92 137.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.744 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.52 HG23 HD12 ' A' ' 9' ' ' LEU . 39.6 p -151.38 48.3 0.82 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.197 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.15 144.81 6.36 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.021 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.442 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.6 tt -164.8 130.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 110.722 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.831 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -67.33 -59.62 6.98 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.672 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.831 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 83.0 Cg_endo -89.52 125.1 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.06 1.84 . . . . 0.0 112.421 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -86.02 -18.62 32.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.623 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HB2' HD11 ' A' ' 93' ' ' LEU . 11.3 pt-20 -156.15 138.46 14.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.238 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.539 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 175.8 148.71 7.03 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.561 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.448 HG12 ' OG1' ' A' ' 22' ' ' THR . 40.6 pt -51.82 157.51 1.97 Allowed Pre-proline 0 CA--C 1.531 0.25 0 CA-C-O 120.573 0.225 . . . . 0.0 111.065 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.691 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 84.8 Cg_exo -47.6 -37.5 26.92 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.713 2.276 . . . . 0.0 113.41 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -76.81 -22.4 53.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 64' ' ' VAL . 96.1 m -52.01 130.88 30.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.796 0.331 . . . . 0.0 111.093 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -65.26 139.05 58.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.682 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.1 m -141.2 125.64 17.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.6 m -93.46 116.71 29.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 55.7 mt -76.54 138.47 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.702 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 10' ' ' VAL . 43.2 mmm-85 -140.39 130.39 24.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.301 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.36 -133.85 1.65 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.629 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -147.61 132.63 18.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.799 0.333 . . . . 0.0 111.111 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 57.5 41.25 26.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.333 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.563 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.5 mp -70.35 -36.22 74.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.733 0.301 . . . . 0.0 110.68 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.86 130.93 1.62 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.559 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.415 ' OG1' ' HB2' ' A' ' 37' ' ' ASP . 81.8 p -65.24 -39.31 92.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.731 0.301 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.467 ' HA2' ' CZ2' ' A' ' 54' ' ' TRP . . . -164.52 -161.18 13.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.778 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.56 -49.25 7.61 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.723 2.282 . . . . 0.0 112.64 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.5 p -62.93 -38.84 92.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.53 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.415 ' HB2' ' OG1' ' A' ' 33' ' ' THR . 8.3 t70 -55.75 -51.67 66.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.18 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.4 tt -70.2 134.27 47.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.552 ' N ' HD23 ' A' ' 38' ' ' LEU . 43.1 pt -145.2 -37.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.195 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.46 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -113.69 142.68 17.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.813 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 42' ' ' THR . 1.1 tm? -149.57 130.78 14.55 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.621 ' N ' HD13 ' A' ' 41' ' ' LEU . 18.5 p -151.88 145.99 25.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.147 0.498 . . . . 0.0 111.888 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 69.8 mt -134.77 118.9 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.238 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.477 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 65.0 m 74.91 -38.01 0.37 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.523 0.514 . . . . 0.0 110.53 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.79 -36.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.104 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -77.19 131.07 38.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 110.853 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.606 ' HA ' HG22 ' A' ' 42' ' ' THR . 14.9 p-10 -74.86 144.91 43.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.894 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.9 m -146.77 43.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.535 ' O ' HD13 ' A' ' 49' ' ' LEU . 2.3 tm? -66.15 -45.99 79.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.709 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.4 pt? -49.19 -41.78 37.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.588 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.6 p -80.54 -35.42 34.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.408 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.28 134.93 56.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.845 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -127.1 134.37 50.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.63 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.467 ' CZ2' ' HA2' ' A' ' 34' ' ' GLY . 81.7 t90 -73.42 152.98 40.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.4 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.6 mmt -145.64 -46.25 0.21 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.777 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.9 t -171.25 177.26 3.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.679 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.13 35.53 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.607 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.1 p -179.31 30.63 0.0 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.868 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.6 ttmt -165.38 133.09 3.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.894 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.8 mt -151.34 113.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.845 0.355 . . . . 0.0 111.044 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.6 t -82.15 130.72 35.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.182 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.574 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.1 p -170.51 153.56 4.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.754 0.312 . . . . 0.0 111.483 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -84.06 136.57 33.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.882 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.691 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 2.5 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.183 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 44' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.419 0 N-CA-C 112.658 -0.177 . . . . 0.0 112.658 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -63.8 132.16 50.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.804 0.335 . . . . 0.0 111.014 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.517 ' O ' HD13 ' A' ' 75' ' ' ILE . 67.9 mt -85.46 129.0 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.533 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 74' ' ' ILE . 41.5 mm -132.76 142.09 43.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.266 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.686 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 6.6 p -141.31 122.52 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.94 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.7 m -87.22 147.7 25.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.37 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.1 p -140.7 140.83 34.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.805 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.548 ' HD2' HD13 ' A' ' 39' ' ' ILE . 14.3 mmmm -51.49 -48.75 62.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 82.2 p -68.98 -46.19 68.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.94 -129.52 0.05 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.885 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.03 -39.29 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.052 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -168.38 129.51 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.686 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -67.67 154.22 52.98 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.204 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 63.3 p -144.22 140.0 29.03 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.608 ' OG ' HG22 ' A' ' 88' ' ' VAL . 42.9 t -154.06 136.41 14.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.99 0.424 . . . . 0.0 111.832 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.9 p -92.71 37.33 1.01 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.173 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.608 HG22 ' OG ' ' A' ' 86' ' ' SER . 33.4 m -148.45 146.61 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.9 m -135.11 136.2 41.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.006 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -86.01 133.84 33.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.557 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -85.24 125.51 32.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.494 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.451 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.5 mm? -85.33 133.88 34.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.843 0.354 . . . . 0.0 111.29 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.539 HD12 ' HA2' ' A' ' 18' ' ' GLY . 80.0 mt -108.16 134.22 51.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.614 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -65.52 124.28 86.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.659 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo . . . . . 0 C--N 1.349 0.588 0 C-N-CA 122.321 2.014 . . . . 0.0 112.356 179.959 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.618 0.247 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HB2' ' HA2' ' A' ' 84' ' ' GLY . 28.9 Cg_endo -62.62 142.93 91.56 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.478 2.119 . . . . 0.0 112.085 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 15.7 Cg_endo -57.32 137.96 84.02 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.614 2.209 . . . . 0.0 112.38 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.488 ' CD1' HG23 ' A' ' 11' ' ' THR . 2.4 tm? -124.88 124.22 41.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.284 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.498 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 68.3 t -86.93 136.88 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.088 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.488 HG23 ' CD1' ' A' ' 9' ' ' LEU . 23.3 p -152.52 45.48 0.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.872 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.67 144.17 6.48 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.206 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.483 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.1 tt -161.16 128.85 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.684 0.278 . . . . 0.0 110.489 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.621 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.6 t -61.96 -57.74 22.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.489 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 85.7 Cg_endo -75.95 -156.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.84 1.693 . . . . 0.0 111.804 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -168.96 -30.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.457 . . . . 0.0 110.34 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HB2' HD21 ' A' ' 93' ' ' LEU . 11.6 pt-20 -153.4 130.87 11.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.285 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.449 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 177.03 152.32 9.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.846 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.446 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 35.6 pt -52.22 162.73 0.81 Allowed Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 122.338 0.255 . . . . 0.0 111.461 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.637 ' HA ' HG23 ' A' ' 64' ' ' VAL . 86.6 Cg_exo -49.84 -43.92 38.82 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.957 2.438 . . . . 0.0 113.942 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.37 -5.57 29.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.2 m -67.93 127.81 34.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.757 0.313 . . . . 0.0 111.121 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HD2' HG13 ' A' ' 61' ' ' VAL . 39.7 ttpt -72.53 138.62 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.36 179.483 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.613 HG12 ' HG3' ' A' ' 15' ' ' PRO . 34.6 m -136.03 127.04 43.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 111.337 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.9 m -87.14 125.46 34.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.275 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 58.8 mt -85.96 139.19 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.909 179.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.486 ' O ' HG13 ' A' ' 10' ' ' VAL . 44.0 mmm-85 -143.13 130.78 21.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.268 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.59 -131.52 1.33 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.598 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -143.69 134.43 25.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.952 0.406 . . . . 0.0 111.698 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.6 m-80 59.88 43.5 14.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.664 178.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.575 HD22 ' O ' ' A' ' 58' ' ' SER . 9.1 mp -83.42 51.09 1.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.947 0.403 . . . . 0.0 110.39 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.13 124.8 0.34 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.532 -179.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.7 p -87.58 38.84 0.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 111.343 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 166.75 146.43 4.85 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.626 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.22 -45.77 32.9 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.639 2.226 . . . . 0.0 112.049 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 p -60.59 -37.82 82.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.873 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' A' ' 79' ' ' LYS . 39.1 t70 -58.2 -41.88 84.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.075 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.467 HD11 HD13 ' A' ' 60' ' ' ILE . 1.8 tt -66.62 75.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.138 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.508 HG21 ' HD3' ' A' ' 79' ' ' LYS . 34.8 pt -76.59 -40.63 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.183 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.437 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -121.76 142.73 15.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.412 -179.018 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.591 HD13 ' N ' ' A' ' 42' ' ' THR . 3.3 tm? -150.0 132.96 16.14 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.591 ' N ' HD13 ' A' ' 41' ' ' LEU . 60.9 p -147.52 127.52 13.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.903 0.383 . . . . 0.0 111.837 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.875 HG21 HG12 ' A' ' 64' ' ' VAL . 72.7 mt -108.19 124.86 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.022 178.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 67.4 m 54.54 41.25 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.021 0.439 . . . . 0.0 110.459 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.57 34.38 89.75 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.747 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -131.31 132.01 44.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.594 0.235 . . . . 0.0 110.538 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.42 ' HA ' HG22 ' A' ' 42' ' ' THR . 22.6 t-20 -63.3 131.05 47.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.714 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.0 m -154.46 37.58 0.43 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 49' ' ' LEU . 2.2 tm? -72.77 -45.6 57.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 110.32 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 50' ' ' LEU . 2.5 pt? -55.74 -40.22 72.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.167 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.0 p -80.05 -37.47 33.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.992 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.581 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.61 133.9 56.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.351 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.92 131.91 51.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.759 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -69.9 151.55 45.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.958 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.0 mmt -142.07 -44.99 0.34 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.02 179.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.6 p -163.34 -164.95 0.99 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.662 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.45 35.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.575 ' O ' HD22 ' A' ' 31' ' ' LEU . 80.8 p -178.96 -43.37 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.364 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -77.63 133.31 38.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.494 -179.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.467 HD13 HD11 ' A' ' 38' ' ' LEU . 68.6 mt -151.33 111.81 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.387 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.411 HG13 ' HD2' ' A' ' 23' ' ' LYS . 60.5 t -80.23 125.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.627 ' SG ' HD11 ' A' ' 43' ' ' ILE . 29.0 p -170.72 131.57 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -87.82 140.4 29.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.875 HG12 HG21 ' A' ' 43' ' ' ILE . 33.4 m . . . . . 0 CA--C 1.534 0.343 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.629 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.333 -0.307 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.32 135.85 42.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.773 0.32 . . . . 0.0 110.821 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.2 mt -85.67 92.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.176 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.475 ' N ' HD12 ' A' ' 75' ' ' ILE . 1.9 mp -86.67 139.66 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.172 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.559 HG23 HD23 ' A' ' 41' ' ' LEU . 7.5 p -141.36 125.46 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.813 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.4 m -95.95 144.14 26.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.406 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.9 p -126.48 141.02 52.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.876 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.508 ' HD3' HG21 ' A' ' 39' ' ' ILE . 23.5 tptm -56.98 -48.93 77.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.899 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -67.66 -55.35 13.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.53 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.39 -124.71 0.69 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.178 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.51 -143.32 3.78 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.099 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.75 117.94 13.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 110.58 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 7' ' ' PRO . . . -92.3 -149.92 25.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.522 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.8 p -155.22 -169.21 3.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.66 0.267 . . . . 0.0 110.542 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.0 p -170.85 128.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.913 0.387 . . . . 0.0 111.319 179.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.5 p -76.27 -34.28 59.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.37 178.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 m -84.66 146.32 6.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.345 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -134.96 134.62 40.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.714 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -89.33 136.67 32.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.664 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -102.55 123.28 46.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.442 179.224 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 92' ' ' LEU . 6.4 mp -85.28 132.08 34.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 0.0 111.4 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 17' ' ' GLU . 84.2 mt -90.67 138.09 31.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.242 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 37.6 mtmm -67.45 135.41 93.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.368 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 44.1 Cg_exo . . . . . 0 C--N 1.344 0.29 0 C-N-CA 122.394 2.063 . . . . 0.0 112.151 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.709 0.29 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.39 138.53 39.23 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.522 2.148 . . . . 0.0 112.13 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 16.9 Cg_endo -58.31 127.73 25.89 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.48 2.12 . . . . 0.0 112.066 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 85' ' ' THR . 64.4 tp -109.91 117.38 33.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.107 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.58 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 89.7 t -83.22 131.31 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.776 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.8 p -149.04 47.9 0.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.032 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.04 147.51 8.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.178 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.577 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.8 tt -161.18 130.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.587 0.232 . . . . 0.0 110.655 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.855 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 44.3 t -63.51 -59.26 12.29 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.31 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.968 ' HG2' HG12 ' A' ' 24' ' ' VAL . 7.3 Cg_exo -71.29 -147.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.93 1.754 . . . . 0.0 111.748 179.032 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -176.4 -25.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.945 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -162.69 129.49 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.129 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 177.48 155.07 13.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.728 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.0 pt -51.14 159.75 0.99 Allowed Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.692 0.282 . . . . 0.0 111.382 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.6 ' HA ' HG23 ' A' ' 64' ' ' VAL . 86.5 Cg_exo -48.28 -48.28 17.33 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.978 2.452 . . . . 0.0 113.96 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -65.85 -5.69 9.82 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.4 m -67.28 126.17 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 111.071 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.625 ' HA ' ' HG2' ' A' ' 63' ' ' ARG . 6.1 ttpm? -71.41 133.19 45.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.618 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.968 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.4 m -131.79 126.1 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 111.007 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.2 m -83.73 125.55 32.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.25 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 60' ' ' ILE . 48.7 mt -82.12 139.21 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.835 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 10' ' ' VAL . 23.2 mmm180 -146.51 132.95 19.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.312 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.21 -130.47 1.2 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.391 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -147.31 132.98 18.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 71.5 m-80 61.07 42.55 12.34 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.615 178.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 58' ' ' SER . 8.9 mp -83.13 49.06 1.47 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.939 0.399 . . . . 0.0 110.664 178.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.3 122.73 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.558 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -91.74 42.44 1.1 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.921 0.391 . . . . 0.0 111.177 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.53 146.44 5.52 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.711 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.9 -42.92 62.61 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.588 2.192 . . . . 0.0 111.901 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.3 p -61.96 -32.65 73.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.995 179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -77.84 45.73 0.53 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.048 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.465 HD21 HD23 ' A' ' 41' ' ' LEU . 1.3 tt -162.1 55.44 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.131 0.491 . . . . 0.0 110.005 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.0 pt -66.54 -37.86 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.323 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.41 138.95 15.34 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.9 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.645 HD13 ' N ' ' A' ' 42' ' ' THR . 2.9 tm? -148.42 134.06 18.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.786 0.327 . . . . 0.0 110.134 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.645 ' N ' HD13 ' A' ' 41' ' ' LEU . 19.4 p -147.13 147.16 30.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.463 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.655 HG21 HG12 ' A' ' 64' ' ' VAL . 75.0 mt -128.8 116.19 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.788 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 69.1 m 70.68 -30.46 0.2 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.982 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.38 -44.18 0.31 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.621 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -80.45 139.48 36.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.856 0.36 . . . . 0.0 111.237 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.442 ' HA ' HG22 ' A' ' 42' ' ' THR . 5.3 m120 -60.85 143.53 54.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.965 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.8 m -145.5 39.09 1.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.599 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.6 tp -70.94 -43.4 68.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.136 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 50' ' ' LEU . 2.6 pt? -55.91 -41.24 74.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.157 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.3 p -79.87 -34.34 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.793 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 61' ' ' VAL . . . -58.48 134.17 56.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.285 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -126.27 122.06 34.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.389 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -70.81 147.15 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 56.3 mtt -149.22 -41.36 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.15 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.6 p -157.47 175.18 14.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.69 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.75 42.03 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.358 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.506 ' O ' HD22 ' A' ' 31' ' ' LEU . 43.8 t -175.93 -40.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.077 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -85.53 133.23 34.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.231 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 74.9 mt -150.72 115.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.648 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 64.3 t -82.01 124.15 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.947 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.653 ' SG ' HD11 ' A' ' 43' ' ' ILE . 22.6 p -171.19 132.01 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.917 0.389 . . . . 0.0 111.26 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.625 ' HG2' ' HA ' ' A' ' 23' ' ' LYS . 98.3 mtt180 -85.93 140.68 30.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.139 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.655 HG12 HG21 ' A' ' 43' ' ' ILE . 34.6 m . . . . . 0 CA--C 1.535 0.372 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.547 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.896 -0.082 . . . . 0.0 112.896 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.8 127.87 34.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.694 0.283 . . . . 0.0 110.856 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.465 ' O ' HD13 ' A' ' 75' ' ' ILE . 65.2 mt -85.81 135.68 24.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.689 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 74' ' ' ILE . 50.4 mm -134.16 139.65 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 111.153 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.6 122.81 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.72 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.7 m -92.02 143.37 26.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.298 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.9 p -134.41 136.56 43.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.056 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -57.61 -47.67 81.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.182 -179.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 88.5 p -64.73 -54.8 25.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.658 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.7 -123.21 1.57 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.421 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.8 -139.03 2.54 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.996 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.576 ' NZ ' ' HB2' ' A' ' 83' ' ' LYS . 4.8 ttmp? -62.45 126.57 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 110.794 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.74 134.69 13.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.802 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 79.8 p -99.31 145.54 27.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.553 0.215 . . . . 0.0 110.684 179.498 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.0 p -141.8 122.05 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.333 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.6 p -93.08 32.97 1.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.399 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.0 m -150.94 150.79 13.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.605 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.0 p -142.99 134.85 26.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.966 0.412 . . . . 0.0 111.217 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.5 ' HD2' HG11 ' A' ' 64' ' ' VAL . 60.1 t80 -85.67 128.16 34.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.817 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -85.0 121.03 27.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.562 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 92' ' ' LEU . 6.8 mp -89.98 128.16 36.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.864 0.364 . . . . 0.0 111.293 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.425 HD12 ' HA2' ' A' ' 18' ' ' GLY . 82.7 mt -85.51 141.51 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.735 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.41 ' HD3' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.06 134.42 95.79 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.876 179.848 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--N 1.347 0.492 0 C-N-CA 122.528 2.152 . . . . 0.0 112.555 -179.926 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.631 0.253 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.91 143.93 74.83 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.526 2.15 . . . . 0.0 111.99 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.497 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 67.4 Cg_exo -50.7 142.49 31.82 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.584 2.189 . . . . 0.0 112.43 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 85' ' ' THR . 63.2 tp -142.9 98.39 3.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.871 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.566 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 59.6 t -73.01 134.09 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.018 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.6 p -148.88 44.67 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.994 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.81 142.77 5.31 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.776 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.515 HG12 ' HD2' ' A' ' 15' ' ' PRO . 18.1 tt -164.67 131.33 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.743 0.306 . . . . 0.0 110.931 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.796 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -68.05 -58.28 8.03 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.855 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.819 ' HG2' HG12 ' A' ' 24' ' ' VAL . 92.0 Cg_endo -92.18 123.8 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.329 2.019 . . . . 0.0 112.262 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -81.72 -20.66 38.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 91' ' ' LYS . 11.0 pt-20 -157.48 138.71 13.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 111.409 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.454 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 178.45 151.76 9.76 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.419 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.517 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 38.4 pt -52.14 163.66 0.68 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.671 0.236 . . . . 0.0 111.15 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.727 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 76.4 Cg_exo -49.08 -47.0 23.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.533 2.155 . . . . 0.0 113.944 -178.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -72.68 -14.65 61.62 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.423 ' OG1' HG12 ' A' ' 19' ' ' ILE . 99.8 m -55.11 122.52 11.17 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.599 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -61.0 136.44 58.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.578 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.819 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.8 m -137.01 122.12 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.099 0.476 . . . . 0.0 111.129 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.0 m -83.84 113.5 20.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.523 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.611 HD12 ' HB ' ' A' ' 60' ' ' ILE . 62.9 mt -79.13 138.61 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.053 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.436 ' O ' HG13 ' A' ' 10' ' ' VAL . 20.6 mmt85 -144.92 129.44 17.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.276 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.62 -134.93 1.83 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.617 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 5.6 mm-40 -150.31 133.79 16.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.915 0.388 . . . . 0.0 111.422 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 57.87 41.9 24.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.069 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.497 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.6 mp -67.52 -38.51 84.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.74 0.305 . . . . 0.0 110.879 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.04 132.64 1.99 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.699 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.0 p -62.12 -35.69 79.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.44 172.48 39.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.375 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.47 -44.59 45.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.605 2.204 . . . . 0.0 112.273 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.8 p -62.74 -39.27 93.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.092 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.536 ' HA ' ' HD3' ' A' ' 79' ' ' LYS . 8.0 t70 -57.66 -40.63 79.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.034 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 tt -75.28 66.75 1.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.265 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.416 ' O ' HD22 ' A' ' 49' ' ' LEU . 36.3 pt -73.27 -33.71 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.96 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -126.3 140.54 12.14 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.531 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 48' ' ' CYS . 53.9 tp -148.72 144.17 26.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.731 0.301 . . . . 0.0 110.57 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 41' ' ' LEU . 11.5 p -161.33 142.15 11.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.286 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.455 HG13 ' SG ' ' A' ' 48' ' ' CYS . 63.9 mt -127.12 115.51 41.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.72 178.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 48.2 t 74.04 -35.79 0.32 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.695 -178.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.97 -36.15 0.28 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.509 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -77.69 139.82 39.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.899 0.381 . . . . 0.0 111.558 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -66.73 151.92 46.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.962 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.567 ' O ' HD23 ' A' ' 41' ' ' LEU . 3.0 p -159.66 45.11 0.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.367 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 39' ' ' ILE . 52.9 tp -88.34 -46.24 9.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.568 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -54.8 -39.76 68.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.871 -179.025 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.3 p -80.25 -38.15 31.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.789 0.328 . . . . 0.0 111.681 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.565 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -60.01 135.99 57.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.016 0.436 . . . . 0.0 111.709 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -123.13 127.85 49.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.591 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 66.4 t90 -69.29 146.09 52.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.473 ' SD ' HG23 ' A' ' 61' ' ' VAL . 87.5 mtp -143.44 -42.23 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.702 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.492 ' C ' ' H ' ' A' ' 58' ' ' SER . 81.2 p -167.11 164.31 15.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.301 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.93 27.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.497 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.8 m -167.33 27.27 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.816 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.5 ttmt -164.92 130.14 2.64 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.926 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.611 ' HB ' HD12 ' A' ' 26' ' ' ILE . 72.4 mt -151.16 118.84 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.473 HG23 ' SD ' ' A' ' 55' ' ' MET . 92.2 t -90.15 129.22 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.003 179.053 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 30.2 p -170.54 151.5 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.322 . . . . 0.0 111.492 -179.144 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.2 134.44 34.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.275 179.136 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.727 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.759 -179.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.217 -0.353 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -161.46 127.8 3.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.861 0.362 . . . . 0.0 110.604 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.53 92.54 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.02 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.3 mm -84.18 139.36 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.742 -179.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 41' ' ' LEU . 46.0 t -141.31 114.3 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.856 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.1 m -81.31 144.3 31.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.913 0.387 . . . . 0.0 111.526 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.2 p -136.8 135.07 37.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.69 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.536 ' HD3' ' HA ' ' A' ' 37' ' ' ASP . 28.3 mtpp -52.74 -47.19 67.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.855 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.8 m -68.33 -48.54 64.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.055 0.455 . . . . 0.0 110.112 179.103 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.27 -121.96 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.542 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.58 -33.9 0.04 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.4 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -168.89 125.07 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 0.0 110.556 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.09 130.61 9.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.93 -0.653 . . . . 0.0 113.132 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 75.7 p -100.99 147.17 26.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.574 0.226 . . . . 0.0 110.767 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.2 p -149.95 126.96 11.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.051 0.453 . . . . 0.0 111.37 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.7 p -78.85 -30.33 45.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.017 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.8 m -83.68 141.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.212 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.7 m -121.69 142.98 49.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.478 ' CE2' HG21 ' A' ' 64' ' ' VAL . 63.1 t80 -97.91 106.98 19.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.234 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 57.4 tttm -70.31 117.41 11.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.215 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.51 HD11 ' CD ' ' A' ' 20' ' ' PRO . 45.4 tp -80.62 132.39 35.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.742 -178.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.415 HD11 ' HG3' ' A' ' 17' ' ' GLU . 84.0 mt -102.78 131.69 49.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.189 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 60.2 mttp -73.1 131.57 83.39 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.773 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 49.2 Cg_exo . . . . . 0 C--N 1.347 0.455 0 C-N-CA 122.581 2.187 . . . . 0.0 112.727 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.629 0.252 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.78 146.75 95.16 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.673 2.248 . . . . 0.0 112.069 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 13.6 Cg_endo -57.17 123.28 13.45 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.424 2.083 . . . . 0.0 112.212 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.5 tp -103.27 121.2 42.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.97 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 62.4 t -95.31 136.48 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 t -169.51 51.11 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.078 0.466 . . . . 0.0 111.305 -179.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.93 143.41 7.27 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.418 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.511 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.4 tt -160.05 130.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.713 0.292 . . . . 0.0 110.967 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.787 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.9 t -66.39 -58.73 9.71 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.607 179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 67.9 Cg_endo -89.22 115.56 0.7 Allowed 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.146 1.897 . . . . 0.0 112.102 179.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -99.1 27.55 5.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.923 0.392 . . . . 0.0 110.632 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' A' ' 93' ' ' LEU . 11.7 pt-20 178.61 131.03 0.07 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.454 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.97 150.59 6.77 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.786 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.443 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.3 pt -57.0 162.34 3.89 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.473 0.178 . . . . 0.0 111.057 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.666 ' HA ' HG23 ' A' ' 64' ' ' VAL . 85.7 Cg_exo -48.96 -46.68 24.23 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.978 2.452 . . . . 0.0 114.019 -178.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' O ' ' HD2' ' A' ' 63' ' ' ARG . 94.6 m95 -69.99 -5.96 29.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.4 m -72.96 127.56 32.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 110.818 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -74.38 125.29 28.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.809 179.904 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.542 HG12 ' HG2' ' A' ' 15' ' ' PRO . 23.7 m -108.38 127.6 64.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.084 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.4 m -78.87 119.49 22.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.332 -179.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 61.8 mt -85.28 140.73 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.411 179.255 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -146.55 136.74 23.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.342 . . . . 0.0 110.872 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.99 -128.42 1.04 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.413 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -143.96 129.58 19.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.0 111.266 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.491 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.5 m-80 58.66 47.56 12.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.108 179.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.8 mp -81.18 53.21 1.97 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.868 0.366 . . . . 0.0 111.02 179.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 37' ' ' ASP . . . 83.86 135.32 2.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.796 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 77.7 p -62.98 -40.77 98.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.656 0.265 . . . . 0.0 111.376 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -161.35 -159.46 10.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.932 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -65.85 -48.22 3.11 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.728 2.285 . . . . 0.0 112.528 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -60.31 -39.52 87.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.695 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 38.8 t70 -63.19 -47.08 84.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.616 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 39' ' ' ILE . 2.3 tt -66.96 129.16 38.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.773 179.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.587 HD13 ' HD2' ' A' ' 79' ' ' LYS . 29.7 pt -137.23 -44.68 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.22 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.485 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -98.67 136.59 12.78 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.309 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.655 HD13 ' N ' ' A' ' 42' ' ' THR . 1.9 tm? -149.43 132.41 16.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 110.195 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.655 ' N ' HD13 ' A' ' 41' ' ' LEU . 16.5 p -151.62 148.79 28.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.489 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.884 HG21 HG12 ' A' ' 64' ' ' VAL . 77.2 mt -133.14 114.33 21.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.584 179.14 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 66.7 m 73.36 -38.56 0.41 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 123.488 0.493 . . . . 0.0 110.545 -178.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 171.45 -41.97 0.18 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.631 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -78.75 135.74 37.2 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.841 0.353 . . . . 0.0 111.14 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.523 ' HA ' HG22 ' A' ' 42' ' ' THR . 4.9 m120 -61.21 141.62 57.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.2 m -139.98 38.43 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.564 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 39' ' ' ILE . 53.5 tp -71.51 -43.77 65.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.353 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -53.57 -42.94 68.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.477 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.3 p -80.47 -37.83 31.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.714 0.292 . . . . 0.0 111.443 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -60.47 129.17 40.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.032 0.444 . . . . 0.0 111.66 -179.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -126.67 132.1 51.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.213 179.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.564 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 54.3 t90 -63.99 149.89 46.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.376 . . . . 0.0 111.019 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 93.4 mmm -143.78 -45.88 0.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.632 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 58' ' ' SER . 70.8 m -163.63 162.06 24.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.474 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.48 36.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.35 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 56' ' ' SER . 78.1 p -175.24 20.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.153 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.1 tttm -165.19 131.68 2.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.487 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.3 mt -147.53 122.2 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.792 0.33 . . . . 0.0 110.998 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.4 t -83.82 133.76 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.941 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.529 ' SG ' HD11 ' A' ' 43' ' ' ILE . 29.9 p -170.53 132.92 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.352 . . . . 0.0 110.919 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 77.6 mtm180 -85.0 134.62 34.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.884 HG12 HG21 ' A' ' 43' ' ' ILE . 27.8 m . . . . . 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.399 179.343 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.88 128.53 36.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 111.413 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.406 ' O ' HD13 ' A' ' 75' ' ' ILE . 66.8 mt -85.91 137.21 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.732 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.406 HD13 ' O ' ' A' ' 74' ' ' ILE . 48.4 mm -134.22 142.23 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.917 0.389 . . . . 0.0 111.388 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.82 128.74 23.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.636 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.565 HG23 ' HA2' ' A' ' 82' ' ' GLY . 24.6 m -102.22 140.13 36.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.42 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.6 p -122.01 149.31 43.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.587 ' HD2' HD13 ' A' ' 39' ' ' ILE . 14.5 mmmm -51.18 -51.4 54.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.204 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.0 m -69.92 -54.47 13.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.627 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.74 -131.03 2.59 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.28 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.565 ' HA2' HG23 ' A' ' 77' ' ' THR . . . -171.83 -143.04 3.92 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.851 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -67.69 117.79 10.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 110.688 179.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.77 -133.42 2.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.735 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 86' ' ' SER . 0.0 OUTLIER -160.21 -176.64 5.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.002 0.43 . . . . 0.0 110.946 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.649 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 79.4 p -169.27 123.88 0.83 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.527 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.1 p -95.03 33.55 1.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.185 178.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.3 m -152.18 152.8 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.537 -179.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.0 p -143.93 141.96 30.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.049 0.452 . . . . 0.0 111.209 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -85.0 131.94 34.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.25 -179.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.745 ' HE2' HD21 ' A' ' 93' ' ' LEU . 6.0 ttpm? -81.58 120.78 25.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.657 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.466 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -81.71 130.93 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.823 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.745 HD21 ' HE2' ' A' ' 91' ' ' LYS . 79.8 mt -107.0 145.2 32.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.233 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -61.26 131.73 92.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.778 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 C--N 1.346 0.406 0 C-N-CA 122.584 2.19 . . . . 0.0 112.406 -179.956 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.428 ' NE2' ' N ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.648 0.261 . . . . 0.0 110.986 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 13.7 Cg_endo -57.03 145.91 83.37 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.749 2.3 . . . . 0.0 112.265 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 52.6 Cg_exo -54.08 138.86 71.36 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.534 2.156 . . . . 0.0 112.342 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 85' ' ' THR . 5.6 tt -133.74 111.77 10.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.323 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 83.9 t -83.75 140.51 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.918 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 t -162.68 46.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.028 0.442 . . . . 0.0 110.793 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.1 142.3 5.96 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.858 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.524 HG12 ' HD2' ' A' ' 15' ' ' PRO . 13.2 tt -164.07 128.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.659 0.266 . . . . 0.0 110.457 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.781 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 45.9 t -63.62 -58.64 14.39 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.83 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 94.0 Cg_endo -89.47 107.29 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.21 1.94 . . . . 0.0 112.188 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -91.03 26.41 2.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 110.587 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' A' ' 93' ' ' LEU . 12.4 pt-20 179.5 130.01 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.287 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.459 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 166.99 148.19 5.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.568 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.0 pt -52.2 154.01 4.47 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.537 0.208 . . . . 0.0 110.786 179.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.677 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 84.2 Cg_exo -47.26 -37.6 24.56 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.018 2.478 . . . . 0.0 113.792 -178.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -73.44 -23.32 60.09 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 m -57.99 128.55 37.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 110.964 -179.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.87 129.84 41.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.538 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.702 HG12 ' HG2' ' A' ' 15' ' ' PRO . 26.8 m -121.4 125.1 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 111.013 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.4 m -75.84 116.89 17.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.921 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 61.5 mt -83.04 136.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.67 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 58' ' ' SER . 29.3 tpt180 -141.49 133.41 27.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.334 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.45 -134.04 1.69 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.48 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -150.25 132.24 15.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.944 0.402 . . . . 0.0 111.281 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.456 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 72.3 m-80 59.3 46.47 12.69 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.673 178.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.4 mp -81.78 52.15 1.86 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 110.694 178.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.06 126.69 0.14 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.419 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.7 p -90.77 42.27 1.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.694 0.283 . . . . 0.0 111.563 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.52 145.81 5.0 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.792 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 -46.38 27.61 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.394 2.063 . . . . 0.0 111.709 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.5 t -62.05 -36.06 80.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.072 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.14 -36.18 67.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 tt -75.57 61.09 1.28 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.488 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.593 HD13 ' HG2' ' A' ' 79' ' ' LYS . 30.7 pt -68.98 -40.1 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.435 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.422 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -110.48 139.75 15.61 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.957 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 42' ' ' THR . 3.0 tm? -148.26 132.06 17.01 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.626 ' N ' HD13 ' A' ' 41' ' ' LEU . 24.0 p -150.51 140.94 22.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.162 0.506 . . . . 0.0 111.843 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.3 mt -137.4 125.79 33.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.573 178.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.522 ' SG ' HD21 ' A' ' 92' ' ' LEU . 69.2 m 58.43 37.98 25.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.163 0.506 . . . . 0.0 110.1 -179.004 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.89 25.31 71.88 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.958 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -131.85 125.33 31.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.54 0.209 . . . . 0.0 110.521 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -63.11 138.17 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.324 . . . . 0.0 110.633 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.0 m -148.84 39.38 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.684 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 39' ' ' ILE . 58.3 tp -69.69 -44.55 70.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.266 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.4 pt? -50.66 -44.16 57.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.297 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.457 HG23 ' HG ' ' A' ' 50' ' ' LEU . 71.8 p -80.77 -37.83 29.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 111.134 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -60.44 130.31 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.718 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -126.82 129.36 48.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.514 179.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 80.8 t90 -64.57 145.92 55.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.618 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.3 mmm -140.14 -45.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 58' ' ' SER . 65.7 m -164.05 160.27 21.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.65 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.39 27.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.838 0.352 . . . . 0.0 111.396 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.3 m -168.03 19.49 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.833 179.341 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.3 tttp -165.19 130.8 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.511 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 68.5 mt -148.84 119.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.952 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.32 134.71 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.555 179.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 45.9 t -170.67 152.84 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.277 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -83.79 135.25 34.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.001 179.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.677 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.625 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.81 -0.116 . . . . 0.0 112.81 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -66.06 130.69 44.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.708 0.289 . . . . 0.0 111.129 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.422 ' O ' HD13 ' A' ' 75' ' ' ILE . 68.8 mt -85.06 131.61 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.355 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 74' ' ' ILE . 39.9 mm -127.4 139.93 50.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.402 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -139.63 120.94 15.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.624 179.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.9 m -94.07 142.47 27.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.2 p -136.92 136.57 38.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.593 ' HG2' HD13 ' A' ' 39' ' ' ILE . 28.3 mtpp -55.96 -50.62 70.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.018 -179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.0 m -67.52 -54.59 18.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.323 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.21 -125.22 0.46 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.108 179.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.55 -141.69 3.22 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.469 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -63.9 128.99 38.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.82 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.11 128.31 8.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.775 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 81.4 p -103.63 148.55 25.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.626 0.25 . . . . 0.0 110.829 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.608 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 40.4 t -154.48 127.82 8.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 111.661 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.4 p -77.55 -32.98 54.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.423 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.6 m -84.47 148.66 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.494 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.3 m -139.29 140.35 37.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.549 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.416 ' CD2' HG11 ' A' ' 64' ' ' VAL . 62.3 t80 -85.05 131.74 34.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.35 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.461 ' HE3' HD21 ' A' ' 93' ' ' LEU . 38.9 ttpt -84.34 122.27 28.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.595 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.522 HD21 ' SG ' ' A' ' 44' ' ' CYS . 3.4 mm? -78.59 131.64 36.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.241 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 17' ' ' GLU . 73.6 mt -108.27 137.45 46.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.585 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 62.0 tttp -61.62 128.58 90.36 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.812 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 47.8 Cg_exo . . . . . 0 C--N 1.347 0.468 0 C-N-CA 122.537 2.158 . . . . 0.0 112.45 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.769 0.319 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.4 mmt -58.34 132.87 54.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.55 ' HE ' ' HB3' ' A' ' 80' ' ' SER . 72.1 mtm-85 -62.85 123.2 17.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -76.4 140.51 68.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.196 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.98 144.79 99.43 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.521 2.147 . . . . 0.0 111.888 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 54.2 Cg_exo -51.41 118.47 4.39 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.317 2.011 . . . . 0.0 112.4 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.5 tp -99.41 131.27 45.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.645 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 85.1 t -116.6 135.91 55.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.672 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -168.82 52.47 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.098 0.475 . . . . 0.0 111.34 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.93 143.53 8.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.579 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.544 HG12 ' HD2' ' A' ' 15' ' ' PRO . 12.7 tt -161.36 131.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.564 0.221 . . . . 0.0 110.782 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.697 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 43.8 t -62.3 -60.23 10.65 Favored Pre-proline 0 CA--C 1.531 0.218 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.132 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 84.8 Cg_endo -79.71 -160.14 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.875 1.717 . . . . 0.0 111.742 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -173.22 21.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.761 0.315 . . . . 0.0 110.967 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.413 ' HB2' HD11 ' A' ' 93' ' ' LEU . 22.8 pt-20 177.78 127.45 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.3 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 164.09 153.03 7.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.886 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 93' ' ' LEU . 34.7 pt -53.92 159.65 2.65 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.435 0.16 . . . . 0.0 110.922 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.841 ' HA ' HG23 ' A' ' 64' ' ' VAL . 75.8 Cg_exo -51.41 -40.75 61.94 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.64 2.227 . . . . 0.0 113.392 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.495 ' HE3' HH11 ' A' ' 63' ' ' ARG . 78.6 m95 -69.56 -5.35 23.79 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.0 m -66.96 132.23 47.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 111.314 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.56 ' HD2' HG13 ' A' ' 61' ' ' VAL . 17.6 tppt? -70.31 138.74 51.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.69 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.576 HG12 ' HG3' ' A' ' 15' ' ' PRO . 35.2 m -145.9 128.55 9.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.96 0.409 . . . . 0.0 111.06 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 84.3 m -87.13 120.99 28.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.8 mt -79.79 139.57 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.115 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HE ' ' HZ3' ' A' ' 59' ' ' LYS . 19.2 mmt85 -137.33 134.74 36.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.33 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.05 -136.25 2.24 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.871 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -152.16 134.42 15.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.972 0.415 . . . . 0.0 111.497 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 60.63 42.0 14.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.603 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.527 HD13 ' HA ' ' A' ' 58' ' ' SER . 9.1 mp -83.85 50.47 1.82 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 110.399 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.48 126.56 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.31 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.9 p -94.97 43.51 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 0.0 111.252 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.41 142.74 4.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.707 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.2 -42.26 58.6 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.595 2.196 . . . . 0.0 112.044 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.3 p -62.96 -38.68 92.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.955 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -56.56 -37.33 70.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.976 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.575 HD21 HD23 ' A' ' 41' ' ' LEU . 1.4 tt -75.46 62.8 1.4 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.466 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.464 HG13 ' N ' ' A' ' 40' ' ' GLY . 35.9 pt -69.25 -41.24 81.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.495 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -110.41 137.87 14.54 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.957 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.602 HD13 ' N ' ' A' ' 42' ' ' THR . 2.3 tm? -149.05 128.96 13.4 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.605 HG22 ' HA ' ' A' ' 47' ' ' ASN . 12.2 p -152.08 138.41 18.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.148 0.499 . . . . 0.0 111.864 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.663 ' HB ' ' H ' ' A' ' 65' ' ' GLY . 71.4 mt -127.53 127.36 68.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.364 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.477 ' SG ' HD11 ' A' ' 92' ' ' LEU . 71.2 m 58.14 36.03 25.55 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.24 -26.71 1.81 Allowed Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.768 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.442 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 78.2 t60 -76.3 135.06 39.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.786 0.327 . . . . 0.0 111.337 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.605 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.8 OUTLIER -73.23 136.22 44.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.659 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.564 ' H ' HD22 ' A' ' 47' ' ' ASN . 72.7 m -152.47 41.87 0.63 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.728 0.299 . . . . 0.0 111.292 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.3 tp -71.38 -43.16 67.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.124 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -50.31 -41.92 51.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.605 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.422 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 72.4 p -80.3 -36.51 34.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.379 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.89 133.66 55.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.712 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -126.9 130.94 51.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.615 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -70.59 146.5 50.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.056 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.8 mmt -136.36 -52.4 0.72 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.643 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.0 m -160.52 -172.61 3.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.462 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.48 41.67 0.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.205 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.527 ' HA ' HD13 ' A' ' 31' ' ' LEU . 47.9 t -175.27 -47.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.753 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.618 ' HZ3' ' HE ' ' A' ' 27' ' ' ARG . 25.0 ttmm -87.8 136.23 33.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.866 0.365 . . . . 0.0 111.638 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -150.51 117.17 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.529 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.56 HG13 ' HD2' ' A' ' 23' ' ' LYS . 57.5 t -85.04 124.17 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.968 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.8 p -170.93 143.82 2.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 0.0 111.238 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.495 HH11 ' HE3' ' A' ' 21' ' ' TRP . 99.2 mtt180 -84.23 132.51 34.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.331 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.841 HG23 ' HA ' ' A' ' 20' ' ' PRO . 16.1 m -59.39 127.65 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.198 0.523 . . . . 0.0 111.635 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.663 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . -70.53 155.5 52.99 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.826 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.414 ' HG2' ' CG ' ' A' ' 46' ' ' HIS . 17.8 pt20 -51.49 143.74 11.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.804 0.335 . . . . 0.0 110.828 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.873 ' HB2' HD12 ' A' ' 92' ' ' LEU . . . -60.15 144.65 49.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.229 0.538 . . . . 0.0 111.998 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -147.84 -43.9 0.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.528 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -76.15 -123.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.203 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -170.41 42.82 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.747 0.308 . . . . 0.0 111.144 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 89' ' ' SER . 24.1 tptm -164.55 -46.44 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.856 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.88 44.82 2.78 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.159 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -75.5 129.57 37.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.752 0.311 . . . . 0.0 110.94 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.1 mt -86.6 92.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.996 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.3 mm -86.52 139.78 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.205 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.9 t -139.6 113.44 6.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.2 m -81.87 144.28 31.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.496 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.0 p -141.32 134.95 30.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.718 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -59.24 -44.98 92.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.102 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.55 ' HB3' ' HE ' ' A' ' 5' ' ' ARG . 50.9 m -61.61 -42.88 99.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.979 0.418 . . . . 0.0 110.068 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.77 -118.15 3.25 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.081 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 -142.42 3.39 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.398 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -70.65 130.98 43.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.873 0.368 . . . . 0.0 110.963 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.48 136.81 15.98 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.67 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.7 p -98.92 140.17 33.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.662 0.268 . . . . 0.0 110.507 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.645 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 39.7 t -129.32 128.78 43.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.977 0.418 . . . . 0.0 111.727 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.2 p -75.4 -35.92 60.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.991 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.8 m -85.27 159.41 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.22 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 71' ' ' LYS . 66.9 m -146.35 137.13 24.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' A' ' 64' ' ' VAL . 46.4 t80 -86.15 129.01 34.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.427 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.457 ' HE3' HD21 ' A' ' 93' ' ' LEU . 38.8 ttpt -83.36 117.92 23.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.265 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.873 HD12 ' HB2' ' A' ' 67' ' ' ALA . 86.5 mt -83.02 128.46 34.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 111.286 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.47 HD12 ' HA2' ' A' ' 18' ' ' GLY . 80.3 mt -99.62 144.16 29.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.892 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -57.93 139.09 83.06 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.88 134.75 42.47 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.666 2.244 . . . . 0.0 112.939 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -74.66 118.74 17.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.536 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.0 tptp . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.795 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.554 0.216 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.4 mtt -61.99 137.67 58.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.84 0.352 . . . . 0.0 111.093 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.1 mtm-85 -61.99 124.93 22.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.03 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -75.72 142.54 73.72 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.093 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.24 145.56 96.1 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.509 2.139 . . . . 0.0 111.82 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.72 118.71 3.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.401 2.068 . . . . 0.0 112.317 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.529 HD13 ' C ' ' A' ' 9' ' ' LEU . 3.4 tm? -98.52 117.79 33.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.646 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 58.8 t -96.1 139.52 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.908 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 t -171.05 48.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 111.205 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.74 139.32 5.59 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.027 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.458 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.6 tt -165.03 132.43 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.75 0.31 . . . . 0.0 110.629 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.81 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.9 t -68.41 -59.35 6.06 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.135 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.85 ' HG2' HG12 ' A' ' 24' ' ' VAL . 68.1 Cg_endo -92.94 121.98 0.48 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.247 1.965 . . . . 0.0 112.961 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -96.71 29.62 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.528 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.546 ' HB2' HD11 ' A' ' 93' ' ' LEU . 23.3 pt-20 179.73 132.24 0.09 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.395 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.462 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 171.92 143.38 4.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.095 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.558 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 35.2 pt -59.14 165.06 3.91 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 120.38 0.134 . . . . 0.0 111.083 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.671 ' HA ' HG23 ' A' ' 64' ' ' VAL . 95.7 Cg_exo -46.27 -41.89 22.16 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.927 2.418 . . . . 0.0 113.61 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -77.22 -17.42 58.49 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.426 ' OG1' HG12 ' A' ' 19' ' ' ILE . 80.9 m -56.89 131.48 49.71 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 111.68 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -73.63 139.84 45.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.566 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.85 HG12 ' HG2' ' A' ' 15' ' ' PRO . 35.0 m -139.55 128.25 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 111.075 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.6 m -89.2 118.3 28.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.1 mt -85.74 138.98 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -143.16 137.34 28.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.82 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -172.98 -129.32 1.14 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.722 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -146.75 136.37 23.03 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 110.939 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 61.65 40.02 13.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.87 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 mp -82.95 50.55 1.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 110.707 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.79 132.5 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.501 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.3 p -60.14 -34.34 73.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.697 0.284 . . . . 0.0 111.037 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.546 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -158.93 -161.43 11.11 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.825 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.86 -43.61 1.67 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.634 2.223 . . . . 0.0 112.7 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.5 p -57.23 -40.92 78.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.287 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.34 -36.77 84.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.0 tp -75.82 62.28 1.53 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.15 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.646 HD13 ' HG2' ' A' ' 79' ' ' LYS . 32.4 pt -69.16 -36.13 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.114 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.468 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -126.71 139.85 11.56 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.781 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.4 tp -150.0 151.78 33.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.683 0.278 . . . . 0.0 110.685 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.1 p -149.72 141.46 23.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.29 0.567 . . . . 0.0 111.975 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.6 mt -137.83 130.69 41.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.246 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.407 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 83.3 m 52.83 30.49 9.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.947 0.404 . . . . 0.0 110.101 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.1 -38.66 3.19 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.987 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.479 ' NE2' ' HA3' ' A' ' 65' ' ' GLY . 30.8 p-80 -86.5 140.5 29.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 117.457 0.628 . . . . 0.0 111.781 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -60.86 145.22 50.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.4 m -149.72 38.03 0.75 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.9 tp -71.57 -47.09 57.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.618 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 51' ' ' THR . 3.3 pp -58.49 -34.96 71.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.514 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.731 ' N ' HD12 ' A' ' 50' ' ' LEU . 22.0 p -80.45 -38.28 30.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.941 0.4 . . . . 0.0 110.891 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -68.62 135.5 51.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.168 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -126.77 128.73 47.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.017 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.546 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 78.6 t90 -61.73 150.08 37.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.914 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.699 ' HG3' HG23 ' A' ' 61' ' ' VAL . 92.4 mmm -143.12 -44.11 0.29 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 67.4 m -161.09 160.72 30.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.028 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.76 -30.36 32.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.559 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.9 m -126.21 36.94 4.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.241 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 60.0 tttm -165.02 132.62 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.4 mt -150.43 122.89 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.699 HG23 ' HG3' ' A' ' 55' ' ' MET . 65.7 t -82.98 129.45 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.242 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.9 p -170.47 136.67 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.894 0.378 . . . . 0.0 111.569 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 59.3 mtt85 -85.18 138.15 32.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.584 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.671 HG23 ' HA ' ' A' ' 20' ' ' PRO . 31.7 m -66.63 -143.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.673 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.479 ' HA3' ' NE2' ' A' ' 46' ' ' HIS . . . 175.81 -141.97 5.87 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.499 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -65.88 136.86 56.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.885 0.374 . . . . 0.0 111.378 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.461 ' HB2' HD23 ' A' ' 92' ' ' LEU . . . -79.08 55.72 1.86 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.386 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -52.21 -42.05 63.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.877 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -70.86 -127.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.294 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -148.94 -53.9 0.18 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.813 0.34 . . . . 0.0 110.653 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -91.69 -47.38 7.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.104 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.65 43.96 0.48 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.296 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.85 130.14 42.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.131 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 66.4 mt -97.42 128.39 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.319 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.82 138.0 49.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.418 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.3 t -124.81 129.1 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.633 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 40' ' ' GLY . 88.0 m -97.71 138.31 35.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.403 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.1 p -135.41 140.32 44.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.155 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.646 ' HG2' HD13 ' A' ' 39' ' ' ILE . 7.2 mtpm? -56.56 -46.72 80.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.779 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.7 p -65.56 -53.59 39.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.024 0.44 . . . . 0.0 110.092 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.52 -124.41 2.24 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.099 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.7 -142.71 3.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.088 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.575 ' HB3' ' NZ ' ' A' ' 83' ' ' LYS . 5.9 ttpm? -71.53 123.29 22.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.715 0.293 . . . . 0.0 110.514 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.91 -160.55 36.66 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.746 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.0 p -154.97 -169.84 3.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.68 0.276 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.612 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 41.0 t -170.99 127.81 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.916 0.389 . . . . 0.0 111.318 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 82.5 p -72.53 -34.05 67.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.14 0.495 . . . . 0.0 110.084 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.9 173.62 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.377 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.8 p -157.41 135.6 11.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.712 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.518 ' CD2' HG11 ' A' ' 64' ' ' VAL . 53.4 t80 -85.4 127.03 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.184 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.598 ' HB3' ' NZ ' ' A' ' 91' ' ' LYS . 5.7 ttpm? -83.88 119.86 25.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.952 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' A' ' 20' ' ' PRO . 26.6 tp -85.19 131.14 34.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.244 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 17' ' ' GLU . 79.6 mt -94.63 136.28 35.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.777 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -63.49 137.92 97.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.31 133.92 52.33 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.493 2.129 . . . . 0.0 112.421 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -71.05 76.96 0.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.737 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.963 -179.703 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.0 t60 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.728 0.299 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -175.15 139.49 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.71 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -171.16 57.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.708 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 2.5 tp-100 -60.6 131.85 91.01 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.924 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 6' ' ' GLN . 46.5 Cg_exo -56.23 144.03 82.98 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.656 2.237 . . . . 0.0 112.473 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.57 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 14.4 Cg_endo -57.34 141.32 94.74 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.744 2.296 . . . . 0.0 112.196 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 85' ' ' THR . 4.4 tt -141.0 121.9 14.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 0.0 110.435 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.528 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 98.5 t -84.61 134.61 26.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.712 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.565 HG23 HD22 ' A' ' 9' ' ' LEU . 34.3 p -153.7 47.26 0.64 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.862 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.95 143.22 6.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.854 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.501 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 14.5 tt -160.53 130.35 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.713 0.292 . . . . 0.0 110.448 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.804 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 52.0 m -63.95 -59.55 11.07 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.155 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.804 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 91.4 Cg_endo -89.56 128.06 1.7 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.232 1.955 . . . . 0.0 112.69 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.3 25.05 11.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.943 0.402 . . . . 0.0 110.242 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 177.57 131.3 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.547 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.25 149.56 5.82 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.445 -0.884 . . . . 0.0 112.8 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 93' ' ' LEU . 35.3 pt -57.16 157.48 11.75 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.437 0.161 . . . . 0.0 110.868 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.639 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 85.8 Cg_exo -48.69 -39.88 38.26 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.874 2.382 . . . . 0.0 113.576 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.408 ' HZ3' HH11 ' A' ' 63' ' ' ARG . 97.0 m95 -71.91 -20.49 61.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.9 m -56.75 131.41 49.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 111.144 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -65.98 135.94 55.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.426 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.57 HG12 ' HG2' ' A' ' 15' ' ' PRO . 33.4 m -134.36 129.42 53.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.39 . . . . 0.0 111.216 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.4 m -85.58 122.78 30.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.011 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.736 HD12 ' HB ' ' A' ' 60' ' ' ILE . 63.8 mt -83.3 137.42 20.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.028 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.491 ' O ' HG13 ' A' ' 10' ' ' VAL . 44.5 mmm-85 -143.89 133.37 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.668 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.13 -134.45 1.73 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.527 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -142.96 128.64 19.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.391 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.57 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 63.7 m-80 52.63 41.47 31.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.139 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.412 HD21 HG22 ' A' ' 26' ' ' ILE . 10.0 mp -60.11 -39.47 86.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.745 0.307 . . . . 0.0 111.047 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.02 132.15 1.97 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.647 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.8 p -64.68 -36.42 84.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 0.0 111.212 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.34 174.52 37.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.424 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.49 -43.46 55.19 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.427 2.085 . . . . 0.0 112.087 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.4 p -61.04 -40.88 95.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.014 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.496 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 64.7 t0 -59.06 -48.66 80.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.663 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.441 HD11 HD13 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -71.18 128.31 35.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.962 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.535 HD13 ' HG2' ' A' ' 79' ' ' LYS . 38.4 pt -143.57 -39.94 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.945 0.402 . . . . 0.0 110.673 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -105.49 133.33 11.53 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.482 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.405 ' HB2' HD23 ' A' ' 49' ' ' LEU . 24.0 tp -150.25 149.39 30.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.689 0.28 . . . . 0.0 110.337 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.2 m -159.41 140.34 12.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 111.508 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.08 126.53 37.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.337 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.601 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 77.4 m 54.82 38.98 31.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.992 0.425 . . . . 0.0 110.545 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.35 27.99 71.61 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.427 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -131.0 132.91 45.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.685 0.279 . . . . 0.0 110.824 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.5 HD22 ' N ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -67.03 133.5 50.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.705 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.5 ' N ' HD22 ' A' ' 47' ' ' ASN . 74.4 m -152.18 40.03 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.96 0.409 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 3.3 tm? -81.52 -43.29 18.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.874 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -53.59 -38.75 64.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.818 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.9 p -79.88 -37.43 34.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.699 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.34 135.74 57.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.974 0.416 . . . . 0.0 112.025 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -126.45 132.35 51.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.359 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -66.29 151.78 46.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.412 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 55.0 mtt -149.83 -42.77 0.13 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.76 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 58' ' ' SER . 86.9 p -169.13 169.65 9.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.533 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.83 34.39 0.1 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.529 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 56' ' ' SER . 78.4 p -177.99 30.13 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.911 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.6 ttmt -165.04 130.12 2.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.791 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.736 ' HB ' HD12 ' A' ' 26' ' ' ILE . 72.3 mt -150.67 122.56 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.0 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 9.0 p -88.33 132.93 32.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.522 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 26.7 p -170.89 156.32 4.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.035 0.445 . . . . 0.0 111.4 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.408 HH11 ' HZ3' ' A' ' 21' ' ' TRP . 98.9 mtt180 -84.01 134.93 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.2 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.639 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.5 t -59.07 134.19 24.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.122 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . -70.16 -123.35 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.293 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.745 ' HG3' ' HE3' ' A' ' 68' ' ' LYS . 20.4 pt20 -165.73 136.55 3.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.773 0.32 . . . . 0.0 110.5 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.601 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -49.71 131.87 21.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.893 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.745 ' HE3' ' HG3' ' A' ' 66' ' ' GLN . 35.0 mmtp -132.11 -50.01 0.94 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.585 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -77.58 -63.07 1.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.555 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.545 ' OD1' ' HG3' ' A' ' 71' ' ' LYS . 1.2 p30 -179.57 -47.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.047 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.545 ' HG3' ' OD1' ' A' ' 70' ' ' ASP . 29.5 mtpp -97.95 -126.68 0.16 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.524 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 44' ' ' CYS . . . -179.1 44.27 0.08 OUTLIER Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.466 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -61.99 132.14 51.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.37 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.8 mt -85.45 92.5 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.165 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.9 mm -91.08 145.63 7.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.153 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.42 128.51 24.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.101 0.477 . . . . 0.0 111.058 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 m -100.63 143.78 30.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.239 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.4 p -130.59 140.76 50.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.562 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 8.0 mtpm? -56.94 -47.99 79.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.248 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 61.4 m -64.75 -54.81 25.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.946 0.403 . . . . 0.0 110.561 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.32 -125.03 1.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.127 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.43 -140.78 3.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.995 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.3 117.76 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.753 0.311 . . . . 0.0 110.375 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.65 -149.16 2.32 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.935 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 40.6 p -155.84 150.73 26.33 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.49 0.316 . . . . 0.0 110.392 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -157.26 127.61 6.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.968 0.413 . . . . 0.0 111.175 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.3 p -107.58 40.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.806 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.69 149.1 15.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.352 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 t -140.11 137.36 34.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.691 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.544 ' HD2' HG11 ' A' ' 64' ' ' VAL . 63.4 t80 -85.25 129.95 34.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.131 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -77.51 125.18 28.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.395 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.3 mt -92.49 124.55 36.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.163 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 19' ' ' ILE . 79.3 mt -89.47 135.25 33.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.641 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 53.3 mtmt -64.21 133.07 95.51 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.056 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 31.8 Cg_exo -60.04 130.48 34.73 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.538 2.159 . . . . 0.0 112.171 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -74.19 115.09 13.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.354 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.62 ' NZ ' ' HB2' ' A' ' 97' ' ' LYS . 9.7 mtmp? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.93 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.6 m170 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.503 0.192 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 85.0 mtp 56.57 47.2 19.04 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.855 0.36 . . . . 0.0 111.146 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.412 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 54.5 ttp180 -62.05 144.59 55.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -59.14 135.9 88.04 Favored Pre-proline 0 N--CA 1.453 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.62 146.29 44.32 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.612 2.208 . . . . 0.0 112.436 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HG2' ' HA3' ' A' ' 84' ' ' GLY . 8.9 Cg_endo -50.62 144.68 24.84 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.982 2.455 . . . . 0.0 112.383 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.534 HD21 HG23 ' A' ' 87' ' ' THR . 2.1 tm? -141.68 119.95 12.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.208 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.565 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 92.7 t -77.37 134.66 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.618 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.459 HG23 HD12 ' A' ' 9' ' ' LEU . 61.3 p -148.0 44.51 1.07 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.206 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.34 145.12 5.65 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.063 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.7 tt -164.57 128.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.64 0.257 . . . . 0.0 110.44 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.829 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 48.0 t -67.14 -60.06 6.56 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.66 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.829 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 68.1 Cg_endo -91.99 114.38 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.149 1.899 . . . . 0.0 112.18 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -92.93 30.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 0.0 110.499 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.516 ' HB2' HD21 ' A' ' 93' ' ' LEU . 15.3 pt-20 178.08 131.21 0.07 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.446 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.8 144.6 4.27 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.067 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 93' ' ' LEU . 41.3 pt -59.42 161.54 10.2 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 121.969 0.107 . . . . 0.0 110.967 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.926 ' HA ' HG13 ' A' ' 64' ' ' VAL . 79.3 Cg_exo -47.92 -37.2 28.79 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.572 2.181 . . . . 0.0 113.036 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.09 -27.87 62.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.8 m -56.5 128.58 36.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 0.0 111.581 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.08 136.86 50.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.544 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.775 HG12 ' HG2' ' A' ' 15' ' ' PRO . 29.4 m -135.85 121.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.947 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.6 m -80.85 116.87 21.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.767 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 55.5 mt -77.42 141.22 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.581 HH11 ' HB2' ' A' ' 59' ' ' LYS . 25.8 mmm180 -146.9 131.01 17.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.411 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.28 -130.78 1.25 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.638 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -146.52 135.87 22.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.886 0.374 . . . . 0.0 111.244 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.5 m-20 61.87 38.05 14.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.356 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.503 HD22 ' O ' ' A' ' 58' ' ' SER . 10.2 mp -84.14 51.01 1.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.951 0.405 . . . . 0.0 110.392 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 57' ' ' ALA . . . 70.87 118.78 0.04 OUTLIER Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.192 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.5 p -90.03 41.52 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 111.365 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.31 151.67 7.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.686 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.78 -43.07 62.72 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.473 2.115 . . . . 0.0 111.724 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.511 ' O ' ' HE2' ' A' ' 79' ' ' LYS . 2.5 t -61.79 -35.51 78.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.597 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.497 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 1.4 m-20 -51.93 -48.85 64.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.454 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.95 127.42 32.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.134 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.524 HD13 ' HD2' ' A' ' 79' ' ' LYS . 36.6 pt -147.26 20.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.094 0.474 . . . . 0.0 110.786 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 176.94 139.34 3.22 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.907 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 75' ' ' ILE . 18.1 tp -149.63 146.38 27.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.885 0.374 . . . . 0.0 111.023 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.408 ' OG1' ' HB ' ' A' ' 75' ' ' ILE . 20.5 p -151.15 134.47 16.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.181 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.684 HG21 HG23 ' A' ' 64' ' ' VAL . 64.7 mt -134.51 125.19 46.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.857 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.645 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 66.2 m 56.71 36.43 27.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.09 0.471 . . . . 0.0 109.991 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.99 33.69 87.93 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.891 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.515 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 80.4 t60 -130.78 131.27 44.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.713 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -67.7 131.78 46.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.638 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.544 ' N ' HD22 ' A' ' 47' ' ' ASN . 71.8 m -153.09 39.01 0.51 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.88 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 69.3 tp -73.96 -47.07 40.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.286 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -52.3 -40.36 61.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.631 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.6 p -80.35 -33.37 37.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.292 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.571 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -52.74 134.4 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.767 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -126.67 130.24 50.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.669 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -71.95 147.43 46.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 96.1 mmm -138.89 -48.37 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.5 m -160.55 -175.03 4.76 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.645 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -78.52 36.23 0.25 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.983 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.503 ' O ' HD22 ' A' ' 31' ' ' LEU . 79.8 p -177.29 -43.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.754 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.581 ' HB2' HH11 ' A' ' 27' ' ' ARG . 24.6 ttmm -84.87 131.25 34.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.047 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.0 mt -149.97 113.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.682 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.432 HG23 ' HG3' ' A' ' 55' ' ' MET . 43.2 t -82.81 130.82 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.431 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.571 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.4 p -170.41 160.28 7.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.905 0.383 . . . . 0.0 111.199 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -83.65 126.17 32.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.805 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.926 HG13 ' HA ' ' A' ' 20' ' ' PRO . 2.3 p -62.96 131.5 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.161 0.505 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.576 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . -71.7 144.82 37.54 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.835 -0.621 . . . . 0.0 113.147 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.546 ' HG3' ' HE2' ' A' ' 68' ' ' LYS . 19.9 pt20 -59.78 145.3 45.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.638 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.805 ' HB2' HD12 ' A' ' 92' ' ' LEU . . . -55.35 134.8 50.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.294 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.546 ' HE2' ' HG3' ' A' ' 66' ' ' GLN . 74.9 mmtt -135.28 -48.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.7 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -77.95 -118.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.192 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -152.61 -44.09 0.1 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.837 0.351 . . . . 0.0 110.706 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.578 ' HB2' ' NZ ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -75.59 -48.57 21.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.261 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.55 43.28 6.2 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.189 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -74.76 140.19 43.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.838 0.352 . . . . 0.0 111.3 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.42 ' O ' HD13 ' A' ' 75' ' ' ILE . 76.9 mt -85.11 136.89 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.525 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.42 HD13 ' O ' ' A' ' 74' ' ' ILE . 49.8 mm -133.43 139.07 49.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.927 0.394 . . . . 0.0 111.624 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.35 126.87 45.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.69 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.7 m -96.73 138.8 33.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.712 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 82' ' ' GLY . 56.7 p -151.95 142.4 22.59 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.465 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.694 ' HD3' ' H ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -54.68 -30.49 55.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.665 0.269 . . . . 0.0 111.353 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -61.73 -57.19 12.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.608 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.45 -45.42 0.92 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.719 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 78' ' ' THR . . . 75.35 120.98 0.12 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.866 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.8 tttm 47.82 65.08 1.38 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.821 0.343 . . . . 0.0 111.047 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.425 ' HA3' ' HG2' ' A' ' 8' ' ' PRO . . . -64.88 -138.88 0.02 OUTLIER Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.88 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.6 p -151.06 -168.35 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.887 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.4 p -169.09 129.64 1.12 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.534 HG23 HD21 ' A' ' 9' ' ' LEU . 61.8 p -93.62 29.21 2.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.101 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 m -154.57 140.72 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 71' ' ' LYS . 79.0 p -120.2 140.52 51.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.537 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.522 ' CD2' HG21 ' A' ' 64' ' ' VAL . 45.0 t80 -89.35 129.95 35.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.621 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -88.33 123.68 33.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.242 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.805 HD12 ' HB2' ' A' ' 67' ' ' ALA . 93.2 mt -88.02 130.64 34.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.079 0.466 . . . . 0.0 111.974 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.549 ' O ' HG22 ' A' ' 19' ' ' ILE . 84.0 mt -88.69 140.7 29.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.723 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.46 128.03 92.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.651 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.99 127.35 25.96 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.511 2.14 . . . . 0.0 112.604 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.18 117.85 16.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.391 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.616 ' NZ ' ' HB3' ' A' ' 97' ' ' LYS . 5.6 ttpm? . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.1 m170 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.76 0.314 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -172.9 139.9 0.89 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.601 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.469 ' HG3' HH11 ' A' ' 5' ' ' ARG . 58.7 mtt85 -64.54 128.18 34.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.407 ' HG3' ' HD2' ' A' ' 7' ' ' PRO . 8.2 tt0 -63.59 137.18 97.02 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.003 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.407 ' HD2' ' HG3' ' A' ' 6' ' ' GLN . 16.9 Cg_endo -56.99 149.42 62.12 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.632 2.222 . . . . 0.0 112.242 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HD3' ' H ' ' A' ' 82' ' ' GLY . 65.6 Cg_exo -51.9 137.09 52.48 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.54 2.16 . . . . 0.0 112.168 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 85' ' ' THR . 3.3 tt -133.78 117.87 17.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.354 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.565 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 95.2 t -82.17 135.82 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.184 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.447 HG23 HD22 ' A' ' 9' ' ' LEU . 80.7 p -147.01 41.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.798 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.29 148.49 7.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.713 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.519 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.1 tt -160.36 132.76 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.763 0.315 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.811 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 45.4 t -66.43 -59.9 7.56 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.661 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.811 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 86.4 Cg_endo -89.87 119.01 0.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.041 1.827 . . . . 0.0 112.389 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -77.54 -20.56 53.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.411 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' OE1' HD11 ' A' ' 93' ' ' LEU . 15.4 pt-20 -157.07 139.88 15.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.03 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.53 147.57 8.58 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.654 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 37.4 pt -55.16 161.91 2.34 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-O 120.547 0.213 . . . . 0.0 111.362 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.881 ' HA ' HG23 ' A' ' 64' ' ' VAL . 85.2 Cg_exo -47.52 -46.17 21.21 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.089 2.526 . . . . 0.0 114.097 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -73.11 -8.29 55.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 m -70.04 128.09 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.992 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 28.5 mtpp -75.65 124.02 26.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.549 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.726 HG12 ' HG2' ' A' ' 15' ' ' PRO . 30.7 m -113.03 121.25 64.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.966 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.5 m -78.4 118.77 20.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.038 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.3 mt -80.63 137.07 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.738 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 58' ' ' SER . 28.3 tpt180 -139.28 126.28 21.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.268 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -167.89 -132.91 1.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.613 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -146.96 137.88 23.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.852 0.358 . . . . 0.0 111.325 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 72.8 m-80 63.84 41.77 6.54 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.369 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 8.8 mp -90.08 46.38 1.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.991 0.424 . . . . 0.0 110.265 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.21 120.34 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.185 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.1 p -91.88 42.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.678 0.275 . . . . 0.0 111.195 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.72 147.76 6.13 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.705 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.13 -45.17 42.65 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.519 2.146 . . . . 0.0 111.716 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 t -62.45 -36.59 82.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.158 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -55.55 -46.09 77.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.975 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -65.83 134.22 52.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.017 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.476 ' N ' HD23 ' A' ' 38' ' ' LEU . 30.2 pt -140.74 -42.5 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.317 . . . . 0.0 111.219 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.455 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -111.17 136.87 13.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.405 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.58 HD13 ' N ' ' A' ' 42' ' ' THR . 1.5 tm? -147.59 127.41 13.49 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.58 ' N ' HD13 ' A' ' 41' ' ' LEU . 22.6 p -152.95 142.02 21.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.514 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.609 HG21 HG12 ' A' ' 64' ' ' VAL . 70.1 mt -137.37 124.76 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.867 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.663 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 78.0 m 58.24 38.69 26.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 110.156 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.57 ' O ' ' HD3' ' A' ' 68' ' ' LYS . . . 62.44 33.35 86.08 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.877 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -131.12 133.46 45.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.771 0.32 . . . . 0.0 110.8 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.532 HD22 ' N ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -66.48 131.29 45.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.468 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.532 ' N ' HD22 ' A' ' 47' ' ' ASN . 74.1 m -151.7 36.58 0.57 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.861 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.9 tp -75.72 -44.74 40.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.731 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 50' ' ' LEU . 2.5 pt? -55.36 -39.33 69.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.9 p -79.93 -38.1 33.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.151 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -61.2 132.72 54.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.39 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -126.5 133.97 51.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.777 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -64.97 147.17 53.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.252 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 93.8 mmm -145.26 -42.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.407 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.764 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 54.7 m -161.59 157.47 24.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.911 0.386 . . . . 0.0 111.099 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 31' ' ' LEU . . . -50.39 -27.57 6.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.419 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.545 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 54.0 m -133.3 42.11 3.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.371 . . . . 0.0 110.719 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.764 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 60.5 tttm -164.5 128.14 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.868 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.3 mt -149.97 118.07 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.506 ' CG1' ' HE3' ' A' ' 23' ' ' LYS . 50.1 t -84.46 130.46 35.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.553 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.547 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.4 p -170.07 131.67 1.03 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.791 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 22.3 ptt-85 -84.96 138.32 32.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.873 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.881 HG23 ' HA ' ' A' ' 20' ' ' PRO . 21.3 m -66.2 -145.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.724 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . -178.79 -40.82 0.07 OUTLIER Glycine 0 C--N 1.334 0.44 0 C-N-CA 119.7 -1.238 . . . . 0.0 113.753 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.558 HE21 ' HD2' ' A' ' 68' ' ' LYS . 15.2 pt20 -171.35 131.48 0.76 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.125 0.462 . . . . 0.0 111.588 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.663 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -83.87 64.77 8.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.586 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 45' ' ' GLY . 57.4 mtpt -50.02 -45.84 52.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.955 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -71.16 -131.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.313 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -145.02 -48.89 0.24 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.866 0.365 . . . . 0.0 110.591 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 89' ' ' SER . 63.1 tttm -74.28 -47.53 34.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.138 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.06 45.49 3.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.472 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.21 134.87 48.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.686 0.279 . . . . 0.0 111.179 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.559 ' O ' HD13 ' A' ' 75' ' ' ILE . 68.2 mt -85.42 134.15 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.474 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.559 HD13 ' O ' ' A' ' 74' ' ' ILE . 37.8 mm -132.97 133.98 58.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.145 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.739 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 53.4 t -141.51 114.37 4.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.825 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.0 m -81.0 142.17 33.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.522 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.5 p -141.93 140.19 32.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.86 0.362 . . . . 0.0 111.426 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.3 mmmm -57.02 -50.69 71.96 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.074 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.0 m -65.07 -53.33 47.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.974 0.416 . . . . 0.0 110.346 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.37 -123.33 0.5 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.148 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.507 ' H ' ' HD3' ' A' ' 8' ' ' PRO . . . -169.44 -141.15 3.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.195 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -62.11 130.08 43.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 110.748 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.739 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -69.69 150.05 48.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.083 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 47.3 p -149.09 145.99 27.5 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.535 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 48.1 t -158.29 134.13 9.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.11 0.481 . . . . 0.0 111.965 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -77.18 -33.41 56.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.517 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -83.74 139.08 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.371 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 71' ' ' LYS . 83.1 p -120.38 140.27 51.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.792 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -86.22 132.75 33.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.721 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.494 ' HD3' HD21 ' A' ' 93' ' ' LEU . 31.7 ttmt -83.27 123.96 30.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.359 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.429 HD13 HG21 ' A' ' 64' ' ' VAL . 56.4 tp -99.06 121.11 40.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.871 0.367 . . . . 0.0 110.734 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 60.4 mt -96.39 139.6 32.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.651 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 61.1 pttt -59.84 134.57 89.72 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.417 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.531 ' HG3' ' HD2' ' A' ' 20' ' ' PRO . 48.1 Cg_exo -58.13 133.26 54.28 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.869 2.379 . . . . 0.0 112.806 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.57 117.85 20.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.651 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.909 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.9 m170 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.678 0.275 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.4 tpt 57.66 51.75 9.08 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.73 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -58.54 135.88 57.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.053 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -62.0 135.47 94.73 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.342 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.27 145.7 73.07 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.449 2.1 . . . . 0.0 111.796 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.538 ' HG2' ' HA2' ' A' ' 84' ' ' GLY . 11.6 Cg_endo -55.93 120.88 8.99 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.367 2.045 . . . . 0.0 112.036 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 9' ' ' LEU . 5.7 tt -102.65 100.81 10.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.477 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.662 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 59.5 t -84.0 136.76 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.596 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 t -169.14 51.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.522 . . . . 0.0 111.188 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.03 141.48 7.01 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.417 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.534 HG12 ' HD2' ' A' ' 15' ' ' PRO . 13.9 tt -164.78 130.71 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.448 0.166 . . . . 0.0 110.662 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.771 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.3 t -59.97 -61.44 7.9 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.919 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 85.9 Cg_endo -83.91 -159.96 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 121.8 1.667 . . . . 0.0 111.104 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -175.25 24.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.111 0.482 . . . . 0.0 110.41 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HB2' HD11 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -179.33 127.33 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.155 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.479 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 165.47 151.35 6.62 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.847 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.403 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 33.7 pt -52.45 161.42 1.08 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.49 0.186 . . . . 0.0 110.986 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.757 ' HA ' HG23 ' A' ' 64' ' ' VAL . 73.7 Cg_exo -50.47 -40.72 53.81 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.694 2.263 . . . . 0.0 113.562 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.516 ' HE3' HH11 ' A' ' 63' ' ' ARG . 84.5 m95 -73.86 -5.8 43.25 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -64.96 129.47 39.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.362 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.07 137.27 51.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.586 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.493 HG21 HG13 ' A' ' 64' ' ' VAL . 34.6 m -144.84 130.59 14.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.973 0.416 . . . . 0.0 110.975 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.6 m -87.67 117.46 26.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.949 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.1 mt -80.38 137.91 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.754 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.611 ' NH1' ' HB2' ' A' ' 59' ' ' LYS . 25.9 mmm180 -139.72 137.59 35.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.949 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.14 -135.54 2.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.368 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 55.9 mm-40 -151.24 138.06 18.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.825 0.345 . . . . 0.0 111.286 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 76.1 m-20 62.59 38.79 12.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.288 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.566 HD23 HD12 ' A' ' 60' ' ' ILE . 9.5 mp -81.67 51.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.872 0.368 . . . . 0.0 111.063 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.429 ' HA2' ' OD2' ' A' ' 37' ' ' ASP . . . 76.5 134.56 0.56 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.893 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.5 p -59.75 -35.38 74.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.617 0.246 . . . . 0.0 111.314 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.58 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -168.24 -159.22 13.41 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.123 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.21 -46.36 15.63 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.954 2.436 . . . . 0.0 112.792 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 p -60.65 -41.22 94.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.511 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.429 ' OD2' ' HA2' ' A' ' 32' ' ' GLY . 64.9 t0 -66.33 -48.09 71.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.819 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.6 tt -64.63 130.75 44.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.989 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.504 ' N ' HD23 ' A' ' 38' ' ' LEU . 25.0 pt -149.36 -43.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.457 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -93.94 52.54 2.25 Favored Glycine 0 CA--C 1.51 -0.24 0 C-N-CA 120.494 -0.86 . . . . 0.0 114.149 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.554 HD13 ' N ' ' A' ' 42' ' ' THR . 2.7 tm? -70.23 127.25 32.14 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.69 HG22 ' HA ' ' A' ' 47' ' ' ASN . 6.9 p -155.58 144.96 20.98 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.153 0.502 . . . . 0.0 111.987 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.7 mt -137.66 123.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.527 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 60.3 m 57.64 36.37 26.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.099 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.46 -36.36 2.95 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.637 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -72.87 131.94 42.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.02 0.41 . . . . 0.0 111.398 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.69 ' HA ' HG22 ' A' ' 42' ' ' THR . 16.2 p-10 -72.56 141.78 48.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.433 ' C ' HD12 ' A' ' 41' ' ' LEU . 76.4 m -149.2 42.56 0.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.519 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 41' ' ' LEU . 33.0 tp -69.18 -44.47 72.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.19 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 51' ' ' THR . 3.6 pp -63.94 -34.48 78.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.173 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.729 ' N ' HD12 ' A' ' 50' ' ' LEU . 20.3 p -79.92 -38.17 33.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.821 0.343 . . . . 0.0 111.281 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -66.21 137.88 57.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.934 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -126.32 128.48 47.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.247 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.58 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 82.0 t90 -65.4 149.77 49.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.225 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.44 ' HG3' HG23 ' A' ' 61' ' ' VAL . 93.4 mmm -142.6 -43.81 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 58' ' ' SER . 48.7 m -155.83 178.02 10.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.674 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.2 37.21 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.564 ' O ' HD22 ' A' ' 31' ' ' LEU . 80.7 p -178.81 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.176 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.611 ' HB2' ' NH1' ' A' ' 27' ' ' ARG . 63.0 tttp -83.96 132.52 34.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.946 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.566 HD12 HD23 ' A' ' 31' ' ' LEU . 74.5 mt -148.62 115.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.668 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.44 HG23 ' HG3' ' A' ' 55' ' ' MET . 40.2 t -84.55 122.75 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.681 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 41.9 t -171.02 146.11 2.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.036 0.446 . . . . 0.0 111.179 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.516 HH11 ' HE3' ' A' ' 21' ' ' TRP . 98.9 mtt180 -85.19 134.09 34.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.207 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.757 HG23 ' HA ' ' A' ' 20' ' ' PRO . 19.4 m -55.72 136.67 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.599 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . -66.29 -125.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.618 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -142.89 143.45 32.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.86 0.362 . . . . 0.0 110.882 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.87 134.88 42.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.793 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -144.71 -41.39 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.612 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.439 HD22 ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -174.48 153.54 1.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.658 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 69' ' ' ASN . 1.5 m-20 73.87 -40.77 0.47 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.653 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 69' ' ' ASN . 83.4 tttt 64.34 124.28 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.871 ' HA3' ' HB2' ' A' ' 89' ' ' SER . . . 75.39 -33.28 1.14 Allowed Glycine 0 CA--C 1.517 0.217 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.957 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -45.16 127.49 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.373 . . . . 0.0 111.586 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.508 ' C ' HD12 ' A' ' 75' ' ' ILE . 68.0 mt -115.47 117.93 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.134 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.809 HG21 ' HE3' ' A' ' 83' ' ' LYS . 3.1 mp -120.98 137.5 54.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.37 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.725 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 3.8 p -141.76 103.58 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.829 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -77.31 131.94 38.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.657 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 82.4 p -123.15 142.32 51.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.091 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -50.78 -48.04 59.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.5 m -69.44 -48.48 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.981 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.83 -128.52 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.615 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.4 -40.99 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.344 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.809 ' HE3' HG21 ' A' ' 75' ' ' ILE . 49.6 tptt -169.72 127.45 0.91 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.76 0.314 . . . . 0.0 110.631 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.725 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -74.02 145.5 35.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.967 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.1 p -143.58 138.63 29.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.597 0.237 . . . . 0.0 110.52 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.662 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 45.2 t -133.13 129.81 38.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.019 0.438 . . . . 0.0 111.493 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.6 p -74.02 -32.43 63.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.573 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -83.88 176.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.372 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.871 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 72.5 p -157.44 133.2 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.649 ' CD2' HG11 ' A' ' 64' ' ' VAL . 69.0 t80 -85.62 127.32 34.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.815 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -85.04 122.31 29.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 110.607 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.522 ' N ' HD22 ' A' ' 92' ' ' LEU . 2.9 mm? -82.21 129.73 34.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.929 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.479 HD12 ' HA2' ' A' ' 18' ' ' GLY . 80.2 mt -100.59 138.94 36.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.6 139.48 96.0 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.039 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.38 133.68 28.92 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.518 2.145 . . . . 0.0 112.045 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.96 76.48 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.133 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.4 pttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.92 -179.834 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.552 0.215 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.5 ttt -62.24 134.54 56.66 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.752 0.31 . . . . 0.0 110.68 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -59.82 134.8 57.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.004 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.714 ' NE2' ' H ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -64.98 136.46 96.8 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.023 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.22 144.28 95.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.614 2.21 . . . . 0.0 112.153 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 51.8 Cg_exo -51.86 133.49 45.63 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.524 2.149 . . . . 0.0 112.185 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.55 HD22 HG23 ' A' ' 11' ' ' THR . 3.3 tt -123.56 118.0 26.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.236 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.514 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 62.8 t -81.34 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.285 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.55 HG23 HD22 ' A' ' 9' ' ' LEU . 71.4 p -147.0 45.2 1.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.033 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' C ' ' HB3' ' A' ' 27' ' ' ARG . . . 178.0 147.51 6.92 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.206 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.51 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.3 tt -160.98 130.42 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.728 0.299 . . . . 0.0 110.499 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.823 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.9 t -68.76 -58.2 7.05 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.685 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.823 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 68.8 Cg_endo -93.03 115.14 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.278 1.985 . . . . 0.0 112.592 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.531 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -96.96 27.79 3.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.939 0.4 . . . . 0.0 110.61 179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HB2' HD21 ' A' ' 93' ' ' LEU . 23.8 pt-20 -179.67 130.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.17 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.537 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 171.88 146.03 5.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.828 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.471 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 29.1 pt -54.17 162.81 1.4 Allowed Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 120.486 0.184 . . . . 0.0 111.28 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 19' ' ' ILE . 85.2 Cg_exo -48.16 -37.87 31.79 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.822 2.348 . . . . 0.0 113.653 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -77.71 -15.71 58.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -60.64 124.71 21.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.678 0.275 . . . . 0.0 111.195 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 25.5 pttm -77.18 127.08 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 0.0 110.431 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.799 HG12 ' HG2' ' A' ' 15' ' ' PRO . 16.6 m -109.45 125.64 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.556 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 84.9 m -72.42 120.88 18.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.82 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.511 HD12 ' HB ' ' A' ' 60' ' ' ILE . 65.5 mt -80.96 139.01 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.002 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 58' ' ' SER . 27.8 tpt180 -147.42 127.3 13.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.894 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.17 -134.58 1.75 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.959 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -149.5 137.55 20.5 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.921 0.391 . . . . 0.0 111.579 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 73.6 m-20 60.61 40.6 16.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.578 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.499 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.2 mp -84.49 53.5 2.68 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.863 0.363 . . . . 0.0 110.597 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.51 129.32 0.43 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.539 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.4 p -97.91 42.56 1.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.328 . . . . 0.0 111.369 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.97 142.21 3.98 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.699 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.528 ' HG3' ' CE3' ' A' ' 54' ' ' TRP . 36.0 Cg_exo -56.56 -47.25 24.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.519 2.146 . . . . 0.0 112.116 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.4 p -65.28 -33.97 77.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.421 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -51.29 -42.88 61.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.997 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.2 tt -65.92 127.12 30.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 40' ' ' GLY . 32.9 pt -134.43 -44.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 111.32 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.5 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -100.86 136.46 12.71 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.463 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.555 HD13 ' N ' ' A' ' 42' ' ' THR . 2.2 tm? -148.8 126.67 11.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 47' ' ' ASN . 7.1 p -155.34 141.75 18.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.161 0.505 . . . . 0.0 111.873 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.8 HG21 HG23 ' A' ' 64' ' ' VAL . 76.5 mt -129.97 124.0 57.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.401 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.578 ' HA ' HD22 ' A' ' 69' ' ' ASN . 63.0 m 55.4 39.45 31.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.11 -32.92 2.23 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.894 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -72.53 129.75 39.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 0.0 111.127 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.663 ' HA ' HG22 ' A' ' 42' ' ' THR . 5.4 m120 -70.44 140.41 51.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.844 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.429 ' C ' HD12 ' A' ' 41' ' ' LEU . 75.1 m -150.39 40.36 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.4 tp -72.38 -43.88 63.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.321 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 50' ' ' LEU . 2.6 pt? -56.39 -38.63 71.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.4 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.0 p -79.84 -36.43 36.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.352 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -59.63 132.98 55.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.561 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -126.92 126.46 43.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.537 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.528 ' CE3' ' HG3' ' A' ' 35' ' ' PRO . 79.6 t90 -69.44 152.85 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.326 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 49.1 mtt -147.56 -44.38 0.17 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.025 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.2 p -169.58 173.57 6.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.637 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.93 37.31 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.524 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.491 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 79.0 p -176.68 24.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.087 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 59.4 tttp -165.31 128.83 2.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.138 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' HB ' HD12 ' A' ' 26' ' ' ILE . 73.4 mt -152.2 119.55 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.655 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.37 134.15 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.616 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.544 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.8 p -169.57 146.2 3.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.845 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.672 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 68.3 mtt-85 -84.03 131.64 34.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.745 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.8 HG23 HG21 ' A' ' 43' ' ' ILE . 8.4 p -67.78 -137.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.085 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.686 ' H ' HG22 ' A' ' 64' ' ' VAL . . . 168.94 -140.78 6.34 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.173 -1.013 . . . . 0.0 113.003 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.504 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 3.0 pt20 -87.72 138.47 31.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 0.0 111.471 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.631 ' HB2' HD12 ' A' ' 92' ' ' LEU . . . -78.02 66.25 3.61 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.461 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.504 ' HG3' ' HG3' ' A' ' 66' ' ' GLN . 57.7 mtpt -51.8 -43.32 63.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.811 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.578 HD22 ' HA ' ' A' ' 44' ' ' CYS . 76.8 m-20 -69.02 -124.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.771 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -163.4 38.73 0.09 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.81 0.338 . . . . 0.0 110.943 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 89' ' ' SER . 38.8 ttmt -171.03 -43.32 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.606 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.528 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . 97.67 47.37 2.14 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.843 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -73.24 130.93 41.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 111.328 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.502 ' O ' HD13 ' A' ' 75' ' ' ILE . 70.4 mt -85.59 135.2 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.226 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.502 HD13 ' O ' ' A' ' 74' ' ' ILE . 40.0 mm -131.55 137.02 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.798 0.332 . . . . 0.0 111.703 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.4 t -141.53 117.84 6.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.937 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -86.05 147.33 26.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.347 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.9 p -139.44 143.7 37.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.4 mmmm -53.97 -55.06 30.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.365 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.1 t -67.65 -55.43 13.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.002 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.28 -128.65 0.38 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.644 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 -137.3 2.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.999 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -65.12 121.4 14.64 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.5 126.78 8.74 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.893 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 73.1 p -99.43 144.05 28.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.412 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 80.9 p -131.98 126.79 34.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.928 0.394 . . . . 0.0 111.581 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.9 p -91.65 35.75 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.604 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.49 156.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.67 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.533 ' HB2' ' O ' ' A' ' 71' ' ' LYS . 84.5 p -138.53 134.63 34.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.946 0.403 . . . . 0.0 111.192 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.651 ' HE2' HG11 ' A' ' 64' ' ' VAL . 39.3 t80 -86.06 131.42 34.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.347 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -83.93 124.79 31.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.062 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.631 HD12 ' HB2' ' A' ' 67' ' ' ALA . 89.2 mt -90.0 127.71 36.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 111.647 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 18' ' ' GLY . 78.3 mt -92.56 139.98 30.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.372 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -56.52 126.89 71.31 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.949 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -53.45 137.75 65.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.869 2.379 . . . . 0.0 112.922 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -70.47 117.89 12.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.881 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.834 -179.838 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.7 m80 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.823 0.344 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.413 ' N ' ' SD ' ' A' ' 4' ' ' MET . 3.2 mpp? -64.42 -45.93 85.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.784 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.572 HH12 ' HB3' ' A' ' 80' ' ' SER . 14.4 tpp85 -62.89 128.29 35.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.52 ' H ' ' CD ' ' A' ' 6' ' ' GLN . 3.2 pm0 -77.23 129.52 77.7 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.055 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.71 148.59 36.94 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.755 2.303 . . . . 0.0 112.375 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.48 142.85 99.58 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.635 2.223 . . . . 0.0 112.054 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.518 HD13 ' C ' ' A' ' 9' ' ' LEU . 3.3 tm? -140.38 119.83 13.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.499 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.1 t -83.58 142.55 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.986 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 t -167.99 49.02 0.05 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.037 0.446 . . . . 0.0 111.363 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.13 138.5 3.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.698 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.518 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.7 tt -165.24 130.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.637 0.256 . . . . 0.0 110.604 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.818 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.6 t -65.46 -59.38 9.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.692 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.818 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 83.7 Cg_endo -90.58 111.72 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.164 1.909 . . . . 0.0 112.155 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -89.33 26.81 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.595 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 176.22 132.25 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.261 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.73 144.22 4.64 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.905 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.429 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 33.1 pt -56.7 160.77 5.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.496 0.189 . . . . 0.0 111.02 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.744 ' HA ' HG13 ' A' ' 64' ' ' VAL . 84.8 Cg_exo -47.07 -45.15 22.02 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.812 2.342 . . . . 0.0 113.544 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -67.2 -22.43 65.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.2 m -62.61 128.21 34.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.136 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 24.7 ttmm -73.83 138.18 44.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.622 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.691 HG12 ' HG2' ' A' ' 15' ' ' PRO . 35.0 m -132.23 125.28 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.002 0.43 . . . . 0.0 111.032 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -85.57 118.8 25.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.097 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 62.4 mt -83.92 137.16 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.431 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -147.66 135.76 21.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.827 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.93 -126.6 0.85 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.21 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -145.18 134.85 23.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 0.0 111.329 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 60.97 42.21 13.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.079 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 mp -83.91 54.93 3.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 0.0 110.964 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.21 134.19 1.9 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.76 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.6 p -67.4 -40.81 85.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.63 0.252 . . . . 0.0 111.62 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.552 ' HA2' ' CZ2' ' A' ' 54' ' ' TRP . . . -156.52 -177.92 30.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.755 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -57.85 -40.27 79.94 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.638 2.225 . . . . 0.0 112.042 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.8 p -59.95 -41.35 91.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.983 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 37.7 t70 -66.82 -46.88 73.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.898 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.511 ' C ' HD13 ' A' ' 38' ' ' LEU . 3.4 tm? -69.85 129.0 38.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.923 0.392 . . . . 0.0 110.347 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.501 HD13 ' HG2' ' A' ' 79' ' ' LYS . 49.8 pt -147.96 -23.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.422 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.91 128.72 6.98 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.848 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' A' ' 52' ' ' ALA . 31.4 tp -150.41 147.15 27.2 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.64 0.257 . . . . 0.0 110.558 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 46' ' ' HIS . 98.2 m -161.69 129.28 4.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.396 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.514 HD11 ' SG ' ' A' ' 62' ' ' CYS . 70.8 mt -105.34 130.52 56.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.449 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 79.7 m 69.26 -66.42 0.26 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.53 0.519 . . . . 0.0 110.971 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.65 26.13 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.493 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.56 ' O ' HG23 ' A' ' 42' ' ' THR . 83.1 t60 -132.18 135.76 46.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.585 0.231 . . . . 0.0 110.707 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -59.29 136.83 58.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.772 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.7 m -151.45 36.28 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.102 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 49.5 tp -70.3 -44.69 67.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.964 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -54.12 -40.77 67.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.049 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.3 p -80.38 -32.67 37.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.04 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.15 133.27 55.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.087 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -127.14 127.1 44.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.129 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.552 ' CZ2' ' HA2' ' A' ' 34' ' ' GLY . 43.4 t90 -67.4 149.09 50.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 110.702 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.688 ' HG3' HG23 ' A' ' 61' ' ' VAL . 94.5 mmm -143.26 -43.13 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.2 t -166.86 172.84 9.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.846 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.58 25.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.641 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.8 m -167.78 21.35 0.03 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.696 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.579 ' NZ ' ' HB2' ' A' ' 59' ' ' LYS . 5.0 ttmp? -165.1 134.87 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.3 mt -146.86 121.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.688 HG23 ' HG3' ' A' ' 55' ' ' MET . 60.7 t -80.89 125.7 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.513 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 28.1 p -170.42 140.56 1.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.021 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 84.4 mtm180 -84.33 136.79 33.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.634 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.744 HG13 ' HA ' ' A' ' 20' ' ' PRO . 4.8 p -54.29 137.73 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.395 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.74 -62.0 4.07 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.801 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' C ' ' HG ' ' A' ' 92' ' ' LEU . 24.7 pt20 -178.6 -138.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.399 -0.222 . . . . 0.0 110.399 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.615 ' HB2' ' CB ' ' A' ' 92' ' ' LEU . . . -139.61 48.03 1.84 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.723 0.297 . . . . 0.0 111.098 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -51.79 -46.32 64.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.174 0.511 . . . . 0.0 110.069 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.537 HD22 ' N ' ' A' ' 69' ' ' ASN . 1.8 m120 -87.39 151.55 22.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.422 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.606 ' OD1' ' HG3' ' A' ' 71' ' ' LYS . 1.2 p30 -56.24 -44.81 79.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.021 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.606 ' HG3' ' OD1' ' A' ' 70' ' ' ASP . 97.1 mttt -86.78 -125.58 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.437 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.51 40.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.311 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -62.76 130.91 47.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 71.8 mt -85.3 131.58 33.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.468 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.0 mm -128.88 139.55 51.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.229 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.78 121.65 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.904 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.8 m -98.09 133.9 41.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.509 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 81.6 p -118.52 142.21 47.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.178 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 37' ' ' ASP . 29.4 mtpp -54.02 -44.88 71.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.633 0.254 . . . . 0.0 110.982 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.572 ' HB3' HH12 ' A' ' 5' ' ' ARG . 49.9 m -66.81 -47.13 72.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.984 0.421 . . . . 0.0 109.957 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.42 -132.53 1.69 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.47 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 83' ' ' LYS . . . 172.81 67.41 0.05 OUTLIER Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.247 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 82' ' ' GLY . 59.2 tttm 67.98 109.28 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.881 0.372 . . . . 0.0 110.439 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.06 -134.32 6.44 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.856 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.427 ' OG1' HD23 ' A' ' 9' ' ' LEU . 74.4 p -145.99 -168.26 2.94 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.578 0.227 . . . . 0.0 110.626 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 78.4 p -169.47 125.35 0.86 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 111.151 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.9 p -90.53 28.37 1.5 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.708 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 m -153.58 149.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.999 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.8 m -134.56 134.86 41.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -85.5 127.67 34.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -81.08 117.15 21.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.553 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.615 ' CB ' ' HB2' ' A' ' 67' ' ' ALA . 1.5 tm? -81.16 128.47 33.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.523 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.586 ' N ' HD13 ' A' ' 92' ' ' LEU . 80.8 mt -99.65 133.51 43.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.845 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -68.05 134.1 91.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.661 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.45 129.95 37.43 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.368 2.046 . . . . 0.0 112.349 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -79.85 119.29 22.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.674 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.869 179.899 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.79 0.328 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 4' ' ' MET . 27.8 ttt -79.67 44.76 0.64 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.078 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.572 ' HA ' ' NE ' ' A' ' 5' ' ' ARG . 12.9 mmp_? -68.79 129.63 40.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.612 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -67.34 133.25 93.17 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.01 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.82 146.59 66.24 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.658 2.239 . . . . 0.0 112.206 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 18.0 Cg_endo -58.31 129.61 33.62 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.596 2.198 . . . . 0.0 112.3 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 85' ' ' THR . 63.2 tp -113.33 119.84 39.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.071 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.43 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 69.7 t -85.29 132.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.069 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.9 p -151.57 47.91 0.81 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.51 144.57 6.43 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.869 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.567 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 13.0 tt -158.95 131.01 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.882 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 53.2 m -60.88 -60.69 9.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.565 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 1.001 ' HG2' HG12 ' A' ' 24' ' ' VAL . 3.7 Cg_exo -75.83 -150.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.954 1.769 . . . . 0.0 111.796 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.515 ' OD1' ' HG2' ' A' ' 17' ' ' GLU . 5.3 p30 -173.94 -22.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.024 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.515 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 16.2 pt-20 -159.51 129.38 5.52 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.685 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 169.69 159.81 16.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.56 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.405 HG21 ' HA ' ' A' ' 95' ' ' PRO . 35.6 pt -51.64 156.75 2.14 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.613 0.244 . . . . 0.0 111.03 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.853 ' HA ' HG23 ' A' ' 64' ' ' VAL . 75.8 Cg_exo -51.88 -41.07 65.16 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.742 2.295 . . . . 0.0 113.496 -179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -70.67 -5.79 32.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -64.02 131.0 46.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.998 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.736 ' HD2' HG13 ' A' ' 61' ' ' VAL . 17.3 tppt? -65.99 136.97 56.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.283 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.001 HG12 ' HG2' ' A' ' 15' ' ' PRO . 26.3 m -141.45 131.34 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.007 0.432 . . . . 0.0 111.309 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.416 ' HB ' ' OG ' ' A' ' 14' ' ' SER . 99.7 m -90.3 122.53 33.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.663 HD12 ' HB ' ' A' ' 60' ' ' ILE . 64.1 mt -79.41 141.5 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.782 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.403 ' HG2' HH11 ' A' ' 27' ' ' ARG . 12.2 tpt180 -147.56 131.39 17.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.318 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.87 -135.62 1.95 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.663 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 67.0 mm-40 -145.93 135.86 23.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.842 0.353 . . . . 0.0 111.44 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.474 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 72.8 m-80 61.59 40.59 13.3 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.351 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 mp -83.57 49.05 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.704 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.72 124.24 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.476 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.8 p -88.29 39.25 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.763 0.316 . . . . 0.0 111.362 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.36 147.47 5.07 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.594 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.92 -41.6 62.54 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.334 2.023 . . . . 0.0 111.77 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.9 p -61.17 -34.67 75.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.771 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.94 46.09 0.56 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.815 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 40' ' ' GLY . 1.9 tt -157.4 121.9 4.35 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.409 HD13 ' CD ' ' A' ' 79' ' ' LYS . 29.0 pt -144.21 33.16 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.989 0.423 . . . . 0.0 111.424 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.453 ' H ' HD23 ' A' ' 38' ' ' LEU . . . -174.04 128.5 1.48 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.39 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.685 HD13 ' N ' ' A' ' 42' ' ' THR . 1.2 tm? -150.56 134.0 16.4 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.685 ' N ' HD13 ' A' ' 41' ' ' LEU . 94.0 m -158.33 128.08 5.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.079 0.466 . . . . 0.0 111.746 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.651 HG21 ' HA ' ' A' ' 64' ' ' VAL . 41.1 mm -115.72 126.09 73.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.387 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.676 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 69.7 m 57.68 45.79 18.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.789 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.508 ' O ' ' HD2' ' A' ' 68' ' ' LYS . . . 61.94 11.65 32.2 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.975 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.479 ' C ' HG23 ' A' ' 42' ' ' THR . 82.1 t60 -116.07 133.12 56.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.328 . . . . 0.0 111.026 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.13 133.29 54.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.987 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.1 m -153.35 39.01 0.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.669 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.1 tp -72.27 -41.97 66.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.459 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 51' ' ' THR . 3.9 pp -58.07 -33.51 69.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.501 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.7 ' N ' HD12 ' A' ' 50' ' ' LEU . 20.3 p -80.03 -37.7 33.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.766 0.317 . . . . 0.0 110.99 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.577 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -59.82 131.13 49.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.735 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -127.21 127.58 44.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.262 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -65.62 141.53 58.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.739 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 95.3 mmm -132.23 -42.65 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.139 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 m -160.93 -166.34 1.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.998 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.04 -7.53 54.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.478 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.4 m -156.23 47.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.078 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 87.3 tttt -164.44 129.11 2.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.9 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.663 ' HB ' HD12 ' A' ' 26' ' ' ILE . 76.2 mt -150.21 126.91 2.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.968 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.736 HG13 ' HD2' ' A' ' 23' ' ' LYS . 89.1 t -84.58 127.89 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.535 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.5 p -170.67 145.09 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.815 0.34 . . . . 0.0 111.198 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -84.63 131.63 34.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.341 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.853 HG23 ' HA ' ' A' ' 20' ' ' PRO . 15.3 m -61.39 124.9 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.421 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.406 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . -74.39 151.28 43.2 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.683 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -52.43 140.75 21.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.749 0.309 . . . . 0.0 110.64 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.676 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -59.71 121.24 11.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.263 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HD2' ' O ' ' A' ' 45' ' ' GLY . 52.5 tttp -87.85 -53.69 4.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.45 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -92.77 -74.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.9 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -160.01 -54.19 0.06 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -78.34 -126.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.143 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 44' ' ' CYS . . . 171.67 48.69 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.53 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -57.87 132.16 52.55 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.01 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 70.4 mt -86.77 121.18 37.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.748 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.9 mm -111.62 138.97 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.307 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.458 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 62.0 t -141.39 110.64 2.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.901 0.382 . . . . 0.0 111.095 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.7 m -79.73 143.39 34.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.823 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.5 p -136.86 139.74 41.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.893 0.377 . . . . 0.0 111.369 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.409 ' CD ' HD13 ' A' ' 39' ' ' ILE . 32.0 mmmt -56.78 -47.43 80.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.055 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.7 m -67.25 -52.83 36.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.607 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 -125.14 2.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.068 -0.586 . . . . 0.0 112.411 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 -134.97 1.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.18 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -60.58 125.46 23.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 0.0 110.524 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.458 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -72.92 130.7 14.48 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.217 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 74.3 p -100.47 147.47 25.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.586 0.232 . . . . 0.0 110.773 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -159.88 125.74 4.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.32 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.7 p -99.0 40.73 1.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.522 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.4 m -147.97 157.34 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.798 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.2 p -150.74 139.24 20.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.542 ' CE2' HG21 ' A' ' 64' ' ' VAL . 68.9 t80 -84.83 127.24 34.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.163 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -72.4 120.26 17.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.338 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' A' ' 67' ' ' ALA . 92.9 mt -90.19 128.95 36.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.285 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.411 HD12 ' HA2' ' A' ' 18' ' ' GLY . 67.1 mt -105.55 140.11 39.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.631 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -58.51 140.22 84.76 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.405 ' HA ' HG21 ' A' ' 19' ' ' ILE . 52.0 Cg_exo -53.9 129.1 32.46 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.534 2.156 . . . . 0.0 112.598 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -82.93 119.15 24.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.495 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.1 pttt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.946 -179.787 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.847 0.356 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -58.32 130.89 48.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.086 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.458 ' HA ' ' NE ' ' A' ' 5' ' ' ARG . 3.6 mmp_? -75.62 135.84 40.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.786 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.706 ' NE2' ' H ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -72.47 133.02 83.22 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.975 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.72 141.78 38.32 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.51 2.14 . . . . 0.0 112.407 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 16.6 Cg_endo -57.57 143.46 94.65 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.735 2.29 . . . . 0.0 112.288 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 10' ' ' VAL . 1.9 tm? -132.12 122.47 25.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.248 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.511 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 63.7 t -83.04 137.65 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.624 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.409 HG23 HD12 ' A' ' 9' ' ' LEU . 68.9 p -148.94 45.6 1.0 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.94 146.34 6.91 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.126 -1.035 . . . . 0.0 113.449 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.1 tt -163.59 128.32 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.677 0.275 . . . . 0.0 110.308 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.869 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 59.1 m -68.48 -60.05 5.21 Favored Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.717 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.919 ' HG2' HG12 ' A' ' 24' ' ' VAL . 70.1 Cg_endo -95.24 106.74 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.399 2.066 . . . . 0.0 112.157 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -91.07 32.31 1.03 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.562 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 179.31 128.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.36 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 169.03 149.45 6.23 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.593 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.3 pt -54.01 160.07 2.49 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.538 0.209 . . . . 0.0 111.04 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.632 ' HA ' HG23 ' A' ' 64' ' ' VAL . 86.1 Cg_exo -49.26 -38.65 42.26 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.889 2.393 . . . . 0.0 113.651 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -75.8 -14.5 60.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 m -63.58 127.92 33.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 111.536 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 54.1 mtmt -74.97 134.65 41.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.324 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.919 HG12 ' HG2' ' A' ' 15' ' ' PRO . 28.4 m -123.41 128.57 74.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.941 0.4 . . . . 0.0 111.339 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.6 m -73.67 117.05 14.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.764 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 60' ' ' ILE . 67.9 mt -86.99 136.08 23.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.063 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.478 ' HE ' ' HG3' ' A' ' 59' ' ' LYS . 21.0 mmt85 -146.5 134.96 21.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.601 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.03 -130.99 1.27 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.466 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -146.49 132.48 19.21 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.855 0.36 . . . . 0.0 111.343 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.519 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.1 m-80 61.27 41.76 12.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.136 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.587 HD22 ' O ' ' A' ' 58' ' ' SER . 10.0 mp -81.86 53.33 2.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.978 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.99 134.32 1.22 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.639 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 p -66.47 -37.47 85.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.665 0.269 . . . . 0.0 111.537 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.42 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -154.79 -174.4 24.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.008 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.77 -43.93 15.0 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.737 2.291 . . . . 0.0 112.567 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.0 p -56.36 -40.63 74.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.828 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 79' ' ' LYS . 37.7 t70 -66.28 -36.86 84.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.736 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.2 tp -74.61 63.06 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.513 ' O ' HD22 ' A' ' 49' ' ' LEU . 32.5 pt -73.0 -37.14 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.158 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -113.51 142.27 17.36 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.037 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.646 HD13 ' N ' ' A' ' 42' ' ' THR . 3.0 tm? -149.62 134.71 18.06 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.646 ' N ' HD13 ' A' ' 41' ' ' LEU . 18.5 p -150.31 151.16 32.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.079 0.466 . . . . 0.0 111.832 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 77.2 mt -136.15 117.49 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.328 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 85.3 m 73.78 -38.3 0.4 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.468 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 168.33 -40.1 0.22 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.962 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -80.24 140.68 36.14 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.92 0.39 . . . . 0.0 111.763 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.541 ' HA ' HG22 ' A' ' 42' ' ' THR . 39.3 t30 -59.8 144.59 48.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.965 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.5 m -149.96 38.28 0.74 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.08 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.513 HD22 ' O ' ' A' ' 39' ' ' ILE . 52.8 tp -73.84 -47.67 36.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.237 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.3 pt? -48.41 -44.44 35.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.727 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.674 HG21 ' HE ' ' A' ' 63' ' ' ARG . 52.9 p -80.12 -37.87 32.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.722 0.296 . . . . 0.0 111.349 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -60.23 137.16 58.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.491 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -126.76 130.72 50.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.506 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.42 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 55.7 t90 -66.53 150.83 48.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.223 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.8 mmt -141.2 -47.49 0.39 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.902 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.2 t -166.41 -175.1 3.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.401 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.73 38.23 0.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.756 0.312 . . . . 0.0 111.169 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.587 ' O ' HD22 ' A' ' 31' ' ' LEU . 80.4 p -175.87 -43.54 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.478 ' HG3' ' HE ' ' A' ' 27' ' ' ARG . 61.9 tttm -82.87 131.94 35.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.227 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 77.2 mt -151.78 105.92 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.598 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.8 p -80.25 130.67 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 110.825 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 31.7 t -170.82 141.33 1.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 111.407 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.674 ' HE ' HG21 ' A' ' 51' ' ' THR . 40.1 ptt180 -85.35 131.88 34.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.392 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.632 HG23 ' HA ' ' A' ' 20' ' ' PRO . 27.0 m -66.68 -149.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.732 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.51 ' C ' ' HB3' ' A' ' 20' ' ' PRO . . . -178.64 -142.22 4.7 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.634 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -77.23 -143.13 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.09 124.27 0.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 110.972 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.54 ' HB3' ' NZ ' ' A' ' 68' ' ' LYS . 3.3 mmmp? -71.09 -52.33 20.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -71.83 -82.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.772 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 64.1 t0 179.7 -47.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.69 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.613 ' HZ3' ' HB3' ' A' ' 89' ' ' SER . 25.6 ttpp -68.71 -116.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.794 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.8 46.72 0.05 OUTLIER Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.476 -0.868 . . . . 0.0 112.717 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.6 ' HB2' ' HZ1' ' A' ' 71' ' ' LYS . 63.9 t0 -63.81 128.63 36.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.928 0.394 . . . . 0.0 111.219 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.528 ' O ' HD13 ' A' ' 75' ' ' ILE . 68.5 mt -85.76 130.74 35.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.326 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.882 HG21 ' HE2' ' A' ' 83' ' ' LYS . 34.5 mm -134.19 145.77 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 111.449 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.2 p -139.55 128.36 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.833 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.5 m -93.61 143.79 25.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.403 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.8 p -137.0 137.42 39.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.541 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 7.5 mtpm? -55.65 -48.26 75.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.4 m -65.87 -55.46 16.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.928 0.394 . . . . 0.0 110.382 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.0 -123.64 0.72 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.161 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.82 -143.04 3.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.005 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.882 ' HE2' HG21 ' A' ' 75' ' ' ILE . 19.7 tptm -69.18 109.72 4.21 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.94 -161.25 7.28 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.181 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.43 ' HA ' ' CD1' ' A' ' 75' ' ' ILE . 44.0 p -154.29 -169.03 3.11 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.427 0.291 . . . . 0.0 110.451 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.511 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 45.4 t -171.16 131.86 0.8 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.755 0.312 . . . . 0.0 111.243 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.7 p -90.49 31.68 1.01 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.78 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.4 m -152.03 142.48 15.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.922 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.613 ' HB3' ' HZ3' ' A' ' 71' ' ' LYS . 77.3 p -125.07 133.72 52.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.72 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.506 ' CE2' HG21 ' A' ' 64' ' ' VAL . 69.5 t80 -85.77 128.08 34.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.866 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -82.48 123.13 28.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.572 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.8 mt -81.84 128.8 34.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.152 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.47 HD12 ' HA2' ' A' ' 18' ' ' GLY . 79.1 mt -98.89 133.38 43.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.724 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 31.0 mmmt -74.37 134.74 76.38 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 51.9 Cg_exo -55.85 130.75 42.06 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.53 2.153 . . . . 0.0 112.352 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -75.22 115.97 15.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.682 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.3 tttm . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.912 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.844 0.354 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 93.0 mmm -57.36 138.42 54.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.728 ' HD3' ' HB3' ' A' ' 80' ' ' SER . 99.5 mtt180 -145.74 45.39 1.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.771 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -60.25 145.53 85.66 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.225 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.451 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 50.9 Cg_exo -54.68 141.08 76.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.626 2.217 . . . . 0.0 112.289 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 48.0 Cg_exo -56.52 137.98 82.66 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.515 2.143 . . . . 0.0 112.148 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 85' ' ' THR . 3.5 tt -130.39 113.25 14.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.107 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.555 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 90.3 t -81.01 135.69 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.421 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.7 p -146.67 42.5 1.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.14 144.74 5.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.75 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.536 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.0 tt -163.07 130.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.62 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.827 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 50.4 m -65.64 -58.94 10.3 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.068 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.827 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 90.9 Cg_endo -95.0 119.99 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.575 2.183 . . . . 0.0 112.478 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -92.92 21.17 5.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.887 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 178.64 135.58 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.655 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.403 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 167.35 145.44 4.5 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.94 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 93' ' ' LEU . 33.4 pt -54.97 159.79 3.51 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 110.723 -0.103 . . . . 0.0 110.723 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.908 ' HA ' HG23 ' A' ' 64' ' ' VAL . 73.7 Cg_exo -48.67 -39.93 38.11 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.574 2.183 . . . . 0.0 113.099 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.406 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 60.4 m95 -69.92 -21.19 63.31 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.6 m -60.94 129.83 43.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 111.452 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.549 ' HD2' HG13 ' A' ' 61' ' ' VAL . 4.5 tppp? -70.34 140.59 52.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.422 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.702 HG12 ' HG2' ' A' ' 15' ' ' PRO . 19.6 m -136.66 133.15 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.2 m -88.13 110.59 20.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.782 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.406 HD11 ' SG ' ' A' ' 62' ' ' CYS . 59.6 mt -75.95 138.8 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.466 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.517 ' O ' HG13 ' A' ' 10' ' ' VAL . 22.2 tpp180 -147.11 128.99 15.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.385 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.77 -136.22 2.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.62 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -148.57 138.41 22.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.941 0.4 . . . . 0.0 111.197 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 62.92 41.18 8.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.289 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.576 HD23 HD12 ' A' ' 60' ' ' ILE . 9.8 mp -85.47 52.07 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.875 0.369 . . . . 0.0 110.495 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.85 125.14 0.19 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.305 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -91.92 39.74 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.753 0.311 . . . . 0.0 111.493 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 169.54 144.74 4.37 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.599 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.88 -43.5 58.74 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.491 2.128 . . . . 0.0 111.997 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.8 p -61.75 -37.48 84.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.193 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 32.7 m-20 -57.1 -44.1 82.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.484 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.445 HD11 HD13 ' A' ' 60' ' ' ILE . 1.2 tt -73.9 67.74 1.26 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.74 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.509 HD13 ' HG2' ' A' ' 79' ' ' LYS . 26.6 pt -75.92 -39.53 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.675 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -114.31 139.17 15.42 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.219 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.576 HD13 ' N ' ' A' ' 42' ' ' THR . 3.0 tm? -150.13 130.11 13.44 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.576 ' N ' HD13 ' A' ' 41' ' ' LEU . 36.2 p -151.61 137.08 17.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 111.748 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.438 ' HB ' ' H ' ' A' ' 65' ' ' GLY . 69.1 mt -125.28 126.13 70.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.648 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.508 ' SG ' HD21 ' A' ' 92' ' ' LEU . 69.5 m 58.19 38.37 26.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.018 0.437 . . . . 0.0 110.335 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.408 ' HA3' ' OD1' ' A' ' 69' ' ' ASN . . . 64.07 34.28 89.49 Favored Glycine 0 C--N 1.331 0.285 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.171 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -131.34 133.38 45.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.299 . . . . 0.0 110.556 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.491 ' HA ' HG22 ' A' ' 42' ' ' THR . 45.7 t30 -68.56 132.94 47.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.051 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.0 m -154.64 36.67 0.41 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.628 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 3.3 tm? -77.51 -46.09 23.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.774 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -52.72 -39.73 62.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.053 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.615 HG21 ' NE ' ' A' ' 63' ' ' ARG . 67.8 p -80.48 -35.67 34.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -55.13 138.37 44.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.514 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -126.07 130.69 51.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.806 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -80.36 150.6 29.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.4 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.9 mtt -147.71 -44.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.482 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 t -165.52 176.42 8.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.447 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.18 43.37 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.219 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.508 ' HA ' HD13 ' A' ' 31' ' ' LEU . 79.7 p -172.31 -42.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.135 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -93.71 130.64 39.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.814 0.34 . . . . 0.0 111.166 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.576 HD12 HD23 ' A' ' 31' ' ' LEU . 80.1 mt -150.33 111.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.666 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.549 HG13 ' HD2' ' A' ' 23' ' ' LYS . 66.2 t -84.39 125.94 40.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.887 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 31.6 p -170.87 151.22 3.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.051 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.615 ' NE ' HG21 ' A' ' 51' ' ' THR . 39.0 ptt180 -83.94 132.37 34.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.501 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.908 HG23 ' HA ' ' A' ' 20' ' ' PRO . 6.5 m -60.06 130.02 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.856 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.438 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . -72.4 154.59 50.59 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.579 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -49.82 149.64 2.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.541 0.21 . . . . 0.0 110.576 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . . . -73.47 59.19 0.59 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.967 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.525 ' HD3' ' C ' ' A' ' 68' ' ' LYS . 12.6 tmtt? -55.45 -47.81 75.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.06 0.457 . . . . 0.0 109.78 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.408 ' OD1' ' HA3' ' A' ' 45' ' ' GLY . 4.8 m120 -83.07 -125.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.802 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -161.19 -40.24 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.789 0.328 . . . . 0.0 110.768 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 89' ' ' SER . 40.1 ttmt -60.27 -42.48 95.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.772 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.428 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . 75.1 37.35 43.26 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.655 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.08 136.8 41.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.686 0.279 . . . . 0.0 110.449 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.6 mt -84.95 92.78 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.007 0.432 . . . . 0.0 110.935 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.8 mm -81.88 137.77 20.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.635 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.2 t -141.54 106.77 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.119 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.0 m -82.16 143.55 31.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.505 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.2 p -141.04 134.8 30.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.519 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.555 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 7.6 mtpm? -55.53 -43.57 75.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.794 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.728 ' HB3' ' HD3' ' A' ' 5' ' ' ARG . 53.8 m -64.43 -48.97 73.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.241 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.46 -121.33 4.85 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.164 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.42 -141.28 3.09 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.182 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.19 127.97 34.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 110.854 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.3 132.38 12.04 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.0 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 78.7 p -99.1 146.18 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.545 0.212 . . . . 0.0 110.64 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.555 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 47.5 t -149.37 132.06 15.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.982 0.42 . . . . 0.0 111.583 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.6 p -72.05 -33.49 68.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.746 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.54 139.43 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.401 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 71' ' ' LYS . 78.1 p -123.62 138.68 54.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.744 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.484 ' CD2' HG11 ' A' ' 64' ' ' VAL . 54.2 t80 -88.26 130.06 35.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -90.43 125.07 35.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.532 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.508 HD21 ' SG ' ' A' ' 44' ' ' CYS . 3.2 mm? -85.25 124.42 31.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 111.046 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 19' ' ' ILE . 80.7 mt -87.24 136.1 33.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.785 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -64.91 131.62 95.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.369 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.94 127.24 25.25 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.419 2.08 . . . . 0.0 112.319 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.57 111.47 4.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.949 179.766 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.1 m170 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.806 0.336 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.5 mmm -68.2 -137.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.789 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -62.85 137.12 58.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.752 0.31 . . . . 0.0 111.065 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -60.33 137.8 91.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.054 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.0 Cg_endo -59.34 142.79 99.57 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.755 2.303 . . . . 0.0 112.216 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 51.8 Cg_exo -55.19 129.73 36.87 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.515 2.144 . . . . 0.0 112.275 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.7 tp -115.01 108.19 16.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.122 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 57.4 t -84.82 137.02 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.454 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 t -166.73 51.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.204 0.526 . . . . 0.0 111.414 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.33 136.77 4.13 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.392 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.539 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.4 tt -165.29 131.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.703 0.287 . . . . 0.0 110.622 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.804 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.6 t -69.35 -58.46 5.97 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.627 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.872 ' HG2' HG12 ' A' ' 24' ' ' VAL . 88.3 Cg_endo -93.24 113.18 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.364 2.043 . . . . 0.0 112.614 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.505 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -95.81 31.65 2.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.897 0.38 . . . . 0.0 110.863 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.688 ' HB2' HD11 ' A' ' 93' ' ' LEU . 15.9 pt-20 -179.45 129.34 0.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.358 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.07 146.9 5.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.988 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 39.6 pt -53.43 160.39 1.86 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.342 0.115 . . . . 0.0 110.949 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.893 ' HA ' HG23 ' A' ' 64' ' ' VAL . 89.3 Cg_exo -48.08 -38.8 32.89 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.622 2.215 . . . . 0.0 113.11 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.593 ' O ' ' HD2' ' A' ' 63' ' ' ARG . 97.4 m95 -72.76 -21.03 61.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.6 m -56.22 127.98 33.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.076 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.552 ' HE2' HG13 ' A' ' 61' ' ' VAL . 60.6 tttm -70.28 142.34 52.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.79 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.872 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.6 m -139.82 126.46 23.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 111.091 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 62.1 m -83.55 87.85 7.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.76 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.652 HD12 HD13 ' A' ' 74' ' ' ILE . 49.8 mm -54.69 133.8 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.758 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 25' ' ' THR . 45.2 mmm-85 -140.44 137.29 33.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -168.12 -134.11 1.66 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.196 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -150.57 135.58 17.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 111.237 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 61.65 41.72 11.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.227 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 mp -82.79 51.24 1.86 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.865 0.364 . . . . 0.0 110.411 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.41 123.45 0.19 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.212 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.7 p -92.29 42.47 1.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.741 0.305 . . . . 0.0 111.352 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.63 143.75 4.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.653 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.427 ' HG3' ' CE3' ' A' ' 54' ' ' TRP . 32.2 Cg_exo -57.3 -46.09 30.47 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.456 2.104 . . . . 0.0 111.749 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 t -62.48 -36.36 82.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.157 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 28.3 m-20 -53.7 -45.46 70.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.623 HD21 HD23 ' A' ' 41' ' ' LEU . 1.4 tt -68.76 131.11 44.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.076 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.51 ' N ' HD23 ' A' ' 38' ' ' LEU . 30.0 pt -138.4 -44.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.593 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.489 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -104.55 135.82 12.71 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.216 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.623 HD23 HD21 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -146.32 121.0 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.828 HG22 ' HA ' ' A' ' 47' ' ' ASN . 33.3 p -153.13 134.82 14.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.179 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 45' ' ' GLY . 76.0 mt -105.38 111.22 33.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.044 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.493 ' SG ' ' HA2' ' A' ' 72' ' ' GLY . 34.5 t 73.91 -37.8 0.38 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.748 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.443 ' HA3' ' HG3' ' A' ' 68' ' ' LYS . . . 171.9 -32.39 0.13 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.528 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -73.58 135.73 43.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.921 0.391 . . . . 0.0 111.459 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.828 ' HA ' HG22 ' A' ' 42' ' ' THR . 43.2 t30 -71.35 138.39 49.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.844 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.2 m -151.89 40.4 0.64 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.965 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.2 tp -74.28 -44.39 52.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.4 pt? -50.57 -42.71 55.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.497 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.418 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 59.1 p -80.31 -35.26 35.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 111.204 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.585 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.77 131.2 50.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.983 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -127.11 129.99 48.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.335 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.427 ' CE3' ' HG3' ' A' ' 35' ' ' PRO . 67.2 t90 -73.35 148.35 43.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.076 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.3 mtt -148.76 -44.01 0.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.317 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.445 ' C ' ' H ' ' A' ' 58' ' ' SER . 64.7 m -160.62 169.97 21.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.727 0.298 . . . . 0.0 110.884 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.78 32.8 0.09 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.344 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 56' ' ' SER . 79.8 p -177.85 34.42 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.544 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -164.58 131.23 3.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.8 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.4 mt -150.1 118.81 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.552 HG13 ' HE2' ' A' ' 23' ' ' LYS . 70.5 t -83.7 125.37 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.585 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.5 p -170.43 148.24 3.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.826 0.346 . . . . 0.0 111.015 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.593 ' HD2' ' O ' ' A' ' 21' ' ' TRP . 37.6 mmt-85 -84.01 131.18 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.126 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.893 HG23 ' HA ' ' A' ' 20' ' ' PRO . 10.4 m -54.81 128.42 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.189 0.519 . . . . 0.0 112.131 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.44 -105.54 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.502 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.674 ' HG3' ' HZ2' ' A' ' 68' ' ' LYS . 25.1 pt20 -162.57 138.96 7.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.721 0.296 . . . . 0.0 110.774 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.746 ' HB2' HD23 ' A' ' 92' ' ' LEU . . . -61.51 96.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.405 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.674 ' HZ2' ' HG3' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -73.58 -43.76 58.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.466 ' N ' HD22 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -170.17 171.82 6.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.861 0.362 . . . . 0.0 111.695 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 69' ' ' ASN . 1.5 m-20 74.87 -62.55 0.45 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.227 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt 177.26 -46.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.982 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.493 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . 146.35 38.66 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.554 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -66.36 139.38 58.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.727 0.298 . . . . 0.0 110.958 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.652 HD13 HD12 ' A' ' 26' ' ' ILE . 72.2 mt -84.32 135.27 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.584 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.55 HD12 ' HD3' ' A' ' 83' ' ' LYS . 46.1 mm -128.66 137.51 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.899 0.38 . . . . 0.0 111.72 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t -141.4 117.5 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.896 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.9 m -87.56 140.69 29.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.975 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.6 p -134.59 137.0 43.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.996 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 37' ' ' ASP . 28.9 mtpp -60.1 -46.27 90.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.3 m -65.11 -52.43 55.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.056 0.455 . . . . 0.0 110.159 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.72 -121.8 2.46 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.063 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.36 -142.19 3.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.355 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.55 ' HD3' HD12 ' A' ' 75' ' ' ILE . 3.5 tmmm? -66.73 125.25 25.25 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 83' ' ' LYS . . . -79.45 131.31 10.5 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.061 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.7 p -99.27 148.24 24.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.642 0.258 . . . . 0.0 110.431 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.581 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 78.9 p -149.23 130.31 14.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.081 0.467 . . . . 0.0 111.817 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 74.0 p -81.51 -31.74 32.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.376 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.9 m -84.22 148.31 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.205 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.0 p -138.97 135.25 34.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.797 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.476 ' CD2' HG11 ' A' ' 64' ' ' VAL . 86.6 t80 -85.64 133.34 34.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.538 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -88.45 123.71 33.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.403 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 67' ' ' ALA . 3.2 mm? -80.13 128.27 33.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.056 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 17' ' ' GLU . 75.8 mt -101.45 135.97 42.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.002 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -67.69 140.97 94.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.808 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.62 134.74 63.77 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.447 2.098 . . . . 0.0 112.284 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -68.68 79.73 0.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.303 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.4 pttt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.928 179.89 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.2 m80 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.65 0.262 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 92.3 mmm -71.43 -145.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.811 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.449 ' HD2' ' OG ' ' A' ' 80' ' ' SER . 99.0 mtt180 63.49 134.92 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.983 0.421 . . . . 0.0 111.27 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -64.24 134.34 95.93 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.17 147.46 94.05 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.614 2.209 . . . . 0.0 112.241 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.09 143.36 18.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.571 2.181 . . . . 0.0 112.331 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 85' ' ' THR . 46.7 tp -135.93 111.57 9.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.568 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 58.8 t -78.36 130.0 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.791 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.427 ' H ' ' HA2' ' A' ' 28' ' ' GLY . 76.5 p -150.92 47.8 0.85 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.093 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.4 145.22 6.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.292 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.486 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.4 tt -164.35 128.18 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.31 . . . . 0.0 110.397 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.793 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.0 t -64.98 -58.26 13.31 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.861 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 79.8 Cg_endo -91.27 110.84 0.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.28 1.987 . . . . 0.0 112.397 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.411 ' OD1' HG23 ' A' ' 13' ' ' ILE . 50.5 m-80 -90.31 24.41 2.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.943 0.402 . . . . 0.0 110.166 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HB2' HD11 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -179.31 132.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.169 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.17 145.84 5.1 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.852 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.512 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.9 pt -55.67 164.18 1.7 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 120.407 0.146 . . . . 0.0 110.707 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 81.4 Cg_exo -47.7 -53.73 6.14 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.605 2.204 . . . . 0.0 113.966 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.416 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 80.2 m95 -68.31 -8.87 43.53 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.465 ' OG1' HG12 ' A' ' 19' ' ' ILE . 73.1 m -62.29 127.29 30.63 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.079 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -69.43 131.63 45.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.36 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.602 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.0 m -125.94 127.78 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.978 0.418 . . . . 0.0 110.999 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.8 m -81.33 118.5 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 60' ' ' ILE . 63.7 mt -79.74 138.49 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.775 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.423 ' O ' HG13 ' A' ' 10' ' ' VAL . 27.1 mmm180 -147.21 136.94 22.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.346 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.17 -132.08 1.41 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.673 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -146.94 131.38 17.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.318 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 60.63 41.85 14.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.166 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.453 HD22 ' O ' ' A' ' 58' ' ' SER . 10.5 mp -81.97 52.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.959 0.409 . . . . 0.0 110.841 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.81 121.44 0.04 OUTLIER Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.404 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.0 p -93.4 41.18 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.8 0.333 . . . . 0.0 111.182 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.0 144.13 5.38 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.464 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HA ' ' CG ' ' A' ' 54' ' ' TRP . 51.3 Cg_exo -54.26 -43.04 62.23 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.538 2.159 . . . . 0.0 112.089 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.8 p -64.01 -35.69 81.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 28.6 m-20 -52.18 -49.06 64.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.005 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.47 ' C ' HD13 ' A' ' 38' ' ' LEU . 3.5 tm? -67.12 132.46 47.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.33 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.433 ' N ' HD13 ' A' ' 38' ' ' LEU . 35.5 pt -147.97 -24.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.998 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.94 137.21 12.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.58 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.784 HD12 ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -149.64 131.67 15.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 47' ' ' ASN . 5.7 p -153.7 141.73 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.134 0.493 . . . . 0.0 111.657 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -135.97 123.23 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.168 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 78.9 m 58.41 40.1 24.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.941 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.02 -32.74 1.73 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.183 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -70.71 133.06 46.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.319 . . . . 0.0 111.356 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.617 ' HA ' HG22 ' A' ' 42' ' ' THR . 15.0 p-10 -74.62 143.94 44.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.73 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.784 ' SG ' HD12 ' A' ' 41' ' ' LEU . 7.5 p -154.12 46.31 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 110.793 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.2 tp -72.95 -48.9 32.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.58 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 51' ' ' THR . 4.1 pp -62.24 -30.37 71.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.599 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.629 ' N ' HD12 ' A' ' 50' ' ' LEU . 41.3 p -79.92 -38.39 32.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.903 0.383 . . . . 0.0 110.91 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.501 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -64.22 138.08 58.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.67 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.37 127.39 45.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.08 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.41 ' CG ' ' HA ' ' A' ' 35' ' ' PRO . 31.1 t90 -63.78 143.57 57.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.111 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 94.0 mmm -132.95 -51.17 0.9 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.718 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.2 m -161.2 -172.15 3.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.62 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.31 39.17 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.276 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.453 ' O ' HD22 ' A' ' 31' ' ' LEU . 40.2 t -178.4 -43.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.177 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.7 tttm -86.81 134.05 33.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.483 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 75.3 mt -151.24 120.29 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.571 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.22 132.39 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.064 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 25.9 t -170.57 141.4 1.89 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.197 0.522 . . . . 0.0 111.545 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.552 ' HE ' HG21 ' A' ' 51' ' ' THR . 39.7 ptt180 -85.37 140.44 30.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.711 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.532 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t -59.74 -42.63 89.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.647 0.737 . . . . 0.0 110.758 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.404 ' C ' ' HB3' ' A' ' 20' ' ' PRO . . . 75.21 -49.92 2.3 Favored Glycine 0 C--N 1.314 -0.648 0 CA-C-N 114.321 -1.308 . . . . 0.0 113.149 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -174.92 -143.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.864 0.332 . . . . 0.0 110.738 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.487 ' HB2' HD22 ' A' ' 92' ' ' LEU . . . -172.95 135.46 0.62 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.776 0.322 . . . . 0.0 111.112 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 68' ' ' LYS . 1.4 tmtp? -117.88 -43.54 2.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.328 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -65.77 -119.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.697 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -167.61 -48.1 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.724 0.297 . . . . 0.0 110.723 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 89' ' ' SER . 0.0 OUTLIER -70.06 -46.52 64.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.701 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.07 44.48 5.36 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.723 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -71.41 131.87 43.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 110.886 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.6 mt -85.6 100.33 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.085 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.3 mm -98.6 138.97 21.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.99 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.52 120.17 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.0 111.288 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.1 m -90.87 145.87 24.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.271 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.4 p -140.49 142.93 35.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.953 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 32.2 mmmt -51.77 -49.12 63.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.231 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.449 ' OG ' ' HD2' ' A' ' 5' ' ' ARG . 47.4 t -67.0 -47.41 71.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.88 -127.81 0.19 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.819 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.12 -39.77 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.851 -0.499 . . . . 0.0 111.851 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -168.06 121.7 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.98 127.05 7.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.368 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.558 ' O ' HD12 ' A' ' 9' ' ' LEU . 81.7 p -99.69 144.63 28.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.568 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 66.5 p -143.36 124.19 14.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.101 0.477 . . . . 0.0 111.794 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.7 p -81.02 -28.69 35.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.245 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.62 141.89 14.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.287 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.575 ' HB2' ' O ' ' A' ' 71' ' ' LYS . 74.1 p -129.77 139.26 51.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.958 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -85.74 129.44 34.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.39 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.41 114.55 20.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.093 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.487 HD22 ' HB2' ' A' ' 67' ' ' ALA . 47.0 tp -78.86 131.07 36.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 111.406 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 17' ' ' GLU . 78.4 mt -98.82 141.27 31.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.764 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -61.92 123.32 77.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.015 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.98 134.06 19.13 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.421 2.081 . . . . 0.0 111.987 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -69.34 77.46 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.507 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.821 179.685 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.8 m170 . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.87 0.367 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.2 ttt -59.4 -51.77 68.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.234 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.488 ' HD2' ' N ' ' A' ' 5' ' ' ARG . 0.3 OUTLIER -71.03 129.13 38.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.062 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -78.57 136.22 59.86 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 17.9 Cg_endo -60.18 139.15 85.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.57 2.18 . . . . 0.0 112.267 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 59.7 Cg_exo -52.8 147.1 33.15 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.82 2.347 . . . . 0.0 112.625 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 85' ' ' THR . 59.8 tp -149.97 112.24 4.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.741 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.49 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 57.3 t -79.02 131.5 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.2 p -147.76 44.22 1.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.43 146.41 6.49 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.778 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.5 tt -161.45 129.66 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.762 0.315 . . . . 0.0 110.629 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.843 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 49.5 m -68.89 -59.88 4.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.805 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.843 ' HD3' ' HB2' ' A' ' 14' ' ' SER . 72.2 Cg_endo -92.49 121.95 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.364 2.042 . . . . 0.0 112.077 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -105.78 28.51 7.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.881 0.372 . . . . 0.0 110.832 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -179.99 129.53 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.436 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.456 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 164.25 148.15 5.34 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.583 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.0 pt -51.62 158.56 1.5 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.481 0.181 . . . . 0.0 110.767 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.785 ' HA ' HG23 ' A' ' 64' ' ' VAL . 73.4 Cg_exo -50.08 -41.67 48.3 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.656 2.237 . . . . 0.0 113.322 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -70.12 -8.97 53.94 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.9 m -67.93 126.9 30.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.765 0.317 . . . . 0.0 110.927 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.583 ' NZ ' ' HB2' ' A' ' 23' ' ' LYS . 4.9 ttmp? -71.02 134.03 46.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.071 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.734 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.7 m -124.37 127.24 73.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 0.0 111.542 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.1 m -78.54 102.33 7.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.7 mt -69.83 139.73 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.09 0.471 . . . . 0.0 111.403 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -144.11 130.95 20.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.205 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.31 -133.17 1.54 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.623 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -150.16 136.8 19.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.914 0.388 . . . . 0.0 111.325 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 61.94 39.05 13.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.508 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 mp -84.98 53.1 2.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.0 110.63 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.08 129.65 1.46 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.509 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.9 p -69.31 -36.63 77.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.76 0.314 . . . . 0.0 111.455 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.445 ' HA2' ' CZ2' ' A' ' 54' ' ' TRP . . . -150.86 174.84 30.07 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.517 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.28 -43.86 54.58 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.795 2.33 . . . . 0.0 112.486 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.3 t -58.56 -40.12 82.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.19 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.02 -46.79 85.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.156 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.3 tt -59.71 129.73 43.33 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.573 HG21 ' HD3' ' A' ' 79' ' ' LYS . 39.6 pt -141.95 -44.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.439 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.528 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -102.55 133.81 11.54 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.628 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 42' ' ' THR . 2.4 tm? -149.48 127.3 11.79 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.748 HG22 ' HA ' ' A' ' 47' ' ' ASN . 11.8 p -155.87 140.82 17.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.525 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.594 HD11 ' SG ' ' A' ' 62' ' ' CYS . 73.3 mt -126.03 123.77 64.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.596 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.601 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 58.9 m 57.37 36.35 27.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.058 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.89 -31.66 3.05 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.055 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.553 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 79.6 t60 -73.7 133.18 43.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.854 0.359 . . . . 0.0 111.408 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.748 ' HA ' HG22 ' A' ' 42' ' ' THR . 42.0 t30 -69.2 138.3 53.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.7 m -151.04 39.27 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 110.7 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.3 tp -75.06 -43.19 54.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.107 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -52.21 -41.61 62.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.281 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.408 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 68.0 p -80.29 -34.62 36.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.175 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 61' ' ' VAL . . . -58.06 131.02 49.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.566 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.424 ' HB3' HG23 ' A' ' 61' ' ' VAL . 17.8 tp10 -126.61 132.31 51.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.573 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.445 ' CZ2' ' HA2' ' A' ' 34' ' ' GLY . 77.0 t90 -68.31 144.84 54.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.196 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.7 mmt -132.65 -47.78 0.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.663 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.6 p -168.54 -157.75 0.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.635 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.37 32.32 1.37 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.355 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.7 p -179.98 37.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.278 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -164.88 129.62 2.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.102 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.4 mt -151.23 111.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.698 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -84.51 130.25 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.349 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.594 ' SG ' HD11 ' A' ' 43' ' ' ILE . 26.4 p -170.97 150.98 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.042 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -84.01 129.79 34.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.785 HG23 ' HA ' ' A' ' 20' ' ' PRO . 14.3 m -65.72 134.65 29.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.102 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 46' ' ' HIS . . . -72.61 -125.49 0.08 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.442 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.441 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 24.9 pt20 -140.53 137.79 34.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.734 0.302 . . . . 0.0 110.576 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.601 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -49.74 134.04 20.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.852 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 66' ' ' GLN . 29.4 mtpp -151.3 -41.39 0.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.381 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -63.54 -53.36 53.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.267 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -173.74 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.427 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -147.34 -56.25 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.814 0.34 . . . . 0.0 111.01 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.432 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . 163.01 43.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.328 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -64.14 131.58 47.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.861 0.362 . . . . 0.0 111.083 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.4 mt -85.36 135.43 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.522 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.9 mm -134.55 133.82 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 0.0 111.713 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.418 HG22 HD22 ' A' ' 41' ' ' LEU . 60.0 t -141.55 118.66 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.22 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.4 m -98.68 131.88 44.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.555 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.1 p -99.48 146.29 26.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.844 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.573 ' HD3' HG21 ' A' ' 39' ' ' ILE . 56.5 tptt -58.57 -49.19 78.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.773 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 81.9 p -70.33 -54.43 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.76 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.53 -127.05 0.35 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.42 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.4 -137.25 2.18 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.17 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -65.17 126.12 27.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.7 0.286 . . . . 0.0 110.569 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.28 -150.19 6.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.154 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 21.5 p -158.09 151.59 23.44 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.706 0.402 . . . . 0.0 110.624 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.3 p -158.66 121.34 3.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.917 0.389 . . . . 0.0 111.431 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 82.6 p -96.07 37.56 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.436 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.6 m -150.56 157.44 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.744 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.5 p -146.0 136.23 23.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.572 ' CE2' HG21 ' A' ' 64' ' ' VAL . 65.4 t80 -85.45 130.44 34.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.863 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -82.19 120.83 25.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.659 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.486 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.3 mm? -83.91 126.96 33.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.018 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.456 HD12 ' HA2' ' A' ' 18' ' ' GLY . 76.9 mt -94.6 134.94 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.823 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 47.5 mmtm -67.01 129.21 94.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.956 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 31.2 Cg_exo -60.83 133.81 50.01 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.65 2.234 . . . . 0.0 112.471 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -73.05 112.84 9.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.634 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.939 -179.991 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.5 t60 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 121.127 0.489 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.8 ptp -160.41 135.52 7.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.745 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.551 ' HA ' ' NE ' ' A' ' 5' ' ' ARG . 4.4 mmp_? 65.31 130.67 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.193 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -63.63 136.94 96.94 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.847 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.15 138.01 78.89 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.543 2.162 . . . . 0.0 112.054 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HG2' ' HA2' ' A' ' 84' ' ' GLY . 14.1 Cg_endo -55.94 134.11 62.11 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.703 2.269 . . . . 0.0 112.331 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 85' ' ' THR . 64.8 tp -120.03 117.65 28.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.018 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.535 ' HB ' ' OG ' ' A' ' 86' ' ' SER . 94.8 t -83.29 132.92 30.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.841 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.0 p -151.34 48.86 0.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.042 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.3 144.83 6.9 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.01 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.655 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.1 tt -163.01 131.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.579 0.228 . . . . 0.0 110.645 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.846 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 48.4 t -63.22 -59.18 12.87 Favored Pre-proline 0 C--N 1.331 -0.239 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.349 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.924 ' HG2' HG12 ' A' ' 24' ' ' VAL . 10.3 Cg_exo -70.7 -148.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.945 1.763 . . . . 0.0 112.035 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -175.4 -23.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.351 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.7 133.94 4.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.832 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 169.69 160.07 17.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.409 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 30.6 pt -50.87 154.68 2.33 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.561 0.22 . . . . 0.0 111.009 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.18 -41.88 48.44 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.902 2.402 . . . . 0.0 113.807 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -70.51 -5.89 32.18 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -66.08 132.09 47.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.808 0.337 . . . . 0.0 111.227 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.581 ' HE3' HG13 ' A' ' 61' ' ' VAL . 87.2 tttt -67.26 137.35 56.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.479 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.924 HG12 ' HG2' ' A' ' 15' ' ' PRO . 35.9 m -140.98 127.23 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.977 0.417 . . . . 0.0 111.015 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.1 m -80.85 121.21 25.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.097 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.0 mt -84.3 135.83 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.726 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 10' ' ' VAL . 83.0 mtm180 -146.2 134.51 21.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.726 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.07 -132.58 1.46 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.58 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -146.09 132.88 20.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.873 0.368 . . . . 0.0 111.352 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 59.11 43.57 17.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.189 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 mp -83.31 47.88 1.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.829 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.47 125.24 0.06 OUTLIER Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.531 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.9 p -92.35 42.87 1.11 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.616 0.246 . . . . 0.0 111.211 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.05 144.81 4.78 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.752 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 10.5 Cg_endo -53.82 -42.87 62.9 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.686 2.258 . . . . 0.0 112.162 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.6 t -60.98 -37.03 81.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.954 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.57 -38.51 69.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.135 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.4 tp -76.31 60.41 1.53 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 0.0 110.914 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.46 HD13 ' HG2' ' A' ' 79' ' ' LYS . 22.6 pt -69.12 -40.06 80.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.318 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.07 138.21 12.89 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.885 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.53 HD13 ' N ' ' A' ' 42' ' ' THR . 3.1 tm? -149.77 127.8 11.93 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.903 HG22 ' HA ' ' A' ' 47' ' ' ASN . 39.3 p -151.53 136.73 17.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.976 0.417 . . . . 0.0 111.64 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.539 HG21 HG23 ' A' ' 64' ' ' VAL . 51.6 mm -107.65 105.62 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.911 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 38.0 t 58.28 45.22 17.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.731 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.14 -38.66 3.14 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.569 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 79.9 t60 -68.38 129.02 38.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.908 0.354 . . . . 0.0 111.141 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.903 ' HA ' HG22 ' A' ' 42' ' ' THR . 13.6 p-10 -73.62 140.76 46.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.603 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.2 m -150.25 40.12 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.764 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.6 tp -72.88 -49.36 30.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.224 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -54.08 -39.46 66.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.499 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.1 p -80.11 -38.11 32.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.576 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -62.5 130.44 45.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.847 0.356 . . . . 0.0 111.686 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 60' ' ' ILE . 44.9 tp10 -126.85 130.87 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.605 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 35' ' ' PRO . 86.9 t90 -65.93 149.76 49.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.979 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.458 ' HG3' HG23 ' A' ' 61' ' ' VAL . 94.9 mmm -142.37 -42.9 0.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.766 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 t -170.63 173.97 5.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.857 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.83 33.43 0.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.283 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.6 p -178.61 23.68 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.588 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -165.67 131.27 2.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.743 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 53' ' ' GLU . 75.6 mt -149.43 120.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.008 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.581 HG13 ' HE3' ' A' ' 23' ' ' LYS . 57.4 t -81.82 126.33 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.471 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 52.7 t -171.08 149.71 2.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.43 . . . . 0.0 111.138 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -84.66 131.43 34.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.308 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.539 HG23 HG21 ' A' ' 43' ' ' ILE . 5.5 p -56.64 136.57 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.065 0.459 . . . . 0.0 111.576 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.408 ' HA3' ' HB ' ' A' ' 43' ' ' ILE . . . -69.01 -127.19 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.603 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -146.45 140.62 26.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 0.0 110.637 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.553 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . . . -68.52 74.1 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.239 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 46' ' ' HIS . 68.0 mttm -64.36 -49.49 71.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.769 0.319 . . . . 0.0 110.86 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -68.4 -63.83 0.98 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 64.7 t0 179.42 -60.67 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.973 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -75.24 -114.58 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.646 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 44' ' ' CYS . . . 173.24 47.55 0.05 OUTLIER Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.193 -1.003 . . . . 0.0 113.2 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -64.22 132.67 51.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.77 0.319 . . . . 0.0 111.042 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.442 HG23 ' CD1' ' A' ' 43' ' ' ILE . 68.5 mt -85.5 92.48 3.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.817 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.5 mm -81.03 138.58 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.195 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.53 113.51 3.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.936 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.5 m -84.47 142.23 30.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.722 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.3 p -137.73 135.52 36.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.047 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HG2' HD13 ' A' ' 39' ' ' ILE . 28.2 mtpp -59.29 -46.72 87.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.004 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.9 p -64.42 -52.83 56.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.03 0.443 . . . . 0.0 110.331 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 -120.97 2.13 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.193 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.76 -140.77 2.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.117 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.439 ' C ' ' HD2' ' A' ' 83' ' ' LYS . 4.3 tmmm? -67.38 127.12 31.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.857 0.36 . . . . 0.0 110.169 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.459 ' HA2' ' HG2' ' A' ' 8' ' ' PRO . . . -78.15 130.64 10.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.346 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.428 HG22 ' HE3' ' A' ' 83' ' ' LYS . 79.3 p -108.15 144.66 35.25 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.535 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 41.3 t -151.31 131.12 13.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.093 0.473 . . . . 0.0 111.875 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.8 p -78.17 -28.39 48.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.781 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.9 m -83.15 153.76 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.362 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.0 p -148.97 138.65 21.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.724 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 64' ' ' VAL . 67.2 t80 -85.2 131.56 34.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.68 ' HD2' HD23 ' A' ' 93' ' ' LEU . 5.8 tmtt? -79.39 119.1 21.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.013 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.476 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -84.61 109.67 18.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 0.0 110.54 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.68 HD23 ' HD2' ' A' ' 91' ' ' LYS . 54.9 mt -85.86 136.68 33.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.955 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -65.51 137.11 96.4 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.168 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.72 132.79 24.13 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.441 2.094 . . . . 0.0 112.469 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -73.16 77.42 1.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.697 -179.886 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.836 0.35 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.7 mtt -78.91 43.55 0.51 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.304 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.425 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 72.3 mtm-85 56.69 51.83 10.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.0 0.429 . . . . 0.0 111.347 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -59.41 141.9 87.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.051 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -57.11 150.7 55.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.79 2.327 . . . . 0.0 112.308 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.543 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 82.1 Cg_exo -48.57 143.07 16.78 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.705 2.27 . . . . 0.0 112.746 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 85' ' ' THR . 4.9 tt -145.03 111.34 5.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.747 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.512 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 66.3 t -81.92 137.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.005 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.422 HG23 ' CD2' ' A' ' 9' ' ' LEU . 30.1 p -154.26 44.52 0.55 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.624 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.46 143.8 6.09 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.845 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.527 HG12 ' HD2' ' A' ' 15' ' ' PRO . 15.8 tt -164.47 129.47 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.0 110.51 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.824 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -65.22 -59.39 9.93 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.942 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.944 ' HG2' HG12 ' A' ' 24' ' ' VAL . 72.8 Cg_endo -94.86 118.89 0.26 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.447 2.098 . . . . 0.0 112.169 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -100.22 30.61 3.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.73 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.592 ' HB2' HD11 ' A' ' 93' ' ' LEU . 11.3 pt-20 179.0 129.39 0.07 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.571 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . 165.09 152.29 6.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.738 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.441 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 31.9 pt -56.12 162.54 2.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.48 0.181 . . . . 0.0 111.11 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.599 ' HB3' ' C ' ' A' ' 65' ' ' GLY . 87.2 Cg_exo -49.23 -46.31 26.42 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.881 2.388 . . . . 0.0 113.768 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -71.4 -4.97 29.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.1 m -63.33 126.99 29.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.845 0.355 . . . . 0.0 110.986 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.484 ' HD2' HG13 ' A' ' 61' ' ' VAL . 17.2 tppt? -67.13 136.31 54.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.148 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.944 HG12 ' HG2' ' A' ' 15' ' ' PRO . 31.6 m -140.59 131.67 29.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.036 0.445 . . . . 0.0 111.51 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.9 m -89.75 116.28 27.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.549 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.44 HD11 ' SG ' ' A' ' 62' ' ' CYS . 57.3 mt -74.61 141.13 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.187 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 27' ' ' ARG . 11.9 tpt180 -147.48 130.75 16.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.997 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.56 -122.61 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.733 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.424 ' OE2' HD13 ' A' ' 9' ' ' LEU . 20.5 pt-20 -162.19 134.23 5.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.963 0.411 . . . . 0.0 111.598 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 60.86 40.21 16.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.86 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.543 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.6 mp -70.31 -41.96 72.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.609 0.242 . . . . 0.0 111.233 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.93 135.47 2.36 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.803 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.9 p -62.7 -39.75 94.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.798 0.332 . . . . 0.0 110.902 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.513 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -165.32 -164.11 20.04 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.66 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.28 -47.11 6.53 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.779 2.319 . . . . 0.0 112.514 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 39' ' ' ILE . 67.2 p -60.12 -40.91 91.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.379 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.732 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 36.5 t70 -62.65 -41.53 99.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.346 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.433 HD11 HD13 ' A' ' 60' ' ' ILE . 1.3 tt -78.33 62.15 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.947 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.638 HD13 ' HG2' ' A' ' 79' ' ' LYS . 27.2 pt -68.96 -41.79 82.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.19 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.433 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -112.21 140.61 16.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.098 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.627 HD13 ' N ' ' A' ' 42' ' ' THR . 3.4 tm? -146.89 134.85 21.4 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.627 ' N ' HD13 ' A' ' 41' ' ' LEU . 14.1 p -150.36 149.82 30.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.101 0.477 . . . . 0.0 111.546 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.712 HG21 ' HA ' ' A' ' 64' ' ' VAL . 71.1 mt -135.75 116.56 18.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.484 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.771 ' HA ' ' HB2' ' A' ' 70' ' ' ASP . 65.4 m 72.82 -35.2 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.813 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 166.11 -41.08 0.27 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.026 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.474 ' H ' ' HD1' ' A' ' 46' ' ' HIS . 27.5 p-80 -80.67 138.48 36.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.959 0.409 . . . . 0.0 111.705 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.493 ' HA ' HG22 ' A' ' 42' ' ' THR . 42.2 t30 -60.68 141.51 56.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.679 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.3 m -143.76 38.15 1.34 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.846 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.55 -42.25 68.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 50' ' ' LEU . 2.6 pt? -57.52 -42.41 82.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.58 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.514 HG21 ' NE ' ' A' ' 63' ' ' ARG . 55.8 p -80.19 -38.19 31.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.691 0.282 . . . . 0.0 111.351 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -63.09 132.9 53.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.333 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -126.38 127.39 45.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.552 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.513 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 75.2 t90 -67.46 149.97 49.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.512 ' SD ' HG23 ' A' ' 61' ' ' VAL . 90.4 mtp -146.04 -41.3 0.21 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.731 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 58' ' ' SER . 33.8 t -165.38 173.86 10.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.685 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.34 21.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.489 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.3 m -167.72 35.31 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.884 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -165.09 127.95 2.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.867 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.433 HD13 HD11 ' A' ' 38' ' ' LEU . 73.9 mt -150.82 125.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.158 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.512 HG23 ' SD ' ' A' ' 55' ' ' MET . 60.8 t -93.4 128.12 45.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.564 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.658 ' SG ' HD11 ' A' ' 43' ' ' ILE . 23.0 p -171.11 157.82 5.31 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.073 0.463 . . . . 0.0 111.772 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.514 ' NE ' HG21 ' A' ' 51' ' ' THR . 40.3 ptt180 -84.59 134.76 34.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.857 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.712 ' HA ' HG21 ' A' ' 43' ' ' ILE . 18.0 m -67.84 -26.67 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.404 0.621 . . . . 0.0 111.338 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.599 ' C ' ' HB3' ' A' ' 20' ' ' PRO . . . 53.9 -158.05 5.33 Favored Glycine 0 C--N 1.315 -0.587 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.734 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -74.62 -140.85 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.492 0.187 . . . . 0.0 111.192 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 71' ' ' LYS . . . -165.43 158.85 16.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.715 0.293 . . . . 0.0 111.013 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -140.56 -42.77 0.4 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.686 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -134.78 -59.61 0.8 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.885 0.374 . . . . 0.0 111.238 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.771 ' HB2' ' HA ' ' A' ' 44' ' ' CYS . 57.0 m-20 -60.28 -39.55 87.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.546 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.583 ' HA ' ' HB1' ' A' ' 67' ' ' ALA . 9.2 ptpp? 45.46 27.59 0.4 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.764 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.631 ' HA3' ' HB3' ' A' ' 89' ' ' SER . . . 161.26 -41.07 0.41 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.369 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.718 ' HB2' ' HB3' ' A' ' 70' ' ' ASP . 27.0 m-20 -61.43 120.31 10.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.806 0.336 . . . . 0.0 111.026 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.498 ' O ' HD13 ' A' ' 75' ' ' ILE . 69.8 mt -85.99 128.67 39.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.35 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.947 HG21 ' HE3' ' A' ' 83' ' ' LYS . 37.0 mm -127.32 142.02 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.926 0.393 . . . . 0.0 111.484 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.819 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 58.4 t -140.65 122.71 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.57 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.3 m -86.48 141.75 28.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.115 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.4 p -136.08 136.01 39.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.804 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.732 ' HE2' ' HA ' ' A' ' 37' ' ' ASP . 48.3 mtmt -57.16 -46.91 82.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 5' ' ' ARG . 50.0 m -68.4 -53.12 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.083 0.468 . . . . 0.0 110.258 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.74 -123.37 0.67 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.189 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.63 -140.78 2.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.325 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.947 ' HE3' HG21 ' A' ' 75' ' ' ILE . 51.1 tptt -63.31 132.42 51.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.949 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.819 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -68.11 159.48 51.34 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.946 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 74.2 p -143.37 145.67 32.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.9 p -157.14 131.51 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 0.0 111.698 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 65.3 p -79.2 -33.06 44.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.538 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.1 m -84.24 158.6 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.396 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.631 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 31.4 m -148.88 139.99 23.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.075 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.548 ' CD2' HG11 ' A' ' 64' ' ' VAL . 68.2 t80 -85.51 133.58 34.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.045 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.705 ' HD2' HD23 ' A' ' 93' ' ' LEU . 5.5 tmtt? -80.76 121.41 25.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.299 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.54 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 94.0 mt -84.82 109.12 17.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 110.202 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.705 HD23 ' HD2' ' A' ' 91' ' ' LYS . 50.0 mt -83.64 138.0 33.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.342 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -62.61 141.59 96.86 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.287 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -53.07 133.93 54.0 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.729 2.286 . . . . 0.0 112.503 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -68.53 115.08 7.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.472 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.314 -0.851 . . . . 0.0 110.955 -179.826 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.91 0.386 . . . . 0.0 111.623 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.2 tpt -170.42 -43.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.658 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.403 ' HG2' ' HB3' ' A' ' 80' ' ' SER . 22.3 tpp180 -58.85 131.78 51.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.693 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -60.53 139.47 92.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.133 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.21 144.34 98.83 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.754 2.302 . . . . 0.0 112.13 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.56 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 10.3 Cg_endo -54.18 115.86 2.65 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.533 2.155 . . . . 0.0 112.109 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.5 tp -90.62 98.37 11.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.196 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.489 HG22 HD21 ' A' ' 31' ' ' LEU . 60.3 t -79.92 135.42 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.273 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 t -167.76 52.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.183 0.516 . . . . 0.0 111.271 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.06 137.67 4.79 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.483 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.613 HG23 ' ND2' ' A' ' 16' ' ' ASN . 14.8 tt -165.15 128.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.709 0.29 . . . . 0.0 110.624 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.807 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.3 t -66.54 -57.92 11.23 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.626 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.864 ' HG2' HG12 ' A' ' 24' ' ' VAL . 98.2 Cg_endo -91.47 110.54 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.336 2.024 . . . . 0.0 112.15 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.613 ' ND2' HG23 ' A' ' 13' ' ' ILE . 1.8 m120 -88.49 26.79 1.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.728 0.299 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 179.82 130.16 0.09 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.521 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.592 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 169.05 143.08 3.72 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.472 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.439 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.6 pt -53.14 161.31 1.34 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 120.434 0.159 . . . . 0.0 111.214 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.913 ' HA ' HG23 ' A' ' 64' ' ' VAL . 88.8 Cg_exo -47.79 -43.48 28.95 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.79 2.327 . . . . 0.0 113.75 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -68.56 -20.66 64.55 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.7 m -59.48 129.1 40.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 111.003 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.562 ' HB3' ' NZ ' ' A' ' 23' ' ' LYS . 6.1 ttpm? -71.56 143.34 49.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.016 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.864 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.8 m -140.27 131.03 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.99 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.1 m -90.33 87.39 6.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.431 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 43' ' ' ILE . 69.8 mt -60.77 137.3 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.572 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' A' ' 58' ' ' SER . 75.9 ttt180 -148.07 140.44 24.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.963 0.411 . . . . 0.0 111.054 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -167.07 -127.61 0.92 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.298 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -150.4 137.21 19.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.921 0.391 . . . . 0.0 111.214 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.484 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 72.4 m-80 64.82 32.49 10.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.496 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 9.2 mp -83.27 48.93 1.46 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.951 0.405 . . . . 0.0 110.607 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.58 121.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.597 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.409 HG22 ' HB2' ' A' ' 57' ' ' ALA . 81.7 p -89.54 41.02 1.02 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.729 0.299 . . . . 0.0 111.126 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.4 146.42 5.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.733 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.21 -43.18 61.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.52 2.146 . . . . 0.0 112.07 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.5 p -59.01 -40.7 85.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.775 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 78' ' ' THR . 55.6 m-20 -58.07 -32.31 67.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.671 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 41' ' ' LEU . 1.0 OUTLIER -76.91 58.09 1.42 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.34 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.9 pt -66.52 -22.49 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.915 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.13 141.94 10.66 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.426 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.585 HD13 ' N ' ' A' ' 42' ' ' THR . 2.9 tm? -149.78 130.4 14.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 46' ' ' HIS . 81.4 m -161.4 127.62 3.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.93 0.395 . . . . 0.0 111.782 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 26' ' ' ILE . 76.9 mt -100.56 129.75 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.588 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.572 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 48.8 t 65.47 -72.74 0.07 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.249 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.7 30.77 0.12 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.427 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.647 ' O ' HG23 ' A' ' 42' ' ' THR . 84.5 t60 -131.08 128.42 40.18 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.799 0.333 . . . . 0.0 110.805 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -63.1 134.5 56.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 71.4 m -152.67 39.69 0.56 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.682 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.91 -46.23 45.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.385 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.433 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.6 pt? -55.5 -37.88 68.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.221 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.6 p -79.94 -36.91 35.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.54 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.93 134.97 56.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.243 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -126.18 129.08 48.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.804 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 87.3 t90 -70.52 145.21 51.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.093 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.6 mmt -132.63 -48.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.771 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.9 m -161.74 -161.78 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.702 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB2' HG22 ' A' ' 33' ' ' THR . . . -91.97 32.86 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.253 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.621 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 83.4 p -178.77 35.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.247 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.571 ' NZ ' ' HB2' ' A' ' 59' ' ' LYS . 5.1 ttmp? -165.41 135.4 3.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.338 . . . . 0.0 111.078 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.408 HD13 HD11 ' A' ' 38' ' ' LEU . 80.6 mt -150.61 120.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.77 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 51.5 t -90.35 127.59 42.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.629 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 27.6 p -170.55 154.63 4.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 111.194 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.15 133.65 34.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.66 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.913 HG23 ' HA ' ' A' ' 20' ' ' PRO . 11.5 m -62.15 130.98 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.934 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.624 ' HA3' ' HB3' ' A' ' 46' ' ' HIS . . . -81.13 163.79 45.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.419 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -48.95 137.35 12.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 111.015 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.572 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . . . -75.95 66.16 2.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.438 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -59.42 -46.25 89.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.916 0.388 . . . . 0.0 110.354 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.4 ' HB3' ' H ' ' A' ' 70' ' ' ASP . 3.6 m120 -67.92 -147.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.749 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 71' ' ' LYS . 55.2 m-20 -154.62 31.9 0.41 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.392 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 30.2 mmtp -158.5 30.63 0.23 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.599 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 33.85 42.15 0.22 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.441 -0.409 . . . . 0.0 113.523 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -65.62 121.94 16.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.524 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.5 mt -97.68 131.23 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.376 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.3 mm -134.22 140.19 46.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.458 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.0 p -140.85 125.68 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.78 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.643 ' HA ' ' H ' ' A' ' 83' ' ' LYS . 15.9 m -90.77 139.96 30.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.724 ' H ' ' HA2' ' A' ' 82' ' ' GLY . 73.8 p -147.41 143.86 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.118 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.428 ' HG2' ' HA ' ' A' ' 37' ' ' ASP . 14.5 mmmm -54.02 -33.88 58.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.055 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.403 ' HB3' ' HG2' ' A' ' 5' ' ' ARG . 49.8 m -63.44 -49.41 73.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.703 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.77 -48.46 0.23 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.759 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.724 ' HA2' ' H ' ' A' ' 78' ' ' THR . . . 75.8 127.19 0.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.873 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.643 ' H ' ' HA ' ' A' ' 77' ' ' THR . 61.7 tttm 51.67 56.93 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 110.995 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.49 -138.4 0.05 OUTLIER Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.848 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.0 p -149.98 -168.2 3.04 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.723 0.297 . . . . 0.0 110.817 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.488 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 45.4 t -167.76 129.3 1.49 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.257 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 77.0 p -92.91 37.84 1.02 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.231 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.6 m -150.73 139.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.88 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.0 m -118.97 127.99 53.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.164 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 64' ' ' VAL . 44.3 t80 -89.31 124.06 34.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.979 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -85.06 91.7 8.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.12 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.879 HD21 ' HG3' ' A' ' 20' ' ' PRO . 31.6 tp -65.14 128.39 35.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.249 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.482 HD12 ' HA2' ' A' ' 18' ' ' GLY . 80.5 mt -80.41 137.0 36.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.072 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.575 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 4.8 ttmp? -64.15 134.7 96.04 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 51.9 Cg_exo -55.0 131.08 44.28 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.487 2.125 . . . . 0.0 112.57 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -73.3 117.01 14.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.111 -179.966 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.4 m80 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.713 0.292 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.8 mmt -66.26 129.78 40.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.774 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -70.27 136.45 49.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.887 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -60.61 136.39 92.49 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.91 139.66 80.79 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.552 2.168 . . . . 0.0 112.234 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 17.3 Cg_endo -58.16 123.2 13.11 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.58 2.187 . . . . 0.0 112.168 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 9' ' ' LEU . 3.0 tm? -94.17 122.0 36.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.553 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 62.1 t -99.6 140.53 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -166.99 50.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 111.348 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.71 140.53 5.74 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.695 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.513 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.3 tt -164.42 131.18 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.722 0.296 . . . . 0.0 110.507 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.835 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.8 t -66.39 -59.13 8.88 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.931 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.837 ' HG2' HG12 ' A' ' 24' ' ' VAL . 88.7 Cg_endo -96.08 119.87 0.21 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.652 2.235 . . . . 0.0 112.137 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -94.69 29.51 2.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.854 0.359 . . . . 0.0 110.713 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.47 ' HB2' HD21 ' A' ' 93' ' ' LEU . 12.2 pt-20 179.06 133.78 0.09 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.602 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.461 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 167.07 146.95 5.07 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.947 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.465 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 37.2 pt -55.78 159.24 5.46 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 110.736 -0.098 . . . . 0.0 110.736 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.799 ' HA ' HG23 ' A' ' 64' ' ' VAL . 3.7 Cg_endo -48.25 -41.9 34.22 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.708 2.272 . . . . 0.0 113.22 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -67.87 -23.06 65.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.7 m -54.43 127.98 29.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.042 0.449 . . . . 0.0 111.659 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.412 ' HE3' ' CG1' ' A' ' 61' ' ' VAL . 86.8 tttt -73.04 140.2 47.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.445 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.837 HG12 ' HG2' ' A' ' 15' ' ' PRO . 30.3 m -141.69 132.91 26.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.908 0.385 . . . . 0.0 111.362 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.0 m -87.61 118.55 27.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.528 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.46 HD11 ' SG ' ' A' ' 62' ' ' CYS . 63.5 mt -80.34 140.41 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.032 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -141.38 135.63 30.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.682 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.24 -134.7 2.0 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.662 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -149.14 136.66 20.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 111.282 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.0 m-20 63.28 36.4 11.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.33 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.1 mp -82.6 61.04 5.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.944 0.402 . . . . 0.0 110.503 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.96 121.27 0.39 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.124 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.3 p -92.18 33.67 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.817 0.341 . . . . 0.0 111.244 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 163.8 149.95 5.93 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.51 -0.853 . . . . 0.0 112.498 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.15 -45.04 41.71 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.525 2.15 . . . . 0.0 111.876 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 t -64.19 -38.14 89.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.231 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 56.7 m-20 -54.61 -54.24 44.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.756 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.476 ' C ' HD13 ' A' ' 38' ' ' LEU . 3.2 tm? -60.99 127.15 30.17 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.586 HG21 ' HD3' ' A' ' 79' ' ' LYS . 41.9 pt -138.31 -25.81 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.694 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.85 142.26 13.35 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.133 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.644 HD13 ' N ' ' A' ' 42' ' ' THR . 1.8 tm? -149.57 131.61 15.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.674 HG22 ' HA ' ' A' ' 47' ' ' ASN . 3.4 p -151.66 146.43 25.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.161 0.505 . . . . 0.0 111.623 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.577 ' HB ' ' H ' ' A' ' 65' ' ' GLY . 80.5 mt -137.53 123.41 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.683 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 80.0 m 57.41 39.54 28.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.259 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.18 -31.29 1.82 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.549 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -73.5 131.09 41.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.829 0.347 . . . . 0.0 111.278 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.674 ' HA ' HG22 ' A' ' 42' ' ' THR . 5.4 m120 -72.35 140.36 48.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.5 m -150.71 39.86 0.72 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.772 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 tp -70.97 -42.57 69.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.364 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -51.13 -43.16 61.12 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.446 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.421 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 60.0 p -80.31 -32.1 38.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.327 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -56.4 131.27 47.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.774 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -127.12 131.96 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.198 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.436 ' CH2' ' HA ' ' A' ' 56' ' ' SER . 65.2 t90 -72.1 146.77 47.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.355 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.516 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 22.1 mmt -133.82 -50.24 0.83 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.066 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.436 ' HA ' ' CH2' ' A' ' 54' ' ' TRP . 78.0 p -169.18 -156.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.703 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -96.01 30.98 2.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.147 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.7 p -178.76 31.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.057 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 55' ' ' MET . 63.0 tttm -165.05 128.39 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.413 ' HB ' HD12 ' A' ' 26' ' ' ILE . 63.8 mt -151.66 114.6 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.882 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.412 ' CG1' ' HE3' ' A' ' 23' ' ' LYS . 90.7 t -80.3 131.87 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.084 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.491 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.4 p -169.08 155.02 6.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.992 0.425 . . . . 0.0 111.405 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -83.99 126.22 32.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.288 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 20' ' ' PRO . 5.2 m -62.92 125.68 19.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.077 0.465 . . . . 0.0 111.103 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.577 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . -72.39 151.19 46.36 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.668 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -47.57 149.09 1.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.559 0.219 . . . . 0.0 110.839 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.47 63.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.744 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 23.6 tptm -58.63 -51.57 69.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.96 0.41 . . . . 0.0 110.449 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -75.17 -122.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.487 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.95 -36.38 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.711 0.291 . . . . 0.0 110.683 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -66.97 -42.36 85.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA2' ' SG ' ' A' ' 44' ' ' CYS . . . 75.85 36.45 42.01 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.406 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.28 137.27 38.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.702 0.287 . . . . 0.0 111.055 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.07 127.78 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.227 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.5 mm -128.1 138.41 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.899 0.381 . . . . 0.0 111.304 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -139.8 119.06 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.678 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 58.2 m -89.07 130.01 35.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.532 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 64.4 p -107.83 143.48 36.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.615 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.586 ' HD3' HG21 ' A' ' 39' ' ' ILE . 53.1 tptt -56.32 -43.79 79.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 0.0 110.369 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 87.2 p -73.06 -56.83 4.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.65 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.2 -125.42 2.02 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.587 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' THR . . . -160.54 -139.63 2.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.398 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.527 ' HB3' ' NZ ' ' A' ' 83' ' ' LYS . 9.0 mtpm? -64.34 126.06 26.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.897 0.379 . . . . 0.0 111.343 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.9 143.42 25.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.403 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.2 p -98.63 139.2 34.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.678 0.275 . . . . 0.0 110.995 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.546 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 63.5 p -136.26 132.27 35.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.418 . . . . 0.0 111.299 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -81.04 -32.16 34.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.922 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.6 m -84.18 176.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.322 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 62.5 m -156.88 138.11 13.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.644 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.511 ' CE2' HG21 ' A' ' 64' ' ' VAL . 52.3 t80 -88.85 132.48 34.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.431 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -91.99 122.3 34.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.276 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.428 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.7 mm? -84.49 127.02 33.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.948 0.404 . . . . 0.0 111.168 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 17' ' ' GLU . 77.9 mt -91.38 138.27 31.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.709 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.591 ' NZ ' ' HB3' ' A' ' 94' ' ' LYS . 3.3 mmmp? -59.21 129.84 86.65 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.546 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.25 129.15 33.09 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.52 2.147 . . . . 0.0 112.56 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -83.27 119.99 25.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.685 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.3 pttt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.922 -179.894 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.631 0.253 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 18.5 ptp -61.7 132.98 54.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 110.525 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.554 ' HA ' ' NE ' ' A' ' 5' ' ' ARG . 4.8 mmp_? -64.69 136.51 57.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.329 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.505 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 4.8 tp60 -62.46 130.32 93.25 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.631 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.505 ' HD2' ' OE1' ' A' ' 6' ' ' GLN . 61.9 Cg_exo -52.01 146.32 30.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.427 2.084 . . . . 0.0 112.222 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 51.2 Cg_exo -54.91 129.46 35.38 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.52 2.147 . . . . 0.0 112.244 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 85' ' ' THR . 59.6 tp -114.92 109.29 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.63 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.56 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 61.2 t -74.76 129.72 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.743 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.6 p -148.32 46.3 1.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.096 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.18 141.56 4.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.201 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.445 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.7 tt -164.66 129.22 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.714 0.292 . . . . 0.0 110.304 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.804 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.8 t -66.12 -58.64 10.33 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.167 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.804 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 90.2 Cg_endo -88.88 124.23 1.51 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.121 1.881 . . . . 0.0 112.881 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.81 26.28 6.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.072 0.463 . . . . 0.0 110.125 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.636 ' HB2' HD11 ' A' ' 93' ' ' LEU . 23.7 pt-20 177.66 131.8 0.06 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.585 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 169.06 141.58 3.26 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.006 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.473 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 37.6 pt -57.44 162.85 4.05 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 122.066 0.146 . . . . 0.0 111.012 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.954 ' HA ' HG23 ' A' ' 64' ' ' VAL . 83.2 Cg_exo -48.19 -39.56 34.34 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.658 2.238 . . . . 0.0 113.311 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.52 ' HZ3' ' NH1' ' A' ' 63' ' ' ARG . 89.9 m95 -70.53 -24.45 62.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -57.64 128.95 39.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 111.279 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -73.87 137.49 43.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.547 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.635 HG12 ' HG2' ' A' ' 15' ' ' PRO . 27.0 m -134.7 132.52 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.03 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.4 m -87.35 113.56 23.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.71 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 77.8 mt -75.22 139.45 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.955 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.602 ' HD2' ' O ' ' A' ' 58' ' ' SER . 27.4 tpt180 -147.25 133.15 19.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.291 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.14 -132.77 1.48 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.634 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 51.7 mt-10 -147.26 134.84 20.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 111.341 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.461 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 75.7 m-20 61.0 41.08 14.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.548 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 58' ' ' SER . 10.0 mp -83.08 46.86 1.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.031 0.443 . . . . 0.0 110.389 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.35 121.8 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.462 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.505 HG22 ' HB2' ' A' ' 57' ' ' ALA . 80.1 p -87.56 39.08 0.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.835 0.35 . . . . 0.0 111.182 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.03 146.25 5.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.445 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.38 -40.94 81.31 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.603 2.202 . . . . 0.0 112.024 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.2 p -59.91 -40.23 88.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.183 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.5 m-20 -58.16 -45.08 88.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.583 HD11 HD13 ' A' ' 60' ' ' ILE . 1.5 tt -61.29 133.93 56.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.81 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.527 ' N ' HD23 ' A' ' 38' ' ' LEU . 26.5 pt -142.84 -44.54 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -102.9 136.05 12.64 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.677 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 42' ' ' THR . 1.7 tm? -149.23 128.17 12.64 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.607 ' N ' HD13 ' A' ' 41' ' ' LEU . 95.7 m -161.41 135.93 7.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.229 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.56 ' HB ' ' H ' ' A' ' 65' ' ' GLY . 73.4 mt -129.87 130.45 66.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.373 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.67 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 63.5 m 56.13 40.64 30.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.631 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.446 ' O ' ' HD2' ' A' ' 68' ' ' LYS . . . 63.28 29.04 73.29 Favored Glycine 0 CA--C 1.518 0.229 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.878 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.502 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 81.9 t60 -130.92 131.42 44.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.73 0.3 . . . . 0.0 110.871 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.552 HD22 ' N ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -66.32 132.86 49.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.632 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.552 ' N ' HD22 ' A' ' 47' ' ' ASN . 72.2 m -152.36 38.42 0.56 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.982 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.25 -42.44 59.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.26 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -53.83 -40.74 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.65 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.727 HG21 ' NE ' ' A' ' 63' ' ' ARG . 62.4 p -79.76 -35.04 39.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.598 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.532 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -54.4 135.01 45.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.633 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.65 132.85 51.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.662 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -70.41 151.79 44.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.059 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.6 mmt -142.95 -44.3 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.924 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.5 p -166.05 -166.09 0.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.749 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 33' ' ' THR . . . -88.02 30.63 0.84 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.266 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.602 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 79.0 p 179.04 37.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.031 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.9 ttmt -164.76 131.82 3.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.983 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.583 HD13 HD11 ' A' ' 38' ' ' LEU . 72.4 mt -150.72 115.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.866 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.4 t -79.93 130.39 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.272 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 53.7 t -170.35 151.9 3.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.025 0.44 . . . . 0.0 111.432 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.727 ' NE ' HG21 ' A' ' 51' ' ' THR . 39.3 ptt180 -84.05 130.02 34.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.201 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.954 HG23 ' HA ' ' A' ' 20' ' ' PRO . 4.9 m -58.71 127.79 18.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 111.61 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.56 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . -72.49 150.21 44.76 Favored Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.035 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -52.45 137.53 29.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.924 0.392 . . . . 0.0 110.831 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.67 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -64.81 134.24 53.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.771 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.446 ' HD2' ' O ' ' A' ' 45' ' ' GLY . 99.5 mttt -136.13 -46.06 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.348 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -72.9 -130.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.477 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -166.25 48.59 0.08 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.06 0.457 . . . . 0.0 110.623 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 89' ' ' SER . 4.7 tppp? -157.6 -41.38 0.07 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.828 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.96 40.71 34.75 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.358 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.13 134.74 35.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.741 0.305 . . . . 0.0 111.015 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.448 ' O ' HD13 ' A' ' 75' ' ' ILE . 67.6 mt -85.67 131.75 33.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.33 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 84' ' ' GLY . 50.5 mm -134.08 135.9 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.391 . . . . 0.0 111.359 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.728 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 99.6 t -141.56 116.98 5.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.811 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.4 m -82.07 146.19 29.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.3 p -141.54 139.85 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.17 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.513 ' HD2' HD13 ' A' ' 39' ' ' ILE . 32.1 mmmt -57.1 -51.09 70.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.007 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.7 t -65.69 -53.48 40.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.004 0.431 . . . . 0.0 110.544 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.77 -123.06 0.26 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.238 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.55 -139.11 2.58 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.188 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.84 131.97 48.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.616 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.728 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -62.41 152.95 43.9 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.691 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 63.0 p -147.93 142.61 26.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.711 0.291 . . . . 0.0 110.713 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.533 ' OG ' ' HB ' ' A' ' 10' ' ' VAL . 42.7 t -160.81 128.16 4.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.948 0.404 . . . . 0.0 111.319 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.0 p -74.57 -30.42 61.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.447 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.0 m -83.79 152.84 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.238 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 71' ' ' LYS . 48.0 m -138.84 141.27 38.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.822 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.526 ' CD2' HG11 ' A' ' 64' ' ' VAL . 41.7 t80 -85.9 127.7 34.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.324 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -82.69 88.24 6.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.243 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.784 HD21 ' HG3' ' A' ' 20' ' ' PRO . 35.4 tp -64.6 127.27 30.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 17' ' ' GLU . 81.2 mt -92.19 136.17 33.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.218 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -72.16 130.6 86.15 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.693 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -53.36 133.65 53.87 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.643 2.229 . . . . 0.0 112.957 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.78 129.56 51.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.662 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.813 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.98 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.1 m80 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.843 0.354 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.7 mtm -79.57 45.54 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.428 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -174.7 131.68 0.34 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.898 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -70.36 127.14 92.38 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.691 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.34 136.42 63.86 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.482 2.121 . . . . 0.0 112.156 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 50.2 Cg_exo -53.92 134.23 58.44 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.492 2.128 . . . . 0.0 112.091 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.672 HD13 ' N ' ' A' ' 10' ' ' VAL . 1.3 tm? -119.71 130.44 55.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.497 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.672 ' N ' HD13 ' A' ' 9' ' ' LEU . 90.5 t -101.92 137.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.744 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.52 HG23 HD12 ' A' ' 9' ' ' LEU . 39.6 p -151.38 48.3 0.82 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.197 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.15 144.81 6.36 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.021 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.442 HG12 ' HD2' ' A' ' 15' ' ' PRO . 17.6 tt -164.8 130.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 110.722 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.831 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -67.33 -59.62 6.98 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.672 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.831 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 83.0 Cg_endo -89.52 125.1 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.06 1.84 . . . . 0.0 112.421 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -86.02 -18.62 32.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.623 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HB2' HD11 ' A' ' 93' ' ' LEU . 11.3 pt-20 -156.15 138.46 14.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.238 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.539 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 175.8 148.71 7.03 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.561 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.448 HG12 ' OG1' ' A' ' 22' ' ' THR . 40.6 pt -51.82 157.51 1.97 Allowed Pre-proline 0 CA--C 1.531 0.25 0 CA-C-O 120.573 0.225 . . . . 0.0 111.065 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.691 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 84.8 Cg_exo -47.6 -37.5 26.92 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.713 2.276 . . . . 0.0 113.41 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -76.81 -22.4 53.68 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 64' ' ' VAL . 96.1 m -52.01 130.88 30.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.796 0.331 . . . . 0.0 111.093 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -65.26 139.05 58.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.682 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.1 m -141.2 125.64 17.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.6 m -93.46 116.71 29.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 55.7 mt -76.54 138.47 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.702 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 10' ' ' VAL . 43.2 mmm-85 -140.39 130.39 24.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.301 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.36 -133.85 1.65 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.629 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -147.61 132.63 18.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.799 0.333 . . . . 0.0 111.111 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 57.5 41.25 26.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.333 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.563 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.5 mp -70.35 -36.22 74.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.733 0.301 . . . . 0.0 110.68 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.86 130.93 1.62 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.559 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.415 ' OG1' ' HB2' ' A' ' 37' ' ' ASP . 81.8 p -65.24 -39.31 92.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.731 0.301 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.467 ' HA2' ' CZ2' ' A' ' 54' ' ' TRP . . . -164.52 -161.18 13.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.778 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.56 -49.25 7.61 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.723 2.282 . . . . 0.0 112.64 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.5 p -62.93 -38.84 92.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.53 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.415 ' HB2' ' OG1' ' A' ' 33' ' ' THR . 8.3 t70 -55.75 -51.67 66.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.18 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 39' ' ' ILE . 1.4 tt -70.2 134.27 47.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.552 ' N ' HD23 ' A' ' 38' ' ' LEU . 43.1 pt -145.2 -37.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.195 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.46 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -113.69 142.68 17.6 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.813 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 42' ' ' THR . 1.1 tm? -149.57 130.78 14.55 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.621 ' N ' HD13 ' A' ' 41' ' ' LEU . 18.5 p -151.88 145.99 25.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.147 0.498 . . . . 0.0 111.888 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 69.8 mt -134.77 118.9 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.238 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.477 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 65.0 m 74.91 -38.01 0.37 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 123.523 0.514 . . . . 0.0 110.53 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.79 -36.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.104 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -77.19 131.07 38.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 110.853 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.606 ' HA ' HG22 ' A' ' 42' ' ' THR . 14.9 p-10 -74.86 144.91 43.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.894 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.9 m -146.77 43.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.535 ' O ' HD13 ' A' ' 49' ' ' LEU . 2.3 tm? -66.15 -45.99 79.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.709 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.4 pt? -49.19 -41.78 37.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.588 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 69.6 p -80.54 -35.42 34.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.408 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -57.28 134.93 56.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.845 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -127.1 134.37 50.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.63 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.467 ' CZ2' ' HA2' ' A' ' 34' ' ' GLY . 81.7 t90 -73.42 152.98 40.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.4 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.6 mmt -145.64 -46.25 0.21 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.777 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.9 t -171.25 177.26 3.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.679 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.13 35.53 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.607 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.1 p -179.31 30.63 0.0 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.868 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.6 ttmt -165.38 133.09 3.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.894 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 77.8 mt -151.34 113.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.845 0.355 . . . . 0.0 111.044 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.6 t -82.15 130.72 35.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.182 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.574 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 29.1 p -170.51 153.56 4.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.754 0.312 . . . . 0.0 111.483 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -84.06 136.57 33.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.882 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.691 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 2.5 t -54.0 135.73 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.183 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . -66.9 -119.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.224 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -162.14 143.26 10.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.573 0.225 . . . . 0.0 110.5 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.48 140.47 5.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.928 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -154.62 -47.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.904 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -174.87 173.99 2.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.197 0.523 . . . . 0.0 111.555 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 72' ' ' GLY . 58.0 t0 47.02 40.57 9.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.274 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 71' ' ' LYS . 4.0 mptp? 62.59 -71.72 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.59 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 44' ' ' CYS . . . 175.83 43.1 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.658 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -63.8 132.16 50.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.804 0.335 . . . . 0.0 111.014 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.517 ' O ' HD13 ' A' ' 75' ' ' ILE . 67.9 mt -85.46 129.0 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.533 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 74' ' ' ILE . 41.5 mm -132.76 142.09 43.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.266 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.686 ' H ' ' HA3' ' A' ' 84' ' ' GLY . 6.6 p -141.31 122.52 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.94 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.7 m -87.22 147.7 25.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.37 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.1 p -140.7 140.83 34.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.805 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.548 ' HD2' HD13 ' A' ' 39' ' ' ILE . 14.3 mmmm -51.49 -48.75 62.77 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 82.2 p -68.98 -46.19 68.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.94 -129.52 0.05 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.885 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.03 -39.29 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.052 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -168.38 129.51 1.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.686 ' HA3' ' H ' ' A' ' 76' ' ' VAL . . . -67.67 154.22 52.98 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.204 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 63.3 p -144.22 140.0 29.03 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.608 ' OG ' HG22 ' A' ' 88' ' ' VAL . 42.9 t -154.06 136.41 14.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.99 0.424 . . . . 0.0 111.832 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.9 p -92.71 37.33 1.01 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.173 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.608 HG22 ' OG ' ' A' ' 86' ' ' SER . 33.4 m -148.45 146.61 17.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.9 m -135.11 136.2 41.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.006 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -86.01 133.84 33.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.557 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -85.24 125.51 32.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.494 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.451 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.5 mm? -85.33 133.88 34.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.843 0.354 . . . . 0.0 111.29 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.539 HD12 ' HA2' ' A' ' 18' ' ' GLY . 80.0 mt -108.16 134.22 51.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.614 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -65.52 124.28 86.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.659 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.07 132.74 33.01 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.321 2.014 . . . . 0.0 112.356 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -110.76 102.78 11.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.833 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.337 -0.839 . . . . 0.0 110.936 179.959 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.756 0.312 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 41.3 tpp -173.75 135.27 0.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.937 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -62.12 106.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.998 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -83.56 140.29 41.34 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.19 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HB2' ' HA2' ' A' ' 84' ' ' GLY . 28.9 Cg_endo -62.62 142.93 91.56 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.478 2.119 . . . . 0.0 112.085 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 15.7 Cg_endo -57.32 137.96 84.02 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.614 2.209 . . . . 0.0 112.38 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.488 ' CD1' HG23 ' A' ' 11' ' ' THR . 2.4 tm? -124.88 124.22 41.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.284 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.498 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 68.3 t -86.93 136.88 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.088 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.488 HG23 ' CD1' ' A' ' 9' ' ' LEU . 23.3 p -152.52 45.48 0.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.872 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.67 144.17 6.48 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.206 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.483 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.1 tt -161.16 128.85 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.684 0.278 . . . . 0.0 110.489 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.621 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 47.6 t -61.96 -57.74 22.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.489 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 85.7 Cg_endo -75.95 -156.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.84 1.693 . . . . 0.0 111.804 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -168.96 -30.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.457 . . . . 0.0 110.34 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HB2' HD21 ' A' ' 93' ' ' LEU . 11.6 pt-20 -153.4 130.87 11.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.285 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.449 ' N ' ' HG ' ' A' ' 93' ' ' LEU . . . 177.03 152.32 9.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.846 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.446 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 35.6 pt -52.22 162.73 0.81 Allowed Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 122.338 0.255 . . . . 0.0 111.461 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.637 ' HA ' HG23 ' A' ' 64' ' ' VAL . 86.6 Cg_exo -49.84 -43.92 38.82 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.957 2.438 . . . . 0.0 113.942 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.37 -5.57 29.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.2 m -67.93 127.81 34.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.757 0.313 . . . . 0.0 111.121 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HD2' HG13 ' A' ' 61' ' ' VAL . 39.7 ttpt -72.53 138.62 47.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.36 179.483 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.613 HG12 ' HG3' ' A' ' 15' ' ' PRO . 34.6 m -136.03 127.04 43.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 111.337 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.9 m -87.14 125.46 34.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.275 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 58.8 mt -85.96 139.19 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.909 179.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.486 ' O ' HG13 ' A' ' 10' ' ' VAL . 44.0 mmm-85 -143.13 130.78 21.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.268 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.59 -131.52 1.33 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.598 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -143.69 134.43 25.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.952 0.406 . . . . 0.0 111.698 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.6 m-80 59.88 43.5 14.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.664 178.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.575 HD22 ' O ' ' A' ' 58' ' ' SER . 9.1 mp -83.42 51.09 1.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.947 0.403 . . . . 0.0 110.39 178.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.13 124.8 0.34 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.532 -179.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.7 p -87.58 38.84 0.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 111.343 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 166.75 146.43 4.85 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.626 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.22 -45.77 32.9 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.639 2.226 . . . . 0.0 112.049 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 p -60.59 -37.82 82.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.873 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' A' ' 79' ' ' LYS . 39.1 t70 -58.2 -41.88 84.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.075 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.467 HD11 HD13 ' A' ' 60' ' ' ILE . 1.8 tt -66.62 75.36 0.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.138 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.508 HG21 ' HD3' ' A' ' 79' ' ' LYS . 34.8 pt -76.59 -40.63 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.183 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.437 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -121.76 142.73 15.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.412 -179.018 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.591 HD13 ' N ' ' A' ' 42' ' ' THR . 3.3 tm? -150.0 132.96 16.14 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.591 ' N ' HD13 ' A' ' 41' ' ' LEU . 60.9 p -147.52 127.52 13.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.903 0.383 . . . . 0.0 111.837 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.875 HG21 HG12 ' A' ' 64' ' ' VAL . 72.7 mt -108.19 124.86 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.022 178.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.666 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 67.4 m 54.54 41.25 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.021 0.439 . . . . 0.0 110.459 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.57 34.38 89.75 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.747 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -131.31 132.01 44.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.594 0.235 . . . . 0.0 110.538 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.42 ' HA ' HG22 ' A' ' 42' ' ' THR . 22.6 t-20 -63.3 131.05 47.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.714 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.0 m -154.46 37.58 0.43 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 49' ' ' LEU . 2.2 tm? -72.77 -45.6 57.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 0.0 110.32 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 50' ' ' LEU . 2.5 pt? -55.74 -40.22 72.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.167 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.0 p -80.05 -37.47 33.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.992 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.581 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -58.61 133.9 56.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.351 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -126.92 131.91 51.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.759 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -69.9 151.55 45.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.958 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.0 mmt -142.07 -44.99 0.34 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.02 179.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.6 p -163.34 -164.95 0.99 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.662 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.45 35.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.575 ' O ' HD22 ' A' ' 31' ' ' LEU . 80.8 p -178.96 -43.37 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.364 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -77.63 133.31 38.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.494 -179.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.467 HD13 HD11 ' A' ' 38' ' ' LEU . 68.6 mt -151.33 111.81 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.387 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.411 HG13 ' HD2' ' A' ' 23' ' ' LYS . 60.5 t -80.23 125.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.627 ' SG ' HD11 ' A' ' 43' ' ' ILE . 29.0 p -170.72 131.57 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -87.82 140.4 29.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.875 HG12 HG21 ' A' ' 43' ' ' ILE . 33.4 m -67.3 -147.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.629 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.611 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . 176.06 -40.74 0.11 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.562 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -174.31 136.66 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.954 0.377 . . . . 0.0 111.422 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.666 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -79.6 61.69 3.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.247 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.529 ' HD3' ' O ' ' A' ' 68' ' ' LYS . 12.1 tmtt? -48.96 -43.31 39.75 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.878 0.37 . . . . 0.0 110.042 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -65.65 -107.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.344 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -173.04 -50.81 0.02 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.766 0.317 . . . . 0.0 110.613 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -76.62 -38.32 54.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.8 37.55 5.46 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.333 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.32 135.85 42.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.773 0.32 . . . . 0.0 110.821 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.2 mt -85.67 92.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.176 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.475 ' N ' HD12 ' A' ' 75' ' ' ILE . 1.9 mp -86.67 139.66 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.172 179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.559 HG23 HD23 ' A' ' 41' ' ' LEU . 7.5 p -141.36 125.46 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.813 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.4 m -95.95 144.14 26.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.406 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.9 p -126.48 141.02 52.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.876 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.508 ' HD3' HG21 ' A' ' 39' ' ' ILE . 23.5 tptm -56.98 -48.93 77.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.899 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -67.66 -55.35 13.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.53 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.39 -124.71 0.69 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.178 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.51 -143.32 3.78 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.099 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.75 117.94 13.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 110.58 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 7' ' ' PRO . . . -92.3 -149.92 25.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.522 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.8 p -155.22 -169.21 3.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.66 0.267 . . . . 0.0 110.542 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.0 p -170.85 128.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.913 0.387 . . . . 0.0 111.319 179.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.5 p -76.27 -34.28 59.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.37 178.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 m -84.66 146.32 6.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.345 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.7 m -134.96 134.62 40.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.714 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -89.33 136.67 32.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.664 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -102.55 123.28 46.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.442 179.224 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 92' ' ' LEU . 6.4 mp -85.28 132.08 34.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.93 0.395 . . . . 0.0 111.4 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 17' ' ' GLU . 84.2 mt -90.67 138.09 31.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.242 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 37.6 mtmm -67.45 135.41 93.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.368 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 44.1 Cg_exo -57.24 128.73 30.84 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.394 2.063 . . . . 0.0 112.151 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.36 113.91 9.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.668 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.5 pttm . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.847 179.864 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.8 m170 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.791 0.329 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' A' ' 4' ' ' MET . 1.6 pmm? -61.75 136.8 58.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.655 ' HB3' ' HA2' ' A' ' 81' ' ' GLY . 22.2 tpp180 -61.61 135.01 57.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.638 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -60.99 130.06 90.9 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.998 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.39 138.53 39.23 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.522 2.148 . . . . 0.0 112.13 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 16.9 Cg_endo -58.31 127.73 25.89 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.48 2.12 . . . . 0.0 112.066 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 85' ' ' THR . 64.4 tp -109.91 117.38 33.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.107 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.58 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 89.7 t -83.22 131.31 34.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.776 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.8 p -149.04 47.9 0.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.032 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.04 147.51 8.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.178 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.577 HG12 ' HD2' ' A' ' 15' ' ' PRO . 14.8 tt -161.18 130.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.587 0.232 . . . . 0.0 110.655 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.855 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 44.3 t -63.51 -59.26 12.29 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.31 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.968 ' HG2' HG12 ' A' ' 24' ' ' VAL . 7.3 Cg_exo -71.29 -147.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.93 1.754 . . . . 0.0 111.748 179.032 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -176.4 -25.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.945 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -162.69 129.49 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.129 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 177.48 155.07 13.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.728 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.0 pt -51.14 159.75 0.99 Allowed Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.692 0.282 . . . . 0.0 111.382 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.62 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 86.5 Cg_exo -48.28 -48.28 17.33 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.978 2.452 . . . . 0.0 113.96 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -65.85 -5.69 9.82 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 95.4 m -67.28 126.17 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 111.071 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.625 ' HA ' ' HG2' ' A' ' 63' ' ' ARG . 6.1 ttpm? -71.41 133.19 45.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.618 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.968 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.4 m -131.79 126.1 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 111.007 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.2 m -83.73 125.55 32.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.25 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 60' ' ' ILE . 48.7 mt -82.12 139.21 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.835 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 10' ' ' VAL . 23.2 mmm180 -146.51 132.95 19.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.312 179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -169.21 -130.47 1.2 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.391 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -147.31 132.98 18.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.902 0.382 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 71.5 m-80 61.07 42.55 12.34 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.615 178.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 58' ' ' SER . 8.9 mp -83.13 49.06 1.47 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.939 0.399 . . . . 0.0 110.664 178.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.3 122.73 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.558 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -91.74 42.44 1.1 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.921 0.391 . . . . 0.0 111.177 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.53 146.44 5.52 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.711 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.9 -42.92 62.61 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.588 2.192 . . . . 0.0 111.901 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.3 p -61.96 -32.65 73.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.995 179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -77.84 45.73 0.53 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.048 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.465 HD21 HD23 ' A' ' 41' ' ' LEU . 1.3 tt -162.1 55.44 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.131 0.491 . . . . 0.0 110.005 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.0 pt -66.54 -37.86 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.323 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.41 138.95 15.34 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.9 -179.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.645 HD13 ' N ' ' A' ' 42' ' ' THR . 2.9 tm? -148.42 134.06 18.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.786 0.327 . . . . 0.0 110.134 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.645 ' N ' HD13 ' A' ' 41' ' ' LEU . 19.4 p -147.13 147.16 30.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.463 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.655 HG21 HG12 ' A' ' 64' ' ' VAL . 75.0 mt -128.8 116.19 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.788 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.678 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 69.1 m 70.68 -30.46 0.2 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.982 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.38 -44.18 0.31 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.621 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -80.45 139.48 36.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.856 0.36 . . . . 0.0 111.237 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.442 ' HA ' HG22 ' A' ' 42' ' ' THR . 5.3 m120 -60.85 143.53 54.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.965 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.8 m -145.5 39.09 1.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.599 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.6 tp -70.94 -43.4 68.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.136 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 50' ' ' LEU . 2.6 pt? -55.91 -41.24 74.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.157 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.3 p -79.87 -34.34 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.793 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 61' ' ' VAL . . . -58.48 134.17 56.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.285 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -126.27 122.06 34.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.389 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -70.81 147.15 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 56.3 mtt -149.22 -41.36 0.15 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.15 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.6 p -157.47 175.18 14.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.69 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.75 42.03 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.358 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.506 ' O ' HD22 ' A' ' 31' ' ' LEU . 43.8 t -175.93 -40.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.077 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -85.53 133.23 34.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.231 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 74.9 mt -150.72 115.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.648 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 52' ' ' ALA . 64.3 t -82.01 124.15 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.947 179.689 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.653 ' SG ' HD11 ' A' ' 43' ' ' ILE . 22.6 p -171.19 132.01 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.917 0.389 . . . . 0.0 111.26 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.625 ' HG2' ' HA ' ' A' ' 23' ' ' LYS . 98.3 mtt180 -85.93 140.68 30.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.139 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.655 HG12 HG21 ' A' ' 43' ' ' ILE . 34.6 m -66.76 -149.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.547 179.525 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.62 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . 179.69 -48.03 0.08 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.653 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -177.53 137.67 0.21 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.23 0.515 . . . . 0.0 111.842 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.678 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -70.25 145.47 51.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.16 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.475 ' HB2' ' HA3' ' A' ' 45' ' ' GLY . 29.0 mtpp -147.17 -46.32 0.17 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.418 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -62.74 -46.49 87.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.561 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -169.17 -40.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.616 0.246 . . . . 0.0 111.35 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.595 ' HB3' ' NZ ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -160.11 -42.66 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.372 -179.746 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.84 39.9 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.896 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.8 127.87 34.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.694 0.283 . . . . 0.0 110.856 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.465 ' O ' HD13 ' A' ' 75' ' ' ILE . 65.2 mt -85.81 135.68 24.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.689 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 74' ' ' ILE . 50.4 mm -134.16 139.65 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 111.153 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.6 122.81 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.72 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.7 m -92.02 143.37 26.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.298 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.9 p -134.41 136.56 43.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.056 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -57.61 -47.67 81.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.182 -179.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 88.5 p -64.73 -54.8 25.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.658 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.655 ' HA2' ' HB3' ' A' ' 5' ' ' ARG . . . -86.7 -123.21 1.57 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.421 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.8 -139.03 2.54 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.996 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.576 ' NZ ' ' HB2' ' A' ' 83' ' ' LYS . 4.8 ttmp? -62.45 126.57 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 110.794 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.74 134.69 13.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.802 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 79.8 p -99.31 145.54 27.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.553 0.215 . . . . 0.0 110.684 179.498 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.0 p -141.8 122.05 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.333 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.6 p -93.08 32.97 1.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.399 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.0 m -150.94 150.79 13.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.605 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.0 p -142.99 134.85 26.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.966 0.412 . . . . 0.0 111.217 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.5 ' HD2' HG11 ' A' ' 64' ' ' VAL . 60.1 t80 -85.67 128.16 34.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.817 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -85.0 121.03 27.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.562 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 92' ' ' LEU . 6.8 mp -89.98 128.16 36.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.864 0.364 . . . . 0.0 111.293 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.425 HD12 ' HA2' ' A' ' 18' ' ' GLY . 82.7 mt -85.51 141.51 29.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.735 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.41 ' HD3' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.06 134.42 95.79 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.876 179.848 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.47 132.74 53.96 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.528 2.152 . . . . 0.0 112.555 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -72.09 115.05 10.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.559 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.8 pttt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.001 -179.888 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.823 0.344 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.556 ' HG3' ' H ' ' A' ' 5' ' ' ARG . 40.9 tpp -71.43 -131.86 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.42 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.556 ' H ' ' HG3' ' A' ' 4' ' ' MET . 1.0 OUTLIER 52.45 42.97 31.4 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.865 0.364 . . . . 0.0 110.964 179.84 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -64.57 133.13 95.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.041 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.91 143.93 74.83 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.526 2.15 . . . . 0.0 111.99 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.497 ' HB3' ' HA ' ' A' ' 31' ' ' LEU . 67.4 Cg_exo -50.7 142.49 31.82 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.584 2.189 . . . . 0.0 112.43 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 85' ' ' THR . 63.2 tp -142.9 98.39 3.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.871 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.566 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 59.6 t -73.01 134.09 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.018 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.6 p -148.88 44.67 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.994 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.81 142.77 5.31 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.776 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.515 HG12 ' HD2' ' A' ' 15' ' ' PRO . 18.1 tt -164.67 131.33 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.743 0.306 . . . . 0.0 110.931 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.796 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.7 t -68.05 -58.28 8.03 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.855 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.819 ' HG2' HG12 ' A' ' 24' ' ' VAL . 92.0 Cg_endo -92.18 123.8 0.68 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.329 2.019 . . . . 0.0 112.262 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -81.72 -20.66 38.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 91' ' ' LYS . 11.0 pt-20 -157.48 138.71 13.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 111.409 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.454 ' O ' HD12 ' A' ' 92' ' ' LEU . . . 178.45 151.76 9.76 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.419 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.517 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 38.4 pt -52.14 163.66 0.68 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.671 0.236 . . . . 0.0 111.15 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.727 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 76.4 Cg_exo -49.08 -47.0 23.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.533 2.155 . . . . 0.0 113.944 -178.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -72.68 -14.65 61.62 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.423 ' OG1' HG12 ' A' ' 19' ' ' ILE . 99.8 m -55.11 122.52 11.17 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.599 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -61.0 136.44 58.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.578 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.819 HG12 ' HG2' ' A' ' 15' ' ' PRO . 34.8 m -137.01 122.12 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.099 0.476 . . . . 0.0 111.129 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.0 m -83.84 113.5 20.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.523 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.611 HD12 ' HB ' ' A' ' 60' ' ' ILE . 62.9 mt -79.13 138.61 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.053 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.436 ' O ' HG13 ' A' ' 10' ' ' VAL . 20.6 mmt85 -144.92 129.44 17.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.276 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 10' ' ' VAL . . . -170.62 -134.93 1.83 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.617 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 5.6 mm-40 -150.31 133.79 16.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.915 0.388 . . . . 0.0 111.422 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 57.87 41.9 24.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.069 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.497 ' HA ' ' HB3' ' A' ' 8' ' ' PRO . 10.6 mp -67.52 -38.51 84.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.74 0.305 . . . . 0.0 110.879 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.04 132.64 1.99 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.699 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.0 p -62.12 -35.69 79.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.44 172.48 39.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.375 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.47 -44.59 45.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.605 2.204 . . . . 0.0 112.273 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.8 p -62.74 -39.27 93.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.092 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.536 ' HA ' ' HD3' ' A' ' 79' ' ' LYS . 8.0 t70 -57.66 -40.63 79.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.034 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 tt -75.28 66.75 1.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.265 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.416 ' O ' HD22 ' A' ' 49' ' ' LEU . 36.3 pt -73.27 -33.71 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.96 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -126.3 140.54 12.14 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.531 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 48' ' ' CYS . 53.9 tp -148.72 144.17 26.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.731 0.301 . . . . 0.0 110.57 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 41' ' ' LEU . 11.5 p -161.33 142.15 11.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.286 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.455 HG13 ' SG ' ' A' ' 48' ' ' CYS . 63.9 mt -127.12 115.51 41.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.72 178.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 48.2 t 74.04 -35.79 0.32 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.695 -178.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 164.97 -36.15 0.28 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.509 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.45 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 83.4 t60 -77.69 139.82 39.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.899 0.381 . . . . 0.0 111.558 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -66.73 151.92 46.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.962 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.567 ' O ' HD23 ' A' ' 41' ' ' LEU . 3.0 p -159.66 45.11 0.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.367 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 39' ' ' ILE . 52.9 tp -88.34 -46.24 9.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.568 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -54.8 -39.76 68.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.871 -179.025 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.3 p -80.25 -38.15 31.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.789 0.328 . . . . 0.0 111.681 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.565 ' HA ' ' HB3' ' A' ' 62' ' ' CYS . . . -60.01 135.99 57.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.016 0.436 . . . . 0.0 111.709 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -123.13 127.85 49.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.591 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 66.4 t90 -69.29 146.09 52.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.887 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.473 ' SD ' HG23 ' A' ' 61' ' ' VAL . 87.5 mtp -143.44 -42.23 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.702 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.492 ' C ' ' H ' ' A' ' 58' ' ' SER . 81.2 p -167.11 164.31 15.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.301 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.93 27.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.497 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.8 m -167.33 27.27 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.816 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 40.5 ttmt -164.92 130.14 2.64 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.926 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.611 ' HB ' HD12 ' A' ' 26' ' ' ILE . 72.4 mt -151.16 118.84 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.473 HG23 ' SD ' ' A' ' 55' ' ' MET . 92.2 t -90.15 129.22 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.003 179.053 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 52' ' ' ALA . 30.2 p -170.54 151.5 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.322 . . . . 0.0 111.492 -179.144 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.2 134.44 34.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.275 179.136 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.727 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t -57.29 128.47 17.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.759 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 46' ' ' HIS . . . -83.8 61.4 4.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.938 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.495 ' H ' ' HB3' ' A' ' 20' ' ' PRO . 19.3 pt20 43.07 -141.39 0.15 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 122.249 0.219 . . . . 0.0 111.31 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.09 119.78 5.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.954 0.407 . . . . 0.0 111.167 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.69 -35.07 30.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.779 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -139.02 -129.27 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.6 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -150.97 48.61 0.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.16 0.505 . . . . 0.0 110.3 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.604 ' HB2' ' NZ ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -82.95 -42.55 17.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.284 -179.805 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.72 72.05 0.75 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.217 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.58 ' HB3' ' HE3' ' A' ' 71' ' ' LYS . 9.4 t0 -161.46 127.8 3.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.861 0.362 . . . . 0.0 110.604 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.53 92.54 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.02 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.3 mm -84.18 139.36 17.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.742 -179.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 41' ' ' LEU . 46.0 t -141.31 114.3 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.856 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.1 m -81.31 144.3 31.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.913 0.387 . . . . 0.0 111.526 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.2 p -136.8 135.07 37.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.69 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.536 ' HD3' ' HA ' ' A' ' 37' ' ' ASP . 28.3 mtpp -52.74 -47.19 67.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.855 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.8 m -68.33 -48.54 64.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.055 0.455 . . . . 0.0 110.112 179.103 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.27 -121.96 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.542 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.58 -33.9 0.04 OUTLIER Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.4 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -168.89 125.07 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 0.0 110.556 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.09 130.61 9.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.93 -0.653 . . . . 0.0 113.132 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 75.7 p -100.99 147.17 26.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.574 0.226 . . . . 0.0 110.767 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 53.2 p -149.95 126.96 11.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.051 0.453 . . . . 0.0 111.37 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.7 p -78.85 -30.33 45.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.017 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.8 m -83.68 141.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.212 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.7 m -121.69 142.98 49.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.108 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.478 ' CE2' HG21 ' A' ' 64' ' ' VAL . 63.1 t80 -97.91 106.98 19.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.234 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 57.4 tttm -70.31 117.41 11.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.215 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.51 HD11 ' CD ' ' A' ' 20' ' ' PRO . 45.4 tp -80.62 132.39 35.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.742 -178.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.415 HD11 ' HG3' ' A' ' 17' ' ' GLU . 84.0 mt -102.78 131.69 49.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.375 179.189 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 60.2 mttp -73.1 131.57 83.39 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.773 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 49.2 Cg_exo -57.52 131.48 44.72 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.581 2.187 . . . . 0.0 112.727 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -72.92 115.59 12.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.518 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.1 tptt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.959 -179.902 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.456 ' O ' ' HB3' ' A' ' 4' ' ' MET . 47.5 m170 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.547 0.213 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.456 ' HB3' ' O ' ' A' ' 3' ' ' HIS . 48.2 tpp 73.56 -41.08 0.48 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.682 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -168.97 140.65 2.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 110.764 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -59.28 133.51 88.05 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.085 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.78 146.75 95.16 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.673 2.248 . . . . 0.0 112.069 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 13.6 Cg_endo -57.17 123.28 13.45 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.424 2.083 . . . . 0.0 112.212 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.5 tp -103.27 121.2 42.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.97 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' A' ' 86' ' ' SER . 62.4 t -95.31 136.48 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.731 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 t -169.51 51.11 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.078 0.466 . . . . 0.0 111.305 -179.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.93 143.41 7.27 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.418 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.511 HG12 ' HD2' ' A' ' 15' ' ' PRO . 16.4 tt -160.05 130.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.713 0.292 . . . . 0.0 110.967 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.787 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 46.9 t -66.39 -58.73 9.71 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.607 179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 67.9 Cg_endo -89.22 115.56 0.7 Allowed 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.146 1.897 . . . . 0.0 112.102 179.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -99.1 27.55 5.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.923 0.392 . . . . 0.0 110.632 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' A' ' 93' ' ' LEU . 11.7 pt-20 178.61 131.03 0.07 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.454 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.97 150.59 6.77 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.786 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.443 ' HB ' ' HD2' ' A' ' 20' ' ' PRO . 36.3 pt -57.0 162.34 3.89 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 120.473 0.178 . . . . 0.0 111.057 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.666 ' HA ' HG23 ' A' ' 64' ' ' VAL . 85.7 Cg_exo -48.96 -46.68 24.23 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.978 2.452 . . . . 0.0 114.019 -178.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' O ' ' HD2' ' A' ' 63' ' ' ARG . 94.6 m95 -69.99 -5.96 29.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.4 m -72.96 127.56 32.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 110.818 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -74.38 125.29 28.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.809 179.904 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG12 ' HG2' ' A' ' 15' ' ' PRO . 23.7 m -108.38 127.6 64.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.084 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.4 m -78.87 119.49 22.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.332 -179.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 61.8 mt -85.28 140.73 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.411 179.255 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -146.55 136.74 23.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.342 . . . . 0.0 110.872 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.99 -128.42 1.04 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.413 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -143.96 129.58 19.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.0 111.266 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.491 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 74.5 m-80 58.66 47.56 12.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.108 179.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.8 mp -81.18 53.21 1.97 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.868 0.366 . . . . 0.0 111.02 179.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 37' ' ' ASP . . . 83.86 135.32 2.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.796 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 77.7 p -62.98 -40.77 98.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.656 0.265 . . . . 0.0 111.376 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 54' ' ' TRP . . . -161.35 -159.46 10.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.932 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -65.85 -48.22 3.11 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.728 2.285 . . . . 0.0 112.528 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -60.31 -39.52 87.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.695 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 38.8 t70 -63.19 -47.08 84.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.616 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 39' ' ' ILE . 2.3 tt -66.96 129.16 38.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.773 179.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.587 HD13 ' HD2' ' A' ' 79' ' ' LYS . 29.7 pt -137.23 -44.68 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.22 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.485 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -98.67 136.59 12.78 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.309 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.655 HD13 ' N ' ' A' ' 42' ' ' THR . 1.9 tm? -149.43 132.41 16.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.76 0.314 . . . . 0.0 110.195 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.655 ' N ' HD13 ' A' ' 41' ' ' LEU . 16.5 p -151.62 148.79 28.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.489 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.884 HG21 HG12 ' A' ' 64' ' ' VAL . 77.2 mt -133.14 114.33 21.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.584 179.14 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.625 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 66.7 m 73.36 -38.56 0.41 Allowed 'General case' 0 CA--C 1.531 0.212 0 O-C-N 123.488 0.493 . . . . 0.0 110.545 -178.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . 171.45 -41.97 0.18 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.631 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.846 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 25.2 p-80 -78.75 135.74 37.2 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.841 0.353 . . . . 0.0 111.14 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.523 ' HA ' HG22 ' A' ' 42' ' ' THR . 4.9 m120 -61.21 141.62 57.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.2 m -139.98 38.43 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.564 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 39' ' ' ILE . 53.5 tp -71.51 -43.77 65.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.353 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.5 pt? -53.57 -42.94 68.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.477 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.3 p -80.47 -37.83 31.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.714 0.292 . . . . 0.0 111.443 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' CB ' ' HG ' ' A' ' 41' ' ' LEU . . . -60.47 129.17 40.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.032 0.444 . . . . 0.0 111.66 -179.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -126.67 132.1 51.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.213 179.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.564 ' CE2' ' HA2' ' A' ' 34' ' ' GLY . 54.3 t90 -63.99 149.89 46.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.376 . . . . 0.0 111.019 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 93.4 mmm -143.78 -45.88 0.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.632 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 58' ' ' SER . 70.8 m -163.63 162.06 24.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.474 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.48 36.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.35 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 56' ' ' SER . 78.1 p -175.24 20.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.153 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.1 tttm -165.19 131.68 2.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.487 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.3 mt -147.53 122.2 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.792 0.33 . . . . 0.0 110.998 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.4 t -83.82 133.76 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.941 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.529 ' SG ' HD11 ' A' ' 43' ' ' ILE . 29.9 p -170.53 132.92 0.99 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.84 0.352 . . . . 0.0 110.919 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 77.6 mtm180 -85.0 134.62 34.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.884 HG12 HG21 ' A' ' 43' ' ' ILE . 27.8 m -70.94 -148.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.399 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 20' ' ' PRO . . . 179.81 -52.91 0.09 OUTLIER Glycine 0 C--N 1.335 0.476 0 C-N-CA 119.88 -1.152 . . . . 0.0 113.494 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -177.17 136.85 0.21 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.101 0.45 . . . . 0.0 111.745 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.625 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -83.52 123.4 29.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.784 179.128 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.846 ' HE3' ' HB3' ' A' ' 46' ' ' HIS . 99.3 mttt -83.14 -54.48 5.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.409 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 73.1 m-20 -67.04 -68.32 0.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.847 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 69' ' ' ASN . 64.8 t0 177.09 -51.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.306 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HD3' ' OD1' ' A' ' 73' ' ' ASP . 49.9 tttp -76.69 -121.4 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.293 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.84 46.55 0.05 OUTLIER Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.538 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.48 ' OD1' ' HD3' ' A' ' 71' ' ' LYS . 1.6 m-20 -63.88 128.53 36.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 111.413 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.406 ' O ' HD13 ' A' ' 75' ' ' ILE . 66.8 mt -85.91 137.21 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.732 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.406 HD13 ' O ' ' A' ' 74' ' ' ILE . 48.4 mm -134.22 142.23 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.917 0.389 . . . . 0.0 111.388 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.82 128.74 23.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.636 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.565 HG23 ' HA2' ' A' ' 82' ' ' GLY . 24.6 m -102.22 140.13 36.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.42 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.6 p -122.01 149.31 43.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.587 ' HD2' HD13 ' A' ' 39' ' ' ILE . 14.5 mmmm -51.18 -51.4 54.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.204 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.0 m -69.92 -54.47 13.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.627 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.74 -131.03 2.59 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.28 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.565 ' HA2' HG23 ' A' ' 77' ' ' THR . . . -171.83 -143.04 3.92 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.851 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -67.69 117.79 10.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 110.688 179.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.77 -133.42 2.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.735 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 86' ' ' SER . 0.0 OUTLIER -160.21 -176.64 5.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.002 0.43 . . . . 0.0 110.946 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.649 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 79.4 p -169.27 123.88 0.83 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.527 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.1 p -95.03 33.55 1.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.185 178.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.3 m -152.18 152.8 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.537 -179.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.0 p -143.93 141.96 30.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.049 0.452 . . . . 0.0 111.209 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -85.0 131.94 34.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.25 -179.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.745 ' HE2' HD21 ' A' ' 93' ' ' LEU . 6.0 ttpm? -81.58 120.78 25.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.657 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.466 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -81.71 130.93 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.823 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.745 HD21 ' HE2' ' A' ' 91' ' ' LYS . 79.8 mt -107.0 145.2 32.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.233 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -61.26 131.73 92.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.778 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.97 135.48 41.09 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.584 2.19 . . . . 0.0 112.406 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -70.5 77.18 0.57 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.124 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.774 179.958 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.428 ' NE2' ' HG2' ' A' ' 4' ' ' MET . 18.9 p-80 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.71 0.29 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.428 ' HG2' ' NE2' ' A' ' 3' ' ' HIS . 92.9 mmm -69.95 -145.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.287 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.408 ' H ' ' HB3' ' A' ' 4' ' ' MET . 56.1 ttp180 -175.76 134.16 0.28 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.478 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.428 ' NE2' ' N ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -141.02 141.48 24.12 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.986 -179.716 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 13.7 Cg_endo -57.03 145.91 83.37 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.749 2.3 . . . . 0.0 112.265 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 52.6 Cg_exo -54.08 138.86 71.36 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.534 2.156 . . . . 0.0 112.342 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 85' ' ' THR . 5.6 tt -133.74 111.77 10.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.323 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 86' ' ' SER . 83.9 t -83.75 140.51 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.918 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 t -162.68 46.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.028 0.442 . . . . 0.0 110.793 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.1 142.3 5.96 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.858 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.524 HG12 ' HD2' ' A' ' 15' ' ' PRO . 13.2 tt -164.07 128.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.659 0.266 . . . . 0.0 110.457 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.781 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 45.9 t -63.62 -58.64 14.39 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.83 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 14' ' ' SER . 94.0 Cg_endo -89.47 107.29 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.21 1.94 . . . . 0.0 112.188 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -91.03 26.41 2.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 110.587 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' A' ' 93' ' ' LEU . 12.4 pt-20 179.5 130.01 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.287 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.459 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . 166.99 148.19 5.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.568 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.0 pt -52.2 154.01 4.47 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.537 0.208 . . . . 0.0 110.786 179.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.677 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 84.2 Cg_exo -47.26 -37.6 24.56 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.018 2.478 . . . . 0.0 113.792 -178.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -73.44 -23.32 60.09 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 m -57.99 128.55 37.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 110.964 -179.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.87 129.84 41.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.538 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.702 HG12 ' HG2' ' A' ' 15' ' ' PRO . 26.8 m -121.4 125.1 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 111.013 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.4 m -75.84 116.89 17.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.921 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 61.5 mt -83.04 136.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.67 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 58' ' ' SER . 29.3 tpt180 -141.49 133.41 27.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.334 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.45 -134.04 1.69 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.48 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -150.25 132.24 15.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.944 0.402 . . . . 0.0 111.281 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.456 ' O ' ' HG3' ' A' ' 8' ' ' PRO . 72.3 m-80 59.3 46.47 12.69 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.673 178.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.4 mp -81.78 52.15 1.86 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 110.694 178.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.06 126.69 0.14 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.419 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.7 p -90.77 42.27 1.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.694 0.283 . . . . 0.0 111.563 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 171.52 145.81 5.0 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.792 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 -46.38 27.61 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.394 2.063 . . . . 0.0 111.709 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.5 t -62.05 -36.06 80.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.072 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.14 -36.18 67.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.031 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 tt -75.57 61.09 1.28 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.488 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.593 HD13 ' HG2' ' A' ' 79' ' ' LYS . 30.7 pt -68.98 -40.1 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.435 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.422 ' N ' HG13 ' A' ' 39' ' ' ILE . . . -110.48 139.75 15.61 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.957 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 42' ' ' THR . 3.0 tm? -148.26 132.06 17.01 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.626 ' N ' HD13 ' A' ' 41' ' ' LEU . 24.0 p -150.51 140.94 22.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.162 0.506 . . . . 0.0 111.843 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.3 mt -137.4 125.79 33.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.573 178.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.522 ' SG ' HD21 ' A' ' 92' ' ' LEU . 69.2 m 58.43 37.98 25.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.163 0.506 . . . . 0.0 110.1 -179.004 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.89 25.31 71.88 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.958 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -131.85 125.33 31.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.54 0.209 . . . . 0.0 110.521 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -63.11 138.17 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.779 0.324 . . . . 0.0 110.633 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.0 m -148.84 39.38 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.684 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 39' ' ' ILE . 58.3 tp -69.69 -44.55 70.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.266 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.4 pt? -50.66 -44.16 57.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.297 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.457 HG23 ' HG ' ' A' ' 50' ' ' LEU . 71.8 p -80.77 -37.83 29.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 111.134 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 62' ' ' CYS . . . -60.44 130.31 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.718 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -126.82 129.36 48.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.514 179.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 80.8 t90 -64.57 145.92 55.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.618 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.3 mmm -140.14 -45.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 58' ' ' SER . 65.7 m -164.05 160.27 21.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.65 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.39 27.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.838 0.352 . . . . 0.0 111.396 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 56' ' ' SER . 68.3 m -168.03 19.49 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.833 179.341 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.3 tttp -165.19 130.8 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.511 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 68.5 mt -148.84 119.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.952 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.6 p -85.32 134.71 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.555 179.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 45.9 t -170.67 152.84 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.277 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -83.79 135.25 34.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.001 179.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.677 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.6 t -56.64 135.82 20.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.625 -178.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.29 -110.3 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.929 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -165.9 139.29 4.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.562 0.22 . . . . 0.0 110.477 179.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.461 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . . . -61.51 78.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.031 -179.195 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -66.75 -50.81 61.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.746 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -77.84 -71.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.833 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 t70 178.29 -47.18 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.118 179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -78.22 -122.78 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.825 -179.81 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.39 40.92 0.07 OUTLIER Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.81 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -66.06 130.69 44.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.708 0.289 . . . . 0.0 111.129 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.422 ' O ' HD13 ' A' ' 75' ' ' ILE . 68.8 mt -85.06 131.61 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.355 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 74' ' ' ILE . 39.9 mm -127.4 139.93 50.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.402 -179.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -139.63 120.94 15.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.624 179.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.9 m -94.07 142.47 27.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.2 p -136.92 136.57 38.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.593 ' HG2' HD13 ' A' ' 39' ' ' ILE . 28.3 mtpp -55.96 -50.62 70.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.018 -179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.0 m -67.52 -54.59 18.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.323 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.21 -125.22 0.46 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.108 179.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.55 -141.69 3.22 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.469 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -63.9 128.99 38.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.82 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.11 128.31 8.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.775 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 81.4 p -103.63 148.55 25.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.626 0.25 . . . . 0.0 110.829 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.608 ' HB2' ' HB ' ' A' ' 10' ' ' VAL . 40.4 t -154.48 127.82 8.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 111.661 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.4 p -77.55 -32.98 54.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.423 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.6 m -84.47 148.66 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.494 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.3 m -139.29 140.35 37.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.549 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.416 ' CD2' HG11 ' A' ' 64' ' ' VAL . 62.3 t80 -85.05 131.74 34.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.35 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.461 ' HE3' HD21 ' A' ' 93' ' ' LEU . 38.9 ttpt -84.34 122.27 28.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.595 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.522 HD21 ' SG ' ' A' ' 44' ' ' CYS . 3.4 mm? -78.59 131.64 36.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.241 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 17' ' ' GLU . 73.6 mt -108.27 137.45 46.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.585 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 62.0 tttp -61.62 128.58 90.36 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.812 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 94' ' ' LYS . 47.8 Cg_exo -57.54 131.48 44.7 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.537 2.158 . . . . 0.0 112.45 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.1 114.81 10.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.416 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.3 pttt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.88 -179.973 . . . . . . . . 0 0 . 1 stop_ save_